data_2jq6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jq6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.2 t . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 113.157 0.799 . . . . 1.72 113.157 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.0 -24.17 11.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 121.329 -0.857 . . . . 1.3200000000000001 112.143 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.98 -13.39 26.45 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.174 -1.012 . . . . 0.71999999999999997 112.452 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.449 ' HE2' ' HB3' ' A' ' 48' ' ' LYS . 7.8 ptpt -112.03 -0.96 15.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 112.745 0.646 . . . . 3.3799999999999999 112.745 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -133.77 2.16 3.4 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.367 0.603 . . . . 1.8300000000000001 110.666 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.444 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 63.5 tttm -54.83 -46.14 99.55 Favored Pre-proline 0 C--O 1.222 -0.386 0 CA-C-N 115.691 -0.686 . . . . 1.73 111.166 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 55.2 Cg_exo -42.47 -33.24 2.59 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 123.074 2.516 . . . . 0.80000000000000004 113.993 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.677 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 25.6 m -73.8 -48.38 31.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.097 0.951 . . . . 1.29 110.022 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.541 ' CD1' ' HB3' ' A' ' 110' ' ' ASN . 7.4 m-85 -76.17 -25.11 54.9 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.47 -0.786 . . . . 1.4299999999999999 110.149 -175.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.588 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 18.3 t70 -82.55 -33.41 28.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.632 -1.167 . . . . 1.1599999999999999 109.637 -176.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.677 ' HG3' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -69.28 -39.41 78.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.331 -0.618 . . . . 1.6299999999999999 109.331 175.742 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.633 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 60.3 mt -69.03 -32.0 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.254 -0.647 . . . . 1.27 109.254 175.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 70.4 t80 -55.64 -52.87 62.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.168 -0.924 . . . . 1.51 110.952 175.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.725 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 82.6 m-85 -75.12 -22.45 58.19 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.941 0.401 . . . . 1.6799999999999999 110.916 177.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.633 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 10.4 m -70.19 -32.64 70.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 1.1799999999999999 111.043 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.466 HD12 ' HG2' ' A' ' 75' ' ' GLU . 63.8 mt -83.6 -8.53 59.29 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.219 -0.289 . . . . 1.3600000000000001 110.219 176.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.6 t 72.89 96.65 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.463 -0.79 . . . . 1.22 111.287 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.725 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 61.5 Cg_endo -83.52 172.27 10.43 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.588 2.192 . . . . 0.57999999999999996 112.28 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.0 t -136.06 114.37 15.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.234 -0.654 . . . . 1.9199999999999999 109.234 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.1 m120 70.31 23.76 4.95 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.133 0.492 . . . . 2.0899999999999999 111.58 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.47 25.21 19.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.954 -0.641 . . . . 0.56999999999999995 112.661 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.615 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -168.5 154.27 6.79 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.6 -0.889 . . . . 2.3300000000000001 108.6 175.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.912 ' HB ' HD22 ' A' ' 71' ' ' ASN . 3.1 pt -86.58 137.19 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 120.316 -0.554 . . . . 1.1799999999999999 110.21 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.8 p -60.3 130.7 47.94 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 107.352 -1.351 . . . . 1.2 107.352 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.659 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -50.98 -25.75 10.31 Favored Glycine 0 C--O 1.22 -0.742 0 C-N-CA 120.682 -0.771 . . . . 0.59999999999999998 113.784 -172.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.48 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -46.92 -55.77 7.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.139 0.47 . . . . 1.1699999999999999 111.467 173.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.912 HD22 ' HB ' ' A' ' 67' ' ' ILE . 9.5 p30 -72.96 -27.07 61.61 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.87 0.367 . . . . 2.1099999999999999 110.545 -175.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.709 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -68.92 -37.29 78.84 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.392 -0.596 . . . . 1.2 109.392 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.9 mmmm -67.72 -38.77 84.04 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.174 -0.921 . . . . 2.3100000000000001 109.843 177.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.79 ' HG2' ' HA ' ' A' ' 71' ' ' ASN . 10.4 mmmm -56.23 -50.6 70.83 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.654 0.74 . . . . 1.6799999999999999 109.655 175.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -55.9 -52.81 62.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.972 -1.467 . . . . 1.48 111.445 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.709 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 12.8 ptp -73.45 -21.88 60.34 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.107 -0.371 . . . . 0.84999999999999998 111.752 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.41 -45.71 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.787 0.327 . . . . 1.25 110.462 174.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 15.2 ptpt -70.83 -14.82 62.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.257 0.551 . . . . 1.79 110.1 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 76' ' ' MET . 67.6 m -63.94 -1.59 1.52 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.563 -0.744 . . . . 1.9399999999999999 111.583 171.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 71.24 72.07 0.18 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.621 0.769 . . . . 3.1200000000000001 111.434 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.829 HD13 ' HE2' ' A' ' 116' ' ' LYS . 29.1 mt -142.77 161.36 49.51 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.934 -0.576 . . . . 1.71 111.782 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -82.56 168.54 14.39 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.093 2.529 . . . . 1.03 110.198 166.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.75 -18.15 63.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.83 0.347 . . . . 1.53 111.5 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -64.63 -67.83 0.4 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.961 -0.563 . . . . 1.75 110.863 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.55 ' O ' HG13 ' A' ' 89' ' ' ILE . 39.8 t -60.64 -44.58 97.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 115.811 -0.631 . . . . 1.28 110.297 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.54 HD13 ' HG3' ' A' ' 76' ' ' MET . 22.7 tp -55.52 -51.35 67.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.325 -0.852 . . . . 2.0699999999999998 111.443 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.36 -43.19 97.54 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.789 -0.641 . . . . 0.45000000000000001 111.967 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.816 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 56.4 pttt -80.39 -16.45 54.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.562 -0.855 . . . . 2.1899999999999999 111.754 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.643 HD11 ' HD3' ' A' ' 116' ' ' LYS . 13.5 mt -71.8 -46.32 61.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.857 -0.794 . . . . 1.8200000000000001 108.857 171.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -56.06 -53.24 59.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.755 -0.657 . . . . 0.35999999999999999 111.212 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.816 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -73.03 -14.31 61.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.117 -0.492 . . . . 2.9500000000000002 112.128 -174.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.607 HD23 HD12 ' A' ' 112' ' ' LEU . 13.6 tp -93.41 -23.89 18.25 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.662 -0.415 . . . . 1.5 110.488 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.706 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -89.04 -42.9 11.48 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.797 0.332 . . . . 1.1499999999999999 111.376 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.507 ' HB2' HD22 ' A' ' 101' ' ' LEU . 55.3 t0 -92.57 105.54 17.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.759 -0.46 . . . . 0.62 109.759 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.5 t -73.09 -27.4 24.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.595 -0.729 . . . . 2.27 111.262 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.16 -26.48 22.41 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.109 -0.496 . . . . 1.7 109.677 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.9 mttt 60.22 58.83 2.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.955 -1.02 . . . . 2.2599999999999998 109.364 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.47 ' HB2' ' HG ' ' A' ' 100' ' ' LEU . 6.4 m-20 -83.57 -35.2 24.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.024 -1.444 . . . . 1.51 111.629 -170.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.72 16.41 33.87 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 109.889 -1.284 . . . . 0.34000000000000002 109.889 -164.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.486 HD13 ' HG3' ' A' ' 66' ' ' LYS . 4.2 pp -153.32 177.01 11.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.379 -0.971 . . . . 1.23 108.379 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.614 ' O ' HG12 ' A' ' 67' ' ' ILE . 46.4 mt -151.74 120.37 6.5 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.231 -1.396 . . . . 1.3700000000000001 107.231 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.418 ' HA ' ' CB ' ' A' ' 66' ' ' LYS . 2.7 p30 -80.96 -175.75 5.55 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.499 -0.881 . . . . 1.5 110.176 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -57.95 -32.52 67.9 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 111.738 0.273 . . . . 1.73 111.738 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 4.0 tp10 -87.33 -27.92 22.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.319 0.581 . . . . 2.1400000000000001 110.029 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.537 ' HB3' HD21 ' A' ' 101' ' ' LEU . 1.1 mt-10 -74.75 -27.91 60.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.05 -0.523 . . . . 1.1100000000000001 110.656 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.672 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -73.61 -36.06 65.44 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.439 -1.319 . . . . 1.8600000000000001 107.439 169.219 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.524 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -56.37 -45.77 80.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.02 -0.537 . . . . 1.02 110.286 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.716 HD11 ' HD3' ' A' ' 132' ' ' PRO . 3.5 tt -71.27 -48.6 49.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.931 -0.577 . . . . 1.8200000000000001 110.278 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.535 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -46.53 -56.25 6.3 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.531 0.519 . . . . 1.0700000000000001 111.138 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.541 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 11.1 t-20 -73.32 -23.98 60.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.601 -0.727 . . . . 1.8899999999999999 110.379 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.596 ' O ' HG21 ' A' ' 115' ' ' VAL . 65.7 t60 -69.76 -41.94 74.52 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.357 -0.609 . . . . 0.59999999999999998 109.357 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.613 HD21 HD23 ' A' ' 122' ' ' LEU . 30.2 mt -73.71 -27.32 61.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.187 -0.461 . . . . 1.23 110.436 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 109' ' ' ALA . 68.7 mt -60.97 -45.46 98.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.464 -0.335 . . . . 1.49 111.021 172.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.463 ' HE3' ' HE1' ' A' ' 53' ' ' TYR . 17.4 ptpt -75.35 -21.18 58.54 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.687 -0.805 . . . . 2.6699999999999999 111.488 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.596 HG21 ' O ' ' A' ' 111' ' ' HIS . 40.1 t -68.43 -43.27 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.471 0.177 . . . . 1.23 110.706 173.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.829 ' HE2' HD13 ' A' ' 81' ' ' LEU . 16.0 pttp -69.12 -28.26 66.3 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.291 -0.633 . . . . 2.4199999999999999 109.291 174.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.1 tt -69.61 -24.28 63.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.53 -0.759 . . . . 1.8200000000000001 110.248 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 6.5 mm-40 -59.02 -13.23 6.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.573 -0.739 . . . . 1.99 111.299 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.81 8.81 29.53 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.924 -0.655 . . . . 1.01 111.926 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.747 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.5 p80 -137.89 135.16 35.86 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.017 -0.364 . . . . 1.0 110.017 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -71.85 164.5 25.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.203 -0.453 . . . . 2.75 111.316 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.613 HD23 HD21 ' A' ' 112' ' ' LEU . 41.8 mt -74.59 137.17 74.16 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.92 -0.582 . . . . 3.1800000000000002 110.268 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 87.3 Cg_endo -90.16 13.83 2.21 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.181 2.588 . . . . 1.1899999999999999 113.396 -172.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.56 22.76 13.5 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.253 -0.43 . . . . 1.8999999999999999 111.162 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -112.55 140.69 47.1 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.366 -0.605 . . . . 2.3599999999999999 109.366 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -121.52 106.23 37.9 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 108.944 -0.762 . . . . 2.3799999999999999 108.944 178.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 2.2 Cg_endo -82.48 148.08 14.3 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.019 2.479 . . . . 1.1799999999999999 112.351 -176.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.52 -13.59 37.32 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.777 2.318 . . . . 1.6100000000000001 112.579 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -98.01 24.22 7.26 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.209 -0.293 . . . . 1.71 110.209 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.45 12.78 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.92 0.391 . . . . 1.8700000000000001 110.481 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.6 m -91.86 128.42 45.98 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.598 -0.519 . . . . 2.27 109.598 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.716 ' HD3' HD11 ' A' ' 108' ' ' LEU . 51.0 Cg_exo . . . . . 0 CA--C 1.535 0.554 0 C-N-CA 122.553 2.168 . . . . 1.29 110.991 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 CA--C 1.538 0.506 0 CA-C-O 121.069 0.461 . . . . 1.72 112.135 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.69 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 84.0 t -88.53 -13.55 9.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 O-C-N 121.553 -0.717 . . . . 1.3200000000000001 111.386 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.46 -12.63 70.02 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 119.457 -1.354 . . . . 0.71999999999999997 111.839 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -111.7 -28.26 8.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.563 0.579 . . . . 3.3799999999999999 112.563 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -108.56 8.41 27.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.473 0.654 . . . . 1.8300000000000001 109.946 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.748 ' HE3' ' HG3' ' A' ' 104' ' ' GLU . 42.5 tttt -57.1 -46.43 99.86 Favored Pre-proline 0 C--O 1.22 -0.466 0 CA-C-N 115.417 -0.811 . . . . 1.73 112.167 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 7.3 Cg_endo -49.95 -28.39 18.54 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 122.561 2.174 . . . . 0.80000000000000004 112.802 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.611 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 9.2 m -72.34 -42.32 65.49 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 122.301 1.048 . . . . 1.29 109.91 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.537 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 8.2 m-85 -79.55 -24.61 42.02 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.109 -0.951 . . . . 1.4299999999999999 109.742 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.579 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 14.3 t70 -81.6 -34.45 30.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.474 -0.785 . . . . 1.1599999999999999 110.63 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.611 ' HG2' ' O ' ' A' ' 52' ' ' THR . 13.2 pt-20 -66.14 -40.45 90.6 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.528 -0.469 . . . . 1.6299999999999999 109.819 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.6 mt -69.54 -29.45 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.114 -0.634 . . . . 1.27 109.612 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.579 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 71.8 t80 -58.59 -58.29 9.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.409 -0.814 . . . . 1.51 111.462 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.45 ' HE1' ' OD1' ' A' ' 54' ' ' ASP . 38.8 m-85 -66.96 -23.02 65.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.959 0.409 . . . . 1.6799999999999999 110.813 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.0 m -70.75 -26.37 63.33 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.019 -0.537 . . . . 1.1799999999999999 110.973 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.489 HD11 ' CG ' ' A' ' 75' ' ' GLU . 53.6 mt -87.74 4.22 45.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.015 0.376 . . . . 1.3600000000000001 112.015 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t 65.48 81.63 0.21 Allowed Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.027 -0.533 . . . . 1.22 110.906 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 72.6 Cg_endo -81.48 153.06 17.95 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.733 2.289 . . . . 0.57999999999999996 113.176 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.7 126.86 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.894 -0.594 . . . . 1.9199999999999999 110.248 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 60.72 23.31 13.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.702 -0.681 . . . . 2.0899999999999999 111.627 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.34 26.67 25.03 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.769 -0.729 . . . . 0.56999999999999995 112.898 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.732 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -160.32 148.56 16.66 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 120.934 0.397 . . . . 2.3300000000000001 110.039 173.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.734 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 4.1 pt -85.89 131.45 34.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.951 -0.568 . . . . 1.1799999999999999 109.965 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.7 p -59.7 112.22 1.73 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.751 -0.833 . . . . 1.2 108.751 174.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.561 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -42.2 -27.21 0.41 Allowed Glycine 0 C--O 1.218 -0.896 0 N-CA-C 116.684 1.434 . . . . 0.59999999999999998 116.684 -160.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.68 -30.87 9.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 118.236 1.018 . . . . 1.1699999999999999 112.359 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.734 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 13.3 p30 -81.07 -38.32 27.53 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.863 0.364 . . . . 2.1099999999999999 111.559 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.656 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -69.39 -34.58 74.73 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.497 0.665 . . . . 1.2 109.223 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.2 mmmm -64.06 -39.25 93.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.756 -1.111 . . . . 2.3100000000000001 108.864 174.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -55.79 -48.49 75.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.355 -0.839 . . . . 1.6799999999999999 109.714 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.633 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 7.2 mm-40 -60.68 -52.19 66.18 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.062 -0.972 . . . . 1.48 112.051 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.656 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 13.4 ptp -69.35 -24.13 63.86 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.878 -0.329 . . . . 0.84999999999999998 111.487 -178.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 73' ' ' LYS . 45.8 t -73.13 -49.08 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.652 0.263 . . . . 1.25 110.644 174.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.633 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 8.0 ptmt -68.06 -11.96 59.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.185 0.517 . . . . 1.79 110.249 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.3 t -68.29 -9.44 47.6 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.942 -0.572 . . . . 1.9399999999999999 110.039 174.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.613 ' HZ3' ' HB2' ' A' ' 80' ' ' LYS . 8.4 mtmp? 73.49 73.19 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.5 0.72 . . . . 3.1200000000000001 110.989 176.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 1.013 HD13 ' HE2' ' A' ' 116' ' ' LYS . 25.1 mt -136.35 163.56 49.11 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.566 -0.743 . . . . 1.71 110.997 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.78 168.71 19.02 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.618 2.212 . . . . 1.03 111.408 167.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -64.72 -26.83 68.54 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.833 0.308 . . . . 1.53 111.833 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.4 p -62.95 -50.82 69.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.259 -0.428 . . . . 1.75 110.896 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 89' ' ' ILE . 46.7 t -66.83 -43.78 89.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.928 -0.578 . . . . 1.28 109.925 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.555 ' CD2' ' HB2' ' A' ' 81' ' ' LEU . 2.8 mm? -48.27 -53.41 17.27 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.282 0.563 . . . . 2.0699999999999998 110.744 172.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.43 -45.96 94.68 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.943 -1.026 . . . . 0.45000000000000001 112.984 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.842 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 56.3 pttt -83.27 -21.54 33.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 119.677 -0.809 . . . . 2.1899999999999999 112.304 -175.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.589 HD12 ' HD3' ' A' ' 116' ' ' LYS . 29.8 mt -67.26 -44.91 87.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.853 -0.795 . . . . 1.8200000000000001 108.853 171.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -62.98 -54.69 34.38 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 115.658 -0.701 . . . . 0.35999999999999999 111.405 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.842 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 64.6 pttt -71.82 -10.17 59.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.571 -0.286 . . . . 2.9500000000000002 111.721 -173.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.623 HD13 ' HA ' ' A' ' 124' ' ' ALA . 8.6 tp -92.34 -34.07 14.34 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.736 -0.468 . . . . 1.5 109.736 173.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.725 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -82.92 -44.44 15.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.896 0.379 . . . . 1.1499999999999999 112.004 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.507 ' HB2' HD23 ' A' ' 101' ' ' LEU . 42.1 t0 -92.01 76.28 5.47 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.81 -0.811 . . . . 0.62 108.81 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.3 t -64.9 -25.22 37.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.258 -0.883 . . . . 2.27 109.982 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -79.48 -25.85 41.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.603 -1.18 . . . . 1.7 110.278 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 55.71 73.82 0.41 Allowed 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.468 -0.787 . . . . 2.2599999999999998 111.525 174.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -123.45 -24.22 4.64 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.409 -1.269 . . . . 1.51 112.419 -169.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.91 16.46 28.26 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.053 -1.07 . . . . 0.34000000000000002 111.82 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.732 HD13 ' HG3' ' A' ' 66' ' ' LYS . 3.3 pp -151.61 -174.57 4.88 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.649 -0.871 . . . . 1.23 108.649 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 105' ' ' GLU . 45.0 mt -150.12 120.56 7.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.218 -0.66 . . . . 1.3700000000000001 109.218 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.8 p-10 -74.98 -175.65 2.65 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.635 -0.506 . . . . 1.5 109.635 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.459 ' OD1' ' HE2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -60.24 -33.85 72.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.663 0.268 . . . . 1.73 111.191 -177.181 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.748 ' HG3' ' HE3' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -83.24 -37.43 23.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.79 -0.186 . . . . 2.1400000000000001 111.037 176.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.531 ' HB3' HD22 ' A' ' 101' ' ' LEU . 3.7 mt-10 -62.43 -38.35 89.41 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.208 -0.197 . . . . 1.1100000000000001 110.99 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.586 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.6 OUTLIER -68.96 -40.1 79.09 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.526 -0.916 . . . . 1.8600000000000001 108.526 172.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.537 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -48.93 -50.67 34.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.597 -0.729 . . . . 1.02 111.426 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.725 ' CD1' ' HA ' ' A' ' 93' ' ' ALA . 0.5 OUTLIER -83.41 -33.36 25.75 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 118.993 -1.083 . . . . 1.8200000000000001 112.031 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.32 -54.18 9.43 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.318 0.58 . . . . 1.0700000000000001 111.173 170.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.472 ' O ' ' HB ' ' A' ' 113' ' ' ILE . 2.9 t-20 -75.97 -33.87 59.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.571 . . . . 1.8899999999999999 110.702 -176.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -66.37 -34.88 78.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.519 . . . . 0.59999999999999998 109.945 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.782 ' HB3' HD21 ' A' ' 122' ' ' LEU . 73.0 mt -71.81 -31.65 66.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.717 -0.674 . . . . 1.23 110.021 176.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.607 ' HA ' ' HE3' ' A' ' 116' ' ' LYS . 60.8 mt -61.11 -42.67 94.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.73 -0.668 . . . . 1.49 110.747 171.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.586 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -68.44 -35.34 77.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.297 -0.41 . . . . 2.6699999999999999 110.335 175.715 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.6 t -59.57 -49.05 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.256 -0.429 . . . . 1.23 111.522 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 1.013 ' HE2' HD13 ' A' ' 81' ' ' LEU . 20.0 pttp -68.0 -28.84 67.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.026 0.441 . . . . 2.4199999999999999 110.303 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.5 tp -70.49 -20.57 62.84 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.847 -0.615 . . . . 1.8200000000000001 110.839 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.586 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 42.2 mt-10 -71.42 -9.84 58.82 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.888 -0.597 . . . . 1.99 111.037 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.43 1.21 24.8 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.2 -1.0 . . . . 1.01 112.948 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.701 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -129.45 134.01 47.6 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -72.12 164.62 25.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.252 0.549 . . . . 2.75 111.242 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.782 HD21 ' HB3' ' A' ' 112' ' ' LEU . 5.2 mp -68.87 141.5 92.43 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.792 -0.64 . . . . 3.1800000000000002 110.46 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.555 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 67.9 Cg_endo -91.5 -7.06 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.483 2.788 . . . . 1.1899999999999999 112.624 -174.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.623 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . 61.53 37.55 16.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.699 -0.682 . . . . 1.8999999999999999 111.319 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.555 ' OD1' ' HG2' ' A' ' 123' ' ' PRO . 1.2 p-10 -111.61 135.5 52.11 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.956 -0.565 . . . . 2.3599999999999999 109.746 170.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 126' ' ' LEU . 22.7 tp -115.49 91.42 28.99 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.191 -0.913 . . . . 2.3799999999999999 109.918 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 94.5 Cg_endo -98.03 171.22 0.67 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.609 2.872 . . . . 1.1799999999999999 113.189 -175.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.418 ' HA ' HG22 ' A' ' 131' ' ' VAL . 9.3 Cg_endo -54.92 -29.49 64.2 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.941 2.427 . . . . 1.6100000000000001 112.993 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.53 ' O ' HD12 ' A' ' 130' ' ' LEU . 16.5 p-80 -84.84 22.16 1.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.997 0.369 . . . . 1.71 111.997 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.53 HD12 ' O ' ' A' ' 129' ' ' HIS . 1.0 OUTLIER -149.76 18.4 0.9 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.582 0.353 . . . . 1.8700000000000001 111.091 169.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.418 HG22 ' HA ' ' A' ' 128' ' ' PRO . 96.7 t -70.19 112.59 13.16 Favored Pre-proline 0 C--N 1.328 -0.356 0 C-N-CA 120.549 -0.46 . . . . 2.27 110.968 -176.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 18.1 Cg_exo . . . . . 0 C--O 1.237 0.439 0 C-N-CA 122.629 2.22 . . . . 1.29 111.841 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.655 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 23.8 t . . . . . 0 C--O 1.223 -0.305 0 N-CA-C 112.561 0.578 . . . . 1.72 112.561 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.722 ' HA ' ' OD1' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -63.07 -13.4 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 O-C-N 121.995 -0.441 . . . . 1.3200000000000001 112.089 -174.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.48 -4.58 31.98 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.255 -0.974 . . . . 0.71999999999999997 111.935 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.655 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 11.7 ptmm? -105.33 -28.32 10.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 111.838 0.31 . . . . 3.3799999999999999 111.838 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.722 ' OD1' ' HA ' ' A' ' 46' ' ' VAL . 12.7 p-10 -114.58 1.34 14.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.051 0.453 . . . . 1.8300000000000001 111.235 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 49.6 tttm -56.48 -46.25 99.84 Favored Pre-proline 0 C--O 1.223 -0.334 0 CA-C-N 115.438 -0.801 . . . . 1.73 112.293 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 4.3 Cg_endo -46.48 -35.09 15.81 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.869 2.38 . . . . 0.80000000000000004 113.315 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.7 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 56.5 m -76.57 -36.44 57.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.376 0.607 . . . . 1.29 110.995 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.411 ' CD1' ' HB3' ' A' ' 110' ' ' ASN . 8.4 m-85 -81.96 -23.87 35.84 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.198 0.523 . . . . 1.4299999999999999 110.224 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.591 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 1.1 t70 -75.44 -39.47 58.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.032 -0.985 . . . . 1.1599999999999999 109.783 175.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.7 ' HG3' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -68.38 -38.65 81.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.504 -0.316 . . . . 1.6299999999999999 110.729 178.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.562 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 48.2 mt -70.95 -29.3 36.61 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 109.366 -0.605 . . . . 1.27 109.366 174.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.591 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 66.1 t80 -57.43 -54.51 46.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.71 -0.677 . . . . 1.51 111.213 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.578 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 75.3 m-85 -71.53 -22.89 61.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.166 0.507 . . . . 1.6799999999999999 110.498 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.562 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 18.3 m -72.09 -30.48 65.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.768 -0.651 . . . . 1.1799999999999999 110.874 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 34.4 mt -84.87 0.94 49.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 1.3600000000000001 110.979 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t 66.46 88.59 0.11 Allowed Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.511 -0.768 . . . . 1.22 111.464 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.578 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 64.8 Cg_endo -85.09 159.88 11.53 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.47 2.113 . . . . 0.57999999999999996 113.257 177.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.8 p -141.46 134.25 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.93 -0.577 . . . . 1.9199999999999999 109.958 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 63.81 20.53 12.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.479 -0.782 . . . . 2.0899999999999999 109.73 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.58 -0.06 67.51 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.145 -0.934 . . . . 0.56999999999999995 113.618 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -134.59 163.78 28.96 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 117.946 0.873 . . . . 2.3300000000000001 110.472 177.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pt -90.49 135.01 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 C-N-CA 120.642 -0.423 . . . . 1.1799999999999999 109.982 170.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.32 126.73 28.84 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.147 -1.057 . . . . 1.2 108.147 171.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.533 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -49.45 -31.91 14.56 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.571 -0.74 . . . . 0.59999999999999998 114.816 -166.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.67 -33.1 21.26 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 117.366 0.583 . . . . 1.1699999999999999 112.389 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.61 -38.49 39.76 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.366 0.603 . . . . 2.1099999999999999 109.932 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.578 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -72.29 -33.21 67.24 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.789 -0.641 . . . . 1.2 109.327 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.4 mmmm -65.34 -37.87 88.39 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 114.959 -1.018 . . . . 2.3100000000000001 108.78 174.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -56.54 -44.65 81.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.942 -1.026 . . . . 1.6799999999999999 110.416 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.649 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 3.3 mm-40 -64.01 -52.87 57.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.142 -0.936 . . . . 1.48 111.74 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.578 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 16.0 ptp -66.37 -21.07 66.23 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.582 -0.447 . . . . 0.84999999999999998 110.807 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 73' ' ' LYS . 5.1 t -68.64 -46.53 79.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 1.25 111.013 172.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.649 ' HE2' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -70.36 -16.36 62.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.12 0.486 . . . . 1.79 110.04 -176.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.9 t -65.01 -6.81 9.48 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.411 -0.813 . . . . 1.9399999999999999 111.716 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 77.9 mttt 67.44 68.22 0.38 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.383 0.611 . . . . 3.1200000000000001 110.596 175.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.52 HD11 HG12 ' A' ' 85' ' ' VAL . 20.7 mt -128.95 156.87 77.3 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.577 -0.738 . . . . 1.71 110.691 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.514 ' HG2' HG23 ' A' ' 85' ' ' VAL . 53.0 Cg_endo -73.21 162.93 39.36 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.194 1.929 . . . . 1.03 110.541 168.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -63.0 -27.47 69.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.334 -0.394 . . . . 1.53 111.539 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.1 p -67.38 -45.76 75.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.2 0.524 . . . . 1.75 110.723 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.55 ' HA ' ' HZ2' ' A' ' 88' ' ' LYS . 90.5 t -67.37 -42.92 87.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 115.904 -0.589 . . . . 1.28 110.053 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.465 ' CD2' ' HB2' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -48.66 -55.29 11.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.4 0.619 . . . . 2.0699999999999998 110.587 171.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -56.79 -53.29 45.19 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.873 -1.058 . . . . 0.45000000000000001 113.247 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.55 ' HZ2' ' HA ' ' A' ' 85' ' ' VAL . 14.4 pttp -81.12 -17.33 50.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.516 -0.873 . . . . 2.1899999999999999 112.651 -173.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.714 HG12 HD13 ' A' ' 122' ' ' LEU . 7.8 mt -69.73 -48.42 64.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 108.71 -0.848 . . . . 1.8200000000000001 108.71 169.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.415 ' CE3' ' HD3' ' A' ' 73' ' ' LYS . 67.2 t-105 -53.44 -55.43 25.22 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.497 -0.774 . . . . 0.35999999999999999 111.237 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.46 -30.28 71.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.38 -0.827 . . . . 2.9500000000000002 112.538 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.498 ' HB3' ' CD1' ' A' ' 112' ' ' LEU . 4.6 tp -84.09 -13.0 54.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.643 -0.503 . . . . 1.5 109.643 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.46 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -101.63 -42.92 6.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.315 -0.402 . . . . 1.1499999999999999 111.38 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.471 ' HB2' HD22 ' A' ' 101' ' ' LEU . 51.5 t0 -80.43 97.76 7.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.312 -0.625 . . . . 0.62 109.312 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -71.95 -28.71 30.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.896 -0.593 . . . . 2.27 110.325 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.2 -26.63 42.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.963 -0.562 . . . . 1.7 109.595 176.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 56.39 44.66 24.12 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.954 0.883 . . . . 2.2599999999999998 109.05 -173.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -108.74 -0.16 20.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.181 -1.372 . . . . 1.51 112.167 -166.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.15 10.26 59.83 Favored Glycine 0 CA--C 1.511 -0.156 0 C-N-CA 120.287 -0.959 . . . . 0.34000000000000002 112.507 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.458 HD12 ' CB ' ' A' ' 66' ' ' LYS . 4.2 pp -152.89 156.13 38.37 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.227 0.537 . . . . 1.23 110.246 175.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.498 HD21 ' HB3' ' A' ' 105' ' ' GLU . 63.4 mt -121.82 119.0 30.39 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.115 -0.948 . . . . 1.3700000000000001 109.48 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.1 p30 -71.09 -178.36 1.96 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.508 -0.553 . . . . 1.5 109.508 174.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.411 ' CG ' ' HZ3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -56.94 -34.44 68.02 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.487 0.66 . . . . 1.73 111.08 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.611 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 23.5 tt0 -83.95 -31.81 25.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.548 0.69 . . . . 2.1400000000000001 109.424 -176.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.498 ' HB3' HD21 ' A' ' 101' ' ' LEU . 3.6 mt-10 -72.91 -30.28 63.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.583 -0.735 . . . . 1.1100000000000001 111.358 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.623 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -68.78 -44.19 74.15 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.062 -1.088 . . . . 1.8600000000000001 108.062 171.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -47.48 -46.6 27.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 1.02 110.62 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.469 ' CD2' ' HG ' ' A' ' 112' ' ' LEU . 1.0 OUTLIER -69.81 -46.66 65.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.8200000000000001 110.427 178.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.476 ' HB3' HD12 ' A' ' 101' ' ' LEU . . . -50.02 -53.76 24.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.089 0.471 . . . . 1.0700000000000001 111.527 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.425 ' HA ' HD13 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -72.39 -25.45 61.5 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.349 -0.611 . . . . 1.8899999999999999 109.349 -177.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.464 ' O ' HG21 ' A' ' 115' ' ' VAL . 51.4 t60 -70.24 -39.8 74.85 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.592 -0.521 . . . . 0.59999999999999998 109.592 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.55 HD21 HD23 ' A' ' 122' ' ' LEU . 46.6 mt -68.78 -36.53 78.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.838 0.352 . . . . 1.23 110.594 177.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 110' ' ' ASN . 95.6 mt -57.42 -48.94 81.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.931 -0.577 . . . . 1.49 110.528 175.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 19.8 ptmt -70.29 -28.46 65.21 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.123 -0.631 . . . . 2.6699999999999999 110.502 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 111' ' ' HIS . 6.4 t -62.13 -45.19 99.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.688 -0.233 . . . . 1.23 110.989 176.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 3.7 ptmm? -84.07 -2.42 56.67 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 119.733 -0.787 . . . . 2.4199999999999999 110.846 178.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.9 tp -83.64 -23.12 31.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.459 -0.571 . . . . 1.8200000000000001 109.459 170.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 48.5 mt-10 -66.44 -14.13 61.75 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.006 -0.543 . . . . 1.99 111.355 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.05 8.13 20.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.628 -0.796 . . . . 1.01 112.589 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.641 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -132.61 140.2 48.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.92 0.391 . . . . 1.0 109.964 177.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -77.06 164.96 25.23 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.865 -0.607 . . . . 2.75 110.962 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.714 HD13 HG12 ' A' ' 89' ' ' ILE . 27.1 mt -70.82 141.89 87.65 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.168 -0.469 . . . . 3.1800000000000002 110.291 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -92.25 12.86 2.0 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.035 2.49 . . . . 1.1899999999999999 113.105 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 59.96 21.93 10.99 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.756 -0.656 . . . . 1.8999999999999999 111.198 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -111.93 139.94 47.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.084 -0.709 . . . . 2.3599999999999999 109.084 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.83 93.34 47.58 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.542 -0.911 . . . . 2.3799999999999999 108.542 176.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -73.21 153.49 51.32 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.828 2.352 . . . . 1.1799999999999999 112.491 -174.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -67.47 -7.21 18.5 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.117 2.545 . . . . 1.6100000000000001 112.374 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -105.82 13.76 29.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.838 -0.619 . . . . 1.71 109.602 175.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 mp -134.6 -4.54 2.57 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.338 -0.846 . . . . 1.8700000000000001 110.658 168.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.3 t -66.03 120.6 70.74 Favored Pre-proline 0 N--CA 1.44 -0.936 0 N-CA-C 109.285 -0.635 . . . . 2.27 109.285 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.611 ' HB3' ' HG2' ' A' ' 104' ' ' GLU . 51.9 Cg_exo . . . . . 0 N--CA 1.453 -0.885 0 C-N-CA 121.899 1.733 . . . . 1.29 109.412 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 t . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 120.941 0.401 . . . . 1.72 111.07 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.594 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 99.1 t -89.26 -20.11 7.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 O-C-N 121.652 -0.655 . . . . 1.3200000000000001 111.865 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.68 -11.59 57.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.612 -1.28 . . . . 0.71999999999999997 112.234 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -109.5 -27.77 9.26 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.311 0.486 . . . . 3.3799999999999999 112.311 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -108.68 7.04 26.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.896 0.855 . . . . 1.8300000000000001 110.336 -173.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.683 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 83.0 tttt -61.5 -40.21 69.1 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 114.661 -1.154 . . . . 1.73 112.82 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.2 Cg_endo -46.2 -30.97 8.36 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 122.678 2.252 . . . . 0.80000000000000004 112.841 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.545 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 99.0 m -75.3 -40.79 58.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.793 0.806 . . . . 1.29 110.566 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.618 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 9.1 m-85 -79.55 -28.49 41.23 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.078 -0.51 . . . . 1.4299999999999999 110.579 -174.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.533 ' OD2' ' HA ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -86.12 -27.64 24.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.799 -0.637 . . . . 1.1599999999999999 110.181 -179.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 52' ' ' THR . 11.5 pt-20 -66.24 -43.1 87.56 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.346 -0.613 . . . . 1.6299999999999999 109.346 173.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.442 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 53.6 mt -67.9 -32.89 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 120.28 -0.568 . . . . 1.27 109.517 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.492 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 79.2 t80 -55.1 -52.99 61.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.477 -0.783 . . . . 1.51 111.276 175.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.533 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 74.7 m-85 -73.92 -23.3 59.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.738 0.304 . . . . 1.6799999999999999 111.314 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.442 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 25.2 m -66.76 -35.24 79.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.057 -0.519 . . . . 1.1799999999999999 110.769 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.521 HD12 ' CG ' ' A' ' 75' ' ' GLU . 54.9 mt -85.39 -4.48 59.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.122 -0.49 . . . . 1.3600000000000001 111.404 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.0 t 67.06 95.21 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 121.586 0.708 . . . . 1.22 111.312 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.533 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 22.9 Cg_endo -80.96 138.84 11.73 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.808 2.339 . . . . 0.57999999999999996 112.377 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.9 m -99.94 122.05 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.044 -0.525 . . . . 1.9199999999999999 110.873 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 62.92 24.14 14.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.65 -0.704 . . . . 2.0899999999999999 111.232 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.74 14.3 53.02 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.963 -0.636 . . . . 0.56999999999999995 113.728 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.941 ' HG3' HD11 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -155.03 151.78 28.83 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.759 -0.46 . . . . 2.3300000000000001 109.759 174.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.921 ' HB ' HD22 ' A' ' 71' ' ' ASN . 4.2 pt -80.5 135.93 24.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 C-N-CA 120.623 -0.431 . . . . 1.1799999999999999 110.529 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.03 128.76 38.41 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.883 -1.155 . . . . 1.2 107.883 167.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.606 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -49.92 -29.43 13.92 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 121.172 -0.537 . . . . 0.59999999999999998 113.917 -169.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.58 47.4 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.721 0.638 . . . . 1.1699999999999999 112.721 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.921 HD22 ' HB ' ' A' ' 67' ' ' ILE . 15.2 p30 -82.1 -33.03 29.93 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.074 0.464 . . . . 2.1099999999999999 110.538 -176.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.647 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -69.93 -35.89 74.9 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.378 0.609 . . . . 1.2 109.388 177.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.652 ' HZ1' ' HB2' ' A' ' 90' ' ' TRP . 31.4 mmmt -66.12 -37.84 86.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.163 -0.926 . . . . 2.3100000000000001 108.984 175.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 78' ' ' LYS . 2.2 tppp? -54.84 -48.2 73.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.683 -0.689 . . . . 1.6799999999999999 109.956 176.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.673 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 3.0 mm-40 -63.43 -51.94 63.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.041 -0.982 . . . . 1.48 111.957 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.647 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 14.9 ptp -67.95 -23.02 65.02 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.481 -0.488 . . . . 0.84999999999999998 111.409 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.502 HG21 HD13 ' A' ' 86' ' ' LEU . 24.9 t -71.85 -49.51 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.481 0.181 . . . . 1.25 111.186 173.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.673 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 2.5 ptmt -69.93 -9.1 53.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.264 0.554 . . . . 1.79 110.306 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.0 t -73.34 0.57 11.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.444 -0.798 . . . . 1.9399999999999999 110.893 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.5 mttp 73.09 68.09 0.11 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.91 -0.586 . . . . 3.1200000000000001 110.872 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.823 HD12 ' HE2' ' A' ' 116' ' ' LYS . 18.4 mt -138.64 159.68 66.46 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.627 -0.715 . . . . 1.71 111.358 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.503 ' HG2' HG22 ' A' ' 85' ' ' VAL . 74.2 Cg_endo -77.95 168.56 21.91 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.836 2.357 . . . . 1.03 111.385 167.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -63.45 -27.72 69.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.153 -0.476 . . . . 1.53 112.044 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -52.6 63.31 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.057 0.456 . . . . 1.75 111.167 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.503 HG22 ' HG2' ' A' ' 82' ' ' PRO . 22.6 t -62.54 -41.98 94.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.822 -0.626 . . . . 1.28 109.723 177.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.502 HD13 HG21 ' A' ' 77' ' ' VAL . 2.7 mm? -49.51 -50.05 43.31 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.837 -0.619 . . . . 2.0699999999999998 111.382 173.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.08 -44.84 86.81 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.946 -0.645 . . . . 0.45000000000000001 113.186 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.583 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 56.3 pttt -76.57 -31.29 57.44 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.964 -0.694 . . . . 2.1899999999999999 111.36 -175.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.552 HG12 HD13 ' A' ' 122' ' ' LEU . 29.7 mt -64.95 -46.22 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 109.325 -0.62 . . . . 1.8200000000000001 109.325 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.652 ' HB2' ' HZ1' ' A' ' 73' ' ' LYS . 76.3 t-105 -52.95 -57.01 11.77 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 115.018 -0.992 . . . . 0.35999999999999999 111.066 177.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -77.52 -9.48 58.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.389 0.515 . . . . 2.9500000000000002 112.389 -171.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.583 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 2.3 tp -88.44 -23.29 23.33 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.707 -0.397 . . . . 1.5 109.977 176.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.549 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -103.66 -39.21 6.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.038 0.447 . . . . 1.1499999999999999 110.886 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.612 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 29.6 t70 -83.43 79.31 9.46 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.234 -0.654 . . . . 0.62 109.234 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 m -61.25 -33.14 55.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.202 -0.908 . . . . 2.27 111.26 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 5.1 p-10 -78.41 -24.78 46.07 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.354 -1.294 . . . . 1.7 111.446 -175.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.612 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 36.7 mtmm 47.63 50.68 14.87 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.114 0.884 . . . . 2.2599999999999998 112.637 176.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -110.68 -10.85 14.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.583 -0.735 . . . . 1.51 110.281 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.09 22.91 9.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.163 -1.018 . . . . 0.34000000000000002 113.015 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.941 HD11 ' HG3' ' A' ' 66' ' ' LYS . 4.1 pp -152.94 168.32 26.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.069 0.434 . . . . 1.23 111.212 174.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.612 ' O ' HG12 ' A' ' 67' ' ' ILE . 50.8 mt -145.08 118.87 9.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.82 -1.178 . . . . 1.3700000000000001 107.82 -166.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.402 ' H ' ' HB2' ' A' ' 105' ' ' GLU . 1.1 p30 -81.98 -173.25 4.38 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.518 -0.473 . . . . 1.5 110.758 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.471 ' OD1' ' HB2' ' A' ' 54' ' ' ASP . 34.1 t70 -55.8 -36.96 67.99 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.423 0.689 . . . . 1.73 112.245 -173.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 4.2 tp10 -90.61 -22.0 21.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.428 0.632 . . . . 2.1400000000000001 110.483 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.571 ' OE1' ' HA ' ' A' ' 101' ' ' LEU . 3.1 mt-10 -73.64 -30.51 62.98 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.0 -0.545 . . . . 1.1100000000000001 110.047 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.619 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.8 OUTLIER -77.4 -34.09 54.88 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.953 -1.129 . . . . 1.8600000000000001 107.953 170.371 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.618 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -53.28 -48.88 67.95 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.378 0.608 . . . . 1.02 110.091 174.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 37.1 tp -75.85 -39.07 57.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.725 -0.67 . . . . 1.8200000000000001 111.363 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.25 -56.46 12.81 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.05 0.452 . . . . 1.0700000000000001 111.166 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.576 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 4.4 t30 -73.63 -24.32 60.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.829 -0.623 . . . . 1.8899999999999999 110.211 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.462 ' O ' HG22 ' A' ' 115' ' ' VAL . 82.6 t60 -70.28 -42.89 71.48 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.277 -0.569 . . . . 0.59999999999999998 109.825 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.549 HD12 ' HB1' ' A' ' 93' ' ' ALA . 80.4 mt -66.98 -31.44 72.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.738 -0.664 . . . . 1.23 109.785 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.717 ' O ' ' HG2' ' A' ' 116' ' ' LYS . 60.0 mt -60.72 -45.49 97.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.512 -0.767 . . . . 1.49 110.684 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.612 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 12.4 ttpt -65.26 -39.56 92.79 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.341 -0.544 . . . . 2.6699999999999999 110.433 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 111' ' ' HIS . 54.7 t -56.79 -46.4 83.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.666 -0.243 . . . . 1.23 111.365 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.823 ' HE2' HD12 ' A' ' 81' ' ' LEU . 14.6 pttp -67.01 -28.19 68.04 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.107 0.479 . . . . 2.4199999999999999 109.92 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.8 tp -80.89 -17.39 50.78 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.868 -0.605 . . . . 1.8200000000000001 110.971 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 45.0 mt-10 -75.46 0.55 16.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.034 0.445 . . . . 1.99 110.712 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.81 3.95 30.01 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.429 -0.891 . . . . 1.01 112.902 171.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.511 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.2 p80 -140.53 134.9 31.29 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.393 -0.523 . . . . 1.0 110.121 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.44 163.78 27.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.534 -0.757 . . . . 2.75 111.007 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.552 HD13 HG12 ' A' ' 89' ' ' ILE . 23.3 mt -69.89 134.34 87.91 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.35 -0.386 . . . . 3.1800000000000002 110.014 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 84.4 Cg_endo -93.18 14.83 1.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.894 2.396 . . . . 1.1899999999999999 113.114 -174.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.56 19.55 10.48 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.202 0.525 . . . . 1.8999999999999999 111.099 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -104.35 111.77 24.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.663 -0.699 . . . . 2.3599999999999999 109.582 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.9 tp -112.24 100.11 48.5 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.069 -0.514 . . . . 2.3799999999999999 109.983 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' A' ' 129' ' ' HIS . 4.7 Cg_endo -89.02 159.7 5.86 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.075 2.516 . . . . 1.1799999999999999 111.238 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.17 28.41 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.842 2.362 . . . . 1.6100000000000001 113.104 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.489 ' H ' ' C ' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -100.35 -25.17 14.32 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.863 -0.791 . . . . 1.71 108.863 174.229 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.49 7.07 6.32 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.976 -0.557 . . . . 1.8700000000000001 111.424 -167.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.99 121.04 84.07 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 108.255 -1.017 . . . . 2.27 108.255 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 CA--C 1.545 1.054 0 C-N-CA 122.743 2.295 . . . . 1.29 113.073 -176.157 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.801 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 21.1 t . . . . . 0 C--O 1.217 -0.651 0 N-CA-C 112.565 0.58 . . . . 1.72 112.565 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -74.99 -15.86 15.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 120.826 -1.171 . . . . 1.3200000000000001 111.592 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.43 -14.12 61.65 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 119.517 -1.325 . . . . 0.71999999999999997 111.714 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.801 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -110.08 -27.87 8.96 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.986 0.422 . . . . 3.3799999999999999 110.874 176.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.774 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.0 OUTLIER -86.37 -18.66 31.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.515 -0.766 . . . . 1.8300000000000001 111.1 -177.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.462 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 58.8 tttm -52.32 -51.05 75.96 Favored Pre-proline 0 C--O 1.217 -0.619 0 CA-C-O 118.662 -0.685 . . . . 1.73 112.643 -174.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 85.9 Cg_exo -41.95 -40.41 6.03 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 122.775 2.317 . . . . 0.80000000000000004 113.676 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.549 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 93.9 m -74.04 -44.15 55.31 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.61 0.719 . . . . 1.29 110.744 -176.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.774 ' CE2' ' HB3' ' A' ' 49' ' ' ASP . 6.1 m-85 -74.64 -24.28 58.8 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.988 -0.551 . . . . 1.4299999999999999 110.109 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.54 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 24.7 t70 -81.1 -37.24 29.27 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.829 -1.078 . . . . 1.1599999999999999 110.257 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 52' ' ' THR . 13.5 pt-20 -67.13 -41.59 85.88 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.256 -0.429 . . . . 1.6299999999999999 109.963 175.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.493 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 56.1 mt -69.52 -30.38 45.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.583 -0.525 . . . . 1.27 109.583 175.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.547 ' CZ ' ' HB3' ' A' ' 62' ' ' PRO . 55.3 t80 -57.68 -55.21 37.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.721 -0.672 . . . . 1.51 111.244 177.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.49 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 68.6 m-85 -70.51 -21.84 62.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.236 0.541 . . . . 1.6799999999999999 110.611 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.493 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 23.0 m -72.97 -24.53 60.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.257 -0.883 . . . . 1.1799999999999999 110.985 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.0 mt -94.54 7.98 43.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 1.3600000000000001 110.828 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.0 t 64.93 90.05 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 123.751 0.657 . . . . 1.22 112.223 175.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.547 ' HB3' ' CZ ' ' A' ' 57' ' ' PHE . 5.7 Cg_exo -75.49 143.12 27.22 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.852 2.368 . . . . 0.57999999999999996 112.819 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.04 117.94 54.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.457 -0.942 . . . . 1.9199999999999999 108.457 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 68.89 21.15 7.69 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.636 0.585 . . . . 2.0899999999999999 111.567 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.42 ' C ' ' HD2' ' A' ' 66' ' ' LYS . . . 93.34 22.56 26.67 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 112.936 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.91 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -160.85 156.07 24.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.247 -0.279 . . . . 2.3300000000000001 110.247 178.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.473 HD11 ' CD2' ' A' ' 106' ' ' PHE . 2.2 pt -86.22 137.56 20.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.776 -0.453 . . . . 1.1799999999999999 109.776 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 p -59.35 128.43 37.04 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.204 -1.036 . . . . 1.2 108.204 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.556 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -52.28 -32.87 37.74 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 114.942 0.737 . . . . 0.59999999999999998 114.942 -164.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.56 -28.01 29.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.291 0.545 . . . . 1.1699999999999999 112.434 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -78.73 -41.7 30.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.423 0.63 . . . . 2.1099999999999999 109.628 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.518 ' CB ' HD11 ' A' ' 101' ' ' LEU . . . -69.95 -31.14 68.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.583 0.706 . . . . 1.2 109.287 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HZ3' ' HB2' ' A' ' 90' ' ' TRP . 30.6 mmmt -65.86 -37.46 86.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.951 -1.022 . . . . 2.3100000000000001 109.004 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.4 -46.01 83.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.476 -0.783 . . . . 1.6799999999999999 109.785 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.889 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 11.4 mm-40 -56.63 -53.02 62.55 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.864 -1.062 . . . . 1.48 111.36 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.487 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 16.7 ptp -72.55 -23.67 61.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.179 -0.464 . . . . 0.84999999999999998 111.685 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 73' ' ' LYS . 20.2 t -67.57 -55.7 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.858 0.361 . . . . 1.25 110.798 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.889 ' HE2' ' HA ' ' A' ' 75' ' ' GLU . 57.2 pttt -67.7 -14.44 62.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.16 0.505 . . . . 1.79 110.977 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.1 t -66.32 -7.47 19.06 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.759 -0.655 . . . . 1.9399999999999999 110.995 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt 72.15 71.7 0.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.399 0.68 . . . . 3.1200000000000001 111.315 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 1.053 HD11 ' HE2' ' A' ' 116' ' ' LYS . 36.4 mt -131.82 162.21 57.82 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.519 -0.764 . . . . 1.71 110.65 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.46 ' HG2' HG21 ' A' ' 85' ' ' VAL . 67.8 Cg_endo -76.76 169.01 22.55 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.568 2.178 . . . . 1.03 110.864 166.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -66.0 -32.08 73.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.66 0.267 . . . . 1.53 111.344 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.5 m -63.6 -50.85 67.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.067 0.46 . . . . 1.75 110.856 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.46 HG21 ' HG2' ' A' ' 82' ' ' PRO . 84.7 t -63.04 -40.1 87.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 115.945 -0.57 . . . . 1.28 110.502 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.737 HD12 ' HB2' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -59.76 -48.99 79.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.879 0.371 . . . . 2.0699999999999998 111.321 177.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.33 -37.51 93.21 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.535 -0.757 . . . . 0.45000000000000001 112.209 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.673 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 17.2 ptmt -83.84 -29.43 27.29 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.241 -0.583 . . . . 2.1899999999999999 110.446 -175.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.5 mm -60.06 -48.04 89.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.363 -0.606 . . . . 1.8200000000000001 109.363 169.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.589 ' HB2' ' HZ3' ' A' ' 73' ' ' LYS . 76.9 t-105 -57.43 -54.35 47.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.449 -0.796 . . . . 0.35999999999999999 111.187 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.673 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 18.1 ptpt -77.78 -8.11 57.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.925 -0.58 . . . . 2.9500000000000002 111.915 -171.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 124' ' ' ALA . 18.2 tp -93.24 -30.89 14.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.996 -0.372 . . . . 1.5 109.996 174.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.479 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -81.84 -42.58 19.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.217 -0.447 . . . . 1.1499999999999999 110.957 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.493 ' HB2' HD23 ' A' ' 101' ' ' LEU . 50.6 t0 -87.28 97.84 11.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.175 0.512 . . . . 0.62 110.323 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 m -73.2 -25.78 21.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.624 -0.716 . . . . 2.27 111.681 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.64 -25.78 26.41 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.377 -0.601 . . . . 1.7 109.377 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.2 mttp 57.27 69.16 0.77 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.131 -0.941 . . . . 2.2599999999999998 110.504 -174.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.466 ' HB2' ' HG ' ' A' ' 100' ' ' LEU . 2.7 m-20 -96.05 -46.18 6.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.802 -1.09 . . . . 1.51 110.6 -174.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.45 14.32 20.33 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 109.435 -1.466 . . . . 0.34000000000000002 109.435 -162.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.91 HD13 ' HG3' ' A' ' 66' ' ' LYS . 3.6 pp -152.8 171.02 18.89 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.048 -1.076 . . . . 1.23 108.292 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.538 HD22 ' HB3' ' A' ' 105' ' ' GLU . 48.0 mt -143.35 117.52 9.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.618 -0.512 . . . . 1.3700000000000001 109.618 -174.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 4.0 p30 -74.3 -174.2 1.91 Allowed 'General case' 0 C--N 1.317 -0.845 0 O-C-N 122.199 -0.313 . . . . 1.5 110.656 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.2 -36.23 65.71 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.088 0.947 . . . . 1.73 109.995 -176.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.527 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 29.4 tt0 -88.19 -25.08 23.1 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.772 -1.103 . . . . 2.1400000000000001 109.871 -173.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.538 ' HB3' HD22 ' A' ' 101' ' ' LEU . 2.0 mt-10 -81.5 -32.36 32.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.041 -0.527 . . . . 1.1100000000000001 111.496 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.629 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -63.82 -43.0 97.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.176 -1.416 . . . . 1.8600000000000001 107.176 169.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.644 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -48.98 -50.24 36.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.602 -0.726 . . . . 1.02 110.842 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.614 HD13 ' HG3' ' A' ' 132' ' ' PRO . 1.4 tt -66.35 -47.94 71.82 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.748 -0.206 . . . . 1.8200000000000001 110.78 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.33 -54.66 33.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.948 0.404 . . . . 1.0700000000000001 111.894 -176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.535 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 9.0 t-20 -70.9 -30.66 67.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.238 0.542 . . . . 1.8899999999999999 109.583 -175.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.477 ' O ' HG21 ' A' ' 115' ' ' VAL . 61.7 t60 -67.94 -37.14 81.25 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.653 -0.703 . . . . 0.59999999999999998 109.897 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.461 ' HA ' ' HB ' ' A' ' 115' ' ' VAL . 21.6 mt -67.9 -33.48 74.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.056 0.455 . . . . 1.23 110.421 175.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.796 ' HA ' ' HE3' ' A' ' 116' ' ' LYS . 75.9 mt -62.13 -45.82 97.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.689 -0.687 . . . . 1.49 110.894 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.463 ' HD3' ' OH ' ' A' ' 53' ' ' TYR . 21.5 ptmt -73.8 -26.86 60.83 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.265 -0.574 . . . . 2.6699999999999999 110.927 176.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 111' ' ' HIS . 3.4 t -62.76 -47.45 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.744 0.307 . . . . 1.23 110.933 176.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 1.053 ' HE2' HD11 ' A' ' 81' ' ' LEU . 20.6 pttp -72.22 -22.47 61.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.09 0.471 . . . . 2.4199999999999999 110.112 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 23.0 tp -70.64 -22.36 62.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.953 -0.567 . . . . 1.8200000000000001 109.782 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 45.6 mt-10 -68.34 -12.01 60.43 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 116.028 -0.533 . . . . 1.99 110.429 173.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.96 -13.76 58.89 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.307 -0.717 . . . . 1.01 111.307 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.407 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -94.49 125.45 39.14 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.71 141.13 35.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.424 -0.807 . . . . 2.75 112.252 -174.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.845 HD13 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -63.75 130.16 94.23 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.882 -1.053 . . . . 3.1800000000000002 110.941 176.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.696 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 13.5 Cg_endo -87.83 1.18 6.9 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.066 2.51 . . . . 1.1899999999999999 114.176 -170.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.4 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . 65.94 18.73 11.15 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.722 0.773 . . . . 1.8999999999999999 109.777 -170.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.696 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 37.0 t70 -105.31 140.68 38.08 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.731 -1.122 . . . . 2.3599999999999999 108.593 175.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.52 102.48 32.81 Favored Pre-proline 0 C--N 1.309 -1.155 0 CA-C-N 115.782 -0.645 . . . . 2.3799999999999999 110.085 -176.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.28 156.64 11.0 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.269 2.646 . . . . 1.1799999999999999 112.415 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.447 ' O ' HG13 ' A' ' 131' ' ' VAL . 18.8 Cg_exo -64.0 -19.01 65.9 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.941 2.427 . . . . 1.6100000000000001 112.241 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -90.2 15.73 9.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.126 -0.488 . . . . 1.71 109.722 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.06 17.52 0.96 Allowed 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.225 -0.898 . . . . 1.8700000000000001 109.483 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 128' ' ' PRO . 9.6 p -98.12 119.26 62.38 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 115.983 -0.553 . . . . 2.27 109.702 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.614 ' HG3' HD13 ' A' ' 108' ' ' LEU . 15.0 Cg_exo . . . . . 0 CA--C 1.538 0.693 0 C-N-CA 122.235 1.957 . . . . 1.29 111.427 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.0 t . . . . . 0 CA--C 1.543 0.695 0 N-CA-C 113.572 0.953 . . . . 1.72 113.572 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.94 -26.49 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.226 -0.922 . . . . 1.3200000000000001 112.022 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.96 -11.19 30.12 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.449 -0.881 . . . . 0.71999999999999997 112.398 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.743 ' HZ1' ' HB3' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -102.01 -27.63 12.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 112.154 0.427 . . . . 3.3799999999999999 112.154 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -114.67 6.67 15.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.187 0.517 . . . . 1.8300000000000001 110.572 -175.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.661 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 74.2 tttt -55.86 -43.47 99.22 Favored Pre-proline 0 C--O 1.22 -0.473 0 CA-C-O 118.774 -0.631 . . . . 1.73 111.757 177.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -44.69 -30.46 4.18 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 122.734 2.289 . . . . 0.80000000000000004 113.304 178.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.686 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 28.6 m -73.43 -43.87 59.46 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.067 0.937 . . . . 1.29 109.937 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.539 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 3.6 m-85 -82.05 -24.93 35.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.597 -0.729 . . . . 1.4299999999999999 110.117 -175.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.537 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 1.7 t70 -77.82 -35.81 50.9 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.949 -1.023 . . . . 1.1599999999999999 109.55 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.686 ' HG3' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -68.03 -36.73 80.42 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.054 -0.521 . . . . 1.6299999999999999 109.778 176.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 55.7 mt -70.42 -33.84 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.462 -0.57 . . . . 1.27 109.462 173.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.537 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 90.3 t80 -56.1 -57.52 11.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.349 -0.842 . . . . 1.51 111.348 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.595 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 57.4 m-85 -68.77 -22.8 64.27 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.991 0.424 . . . . 1.6799999999999999 111.045 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.9 m -70.06 -27.92 65.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.927 -0.579 . . . . 1.1799999999999999 110.698 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 63.6 mt -87.24 -3.97 59.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.644 -0.253 . . . . 1.3600000000000001 111.063 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.2 t 69.05 86.9 0.12 Allowed Pre-proline 0 N--CA 1.468 0.443 0 O-C-N 123.847 0.717 . . . . 1.22 111.533 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.595 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 59.6 Cg_endo -77.0 151.97 31.27 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.882 2.388 . . . . 0.57999999999999996 113.443 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.5 m -120.1 121.6 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.577 -0.738 . . . . 1.9199999999999999 110.756 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 63.26 24.25 14.2 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.915 -0.584 . . . . 2.0899999999999999 112.014 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.43 36.78 9.35 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.687 -0.768 . . . . 0.56999999999999995 112.754 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.612 ' HG3' HD11 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -171.56 162.99 6.63 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.327 -0.62 . . . . 2.3300000000000001 109.327 169.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.549 HD12 ' CD2' ' A' ' 106' ' ' PHE . 2.0 pt -92.97 134.85 29.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 109.741 -0.466 . . . . 1.1799999999999999 109.741 170.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 p -59.33 134.32 56.89 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.652 -1.24 . . . . 1.2 107.652 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.607 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -52.18 -28.26 25.87 Favored Glycine 0 C--O 1.22 -0.732 0 N-CA-C 115.422 0.929 . . . . 0.59999999999999998 115.422 -167.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.91 -27.03 50.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.774 0.787 . . . . 1.1699999999999999 112.047 175.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.414 ' ND2' ' N ' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -79.31 -36.5 39.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.785 0.802 . . . . 2.1099999999999999 109.472 -178.13 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -75.8 -31.34 59.39 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.235 -0.893 . . . . 1.2 110.09 177.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 14.2 mmmm -65.18 -34.51 78.56 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.433 -0.951 . . . . 2.3100000000000001 108.433 173.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 74' ' ' LYS . 1.7 tppp? -58.96 -49.02 79.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.122 -0.944 . . . . 1.6799999999999999 109.719 174.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 57.4 mm-40 -56.69 -53.02 62.51 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.254 -0.884 . . . . 1.48 112.226 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.638 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 15.0 ptp -70.8 -24.7 62.62 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.698 -0.401 . . . . 0.84999999999999998 110.857 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.06 -46.02 82.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 122.109 -0.369 . . . . 1.25 110.991 172.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 18.1 ptpt -73.79 -18.28 60.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.72 -0.218 . . . . 1.79 111.432 -175.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.2 p -67.33 3.22 1.32 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.546 0.573 . . . . 1.9399999999999999 112.546 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 74.44 29.34 1.21 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.987 0.515 . . . . 3.1200000000000001 111.003 172.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.569 HD11 ' HD3' ' A' ' 116' ' ' LYS . 61.6 mt -109.44 162.05 21.67 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.125 -0.488 . . . . 1.71 111.33 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.561 ' O ' HD22 ' A' ' 86' ' ' LEU . 92.3 Cg_endo -81.96 150.43 16.06 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.745 2.297 . . . . 1.03 111.464 174.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -51.29 -29.9 16.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.536 -0.756 . . . . 1.53 112.657 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -62.95 -49.64 73.95 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.429 0.633 . . . . 1.75 110.71 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.549 ' O ' HG13 ' A' ' 89' ' ' ILE . 67.6 t -63.52 -41.83 94.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-N 115.273 -0.876 . . . . 1.28 110.315 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.561 HD22 ' O ' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -64.18 -39.05 93.17 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.721 0.296 . . . . 2.0699999999999998 110.765 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -57.92 -45.96 93.04 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.913 -0.66 . . . . 0.45000000000000001 111.907 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.683 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 44.7 pttt -81.1 -27.76 35.47 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.739 -0.785 . . . . 2.1899999999999999 111.715 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 85' ' ' VAL . 60.0 mt -60.6 -46.3 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 109.662 -0.496 . . . . 1.8200000000000001 109.662 171.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -56.99 -56.92 15.5 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.702 -0.681 . . . . 0.35999999999999999 111.088 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.683 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 9.0 ptpp? -70.38 -9.51 56.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 2.9500000000000002 111.665 -174.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.532 HD12 ' HA ' ' A' ' 124' ' ' ALA . 14.0 tp -93.32 -33.05 14.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 1.5 110.347 175.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.31 -42.84 12.6 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.121 0.415 . . . . 1.1499999999999999 112.121 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.493 ' HB2' HD22 ' A' ' 101' ' ' LEU . 53.8 t0 -84.98 98.65 10.5 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.628 -0.508 . . . . 0.62 109.628 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.02 -29.82 34.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.532 -0.758 . . . . 2.27 111.244 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -27.39 37.57 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.177 -0.675 . . . . 1.7 109.177 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 58.8 45.52 15.39 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 122.318 1.056 . . . . 2.2599999999999998 108.439 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -105.0 6.7 33.65 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.649 -1.614 . . . . 1.51 111.801 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.51 18.62 70.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.467 -0.873 . . . . 0.34000000000000002 112.527 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.612 HD11 ' HG3' ' A' ' 66' ' ' LYS . 4.3 pp -153.3 175.21 13.35 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.693 -0.484 . . . . 1.23 109.693 175.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.56 HD11 ' CB ' ' A' ' 72' ' ' ALA . 46.3 mt -149.79 113.45 5.03 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.931 -1.136 . . . . 1.3700000000000001 107.931 -173.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.1 p-10 -75.75 -172.54 1.93 Allowed 'General case' 0 C--N 1.313 -0.991 0 O-C-N 122.352 -0.217 . . . . 1.5 110.678 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.52 -36.42 66.69 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.852 0.358 . . . . 1.73 111.057 -175.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.51 -26.81 19.58 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.013 0.375 . . . . 2.1400000000000001 112.013 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.503 ' HB3' HD21 ' A' ' 101' ' ' LEU . 2.3 mt-10 -70.8 -34.55 71.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.026 0.441 . . . . 1.1100000000000001 109.91 175.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.666 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -66.7 -42.56 86.24 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 107.649 -1.241 . . . . 1.8600000000000001 107.649 170.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.539 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -53.0 -41.02 64.23 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.846 -0.616 . . . . 1.02 110.558 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.462 HD13 ' HD3' ' A' ' 132' ' ' PRO . 1.0 OUTLIER -73.74 -50.84 18.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.004 -0.544 . . . . 1.8200000000000001 110.883 178.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.42 ' HB2' HD13 ' A' ' 101' ' ' LEU . . . -50.9 -52.07 45.61 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.26 0.552 . . . . 1.0700000000000001 111.198 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.506 ' HB2' ' HE1' ' A' ' 106' ' ' PHE . 7.2 t-20 -71.18 -27.16 63.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.646 -0.706 . . . . 1.8899999999999999 109.515 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.502 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 60.8 t60 -68.69 -40.83 79.88 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 120.19 -0.604 . . . . 0.59999999999999998 109.59 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.525 ' HA ' ' HB ' ' A' ' 115' ' ' VAL . 42.8 mt -68.57 -35.37 77.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.307 -0.406 . . . . 1.23 110.735 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 110' ' ' ASN . 97.4 mt -59.26 -52.43 60.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.334 -0.394 . . . . 1.49 110.186 174.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 19.1 ptmt -72.28 -21.61 61.33 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.126 -0.63 . . . . 2.6699999999999999 110.858 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.525 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 2.5 t -59.15 -47.47 90.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.998 -0.371 . . . . 1.23 109.998 171.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.773 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 4.8 ptmm? -85.44 2.63 43.71 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 120.182 -0.607 . . . . 2.4199999999999999 110.527 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.8 tp -88.4 -19.52 26.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.573 -0.74 . . . . 1.8200000000000001 109.311 168.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 55.2 mt-10 -67.08 -17.18 64.77 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.889 -0.596 . . . . 1.99 110.234 176.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.39 -21.34 13.05 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.026 -0.607 . . . . 1.01 111.94 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.773 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -106.83 135.94 47.51 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.89 -1.152 . . . . 1.0 107.89 174.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.502 ' HA ' ' CB ' ' A' ' 116' ' ' LYS . 13.4 pt-20 -93.26 163.29 13.67 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.737 -0.785 . . . . 2.75 110.937 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.804 ' H ' HD12 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -62.86 127.57 90.76 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-O 121.367 0.603 . . . . 3.1800000000000002 110.763 177.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.497 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 72.8 Cg_endo -95.86 13.8 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.478 2.786 . . . . 1.1899999999999999 113.014 -174.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.532 ' HA ' HD12 ' A' ' 92' ' ' LEU . . . 65.87 36.31 6.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.311 -0.858 . . . . 1.8999999999999999 111.181 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.497 ' OD1' ' HG2' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -114.99 142.69 46.29 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.55 0.69 . . . . 2.3599999999999999 109.914 169.256 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.3 tp -126.25 96.54 36.39 Favored Pre-proline 0 C--N 1.306 -1.32 0 CA-C-N 114.964 -1.017 . . . . 2.3799999999999999 110.032 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -73.2 150.81 48.23 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.755 2.303 . . . . 1.1799999999999999 111.833 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.22 -16.25 45.23 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.785 2.323 . . . . 1.6100000000000001 112.248 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.406 ' O ' HD13 ' A' ' 130' ' ' LEU . 21.6 p-80 -98.38 21.83 10.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.143 -0.481 . . . . 1.71 110.867 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 129' ' ' HIS . 1.0 OUTLIER -138.27 12.91 2.82 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.576 -0.284 . . . . 1.8700000000000001 110.729 174.143 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 m -91.18 125.55 58.06 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 109.401 -0.592 . . . . 2.27 109.401 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.462 ' HD3' HD13 ' A' ' 108' ' ' LEU . 51.3 Cg_exo . . . . . 0 CA--C 1.535 0.538 0 C-N-CA 122.6 2.2 . . . . 1.29 111.829 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 121.126 0.488 . . . . 1.72 111.266 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 t -88.14 -17.69 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 O-C-N 121.667 -0.646 . . . . 1.3200000000000001 111.194 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.78 -16.37 59.09 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.441 -0.885 . . . . 0.71999999999999997 111.906 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.475 ' HZ2' ' CG ' ' A' ' 49' ' ' ASP . 10.5 ptmm? -99.82 -28.21 13.24 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.991 0.367 . . . . 3.3799999999999999 111.991 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.475 ' CG ' ' HZ2' ' A' ' 48' ' ' LYS . 60.2 m-20 -108.01 0.4 21.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.956 0.408 . . . . 1.8300000000000001 111.094 -173.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 54.2 tttp -51.37 -48.63 85.59 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.048 -0.523 . . . . 1.73 112.063 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 26.2 Cg_endo -62.02 -28.99 81.04 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.762 1.641 . . . . 0.80000000000000004 111.902 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.585 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 92.4 m -74.72 -37.69 62.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.719 0.771 . . . . 1.29 110.274 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.466 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 24.0 m-85 -74.51 -24.41 58.98 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.829 -0.623 . . . . 1.4299999999999999 110.269 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.578 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 13.1 t70 -81.36 -32.39 32.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.577 -0.738 . . . . 1.1599999999999999 110.887 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 52' ' ' THR . 17.2 pt-20 -70.0 -44.38 69.5 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.926 -0.484 . . . . 1.6299999999999999 110.022 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.52 -30.12 48.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.819 0.818 . . . . 1.27 109.066 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.904 ' HE1' HG21 ' A' ' 67' ' ' ILE . 0.7 OUTLIER -64.88 -57.21 9.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.304 -1.316 . . . . 1.51 111.019 176.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.605 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 27.6 m-85 -62.88 -22.82 66.99 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.998 0.427 . . . . 1.6799999999999999 110.965 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.7 m -69.09 -22.07 64.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.647 -0.706 . . . . 1.1799999999999999 110.834 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.9 mt -97.47 -7.24 32.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.53 -0.305 . . . . 1.3600000000000001 110.649 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.419 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 10.3 t 70.12 95.11 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.694 0.798 . . . . 1.22 111.797 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.657 ' HB3' ' CE1' ' A' ' 57' ' ' PHE . 11.0 Cg_endo -62.09 160.87 28.39 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.422 2.748 . . . . 0.57999999999999996 113.855 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.631 HG13 HD21 ' A' ' 64' ' ' ASN . 87.2 t -129.12 102.99 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.315 -0.857 . . . . 1.9199999999999999 110.006 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.631 HD21 HG13 ' A' ' 63' ' ' VAL . 53.7 m-80 66.17 28.19 10.18 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.008 0.523 . . . . 2.0899999999999999 111.859 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.89 21.89 27.09 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.895 -0.669 . . . . 0.56999999999999995 113.301 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.649 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -169.98 152.0 4.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.147 -1.057 . . . . 2.3300000000000001 108.147 174.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.904 HG21 ' HE1' ' A' ' 57' ' ' PHE . 1.1 pt -90.8 139.28 17.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 119.531 -0.868 . . . . 1.1799999999999999 110.183 174.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.6 p -60.37 139.58 57.59 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.338 -0.986 . . . . 1.2 108.338 169.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.55 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -53.5 -35.72 52.03 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 115.098 0.799 . . . . 0.59999999999999998 115.098 -164.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.01 -22.44 15.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.54 0.67 . . . . 1.1699999999999999 112.794 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -80.25 -40.68 26.51 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.675 0.75 . . . . 2.1099999999999999 109.689 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.619 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -73.79 -31.25 63.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.436 -0.802 . . . . 1.2 109.663 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.2 mmmm -64.29 -35.03 79.5 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.643 -0.873 . . . . 2.3100000000000001 108.643 173.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 1.1 tppp? -59.16 -44.66 92.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.337 -0.847 . . . . 1.6799999999999999 110.006 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 60.2 mm-40 -60.16 -53.17 60.85 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.275 -0.875 . . . . 1.48 111.823 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.619 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 12.5 ptp -71.13 -18.23 62.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.432 -0.349 . . . . 0.84999999999999998 110.858 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.479 HG23 HD13 ' A' ' 86' ' ' LEU . 2.4 t -74.23 -47.91 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.309 -0.405 . . . . 1.25 110.795 171.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 18.1 ptpt -70.39 -13.33 62.1 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.976 0.417 . . . . 1.79 110.354 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.5 t -65.86 -7.34 15.79 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.896 -0.593 . . . . 1.9399999999999999 110.517 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 68.04 67.56 0.34 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.927 0.891 . . . . 3.1200000000000001 110.889 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.974 HD21 ' HE3' ' A' ' 116' ' ' LYS . 22.6 mt -132.65 159.73 71.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.897 -0.592 . . . . 1.71 111.029 -175.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.517 ' HG2' HG23 ' A' ' 85' ' ' VAL . 62.9 Cg_endo -76.96 163.62 30.78 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.536 2.157 . . . . 1.03 110.922 169.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -61.57 -24.09 66.42 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.248 0.462 . . . . 1.53 112.248 -174.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.8 m -62.78 -48.94 76.97 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 120.998 0.428 . . . . 1.75 110.74 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.517 HG23 ' HG2' ' A' ' 82' ' ' PRO . 21.8 t -67.23 -43.53 88.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.328 -0.619 . . . . 1.28 109.328 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.479 HD13 HG23 ' A' ' 77' ' ' VAL . 3.3 mm? -46.55 -57.49 4.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.531 -0.759 . . . . 2.0699999999999998 111.009 172.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.4 -40.74 99.07 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.031 -0.986 . . . . 0.45000000000000001 113.702 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.834 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 55.7 pttt -85.28 -25.09 27.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.618 -0.833 . . . . 2.1899999999999999 112.209 -175.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.603 HG12 ' CD1' ' A' ' 122' ' ' LEU . 18.6 mt -65.2 -43.05 95.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.424 -0.954 . . . . 1.8200000000000001 108.424 170.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.427 ' CH2' ' HG ' ' A' ' 101' ' ' LEU . 73.9 t-105 -60.57 -53.29 59.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.943 -1.026 . . . . 0.35999999999999999 111.301 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.834 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -72.82 -12.34 60.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.579 -0.282 . . . . 2.9500000000000002 111.616 -174.383 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.2 tp -91.25 -25.12 19.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.689 -0.486 . . . . 1.5 109.689 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.62 ' HA ' HD11 ' A' ' 108' ' ' LEU . . . -93.1 -43.08 9.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.031 0.443 . . . . 1.1499999999999999 112.0 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.497 ' HB2' HD21 ' A' ' 101' ' ' LEU . 46.9 t0 -88.46 94.29 9.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.193 0.52 . . . . 0.62 110.171 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.5 t -64.35 -23.27 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.289 -0.869 . . . . 2.27 111.18 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.0 -26.77 15.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.57 -0.741 . . . . 1.7 110.726 -174.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt 60.23 58.71 2.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.348 1.071 . . . . 2.2599999999999998 109.096 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -106.11 -18.81 13.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.454 -1.703 . . . . 1.51 111.278 -170.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.64 13.89 49.08 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.479 -0.867 . . . . 0.34000000000000002 112.553 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.6 pp -148.05 179.0 8.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.767 -0.457 . . . . 1.23 109.767 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.584 HD11 ' CB ' ' A' ' 72' ' ' ALA . 25.2 mt -151.27 114.64 4.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.83 -1.174 . . . . 1.3700000000000001 107.83 -175.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.5 p30 -78.98 -174.36 4.0 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.49 -0.484 . . . . 1.5 109.996 178.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.63 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 3.9 p30 -57.84 -33.73 68.96 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.16 0.429 . . . . 1.73 112.16 -174.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.931 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 16.5 tt0 -85.74 -27.0 25.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.53 0.681 . . . . 2.1400000000000001 110.391 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.542 ' HB3' HD23 ' A' ' 101' ' ' LEU . 3.0 mt-10 -75.25 -33.69 61.33 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.603 -0.726 . . . . 1.1100000000000001 110.499 176.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -66.89 -40.87 87.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.753 -1.203 . . . . 1.8600000000000001 107.753 172.098 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.466 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -52.61 -48.94 65.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.289 -0.868 . . . . 1.02 110.799 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.62 HD11 ' HA ' ' A' ' 93' ' ' ALA . 1.3 tt -65.55 -53.27 44.45 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.352 -0.385 . . . . 1.8200000000000001 110.121 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.402 ' HB2' HD13 ' A' ' 101' ' ' LEU . . . -49.6 -53.36 24.41 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.619 0.6 . . . . 1.0700000000000001 112.619 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.442 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 10.2 t-20 -70.57 -32.1 69.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.169 0.509 . . . . 1.8899999999999999 110.167 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.528 ' O ' HG23 ' A' ' 115' ' ' VAL . 78.0 t60 -66.4 -35.26 79.86 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.975 -0.557 . . . . 0.59999999999999998 109.706 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.2 mt -69.12 -36.6 77.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.843 -0.617 . . . . 1.23 110.463 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.582 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 47.5 mm -59.49 -41.66 85.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.884 0.373 . . . . 1.49 110.195 172.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.681 ' HE2' ' O ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -57.11 -49.39 76.06 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.72 -0.673 . . . . 2.6699999999999999 109.624 173.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 111' ' ' HIS . 78.6 t -60.32 -42.07 89.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.766 -0.652 . . . . 1.23 111.577 -176.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.974 ' HE3' HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -75.27 -21.56 58.43 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.863 -0.335 . . . . 2.4199999999999999 111.278 178.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.1 tp -79.75 -19.4 48.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.746 0.307 . . . . 1.8200000000000001 110.535 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.598 ' HG2' ' NZ ' ' A' ' 114' ' ' LYS . 37.2 mt-10 -62.92 -16.73 60.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.148 0.499 . . . . 1.99 110.427 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 112.07 4.91 25.57 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.667 -0.777 . . . . 1.01 111.627 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.482 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 2.7 p80 -126.85 140.41 52.37 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.305 0.574 . . . . 1.0 110.36 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -71.77 152.16 42.94 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.123 -0.944 . . . . 2.75 111.363 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.603 ' CD1' HG12 ' A' ' 89' ' ' ILE . 39.9 mt -67.12 141.15 96.17 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 115.839 -0.619 . . . . 3.1800000000000002 110.398 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -87.64 4.04 6.08 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.055 2.503 . . . . 1.1899999999999999 113.515 -173.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 58.81 19.95 7.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.37 0.605 . . . . 1.8999999999999999 111.1 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -112.91 136.2 52.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.741 -0.837 . . . . 2.3599999999999999 108.741 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.59 HD21 HG22 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -116.16 102.62 53.69 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 109.303 -0.629 . . . . 2.3799999999999999 109.303 -177.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 2.0 Cg_endo -79.96 157.27 23.83 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.061 2.507 . . . . 1.1799999999999999 112.155 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -55.0 -40.33 86.47 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.397 2.065 . . . . 1.6100000000000001 111.843 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.64 ' O ' HD11 ' A' ' 130' ' ' LEU . 50.1 p-80 -81.89 30.88 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.658 -0.701 . . . . 1.71 111.709 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.64 HD11 ' O ' ' A' ' 129' ' ' HIS . 0.7 OUTLIER -146.86 9.89 1.02 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.063 0.394 . . . . 1.8700000000000001 112.063 171.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.59 HG22 HD21 ' A' ' 126' ' ' LEU . 7.3 t -97.33 115.16 65.68 Favored Pre-proline 0 C--N 1.322 -0.598 0 C-N-CA 120.177 -0.609 . . . . 2.27 110.806 176.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.931 ' HB3' ' HG2' ' A' ' 104' ' ' GLU . 84.0 Cg_exo . . . . . 0 N--CA 1.46 -0.474 0 C-N-CA 123.751 2.967 . . . . 1.29 111.49 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 t . . . . . 0 CA--C 1.546 0.81 0 CA-C-O 121.043 0.449 . . . . 1.72 111.823 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 1.2 t -94.76 -21.99 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 121.46 -0.775 . . . . 1.3200000000000001 111.672 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.78 -14.25 57.91 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.074 -1.06 . . . . 0.71999999999999997 111.842 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -104.53 -28.35 11.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 111.923 0.342 . . . . 3.3799999999999999 111.923 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -107.36 1.94 24.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.515 0.674 . . . . 1.8300000000000001 110.154 -171.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 55.7 tttm -55.69 -46.99 99.65 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.05 -0.977 . . . . 1.73 112.086 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 11.1 Cg_endo -55.84 -26.87 59.68 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.23 1.953 . . . . 0.80000000000000004 112.636 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.544 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . 9.5 m -70.35 -45.16 66.68 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.852 0.834 . . . . 1.29 108.99 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.556 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 16.7 m-85 -75.74 -24.21 56.1 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.116 -0.947 . . . . 1.4299999999999999 109.581 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.596 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 15.1 t70 -78.09 -37.98 45.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.534 -0.757 . . . . 1.1599999999999999 111.145 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.544 ' OE2' ' HA ' ' A' ' 52' ' ' THR . 15.5 pt-20 -68.06 -37.1 80.92 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.515 -0.474 . . . . 1.6299999999999999 110.559 176.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 52' ' ' THR . 48.7 mt -70.14 -28.24 35.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.251 0.548 . . . . 1.27 109.612 173.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 66.4 t80 -61.51 -54.17 46.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.347 -0.842 . . . . 1.51 111.194 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.578 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 42.0 m-85 -68.75 -22.5 64.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.132 0.492 . . . . 1.6799999999999999 110.786 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.9 m -72.77 -25.69 61.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.696 -0.683 . . . . 1.1799999999999999 110.863 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.475 HD13 ' HG2' ' A' ' 75' ' ' GLU . 25.9 mt -87.6 -0.01 56.26 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.638 -0.256 . . . . 1.3600000000000001 111.439 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 t 67.55 87.51 0.12 Allowed Pre-proline 0 N--CA 1.467 0.377 0 CA-C-O 121.297 0.57 . . . . 1.22 110.916 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.578 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 71.6 Cg_endo -81.03 159.28 20.75 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.634 2.222 . . . . 0.57999999999999996 112.65 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 97.4 t -128.92 121.21 53.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.081 -0.509 . . . . 1.9199999999999999 109.794 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 66.38 23.04 10.69 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.117 -0.492 . . . . 2.0899999999999999 112.168 174.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.21 23.02 23.4 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.871 -0.68 . . . . 0.56999999999999995 112.114 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.885 ' HG3' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -167.48 159.77 12.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.588 -0.523 . . . . 2.3300000000000001 109.588 175.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pt -89.76 132.43 34.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 120.129 -0.628 . . . . 1.1799999999999999 110.345 173.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -59.2 130.55 47.5 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.693 -1.225 . . . . 1.2 107.693 170.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.579 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -53.71 -26.26 31.75 Favored Glycine 0 C--O 1.219 -0.819 0 N-CA-C 114.69 0.636 . . . . 0.59999999999999998 114.69 -166.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.15 -39.53 43.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 117.475 0.637 . . . . 1.1699999999999999 111.437 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.44 -31.83 48.27 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.16 -0.473 . . . . 2.1099999999999999 110.087 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.673 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -74.05 -36.19 64.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.678 -0.692 . . . . 1.2 109.718 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 14.7 mmmm -66.28 -37.97 86.7 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.707 -0.849 . . . . 2.3100000000000001 108.707 173.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -56.59 -44.89 81.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.526 -0.761 . . . . 1.6799999999999999 110.255 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.475 ' HG2' HD13 ' A' ' 60' ' ' LEU . 1.8 tp10 -61.81 -53.07 60.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.544 -1.207 . . . . 1.48 111.162 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.673 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 12.5 ptp -73.05 -16.69 61.48 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 122.068 -0.395 . . . . 0.84999999999999998 111.353 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 86' ' ' LEU . 2.3 t -74.17 -49.64 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.577 0.227 . . . . 1.25 110.832 173.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 14.6 ptpt -68.28 -12.18 60.62 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.085 0.469 . . . . 1.79 109.851 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 76' ' ' MET . 62.4 m -67.69 3.93 1.26 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.29 -0.868 . . . . 1.9399999999999999 111.835 170.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 74.36 37.95 0.55 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.26 0.624 . . . . 3.1200000000000001 111.686 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.574 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . 22.8 mt -113.49 157.47 41.26 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 120.809 -0.357 . . . . 1.71 111.539 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.445 ' O ' HD23 ' A' ' 86' ' ' LEU . 84.3 Cg_endo -83.91 164.26 13.69 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.898 2.399 . . . . 1.03 111.307 169.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.524 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 8.5 m120 -54.75 -29.34 53.62 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.282 0.475 . . . . 1.53 112.282 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -59.94 -54.02 50.96 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.302 0.572 . . . . 1.75 110.776 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 24.0 t -66.31 -41.68 89.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.641 -0.708 . . . . 1.28 109.927 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.574 ' CD2' ' HB2' ' A' ' 81' ' ' LEU . 3.9 mm? -49.52 -55.13 14.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.9 -0.591 . . . . 2.0699999999999998 110.856 173.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.91 -44.5 97.33 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.392 -0.822 . . . . 0.45000000000000001 113.324 -175.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.608 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 55.5 pttt -80.19 -27.45 38.87 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.654 -0.818 . . . . 2.1899999999999999 111.676 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 mt -69.63 -41.55 80.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 120.536 -0.465 . . . . 1.8200000000000001 109.841 173.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.436 ' CH2' ' HG ' ' A' ' 101' ' ' LEU . 75.9 t-105 -55.87 -58.85 6.13 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.754 -0.657 . . . . 0.35999999999999999 110.346 175.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.608 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -69.44 -17.26 63.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.812 -0.631 . . . . 2.9500000000000002 111.765 -172.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 14.3 tp -82.35 -37.4 25.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.129 -0.323 . . . . 1.5 110.129 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.712 ' HA ' HD11 ' A' ' 108' ' ' LEU . . . -91.08 -33.75 15.36 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 120.556 -0.458 . . . . 1.1499999999999999 111.528 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.552 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 27.6 t0 -83.84 80.97 8.97 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.615 0.721 . . . . 0.62 109.922 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.441 HG21 HD13 ' A' ' 126' ' ' LEU . 16.0 t -67.34 -25.44 33.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 114.917 -1.038 . . . . 2.27 110.817 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.409 ' C ' ' HG3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -90.43 -23.84 20.91 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.619 -0.718 . . . . 1.7 112.234 -178.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.552 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 21.8 mtpt 67.02 45.22 1.8 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.769 0.795 . . . . 2.2599999999999998 110.364 167.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 p30 -105.31 -1.06 25.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.759 -1.11 . . . . 1.51 112.371 -171.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.87 19.38 77.71 Favored Glycine 0 C--N 1.322 -0.224 0 C-N-CA 119.506 -1.33 . . . . 0.34000000000000002 112.326 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.885 HD12 ' HG3' ' A' ' 66' ' ' LYS . 4.4 pp -151.33 171.41 17.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.796 -0.816 . . . . 1.23 108.796 174.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 105' ' ' GLU . 44.2 mt -148.59 116.17 6.26 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.82 -1.178 . . . . 1.3700000000000001 107.82 -172.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -77.13 -175.94 3.83 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.086 -0.646 . . . . 1.5 109.366 178.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -60.26 -31.18 69.97 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.358 0.526 . . . . 1.73 111.164 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.635 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 34.0 tt0 -73.91 -39.94 63.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.426 0.631 . . . . 2.1400000000000001 110.107 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . 3.8 mt-10 -66.99 -39.16 87.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.672 -0.695 . . . . 1.1100000000000001 111.919 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.628 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -64.63 -39.2 93.28 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.158 -1.052 . . . . 1.8600000000000001 108.158 175.32 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.556 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -50.95 -49.14 60.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 1.02 110.581 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.727 HD12 ' HD3' ' A' ' 132' ' ' PRO . 1.1 tt -70.56 -50.42 37.65 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.443 -0.503 . . . . 1.8200000000000001 110.509 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.451 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -45.73 -55.63 6.25 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.33 0.492 . . . . 1.0700000000000001 112.33 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.551 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 2.6 t-20 -72.84 -23.31 60.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.677 -0.49 . . . . 1.8899999999999999 109.677 -177.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.485 ' CD2' HD13 ' A' ' 130' ' ' LEU . 70.8 t60 -68.01 -43.93 77.71 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.236 -0.653 . . . . 0.59999999999999998 109.236 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.695 HD22 HD13 ' A' ' 122' ' ' LEU . 46.7 mt -64.64 -32.81 74.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.107 -0.497 . . . . 1.23 110.191 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 109' ' ' ALA . 41.4 mm -61.11 -50.92 78.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.886 -0.597 . . . . 1.49 111.001 176.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.465 ' HD3' ' OH ' ' A' ' 53' ' ' TYR . 18.7 ptmt -72.33 -24.47 61.31 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.086 -0.646 . . . . 2.6699999999999999 110.823 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 111' ' ' HIS . 11.5 t -60.46 -47.22 93.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.318 -0.401 . . . . 1.23 110.39 172.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 0.9 OUTLIER -85.38 0.5 51.97 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 120.36 -0.536 . . . . 2.4199999999999999 110.635 178.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.1 tp -81.83 -26.6 34.15 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.604 -0.517 . . . . 1.8200000000000001 109.604 171.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.33 -22.17 65.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.801 -0.636 . . . . 1.99 111.169 177.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.09 10.79 13.24 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.351 -0.928 . . . . 1.01 112.698 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.585 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -127.21 133.49 50.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 174.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -78.34 163.36 25.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.783 0.325 . . . . 2.75 110.935 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.695 HD13 HD22 ' A' ' 112' ' ' LEU . 3.5 mm? -70.44 144.86 92.27 Favored Pre-proline 0 CA--C 1.513 -0.474 0 CA-C-N 116.077 -0.51 . . . . 3.1800000000000002 111.818 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.552 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 68.9 Cg_endo -77.62 -6.37 16.12 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 124.453 3.435 . . . . 1.1899999999999999 113.404 -173.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.22 19.53 11.72 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.632 0.73 . . . . 1.8999999999999999 109.655 -170.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.552 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 38.8 t70 -120.45 145.82 46.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.943 -1.026 . . . . 2.3599999999999999 108.985 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.441 HD13 HG21 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -115.15 104.41 53.79 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 116.353 -0.385 . . . . 2.3799999999999999 110.018 -176.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 5.7 Cg_endo -87.9 147.01 6.85 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.334 2.689 . . . . 1.1799999999999999 111.982 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -55.08 -30.35 69.95 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.762 2.308 . . . . 1.6100000000000001 113.321 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -80.94 22.72 0.6 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.995 -0.282 . . . . 1.71 111.109 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.485 HD13 ' CD2' ' A' ' 111' ' ' HIS . 0.6 OUTLIER -150.29 8.52 0.62 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.619 -0.433 . . . . 1.8700000000000001 111.477 177.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.1 132.09 31.57 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.942 -0.762 . . . . 2.27 108.942 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.727 ' HD3' HD12 ' A' ' 108' ' ' LEU . 37.4 Cg_exo . . . . . 0 C--O 1.237 0.448 0 C-N-CA 122.29 1.994 . . . . 1.29 112.539 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 t . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 112.153 0.427 . . . . 1.72 112.153 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 2.2 t -80.54 -17.74 12.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 120.951 -1.093 . . . . 1.3200000000000001 111.321 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.71 -17.15 62.27 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.694 -1.241 . . . . 0.71999999999999997 111.741 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -106.97 -29.4 9.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.002 0.371 . . . . 3.3799999999999999 112.002 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 84.5 m-20 -89.33 -11.55 43.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 1.8300000000000001 110.676 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 49.9 tttm -49.87 -51.48 60.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.209 -0.905 . . . . 1.73 112.409 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 8.0 Cg_endo -50.6 -35.64 47.39 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 122.726 2.284 . . . . 0.80000000000000004 113.837 -178.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.655 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 87.5 m -72.5 -40.64 66.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.999 0.904 . . . . 1.29 110.328 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.643 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 10.3 m-85 -76.86 -23.85 52.63 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.766 0.793 . . . . 1.4299999999999999 109.279 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.531 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 7.2 t70 -80.66 -33.32 35.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.635 -1.166 . . . . 1.1599999999999999 110.776 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 52' ' ' THR . 14.0 pt-20 -69.47 -35.9 76.04 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.606 -0.516 . . . . 1.6299999999999999 109.606 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 52' ' ' THR . 46.5 mt -71.84 -29.8 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.224 -0.658 . . . . 1.27 109.224 174.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.531 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 72.7 t80 -61.81 -57.42 11.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.146 -0.933 . . . . 1.51 111.534 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -64.1 -22.32 66.89 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.037 0.446 . . . . 1.6799999999999999 110.908 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.5 m -73.07 -32.05 64.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.923 -0.58 . . . . 1.1799999999999999 111.516 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.1 mt -84.89 1.3 47.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.624 0.25 . . . . 1.3600000000000001 111.261 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t 70.9 85.76 0.12 Allowed Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.604 -0.726 . . . . 1.22 111.125 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.63 123.86 4.42 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.702 2.268 . . . . 0.57999999999999996 112.647 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.5 t -87.33 109.72 19.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.245 -0.434 . . . . 1.9199999999999999 110.027 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.06 23.75 11.05 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.322 0.389 . . . . 2.0899999999999999 111.378 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.67 27.79 12.29 Favored Glycine 0 C--O 1.228 -0.254 0 C-N-CA 121.054 -0.593 . . . . 0.56999999999999995 113.565 170.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.579 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -164.39 147.39 9.09 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.306 -0.627 . . . . 2.3300000000000001 109.306 172.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.959 ' HB ' HD22 ' A' ' 71' ' ' ASN . 3.0 pt -86.89 137.11 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 120.695 -0.402 . . . . 1.1799999999999999 110.437 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.5 p -60.32 124.3 19.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.755 -1.202 . . . . 1.2 107.755 170.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.578 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -46.94 -31.76 5.77 Favored Glycine 0 C--O 1.222 -0.608 0 C-N-CA 121.302 -0.475 . . . . 0.59999999999999998 114.26 -168.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -43.73 -52.0 6.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.31 0.485 . . . . 1.1699999999999999 112.31 173.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.959 HD22 ' HB ' ' A' ' 67' ' ' ILE . 11.7 p30 -71.03 -30.85 67.17 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.056 0.389 . . . . 2.1099999999999999 110.586 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.576 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -72.12 -31.76 66.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.585 0.707 . . . . 1.2 109.612 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 31.6 mmmt -68.32 -35.85 78.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.072 -0.967 . . . . 2.3100000000000001 109.474 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.795 ' HG2' ' HA ' ' A' ' 71' ' ' ASN . 9.0 mmmm -59.45 -48.58 81.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 1.6799999999999999 109.503 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 23.6 mm-40 -54.73 -52.49 62.33 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.793 -1.094 . . . . 1.48 112.182 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.576 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 14.7 ptp -69.54 -29.38 66.95 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.126 -0.63 . . . . 0.84999999999999998 110.916 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.42 -45.83 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.489 0.185 . . . . 1.25 110.854 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 17.4 ptpt -72.78 -14.32 61.5 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.038 0.446 . . . . 1.79 110.458 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.495 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 50.1 m -66.15 -13.03 59.51 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.454 -0.794 . . . . 1.9399999999999999 110.186 168.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 97.3 mttt 71.91 39.63 0.81 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.599 0.76 . . . . 3.1200000000000001 112.014 165.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.876 HD11 ' HE2' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -102.18 159.45 29.34 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.841 -0.618 . . . . 1.71 110.115 -179.142 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.519 ' HG2' HG22 ' A' ' 85' ' ' VAL . 31.6 Cg_endo -66.88 153.3 78.39 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.893 1.729 . . . . 1.03 110.742 172.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.747 ' HA ' HD11 ' A' ' 86' ' ' LEU . 0.9 OUTLIER -49.86 -31.74 12.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.005 -0.543 . . . . 1.53 112.042 -179.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.5 m -60.33 -55.59 31.84 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.209 0.528 . . . . 1.75 110.628 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 89' ' ' ILE . 91.1 t -60.63 -44.46 96.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 CA-C-N 115.745 -0.661 . . . . 1.28 110.071 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.747 HD11 ' HA ' ' A' ' 83' ' ' ASN . 24.9 mt -60.08 -49.96 75.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.383 -0.372 . . . . 2.0699999999999998 111.984 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -55.77 -42.41 85.43 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.146 -0.782 . . . . 0.45000000000000001 111.146 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 61.6 pttt -86.51 -13.49 45.83 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.491 -0.883 . . . . 2.1899999999999999 111.778 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 85' ' ' VAL . 23.0 mt -71.59 -43.51 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 N-CA-C 108.511 -0.922 . . . . 1.8200000000000001 108.511 170.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.482 ' HB2' ' HZ3' ' A' ' 73' ' ' LYS . 71.4 t-105 -60.36 -56.77 17.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.82 -0.627 . . . . 0.35999999999999999 111.021 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 62.7 mttm -72.22 -21.45 61.4 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.65 -0.705 . . . . 2.9500000000000002 111.965 -169.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 5.5 tp -86.32 -19.65 29.51 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.801 -0.444 . . . . 1.5 109.801 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.873 ' HA ' HD21 ' A' ' 108' ' ' LEU . . . -93.05 -44.29 8.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.126 0.488 . . . . 1.1499999999999999 110.921 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.486 ' HB2' HD22 ' A' ' 101' ' ' LEU . 46.9 t0 -87.99 74.46 8.93 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.031 -1.1 . . . . 0.62 108.031 173.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.1 t -69.87 -6.96 7.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.19 -0.914 . . . . 2.27 109.81 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -94.18 -26.33 16.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.967 -1.015 . . . . 1.7 109.725 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 59.66 73.34 0.49 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.329 -0.85 . . . . 2.2599999999999998 111.833 169.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.484 ' OD1' ' HG ' ' A' ' 100' ' ' LEU . 1.4 p30 -128.28 -23.47 3.25 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.913 -1.039 . . . . 1.51 112.078 -171.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.78 7.47 38.88 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.165 -1.016 . . . . 0.34000000000000002 112.529 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.484 ' HG ' ' OD1' ' A' ' 98' ' ' ASP . 3.6 pp -142.21 -175.21 4.35 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.805 -0.813 . . . . 1.23 108.805 174.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.624 ' O ' HG12 ' A' ' 67' ' ' ILE . 50.8 mt -151.45 112.6 4.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.367 -1.345 . . . . 1.3700000000000001 107.367 -177.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.7 p30 -76.73 -175.75 3.55 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.674 -0.81 . . . . 1.5 109.809 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.08 -32.96 66.8 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.105 0.478 . . . . 1.73 111.879 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 35.5 tt0 -85.81 -29.01 24.12 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.314 0.578 . . . . 2.1400000000000001 110.246 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HB3' HD21 ' A' ' 101' ' ' LEU . 4.0 mt-10 -75.15 -33.39 61.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.764 -0.653 . . . . 1.1100000000000001 110.977 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.666 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.6 OUTLIER -66.99 -40.23 87.32 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.638 -1.245 . . . . 1.8600000000000001 107.638 171.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.643 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -51.15 -46.19 61.94 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.078 -0.51 . . . . 1.02 110.607 175.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.873 HD21 ' HA ' ' A' ' 93' ' ' ALA . 1.4 tt -67.6 -48.89 65.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.309 -0.405 . . . . 1.8200000000000001 110.353 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.448 ' HB3' HD13 ' A' ' 101' ' ' LEU . . . -49.88 -57.29 7.75 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.921 -0.582 . . . . 1.0700000000000001 112.296 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.446 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 11.4 t-20 -70.61 -28.64 65.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.02 0.438 . . . . 1.8899999999999999 110.066 -174.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.531 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 66.7 t60 -69.88 -36.37 75.4 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.59999999999999998 110.032 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.486 HD23 HD23 ' A' ' 122' ' ' LEU . 41.8 mt -69.2 -35.97 76.8 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.949 -0.389 . . . . 1.23 109.949 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.668 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 76.3 mt -58.37 -45.21 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.414 -0.357 . . . . 1.49 111.379 172.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.549 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 5.5 ptmm? -67.7 -33.05 74.13 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 119.658 -0.817 . . . . 2.6699999999999999 110.605 177.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 111' ' ' HIS . 37.4 t -62.75 -44.25 99.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.899 0.38 . . . . 1.23 110.719 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.876 ' HE2' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -76.6 -6.88 53.85 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.099 0.476 . . . . 2.4199999999999999 110.391 176.173 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.1 tp -91.09 -15.89 28.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.339 0.59 . . . . 1.8200000000000001 109.831 172.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 50.0 mt-10 -81.42 2.07 30.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.635 -0.711 . . . . 1.99 110.761 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.79 5.75 33.25 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.281 -0.962 . . . . 1.01 113.076 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.608 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -141.13 137.29 32.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.304 0.573 . . . . 1.0 111.161 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.54 163.93 25.88 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.216 -0.902 . . . . 2.75 111.421 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.486 HD23 HD23 ' A' ' 112' ' ' LEU . 39.4 mt -73.36 144.9 84.71 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.908 -0.587 . . . . 3.1800000000000002 110.823 -178.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.52 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 46.9 Cg_endo -82.56 -1.07 10.45 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.216 2.611 . . . . 1.1899999999999999 113.497 -172.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.54 19.4 11.21 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.744 0.783 . . . . 1.8999999999999999 109.954 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.52 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 32.2 t70 -117.31 150.53 38.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.687 -1.142 . . . . 2.3599999999999999 109.207 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 2.3 tm? -124.37 103.14 32.61 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 109.216 -0.661 . . . . 2.3799999999999999 109.216 -177.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 4.8 Cg_exo -77.55 147.92 25.65 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.97 2.447 . . . . 1.1799999999999999 112.66 -176.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.421 ' HA ' HG13 ' A' ' 131' ' ' VAL . 50.9 Cg_exo -53.45 -35.52 76.2 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.258 2.639 . . . . 1.6100000000000001 112.848 177.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.532 ' O ' HD13 ' A' ' 130' ' ' LEU . 49.9 p-80 -82.27 18.48 1.41 Allowed 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 120.62 -0.432 . . . . 1.71 110.996 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.532 HD13 ' O ' ' A' ' 129' ' ' HIS . 2.9 mp -138.7 16.41 2.7 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.475 0.485 . . . . 1.8700000000000001 110.888 172.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.421 HG13 ' HA ' ' A' ' 128' ' ' PRO . 32.4 m -77.66 116.52 58.87 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 120.133 -0.627 . . . . 2.27 110.211 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 C--O 1.239 0.557 0 C-N-CA 122.099 1.866 . . . . 1.29 111.611 178.466 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.437 ' HB ' ' CE1' ' A' ' 111' ' ' HIS . 12.4 t . . . . . 0 N--CA 1.448 -0.527 0 CA-C-O 121.011 0.434 . . . . 1.72 111.408 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 4.1 t -83.6 -27.66 7.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 121.771 -0.581 . . . . 1.3200000000000001 111.717 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.43 -19.47 53.39 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 119.564 -1.303 . . . . 0.71999999999999997 112.053 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -101.63 -28.6 12.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.336 0.495 . . . . 3.3799999999999999 112.336 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -106.55 5.81 29.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.716 0.77 . . . . 1.8300000000000001 110.36 -172.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 62.0 tttm -59.34 -46.69 99.02 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.17 -0.923 . . . . 1.73 112.222 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 18.2 Cg_endo -60.02 -23.48 73.23 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.905 1.737 . . . . 0.80000000000000004 112.397 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.761 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 81.8 m -78.23 -36.48 47.02 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.433 0.635 . . . . 1.29 110.023 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.451 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 16.1 m-85 -80.55 -25.34 38.67 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.344 -0.942 . . . . 1.4299999999999999 109.917 177.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 4.4 t70 -76.45 -34.94 58.71 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.096 -0.956 . . . . 1.1599999999999999 110.154 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.761 ' HG2' ' O ' ' A' ' 52' ' ' THR . 12.7 pt-20 -65.3 -42.28 93.21 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.53 -0.544 . . . . 1.6299999999999999 109.53 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 52' ' ' THR . 60.0 mt -67.38 -32.72 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 109.621 -0.511 . . . . 1.27 109.621 175.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.544 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 66.8 t80 -57.06 -55.27 36.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.192 -0.913 . . . . 1.51 111.755 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.479 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 67.7 m-85 -69.23 -23.1 63.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.989 0.423 . . . . 1.6799999999999999 110.61 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.0 m -70.41 -21.69 62.81 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.614 -0.721 . . . . 1.1799999999999999 110.771 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 mt -88.7 -1.05 57.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.664 -0.244 . . . . 1.3600000000000001 111.301 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.2 t 65.55 81.12 0.22 Allowed Pre-proline 0 N--CA 1.465 0.315 0 O-C-N 123.594 0.559 . . . . 1.22 111.218 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 62.9 Cg_endo -80.22 166.56 20.43 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.346 2.031 . . . . 0.57999999999999996 111.517 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 64' ' ' ASN . 2.2 m -135.57 118.66 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 121.211 -0.196 . . . . 1.9199999999999999 110.62 -177.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.639 ' HB3' ' HZ1' ' A' ' 66' ' ' LYS . 8.3 t30 67.95 21.66 8.84 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 122.242 1.02 . . . . 2.0899999999999999 109.901 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.34 26.19 16.57 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.592 -0.813 . . . . 0.56999999999999995 114.418 172.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.639 ' HZ1' ' HB3' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -166.21 157.28 13.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.488 0.644 . . . . 2.3300000000000001 110.075 174.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.419 HD11 ' CD2' ' A' ' 106' ' ' PHE . 1.8 pt -91.58 128.92 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 120.622 -0.431 . . . . 1.1799999999999999 110.564 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -71.79 82.6 0.89 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.899 -0.592 . . . . 1.2 111.485 179.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.457 ' H ' ' HA ' ' A' ' 100' ' ' LEU . . . 44.28 -76.58 0.0 OUTLIER Glycine 0 C--O 1.226 -0.347 0 CA-C-N 113.844 -1.525 . . . . 0.59999999999999998 116.201 167.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' THR . . . -46.6 -29.01 1.63 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.043 0.757 . . . . 1.1699999999999999 113.043 -176.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -71.72 -42.65 67.07 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.148 0.499 . . . . 2.1099999999999999 110.101 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.456 ' CB ' HD11 ' A' ' 101' ' ' LEU . . . -72.0 -33.89 68.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.48 0.657 . . . . 1.2 109.993 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.645 ' O ' HG23 ' A' ' 77' ' ' VAL . 29.6 mmmt -64.32 -38.95 92.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.363 -0.835 . . . . 2.3100000000000001 109.576 174.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 74' ' ' LYS . 1.0 OUTLIER -54.84 -47.18 74.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.506 -0.77 . . . . 1.6799999999999999 109.992 175.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.662 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 8.7 mm-40 -60.7 -48.67 80.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.371 -1.286 . . . . 1.48 111.919 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.464 ' SD ' ' HD2' ' A' ' 73' ' ' LYS . 17.6 ptp -70.34 -15.53 62.88 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.739 -0.384 . . . . 0.84999999999999998 111.125 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 73' ' ' LYS . 54.0 t -75.41 -50.25 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.749 0.309 . . . . 1.25 110.56 171.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.662 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 8.7 ptmt -68.72 -11.83 60.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.089 0.471 . . . . 1.79 110.453 -177.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.3 t -69.24 -8.1 42.83 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.845 -0.616 . . . . 1.9399999999999999 110.409 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 47.5 mttp 65.98 68.58 0.46 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.552 -0.749 . . . . 3.1200000000000001 110.431 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.672 ' HB2' HD12 ' A' ' 86' ' ' LEU . 27.7 mt -130.09 158.93 72.57 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.426 -0.806 . . . . 1.71 110.632 -175.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.464 ' HG2' HG21 ' A' ' 85' ' ' VAL . 61.5 Cg_endo -75.5 164.35 32.6 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.322 2.015 . . . . 1.03 110.796 168.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -63.95 -25.91 68.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.897 0.38 . . . . 1.53 111.326 -177.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -53.99 48.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.232 0.539 . . . . 1.75 110.527 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.464 HG21 ' HG2' ' A' ' 82' ' ' PRO . 85.1 t -63.75 -46.21 95.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.506 -0.77 . . . . 1.28 110.382 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.672 HD12 ' HB2' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -53.87 -53.0 58.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.016 0.436 . . . . 2.0699999999999998 111.766 177.057 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.84 -35.03 89.44 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.7 -0.682 . . . . 0.45000000000000001 112.539 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.858 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 53.6 pttt -89.32 -21.0 23.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.703 -0.799 . . . . 2.1899999999999999 111.009 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.2 mt -69.4 -43.52 80.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.299 -0.63 . . . . 1.8200000000000001 109.299 170.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.448 ' CE3' ' HD3' ' A' ' 73' ' ' LYS . 76.6 t-105 -58.6 -54.98 40.93 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.214 -0.448 . . . . 0.35999999999999999 110.882 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.858 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -71.46 -15.6 62.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.879 -0.6 . . . . 2.9500000000000002 112.031 -173.125 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.448 HD23 HD21 ' A' ' 122' ' ' LEU . 13.4 tp -94.24 -24.93 17.27 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.929 -0.308 . . . . 1.5 110.26 176.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.862 ' HA ' HD21 ' A' ' 108' ' ' LEU . . . -80.34 -42.66 22.53 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.096 0.474 . . . . 1.1499999999999999 110.614 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.467 ' HB2' HD23 ' A' ' 101' ' ' LEU . 48.3 t0 -100.99 114.54 28.56 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.458 -0.571 . . . . 0.62 109.458 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.2 t -74.68 -23.04 17.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.189 -0.914 . . . . 2.27 111.554 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.85 -25.4 13.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.985 0.421 . . . . 1.7 110.192 -175.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.458 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 57.8 mttt 60.92 71.71 0.55 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.129 -0.941 . . . . 2.2599999999999998 110.87 169.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.414 ' OD1' ' HG ' ' A' ' 100' ' ' LEU . 1.9 p30 -101.66 -22.27 14.48 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.384 -1.28 . . . . 1.51 111.749 -171.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.41 9.81 28.53 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.71 -0.757 . . . . 0.34000000000000002 112.392 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.457 ' HA ' ' H ' ' A' ' 69' ' ' GLY . 3.7 pp -148.26 178.61 8.42 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.252 0.621 . . . . 1.23 109.521 176.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.507 HD22 ' HB3' ' A' ' 105' ' ' GLU . 87.2 mt -146.96 122.55 10.46 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.25 -0.648 . . . . 1.3700000000000001 109.25 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.518 ' HA ' ' HB2' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -74.16 -173.96 1.8 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.866 -0.521 . . . . 1.5 110.317 176.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -59.83 -34.05 72.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.98 0.419 . . . . 1.73 111.404 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 26.3 tt0 -86.3 -33.87 20.51 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.918 0.39 . . . . 2.1400000000000001 110.755 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.507 ' HB3' HD22 ' A' ' 101' ' ' LEU . 2.4 mt-10 -62.2 -39.2 91.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.298 -0.41 . . . . 1.1100000000000001 110.496 174.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.584 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -62.88 -43.61 98.33 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.193 -1.04 . . . . 1.8600000000000001 108.193 173.197 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 104' ' ' GLU . . . -50.75 -47.44 59.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.683 -0.69 . . . . 1.02 110.986 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.862 HD21 ' HA ' ' A' ' 93' ' ' ALA . 2.5 tt -66.82 -50.77 61.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.021 -0.363 . . . . 1.8200000000000001 110.021 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.416 ' HB1' HD13 ' A' ' 101' ' ' LEU . . . -49.81 -57.21 7.82 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.796 0.665 . . . . 1.0700000000000001 112.796 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.426 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 0.2 OUTLIER -66.72 -29.04 68.92 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.286 0.565 . . . . 1.8899999999999999 109.485 -176.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.544 ' O ' HG21 ' A' ' 115' ' ' VAL . 64.5 t60 -68.1 -42.9 79.62 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.992 -0.549 . . . . 0.59999999999999998 109.886 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.679 ' HB3' HD23 ' A' ' 122' ' ' LEU . 34.5 mt -64.03 -34.68 78.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.064 -0.516 . . . . 1.23 110.589 176.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 110' ' ' ASN . 95.2 mt -61.41 -48.6 88.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.921 -0.581 . . . . 1.49 110.495 174.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 17.6 ptpt -72.48 -21.29 61.23 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 119.651 -0.819 . . . . 2.6699999999999999 111.007 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.544 HG21 ' O ' ' A' ' 111' ' ' HIS . 15.4 t -60.57 -47.97 90.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.595 0.236 . . . . 1.23 110.452 171.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 5.7 ptmm? -84.98 -1.21 56.51 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.259 -0.576 . . . . 2.4199999999999999 110.379 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.516 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 38.2 tp -85.89 -19.79 30.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.473 -0.785 . . . . 1.8200000000000001 108.963 172.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 43.0 mt-10 -67.87 -16.52 64.13 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 115.558 -0.746 . . . . 1.99 109.529 173.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.57 -20.21 13.77 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.65 -0.704 . . . . 1.01 112.175 174.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.652 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -99.13 138.91 35.55 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -73.37 164.0 27.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.242 0.544 . . . . 2.75 111.335 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.679 HD23 ' HB3' ' A' ' 112' ' ' LEU . 4.5 mp -73.23 141.7 81.16 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.448 -0.796 . . . . 3.1800000000000002 110.391 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -88.66 -0.01 6.5 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.344 2.696 . . . . 1.1899999999999999 113.52 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 60.89 27.84 17.65 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.463 0.649 . . . . 1.8999999999999999 110.857 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -130.15 126.48 37.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.5 -0.773 . . . . 2.3599999999999999 109.148 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 126' ' ' LEU . 1.1 tm? -103.35 103.2 33.81 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.227 -0.657 . . . . 2.3799999999999999 109.227 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -87.36 164.42 8.2 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.449 2.766 . . . . 1.1799999999999999 112.669 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.432 ' O ' HG13 ' A' ' 131' ' ' VAL . 12.2 Cg_endo -56.03 -26.44 59.27 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.444 2.763 . . . . 1.6100000000000001 113.446 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.554 ' O ' HD12 ' A' ' 130' ' ' LEU . 7.3 p-80 -86.55 23.41 1.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.517 -0.473 . . . . 1.71 111.271 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 129' ' ' HIS . 0.3 OUTLIER -149.61 14.68 0.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.955 0.159 . . . . 1.8700000000000001 111.107 175.386 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 128' ' ' PRO . 7.4 p -82.72 111.31 28.28 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.25 0.548 . . . . 2.27 111.025 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo . . . . . 0 C--O 1.234 0.309 0 C-N-CA 122.724 2.283 . . . . 1.29 113.373 -177.728 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 N-CA-C 112.593 -0.203 . . . . 42.409999999999997 112.593 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -88.67 8.01 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.288 2.659 . . . . 42.020000000000003 112.86 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -107.56 124.34 49.79 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.662 -0.866 . . . . 43.539999999999999 108.662 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.06 0.62 82.96 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.728 -0.748 . . . . 41.520000000000003 111.363 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.6 t -164.6 131.56 3.08 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.733 -0.84 . . . . 40.310000000000002 108.733 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.1 pm0 -76.16 116.82 17.22 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.619 0.723 . . . . 38.670000000000002 111.033 -177.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.1 t -84.83 99.0 10.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.338 -0.846 . . . . 37.359999999999999 109.254 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.694 ' H ' HD21 ' A' ' 8' ' ' LEU . 2.4 pt? -88.84 140.43 29.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.709 -0.678 . . . . 36.490000000000002 110.396 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.3 mmm -72.45 144.36 86.46 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.427 -0.582 . . . . 35.119999999999997 109.427 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -48.47 -46.84 22.19 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.295 2.663 . . . . 34.549999999999997 112.098 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.1 t -109.79 112.06 23.88 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.09 -0.707 . . . . 34.009999999999998 109.09 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.66 97.27 7.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.948 0.404 . . . . 34.789999999999999 110.683 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 m -111.67 141.1 28.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.127 -0.488 . . . . 34.009999999999998 110.619 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -106.64 115.21 47.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.951 -0.568 . . . . 35.259999999999998 110.784 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.694 ' HB3' ' HB1' ' A' ' 18' ' ' ALA . 98.4 mttt -102.24 86.48 2.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.969 -0.559 . . . . 35.140000000000001 110.071 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.2 112.79 4.19 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.512 -0.767 . . . . 36.799999999999997 112.652 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.85 0.88 89.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.206 -0.521 . . . . 37.009999999999998 112.403 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.694 ' HB1' ' HB3' ' A' ' 15' ' ' LYS . . . -105.34 98.95 8.58 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.862 0.363 . . . . 35.420000000000002 111.012 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -78.46 103.78 8.63 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.334 -0.617 . . . . 36.07 109.334 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -89.26 125.52 35.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.427 -0.806 . . . . 33.780000000000001 111.612 -169.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.34 67.06 0.51 Allowed Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.858 -0.687 . . . . 33.630000000000003 111.786 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.4 m -69.95 112.1 6.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.089 0.471 . . . . 32.890000000000001 110.78 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 62.7 mtm -75.95 102.28 5.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.018 -0.537 . . . . 33.770000000000003 109.649 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -81.51 158.18 24.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.084 -0.507 . . . . 33.939999999999998 111.14 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.66 -33.69 4.36 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.673 -1.071 . . . . 33.689999999999998 114.623 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -85.64 132.94 4.3 Favored 'Trans proline' 0 C--N 1.351 0.707 0 CA-C-N 120.955 2.377 . . . . 32.880000000000003 111.686 172.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -127.62 130.35 48.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.86 0.362 . . . . 34.68 111.029 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.11 158.28 20.01 Favored Glycine 0 N--CA 1.454 -0.133 0 CA-C-N 116.108 -0.496 . . . . 31.800000000000001 112.036 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -165.41 123.1 1.55 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.867 0.333 . . . . 31.699999999999999 110.147 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.93 116.77 0.76 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.83 -0.7 . . . . 29.09 112.305 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -95.75 170.23 9.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.459 0.171 . . . . 27.890000000000001 110.57 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.37 91.88 0.95 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.7 -0.762 . . . . 25.079999999999998 111.955 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -77.52 132.67 38.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.698 0.285 . . . . 22.670000000000002 110.735 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.18 98.04 1.59 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.782 -0.723 . . . . 19.579999999999998 111.791 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.1 118.57 19.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.824 0.345 . . . . 17.84 111.197 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.16 101.85 1.85 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.772 -0.728 . . . . 15.130000000000001 111.504 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.97 -177.01 5.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.513 0.197 . . . . 13.02 110.761 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.41 71.54 2.91 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.351 -0.928 . . . . 10.74 111.98 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.8 pt -67.2 154.44 8.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.275 -1.009 . . . . 9.4800000000000004 108.275 170.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.88 72.96 2.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.485 0.659 . . . . 6.75 110.715 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -128.18 95.81 4.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.044 -0.98 . . . . 6.3099999999999996 110.396 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.7 p -113.32 93.28 2.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.856 0.836 . . . . 3.5600000000000001 110.289 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -142.36 100.84 3.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.392 -0.822 . . . . 3.9399999999999999 111.032 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.702 ' CE2' ' HG ' ' A' ' 130' ' ' LEU . 7.1 t90 -73.9 140.68 45.82 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.053 -0.721 . . . . 1.72 109.053 174.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.466 ' N ' ' CD1' ' A' ' 44' ' ' TRP . 18.2 t -52.74 -12.84 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 114.142 -1.39 . . . . 1.72 113.157 -175.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.0 -24.17 11.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 121.329 -0.857 . . . . 1.3200000000000001 112.143 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.98 -13.39 26.45 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.174 -1.012 . . . . 0.71999999999999997 112.452 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.449 ' HE2' ' HB3' ' A' ' 48' ' ' LYS . 7.8 ptpt -112.03 -0.96 15.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 112.745 0.646 . . . . 3.3799999999999999 112.745 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -133.77 2.16 3.4 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.367 0.603 . . . . 1.8300000000000001 110.666 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.444 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 63.5 tttm -54.83 -46.14 99.55 Favored Pre-proline 0 C--O 1.222 -0.386 0 CA-C-N 115.691 -0.686 . . . . 1.73 111.166 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 55.2 Cg_exo -42.47 -33.24 2.59 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 123.074 2.516 . . . . 0.80000000000000004 113.993 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.677 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 25.6 m -73.8 -48.38 31.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.097 0.951 . . . . 1.29 110.022 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.541 ' CD1' ' HB3' ' A' ' 110' ' ' ASN . 7.4 m-85 -76.17 -25.11 54.9 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.47 -0.786 . . . . 1.4299999999999999 110.149 -175.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.588 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 18.3 t70 -82.55 -33.41 28.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.632 -1.167 . . . . 1.1599999999999999 109.637 -176.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.677 ' HG3' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -69.28 -39.41 78.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.331 -0.618 . . . . 1.6299999999999999 109.331 175.742 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.633 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 60.3 mt -69.03 -32.0 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.254 -0.647 . . . . 1.27 109.254 175.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 70.4 t80 -55.64 -52.87 62.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.168 -0.924 . . . . 1.51 110.952 175.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.725 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 82.6 m-85 -75.12 -22.45 58.19 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.941 0.401 . . . . 1.6799999999999999 110.916 177.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.633 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 10.4 m -70.19 -32.64 70.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 1.1799999999999999 111.043 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.466 HD12 ' HG2' ' A' ' 75' ' ' GLU . 63.8 mt -83.6 -8.53 59.29 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.219 -0.289 . . . . 1.3600000000000001 110.219 176.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.6 t 72.89 96.65 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.463 -0.79 . . . . 1.22 111.287 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.725 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 61.5 Cg_endo -83.52 172.27 10.43 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.588 2.192 . . . . 0.57999999999999996 112.28 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.0 t -136.06 114.37 15.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.234 -0.654 . . . . 1.9199999999999999 109.234 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.1 m120 70.31 23.76 4.95 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.133 0.492 . . . . 2.0899999999999999 111.58 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.47 25.21 19.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.954 -0.641 . . . . 0.56999999999999995 112.661 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.615 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -168.5 154.27 6.79 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.6 -0.889 . . . . 2.3300000000000001 108.6 175.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.912 ' HB ' HD22 ' A' ' 71' ' ' ASN . 3.1 pt -86.58 137.19 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 120.316 -0.554 . . . . 1.1799999999999999 110.21 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.8 p -60.3 130.7 47.94 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 107.352 -1.351 . . . . 1.2 107.352 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.659 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -50.98 -25.75 10.31 Favored Glycine 0 C--O 1.22 -0.742 0 C-N-CA 120.682 -0.771 . . . . 0.59999999999999998 113.784 -172.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.48 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -46.92 -55.77 7.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.139 0.47 . . . . 1.1699999999999999 111.467 173.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.912 HD22 ' HB ' ' A' ' 67' ' ' ILE . 9.5 p30 -72.96 -27.07 61.61 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.87 0.367 . . . . 2.1099999999999999 110.545 -175.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.709 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -68.92 -37.29 78.84 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.392 -0.596 . . . . 1.2 109.392 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.9 mmmm -67.72 -38.77 84.04 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.174 -0.921 . . . . 2.3100000000000001 109.843 177.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.79 ' HG2' ' HA ' ' A' ' 71' ' ' ASN . 10.4 mmmm -56.23 -50.6 70.83 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.654 0.74 . . . . 1.6799999999999999 109.655 175.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -55.9 -52.81 62.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.972 -1.467 . . . . 1.48 111.445 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.709 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 12.8 ptp -73.45 -21.88 60.34 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.107 -0.371 . . . . 0.84999999999999998 111.752 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.41 -45.71 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.787 0.327 . . . . 1.25 110.462 174.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 15.2 ptpt -70.83 -14.82 62.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.257 0.551 . . . . 1.79 110.1 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 76' ' ' MET . 67.6 m -63.94 -1.59 1.52 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.563 -0.744 . . . . 1.9399999999999999 111.583 171.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 71.24 72.07 0.18 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.621 0.769 . . . . 3.1200000000000001 111.434 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.829 HD13 ' HE2' ' A' ' 116' ' ' LYS . 29.1 mt -142.77 161.36 49.51 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.934 -0.576 . . . . 1.71 111.782 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -82.56 168.54 14.39 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.093 2.529 . . . . 1.03 110.198 166.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.75 -18.15 63.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.83 0.347 . . . . 1.53 111.5 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -64.63 -67.83 0.4 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.961 -0.563 . . . . 1.75 110.863 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.55 ' O ' HG13 ' A' ' 89' ' ' ILE . 39.8 t -60.64 -44.58 97.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 115.811 -0.631 . . . . 1.28 110.297 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.54 HD13 ' HG3' ' A' ' 76' ' ' MET . 22.7 tp -55.52 -51.35 67.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.325 -0.852 . . . . 2.0699999999999998 111.443 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.36 -43.19 97.54 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.789 -0.641 . . . . 0.45000000000000001 111.967 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.816 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 56.4 pttt -80.39 -16.45 54.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.562 -0.855 . . . . 2.1899999999999999 111.754 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.643 HD11 ' HD3' ' A' ' 116' ' ' LYS . 13.5 mt -71.8 -46.32 61.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.857 -0.794 . . . . 1.8200000000000001 108.857 171.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -56.06 -53.24 59.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.755 -0.657 . . . . 0.35999999999999999 111.212 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.816 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -73.03 -14.31 61.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.117 -0.492 . . . . 2.9500000000000002 112.128 -174.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.607 HD23 HD12 ' A' ' 112' ' ' LEU . 13.6 tp -93.41 -23.89 18.25 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.662 -0.415 . . . . 1.5 110.488 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.706 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -89.04 -42.9 11.48 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.797 0.332 . . . . 1.1499999999999999 111.376 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.62 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 55.3 t0 -92.57 105.54 17.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.759 -0.46 . . . . 0.62 109.759 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.522 HG21 ' HG3' ' A' ' 135' ' ' LYS . 23.5 t -73.09 -27.4 24.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.595 -0.729 . . . . 2.27 111.262 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.613 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.0 OUTLIER -88.16 -26.48 22.41 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.109 -0.496 . . . . 1.7 109.677 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.9 mttt 60.22 58.83 2.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.955 -1.02 . . . . 2.2599999999999998 109.364 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.632 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 6.4 m-20 -83.57 -35.2 24.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.024 -1.444 . . . . 1.51 111.629 -170.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.72 16.41 33.87 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 109.889 -1.284 . . . . 0.34000000000000002 109.889 -164.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.486 HD13 ' HG3' ' A' ' 66' ' ' LYS . 4.2 pp -153.32 177.01 11.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.379 -0.971 . . . . 1.23 108.379 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.614 ' O ' HG12 ' A' ' 67' ' ' ILE . 46.4 mt -151.74 120.37 6.5 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.231 -1.396 . . . . 1.3700000000000001 107.231 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.418 ' HA ' ' CB ' ' A' ' 66' ' ' LYS . 2.7 p30 -80.96 -175.75 5.55 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.499 -0.881 . . . . 1.5 110.176 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -57.95 -32.52 67.9 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 111.738 0.273 . . . . 1.73 111.738 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.701 ' HG2' ' HD2' ' A' ' 133' ' ' PRO . 4.0 tp10 -87.33 -27.92 22.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.319 0.581 . . . . 2.1400000000000001 110.029 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.537 ' HB3' HD21 ' A' ' 101' ' ' LEU . 1.1 mt-10 -74.75 -27.91 60.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.05 -0.523 . . . . 1.1100000000000001 110.656 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.672 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -73.61 -36.06 65.44 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.439 -1.319 . . . . 1.8600000000000001 107.439 169.219 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.524 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -56.37 -45.77 80.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.02 -0.537 . . . . 1.02 110.286 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.716 HD11 ' HD3' ' A' ' 132' ' ' PRO . 3.5 tt -71.27 -48.6 49.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.931 -0.577 . . . . 1.8200000000000001 110.278 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.535 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -46.53 -56.25 6.3 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.531 0.519 . . . . 1.0700000000000001 111.138 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.541 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 11.1 t-20 -73.32 -23.98 60.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.601 -0.727 . . . . 1.8899999999999999 110.379 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.596 ' O ' HG21 ' A' ' 115' ' ' VAL . 65.7 t60 -69.76 -41.94 74.52 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.357 -0.609 . . . . 0.59999999999999998 109.357 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.613 HD21 HD23 ' A' ' 122' ' ' LEU . 30.2 mt -73.71 -27.32 61.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.187 -0.461 . . . . 1.23 110.436 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 109' ' ' ALA . 68.7 mt -60.97 -45.46 98.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.464 -0.335 . . . . 1.49 111.021 172.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.463 ' HE3' ' HE1' ' A' ' 53' ' ' TYR . 17.4 ptpt -75.35 -21.18 58.54 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.687 -0.805 . . . . 2.6699999999999999 111.488 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.596 HG21 ' O ' ' A' ' 111' ' ' HIS . 40.1 t -68.43 -43.27 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.471 0.177 . . . . 1.23 110.706 173.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.829 ' HE2' HD13 ' A' ' 81' ' ' LEU . 16.0 pttp -69.12 -28.26 66.3 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.291 -0.633 . . . . 2.4199999999999999 109.291 174.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.1 tt -69.61 -24.28 63.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.53 -0.759 . . . . 1.8200000000000001 110.248 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 6.5 mm-40 -59.02 -13.23 6.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.573 -0.739 . . . . 1.99 111.299 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.81 8.81 29.53 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.924 -0.655 . . . . 1.01 111.926 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.747 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.5 p80 -137.89 135.16 35.86 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.017 -0.364 . . . . 1.0 110.017 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -71.85 164.5 25.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.203 -0.453 . . . . 2.75 111.316 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.613 HD23 HD21 ' A' ' 112' ' ' LEU . 41.8 mt -74.59 137.17 74.16 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.92 -0.582 . . . . 3.1800000000000002 110.268 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 87.3 Cg_endo -90.16 13.83 2.21 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.181 2.588 . . . . 1.1899999999999999 113.396 -172.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.56 22.76 13.5 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.253 -0.43 . . . . 1.8999999999999999 111.162 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -112.55 140.69 47.1 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.366 -0.605 . . . . 2.3599999999999999 109.366 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -121.52 106.23 37.9 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 108.944 -0.762 . . . . 2.3799999999999999 108.944 178.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 2.2 Cg_endo -82.48 148.08 14.3 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.019 2.479 . . . . 1.1799999999999999 112.351 -176.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.52 -13.59 37.32 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.777 2.318 . . . . 1.6100000000000001 112.579 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -98.01 24.22 7.26 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.209 -0.293 . . . . 1.71 110.209 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.702 ' HG ' ' CE2' ' A' ' 44' ' ' TRP . 0.3 OUTLIER -149.45 12.78 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.92 0.391 . . . . 1.8700000000000001 110.481 177.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.6 m -91.86 128.42 45.98 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.598 -0.519 . . . . 2.27 109.598 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.716 ' HD3' HD11 ' A' ' 108' ' ' LEU . 51.0 Cg_exo -54.57 148.05 45.71 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.553 2.168 . . . . 1.29 110.991 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.701 ' HD2' ' HG2' ' A' ' 104' ' ' GLU . 72.2 Cg_exo -39.52 -47.34 3.42 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.95 3.1 . . . . 1.6699999999999999 114.372 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.415 ' HB3' ' HD2' ' A' ' 135' ' ' LYS . 29.2 t -58.71 -24.06 60.78 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.59 0.589 . . . . 2.7000000000000002 112.59 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.522 ' HG3' HG21 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -120.96 34.29 5.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.995 0.426 . . . . 4.0499999999999998 111.637 -173.512 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -69.57 78.12 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.73 0.776 . . . . 5.2599999999999998 110.949 175.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -162.67 134.29 5.18 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.865 -0.522 . . . . 5.5199999999999996 111.826 -172.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -106.05 106.24 16.65 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.514 -0.551 . . . . 7.0 109.514 174.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.66 -0.686 . . . . 6.9100000000000001 110.007 -178.793 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.632 'CA ' ' OD2' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 CA-C-O 119.926 -0.375 . . . . 42.409999999999997 112.989 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.18 -50.35 7.51 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.033 2.489 . . . . 42.020000000000003 113.289 -176.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.9 pp -65.31 143.84 57.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.006 0.431 . . . . 43.539999999999999 110.6 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.03 -28.19 10.81 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.248 -1.141 . . . . 41.520000000000003 110.248 -172.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 m -90.2 115.69 27.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.192 -0.504 . . . . 40.310000000000002 109.777 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -90.68 129.86 36.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.856 0.36 . . . . 38.670000000000002 111.71 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.4 t -88.1 110.73 20.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.18 -0.674 . . . . 37.359999999999999 109.18 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.1 tp -99.34 107.42 19.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 36.490000000000002 111.01 -176.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.414 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 25.6 mmt -95.42 116.1 66.01 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 35.119999999999997 110.031 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 29.9 Cg_exo -62.22 -32.39 82.46 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.883 2.389 . . . . 34.549999999999997 112.856 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.7 t -118.0 96.01 5.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.117 0.484 . . . . 34.009999999999998 110.726 -177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -140.16 93.02 2.59 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.066 -0.716 . . . . 34.789999999999999 109.066 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.7 t -89.96 105.15 15.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.219 -0.446 . . . . 34.009999999999998 110.408 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.3 t -113.26 109.16 27.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.149 -0.478 . . . . 35.259999999999998 111.568 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 47.3 mtmt -126.92 112.78 15.7 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.962 -0.755 . . . . 35.140000000000001 108.962 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.93 105.15 3.26 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.812 -0.708 . . . . 36.799999999999997 112.488 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.88 5.82 86.88 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.075 -0.584 . . . . 37.009999999999998 112.585 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . . . -87.71 104.56 16.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.778 0.323 . . . . 35.420000000000002 111.272 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -80.76 141.93 34.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.003 -0.544 . . . . 36.07 110.429 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -121.85 149.15 43.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.327 -0.397 . . . . 33.780000000000001 110.175 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.74 116.04 5.3 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.629 -0.796 . . . . 33.630000000000003 112.586 -175.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.9 p -88.97 111.54 22.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.044 0.45 . . . . 32.890000000000001 110.993 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 55.1 mtt -65.91 131.22 45.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 33.770000000000003 111.789 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -118.49 140.08 50.44 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.456 -0.572 . . . . 33.939999999999998 109.456 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.72 -32.31 5.04 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.924 -0.931 . . . . 33.689999999999998 114.168 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.81 124.79 10.97 Favored 'Trans proline' 0 C--N 1.355 0.908 0 CA-C-N 120.592 2.196 . . . . 32.880000000000003 111.289 168.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -100.01 111.47 23.77 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.969 -0.382 . . . . 34.68 109.969 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.11 153.71 40.02 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.392 -0.909 . . . . 31.800000000000001 111.99 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -82.85 125.43 31.32 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.687 -0.486 . . . . 31.699999999999999 109.687 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -150.3 121.37 1.24 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.15 -1.024 . . . . 29.09 112.876 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -131.64 168.35 17.88 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.109 -0.7 . . . . 27.890000000000001 109.109 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.29 93.56 0.14 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.068 -0.587 . . . . 25.079999999999998 111.809 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.47 163.94 13.2 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.088 0.471 . . . . 22.670000000000002 111.425 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.46 104.44 1.32 Allowed Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.428 -1.069 . . . . 19.579999999999998 110.428 172.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -39.26 117.54 0.71 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.122 0.569 . . . . 17.84 112.524 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.49 139.89 14.74 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.548 -0.751 . . . . 15.130000000000001 111.556 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.454 ' HG2' ' H ' ' A' ' 38' ' ' GLY . 11.8 tt0 -95.16 -174.05 3.11 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.332 -0.247 . . . . 13.02 110.332 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.454 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -75.94 72.09 1.86 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.66 -0.781 . . . . 10.74 113.093 -171.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 pt -58.13 144.97 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 109.264 -0.643 . . . . 9.4800000000000004 109.264 169.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.41 79.27 2.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.115 0.484 . . . . 6.75 111.501 -172.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -121.58 107.89 12.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.599 -0.728 . . . . 6.3099999999999996 109.725 172.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 p -77.53 134.21 28.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.018 -0.537 . . . . 3.5600000000000001 109.9 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -146.53 124.34 11.93 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.737 -0.665 . . . . 3.9399999999999999 109.545 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.684 ' NE1' ' HG ' ' A' ' 130' ' ' LEU . 13.6 t90 -89.28 137.35 32.4 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.603 0.716 . . . . 1.72 109.417 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 t -62.89 -10.75 6.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.747 -1.115 . . . . 1.72 112.135 -173.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.69 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 84.0 t -88.53 -13.55 9.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 O-C-N 121.553 -0.717 . . . . 1.3200000000000001 111.386 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.46 -12.63 70.02 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 119.457 -1.354 . . . . 0.71999999999999997 111.839 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -111.7 -28.26 8.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.563 0.579 . . . . 3.3799999999999999 112.563 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -108.56 8.41 27.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.473 0.654 . . . . 1.8300000000000001 109.946 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.748 ' HE3' ' HG3' ' A' ' 104' ' ' GLU . 42.5 tttt -57.1 -46.43 99.86 Favored Pre-proline 0 C--O 1.22 -0.466 0 CA-C-N 115.417 -0.811 . . . . 1.73 112.167 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 7.3 Cg_endo -49.95 -28.39 18.54 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 122.561 2.174 . . . . 0.80000000000000004 112.802 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.611 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 9.2 m -72.34 -42.32 65.49 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 122.301 1.048 . . . . 1.29 109.91 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.537 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 8.2 m-85 -79.55 -24.61 42.02 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.109 -0.951 . . . . 1.4299999999999999 109.742 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.579 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 14.3 t70 -81.6 -34.45 30.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.474 -0.785 . . . . 1.1599999999999999 110.63 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.611 ' HG2' ' O ' ' A' ' 52' ' ' THR . 13.2 pt-20 -66.14 -40.45 90.6 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.528 -0.469 . . . . 1.6299999999999999 109.819 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.6 mt -69.54 -29.45 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.114 -0.634 . . . . 1.27 109.612 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.579 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 71.8 t80 -58.59 -58.29 9.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.409 -0.814 . . . . 1.51 111.462 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.45 ' HE1' ' OD1' ' A' ' 54' ' ' ASP . 38.8 m-85 -66.96 -23.02 65.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.959 0.409 . . . . 1.6799999999999999 110.813 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.0 m -70.75 -26.37 63.33 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.019 -0.537 . . . . 1.1799999999999999 110.973 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.489 HD11 ' CG ' ' A' ' 75' ' ' GLU . 53.6 mt -87.74 4.22 45.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.015 0.376 . . . . 1.3600000000000001 112.015 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t 65.48 81.63 0.21 Allowed Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.027 -0.533 . . . . 1.22 110.906 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 72.6 Cg_endo -81.48 153.06 17.95 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.733 2.289 . . . . 0.57999999999999996 113.176 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.7 126.86 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.894 -0.594 . . . . 1.9199999999999999 110.248 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 60.72 23.31 13.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.702 -0.681 . . . . 2.0899999999999999 111.627 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.34 26.67 25.03 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.769 -0.729 . . . . 0.56999999999999995 112.898 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.732 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -160.32 148.56 16.66 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 120.934 0.397 . . . . 2.3300000000000001 110.039 173.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.734 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 4.1 pt -85.89 131.45 34.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.951 -0.568 . . . . 1.1799999999999999 109.965 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.7 p -59.7 112.22 1.73 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.751 -0.833 . . . . 1.2 108.751 174.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.561 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -42.2 -27.21 0.41 Allowed Glycine 0 C--O 1.218 -0.896 0 N-CA-C 116.684 1.434 . . . . 0.59999999999999998 116.684 -160.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.68 -30.87 9.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 118.236 1.018 . . . . 1.1699999999999999 112.359 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.734 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 13.3 p30 -81.07 -38.32 27.53 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.863 0.364 . . . . 2.1099999999999999 111.559 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.656 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -69.39 -34.58 74.73 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.497 0.665 . . . . 1.2 109.223 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.2 mmmm -64.06 -39.25 93.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.756 -1.111 . . . . 2.3100000000000001 108.864 174.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -55.79 -48.49 75.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.355 -0.839 . . . . 1.6799999999999999 109.714 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.633 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 7.2 mm-40 -60.68 -52.19 66.18 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.062 -0.972 . . . . 1.48 112.051 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.656 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 13.4 ptp -69.35 -24.13 63.86 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.878 -0.329 . . . . 0.84999999999999998 111.487 -178.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 73' ' ' LYS . 45.8 t -73.13 -49.08 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.652 0.263 . . . . 1.25 110.644 174.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.633 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 8.0 ptmt -68.06 -11.96 59.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.185 0.517 . . . . 1.79 110.249 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.3 t -68.29 -9.44 47.6 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.942 -0.572 . . . . 1.9399999999999999 110.039 174.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.613 ' HZ3' ' HB2' ' A' ' 80' ' ' LYS . 8.4 mtmp? 73.49 73.19 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.5 0.72 . . . . 3.1200000000000001 110.989 176.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 1.013 HD13 ' HE2' ' A' ' 116' ' ' LYS . 25.1 mt -136.35 163.56 49.11 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.566 -0.743 . . . . 1.71 110.997 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.78 168.71 19.02 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.618 2.212 . . . . 1.03 111.408 167.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -64.72 -26.83 68.54 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.833 0.308 . . . . 1.53 111.833 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.4 p -62.95 -50.82 69.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.259 -0.428 . . . . 1.75 110.896 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 89' ' ' ILE . 46.7 t -66.83 -43.78 89.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.928 -0.578 . . . . 1.28 109.925 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.555 ' CD2' ' HB2' ' A' ' 81' ' ' LEU . 2.8 mm? -48.27 -53.41 17.27 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.282 0.563 . . . . 2.0699999999999998 110.744 172.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.43 -45.96 94.68 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.943 -1.026 . . . . 0.45000000000000001 112.984 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.842 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 56.3 pttt -83.27 -21.54 33.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 119.677 -0.809 . . . . 2.1899999999999999 112.304 -175.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.589 HD12 ' HD3' ' A' ' 116' ' ' LYS . 29.8 mt -67.26 -44.91 87.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.853 -0.795 . . . . 1.8200000000000001 108.853 171.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -62.98 -54.69 34.38 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 115.658 -0.701 . . . . 0.35999999999999999 111.405 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.842 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 64.6 pttt -71.82 -10.17 59.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.571 -0.286 . . . . 2.9500000000000002 111.721 -173.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.623 HD13 ' HA ' ' A' ' 124' ' ' ALA . 8.6 tp -92.34 -34.07 14.34 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.736 -0.468 . . . . 1.5 109.736 173.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.725 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -82.92 -44.44 15.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.896 0.379 . . . . 1.1499999999999999 112.004 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.625 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 42.1 t0 -92.01 76.28 5.47 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.81 -0.811 . . . . 0.62 108.81 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.415 HG11 ' HE2' ' A' ' 135' ' ' LYS . 16.3 t -64.9 -25.22 37.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.258 -0.883 . . . . 2.27 109.982 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -79.48 -25.85 41.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.603 -1.18 . . . . 1.7 110.278 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 55.71 73.82 0.41 Allowed 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.468 -0.787 . . . . 2.2599999999999998 111.525 174.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -123.45 -24.22 4.64 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.409 -1.269 . . . . 1.51 112.419 -169.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.91 16.46 28.26 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.053 -1.07 . . . . 0.34000000000000002 111.82 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.732 HD13 ' HG3' ' A' ' 66' ' ' LYS . 3.3 pp -151.61 -174.57 4.88 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.649 -0.871 . . . . 1.23 108.649 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 105' ' ' GLU . 45.0 mt -150.12 120.56 7.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.218 -0.66 . . . . 1.3700000000000001 109.218 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.8 p-10 -74.98 -175.65 2.65 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.635 -0.506 . . . . 1.5 109.635 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.459 ' OD1' ' HE2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -60.24 -33.85 72.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.663 0.268 . . . . 1.73 111.191 -177.181 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.748 ' HG3' ' HE3' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -83.24 -37.43 23.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.79 -0.186 . . . . 2.1400000000000001 111.037 176.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.531 ' HB3' HD22 ' A' ' 101' ' ' LEU . 3.7 mt-10 -62.43 -38.35 89.41 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.208 -0.197 . . . . 1.1100000000000001 110.99 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.586 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.6 OUTLIER -68.96 -40.1 79.09 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.526 -0.916 . . . . 1.8600000000000001 108.526 172.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.537 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -48.93 -50.67 34.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.597 -0.729 . . . . 1.02 111.426 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.725 ' CD1' ' HA ' ' A' ' 93' ' ' ALA . 0.5 OUTLIER -83.41 -33.36 25.75 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 118.993 -1.083 . . . . 1.8200000000000001 112.031 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.32 -54.18 9.43 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.318 0.58 . . . . 1.0700000000000001 111.173 170.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.472 ' O ' ' HB ' ' A' ' 113' ' ' ILE . 2.9 t-20 -75.97 -33.87 59.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.571 . . . . 1.8899999999999999 110.702 -176.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -66.37 -34.88 78.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.519 . . . . 0.59999999999999998 109.945 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.782 ' HB3' HD21 ' A' ' 122' ' ' LEU . 73.0 mt -71.81 -31.65 66.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.717 -0.674 . . . . 1.23 110.021 176.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.607 ' HA ' ' HE3' ' A' ' 116' ' ' LYS . 60.8 mt -61.11 -42.67 94.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.73 -0.668 . . . . 1.49 110.747 171.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.586 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -68.44 -35.34 77.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.297 -0.41 . . . . 2.6699999999999999 110.335 175.715 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.6 t -59.57 -49.05 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.256 -0.429 . . . . 1.23 111.522 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 1.013 ' HE2' HD13 ' A' ' 81' ' ' LEU . 20.0 pttp -68.0 -28.84 67.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.026 0.441 . . . . 2.4199999999999999 110.303 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.5 tp -70.49 -20.57 62.84 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.847 -0.615 . . . . 1.8200000000000001 110.839 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.586 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 42.2 mt-10 -71.42 -9.84 58.82 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.888 -0.597 . . . . 1.99 111.037 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.43 1.21 24.8 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.2 -1.0 . . . . 1.01 112.948 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.701 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -129.45 134.01 47.6 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -72.12 164.62 25.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.252 0.549 . . . . 2.75 111.242 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.782 HD21 ' HB3' ' A' ' 112' ' ' LEU . 5.2 mp -68.87 141.5 92.43 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.792 -0.64 . . . . 3.1800000000000002 110.46 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.555 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 67.9 Cg_endo -91.5 -7.06 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.483 2.788 . . . . 1.1899999999999999 112.624 -174.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.623 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . 61.53 37.55 16.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.699 -0.682 . . . . 1.8999999999999999 111.319 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.555 ' OD1' ' HG2' ' A' ' 123' ' ' PRO . 1.2 p-10 -111.61 135.5 52.11 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.956 -0.565 . . . . 2.3599999999999999 109.746 170.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 126' ' ' LEU . 22.7 tp -115.49 91.42 28.99 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.191 -0.913 . . . . 2.3799999999999999 109.918 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 94.5 Cg_endo -98.03 171.22 0.67 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.609 2.872 . . . . 1.1799999999999999 113.189 -175.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.418 ' HA ' HG22 ' A' ' 131' ' ' VAL . 9.3 Cg_endo -54.92 -29.49 64.2 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.941 2.427 . . . . 1.6100000000000001 112.993 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.53 ' O ' HD12 ' A' ' 130' ' ' LEU . 16.5 p-80 -84.84 22.16 1.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.997 0.369 . . . . 1.71 111.997 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.684 ' HG ' ' NE1' ' A' ' 44' ' ' TRP . 1.0 OUTLIER -149.76 18.4 0.9 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.582 0.353 . . . . 1.8700000000000001 111.091 169.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.418 HG22 ' HA ' ' A' ' 128' ' ' PRO . 96.7 t -70.19 112.59 13.16 Favored Pre-proline 0 C--N 1.328 -0.356 0 C-N-CA 120.549 -0.46 . . . . 2.27 110.968 -176.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.654 ' HB2' ' HG3' ' A' ' 135' ' ' LYS . 18.1 Cg_exo -66.25 123.07 10.7 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.629 2.22 . . . . 1.29 111.841 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.672 ' HD2' ' HG2' ' A' ' 104' ' ' GLU . 16.0 Cg_exo -68.32 2.62 2.64 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.191 2.594 . . . . 1.6699999999999999 112.411 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 59.1 p -97.63 -30.45 12.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.622 0.248 . . . . 2.7000000000000002 111.356 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.654 ' HG3' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -91.11 2.29 56.44 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.673 -0.411 . . . . 4.0499999999999998 111.81 -176.176 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.33 82.38 0.76 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.276 -0.638 . . . . 5.2599999999999998 109.276 172.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -147.05 132.25 18.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.662 -0.699 . . . . 5.5199999999999996 110.187 -176.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -133.86 100.93 4.9 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.421 -0.585 . . . . 7.0 109.421 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 . . . . . 0 C--O 1.247 0.959 0 CA-C-O 117.986 -1.007 . . . . 6.9100000000000001 110.167 -176.29 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.625 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 N-CA-C 111.898 -0.481 . . . . 42.409999999999997 111.898 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.06 -18.23 24.16 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.881 2.387 . . . . 42.020000000000003 113.187 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 34.9 tp -108.48 135.16 50.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.586 -0.524 . . . . 43.539999999999999 109.586 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.64 30.59 8.92 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.645 -0.982 . . . . 41.520000000000003 110.645 -173.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 p -81.91 130.84 35.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.064 -0.568 . . . . 40.310000000000002 111.295 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -94.67 131.9 39.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.604 -0.726 . . . . 38.670000000000002 110.518 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.7 t -81.79 98.9 8.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.079 -0.51 . . . . 37.359999999999999 110.265 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.7 mt -83.61 95.94 8.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.816 -0.629 . . . . 36.490000000000002 110.197 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 92.3 mmm -82.79 133.67 48.54 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.956 -0.566 . . . . 35.119999999999997 111.01 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.73 -27.85 75.96 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.751 2.301 . . . . 34.549999999999997 111.727 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 p -83.94 90.18 7.36 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.46 -0.791 . . . . 34.009999999999998 110.769 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -124.69 84.05 2.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.614 -0.721 . . . . 34.789999999999999 109.95 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.7 p -85.79 130.84 35.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.969 -0.559 . . . . 34.009999999999998 110.798 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.1 m -122.27 134.58 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.764 -0.653 . . . . 35.259999999999998 110.357 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.623 ' HB3' ' HB2' ' A' ' 18' ' ' ALA . 98.7 mttt -115.49 85.52 2.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.186 0.517 . . . . 35.140000000000001 110.685 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.22 105.58 2.18 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.659 -0.782 . . . . 36.799999999999997 111.961 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.42 25.45 70.42 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.803 -0.713 . . . . 37.009999999999998 112.097 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.623 ' HB2' ' HB3' ' A' ' 15' ' ' LYS . . . -126.97 107.43 10.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.807 0.337 . . . . 35.420000000000002 110.484 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -119.11 105.53 11.49 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.299 -0.409 . . . . 36.07 110.8 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.53 90.96 2.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.234 0.54 . . . . 33.780000000000001 109.888 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.25 69.94 2.52 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.761 -0.654 . . . . 33.630000000000003 112.031 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 p -78.45 99.25 6.35 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.016 0.436 . . . . 32.890000000000001 110.058 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.6 tpt -142.68 137.1 29.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.98 -0.555 . . . . 33.770000000000003 110.321 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -109.36 162.26 14.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.843 -0.617 . . . . 33.939999999999998 109.471 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.3 -33.15 4.62 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 119.156 -0.802 . . . . 33.689999999999998 113.716 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -82.43 19.1 1.33 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 CA-C-N 120.444 2.122 . . . . 32.880000000000003 111.447 168.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -90.92 113.18 25.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.688 -0.687 . . . . 34.68 110.078 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.31 -178.78 47.64 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 111.223 -0.751 . . . . 31.800000000000001 111.223 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -99.94 123.35 44.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.544 -0.539 . . . . 31.699999999999999 109.544 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.41 -172.38 44.49 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.182 -0.767 . . . . 29.09 111.182 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -71.84 127.49 32.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.041 0.42 . . . . 27.890000000000001 110.403 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.44 157.21 50.66 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.066 -0.588 . . . . 25.079999999999998 112.088 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -70.53 134.16 47.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.788 0.328 . . . . 22.670000000000002 111.218 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.03 141.54 29.34 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.254 -0.738 . . . . 19.579999999999998 111.254 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.54 127.28 13.08 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.11 0.481 . . . . 17.84 112.269 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -115.29 139.96 15.91 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 111.173 -0.771 . . . . 15.130000000000001 111.173 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -86.04 154.04 21.7 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.592 0.234 . . . . 13.02 110.579 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.6 71.64 2.08 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.684 -0.769 . . . . 10.74 111.446 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 pt -62.09 153.37 6.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.044 -0.724 . . . . 9.4800000000000004 109.044 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -75.77 77.67 2.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.019 0.914 . . . . 6.75 111.466 -172.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.72 105.79 1.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.977 -1.01 . . . . 6.3099999999999996 110.027 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 p -118.15 111.87 35.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.502 0.668 . . . . 3.5600000000000001 111.629 -176.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -147.71 108.05 4.1 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.602 -0.726 . . . . 3.9399999999999999 110.357 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.736 ' CE2' ' HB ' ' A' ' 46' ' ' VAL . 11.8 t90 -116.78 139.99 49.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.648 0.737 . . . . 1.72 109.799 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.655 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 23.8 t -53.94 -25.92 13.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.201 -1.363 . . . . 1.72 112.561 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.736 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 0.5 OUTLIER -63.07 -13.4 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 O-C-N 121.995 -0.441 . . . . 1.3200000000000001 112.089 -174.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.48 -4.58 31.98 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.255 -0.974 . . . . 0.71999999999999997 111.935 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.655 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 11.7 ptmm? -105.33 -28.32 10.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 111.838 0.31 . . . . 3.3799999999999999 111.838 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.722 ' OD1' ' HA ' ' A' ' 46' ' ' VAL . 12.7 p-10 -114.58 1.34 14.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.051 0.453 . . . . 1.8300000000000001 111.235 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 49.6 tttm -56.48 -46.25 99.84 Favored Pre-proline 0 C--O 1.223 -0.334 0 CA-C-N 115.438 -0.801 . . . . 1.73 112.293 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 4.3 Cg_endo -46.48 -35.09 15.81 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.869 2.38 . . . . 0.80000000000000004 113.315 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.7 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 56.5 m -76.57 -36.44 57.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.376 0.607 . . . . 1.29 110.995 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.411 ' CD1' ' HB3' ' A' ' 110' ' ' ASN . 8.4 m-85 -81.96 -23.87 35.84 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.198 0.523 . . . . 1.4299999999999999 110.224 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.591 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 1.1 t70 -75.44 -39.47 58.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.032 -0.985 . . . . 1.1599999999999999 109.783 175.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.7 ' HG3' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -68.38 -38.65 81.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.504 -0.316 . . . . 1.6299999999999999 110.729 178.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.562 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 48.2 mt -70.95 -29.3 36.61 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 109.366 -0.605 . . . . 1.27 109.366 174.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.591 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 66.1 t80 -57.43 -54.51 46.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.71 -0.677 . . . . 1.51 111.213 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.578 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 75.3 m-85 -71.53 -22.89 61.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.166 0.507 . . . . 1.6799999999999999 110.498 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.562 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 18.3 m -72.09 -30.48 65.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.768 -0.651 . . . . 1.1799999999999999 110.874 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 34.4 mt -84.87 0.94 49.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 1.3600000000000001 110.979 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t 66.46 88.59 0.11 Allowed Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.511 -0.768 . . . . 1.22 111.464 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.578 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 64.8 Cg_endo -85.09 159.88 11.53 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.47 2.113 . . . . 0.57999999999999996 113.257 177.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.8 p -141.46 134.25 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.93 -0.577 . . . . 1.9199999999999999 109.958 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 63.81 20.53 12.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.479 -0.782 . . . . 2.0899999999999999 109.73 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.58 -0.06 67.51 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.145 -0.934 . . . . 0.56999999999999995 113.618 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -134.59 163.78 28.96 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 117.946 0.873 . . . . 2.3300000000000001 110.472 177.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pt -90.49 135.01 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 C-N-CA 120.642 -0.423 . . . . 1.1799999999999999 109.982 170.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.32 126.73 28.84 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.147 -1.057 . . . . 1.2 108.147 171.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.533 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -49.45 -31.91 14.56 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.571 -0.74 . . . . 0.59999999999999998 114.816 -166.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.67 -33.1 21.26 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 117.366 0.583 . . . . 1.1699999999999999 112.389 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.61 -38.49 39.76 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.366 0.603 . . . . 2.1099999999999999 109.932 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.578 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -72.29 -33.21 67.24 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.789 -0.641 . . . . 1.2 109.327 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.4 mmmm -65.34 -37.87 88.39 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 114.959 -1.018 . . . . 2.3100000000000001 108.78 174.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -56.54 -44.65 81.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.942 -1.026 . . . . 1.6799999999999999 110.416 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.649 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 3.3 mm-40 -64.01 -52.87 57.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.142 -0.936 . . . . 1.48 111.74 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.578 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 16.0 ptp -66.37 -21.07 66.23 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.582 -0.447 . . . . 0.84999999999999998 110.807 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 73' ' ' LYS . 5.1 t -68.64 -46.53 79.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 1.25 111.013 172.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.649 ' HE2' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -70.36 -16.36 62.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.12 0.486 . . . . 1.79 110.04 -176.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.9 t -65.01 -6.81 9.48 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.411 -0.813 . . . . 1.9399999999999999 111.716 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 77.9 mttt 67.44 68.22 0.38 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.383 0.611 . . . . 3.1200000000000001 110.596 175.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.52 HD11 HG12 ' A' ' 85' ' ' VAL . 20.7 mt -128.95 156.87 77.3 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.577 -0.738 . . . . 1.71 110.691 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.514 ' HG2' HG23 ' A' ' 85' ' ' VAL . 53.0 Cg_endo -73.21 162.93 39.36 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.194 1.929 . . . . 1.03 110.541 168.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -63.0 -27.47 69.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.334 -0.394 . . . . 1.53 111.539 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.1 p -67.38 -45.76 75.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.2 0.524 . . . . 1.75 110.723 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.55 ' HA ' ' HZ2' ' A' ' 88' ' ' LYS . 90.5 t -67.37 -42.92 87.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 115.904 -0.589 . . . . 1.28 110.053 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.465 ' CD2' ' HB2' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -48.66 -55.29 11.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.4 0.619 . . . . 2.0699999999999998 110.587 171.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -56.79 -53.29 45.19 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.873 -1.058 . . . . 0.45000000000000001 113.247 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.55 ' HZ2' ' HA ' ' A' ' 85' ' ' VAL . 14.4 pttp -81.12 -17.33 50.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.516 -0.873 . . . . 2.1899999999999999 112.651 -173.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.714 HG12 HD13 ' A' ' 122' ' ' LEU . 7.8 mt -69.73 -48.42 64.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 108.71 -0.848 . . . . 1.8200000000000001 108.71 169.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.415 ' CE3' ' HD3' ' A' ' 73' ' ' LYS . 67.2 t-105 -53.44 -55.43 25.22 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.497 -0.774 . . . . 0.35999999999999999 111.237 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.46 -30.28 71.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.38 -0.827 . . . . 2.9500000000000002 112.538 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.498 ' HB3' ' CD1' ' A' ' 112' ' ' LEU . 4.6 tp -84.09 -13.0 54.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.643 -0.503 . . . . 1.5 109.643 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.46 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -101.63 -42.92 6.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.315 -0.402 . . . . 1.1499999999999999 111.38 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.636 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 51.5 t0 -80.43 97.76 7.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.312 -0.625 . . . . 0.62 109.312 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.527 ' HB ' ' HE2' ' A' ' 135' ' ' LYS . 44.4 t -71.95 -28.71 30.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.896 -0.593 . . . . 2.27 110.325 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.602 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 0.2 OUTLIER -79.2 -26.63 42.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.963 -0.562 . . . . 1.7 109.595 176.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 56.39 44.66 24.12 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.954 0.883 . . . . 2.2599999999999998 109.05 -173.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -108.74 -0.16 20.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.181 -1.372 . . . . 1.51 112.167 -166.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.15 10.26 59.83 Favored Glycine 0 CA--C 1.511 -0.156 0 C-N-CA 120.287 -0.959 . . . . 0.34000000000000002 112.507 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.458 HD12 ' CB ' ' A' ' 66' ' ' LYS . 4.2 pp -152.89 156.13 38.37 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.227 0.537 . . . . 1.23 110.246 175.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.498 HD21 ' HB3' ' A' ' 105' ' ' GLU . 63.4 mt -121.82 119.0 30.39 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.115 -0.948 . . . . 1.3700000000000001 109.48 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.1 p30 -71.09 -178.36 1.96 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.508 -0.553 . . . . 1.5 109.508 174.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.411 ' CG ' ' HZ3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -56.94 -34.44 68.02 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.487 0.66 . . . . 1.73 111.08 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.611 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 23.5 tt0 -83.95 -31.81 25.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.548 0.69 . . . . 2.1400000000000001 109.424 -176.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.498 ' HB3' HD21 ' A' ' 101' ' ' LEU . 3.6 mt-10 -72.91 -30.28 63.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.583 -0.735 . . . . 1.1100000000000001 111.358 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.623 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -68.78 -44.19 74.15 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.062 -1.088 . . . . 1.8600000000000001 108.062 171.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -47.48 -46.6 27.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 1.02 110.62 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.708 ' HG ' ' CH2' ' A' ' 44' ' ' TRP . 1.0 OUTLIER -69.81 -46.66 65.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.8200000000000001 110.427 178.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.476 ' HB3' HD12 ' A' ' 101' ' ' LEU . . . -50.02 -53.76 24.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.089 0.471 . . . . 1.0700000000000001 111.527 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.425 ' HA ' HD13 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -72.39 -25.45 61.5 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.349 -0.611 . . . . 1.8899999999999999 109.349 -177.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.464 ' O ' HG21 ' A' ' 115' ' ' VAL . 51.4 t60 -70.24 -39.8 74.85 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.592 -0.521 . . . . 0.59999999999999998 109.592 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.55 HD21 HD23 ' A' ' 122' ' ' LEU . 46.6 mt -68.78 -36.53 78.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.838 0.352 . . . . 1.23 110.594 177.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 110' ' ' ASN . 95.6 mt -57.42 -48.94 81.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.931 -0.577 . . . . 1.49 110.528 175.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 19.8 ptmt -70.29 -28.46 65.21 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.123 -0.631 . . . . 2.6699999999999999 110.502 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 111' ' ' HIS . 6.4 t -62.13 -45.19 99.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.688 -0.233 . . . . 1.23 110.989 176.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 3.7 ptmm? -84.07 -2.42 56.67 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 119.733 -0.787 . . . . 2.4199999999999999 110.846 178.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.9 tp -83.64 -23.12 31.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.459 -0.571 . . . . 1.8200000000000001 109.459 170.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 48.5 mt-10 -66.44 -14.13 61.75 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.006 -0.543 . . . . 1.99 111.355 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.05 8.13 20.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.628 -0.796 . . . . 1.01 112.589 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.641 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -132.61 140.2 48.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.92 0.391 . . . . 1.0 109.964 177.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -77.06 164.96 25.23 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.865 -0.607 . . . . 2.75 110.962 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.714 HD13 HG12 ' A' ' 89' ' ' ILE . 27.1 mt -70.82 141.89 87.65 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.168 -0.469 . . . . 3.1800000000000002 110.291 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -92.25 12.86 2.0 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.035 2.49 . . . . 1.1899999999999999 113.105 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 59.96 21.93 10.99 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.756 -0.656 . . . . 1.8999999999999999 111.198 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -111.93 139.94 47.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.084 -0.709 . . . . 2.3599999999999999 109.084 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.83 93.34 47.58 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.542 -0.911 . . . . 2.3799999999999999 108.542 176.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -73.21 153.49 51.32 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.828 2.352 . . . . 1.1799999999999999 112.491 -174.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -67.47 -7.21 18.5 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.117 2.545 . . . . 1.6100000000000001 112.374 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -105.82 13.76 29.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.838 -0.619 . . . . 1.71 109.602 175.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.565 ' HG ' ' NE1' ' A' ' 44' ' ' TRP . 1.5 mp -134.6 -4.54 2.57 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.338 -0.846 . . . . 1.8700000000000001 110.658 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.584 HG12 ' HD2' ' A' ' 136' ' ' ARG . 29.3 t -66.03 120.6 70.74 Favored Pre-proline 0 N--CA 1.44 -0.936 0 N-CA-C 109.285 -0.635 . . . . 2.27 109.285 174.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.87 ' HB2' ' HG2' ' A' ' 135' ' ' LYS . 51.9 Cg_exo -53.07 122.67 11.55 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.899 1.733 . . . . 1.29 109.412 174.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.03 -33.02 25.29 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.332 2.688 . . . . 1.6699999999999999 113.712 -172.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.3 m -80.28 -2.59 45.78 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.634 0.235 . . . . 2.7000000000000002 111.634 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.87 ' HG2' ' HB2' ' A' ' 132' ' ' PRO . 14.2 mmmt -102.58 5.26 39.18 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.055 -0.35 . . . . 4.0499999999999998 110.055 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.631 ' HA ' ' NH1' ' A' ' 136' ' ' ARG . 9.3 mmm180 -75.69 101.64 5.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.934 0.397 . . . . 5.2599999999999998 111.307 174.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.92 121.79 9.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.901 -0.591 . . . . 5.5199999999999996 110.596 172.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -98.12 110.09 22.73 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.142 -0.481 . . . . 7.0 110.34 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.534 -0.746 . . . . 6.9100000000000001 109.711 175.207 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.636 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 111.971 -0.452 . . . . 42.409999999999997 111.971 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.29 -23.69 58.96 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.782 2.321 . . . . 42.020000000000003 112.382 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -81.66 133.97 35.42 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.398 -0.593 . . . . 43.539999999999999 109.398 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.42 29.48 58.07 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.47 -0.872 . . . . 41.520000000000003 111.651 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 p -76.94 161.81 28.08 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 120.661 0.267 . . . . 40.310000000000002 110.616 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -55.07 118.12 4.05 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.016 -0.538 . . . . 38.670000000000002 111.056 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.9 m -111.84 119.66 39.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.823 -0.626 . . . . 37.359999999999999 110.452 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.3 tp -100.98 144.43 29.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.921 -0.581 . . . . 36.490000000000002 109.97 177.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.7 mtm -71.05 153.33 94.64 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.356 -0.384 . . . . 35.119999999999997 110.762 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -58.58 162.27 12.96 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.991 2.46 . . . . 34.549999999999997 112.982 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.9 t -99.91 103.43 15.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.722 -0.672 . . . . 34.009999999999998 109.833 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -74.49 170.5 15.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.941 0.401 . . . . 34.789999999999999 111.305 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.36 116.03 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 34.009999999999998 110.473 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.09 141.65 41.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.35 -0.386 . . . . 35.259999999999998 110.758 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -149.91 97.12 2.54 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.637 -0.505 . . . . 35.140000000000001 109.637 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.13 147.36 16.82 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.99 -0.624 . . . . 36.799999999999997 112.576 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 6.7 70.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.938 -0.648 . . . . 37.009999999999998 112.769 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.1 90.57 6.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.006 0.431 . . . . 35.420000000000002 111.207 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -119.98 122.97 42.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.96 -0.564 . . . . 36.07 110.626 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -115.3 143.75 44.79 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.708 -0.478 . . . . 33.780000000000001 109.708 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.99 67.13 0.89 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.595 -0.812 . . . . 33.630000000000003 111.621 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m -117.22 104.1 10.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.11 -0.33 . . . . 32.890000000000001 110.11 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -133.12 108.65 8.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.42 0.628 . . . . 33.770000000000003 111.038 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -122.99 113.7 19.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.533 -0.758 . . . . 33.939999999999998 109.939 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.4 ' N ' ' CD ' ' A' ' 26' ' ' PRO . . . 119.03 -32.32 5.16 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.952 -0.915 . . . . 33.689999999999998 114.451 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 25' ' ' GLY . 9.5 Cg_exo -74.7 107.02 2.37 Favored 'Trans proline' 0 C--N 1.36 1.171 0 CA-C-N 120.837 2.319 . . . . 32.880000000000003 112.067 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -87.29 49.03 1.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.198 0.523 . . . . 34.68 110.477 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.54 117.48 0.46 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.525 -0.762 . . . . 31.800000000000001 111.768 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -104.12 122.84 46.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.054 -0.35 . . . . 31.699999999999999 110.054 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.25 96.39 0.1 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.609 -0.805 . . . . 29.09 111.463 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -130.84 142.5 50.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.909 0.385 . . . . 27.890000000000001 111.066 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.55 99.28 1.33 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.128 -0.789 . . . . 25.079999999999998 111.128 173.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -72.87 118.13 15.44 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.896 -0.409 . . . . 22.670000000000002 109.896 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.08 138.67 14.64 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.879 -0.677 . . . . 19.579999999999998 112.561 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.31 139.79 48.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.84 0.352 . . . . 17.84 110.245 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.95 133.77 11.81 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 121.007 -0.616 . . . . 15.130000000000001 111.63 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.477 ' HG2' ' H ' ' A' ' 38' ' ' GLY . 38.4 tt0 -88.14 172.64 9.35 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.457 -0.572 . . . . 13.02 109.457 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.477 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -78.76 87.67 1.15 Allowed Glycine 0 CA--C 1.501 -0.819 0 C-N-CA 120.706 -0.759 . . . . 10.74 112.046 -175.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.68 149.74 11.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.781 -0.822 . . . . 9.4800000000000004 108.781 169.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -76.66 72.98 3.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.434 0.635 . . . . 6.75 110.946 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -134.69 96.0 3.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.111 -0.95 . . . . 6.3099999999999996 109.498 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.3 t -121.49 119.99 60.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.265 -0.425 . . . . 3.5600000000000001 110.815 -176.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -121.07 94.92 4.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.193 -0.458 . . . . 3.9399999999999999 111.004 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.697 ' CD1' HD23 ' A' ' 130' ' ' LEU . 6.5 t90 -126.33 137.18 53.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.212 0.53 . . . . 1.72 109.799 170.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.552 ' H ' ' HD1' ' A' ' 44' ' ' TRP . 8.0 t -78.51 -4.52 6.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.365 -0.834 . . . . 1.72 111.07 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.628 HG21 ' NE1' ' A' ' 44' ' ' TRP . 99.1 t -89.26 -20.11 7.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 O-C-N 121.652 -0.655 . . . . 1.3200000000000001 111.865 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.68 -11.59 57.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.612 -1.28 . . . . 0.71999999999999997 112.234 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -109.5 -27.77 9.26 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.311 0.486 . . . . 3.3799999999999999 112.311 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -108.68 7.04 26.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.896 0.855 . . . . 1.8300000000000001 110.336 -173.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.683 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 83.0 tttt -61.5 -40.21 69.1 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 114.661 -1.154 . . . . 1.73 112.82 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.2 Cg_endo -46.2 -30.97 8.36 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 122.678 2.252 . . . . 0.80000000000000004 112.841 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.545 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 99.0 m -75.3 -40.79 58.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.793 0.806 . . . . 1.29 110.566 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.618 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 9.1 m-85 -79.55 -28.49 41.23 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.078 -0.51 . . . . 1.4299999999999999 110.579 -174.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.533 ' OD2' ' HA ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -86.12 -27.64 24.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.799 -0.637 . . . . 1.1599999999999999 110.181 -179.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 52' ' ' THR . 11.5 pt-20 -66.24 -43.1 87.56 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.346 -0.613 . . . . 1.6299999999999999 109.346 173.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.442 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 53.6 mt -67.9 -32.89 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 120.28 -0.568 . . . . 1.27 109.517 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.492 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 79.2 t80 -55.1 -52.99 61.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.477 -0.783 . . . . 1.51 111.276 175.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.533 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 74.7 m-85 -73.92 -23.3 59.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.738 0.304 . . . . 1.6799999999999999 111.314 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.442 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 25.2 m -66.76 -35.24 79.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.057 -0.519 . . . . 1.1799999999999999 110.769 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.521 HD12 ' CG ' ' A' ' 75' ' ' GLU . 54.9 mt -85.39 -4.48 59.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.122 -0.49 . . . . 1.3600000000000001 111.404 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.0 t 67.06 95.21 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 121.586 0.708 . . . . 1.22 111.312 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.533 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 22.9 Cg_endo -80.96 138.84 11.73 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.808 2.339 . . . . 0.57999999999999996 112.377 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.9 m -99.94 122.05 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.044 -0.525 . . . . 1.9199999999999999 110.873 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 62.92 24.14 14.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.65 -0.704 . . . . 2.0899999999999999 111.232 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.74 14.3 53.02 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.963 -0.636 . . . . 0.56999999999999995 113.728 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.941 ' HG3' HD11 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -155.03 151.78 28.83 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.759 -0.46 . . . . 2.3300000000000001 109.759 174.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.921 ' HB ' HD22 ' A' ' 71' ' ' ASN . 4.2 pt -80.5 135.93 24.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 C-N-CA 120.623 -0.431 . . . . 1.1799999999999999 110.529 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.03 128.76 38.41 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.883 -1.155 . . . . 1.2 107.883 167.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.606 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -49.92 -29.43 13.92 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 121.172 -0.537 . . . . 0.59999999999999998 113.917 -169.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.58 47.4 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.721 0.638 . . . . 1.1699999999999999 112.721 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.921 HD22 ' HB ' ' A' ' 67' ' ' ILE . 15.2 p30 -82.1 -33.03 29.93 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.074 0.464 . . . . 2.1099999999999999 110.538 -176.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.647 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -69.93 -35.89 74.9 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.378 0.609 . . . . 1.2 109.388 177.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.652 ' HZ1' ' HB2' ' A' ' 90' ' ' TRP . 31.4 mmmt -66.12 -37.84 86.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.163 -0.926 . . . . 2.3100000000000001 108.984 175.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 78' ' ' LYS . 2.2 tppp? -54.84 -48.2 73.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.683 -0.689 . . . . 1.6799999999999999 109.956 176.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.673 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 3.0 mm-40 -63.43 -51.94 63.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.041 -0.982 . . . . 1.48 111.957 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.647 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 14.9 ptp -67.95 -23.02 65.02 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.481 -0.488 . . . . 0.84999999999999998 111.409 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.502 HG21 HD13 ' A' ' 86' ' ' LEU . 24.9 t -71.85 -49.51 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.481 0.181 . . . . 1.25 111.186 173.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.673 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 2.5 ptmt -69.93 -9.1 53.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.264 0.554 . . . . 1.79 110.306 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.0 t -73.34 0.57 11.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.444 -0.798 . . . . 1.9399999999999999 110.893 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.5 mttp 73.09 68.09 0.11 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.91 -0.586 . . . . 3.1200000000000001 110.872 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.823 HD12 ' HE2' ' A' ' 116' ' ' LYS . 18.4 mt -138.64 159.68 66.46 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.627 -0.715 . . . . 1.71 111.358 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.503 ' HG2' HG22 ' A' ' 85' ' ' VAL . 74.2 Cg_endo -77.95 168.56 21.91 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.836 2.357 . . . . 1.03 111.385 167.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -63.45 -27.72 69.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.153 -0.476 . . . . 1.53 112.044 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -52.6 63.31 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.057 0.456 . . . . 1.75 111.167 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.503 HG22 ' HG2' ' A' ' 82' ' ' PRO . 22.6 t -62.54 -41.98 94.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.822 -0.626 . . . . 1.28 109.723 177.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.502 HD13 HG21 ' A' ' 77' ' ' VAL . 2.7 mm? -49.51 -50.05 43.31 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.837 -0.619 . . . . 2.0699999999999998 111.382 173.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.08 -44.84 86.81 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.946 -0.645 . . . . 0.45000000000000001 113.186 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.583 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 56.3 pttt -76.57 -31.29 57.44 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.964 -0.694 . . . . 2.1899999999999999 111.36 -175.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.552 HG12 HD13 ' A' ' 122' ' ' LEU . 29.7 mt -64.95 -46.22 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 109.325 -0.62 . . . . 1.8200000000000001 109.325 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.652 ' HB2' ' HZ1' ' A' ' 73' ' ' LYS . 76.3 t-105 -52.95 -57.01 11.77 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 115.018 -0.992 . . . . 0.35999999999999999 111.066 177.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -77.52 -9.48 58.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.389 0.515 . . . . 2.9500000000000002 112.389 -171.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.583 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 2.3 tp -88.44 -23.29 23.33 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.707 -0.397 . . . . 1.5 109.977 176.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.549 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -103.66 -39.21 6.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.038 0.447 . . . . 1.1499999999999999 110.886 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.651 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 29.6 t70 -83.43 79.31 9.46 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.234 -0.654 . . . . 0.62 109.234 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.772 HG22 ' HG3' ' A' ' 135' ' ' LYS . 7.1 m -61.25 -33.14 55.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.202 -0.908 . . . . 2.27 111.26 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 5.1 p-10 -78.41 -24.78 46.07 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.354 -1.294 . . . . 1.7 111.446 -175.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.612 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 36.7 mtmm 47.63 50.68 14.87 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.114 0.884 . . . . 2.2599999999999998 112.637 176.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -110.68 -10.85 14.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.583 -0.735 . . . . 1.51 110.281 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.09 22.91 9.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.163 -1.018 . . . . 0.34000000000000002 113.015 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.941 HD11 ' HG3' ' A' ' 66' ' ' LYS . 4.1 pp -152.94 168.32 26.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.069 0.434 . . . . 1.23 111.212 174.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.612 ' O ' HG12 ' A' ' 67' ' ' ILE . 50.8 mt -145.08 118.87 9.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.82 -1.178 . . . . 1.3700000000000001 107.82 -166.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.402 ' H ' ' HB2' ' A' ' 105' ' ' GLU . 1.1 p30 -81.98 -173.25 4.38 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.518 -0.473 . . . . 1.5 110.758 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.471 ' OD1' ' HB2' ' A' ' 54' ' ' ASP . 34.1 t70 -55.8 -36.96 67.99 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.423 0.689 . . . . 1.73 112.245 -173.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.81 ' HG2' ' HD3' ' A' ' 133' ' ' PRO . 4.2 tp10 -90.61 -22.0 21.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.428 0.632 . . . . 2.1400000000000001 110.483 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.571 ' OE1' ' HA ' ' A' ' 101' ' ' LEU . 3.1 mt-10 -73.64 -30.51 62.98 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.0 -0.545 . . . . 1.1100000000000001 110.047 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.619 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.8 OUTLIER -77.4 -34.09 54.88 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.953 -1.129 . . . . 1.8600000000000001 107.953 170.371 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.618 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -53.28 -48.88 67.95 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.378 0.608 . . . . 1.02 110.091 174.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 37.1 tp -75.85 -39.07 57.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.725 -0.67 . . . . 1.8200000000000001 111.363 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.25 -56.46 12.81 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.05 0.452 . . . . 1.0700000000000001 111.166 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.576 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 4.4 t30 -73.63 -24.32 60.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.829 -0.623 . . . . 1.8899999999999999 110.211 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.462 ' O ' HG22 ' A' ' 115' ' ' VAL . 82.6 t60 -70.28 -42.89 71.48 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.277 -0.569 . . . . 0.59999999999999998 109.825 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.549 HD12 ' HB1' ' A' ' 93' ' ' ALA . 80.4 mt -66.98 -31.44 72.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.738 -0.664 . . . . 1.23 109.785 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.717 ' O ' ' HG2' ' A' ' 116' ' ' LYS . 60.0 mt -60.72 -45.49 97.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.512 -0.767 . . . . 1.49 110.684 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.612 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 12.4 ttpt -65.26 -39.56 92.79 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.341 -0.544 . . . . 2.6699999999999999 110.433 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 111' ' ' HIS . 54.7 t -56.79 -46.4 83.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.666 -0.243 . . . . 1.23 111.365 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.823 ' HE2' HD12 ' A' ' 81' ' ' LEU . 14.6 pttp -67.01 -28.19 68.04 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.107 0.479 . . . . 2.4199999999999999 109.92 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.8 tp -80.89 -17.39 50.78 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.868 -0.605 . . . . 1.8200000000000001 110.971 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 45.0 mt-10 -75.46 0.55 16.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.034 0.445 . . . . 1.99 110.712 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.81 3.95 30.01 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.429 -0.891 . . . . 1.01 112.902 171.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.511 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.2 p80 -140.53 134.9 31.29 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.393 -0.523 . . . . 1.0 110.121 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.44 163.78 27.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.534 -0.757 . . . . 2.75 111.007 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.552 HD13 HG12 ' A' ' 89' ' ' ILE . 23.3 mt -69.89 134.34 87.91 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.35 -0.386 . . . . 3.1800000000000002 110.014 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 84.4 Cg_endo -93.18 14.83 1.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.894 2.396 . . . . 1.1899999999999999 113.114 -174.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.56 19.55 10.48 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.202 0.525 . . . . 1.8999999999999999 111.099 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -104.35 111.77 24.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.663 -0.699 . . . . 2.3599999999999999 109.582 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.9 tp -112.24 100.11 48.5 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.069 -0.514 . . . . 2.3799999999999999 109.983 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' A' ' 129' ' ' HIS . 4.7 Cg_endo -89.02 159.7 5.86 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.075 2.516 . . . . 1.1799999999999999 111.238 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.17 28.41 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.842 2.362 . . . . 1.6100000000000001 113.104 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.489 ' H ' ' C ' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -100.35 -25.17 14.32 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.863 -0.791 . . . . 1.71 108.863 174.229 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.697 HD23 ' CD1' ' A' ' 44' ' ' TRP . 0.7 OUTLIER -127.49 7.07 6.32 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.976 -0.557 . . . . 1.8700000000000001 111.424 -167.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.99 121.04 84.07 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 108.255 -1.017 . . . . 2.27 108.255 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 1.116 ' HB2' ' HE3' ' A' ' 135' ' ' LYS . 53.5 Cg_exo -47.8 152.58 2.9 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.743 2.295 . . . . 1.29 113.073 -176.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.81 ' HD3' ' HG2' ' A' ' 104' ' ' GLU . 94.1 Cg_exo -43.39 -56.51 2.28 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 124.145 3.23 . . . . 1.6699999999999999 114.365 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.4 m -67.5 -4.68 12.15 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.345 0.498 . . . . 2.7000000000000002 112.345 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 1.116 ' HE3' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -120.71 10.59 11.03 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.671 0.619 . . . . 4.0499999999999998 112.671 -171.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.615 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 0.1 OUTLIER -85.43 74.8 10.29 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.54 -0.464 . . . . 5.2599999999999998 110.071 178.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -165.67 141.63 5.17 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.248 0.547 . . . . 5.5199999999999996 111.798 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -116.98 113.34 22.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.048 -0.978 . . . . 7.0 108.457 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.026 0 O-C-N 123.683 0.614 . . . . 6.9100000000000001 109.86 -168.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.651 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.41 ' HA2' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.774 -0.531 . . . . 42.409999999999997 111.774 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.41 ' HD3' ' HA2' ' A' ' 1' ' ' GLY . 7.7 Cg_exo -72.99 -41.83 1.22 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.771 2.314 . . . . 42.020000000000003 112.007 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.9 tp -72.05 133.22 45.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.933 -0.576 . . . . 43.539999999999999 110.54 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.01 -2.2 65.88 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.935 -0.65 . . . . 41.520000000000003 112.318 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.8 t -96.71 131.31 43.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.82 0.343 . . . . 40.310000000000002 110.487 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -78.01 122.25 25.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.021 -0.536 . . . . 38.670000000000002 109.643 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.3 m -78.08 109.03 11.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.289 -0.414 . . . . 37.359999999999999 110.714 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.71 131.27 45.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.698 -0.683 . . . . 36.490000000000002 110.821 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 65.7 mtt -108.57 123.93 35.86 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.102 -0.499 . . . . 35.119999999999997 110.082 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -58.39 -33.84 98.18 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.212 2.608 . . . . 34.549999999999997 112.352 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 p -107.62 89.04 2.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.329 0.585 . . . . 34.009999999999998 110.388 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -101.68 59.81 0.87 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.718 -0.674 . . . . 34.789999999999999 110.392 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.5 t -119.4 105.0 16.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.76 -0.655 . . . . 34.009999999999998 110.156 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 m -88.79 102.63 13.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.558 0.694 . . . . 35.259999999999998 110.917 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.885 ' HB3' ' HB2' ' A' ' 18' ' ' ALA . 68.2 mttm -85.99 82.93 7.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.727 -0.67 . . . . 35.140000000000001 110.322 177.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.31 109.42 2.8 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.939 -0.648 . . . . 36.799999999999997 112.137 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.16 4.59 90.17 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.971 -0.633 . . . . 37.009999999999998 112.503 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.885 ' HB2' ' HB3' ' A' ' 15' ' ' LYS . . . -94.44 97.89 10.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.994 0.426 . . . . 35.420000000000002 110.619 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -87.71 117.36 26.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.933 -0.576 . . . . 36.07 110.501 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.57 139.05 39.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.106 0.479 . . . . 33.780000000000001 110.174 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -112.42 83.93 0.34 Allowed Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.686 -0.688 . . . . 33.630000000000003 111.519 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.4 m -147.33 143.37 28.0 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.364 -0.236 . . . . 32.890000000000001 110.364 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.4 tpt -60.45 138.24 58.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.241 0.544 . . . . 33.770000000000003 111.648 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -90.89 149.81 21.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.736 -0.665 . . . . 33.939999999999998 110.146 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.65 -32.01 5.17 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.674 -1.07 . . . . 33.689999999999998 114.682 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -73.28 1.27 6.89 Favored 'Trans proline' 0 C--N 1.359 1.122 0 CA-C-N 120.992 2.396 . . . . 32.880000000000003 112.295 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -82.6 123.66 29.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.25 -0.432 . . . . 34.68 110.028 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.24 171.18 53.22 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.734 -0.746 . . . . 31.800000000000001 112.811 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . 36.8 m80 -132.8 164.92 25.76 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.354 -0.61 . . . . 31.699999999999999 109.354 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.21 96.15 1.46 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.422 -0.894 . . . . 29.09 111.958 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.509 ' CZ ' ' HB2' ' A' ' 29' ' ' HIS . 33.9 m-85 -110.52 170.0 8.38 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.895 -0.409 . . . . 27.890000000000001 109.895 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.63 158.3 49.59 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.917 -0.873 . . . . 25.079999999999998 110.917 169.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -47.16 132.69 12.32 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.529 0.566 . . . . 22.670000000000002 112.529 -176.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.67 108.22 2.73 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.476 -1.05 . . . . 19.579999999999998 110.476 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.75 140.98 58.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.776 0.322 . . . . 17.84 110.368 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.69 109.81 3.17 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.744 -0.741 . . . . 15.130000000000001 112.278 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -78.91 -175.89 4.73 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.342 -0.244 . . . . 13.02 110.342 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.56 71.9 2.76 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.388 -0.91 . . . . 10.74 112.765 -172.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 pp -66.61 154.92 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 109.118 -0.697 . . . . 9.4800000000000004 109.118 168.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.82 75.65 2.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.449 0.642 . . . . 6.75 110.905 -175.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -94.1 87.54 5.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.357 -0.838 . . . . 6.3099999999999996 109.318 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.93 135.66 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.915 -0.584 . . . . 3.5600000000000001 110.952 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -82.41 110.41 17.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.594 0.712 . . . . 3.9399999999999999 110.731 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.593 ' CD2' ' HA ' ' A' ' 130' ' ' LEU . 6.5 t90 -120.13 141.3 49.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.137 -0.938 . . . . 1.72 109.173 175.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.801 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 21.1 t -49.96 -18.73 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 CA-C-N 114.985 -1.007 . . . . 1.72 112.565 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.504 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 1.0 OUTLIER -74.99 -15.86 15.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 120.826 -1.171 . . . . 1.3200000000000001 111.592 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.43 -14.12 61.65 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 119.517 -1.325 . . . . 0.71999999999999997 111.714 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.801 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -110.08 -27.87 8.96 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.986 0.422 . . . . 3.3799999999999999 110.874 176.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.774 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.0 OUTLIER -86.37 -18.66 31.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.515 -0.766 . . . . 1.8300000000000001 111.1 -177.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.462 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 58.8 tttm -52.32 -51.05 75.96 Favored Pre-proline 0 C--O 1.217 -0.619 0 CA-C-O 118.662 -0.685 . . . . 1.73 112.643 -174.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 85.9 Cg_exo -41.95 -40.41 6.03 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 122.775 2.317 . . . . 0.80000000000000004 113.676 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.549 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 93.9 m -74.04 -44.15 55.31 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.61 0.719 . . . . 1.29 110.744 -176.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.774 ' CE2' ' HB3' ' A' ' 49' ' ' ASP . 6.1 m-85 -74.64 -24.28 58.8 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.988 -0.551 . . . . 1.4299999999999999 110.109 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.54 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 24.7 t70 -81.1 -37.24 29.27 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.829 -1.078 . . . . 1.1599999999999999 110.257 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 52' ' ' THR . 13.5 pt-20 -67.13 -41.59 85.88 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.256 -0.429 . . . . 1.6299999999999999 109.963 175.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.493 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 56.1 mt -69.52 -30.38 45.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.583 -0.525 . . . . 1.27 109.583 175.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.547 ' CZ ' ' HB3' ' A' ' 62' ' ' PRO . 55.3 t80 -57.68 -55.21 37.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.721 -0.672 . . . . 1.51 111.244 177.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.49 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 68.6 m-85 -70.51 -21.84 62.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.236 0.541 . . . . 1.6799999999999999 110.611 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.493 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 23.0 m -72.97 -24.53 60.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.257 -0.883 . . . . 1.1799999999999999 110.985 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.0 mt -94.54 7.98 43.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 1.3600000000000001 110.828 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.0 t 64.93 90.05 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 123.751 0.657 . . . . 1.22 112.223 175.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.547 ' HB3' ' CZ ' ' A' ' 57' ' ' PHE . 5.7 Cg_exo -75.49 143.12 27.22 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.852 2.368 . . . . 0.57999999999999996 112.819 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.04 117.94 54.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.457 -0.942 . . . . 1.9199999999999999 108.457 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 68.89 21.15 7.69 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.636 0.585 . . . . 2.0899999999999999 111.567 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.42 ' C ' ' HD2' ' A' ' 66' ' ' LYS . . . 93.34 22.56 26.67 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.148 -0.478 . . . . 0.56999999999999995 112.936 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.91 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -160.85 156.07 24.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.247 -0.279 . . . . 2.3300000000000001 110.247 178.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.473 HD11 ' CD2' ' A' ' 106' ' ' PHE . 2.2 pt -86.22 137.56 20.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.776 -0.453 . . . . 1.1799999999999999 109.776 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 p -59.35 128.43 37.04 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.204 -1.036 . . . . 1.2 108.204 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.556 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -52.28 -32.87 37.74 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 114.942 0.737 . . . . 0.59999999999999998 114.942 -164.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.56 -28.01 29.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.291 0.545 . . . . 1.1699999999999999 112.434 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -78.73 -41.7 30.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.423 0.63 . . . . 2.1099999999999999 109.628 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.518 ' CB ' HD11 ' A' ' 101' ' ' LEU . . . -69.95 -31.14 68.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.583 0.706 . . . . 1.2 109.287 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HZ3' ' HB2' ' A' ' 90' ' ' TRP . 30.6 mmmt -65.86 -37.46 86.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.951 -1.022 . . . . 2.3100000000000001 109.004 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.4 -46.01 83.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.476 -0.783 . . . . 1.6799999999999999 109.785 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.889 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 11.4 mm-40 -56.63 -53.02 62.55 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.864 -1.062 . . . . 1.48 111.36 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.487 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 16.7 ptp -72.55 -23.67 61.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.179 -0.464 . . . . 0.84999999999999998 111.685 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 73' ' ' LYS . 20.2 t -67.57 -55.7 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.858 0.361 . . . . 1.25 110.798 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.889 ' HE2' ' HA ' ' A' ' 75' ' ' GLU . 57.2 pttt -67.7 -14.44 62.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.16 0.505 . . . . 1.79 110.977 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.1 t -66.32 -7.47 19.06 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.759 -0.655 . . . . 1.9399999999999999 110.995 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt 72.15 71.7 0.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.399 0.68 . . . . 3.1200000000000001 111.315 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 1.053 HD11 ' HE2' ' A' ' 116' ' ' LYS . 36.4 mt -131.82 162.21 57.82 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.519 -0.764 . . . . 1.71 110.65 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.46 ' HG2' HG21 ' A' ' 85' ' ' VAL . 67.8 Cg_endo -76.76 169.01 22.55 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.568 2.178 . . . . 1.03 110.864 166.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -66.0 -32.08 73.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.66 0.267 . . . . 1.53 111.344 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.5 m -63.6 -50.85 67.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.067 0.46 . . . . 1.75 110.856 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.46 HG21 ' HG2' ' A' ' 82' ' ' PRO . 84.7 t -63.04 -40.1 87.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 115.945 -0.57 . . . . 1.28 110.502 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.737 HD12 ' HB2' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -59.76 -48.99 79.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.879 0.371 . . . . 2.0699999999999998 111.321 177.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.33 -37.51 93.21 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.535 -0.757 . . . . 0.45000000000000001 112.209 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.673 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 17.2 ptmt -83.84 -29.43 27.29 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.241 -0.583 . . . . 2.1899999999999999 110.446 -175.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.5 mm -60.06 -48.04 89.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.363 -0.606 . . . . 1.8200000000000001 109.363 169.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.589 ' HB2' ' HZ3' ' A' ' 73' ' ' LYS . 76.9 t-105 -57.43 -54.35 47.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.449 -0.796 . . . . 0.35999999999999999 111.187 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.673 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 18.1 ptpt -77.78 -8.11 57.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.925 -0.58 . . . . 2.9500000000000002 111.915 -171.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 124' ' ' ALA . 18.2 tp -93.24 -30.89 14.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.996 -0.372 . . . . 1.5 109.996 174.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.479 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -81.84 -42.58 19.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.217 -0.447 . . . . 1.1499999999999999 110.957 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.615 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 50.6 t0 -87.28 97.84 11.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.175 0.512 . . . . 0.62 110.323 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.717 ' CG2' ' HG3' ' A' ' 135' ' ' LYS . 29.7 m -73.2 -25.78 21.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.624 -0.716 . . . . 2.27 111.681 -178.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.625 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 0.1 OUTLIER -85.64 -25.78 26.41 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.377 -0.601 . . . . 1.7 109.377 179.054 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.2 mttp 57.27 69.16 0.77 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.131 -0.941 . . . . 2.2599999999999998 110.504 -174.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.615 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 2.7 m-20 -96.05 -46.18 6.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.802 -1.09 . . . . 1.51 110.6 -174.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.45 14.32 20.33 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 109.435 -1.466 . . . . 0.34000000000000002 109.435 -162.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.91 HD13 ' HG3' ' A' ' 66' ' ' LYS . 3.6 pp -152.8 171.02 18.89 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.048 -1.076 . . . . 1.23 108.292 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.538 HD22 ' HB3' ' A' ' 105' ' ' GLU . 48.0 mt -143.35 117.52 9.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.618 -0.512 . . . . 1.3700000000000001 109.618 -174.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 4.0 p30 -74.3 -174.2 1.91 Allowed 'General case' 0 C--N 1.317 -0.845 0 O-C-N 122.199 -0.313 . . . . 1.5 110.656 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.2 -36.23 65.71 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.088 0.947 . . . . 1.73 109.995 -176.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.527 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 29.4 tt0 -88.19 -25.08 23.1 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.772 -1.103 . . . . 2.1400000000000001 109.871 -173.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.538 ' HB3' HD22 ' A' ' 101' ' ' LEU . 2.0 mt-10 -81.5 -32.36 32.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.041 -0.527 . . . . 1.1100000000000001 111.496 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.629 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -63.82 -43.0 97.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.176 -1.416 . . . . 1.8600000000000001 107.176 169.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.644 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -48.98 -50.24 36.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.602 -0.726 . . . . 1.02 110.842 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.614 HD13 ' HG3' ' A' ' 132' ' ' PRO . 1.4 tt -66.35 -47.94 71.82 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.748 -0.206 . . . . 1.8200000000000001 110.78 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.33 -54.66 33.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.948 0.404 . . . . 1.0700000000000001 111.894 -176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.535 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 9.0 t-20 -70.9 -30.66 67.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.238 0.542 . . . . 1.8899999999999999 109.583 -175.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.477 ' O ' HG21 ' A' ' 115' ' ' VAL . 61.7 t60 -67.94 -37.14 81.25 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.653 -0.703 . . . . 0.59999999999999998 109.897 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.461 ' HA ' ' HB ' ' A' ' 115' ' ' VAL . 21.6 mt -67.9 -33.48 74.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.056 0.455 . . . . 1.23 110.421 175.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.796 ' HA ' ' HE3' ' A' ' 116' ' ' LYS . 75.9 mt -62.13 -45.82 97.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.689 -0.687 . . . . 1.49 110.894 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.463 ' HD3' ' OH ' ' A' ' 53' ' ' TYR . 21.5 ptmt -73.8 -26.86 60.83 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.265 -0.574 . . . . 2.6699999999999999 110.927 176.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 111' ' ' HIS . 3.4 t -62.76 -47.45 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.744 0.307 . . . . 1.23 110.933 176.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 1.053 ' HE2' HD11 ' A' ' 81' ' ' LEU . 20.6 pttp -72.22 -22.47 61.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.09 0.471 . . . . 2.4199999999999999 110.112 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 23.0 tp -70.64 -22.36 62.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.953 -0.567 . . . . 1.8200000000000001 109.782 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 45.6 mt-10 -68.34 -12.01 60.43 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 116.028 -0.533 . . . . 1.99 110.429 173.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.96 -13.76 58.89 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.307 -0.717 . . . . 1.01 111.307 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.407 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -94.49 125.45 39.14 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.71 141.13 35.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.424 -0.807 . . . . 2.75 112.252 -174.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.845 HD13 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -63.75 130.16 94.23 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.882 -1.053 . . . . 3.1800000000000002 110.941 176.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.696 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 13.5 Cg_endo -87.83 1.18 6.9 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.066 2.51 . . . . 1.1899999999999999 114.176 -170.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.4 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . 65.94 18.73 11.15 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.722 0.773 . . . . 1.8999999999999999 109.777 -170.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.696 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 37.0 t70 -105.31 140.68 38.08 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.731 -1.122 . . . . 2.3599999999999999 108.593 175.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.52 102.48 32.81 Favored Pre-proline 0 C--N 1.309 -1.155 0 CA-C-N 115.782 -0.645 . . . . 2.3799999999999999 110.085 -176.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.28 156.64 11.0 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.269 2.646 . . . . 1.1799999999999999 112.415 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.447 ' O ' HG13 ' A' ' 131' ' ' VAL . 18.8 Cg_exo -64.0 -19.01 65.9 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.941 2.427 . . . . 1.6100000000000001 112.241 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -90.2 15.73 9.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.126 -0.488 . . . . 1.71 109.722 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.593 ' HA ' ' CD2' ' A' ' 44' ' ' TRP . 0.2 OUTLIER -149.06 17.52 0.96 Allowed 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.225 -0.898 . . . . 1.8700000000000001 109.483 175.079 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 128' ' ' PRO . 9.6 p -98.12 119.26 62.38 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 115.983 -0.553 . . . . 2.27 109.702 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.708 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 15.0 Cg_exo -62.43 115.71 3.05 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.235 1.957 . . . . 1.29 111.427 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.99 -16.6 28.98 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.862 2.374 . . . . 1.6699999999999999 115.031 -172.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 56.9 m -76.6 -9.52 58.72 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.457 -0.777 . . . . 2.7000000000000002 111.163 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.717 ' HG3' ' CG2' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -112.33 -7.7 13.97 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.769 -0.826 . . . . 4.0499999999999998 108.769 176.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 17.7 mmm180 -96.69 111.33 23.53 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.531 -1.213 . . . . 5.2599999999999998 110.417 174.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.66 144.41 26.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.939 -0.573 . . . . 5.5199999999999996 109.823 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -92.41 124.2 36.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.658 -0.701 . . . . 7.0 110.864 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.238 -0.886 . . . . 6.9100000000000001 109.589 173.916 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.625 'CA ' ' OD2' ' A' ' 96' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 111.85 -0.5 . . . . 42.409999999999997 111.85 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.686 ' HB2' HD12 ' A' ' 3' ' ' LEU . 2.7 Cg_exo -78.53 -46.68 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.958 2.439 . . . . 42.020000000000003 111.81 175.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' A' ' 2' ' ' PRO . 6.3 mp -98.3 139.46 34.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.862 -0.608 . . . . 43.539999999999999 109.8 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.25 -27.57 6.8 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.761 -0.733 . . . . 41.520000000000003 112.937 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.9 m -90.17 117.73 29.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.75 0.31 . . . . 40.310000000000002 110.267 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -71.06 130.68 42.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.828 -0.624 . . . . 38.670000000000002 110.435 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.06 99.02 3.79 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.29 -0.633 . . . . 37.359999999999999 109.29 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.3 tp -82.24 125.27 30.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.318 -0.401 . . . . 36.490000000000002 110.884 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 22.2 ptt? -94.14 130.55 33.91 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.858 -0.61 . . . . 35.119999999999997 109.427 173.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 49.9 Cg_exo -56.14 -39.41 91.41 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.778 2.319 . . . . 34.549999999999997 112.73 -176.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 p -87.05 91.81 8.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.116 0.484 . . . . 34.009999999999998 110.186 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -133.18 101.75 5.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.983 -0.553 . . . . 34.789999999999999 110.548 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 m -132.13 121.18 45.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.831 -0.622 . . . . 34.009999999999998 109.748 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.5 t -82.04 96.0 3.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.375 0.607 . . . . 35.259999999999998 111.255 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -98.06 79.61 2.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.561 0.696 . . . . 35.140000000000001 109.9 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -105.94 108.06 2.9 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.839 -0.696 . . . . 36.799999999999997 112.341 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.18 24.0 74.72 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.222 -0.513 . . . . 37.009999999999998 113.094 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.12 104.45 9.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.989 0.423 . . . . 35.420000000000002 111.058 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -107.96 88.58 2.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.993 -0.549 . . . . 36.07 109.945 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -117.93 112.81 20.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.782 -0.645 . . . . 33.780000000000001 110.919 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.72 66.38 0.24 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.898 -0.881 . . . . 33.630000000000003 110.898 175.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 t -120.67 130.43 54.1 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.113 0.482 . . . . 32.890000000000001 110.452 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 62.9 mtt -107.07 95.71 5.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.951 -0.568 . . . . 33.770000000000003 110.213 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -114.54 140.41 48.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.698 -0.683 . . . . 33.939999999999998 109.81 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.91 -32.48 4.77 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.092 -0.838 . . . . 33.689999999999998 113.811 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -70.73 95.91 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 120.59 2.195 . . . . 32.880000000000003 110.427 165.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -80.24 115.45 19.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.965 -0.561 . . . . 34.68 111.571 -173.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.72 129.5 1.17 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.634 -0.712 . . . . 31.800000000000001 111.797 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -76.1 140.26 41.75 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.951 -0.389 . . . . 31.699999999999999 109.951 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.55 177.49 33.7 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.219 -0.991 . . . . 29.09 112.3 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -138.88 144.39 39.15 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.609 0.243 . . . . 27.890000000000001 110.469 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.83 92.07 0.38 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.651 -0.785 . . . . 25.079999999999998 112.16 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.27 122.33 23.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.708 0.29 . . . . 22.670000000000002 110.413 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.68 115.01 4.26 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.731 -0.747 . . . . 19.579999999999998 111.745 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.98 116.37 18.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.963 0.411 . . . . 17.84 110.245 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.07 103.19 1.14 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.617 -0.802 . . . . 15.130000000000001 112.692 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -100.41 -175.38 2.9 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.479 -0.563 . . . . 13.02 109.479 173.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.51 72.32 2.38 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 119.971 -1.109 . . . . 10.74 111.021 175.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.2 pt -60.32 150.55 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 109.068 -0.716 . . . . 9.4800000000000004 109.068 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.43 ' HB3' ' HE ' ' A' ' 136' ' ' ARG . 8.8 t70 -74.74 80.51 2.07 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.56 -0.533 . . . . 6.75 109.56 -175.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -75.29 98.95 3.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.431 -0.804 . . . . 6.3099999999999996 110.512 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.64 142.65 39.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.551 -0.749 . . . . 3.5600000000000001 110.08 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -98.85 94.28 6.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.297 0.57 . . . . 3.9399999999999999 110.232 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.614 ' CH2' ' HG ' ' A' ' 108' ' ' LEU . 3.8 t90 -75.96 142.39 41.98 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.385 -0.825 . . . . 1.72 109.554 173.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.506 ' N ' ' CD1' ' A' ' 44' ' ' TRP . 12.0 t -45.61 -14.21 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.936 1.294 . . . . 1.72 113.572 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.465 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 2.1 t -86.94 -26.49 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.226 -0.922 . . . . 1.3200000000000001 112.022 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.96 -11.19 30.12 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.449 -0.881 . . . . 0.71999999999999997 112.398 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.743 ' HZ1' ' HB3' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -102.01 -27.63 12.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 112.154 0.427 . . . . 3.3799999999999999 112.154 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -114.67 6.67 15.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.187 0.517 . . . . 1.8300000000000001 110.572 -175.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.661 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 74.2 tttt -55.86 -43.47 99.22 Favored Pre-proline 0 C--O 1.22 -0.473 0 CA-C-O 118.774 -0.631 . . . . 1.73 111.757 177.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -44.69 -30.46 4.18 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 122.734 2.289 . . . . 0.80000000000000004 113.304 178.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.686 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 28.6 m -73.43 -43.87 59.46 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.067 0.937 . . . . 1.29 109.937 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.539 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 3.6 m-85 -82.05 -24.93 35.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.597 -0.729 . . . . 1.4299999999999999 110.117 -175.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.537 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 1.7 t70 -77.82 -35.81 50.9 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.949 -1.023 . . . . 1.1599999999999999 109.55 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.686 ' HG3' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -68.03 -36.73 80.42 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.054 -0.521 . . . . 1.6299999999999999 109.778 176.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 55.7 mt -70.42 -33.84 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.462 -0.57 . . . . 1.27 109.462 173.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.537 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 90.3 t80 -56.1 -57.52 11.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.349 -0.842 . . . . 1.51 111.348 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.595 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 57.4 m-85 -68.77 -22.8 64.27 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.991 0.424 . . . . 1.6799999999999999 111.045 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.9 m -70.06 -27.92 65.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.927 -0.579 . . . . 1.1799999999999999 110.698 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 63.6 mt -87.24 -3.97 59.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.644 -0.253 . . . . 1.3600000000000001 111.063 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.2 t 69.05 86.9 0.12 Allowed Pre-proline 0 N--CA 1.468 0.443 0 O-C-N 123.847 0.717 . . . . 1.22 111.533 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.595 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 59.6 Cg_endo -77.0 151.97 31.27 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.882 2.388 . . . . 0.57999999999999996 113.443 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.5 m -120.1 121.6 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.577 -0.738 . . . . 1.9199999999999999 110.756 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 63.26 24.25 14.2 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.915 -0.584 . . . . 2.0899999999999999 112.014 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.43 36.78 9.35 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.687 -0.768 . . . . 0.56999999999999995 112.754 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.612 ' HG3' HD11 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -171.56 162.99 6.63 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.327 -0.62 . . . . 2.3300000000000001 109.327 169.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.549 HD12 ' CD2' ' A' ' 106' ' ' PHE . 2.0 pt -92.97 134.85 29.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 109.741 -0.466 . . . . 1.1799999999999999 109.741 170.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 p -59.33 134.32 56.89 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.652 -1.24 . . . . 1.2 107.652 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.607 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -52.18 -28.26 25.87 Favored Glycine 0 C--O 1.22 -0.732 0 N-CA-C 115.422 0.929 . . . . 0.59999999999999998 115.422 -167.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.91 -27.03 50.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.774 0.787 . . . . 1.1699999999999999 112.047 175.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.414 ' ND2' ' N ' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -79.31 -36.5 39.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.785 0.802 . . . . 2.1099999999999999 109.472 -178.13 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -75.8 -31.34 59.39 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.235 -0.893 . . . . 1.2 110.09 177.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 14.2 mmmm -65.18 -34.51 78.56 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.433 -0.951 . . . . 2.3100000000000001 108.433 173.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 74' ' ' LYS . 1.7 tppp? -58.96 -49.02 79.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.122 -0.944 . . . . 1.6799999999999999 109.719 174.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 57.4 mm-40 -56.69 -53.02 62.51 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.254 -0.884 . . . . 1.48 112.226 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.638 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 15.0 ptp -70.8 -24.7 62.62 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.698 -0.401 . . . . 0.84999999999999998 110.857 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.06 -46.02 82.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 122.109 -0.369 . . . . 1.25 110.991 172.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 18.1 ptpt -73.79 -18.28 60.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.72 -0.218 . . . . 1.79 111.432 -175.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.2 p -67.33 3.22 1.32 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.546 0.573 . . . . 1.9399999999999999 112.546 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 74.44 29.34 1.21 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.987 0.515 . . . . 3.1200000000000001 111.003 172.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.569 HD11 ' HD3' ' A' ' 116' ' ' LYS . 61.6 mt -109.44 162.05 21.67 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.125 -0.488 . . . . 1.71 111.33 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.561 ' O ' HD22 ' A' ' 86' ' ' LEU . 92.3 Cg_endo -81.96 150.43 16.06 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.745 2.297 . . . . 1.03 111.464 174.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -51.29 -29.9 16.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.536 -0.756 . . . . 1.53 112.657 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -62.95 -49.64 73.95 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.429 0.633 . . . . 1.75 110.71 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.549 ' O ' HG13 ' A' ' 89' ' ' ILE . 67.6 t -63.52 -41.83 94.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-N 115.273 -0.876 . . . . 1.28 110.315 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.561 HD22 ' O ' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -64.18 -39.05 93.17 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.721 0.296 . . . . 2.0699999999999998 110.765 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -57.92 -45.96 93.04 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.913 -0.66 . . . . 0.45000000000000001 111.907 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.683 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 44.7 pttt -81.1 -27.76 35.47 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.739 -0.785 . . . . 2.1899999999999999 111.715 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 85' ' ' VAL . 60.0 mt -60.6 -46.3 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 109.662 -0.496 . . . . 1.8200000000000001 109.662 171.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -56.99 -56.92 15.5 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.702 -0.681 . . . . 0.35999999999999999 111.088 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.683 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 9.0 ptpp? -70.38 -9.51 56.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 2.9500000000000002 111.665 -174.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.532 HD12 ' HA ' ' A' ' 124' ' ' ALA . 14.0 tp -93.32 -33.05 14.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 1.5 110.347 175.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.31 -42.84 12.6 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.121 0.415 . . . . 1.1499999999999999 112.121 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.648 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 53.8 t0 -84.98 98.65 10.5 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.628 -0.508 . . . . 0.62 109.628 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.51 ' HB ' ' HE2' ' A' ' 135' ' ' LYS . 41.0 t -72.02 -29.82 34.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.532 -0.758 . . . . 2.27 111.244 -174.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.601 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.0 OUTLIER -80.55 -27.39 37.57 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.177 -0.675 . . . . 1.7 109.177 179.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 58.8 45.52 15.39 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 122.318 1.056 . . . . 2.2599999999999998 108.439 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -105.0 6.7 33.65 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.649 -1.614 . . . . 1.51 111.801 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.51 18.62 70.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.467 -0.873 . . . . 0.34000000000000002 112.527 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.612 HD11 ' HG3' ' A' ' 66' ' ' LYS . 4.3 pp -153.3 175.21 13.35 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.693 -0.484 . . . . 1.23 109.693 175.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.56 HD11 ' CB ' ' A' ' 72' ' ' ALA . 46.3 mt -149.79 113.45 5.03 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.931 -1.136 . . . . 1.3700000000000001 107.931 -173.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.1 p-10 -75.75 -172.54 1.93 Allowed 'General case' 0 C--N 1.313 -0.991 0 O-C-N 122.352 -0.217 . . . . 1.5 110.678 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.52 -36.42 66.69 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.852 0.358 . . . . 1.73 111.057 -175.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.51 -26.81 19.58 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.013 0.375 . . . . 2.1400000000000001 112.013 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.595 ' OE1' 'CA ' ' A' ' 141' ' ' ' CA' . 2.3 mt-10 -70.8 -34.55 71.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.026 0.441 . . . . 1.1100000000000001 109.91 175.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.666 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -66.7 -42.56 86.24 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 107.649 -1.241 . . . . 1.8600000000000001 107.649 170.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.539 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -53.0 -41.02 64.23 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.846 -0.616 . . . . 1.02 110.558 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.614 ' HG ' ' CH2' ' A' ' 44' ' ' TRP . 1.0 OUTLIER -73.74 -50.84 18.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.004 -0.544 . . . . 1.8200000000000001 110.883 178.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.42 ' HB2' HD13 ' A' ' 101' ' ' LEU . . . -50.9 -52.07 45.61 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.26 0.552 . . . . 1.0700000000000001 111.198 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.506 ' HB2' ' HE1' ' A' ' 106' ' ' PHE . 7.2 t-20 -71.18 -27.16 63.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.646 -0.706 . . . . 1.8899999999999999 109.515 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.502 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 60.8 t60 -68.69 -40.83 79.88 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 120.19 -0.604 . . . . 0.59999999999999998 109.59 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.525 ' HA ' ' HB ' ' A' ' 115' ' ' VAL . 42.8 mt -68.57 -35.37 77.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.307 -0.406 . . . . 1.23 110.735 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 110' ' ' ASN . 97.4 mt -59.26 -52.43 60.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.334 -0.394 . . . . 1.49 110.186 174.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 19.1 ptmt -72.28 -21.61 61.33 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.126 -0.63 . . . . 2.6699999999999999 110.858 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.525 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 2.5 t -59.15 -47.47 90.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.998 -0.371 . . . . 1.23 109.998 171.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.773 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 4.8 ptmm? -85.44 2.63 43.71 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 120.182 -0.607 . . . . 2.4199999999999999 110.527 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.8 tp -88.4 -19.52 26.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.573 -0.74 . . . . 1.8200000000000001 109.311 168.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 55.2 mt-10 -67.08 -17.18 64.77 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.889 -0.596 . . . . 1.99 110.234 176.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.39 -21.34 13.05 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.026 -0.607 . . . . 1.01 111.94 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.773 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -106.83 135.94 47.51 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.89 -1.152 . . . . 1.0 107.89 174.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.502 ' HA ' ' CB ' ' A' ' 116' ' ' LYS . 13.4 pt-20 -93.26 163.29 13.67 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.737 -0.785 . . . . 2.75 110.937 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.804 ' H ' HD12 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -62.86 127.57 90.76 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-O 121.367 0.603 . . . . 3.1800000000000002 110.763 177.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.497 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 72.8 Cg_endo -95.86 13.8 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.478 2.786 . . . . 1.1899999999999999 113.014 -174.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.532 ' HA ' HD12 ' A' ' 92' ' ' LEU . . . 65.87 36.31 6.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.311 -0.858 . . . . 1.8999999999999999 111.181 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.497 ' OD1' ' HG2' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -114.99 142.69 46.29 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.55 0.69 . . . . 2.3599999999999999 109.914 169.256 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.3 tp -126.25 96.54 36.39 Favored Pre-proline 0 C--N 1.306 -1.32 0 CA-C-N 114.964 -1.017 . . . . 2.3799999999999999 110.032 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -73.2 150.81 48.23 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.755 2.303 . . . . 1.1799999999999999 111.833 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.22 -16.25 45.23 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.785 2.323 . . . . 1.6100000000000001 112.248 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.406 ' O ' HD13 ' A' ' 130' ' ' LEU . 21.6 p-80 -98.38 21.83 10.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.143 -0.481 . . . . 1.71 110.867 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.535 ' HG ' ' NE1' ' A' ' 44' ' ' TRP . 1.0 OUTLIER -138.27 12.91 2.82 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.576 -0.284 . . . . 1.8700000000000001 110.729 174.143 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 m -91.18 125.55 58.06 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 109.401 -0.592 . . . . 2.27 109.401 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.744 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 51.3 Cg_exo -50.65 146.9 19.0 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.6 2.2 . . . . 1.29 111.829 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -43.24 -27.9 1.28 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.399 3.399 . . . . 1.6699999999999999 115.957 -175.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.5 m -88.72 -10.55 47.97 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.654 0.612 . . . . 2.7000000000000002 112.654 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.744 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -119.46 9.15 11.48 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.508 0.558 . . . . 4.0499999999999998 112.508 -177.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.43 ' HE ' ' HB3' ' A' ' 40' ' ' ASP . 0.6 OUTLIER -84.55 95.59 8.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.984 0.421 . . . . 5.2599999999999998 110.28 173.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -167.5 136.41 2.62 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.255 -0.276 . . . . 5.5199999999999996 110.255 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.595 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 61.2 m-70 -92.21 96.95 10.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.941 -0.572 . . . . 7.0 110.001 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.595 ' HG2' ' O ' ' A' ' 138' ' ' HIS . 7.1 mm-40 . . . . . 0 C--O 1.254 1.312 0 O-C-N 125.198 1.561 . . . . 6.9100000000000001 108.237 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.648 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 111.957 -0.457 . . . . 42.409999999999997 111.957 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.18 133.11 39.21 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.805 2.336 . . . . 42.020000000000003 112.039 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.415 HD13 ' N ' ' A' ' 3' ' ' LEU . 6.0 mp -72.79 144.7 47.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.105 -0.498 . . . . 43.539999999999999 110.01 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.97 -8.83 18.71 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.722 -0.751 . . . . 41.520000000000003 111.507 -173.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.2 m -85.84 153.05 22.52 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.266 -0.642 . . . . 40.310000000000002 109.266 173.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -68.36 127.12 31.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.203 0.525 . . . . 38.670000000000002 111.934 -174.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.9 m -80.8 134.06 35.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.346 -0.843 . . . . 37.359999999999999 109.952 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.8 mt -102.46 161.55 13.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.066 0.46 . . . . 36.490000000000002 111.382 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.6 mtt -105.86 145.12 30.27 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.699 -0.682 . . . . 35.119999999999997 109.994 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.78 -37.53 66.76 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.328 2.019 . . . . 34.549999999999997 112.071 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.6 m -86.13 89.72 7.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.181 -0.463 . . . . 34.009999999999998 109.948 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -95.56 94.45 7.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.201 0.524 . . . . 34.789999999999999 109.589 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.12 129.91 66.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.693 -0.685 . . . . 34.009999999999998 111.151 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 p -119.57 124.62 73.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.828 -0.624 . . . . 35.259999999999998 110.366 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -113.25 105.78 13.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.102 -0.499 . . . . 35.140000000000001 110.311 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.63 124.2 17.74 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.991 -0.623 . . . . 36.799999999999997 112.048 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.41 23.03 41.55 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.417 -0.897 . . . . 37.009999999999998 112.371 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.08 133.78 55.75 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.295 -0.261 . . . . 35.420000000000002 110.295 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -80.34 118.67 22.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.278 0.561 . . . . 36.07 110.472 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -143.37 134.22 25.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.725 -0.67 . . . . 33.780000000000001 110.402 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.53 67.48 0.56 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.702 -0.761 . . . . 33.630000000000003 111.84 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.3 p -106.46 144.97 32.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.79 0.328 . . . . 32.890000000000001 111.199 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.5 ptp -147.52 138.95 23.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.737 -0.468 . . . . 33.770000000000003 109.737 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.47 ' C ' ' HD2' ' A' ' 26' ' ' PRO . 87.0 m-20 -101.31 146.88 26.98 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.456 -0.338 . . . . 33.939999999999998 111.139 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.607 ' N ' ' HD2' ' A' ' 26' ' ' PRO . . . 119.84 -33.33 4.64 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 118.497 -1.168 . . . . 33.689999999999998 115.13 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 25' ' ' GLY . 9.5 Cg_endo -55.99 -40.93 81.93 Favored 'Trans proline' 0 C--N 1.361 1.219 0 CA-C-N 121.068 2.434 . . . . 32.880000000000003 112.611 175.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -127.52 161.87 27.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.022 -0.535 . . . . 34.68 110.073 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.11 154.69 45.02 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.993 -0.622 . . . . 31.800000000000001 111.85 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -79.76 126.56 31.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.233 0.54 . . . . 31.699999999999999 111.4 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.01 -175.15 25.55 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.83 -0.7 . . . . 29.09 111.472 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -111.7 168.08 9.84 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.758 0.279 . . . . 27.890000000000001 110.446 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.74 95.09 0.69 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.963 -0.637 . . . . 25.079999999999998 111.681 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -130.47 153.99 48.23 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.622 0.248 . . . . 22.670000000000002 110.373 -177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.98 98.25 1.7 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.513 -0.851 . . . . 19.579999999999998 111.122 173.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.18 160.96 19.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.98 0.419 . . . . 17.84 111.254 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.99 100.77 1.19 Allowed Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 111.039 -0.825 . . . . 15.130000000000001 111.039 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -76.95 -173.7 2.81 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.33 -0.435 . . . . 13.02 110.805 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.23 73.48 2.17 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 110.752 -0.939 . . . . 10.74 110.752 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 39' ' ' ILE . 9.1 mt -63.34 156.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.079 -1.061 . . . . 9.4800000000000004 108.759 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.44 69.77 1.2 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.905 0.86 . . . . 6.75 109.169 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -142.16 106.45 4.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.35 -1.296 . . . . 6.3099999999999996 108.638 172.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.5 91.62 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.253 0.549 . . . . 3.5600000000000001 110.309 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -119.38 88.71 2.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.661 -0.699 . . . . 3.9399999999999999 109.436 172.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.649 ' NE1' ' HG ' ' A' ' 130' ' ' LEU . 9.6 t90 -96.52 137.82 35.02 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.416 -0.811 . . . . 1.72 109.729 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.513 ' H ' ' HD1' ' A' ' 44' ' ' TRP . 4.8 t -71.26 1.08 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 114.502 -1.226 . . . . 1.72 111.266 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 44' ' ' TRP . 2.3 t -88.14 -17.69 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 O-C-N 121.667 -0.646 . . . . 1.3200000000000001 111.194 175.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.78 -16.37 59.09 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.441 -0.885 . . . . 0.71999999999999997 111.906 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.475 ' HZ2' ' CG ' ' A' ' 49' ' ' ASP . 10.5 ptmm? -99.82 -28.21 13.24 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.991 0.367 . . . . 3.3799999999999999 111.991 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.475 ' CG ' ' HZ2' ' A' ' 48' ' ' LYS . 60.2 m-20 -108.01 0.4 21.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.956 0.408 . . . . 1.8300000000000001 111.094 -173.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 54.2 tttp -51.37 -48.63 85.59 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.048 -0.523 . . . . 1.73 112.063 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 26.2 Cg_endo -62.02 -28.99 81.04 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.762 1.641 . . . . 0.80000000000000004 111.902 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.585 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 92.4 m -74.72 -37.69 62.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.719 0.771 . . . . 1.29 110.274 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.466 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 24.0 m-85 -74.51 -24.41 58.98 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.829 -0.623 . . . . 1.4299999999999999 110.269 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.578 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 13.1 t70 -81.36 -32.39 32.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.577 -0.738 . . . . 1.1599999999999999 110.887 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 52' ' ' THR . 17.2 pt-20 -70.0 -44.38 69.5 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.926 -0.484 . . . . 1.6299999999999999 110.022 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.52 -30.12 48.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.819 0.818 . . . . 1.27 109.066 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.904 ' HE1' HG21 ' A' ' 67' ' ' ILE . 0.7 OUTLIER -64.88 -57.21 9.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.304 -1.316 . . . . 1.51 111.019 176.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.605 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 27.6 m-85 -62.88 -22.82 66.99 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.998 0.427 . . . . 1.6799999999999999 110.965 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.7 m -69.09 -22.07 64.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.647 -0.706 . . . . 1.1799999999999999 110.834 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.9 mt -97.47 -7.24 32.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.53 -0.305 . . . . 1.3600000000000001 110.649 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.419 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 10.3 t 70.12 95.11 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.694 0.798 . . . . 1.22 111.797 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.657 ' HB3' ' CE1' ' A' ' 57' ' ' PHE . 11.0 Cg_endo -62.09 160.87 28.39 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.422 2.748 . . . . 0.57999999999999996 113.855 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.631 HG13 HD21 ' A' ' 64' ' ' ASN . 87.2 t -129.12 102.99 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.315 -0.857 . . . . 1.9199999999999999 110.006 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.631 HD21 HG13 ' A' ' 63' ' ' VAL . 53.7 m-80 66.17 28.19 10.18 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.008 0.523 . . . . 2.0899999999999999 111.859 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.89 21.89 27.09 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.895 -0.669 . . . . 0.56999999999999995 113.301 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.649 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -169.98 152.0 4.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.147 -1.057 . . . . 2.3300000000000001 108.147 174.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.904 HG21 ' HE1' ' A' ' 57' ' ' PHE . 1.1 pt -90.8 139.28 17.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 119.531 -0.868 . . . . 1.1799999999999999 110.183 174.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.6 p -60.37 139.58 57.59 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.338 -0.986 . . . . 1.2 108.338 169.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.55 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -53.5 -35.72 52.03 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 115.098 0.799 . . . . 0.59999999999999998 115.098 -164.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.01 -22.44 15.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.54 0.67 . . . . 1.1699999999999999 112.794 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -80.25 -40.68 26.51 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.675 0.75 . . . . 2.1099999999999999 109.689 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.619 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -73.79 -31.25 63.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.436 -0.802 . . . . 1.2 109.663 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.2 mmmm -64.29 -35.03 79.5 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.643 -0.873 . . . . 2.3100000000000001 108.643 173.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 1.1 tppp? -59.16 -44.66 92.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.337 -0.847 . . . . 1.6799999999999999 110.006 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 60.2 mm-40 -60.16 -53.17 60.85 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.275 -0.875 . . . . 1.48 111.823 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.619 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 12.5 ptp -71.13 -18.23 62.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.432 -0.349 . . . . 0.84999999999999998 110.858 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.479 HG23 HD13 ' A' ' 86' ' ' LEU . 2.4 t -74.23 -47.91 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.309 -0.405 . . . . 1.25 110.795 171.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 18.1 ptpt -70.39 -13.33 62.1 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.976 0.417 . . . . 1.79 110.354 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.5 t -65.86 -7.34 15.79 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.896 -0.593 . . . . 1.9399999999999999 110.517 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 68.04 67.56 0.34 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.927 0.891 . . . . 3.1200000000000001 110.889 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.974 HD21 ' HE3' ' A' ' 116' ' ' LYS . 22.6 mt -132.65 159.73 71.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.897 -0.592 . . . . 1.71 111.029 -175.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.517 ' HG2' HG23 ' A' ' 85' ' ' VAL . 62.9 Cg_endo -76.96 163.62 30.78 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.536 2.157 . . . . 1.03 110.922 169.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -61.57 -24.09 66.42 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.248 0.462 . . . . 1.53 112.248 -174.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.8 m -62.78 -48.94 76.97 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 120.998 0.428 . . . . 1.75 110.74 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.517 HG23 ' HG2' ' A' ' 82' ' ' PRO . 21.8 t -67.23 -43.53 88.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.328 -0.619 . . . . 1.28 109.328 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.479 HD13 HG23 ' A' ' 77' ' ' VAL . 3.3 mm? -46.55 -57.49 4.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.531 -0.759 . . . . 2.0699999999999998 111.009 172.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.4 -40.74 99.07 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.031 -0.986 . . . . 0.45000000000000001 113.702 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.834 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 55.7 pttt -85.28 -25.09 27.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.618 -0.833 . . . . 2.1899999999999999 112.209 -175.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.603 HG12 ' CD1' ' A' ' 122' ' ' LEU . 18.6 mt -65.2 -43.05 95.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.424 -0.954 . . . . 1.8200000000000001 108.424 170.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.427 ' CH2' ' HG ' ' A' ' 101' ' ' LEU . 73.9 t-105 -60.57 -53.29 59.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.943 -1.026 . . . . 0.35999999999999999 111.301 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.834 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -72.82 -12.34 60.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.579 -0.282 . . . . 2.9500000000000002 111.616 -174.383 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.2 tp -91.25 -25.12 19.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.689 -0.486 . . . . 1.5 109.689 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.62 ' HA ' HD11 ' A' ' 108' ' ' LEU . . . -93.1 -43.08 9.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.031 0.443 . . . . 1.1499999999999999 112.0 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.497 ' HB2' HD21 ' A' ' 101' ' ' LEU . 46.9 t0 -88.46 94.29 9.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.193 0.52 . . . . 0.62 110.171 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.646 HG21 ' HG3' ' A' ' 135' ' ' LYS . 56.5 t -64.35 -23.27 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.289 -0.869 . . . . 2.27 111.18 -176.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.0 -26.77 15.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.57 -0.741 . . . . 1.7 110.726 -174.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt 60.23 58.71 2.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.348 1.071 . . . . 2.2599999999999998 109.096 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -106.11 -18.81 13.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.454 -1.703 . . . . 1.51 111.278 -170.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.64 13.89 49.08 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.479 -0.867 . . . . 0.34000000000000002 112.553 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.6 pp -148.05 179.0 8.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.767 -0.457 . . . . 1.23 109.767 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.584 HD11 ' CB ' ' A' ' 72' ' ' ALA . 25.2 mt -151.27 114.64 4.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.83 -1.174 . . . . 1.3700000000000001 107.83 -175.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.5 p30 -78.98 -174.36 4.0 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.49 -0.484 . . . . 1.5 109.996 178.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.63 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 3.9 p30 -57.84 -33.73 68.96 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.16 0.429 . . . . 1.73 112.16 -174.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.931 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 16.5 tt0 -85.74 -27.0 25.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.53 0.681 . . . . 2.1400000000000001 110.391 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.542 ' HB3' HD23 ' A' ' 101' ' ' LEU . 3.0 mt-10 -75.25 -33.69 61.33 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.603 -0.726 . . . . 1.1100000000000001 110.499 176.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -66.89 -40.87 87.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.753 -1.203 . . . . 1.8600000000000001 107.753 172.098 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.466 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -52.61 -48.94 65.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.289 -0.868 . . . . 1.02 110.799 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.62 HD11 ' HA ' ' A' ' 93' ' ' ALA . 1.3 tt -65.55 -53.27 44.45 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.352 -0.385 . . . . 1.8200000000000001 110.121 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.402 ' HB2' HD13 ' A' ' 101' ' ' LEU . . . -49.6 -53.36 24.41 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.619 0.6 . . . . 1.0700000000000001 112.619 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.442 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 10.2 t-20 -70.57 -32.1 69.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.169 0.509 . . . . 1.8899999999999999 110.167 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.528 ' O ' HG23 ' A' ' 115' ' ' VAL . 78.0 t60 -66.4 -35.26 79.86 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.975 -0.557 . . . . 0.59999999999999998 109.706 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.2 mt -69.12 -36.6 77.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.843 -0.617 . . . . 1.23 110.463 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.582 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 47.5 mm -59.49 -41.66 85.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.884 0.373 . . . . 1.49 110.195 172.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.681 ' HE2' ' O ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -57.11 -49.39 76.06 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.72 -0.673 . . . . 2.6699999999999999 109.624 173.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 111' ' ' HIS . 78.6 t -60.32 -42.07 89.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.766 -0.652 . . . . 1.23 111.577 -176.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.974 ' HE3' HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -75.27 -21.56 58.43 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.863 -0.335 . . . . 2.4199999999999999 111.278 178.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.1 tp -79.75 -19.4 48.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.746 0.307 . . . . 1.8200000000000001 110.535 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.598 ' HG2' ' NZ ' ' A' ' 114' ' ' LYS . 37.2 mt-10 -62.92 -16.73 60.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.148 0.499 . . . . 1.99 110.427 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 112.07 4.91 25.57 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.667 -0.777 . . . . 1.01 111.627 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.482 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 2.7 p80 -126.85 140.41 52.37 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.305 0.574 . . . . 1.0 110.36 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -71.77 152.16 42.94 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.123 -0.944 . . . . 2.75 111.363 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.603 ' CD1' HG12 ' A' ' 89' ' ' ILE . 39.9 mt -67.12 141.15 96.17 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 115.839 -0.619 . . . . 3.1800000000000002 110.398 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -87.64 4.04 6.08 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.055 2.503 . . . . 1.1899999999999999 113.515 -173.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 58.81 19.95 7.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.37 0.605 . . . . 1.8999999999999999 111.1 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -112.91 136.2 52.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.741 -0.837 . . . . 2.3599999999999999 108.741 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.59 HD21 HG22 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -116.16 102.62 53.69 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 109.303 -0.629 . . . . 2.3799999999999999 109.303 -177.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 2.0 Cg_endo -79.96 157.27 23.83 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.061 2.507 . . . . 1.1799999999999999 112.155 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -55.0 -40.33 86.47 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.397 2.065 . . . . 1.6100000000000001 111.843 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.64 ' O ' HD11 ' A' ' 130' ' ' LEU . 50.1 p-80 -81.89 30.88 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.658 -0.701 . . . . 1.71 111.709 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.649 ' HG ' ' NE1' ' A' ' 44' ' ' TRP . 0.7 OUTLIER -146.86 9.89 1.02 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.063 0.394 . . . . 1.8700000000000001 112.063 171.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.59 HG22 HD21 ' A' ' 126' ' ' LEU . 7.3 t -97.33 115.16 65.68 Favored Pre-proline 0 C--N 1.322 -0.598 0 C-N-CA 120.177 -0.609 . . . . 2.27 110.806 176.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.931 ' HB3' ' HG2' ' A' ' 104' ' ' GLU . 84.0 Cg_exo -49.4 128.45 20.45 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.751 2.967 . . . . 1.29 111.49 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.43 ' HA ' ' NH1' ' A' ' 136' ' ' ARG . 99.0 Cg_exo -45.48 -31.99 7.53 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.035 2.49 . . . . 1.6699999999999999 113.211 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.5 p -67.24 -19.16 65.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.173 0.805 . . . . 2.7000000000000002 113.173 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.646 ' HG3' HG21 ' A' ' 95' ' ' VAL . 13.9 mmmt -82.68 -2.76 55.0 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 120.222 -0.591 . . . . 4.0499999999999998 111.758 -171.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.459 ' HG2' HH11 ' A' ' 136' ' ' ARG . 3.6 ptp85 -110.48 68.62 0.67 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.24 -0.652 . . . . 5.2599999999999998 109.24 173.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.3 mtp85 -155.1 120.26 4.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.902 -0.59 . . . . 5.5199999999999996 111.411 -175.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -130.6 106.85 8.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.713 -0.676 . . . . 7.0 109.872 172.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 C--O 1.252 1.217 0 CA-C-O 118.475 -0.774 . . . . 6.9100000000000001 110.068 178.065 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 5' ' ' SER . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 111.47 -0.652 . . . . 42.409999999999997 111.47 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.82 -28.29 51.18 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.588 2.192 . . . . 42.020000000000003 112.029 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -114.86 126.93 55.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.128 -0.693 . . . . 43.539999999999999 109.128 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.58 -32.37 7.29 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.851 -0.69 . . . . 41.520000000000003 112.129 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 2.8 m -105.44 104.44 14.16 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.982 -0.747 . . . . 40.310000000000002 108.982 175.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -84.75 145.65 27.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.171 0.51 . . . . 38.670000000000002 111.665 -173.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.2 t -103.37 123.6 47.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.805 -0.634 . . . . 37.359999999999999 109.369 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.7 92.09 8.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.186 0.517 . . . . 36.490000000000002 110.991 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 89.9 mmm -111.03 113.14 55.0 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.682 -0.69 . . . . 35.119999999999997 110.276 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.45 -11.27 31.55 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.889 2.393 . . . . 34.549999999999997 111.95 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 t -94.44 92.96 7.39 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.827 -0.624 . . . . 34.009999999999998 109.668 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -127.25 105.64 8.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.774 -0.648 . . . . 34.789999999999999 109.893 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.87 130.24 43.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.182 -0.463 . . . . 34.009999999999998 110.369 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.68 135.8 32.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.998 0.428 . . . . 35.259999999999998 110.006 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -122.08 132.99 54.77 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.138 -0.483 . . . . 35.140000000000001 110.341 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.54 129.45 28.0 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.396 -0.907 . . . . 36.799999999999997 111.28 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.67 -11.78 68.02 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.86 -0.686 . . . . 37.009999999999998 111.998 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.17 88.12 3.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.412 -0.588 . . . . 35.420000000000002 109.412 176.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -104.57 100.96 10.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.871 -0.604 . . . . 36.07 111.247 -174.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -116.72 144.94 43.84 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.799 -0.637 . . . . 33.780000000000001 109.727 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.77 121.85 6.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.824 -0.703 . . . . 33.630000000000003 112.585 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.9 p -92.07 156.04 17.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.674 0.273 . . . . 32.890000000000001 110.784 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 72.1 mtm -87.04 102.98 14.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.911 0.386 . . . . 33.770000000000003 110.33 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -107.31 137.01 46.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.95 -0.568 . . . . 33.939999999999998 110.899 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.5 -32.86 4.88 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.686 -1.063 . . . . 33.689999999999998 114.73 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -67.76 -53.02 0.47 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 CA-C-N 120.931 2.366 . . . . 32.880000000000003 111.851 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -86.77 104.29 16.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.196 -0.457 . . . . 34.68 109.939 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.54 120.78 18.35 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.957 -0.639 . . . . 31.800000000000001 112.428 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -139.8 128.49 23.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.804 0.335 . . . . 31.699999999999999 110.442 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.33 125.46 7.68 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.494 -0.86 . . . . 29.09 112.494 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -123.9 108.87 12.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.521 0.201 . . . . 27.890000000000001 110.646 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.45 116.66 5.87 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.758 -0.734 . . . . 25.079999999999998 111.652 174.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -93.36 119.2 32.21 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.033 0.444 . . . . 22.670000000000002 110.783 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.38 140.1 18.73 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.042 -0.599 . . . . 19.579999999999998 112.05 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.34 121.89 15.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.093 0.473 . . . . 17.84 111.073 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.55 114.15 3.77 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 111.266 -0.734 . . . . 15.130000000000001 111.266 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.84 153.84 34.43 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.371 -0.415 . . . . 13.02 110.777 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.88 72.24 2.47 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.61 -0.805 . . . . 10.74 111.549 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.22 154.73 3.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.391 -0.404 . . . . 9.4800000000000004 109.971 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -75.8 70.07 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.225 -0.59 . . . . 6.75 110.622 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -147.82 82.18 1.51 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.133 -0.94 . . . . 6.3099999999999996 108.816 173.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.12 92.58 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.808 0.813 . . . . 3.5600000000000001 110.883 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -94.42 89.63 5.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.305 -0.861 . . . . 3.9399999999999999 109.155 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.79 ' CH2' ' HG ' ' A' ' 108' ' ' LEU . 12.5 t90 -98.5 137.0 37.82 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.989 0.9 . . . . 1.72 109.554 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.522 ' H ' ' HD1' ' A' ' 44' ' ' TRP . 8.0 t -67.74 4.97 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 113.831 -1.531 . . . . 1.72 111.823 -176.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.687 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 1.2 t -94.76 -21.99 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 121.46 -0.775 . . . . 1.3200000000000001 111.672 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.78 -14.25 57.91 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.074 -1.06 . . . . 0.71999999999999997 111.842 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -104.53 -28.35 11.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 111.923 0.342 . . . . 3.3799999999999999 111.923 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -107.36 1.94 24.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.515 0.674 . . . . 1.8300000000000001 110.154 -171.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 55.7 tttm -55.69 -46.99 99.65 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.05 -0.977 . . . . 1.73 112.086 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 11.1 Cg_endo -55.84 -26.87 59.68 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.23 1.953 . . . . 0.80000000000000004 112.636 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.544 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . 9.5 m -70.35 -45.16 66.68 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.852 0.834 . . . . 1.29 108.99 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.556 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 16.7 m-85 -75.74 -24.21 56.1 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.116 -0.947 . . . . 1.4299999999999999 109.581 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.596 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 15.1 t70 -78.09 -37.98 45.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.534 -0.757 . . . . 1.1599999999999999 111.145 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.544 ' OE2' ' HA ' ' A' ' 52' ' ' THR . 15.5 pt-20 -68.06 -37.1 80.92 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.515 -0.474 . . . . 1.6299999999999999 110.559 176.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 52' ' ' THR . 48.7 mt -70.14 -28.24 35.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.251 0.548 . . . . 1.27 109.612 173.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.596 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 66.4 t80 -61.51 -54.17 46.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.347 -0.842 . . . . 1.51 111.194 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.578 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 42.0 m-85 -68.75 -22.5 64.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.132 0.492 . . . . 1.6799999999999999 110.786 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.9 m -72.77 -25.69 61.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.696 -0.683 . . . . 1.1799999999999999 110.863 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.475 HD13 ' HG2' ' A' ' 75' ' ' GLU . 25.9 mt -87.6 -0.01 56.26 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.638 -0.256 . . . . 1.3600000000000001 111.439 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 t 67.55 87.51 0.12 Allowed Pre-proline 0 N--CA 1.467 0.377 0 CA-C-O 121.297 0.57 . . . . 1.22 110.916 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.578 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 71.6 Cg_endo -81.03 159.28 20.75 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.634 2.222 . . . . 0.57999999999999996 112.65 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 97.4 t -128.92 121.21 53.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.081 -0.509 . . . . 1.9199999999999999 109.794 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 66.38 23.04 10.69 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.117 -0.492 . . . . 2.0899999999999999 112.168 174.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.21 23.02 23.4 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.871 -0.68 . . . . 0.56999999999999995 112.114 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.885 ' HG3' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -167.48 159.77 12.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.588 -0.523 . . . . 2.3300000000000001 109.588 175.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pt -89.76 132.43 34.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 120.129 -0.628 . . . . 1.1799999999999999 110.345 173.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -59.2 130.55 47.5 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.693 -1.225 . . . . 1.2 107.693 170.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.579 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -53.71 -26.26 31.75 Favored Glycine 0 C--O 1.219 -0.819 0 N-CA-C 114.69 0.636 . . . . 0.59999999999999998 114.69 -166.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.15 -39.53 43.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 117.475 0.637 . . . . 1.1699999999999999 111.437 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.44 -31.83 48.27 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.16 -0.473 . . . . 2.1099999999999999 110.087 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.673 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -74.05 -36.19 64.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.678 -0.692 . . . . 1.2 109.718 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 14.7 mmmm -66.28 -37.97 86.7 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.707 -0.849 . . . . 2.3100000000000001 108.707 173.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -56.59 -44.89 81.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.526 -0.761 . . . . 1.6799999999999999 110.255 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.475 ' HG2' HD13 ' A' ' 60' ' ' LEU . 1.8 tp10 -61.81 -53.07 60.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.544 -1.207 . . . . 1.48 111.162 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.673 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 12.5 ptp -73.05 -16.69 61.48 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 122.068 -0.395 . . . . 0.84999999999999998 111.353 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 86' ' ' LEU . 2.3 t -74.17 -49.64 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.577 0.227 . . . . 1.25 110.832 173.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 14.6 ptpt -68.28 -12.18 60.62 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.085 0.469 . . . . 1.79 109.851 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 76' ' ' MET . 62.4 m -67.69 3.93 1.26 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.29 -0.868 . . . . 1.9399999999999999 111.835 170.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 74.36 37.95 0.55 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.26 0.624 . . . . 3.1200000000000001 111.686 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.574 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . 22.8 mt -113.49 157.47 41.26 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 120.809 -0.357 . . . . 1.71 111.539 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.445 ' O ' HD23 ' A' ' 86' ' ' LEU . 84.3 Cg_endo -83.91 164.26 13.69 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.898 2.399 . . . . 1.03 111.307 169.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.524 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 8.5 m120 -54.75 -29.34 53.62 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.282 0.475 . . . . 1.53 112.282 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -59.94 -54.02 50.96 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.302 0.572 . . . . 1.75 110.776 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 24.0 t -66.31 -41.68 89.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.641 -0.708 . . . . 1.28 109.927 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.574 ' CD2' ' HB2' ' A' ' 81' ' ' LEU . 3.9 mm? -49.52 -55.13 14.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.9 -0.591 . . . . 2.0699999999999998 110.856 173.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.91 -44.5 97.33 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.392 -0.822 . . . . 0.45000000000000001 113.324 -175.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.608 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 55.5 pttt -80.19 -27.45 38.87 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.654 -0.818 . . . . 2.1899999999999999 111.676 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 mt -69.63 -41.55 80.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 120.536 -0.465 . . . . 1.8200000000000001 109.841 173.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.436 ' CH2' ' HG ' ' A' ' 101' ' ' LEU . 75.9 t-105 -55.87 -58.85 6.13 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.754 -0.657 . . . . 0.35999999999999999 110.346 175.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.608 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -69.44 -17.26 63.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.812 -0.631 . . . . 2.9500000000000002 111.765 -172.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 14.3 tp -82.35 -37.4 25.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.129 -0.323 . . . . 1.5 110.129 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.712 ' HA ' HD11 ' A' ' 108' ' ' LEU . . . -91.08 -33.75 15.36 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 120.556 -0.458 . . . . 1.1499999999999999 111.528 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.628 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 27.6 t0 -83.84 80.97 8.97 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.615 0.721 . . . . 0.62 109.922 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.441 HG21 HD13 ' A' ' 126' ' ' LEU . 16.0 t -67.34 -25.44 33.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 114.917 -1.038 . . . . 2.27 110.817 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.626 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.0 OUTLIER -90.43 -23.84 20.91 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.619 -0.718 . . . . 1.7 112.234 -178.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.552 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 21.8 mtpt 67.02 45.22 1.8 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.769 0.795 . . . . 2.2599999999999998 110.364 167.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 p30 -105.31 -1.06 25.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.759 -1.11 . . . . 1.51 112.371 -171.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.87 19.38 77.71 Favored Glycine 0 C--N 1.322 -0.224 0 C-N-CA 119.506 -1.33 . . . . 0.34000000000000002 112.326 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.885 HD12 ' HG3' ' A' ' 66' ' ' LYS . 4.4 pp -151.33 171.41 17.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.796 -0.816 . . . . 1.23 108.796 174.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 105' ' ' GLU . 44.2 mt -148.59 116.17 6.26 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.82 -1.178 . . . . 1.3700000000000001 107.82 -172.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -77.13 -175.94 3.83 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.086 -0.646 . . . . 1.5 109.366 178.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -60.26 -31.18 69.97 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.358 0.526 . . . . 1.73 111.164 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.635 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 34.0 tt0 -73.91 -39.94 63.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.426 0.631 . . . . 2.1400000000000001 110.107 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.665 ' OE2' 'CA ' ' A' ' 141' ' ' ' CA' . 3.8 mt-10 -66.99 -39.16 87.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.672 -0.695 . . . . 1.1100000000000001 111.919 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.628 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -64.63 -39.2 93.28 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.158 -1.052 . . . . 1.8600000000000001 108.158 175.32 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.556 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -50.95 -49.14 60.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 1.02 110.581 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.79 ' HG ' ' CH2' ' A' ' 44' ' ' TRP . 1.1 tt -70.56 -50.42 37.65 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.443 -0.503 . . . . 1.8200000000000001 110.509 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.451 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -45.73 -55.63 6.25 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.33 0.492 . . . . 1.0700000000000001 112.33 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.551 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 2.6 t-20 -72.84 -23.31 60.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.677 -0.49 . . . . 1.8899999999999999 109.677 -177.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.485 ' CD2' HD13 ' A' ' 130' ' ' LEU . 70.8 t60 -68.01 -43.93 77.71 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.236 -0.653 . . . . 0.59999999999999998 109.236 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.695 HD22 HD13 ' A' ' 122' ' ' LEU . 46.7 mt -64.64 -32.81 74.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.107 -0.497 . . . . 1.23 110.191 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 109' ' ' ALA . 41.4 mm -61.11 -50.92 78.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.886 -0.597 . . . . 1.49 111.001 176.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.465 ' HD3' ' OH ' ' A' ' 53' ' ' TYR . 18.7 ptmt -72.33 -24.47 61.31 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.086 -0.646 . . . . 2.6699999999999999 110.823 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 111' ' ' HIS . 11.5 t -60.46 -47.22 93.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.318 -0.401 . . . . 1.23 110.39 172.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 0.9 OUTLIER -85.38 0.5 51.97 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 120.36 -0.536 . . . . 2.4199999999999999 110.635 178.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.1 tp -81.83 -26.6 34.15 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.604 -0.517 . . . . 1.8200000000000001 109.604 171.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.33 -22.17 65.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.801 -0.636 . . . . 1.99 111.169 177.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.09 10.79 13.24 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.351 -0.928 . . . . 1.01 112.698 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.585 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -127.21 133.49 50.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 174.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -78.34 163.36 25.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.783 0.325 . . . . 2.75 110.935 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.695 HD13 HD22 ' A' ' 112' ' ' LEU . 3.5 mm? -70.44 144.86 92.27 Favored Pre-proline 0 CA--C 1.513 -0.474 0 CA-C-N 116.077 -0.51 . . . . 3.1800000000000002 111.818 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.552 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 68.9 Cg_endo -77.62 -6.37 16.12 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 124.453 3.435 . . . . 1.1899999999999999 113.404 -173.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.22 19.53 11.72 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.632 0.73 . . . . 1.8999999999999999 109.655 -170.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.552 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 38.8 t70 -120.45 145.82 46.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.943 -1.026 . . . . 2.3599999999999999 108.985 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.441 HD13 HG21 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -115.15 104.41 53.79 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 116.353 -0.385 . . . . 2.3799999999999999 110.018 -176.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 5.7 Cg_endo -87.9 147.01 6.85 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.334 2.689 . . . . 1.1799999999999999 111.982 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -55.08 -30.35 69.95 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.762 2.308 . . . . 1.6100000000000001 113.321 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -80.94 22.72 0.6 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.995 -0.282 . . . . 1.71 111.109 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.515 ' HA ' ' CD2' ' A' ' 44' ' ' TRP . 0.6 OUTLIER -150.29 8.52 0.62 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.619 -0.433 . . . . 1.8700000000000001 111.477 177.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.1 132.09 31.57 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.942 -0.762 . . . . 2.27 108.942 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.835 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 37.4 Cg_exo -57.23 142.92 94.68 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.29 1.994 . . . . 1.29 112.539 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.423 ' HD2' ' CD ' ' A' ' 104' ' ' GLU . 89.7 Cg_exo -46.06 -23.77 1.99 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.581 3.521 . . . . 1.6699999999999999 115.914 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.6 p -82.33 -24.05 34.79 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.837 -0.539 . . . . 2.7000000000000002 112.32 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.835 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -119.15 17.9 13.13 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.553 0.575 . . . . 4.0499999999999998 112.553 -174.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.76 71.3 1.45 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.19 0.519 . . . . 5.2599999999999998 110.016 172.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -157.83 113.85 2.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.922 -0.581 . . . . 5.5199999999999996 110.754 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -93.09 111.02 22.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.031 -0.532 . . . . 7.0 109.569 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.319 -0.848 . . . . 6.9100000000000001 110.047 -176.342 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.665 'CA ' ' OE2' ' A' ' 105' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 112.509 -0.237 . . . . 42.409999999999997 112.509 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.16 -58.21 0.32 Allowed 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.067 2.512 . . . . 42.020000000000003 113.127 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.676 ' H ' HD22 ' A' ' 3' ' ' LEU . 2.5 pt? -87.52 145.51 26.2 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.516 -0.311 . . . . 43.539999999999999 110.672 -176.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 112.83 -15.18 23.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.974 -0.631 . . . . 41.520000000000003 112.438 177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.5 m -83.53 102.62 12.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.873 0.368 . . . . 40.310000000000002 110.663 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -64.84 135.75 56.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.915 -0.584 . . . . 38.670000000000002 110.022 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.4 t -89.92 114.22 25.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.094 0.473 . . . . 37.359999999999999 110.993 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -129.04 140.2 51.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.842 -0.617 . . . . 36.490000000000002 109.856 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.441 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 65.0 mtt -84.3 132.04 48.74 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 110.32 -0.252 . . . . 35.119999999999997 110.32 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 54.4 Cg_exo -52.01 -72.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.262 2.641 . . . . 34.549999999999997 113.548 -172.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 p -93.73 89.54 6.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.246 0.546 . . . . 34.009999999999998 110.459 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -104.32 93.99 5.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.537 -0.756 . . . . 34.789999999999999 109.834 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.29 136.49 57.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.819 -0.628 . . . . 34.009999999999998 109.609 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 p -119.16 112.46 37.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.395 0.617 . . . . 35.259999999999998 111.559 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -101.07 75.71 1.68 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.587 -0.733 . . . . 35.140000000000001 109.199 175.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.43 105.42 1.84 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.713 -0.756 . . . . 36.799999999999997 112.904 -173.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.95 26.66 70.36 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 121.545 -0.36 . . . . 37.009999999999998 112.822 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.27 123.89 39.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.645 0.26 . . . . 35.420000000000002 110.447 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -83.55 106.31 15.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.088 -0.505 . . . . 36.07 110.432 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -90.81 93.3 9.17 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.915 -0.772 . . . . 33.780000000000001 108.915 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.6 128.26 9.11 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.587 -0.816 . . . . 33.630000000000003 112.479 -174.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.0 m -147.86 104.79 3.61 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.947 0.403 . . . . 32.890000000000001 110.435 176.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.437 ' HE3' ' HG3' ' A' ' 26' ' ' PRO . 21.7 ptm -154.99 118.75 4.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.327 0.584 . . . . 33.770000000000003 110.461 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -110.21 132.46 54.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.809 -0.632 . . . . 33.939999999999998 110.066 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.687 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . 112.62 12.74 12.46 Favored Glycine 0 CA--C 1.543 1.783 0 CA-C-O 118.226 -1.319 . . . . 33.689999999999998 115.801 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.687 ' HD3' ' N ' ' A' ' 25' ' ' GLY . 7.8 Cg_exo -72.72 -57.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.366 1.464 0 CA-C-N 122.059 2.93 . . . . 32.880000000000003 111.504 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -127.39 141.74 51.61 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.537 -0.542 . . . . 34.68 109.537 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.19 169.05 14.05 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.872 -0.68 . . . . 31.800000000000001 111.447 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -80.99 163.88 22.95 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.643 -0.503 . . . . 31.699999999999999 109.643 177.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.79 97.71 0.09 OUTLIER Glycine 0 C--N 1.33 0.241 0 O-C-N 123.393 0.433 . . . . 29.09 113.66 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -102.77 170.87 7.74 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.041 -0.355 . . . . 27.890000000000001 110.041 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.14 136.91 49.5 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.116 -0.564 . . . . 25.079999999999998 112.95 -175.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -61.18 131.39 50.32 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.717 0.294 . . . . 22.670000000000002 110.766 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.99 135.7 12.81 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.682 -0.771 . . . . 19.579999999999998 113.307 -173.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.42 161.68 14.13 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.096 -0.335 . . . . 17.84 110.096 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.78 104.08 1.65 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.068 -0.587 . . . . 15.130000000000001 112.738 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER -94.07 -178.05 4.51 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.105 -0.702 . . . . 13.02 109.105 177.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.44 ' H ' ' CD ' ' A' ' 37' ' ' GLU . . . -77.93 71.16 2.43 Favored Glycine 0 CA--C 1.503 -0.711 0 C-N-CA 120.306 -0.949 . . . . 10.74 111.99 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 pt -63.89 157.22 4.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.588 -0.806 . . . . 9.4800000000000004 109.013 171.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.17 80.72 1.29 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.983 0.897 . . . . 6.75 109.824 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.62 104.28 0.26 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.293 -1.321 . . . . 6.3099999999999996 110.117 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 p -114.63 103.65 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.66 0.743 . . . . 3.5600000000000001 110.828 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -93.65 93.14 7.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.725 -0.67 . . . . 3.9399999999999999 109.761 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.725 ' CH2' ' HG ' ' A' ' 108' ' ' LEU . 10.5 t90 -125.05 140.11 53.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.63 -0.713 . . . . 1.72 110.202 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.527 ' H ' ' HD1' ' A' ' 44' ' ' TRP . 14.1 t -61.14 -12.23 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 114.928 -1.033 . . . . 1.72 112.153 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 2.2 t -80.54 -17.74 12.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 120.951 -1.093 . . . . 1.3200000000000001 111.321 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.71 -17.15 62.27 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.694 -1.241 . . . . 0.71999999999999997 111.741 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -106.97 -29.4 9.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.002 0.371 . . . . 3.3799999999999999 112.002 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 84.5 m-20 -89.33 -11.55 43.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 1.8300000000000001 110.676 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 49.9 tttm -49.87 -51.48 60.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.209 -0.905 . . . . 1.73 112.409 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 8.0 Cg_endo -50.6 -35.64 47.39 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 122.726 2.284 . . . . 0.80000000000000004 113.837 -178.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.655 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 87.5 m -72.5 -40.64 66.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.999 0.904 . . . . 1.29 110.328 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.643 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 10.3 m-85 -76.86 -23.85 52.63 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.766 0.793 . . . . 1.4299999999999999 109.279 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.531 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 7.2 t70 -80.66 -33.32 35.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.635 -1.166 . . . . 1.1599999999999999 110.776 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 52' ' ' THR . 14.0 pt-20 -69.47 -35.9 76.04 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.606 -0.516 . . . . 1.6299999999999999 109.606 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 52' ' ' THR . 46.5 mt -71.84 -29.8 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.224 -0.658 . . . . 1.27 109.224 174.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.531 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 72.7 t80 -61.81 -57.42 11.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.146 -0.933 . . . . 1.51 111.534 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -64.1 -22.32 66.89 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.037 0.446 . . . . 1.6799999999999999 110.908 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.5 m -73.07 -32.05 64.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.923 -0.58 . . . . 1.1799999999999999 111.516 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.1 mt -84.89 1.3 47.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.624 0.25 . . . . 1.3600000000000001 111.261 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t 70.9 85.76 0.12 Allowed Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.604 -0.726 . . . . 1.22 111.125 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.63 123.86 4.42 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.702 2.268 . . . . 0.57999999999999996 112.647 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.5 t -87.33 109.72 19.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.245 -0.434 . . . . 1.9199999999999999 110.027 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.06 23.75 11.05 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.322 0.389 . . . . 2.0899999999999999 111.378 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.67 27.79 12.29 Favored Glycine 0 C--O 1.228 -0.254 0 C-N-CA 121.054 -0.593 . . . . 0.56999999999999995 113.565 170.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.579 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -164.39 147.39 9.09 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.306 -0.627 . . . . 2.3300000000000001 109.306 172.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.959 ' HB ' HD22 ' A' ' 71' ' ' ASN . 3.0 pt -86.89 137.11 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 120.695 -0.402 . . . . 1.1799999999999999 110.437 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.5 p -60.32 124.3 19.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.755 -1.202 . . . . 1.2 107.755 170.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.578 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -46.94 -31.76 5.77 Favored Glycine 0 C--O 1.222 -0.608 0 C-N-CA 121.302 -0.475 . . . . 0.59999999999999998 114.26 -168.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -43.73 -52.0 6.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.31 0.485 . . . . 1.1699999999999999 112.31 173.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.959 HD22 ' HB ' ' A' ' 67' ' ' ILE . 11.7 p30 -71.03 -30.85 67.17 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.056 0.389 . . . . 2.1099999999999999 110.586 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.576 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -72.12 -31.76 66.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.585 0.707 . . . . 1.2 109.612 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 31.6 mmmt -68.32 -35.85 78.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.072 -0.967 . . . . 2.3100000000000001 109.474 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.795 ' HG2' ' HA ' ' A' ' 71' ' ' ASN . 9.0 mmmm -59.45 -48.58 81.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 1.6799999999999999 109.503 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 23.6 mm-40 -54.73 -52.49 62.33 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.793 -1.094 . . . . 1.48 112.182 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.576 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 14.7 ptp -69.54 -29.38 66.95 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.126 -0.63 . . . . 0.84999999999999998 110.916 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.42 -45.83 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.489 0.185 . . . . 1.25 110.854 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 17.4 ptpt -72.78 -14.32 61.5 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.038 0.446 . . . . 1.79 110.458 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.495 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 50.1 m -66.15 -13.03 59.51 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.454 -0.794 . . . . 1.9399999999999999 110.186 168.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 97.3 mttt 71.91 39.63 0.81 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.599 0.76 . . . . 3.1200000000000001 112.014 165.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.876 HD11 ' HE2' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -102.18 159.45 29.34 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.841 -0.618 . . . . 1.71 110.115 -179.142 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.519 ' HG2' HG22 ' A' ' 85' ' ' VAL . 31.6 Cg_endo -66.88 153.3 78.39 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.893 1.729 . . . . 1.03 110.742 172.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.747 ' HA ' HD11 ' A' ' 86' ' ' LEU . 0.9 OUTLIER -49.86 -31.74 12.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.005 -0.543 . . . . 1.53 112.042 -179.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.5 m -60.33 -55.59 31.84 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.209 0.528 . . . . 1.75 110.628 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 89' ' ' ILE . 91.1 t -60.63 -44.46 96.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 CA-C-N 115.745 -0.661 . . . . 1.28 110.071 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.747 HD11 ' HA ' ' A' ' 83' ' ' ASN . 24.9 mt -60.08 -49.96 75.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.383 -0.372 . . . . 2.0699999999999998 111.984 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -55.77 -42.41 85.43 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.146 -0.782 . . . . 0.45000000000000001 111.146 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 61.6 pttt -86.51 -13.49 45.83 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.491 -0.883 . . . . 2.1899999999999999 111.778 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 85' ' ' VAL . 23.0 mt -71.59 -43.51 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 N-CA-C 108.511 -0.922 . . . . 1.8200000000000001 108.511 170.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.482 ' HB2' ' HZ3' ' A' ' 73' ' ' LYS . 71.4 t-105 -60.36 -56.77 17.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.82 -0.627 . . . . 0.35999999999999999 111.021 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 62.7 mttm -72.22 -21.45 61.4 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.65 -0.705 . . . . 2.9500000000000002 111.965 -169.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 5.5 tp -86.32 -19.65 29.51 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.801 -0.444 . . . . 1.5 109.801 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.873 ' HA ' HD21 ' A' ' 108' ' ' LEU . . . -93.05 -44.29 8.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.126 0.488 . . . . 1.1499999999999999 110.921 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 46.9 t0 -87.99 74.46 8.93 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.031 -1.1 . . . . 0.62 108.031 173.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.45 HG13 ' NZ ' ' A' ' 135' ' ' LYS . 17.1 t -69.87 -6.96 7.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.19 -0.914 . . . . 2.27 109.81 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -94.18 -26.33 16.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.967 -1.015 . . . . 1.7 109.725 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 59.66 73.34 0.49 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.329 -0.85 . . . . 2.2599999999999998 111.833 169.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.68 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 1.4 p30 -128.28 -23.47 3.25 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.913 -1.039 . . . . 1.51 112.078 -171.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.78 7.47 38.88 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.165 -1.016 . . . . 0.34000000000000002 112.529 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.484 ' HG ' ' OD1' ' A' ' 98' ' ' ASP . 3.6 pp -142.21 -175.21 4.35 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.805 -0.813 . . . . 1.23 108.805 174.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.624 ' O ' HG12 ' A' ' 67' ' ' ILE . 50.8 mt -151.45 112.6 4.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.367 -1.345 . . . . 1.3700000000000001 107.367 -177.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.7 p30 -76.73 -175.75 3.55 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.674 -0.81 . . . . 1.5 109.809 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.08 -32.96 66.8 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.105 0.478 . . . . 1.73 111.879 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 35.5 tt0 -85.81 -29.01 24.12 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.314 0.578 . . . . 2.1400000000000001 110.246 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HB3' HD21 ' A' ' 101' ' ' LEU . 4.0 mt-10 -75.15 -33.39 61.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.764 -0.653 . . . . 1.1100000000000001 110.977 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.666 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.6 OUTLIER -66.99 -40.23 87.32 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.638 -1.245 . . . . 1.8600000000000001 107.638 171.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.643 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -51.15 -46.19 61.94 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.078 -0.51 . . . . 1.02 110.607 175.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.873 HD21 ' HA ' ' A' ' 93' ' ' ALA . 1.4 tt -67.6 -48.89 65.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.309 -0.405 . . . . 1.8200000000000001 110.353 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.448 ' HB3' HD13 ' A' ' 101' ' ' LEU . . . -49.88 -57.29 7.75 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.921 -0.582 . . . . 1.0700000000000001 112.296 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.446 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 11.4 t-20 -70.61 -28.64 65.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.02 0.438 . . . . 1.8899999999999999 110.066 -174.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.531 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 66.7 t60 -69.88 -36.37 75.4 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.59999999999999998 110.032 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.486 HD23 HD23 ' A' ' 122' ' ' LEU . 41.8 mt -69.2 -35.97 76.8 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.949 -0.389 . . . . 1.23 109.949 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.668 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 76.3 mt -58.37 -45.21 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.414 -0.357 . . . . 1.49 111.379 172.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.549 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 5.5 ptmm? -67.7 -33.05 74.13 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 119.658 -0.817 . . . . 2.6699999999999999 110.605 177.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 111' ' ' HIS . 37.4 t -62.75 -44.25 99.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.899 0.38 . . . . 1.23 110.719 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.876 ' HE2' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -76.6 -6.88 53.85 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.099 0.476 . . . . 2.4199999999999999 110.391 176.173 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.1 tp -91.09 -15.89 28.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.339 0.59 . . . . 1.8200000000000001 109.831 172.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 50.0 mt-10 -81.42 2.07 30.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.635 -0.711 . . . . 1.99 110.761 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.79 5.75 33.25 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.281 -0.962 . . . . 1.01 113.076 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.608 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -141.13 137.29 32.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.304 0.573 . . . . 1.0 111.161 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.54 163.93 25.88 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.216 -0.902 . . . . 2.75 111.421 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.486 HD23 HD23 ' A' ' 112' ' ' LEU . 39.4 mt -73.36 144.9 84.71 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.908 -0.587 . . . . 3.1800000000000002 110.823 -178.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.52 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 46.9 Cg_endo -82.56 -1.07 10.45 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.216 2.611 . . . . 1.1899999999999999 113.497 -172.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.54 19.4 11.21 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.744 0.783 . . . . 1.8999999999999999 109.954 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.52 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 32.2 t70 -117.31 150.53 38.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.687 -1.142 . . . . 2.3599999999999999 109.207 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 2.3 tm? -124.37 103.14 32.61 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 109.216 -0.661 . . . . 2.3799999999999999 109.216 -177.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 4.8 Cg_exo -77.55 147.92 25.65 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.97 2.447 . . . . 1.1799999999999999 112.66 -176.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.421 ' HA ' HG13 ' A' ' 131' ' ' VAL . 50.9 Cg_exo -53.45 -35.52 76.2 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.258 2.639 . . . . 1.6100000000000001 112.848 177.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.532 ' O ' HD13 ' A' ' 130' ' ' LEU . 49.9 p-80 -82.27 18.48 1.41 Allowed 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 120.62 -0.432 . . . . 1.71 110.996 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.592 ' HG ' ' CE2' ' A' ' 44' ' ' TRP . 2.9 mp -138.7 16.41 2.7 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.475 0.485 . . . . 1.8700000000000001 110.888 172.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.421 HG13 ' HA ' ' A' ' 128' ' ' PRO . 32.4 m -77.66 116.52 58.87 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 120.133 -0.627 . . . . 2.27 110.211 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.602 ' HG2' ' HG3' ' A' ' 135' ' ' LYS . 37.2 Cg_endo -67.59 116.75 4.41 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.099 1.866 . . . . 1.29 111.611 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.4 -24.06 20.52 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 123.033 2.488 . . . . 1.6699999999999999 112.695 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.6 t -56.49 -33.5 66.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.409 -0.36 . . . . 2.7000000000000002 111.027 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.653 ' HD3' ' HD2' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -100.48 4.51 43.72 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.372 0.606 . . . . 4.0499999999999998 110.632 178.257 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.653 ' HD2' ' HD3' ' A' ' 135' ' ' LYS . 10.0 mmm180 -94.96 69.49 3.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.189 -0.459 . . . . 5.2599999999999998 110.523 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.437 ' NH1' ' HA ' ' A' ' 135' ' ' LYS . 0.5 OUTLIER -83.1 101.92 11.48 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.857 -0.61 . . . . 5.5199999999999996 110.527 177.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -98.95 95.57 7.25 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.703 -0.851 . . . . 7.0 108.703 172.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.694 -0.669 . . . . 6.9100000000000001 110.039 178.162 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.68 'CA ' ' OD2' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.931 0 N-CA-C 111.734 -0.546 . . . . 42.409999999999997 111.734 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.62 112.78 3.15 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.646 2.231 . . . . 42.020000000000003 111.339 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.68 109.17 17.81 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.932 -0.396 . . . . 43.539999999999999 109.932 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.3 4.67 64.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.152 -0.547 . . . . 41.520000000000003 112.059 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.6 m -74.93 130.59 39.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.123 0.487 . . . . 40.310000000000002 110.963 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.06 116.72 9.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.337 -0.847 . . . . 38.670000000000002 110.953 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.0 m -75.92 107.09 7.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.918 -0.583 . . . . 37.359999999999999 109.909 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.8 tp -85.18 135.68 33.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.007 -0.542 . . . . 36.490000000000002 110.529 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.414 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 64.9 mtm -101.22 119.7 57.08 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.99 -0.55 . . . . 35.119999999999997 110.121 177.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 9' ' ' MET . 11.9 Cg_endo -56.19 111.12 0.68 Allowed 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.613 2.208 . . . . 34.549999999999997 111.513 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.8 m -84.38 88.76 7.28 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.228 0.537 . . . . 34.009999999999998 110.658 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -90.82 98.14 11.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.301 -0.629 . . . . 34.789999999999999 109.301 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.0 m -90.53 126.92 43.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.108 -0.496 . . . . 34.009999999999998 111.427 -176.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.3 t -81.32 95.28 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.47 -0.937 . . . . 35.259999999999998 108.47 173.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -108.53 143.09 38.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.021 -0.99 . . . . 35.140000000000001 110.66 -171.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.96 130.09 27.32 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.337 -1.105 . . . . 36.799999999999997 110.337 174.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.06 30.57 12.43 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.224 -0.989 . . . . 37.009999999999998 111.027 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.74 123.63 18.92 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.857 0.36 . . . . 35.420000000000002 110.659 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -88.33 129.35 35.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.969 -0.56 . . . . 36.07 110.263 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -72.96 116.37 13.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.121 -0.491 . . . . 33.780000000000001 111.137 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.96 67.68 0.27 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.756 -0.735 . . . . 33.630000000000003 111.365 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.1 t -84.58 152.99 23.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.84 0.353 . . . . 32.890000000000001 110.917 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.69 138.88 45.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 33.770000000000003 109.765 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -102.41 141.25 35.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.452 -0.34 . . . . 33.939999999999998 110.326 -174.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.697 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . 115.37 3.8 20.63 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-O 118.028 -1.429 . . . . 33.689999999999998 115.894 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.697 ' HD3' ' N ' ' A' ' 25' ' ' GLY . 2.7 Cg_endo -82.33 -19.14 6.77 Favored 'Trans proline' 0 C--N 1.372 1.795 0 CA-C-N 122.355 3.077 . . . . 32.880000000000003 112.403 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -127.25 153.69 45.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.658 -0.497 . . . . 34.68 109.658 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.57 115.89 7.41 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.808 -0.711 . . . . 31.800000000000001 111.886 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -130.9 152.92 49.7 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.848 -0.427 . . . . 31.699999999999999 109.848 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.43 -172.59 2.18 Favored Glycine 0 CA--C 1.521 0.429 0 O-C-N 123.841 0.713 . . . . 29.09 112.668 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -59.56 167.36 2.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.707 0.289 . . . . 27.890000000000001 111.198 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.42 107.61 1.06 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.073 -0.512 . . . . 25.079999999999998 112.353 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -81.1 117.18 21.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.021 0.439 . . . . 22.670000000000002 110.582 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.21 126.26 7.75 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.633 -0.712 . . . . 19.579999999999998 112.3 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.69 162.27 14.01 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.01 -0.367 . . . . 17.84 110.01 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -110.93 116.37 4.26 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.935 -0.65 . . . . 15.130000000000001 111.726 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -81.42 179.7 7.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.495 0.188 . . . . 13.02 110.6 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.53 71.76 2.88 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.302 -0.952 . . . . 10.74 112.732 -172.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 pp -71.18 155.92 7.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 108.414 -0.958 . . . . 9.4800000000000004 108.414 168.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -75.24 73.41 2.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.931 0.872 . . . . 6.75 111.312 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -110.72 81.57 1.45 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.226 -1.398 . . . . 6.3099999999999996 107.226 170.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.97 110.35 28.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.176 0.513 . . . . 3.5600000000000001 111.975 -169.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -140.59 103.02 4.45 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.217 -1.031 . . . . 3.9399999999999999 108.217 167.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.64 ' CE2' ' HG ' ' A' ' 130' ' ' LEU . 9.1 t90 -86.71 133.48 33.67 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.724 0.773 . . . . 1.72 109.837 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.49 ' H ' ' HD1' ' A' ' 44' ' ' TRP . 12.4 t -69.35 -6.17 5.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.596 -1.184 . . . . 1.72 111.408 -177.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 4.1 t -83.6 -27.66 7.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 121.771 -0.581 . . . . 1.3200000000000001 111.717 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.43 -19.47 53.39 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 119.564 -1.303 . . . . 0.71999999999999997 112.053 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -101.63 -28.6 12.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.336 0.495 . . . . 3.3799999999999999 112.336 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -106.55 5.81 29.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.716 0.77 . . . . 1.8300000000000001 110.36 -172.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 62.0 tttm -59.34 -46.69 99.02 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.17 -0.923 . . . . 1.73 112.222 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 18.2 Cg_endo -60.02 -23.48 73.23 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.905 1.737 . . . . 0.80000000000000004 112.397 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.761 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 81.8 m -78.23 -36.48 47.02 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.433 0.635 . . . . 1.29 110.023 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.451 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 16.1 m-85 -80.55 -25.34 38.67 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.344 -0.942 . . . . 1.4299999999999999 109.917 177.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 4.4 t70 -76.45 -34.94 58.71 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.096 -0.956 . . . . 1.1599999999999999 110.154 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.761 ' HG2' ' O ' ' A' ' 52' ' ' THR . 12.7 pt-20 -65.3 -42.28 93.21 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.53 -0.544 . . . . 1.6299999999999999 109.53 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 52' ' ' THR . 60.0 mt -67.38 -32.72 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 109.621 -0.511 . . . . 1.27 109.621 175.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.544 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 66.8 t80 -57.06 -55.27 36.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.192 -0.913 . . . . 1.51 111.755 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.479 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 67.7 m-85 -69.23 -23.1 63.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.989 0.423 . . . . 1.6799999999999999 110.61 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.0 m -70.41 -21.69 62.81 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.614 -0.721 . . . . 1.1799999999999999 110.771 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 mt -88.7 -1.05 57.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.664 -0.244 . . . . 1.3600000000000001 111.301 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.2 t 65.55 81.12 0.22 Allowed Pre-proline 0 N--CA 1.465 0.315 0 O-C-N 123.594 0.559 . . . . 1.22 111.218 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 62.9 Cg_endo -80.22 166.56 20.43 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.346 2.031 . . . . 0.57999999999999996 111.517 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 64' ' ' ASN . 2.2 m -135.57 118.66 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 121.211 -0.196 . . . . 1.9199999999999999 110.62 -177.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.639 ' HB3' ' HZ1' ' A' ' 66' ' ' LYS . 8.3 t30 67.95 21.66 8.84 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 122.242 1.02 . . . . 2.0899999999999999 109.901 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.34 26.19 16.57 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.592 -0.813 . . . . 0.56999999999999995 114.418 172.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.639 ' HZ1' ' HB3' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -166.21 157.28 13.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.488 0.644 . . . . 2.3300000000000001 110.075 174.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.419 HD11 ' CD2' ' A' ' 106' ' ' PHE . 1.8 pt -91.58 128.92 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 120.622 -0.431 . . . . 1.1799999999999999 110.564 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -71.79 82.6 0.89 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.899 -0.592 . . . . 1.2 111.485 179.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.457 ' H ' ' HA ' ' A' ' 100' ' ' LEU . . . 44.28 -76.58 0.0 OUTLIER Glycine 0 C--O 1.226 -0.347 0 CA-C-N 113.844 -1.525 . . . . 0.59999999999999998 116.201 167.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' THR . . . -46.6 -29.01 1.63 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.043 0.757 . . . . 1.1699999999999999 113.043 -176.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -71.72 -42.65 67.07 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.148 0.499 . . . . 2.1099999999999999 110.101 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.456 ' CB ' HD11 ' A' ' 101' ' ' LEU . . . -72.0 -33.89 68.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.48 0.657 . . . . 1.2 109.993 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.645 ' O ' HG23 ' A' ' 77' ' ' VAL . 29.6 mmmt -64.32 -38.95 92.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.363 -0.835 . . . . 2.3100000000000001 109.576 174.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 74' ' ' LYS . 1.0 OUTLIER -54.84 -47.18 74.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.506 -0.77 . . . . 1.6799999999999999 109.992 175.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.662 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 8.7 mm-40 -60.7 -48.67 80.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.371 -1.286 . . . . 1.48 111.919 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.464 ' SD ' ' HD2' ' A' ' 73' ' ' LYS . 17.6 ptp -70.34 -15.53 62.88 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.739 -0.384 . . . . 0.84999999999999998 111.125 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 73' ' ' LYS . 54.0 t -75.41 -50.25 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.749 0.309 . . . . 1.25 110.56 171.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.662 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 8.7 ptmt -68.72 -11.83 60.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.089 0.471 . . . . 1.79 110.453 -177.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.3 t -69.24 -8.1 42.83 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.845 -0.616 . . . . 1.9399999999999999 110.409 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 47.5 mttp 65.98 68.58 0.46 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.552 -0.749 . . . . 3.1200000000000001 110.431 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.672 ' HB2' HD12 ' A' ' 86' ' ' LEU . 27.7 mt -130.09 158.93 72.57 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.426 -0.806 . . . . 1.71 110.632 -175.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.464 ' HG2' HG21 ' A' ' 85' ' ' VAL . 61.5 Cg_endo -75.5 164.35 32.6 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.322 2.015 . . . . 1.03 110.796 168.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -63.95 -25.91 68.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.897 0.38 . . . . 1.53 111.326 -177.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -53.99 48.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.232 0.539 . . . . 1.75 110.527 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.464 HG21 ' HG2' ' A' ' 82' ' ' PRO . 85.1 t -63.75 -46.21 95.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.506 -0.77 . . . . 1.28 110.382 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.672 HD12 ' HB2' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -53.87 -53.0 58.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.016 0.436 . . . . 2.0699999999999998 111.766 177.057 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.84 -35.03 89.44 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.7 -0.682 . . . . 0.45000000000000001 112.539 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.858 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 53.6 pttt -89.32 -21.0 23.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.703 -0.799 . . . . 2.1899999999999999 111.009 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.2 mt -69.4 -43.52 80.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.299 -0.63 . . . . 1.8200000000000001 109.299 170.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.448 ' CE3' ' HD3' ' A' ' 73' ' ' LYS . 76.6 t-105 -58.6 -54.98 40.93 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.214 -0.448 . . . . 0.35999999999999999 110.882 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.858 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -71.46 -15.6 62.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.879 -0.6 . . . . 2.9500000000000002 112.031 -173.125 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.448 HD23 HD21 ' A' ' 122' ' ' LEU . 13.4 tp -94.24 -24.93 17.27 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.929 -0.308 . . . . 1.5 110.26 176.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.862 ' HA ' HD21 ' A' ' 108' ' ' LEU . . . -80.34 -42.66 22.53 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.096 0.474 . . . . 1.1499999999999999 110.614 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.467 ' HB2' HD23 ' A' ' 101' ' ' LEU . 48.3 t0 -100.99 114.54 28.56 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.458 -0.571 . . . . 0.62 109.458 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.2 t -74.68 -23.04 17.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.189 -0.914 . . . . 2.27 111.554 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.1 OUTLIER -103.85 -25.4 13.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.985 0.421 . . . . 1.7 110.192 -175.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.458 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 57.8 mttt 60.92 71.71 0.55 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.129 -0.941 . . . . 2.2599999999999998 110.87 169.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.622 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 1.9 p30 -101.66 -22.27 14.48 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.384 -1.28 . . . . 1.51 111.749 -171.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.41 9.81 28.53 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.71 -0.757 . . . . 0.34000000000000002 112.392 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.457 ' HA ' ' H ' ' A' ' 69' ' ' GLY . 3.7 pp -148.26 178.61 8.42 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.252 0.621 . . . . 1.23 109.521 176.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.507 HD22 ' HB3' ' A' ' 105' ' ' GLU . 87.2 mt -146.96 122.55 10.46 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.25 -0.648 . . . . 1.3700000000000001 109.25 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.518 ' HA ' ' HB2' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -74.16 -173.96 1.8 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.866 -0.521 . . . . 1.5 110.317 176.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -59.83 -34.05 72.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.98 0.419 . . . . 1.73 111.404 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 26.3 tt0 -86.3 -33.87 20.51 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.918 0.39 . . . . 2.1400000000000001 110.755 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.626 ' OE2' 'CA ' ' A' ' 141' ' ' ' CA' . 2.4 mt-10 -62.2 -39.2 91.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.298 -0.41 . . . . 1.1100000000000001 110.496 174.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.584 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -62.88 -43.61 98.33 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.193 -1.04 . . . . 1.8600000000000001 108.193 173.197 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 104' ' ' GLU . . . -50.75 -47.44 59.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.683 -0.69 . . . . 1.02 110.986 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.862 HD21 ' HA ' ' A' ' 93' ' ' ALA . 2.5 tt -66.82 -50.77 61.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.021 -0.363 . . . . 1.8200000000000001 110.021 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.416 ' HB1' HD13 ' A' ' 101' ' ' LEU . . . -49.81 -57.21 7.82 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.796 0.665 . . . . 1.0700000000000001 112.796 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.426 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 0.2 OUTLIER -66.72 -29.04 68.92 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.286 0.565 . . . . 1.8899999999999999 109.485 -176.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.544 ' O ' HG21 ' A' ' 115' ' ' VAL . 64.5 t60 -68.1 -42.9 79.62 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.992 -0.549 . . . . 0.59999999999999998 109.886 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.679 ' HB3' HD23 ' A' ' 122' ' ' LEU . 34.5 mt -64.03 -34.68 78.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.064 -0.516 . . . . 1.23 110.589 176.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 110' ' ' ASN . 95.2 mt -61.41 -48.6 88.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.921 -0.581 . . . . 1.49 110.495 174.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 17.6 ptpt -72.48 -21.29 61.23 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 119.651 -0.819 . . . . 2.6699999999999999 111.007 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.544 HG21 ' O ' ' A' ' 111' ' ' HIS . 15.4 t -60.57 -47.97 90.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.595 0.236 . . . . 1.23 110.452 171.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 5.7 ptmm? -84.98 -1.21 56.51 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.259 -0.576 . . . . 2.4199999999999999 110.379 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.516 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 38.2 tp -85.89 -19.79 30.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.473 -0.785 . . . . 1.8200000000000001 108.963 172.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 43.0 mt-10 -67.87 -16.52 64.13 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 115.558 -0.746 . . . . 1.99 109.529 173.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.57 -20.21 13.77 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.65 -0.704 . . . . 1.01 112.175 174.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.652 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -99.13 138.91 35.55 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -73.37 164.0 27.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.242 0.544 . . . . 2.75 111.335 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.679 HD23 ' HB3' ' A' ' 112' ' ' LEU . 4.5 mp -73.23 141.7 81.16 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.448 -0.796 . . . . 3.1800000000000002 110.391 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -88.66 -0.01 6.5 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.344 2.696 . . . . 1.1899999999999999 113.52 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 60.89 27.84 17.65 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.463 0.649 . . . . 1.8999999999999999 110.857 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -130.15 126.48 37.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.5 -0.773 . . . . 2.3599999999999999 109.148 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 126' ' ' LEU . 1.1 tm? -103.35 103.2 33.81 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.227 -0.657 . . . . 2.3799999999999999 109.227 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -87.36 164.42 8.2 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.449 2.766 . . . . 1.1799999999999999 112.669 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.432 ' O ' HG13 ' A' ' 131' ' ' VAL . 12.2 Cg_endo -56.03 -26.44 59.27 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.444 2.763 . . . . 1.6100000000000001 113.446 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.554 ' O ' HD12 ' A' ' 130' ' ' LEU . 7.3 p-80 -86.55 23.41 1.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.517 -0.473 . . . . 1.71 111.271 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.64 ' HG ' ' CE2' ' A' ' 44' ' ' TRP . 0.3 OUTLIER -149.61 14.68 0.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.955 0.159 . . . . 1.8700000000000001 111.107 175.386 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 128' ' ' PRO . 7.4 p -82.72 111.31 28.28 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.25 0.548 . . . . 2.27 111.025 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.593 ' HG2' ' HG3' ' A' ' 135' ' ' LYS . 22.6 Cg_endo -63.44 120.9 8.49 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.724 2.283 . . . . 1.29 113.373 -177.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.41 ' HD2' ' OE1' ' A' ' 104' ' ' GLU . 31.6 Cg_exo -61.57 0.24 1.17 Allowed 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.082 2.522 . . . . 1.6699999999999999 112.54 170.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 27.4 t -79.35 -33.91 42.61 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.679 -0.237 . . . . 2.7000000000000002 111.354 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.593 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -87.45 1.51 53.24 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.919 0.711 . . . . 4.0499999999999998 112.919 -171.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.413 ' H ' ' HG3' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -79.45 69.22 5.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.428 0.632 . . . . 5.2599999999999998 111.292 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.2 ptm85 -133.76 107.77 8.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.435 0.636 . . . . 5.5199999999999996 110.145 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -106.87 140.02 40.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.634 -0.712 . . . . 7.0 110.923 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 . . . . . 0 C--O 1.244 0.774 0 CA-C-O 118.192 -0.909 . . . . 6.9100000000000001 109.109 174.096 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.626 'CA ' ' OE2' ' A' ' 105' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.2 t . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 113.157 0.799 . . . . 1.21 113.157 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.0 -24.17 11.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 121.329 -0.857 . . . . 0.66000000000000003 112.143 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.98 -13.39 26.45 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.174 -1.012 . . . . 0.71999999999999997 112.452 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.479 ' HE2' ' HB3' ' A' ' 48' ' ' LYS . 7.8 ptpt -112.03 -0.96 15.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 112.745 0.646 . . . . 2.9700000000000002 112.745 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -133.77 2.16 3.4 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.367 0.603 . . . . 1.8300000000000001 110.666 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 63.5 tttm -54.83 -46.14 99.55 Favored Pre-proline 0 C--O 1.222 -0.386 0 CA-C-N 115.691 -0.686 . . . . 1.1299999999999999 111.166 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 55.2 Cg_exo -42.47 -33.24 2.59 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 123.074 2.516 . . . . 0.56000000000000005 113.993 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.681 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 25.6 m -73.8 -48.38 31.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.097 0.951 . . . . 0.59999999999999998 110.022 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.538 ' CD1' ' HB3' ' A' ' 110' ' ' ASN . 7.4 m-85 -76.17 -25.11 54.9 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.47 -0.786 . . . . 0.93999999999999995 110.149 -175.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.591 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 18.3 t70 -82.55 -33.41 28.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.632 -1.167 . . . . 1.1599999999999999 109.637 -176.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.681 ' HG3' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -69.28 -39.41 78.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.331 -0.618 . . . . 1.6299999999999999 109.331 175.742 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.617 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 60.3 mt -69.03 -32.0 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.254 -0.647 . . . . 0.60999999999999999 109.254 175.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.591 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 70.4 t80 -55.64 -52.87 62.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.168 -0.924 . . . . 0.88 110.952 175.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.735 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 82.6 m-85 -75.12 -22.45 58.19 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.941 0.401 . . . . 1.03 110.916 177.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.617 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 10.4 m -70.19 -32.64 70.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.44 111.043 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.8 mt -83.6 -8.53 59.29 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.219 -0.289 . . . . 0.79000000000000004 110.219 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.6 t 72.89 96.65 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.463 -0.79 . . . . 0.64000000000000001 111.287 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.735 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 61.5 Cg_endo -83.52 172.27 10.43 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.588 2.192 . . . . 0.46000000000000002 112.28 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.0 t -136.06 114.37 15.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.234 -0.654 . . . . 1.3300000000000001 109.234 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 70.31 23.76 4.95 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.133 0.492 . . . . 1.6699999999999999 111.58 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.47 25.21 19.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.954 -0.641 . . . . 0.5 112.661 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.607 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -168.5 154.27 6.79 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.6 -0.889 . . . . 1.8200000000000001 108.6 175.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.86 ' HB ' HD21 ' A' ' 71' ' ' ASN . 3.1 pt -86.58 137.19 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 120.316 -0.554 . . . . 0.40999999999999998 110.21 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.8 p -60.3 130.7 47.94 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 107.352 -1.351 . . . . 0.69999999999999996 107.352 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.669 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -50.98 -25.75 10.31 Favored Glycine 0 C--O 1.22 -0.742 0 C-N-CA 120.682 -0.771 . . . . 0.38 113.784 -172.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -46.92 -55.77 7.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.139 0.47 . . . . 0.44 111.467 173.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.86 HD21 ' HB ' ' A' ' 67' ' ' ILE . 9.5 p30 -72.96 -27.07 61.61 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.87 0.367 . . . . 2.1099999999999999 110.545 -175.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.728 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -68.92 -37.29 78.84 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.392 -0.596 . . . . 0.41999999999999998 109.392 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.669 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.9 mmmm -67.72 -38.77 84.04 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.174 -0.921 . . . . 1.6899999999999999 109.843 177.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.809 ' HG2' ' HA ' ' A' ' 71' ' ' ASN . 10.4 mmmm -56.23 -50.6 70.83 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.654 0.74 . . . . 1.3500000000000001 109.655 175.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -55.9 -52.81 62.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.972 -1.467 . . . . 1.48 111.445 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.728 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 12.8 ptp -73.45 -21.88 60.34 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.107 -0.371 . . . . 0.65000000000000002 111.752 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.41 -45.71 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.787 0.327 . . . . 0.58999999999999997 110.462 174.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 15.2 ptpt -70.83 -14.82 62.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.257 0.551 . . . . 1.2 110.1 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 76' ' ' MET . 67.6 m -63.94 -1.59 1.52 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.563 -0.744 . . . . 1.3700000000000001 111.583 171.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 71.24 72.07 0.18 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.621 0.769 . . . . 2.6499999999999999 111.434 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.843 HD11 ' HE2' ' A' ' 116' ' ' LYS . 29.1 mt -142.77 161.36 49.51 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.934 -0.576 . . . . 1.1599999999999999 111.782 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -82.56 168.54 14.39 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.093 2.529 . . . . 0.94999999999999996 110.198 166.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -63.75 -18.15 63.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.83 0.347 . . . . 1.53 111.5 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -64.63 -67.83 0.4 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.961 -0.563 . . . . 1.24 110.863 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 89' ' ' ILE . 39.8 t -60.64 -44.58 97.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 115.811 -0.631 . . . . 0.71999999999999997 110.297 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.563 HD11 ' HG3' ' A' ' 76' ' ' MET . 22.7 tp -55.52 -51.35 67.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.325 -0.852 . . . . 1.45 111.443 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.36 -43.19 97.54 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.789 -0.641 . . . . 0.39000000000000001 111.967 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.831 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 56.4 pttt -80.39 -16.45 54.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.562 -0.855 . . . . 1.6599999999999999 111.754 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.656 HD11 ' HD3' ' A' ' 116' ' ' LYS . 13.5 mt -71.8 -46.32 61.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.857 -0.794 . . . . 1.1499999999999999 108.857 171.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -56.06 -53.24 59.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.755 -0.657 . . . . 0.29999999999999999 111.212 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.831 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -73.03 -14.31 61.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.117 -0.492 . . . . 2.54 112.128 -174.67 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.614 HD23 HD13 ' A' ' 112' ' ' LEU . 13.6 tp -93.41 -23.89 18.25 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.662 -0.415 . . . . 0.85999999999999999 110.488 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.724 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -89.04 -42.9 11.48 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.797 0.332 . . . . 0.45000000000000001 111.376 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.567 ' HB2' HD21 ' A' ' 101' ' ' LEU . 55.3 t0 -92.57 105.54 17.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.759 -0.46 . . . . 0.62 109.759 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.5 t -73.09 -27.4 24.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.595 -0.729 . . . . 1.76 111.262 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.16 -26.48 22.41 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.109 -0.496 . . . . 1.7 109.677 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.9 mttt 60.22 58.83 2.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.955 -1.02 . . . . 1.74 109.364 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.503 ' HB2' ' HG ' ' A' ' 100' ' ' LEU . 6.4 m-20 -83.57 -35.2 24.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.024 -1.444 . . . . 1.51 111.629 -170.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.72 16.41 33.87 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 109.889 -1.284 . . . . 0.28999999999999998 109.889 -164.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.542 HD13 ' HG3' ' A' ' 66' ' ' LYS . 4.2 pp -153.32 177.01 11.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.379 -0.971 . . . . 0.54000000000000004 108.379 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.634 ' O ' HG12 ' A' ' 67' ' ' ILE . 46.4 mt -151.74 120.37 6.5 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.231 -1.396 . . . . 0.68000000000000005 107.231 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.7 p30 -80.96 -175.75 5.55 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.499 -0.881 . . . . 1.5 110.176 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -57.95 -32.52 67.9 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 111.738 0.273 . . . . 1.73 111.738 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 4.0 tp10 -87.33 -27.92 22.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.319 0.581 . . . . 2.1400000000000001 110.029 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.474 ' HB3' HD22 ' A' ' 101' ' ' LEU . 1.1 mt-10 -74.75 -27.91 60.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.05 -0.523 . . . . 1.1100000000000001 110.656 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.673 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -73.61 -36.06 65.44 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.439 -1.319 . . . . 1.0700000000000001 107.439 169.219 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.538 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -56.37 -45.77 80.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.02 -0.537 . . . . 0.19 110.286 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.724 HD22 ' HA ' ' A' ' 93' ' ' ALA . 3.5 tt -71.27 -48.6 49.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.931 -0.577 . . . . 1.23 110.278 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.533 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -46.53 -56.25 6.3 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.531 0.519 . . . . 0.22 111.138 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.538 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 11.1 t-20 -73.32 -23.98 60.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.601 -0.727 . . . . 1.1799999999999999 110.379 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.591 ' O ' HG23 ' A' ' 115' ' ' VAL . 65.7 t60 -69.76 -41.94 74.52 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.357 -0.609 . . . . 0.48999999999999999 109.357 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.635 HD22 HD22 ' A' ' 122' ' ' LEU . 30.2 mt -73.71 -27.32 61.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.187 -0.461 . . . . 0.55000000000000004 110.436 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 109' ' ' ALA . 68.7 mt -60.97 -45.46 98.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.464 -0.335 . . . . 0.81000000000000005 111.021 172.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.463 ' HE3' ' HE1' ' A' ' 53' ' ' TYR . 17.4 ptpt -75.35 -21.18 58.54 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.687 -0.805 . . . . 2.2200000000000002 111.488 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 111' ' ' HIS . 40.1 t -68.43 -43.27 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.471 0.177 . . . . 0.48999999999999999 110.706 173.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.843 ' HE2' HD11 ' A' ' 81' ' ' LEU . 16.0 pttp -69.12 -28.26 66.3 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.291 -0.633 . . . . 1.9099999999999999 109.291 174.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.1 tt -69.61 -24.28 63.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.53 -0.759 . . . . 1.28 110.248 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 6.5 mm-40 -59.02 -13.23 6.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.573 -0.739 . . . . 1.99 111.299 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.81 8.81 29.53 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.924 -0.655 . . . . 1.01 111.926 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.754 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.5 p80 -137.89 135.16 35.86 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.017 -0.364 . . . . 0.87 110.017 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -71.85 164.5 25.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.203 -0.453 . . . . 2.75 111.316 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.635 HD22 HD22 ' A' ' 112' ' ' LEU . 41.8 mt -74.59 137.17 74.16 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.92 -0.582 . . . . 2.7000000000000002 110.268 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 87.3 Cg_endo -90.16 13.83 2.21 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.181 2.588 . . . . 1.1000000000000001 113.396 -172.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.56 22.76 13.5 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.253 -0.43 . . . . 1.3400000000000001 111.162 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -112.55 140.69 47.1 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.366 -0.605 . . . . 2.3599999999999999 109.366 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -121.52 106.23 37.9 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 108.944 -0.762 . . . . 1.8300000000000001 108.944 178.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 2.2 Cg_endo -82.48 148.08 14.3 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.019 2.479 . . . . 1.0 112.351 -176.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.52 -13.59 37.32 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.777 2.318 . . . . 1.3400000000000001 112.579 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -98.01 24.22 7.26 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.209 -0.293 . . . . 1.48 110.209 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.45 12.78 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.92 0.391 . . . . 1.29 110.481 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.6 m -91.86 128.42 45.98 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.598 -0.519 . . . . 1.72 109.598 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.724 ' HD3' HD12 ' A' ' 108' ' ' LEU . 51.0 Cg_exo . . . . . 0 CA--C 1.535 0.554 0 C-N-CA 122.553 2.168 . . . . 1.04 110.991 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 CA--C 1.538 0.506 0 CA-C-O 121.069 0.461 . . . . 1.21 112.135 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.689 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 84.0 t -88.53 -13.55 9.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 O-C-N 121.553 -0.717 . . . . 0.66000000000000003 111.386 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.46 -12.63 70.02 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 119.457 -1.354 . . . . 0.71999999999999997 111.839 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -111.7 -28.26 8.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.563 0.579 . . . . 2.9700000000000002 112.563 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -108.56 8.41 27.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.473 0.654 . . . . 1.8300000000000001 109.946 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.769 ' HE3' ' HG3' ' A' ' 104' ' ' GLU . 42.5 tttt -57.1 -46.43 99.86 Favored Pre-proline 0 C--O 1.22 -0.466 0 CA-C-N 115.417 -0.811 . . . . 1.1299999999999999 112.167 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 7.3 Cg_endo -49.95 -28.39 18.54 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 122.561 2.174 . . . . 0.56000000000000005 112.802 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.629 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 9.2 m -72.34 -42.32 65.49 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 122.301 1.048 . . . . 0.59999999999999998 109.91 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.546 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 8.2 m-85 -79.55 -24.61 42.02 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.109 -0.951 . . . . 0.93999999999999995 109.742 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.588 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 14.3 t70 -81.6 -34.45 30.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.474 -0.785 . . . . 1.1599999999999999 110.63 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.629 ' HG2' ' O ' ' A' ' 52' ' ' THR . 13.2 pt-20 -66.14 -40.45 90.6 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.528 -0.469 . . . . 1.6299999999999999 109.819 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.6 mt -69.54 -29.45 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.114 -0.634 . . . . 0.60999999999999999 109.612 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 71.8 t80 -58.59 -58.29 9.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.409 -0.814 . . . . 0.88 111.462 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.449 ' HE1' ' OD1' ' A' ' 54' ' ' ASP . 38.8 m-85 -66.96 -23.02 65.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.959 0.409 . . . . 1.03 110.813 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.0 m -70.75 -26.37 63.33 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.019 -0.537 . . . . 0.44 110.973 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.526 HD11 ' CG ' ' A' ' 75' ' ' GLU . 53.6 mt -87.74 4.22 45.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.015 0.376 . . . . 0.79000000000000004 112.015 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t 65.48 81.63 0.21 Allowed Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.027 -0.533 . . . . 0.64000000000000001 110.906 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 72.6 Cg_endo -81.48 153.06 17.95 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.733 2.289 . . . . 0.46000000000000002 113.176 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.7 126.86 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.894 -0.594 . . . . 1.3300000000000001 110.248 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 60.72 23.31 13.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.702 -0.681 . . . . 1.6699999999999999 111.627 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.34 26.67 25.03 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.769 -0.729 . . . . 0.5 112.898 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.722 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -160.32 148.56 16.66 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 120.934 0.397 . . . . 1.8200000000000001 110.039 173.522 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.729 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 4.1 pt -85.89 131.45 34.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.951 -0.568 . . . . 0.40999999999999998 109.965 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.7 p -59.7 112.22 1.73 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.751 -0.833 . . . . 0.69999999999999996 108.751 174.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.566 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -42.2 -27.21 0.41 Allowed Glycine 0 C--O 1.218 -0.896 0 N-CA-C 116.684 1.434 . . . . 0.38 116.684 -160.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.68 -30.87 9.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 118.236 1.018 . . . . 0.44 112.359 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.729 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 13.3 p30 -81.07 -38.32 27.53 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.863 0.364 . . . . 2.1099999999999999 111.559 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.666 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -69.39 -34.58 74.73 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.497 0.665 . . . . 0.41999999999999998 109.223 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.566 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.2 mmmm -64.06 -39.25 93.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.756 -1.111 . . . . 1.6899999999999999 108.864 174.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -55.79 -48.49 75.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.355 -0.839 . . . . 1.3500000000000001 109.714 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.651 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 7.2 mm-40 -60.68 -52.19 66.18 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.062 -0.972 . . . . 1.48 112.051 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.666 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 13.4 ptp -69.35 -24.13 63.86 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.878 -0.329 . . . . 0.65000000000000002 111.487 -178.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 73' ' ' LYS . 45.8 t -73.13 -49.08 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.652 0.263 . . . . 0.58999999999999997 110.644 174.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.651 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 8.0 ptmt -68.06 -11.96 59.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.185 0.517 . . . . 1.2 110.249 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.3 t -68.29 -9.44 47.6 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.942 -0.572 . . . . 1.3700000000000001 110.039 174.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.486 ' NZ ' ' HB2' ' A' ' 80' ' ' LYS . 8.4 mtmp? 73.49 73.19 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.5 0.72 . . . . 2.6499999999999999 110.989 176.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.034 HD11 ' HE2' ' A' ' 116' ' ' LYS . 25.1 mt -136.35 163.56 49.11 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.566 -0.743 . . . . 1.1599999999999999 110.997 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.425 ' HG2' HG23 ' A' ' 85' ' ' VAL . 71.7 Cg_endo -79.78 168.71 19.02 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.618 2.212 . . . . 0.94999999999999996 111.408 167.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 93.8 m-20 -64.72 -26.83 68.54 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.833 0.308 . . . . 1.53 111.833 -177.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.4 p -62.95 -50.82 69.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.259 -0.428 . . . . 1.24 110.896 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 89' ' ' ILE . 46.7 t -66.83 -43.78 89.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.928 -0.578 . . . . 0.71999999999999997 109.925 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.564 ' CD2' ' HB2' ' A' ' 81' ' ' LEU . 2.8 mm? -48.27 -53.41 17.27 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.282 0.563 . . . . 1.45 110.744 172.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.43 -45.96 94.68 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.943 -1.026 . . . . 0.39000000000000001 112.984 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.87 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 56.3 pttt -83.27 -21.54 33.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 119.677 -0.809 . . . . 1.6599999999999999 112.304 -175.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.599 HD11 ' HD3' ' A' ' 116' ' ' LYS . 29.8 mt -67.26 -44.91 87.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.853 -0.795 . . . . 1.1499999999999999 108.853 171.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -62.98 -54.69 34.38 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 115.658 -0.701 . . . . 0.29999999999999999 111.405 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.87 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 64.6 pttt -71.82 -10.17 59.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.571 -0.286 . . . . 2.54 111.721 -173.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.645 HD13 ' HA ' ' A' ' 124' ' ' ALA . 8.6 tp -92.34 -34.07 14.34 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.736 -0.468 . . . . 0.85999999999999999 109.736 173.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.729 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -82.92 -44.44 15.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.896 0.379 . . . . 0.45000000000000001 112.004 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.519 ' HB2' HD21 ' A' ' 101' ' ' LEU . 42.1 t0 -92.01 76.28 5.47 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.81 -0.811 . . . . 0.62 108.81 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.3 t -64.9 -25.22 37.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.258 -0.883 . . . . 1.76 109.982 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -79.48 -25.85 41.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.603 -1.18 . . . . 1.7 110.278 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 55.71 73.82 0.41 Allowed 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.468 -0.787 . . . . 1.74 111.525 174.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -123.45 -24.22 4.64 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.409 -1.269 . . . . 1.51 112.419 -169.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.91 16.46 28.26 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.053 -1.07 . . . . 0.28999999999999998 111.82 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.722 HD13 ' HG3' ' A' ' 66' ' ' LYS . 3.3 pp -151.61 -174.57 4.88 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.649 -0.871 . . . . 0.54000000000000004 108.649 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.608 HD12 ' HB1' ' A' ' 72' ' ' ALA . 45.0 mt -150.12 120.56 7.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.218 -0.66 . . . . 0.68000000000000005 109.218 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.8 p-10 -74.98 -175.65 2.65 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.635 -0.506 . . . . 1.5 109.635 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.456 ' OD1' ' HE2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -60.24 -33.85 72.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.663 0.268 . . . . 1.73 111.191 -177.181 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.769 ' HG3' ' HE3' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -83.24 -37.43 23.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.79 -0.186 . . . . 2.1400000000000001 111.037 176.699 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.545 ' HB3' HD22 ' A' ' 101' ' ' LEU . 3.7 mt-10 -62.43 -38.35 89.41 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.208 -0.197 . . . . 1.1100000000000001 110.99 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.584 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.6 OUTLIER -68.96 -40.1 79.09 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.526 -0.916 . . . . 1.0700000000000001 108.526 172.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.546 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -48.93 -50.67 34.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.597 -0.729 . . . . 0.19 111.426 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.729 ' CD1' ' HA ' ' A' ' 93' ' ' ALA . 0.5 OUTLIER -83.41 -33.36 25.75 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 118.993 -1.083 . . . . 1.23 112.031 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.32 -54.18 9.43 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.318 0.58 . . . . 0.22 111.173 170.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.482 ' HA ' HD12 ' A' ' 113' ' ' ILE . 2.9 t-20 -75.97 -33.87 59.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.571 . . . . 1.1799999999999999 110.702 -176.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 108' ' ' LEU . 85.5 t60 -66.37 -34.88 78.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.519 . . . . 0.48999999999999999 109.945 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.802 ' HB3' HD21 ' A' ' 122' ' ' LEU . 73.0 mt -71.81 -31.65 66.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.717 -0.674 . . . . 0.55000000000000004 110.021 176.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.597 ' HA ' ' HE3' ' A' ' 116' ' ' LYS . 60.8 mt -61.11 -42.67 94.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.73 -0.668 . . . . 0.81000000000000005 110.747 171.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.601 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -68.44 -35.34 77.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.297 -0.41 . . . . 2.2200000000000002 110.335 175.715 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.6 t -59.57 -49.05 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.256 -0.429 . . . . 0.48999999999999999 111.522 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 1.034 ' HE2' HD11 ' A' ' 81' ' ' LEU . 20.0 pttp -68.0 -28.84 67.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.026 0.441 . . . . 1.9099999999999999 110.303 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.5 tp -70.49 -20.57 62.84 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.847 -0.615 . . . . 1.28 110.839 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.601 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 42.2 mt-10 -71.42 -9.84 58.82 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.888 -0.597 . . . . 1.99 111.037 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.43 1.21 24.8 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.2 -1.0 . . . . 1.01 112.948 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.716 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -129.45 134.01 47.6 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.874 -0.417 . . . . 0.87 109.874 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -72.12 164.62 25.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.252 0.549 . . . . 2.75 111.242 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.802 HD21 ' HB3' ' A' ' 112' ' ' LEU . 5.2 mp -68.87 141.5 92.43 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.792 -0.64 . . . . 2.7000000000000002 110.46 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.578 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 67.9 Cg_endo -91.5 -7.06 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.483 2.788 . . . . 1.1000000000000001 112.624 -174.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.645 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . 61.53 37.55 16.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.699 -0.682 . . . . 1.3400000000000001 111.319 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.578 ' OD1' ' HG2' ' A' ' 123' ' ' PRO . 1.2 p-10 -111.61 135.5 52.11 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.956 -0.565 . . . . 2.3599999999999999 109.746 170.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.7 tp -115.49 91.42 28.99 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.191 -0.913 . . . . 1.8300000000000001 109.918 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 94.5 Cg_endo -98.03 171.22 0.67 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.609 2.872 . . . . 1.0 113.189 -175.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.55 ' HA ' HG23 ' A' ' 131' ' ' VAL . 9.3 Cg_endo -54.92 -29.49 64.2 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.941 2.427 . . . . 1.3400000000000001 112.993 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.543 ' O ' HD12 ' A' ' 130' ' ' LEU . 16.5 p-80 -84.84 22.16 1.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.997 0.369 . . . . 1.48 111.997 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 129' ' ' HIS . 1.0 OUTLIER -149.76 18.4 0.9 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.582 0.353 . . . . 1.29 111.091 169.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.55 HG23 ' HA ' ' A' ' 128' ' ' PRO . 96.7 t -70.19 112.59 13.16 Favored Pre-proline 0 C--N 1.328 -0.356 0 C-N-CA 120.549 -0.46 . . . . 1.72 110.968 -176.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo . . . . . 0 C--O 1.237 0.439 0 C-N-CA 122.629 2.22 . . . . 1.04 111.841 179.066 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.661 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 23.8 t . . . . . 0 C--O 1.223 -0.305 0 N-CA-C 112.561 0.578 . . . . 1.21 112.561 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.714 ' HA ' ' OD1' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -63.07 -13.4 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 O-C-N 121.995 -0.441 . . . . 0.66000000000000003 112.089 -174.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.48 -4.58 31.98 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.255 -0.974 . . . . 0.71999999999999997 111.935 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 11.7 ptmm? -105.33 -28.32 10.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 111.838 0.31 . . . . 2.9700000000000002 111.838 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.714 ' OD1' ' HA ' ' A' ' 46' ' ' VAL . 12.7 p-10 -114.58 1.34 14.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.051 0.453 . . . . 1.8300000000000001 111.235 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.619 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 49.6 tttm -56.48 -46.25 99.84 Favored Pre-proline 0 C--O 1.223 -0.334 0 CA-C-N 115.438 -0.801 . . . . 1.1299999999999999 112.293 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 4.3 Cg_endo -46.48 -35.09 15.81 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.869 2.38 . . . . 0.56000000000000005 113.315 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.707 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 56.5 m -76.57 -36.44 57.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.376 0.607 . . . . 0.59999999999999998 110.995 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' A' ' 110' ' ' ASN . 8.4 m-85 -81.96 -23.87 35.84 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.198 0.523 . . . . 0.93999999999999995 110.224 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.605 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 1.1 t70 -75.44 -39.47 58.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.032 -0.985 . . . . 1.1599999999999999 109.783 175.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.707 ' HG3' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -68.38 -38.65 81.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.504 -0.316 . . . . 1.6299999999999999 110.729 178.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.533 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 48.2 mt -70.95 -29.3 36.61 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 109.366 -0.605 . . . . 0.60999999999999999 109.366 174.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.605 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 66.1 t80 -57.43 -54.51 46.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.71 -0.677 . . . . 0.88 111.213 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.586 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 75.3 m-85 -71.53 -22.89 61.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.166 0.507 . . . . 1.03 110.498 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.533 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 18.3 m -72.09 -30.48 65.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.768 -0.651 . . . . 0.44 110.874 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 34.4 mt -84.87 0.94 49.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.79000000000000004 110.979 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t 66.46 88.59 0.11 Allowed Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.511 -0.768 . . . . 0.64000000000000001 111.464 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.586 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 64.8 Cg_endo -85.09 159.88 11.53 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.47 2.113 . . . . 0.46000000000000002 113.257 177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.8 p -141.46 134.25 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.93 -0.577 . . . . 1.3300000000000001 109.958 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 63.81 20.53 12.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.479 -0.782 . . . . 1.6699999999999999 109.73 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.58 -0.06 67.51 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.145 -0.934 . . . . 0.5 113.618 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -134.59 163.78 28.96 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 117.946 0.873 . . . . 1.8200000000000001 110.472 177.7 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pt -90.49 135.01 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 C-N-CA 120.642 -0.423 . . . . 0.40999999999999998 109.982 170.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.32 126.73 28.84 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.147 -1.057 . . . . 0.69999999999999996 108.147 171.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.54 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -49.45 -31.91 14.56 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.571 -0.74 . . . . 0.38 114.816 -166.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.67 -33.1 21.26 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 117.366 0.583 . . . . 0.44 112.389 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.61 -38.49 39.76 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.366 0.603 . . . . 2.1099999999999999 109.932 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.581 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -72.29 -33.21 67.24 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.789 -0.641 . . . . 0.41999999999999998 109.327 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.4 mmmm -65.34 -37.87 88.39 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 114.959 -1.018 . . . . 1.6899999999999999 108.78 174.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -56.54 -44.65 81.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.942 -1.026 . . . . 1.3500000000000001 110.416 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.667 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 3.3 mm-40 -64.01 -52.87 57.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.142 -0.936 . . . . 1.48 111.74 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.581 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 16.0 ptp -66.37 -21.07 66.23 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.582 -0.447 . . . . 0.65000000000000002 110.807 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 73' ' ' LYS . 5.1 t -68.64 -46.53 79.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.58999999999999997 111.013 172.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.667 ' HE2' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -70.36 -16.36 62.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.12 0.486 . . . . 1.2 110.04 -176.532 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.9 t -65.01 -6.81 9.48 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.411 -0.813 . . . . 1.3700000000000001 111.716 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 77.9 mttt 67.44 68.22 0.38 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.383 0.611 . . . . 2.6499999999999999 110.596 175.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.51 HD13 HG12 ' A' ' 85' ' ' VAL . 20.7 mt -128.95 156.87 77.3 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.577 -0.738 . . . . 1.1599999999999999 110.691 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.556 ' HG2' HG23 ' A' ' 85' ' ' VAL . 53.0 Cg_endo -73.21 162.93 39.36 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.194 1.929 . . . . 0.94999999999999996 110.541 168.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -63.0 -27.47 69.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.334 -0.394 . . . . 1.53 111.539 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.1 p -67.38 -45.76 75.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.2 0.524 . . . . 1.24 110.723 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.556 HG23 ' HG2' ' A' ' 82' ' ' PRO . 90.5 t -67.37 -42.92 87.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 115.904 -0.589 . . . . 0.71999999999999997 110.053 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.476 ' CD2' ' HB2' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -48.66 -55.29 11.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.4 0.619 . . . . 1.45 110.587 171.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -56.79 -53.29 45.19 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.873 -1.058 . . . . 0.39000000000000001 113.247 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 14.4 pttp -81.12 -17.33 50.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.516 -0.873 . . . . 1.6599999999999999 112.651 -173.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.745 HG12 HD11 ' A' ' 122' ' ' LEU . 7.8 mt -69.73 -48.42 64.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 108.71 -0.848 . . . . 1.1499999999999999 108.71 169.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.433 ' CE3' ' HD3' ' A' ' 73' ' ' LYS . 67.2 t-105 -53.44 -55.43 25.22 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.497 -0.774 . . . . 0.29999999999999999 111.237 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.46 -30.28 71.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.38 -0.827 . . . . 2.54 112.538 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 112' ' ' LEU . 4.6 tp -84.09 -13.0 54.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.643 -0.503 . . . . 0.85999999999999999 109.643 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.495 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -101.63 -42.92 6.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.315 -0.402 . . . . 0.45000000000000001 111.38 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.445 ' HB2' HD21 ' A' ' 101' ' ' LEU . 51.5 t0 -80.43 97.76 7.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.312 -0.625 . . . . 0.62 109.312 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -71.95 -28.71 30.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.896 -0.593 . . . . 1.76 110.325 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.2 -26.63 42.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.963 -0.562 . . . . 1.7 109.595 176.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 56.39 44.66 24.12 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.954 0.883 . . . . 1.74 109.05 -173.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -108.74 -0.16 20.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.181 -1.372 . . . . 1.51 112.167 -166.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.15 10.26 59.83 Favored Glycine 0 CA--C 1.511 -0.156 0 C-N-CA 120.287 -0.959 . . . . 0.28999999999999998 112.507 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.464 HD13 ' CB ' ' A' ' 66' ' ' LYS . 4.2 pp -152.89 156.13 38.37 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.227 0.537 . . . . 0.54000000000000004 110.246 175.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 105' ' ' GLU . 63.4 mt -121.82 119.0 30.39 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.115 -0.948 . . . . 0.68000000000000005 109.48 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.1 p30 -71.09 -178.36 1.96 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.508 -0.553 . . . . 1.5 109.508 174.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -34.44 68.02 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.487 0.66 . . . . 1.73 111.08 -178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.591 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 23.5 tt0 -83.95 -31.81 25.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.548 0.69 . . . . 2.1400000000000001 109.424 -176.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HB3' HD22 ' A' ' 101' ' ' LEU . 3.6 mt-10 -72.91 -30.28 63.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.583 -0.735 . . . . 1.1100000000000001 111.358 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.624 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -68.78 -44.19 74.15 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.062 -1.088 . . . . 1.0700000000000001 108.062 171.396 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 104' ' ' GLU . . . -47.48 -46.6 27.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 0.19 110.62 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.495 HD13 ' HA ' ' A' ' 93' ' ' ALA . 1.0 OUTLIER -69.81 -46.66 65.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.23 110.427 178.634 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.44 ' HB2' HD13 ' A' ' 101' ' ' LEU . . . -50.02 -53.76 24.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.089 0.471 . . . . 0.22 111.527 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.431 ' HA ' HD12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -72.39 -25.45 61.5 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.349 -0.611 . . . . 1.1799999999999999 109.349 -177.101 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.48 ' O ' HG23 ' A' ' 115' ' ' VAL . 51.4 t60 -70.24 -39.8 74.85 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.592 -0.521 . . . . 0.48999999999999999 109.592 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.525 HD22 HD22 ' A' ' 122' ' ' LEU . 46.6 mt -68.78 -36.53 78.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.838 0.352 . . . . 0.55000000000000004 110.594 177.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 110' ' ' ASN . 95.6 mt -57.42 -48.94 81.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.931 -0.577 . . . . 0.81000000000000005 110.528 175.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 19.8 ptmt -70.29 -28.46 65.21 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.123 -0.631 . . . . 2.2200000000000002 110.502 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 111' ' ' HIS . 6.4 t -62.13 -45.19 99.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.688 -0.233 . . . . 0.48999999999999999 110.989 176.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 3.7 ptmm? -84.07 -2.42 56.67 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 119.733 -0.787 . . . . 1.9099999999999999 110.846 178.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.9 tp -83.64 -23.12 31.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.459 -0.571 . . . . 1.28 109.459 170.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 48.5 mt-10 -66.44 -14.13 61.75 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.006 -0.543 . . . . 1.99 111.355 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.05 8.13 20.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.628 -0.796 . . . . 1.01 112.589 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -132.61 140.2 48.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.92 0.391 . . . . 0.87 109.964 177.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -77.06 164.96 25.23 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.865 -0.607 . . . . 2.75 110.962 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.745 HD11 HG12 ' A' ' 89' ' ' ILE . 27.1 mt -70.82 141.89 87.65 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.168 -0.469 . . . . 2.7000000000000002 110.291 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -92.25 12.86 2.0 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.035 2.49 . . . . 1.1000000000000001 113.105 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 59.96 21.93 10.99 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.756 -0.656 . . . . 1.3400000000000001 111.198 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -111.93 139.94 47.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.084 -0.709 . . . . 2.3599999999999999 109.084 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.83 93.34 47.58 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.542 -0.911 . . . . 1.8300000000000001 108.542 176.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 9.8 Cg_exo -73.21 153.49 51.32 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.828 2.352 . . . . 1.0 112.491 -174.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -67.47 -7.21 18.5 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.117 2.545 . . . . 1.3400000000000001 112.374 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -105.82 13.76 29.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.838 -0.619 . . . . 1.48 109.602 175.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 1.5 mp -134.6 -4.54 2.57 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.338 -0.846 . . . . 1.29 110.658 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 127' ' ' PRO . 29.3 t -66.03 120.6 70.74 Favored Pre-proline 0 N--CA 1.44 -0.936 0 N-CA-C 109.285 -0.635 . . . . 1.72 109.285 174.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.591 ' HB3' ' HG2' ' A' ' 104' ' ' GLU . 51.9 Cg_exo . . . . . 0 N--CA 1.453 -0.885 0 C-N-CA 121.899 1.733 . . . . 1.04 109.412 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 t . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 120.941 0.401 . . . . 1.21 111.07 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.605 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 99.1 t -89.26 -20.11 7.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 O-C-N 121.652 -0.655 . . . . 0.66000000000000003 111.865 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.68 -11.59 57.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.612 -1.28 . . . . 0.71999999999999997 112.234 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -109.5 -27.77 9.26 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.311 0.486 . . . . 2.9700000000000002 112.311 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -108.68 7.04 26.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.896 0.855 . . . . 1.8300000000000001 110.336 -173.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.688 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 83.0 tttt -61.5 -40.21 69.1 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 114.661 -1.154 . . . . 1.1299999999999999 112.82 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.2 Cg_endo -46.2 -30.97 8.36 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 122.678 2.252 . . . . 0.56000000000000005 112.841 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.569 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 99.0 m -75.3 -40.79 58.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.793 0.806 . . . . 0.59999999999999998 110.566 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.627 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 9.1 m-85 -79.55 -28.49 41.23 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.078 -0.51 . . . . 0.93999999999999995 110.579 -174.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.591 ' OD2' ' HA ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -86.12 -27.64 24.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.799 -0.637 . . . . 1.1599999999999999 110.181 -179.064 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 52' ' ' THR . 11.5 pt-20 -66.24 -43.1 87.56 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.346 -0.613 . . . . 1.6299999999999999 109.346 173.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 52' ' ' THR . 53.6 mt -67.9 -32.89 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 120.28 -0.568 . . . . 0.60999999999999999 109.517 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 79.2 t80 -55.1 -52.99 61.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.477 -0.783 . . . . 0.88 111.276 175.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.548 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 74.7 m-85 -73.92 -23.3 59.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.738 0.304 . . . . 1.03 111.314 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 25.2 m -66.76 -35.24 79.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.057 -0.519 . . . . 0.44 110.769 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.533 HD11 ' CG ' ' A' ' 75' ' ' GLU . 54.9 mt -85.39 -4.48 59.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.122 -0.49 . . . . 0.79000000000000004 111.404 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.0 t 67.06 95.21 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 121.586 0.708 . . . . 0.64000000000000001 111.312 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.548 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 22.9 Cg_endo -80.96 138.84 11.73 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.808 2.339 . . . . 0.46000000000000002 112.377 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.401 HG21 HG23 ' A' ' 68' ' ' THR . 13.9 m -99.94 122.05 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.044 -0.525 . . . . 1.3300000000000001 110.873 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 62.92 24.14 14.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.65 -0.704 . . . . 1.6699999999999999 111.232 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.74 14.3 53.02 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.963 -0.636 . . . . 0.5 113.728 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.951 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -155.03 151.78 28.83 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.759 -0.46 . . . . 1.8200000000000001 109.759 174.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.878 ' HB ' HD21 ' A' ' 71' ' ' ASN . 4.2 pt -80.5 135.93 24.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 C-N-CA 120.623 -0.431 . . . . 0.40999999999999998 110.529 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.401 HG23 HG21 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -60.03 128.76 38.41 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.883 -1.155 . . . . 0.69999999999999996 107.883 167.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.611 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -49.92 -29.43 13.92 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 121.172 -0.537 . . . . 0.38 113.917 -169.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.58 47.4 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.721 0.638 . . . . 0.44 112.721 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.878 HD21 ' HB ' ' A' ' 67' ' ' ILE . 15.2 p30 -82.1 -33.03 29.93 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.074 0.464 . . . . 2.1099999999999999 110.538 -176.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.656 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -69.93 -35.89 74.9 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.378 0.609 . . . . 0.41999999999999998 109.388 177.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 31.4 mmmt -66.12 -37.84 86.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.163 -0.926 . . . . 1.6899999999999999 108.984 175.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.463 ' O ' ' HD2' ' A' ' 78' ' ' LYS . 2.2 tppp? -54.84 -48.2 73.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.683 -0.689 . . . . 1.3500000000000001 109.956 176.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.691 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 3.0 mm-40 -63.43 -51.94 63.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.041 -0.982 . . . . 1.48 111.957 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.656 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 14.9 ptp -67.95 -23.02 65.02 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.481 -0.488 . . . . 0.65000000000000002 111.409 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.471 HG23 HD11 ' A' ' 86' ' ' LEU . 24.9 t -71.85 -49.51 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.481 0.181 . . . . 0.58999999999999997 111.186 173.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.691 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 2.5 ptmt -69.93 -9.1 53.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.264 0.554 . . . . 1.2 110.306 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.0 t -73.34 0.57 11.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.444 -0.798 . . . . 1.3700000000000001 110.893 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.5 mttp 73.09 68.09 0.11 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.91 -0.586 . . . . 2.6499999999999999 110.872 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.824 HD11 ' HE2' ' A' ' 116' ' ' LYS . 18.4 mt -138.64 159.68 66.46 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.627 -0.715 . . . . 1.1599999999999999 111.358 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.535 ' HG2' HG23 ' A' ' 85' ' ' VAL . 74.2 Cg_endo -77.95 168.56 21.91 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.836 2.357 . . . . 0.94999999999999996 111.385 167.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 92.5 m-20 -63.45 -27.72 69.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.153 -0.476 . . . . 1.53 112.044 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -52.6 63.31 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.057 0.456 . . . . 1.24 111.167 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.535 HG23 ' HG2' ' A' ' 82' ' ' PRO . 22.6 t -62.54 -41.98 94.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.822 -0.626 . . . . 0.71999999999999997 109.723 177.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.471 HD11 HG23 ' A' ' 77' ' ' VAL . 2.7 mm? -49.51 -50.05 43.31 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.837 -0.619 . . . . 1.45 111.382 173.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.08 -44.84 86.81 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.946 -0.645 . . . . 0.39000000000000001 113.186 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.589 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 56.3 pttt -76.57 -31.29 57.44 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.964 -0.694 . . . . 1.6599999999999999 111.36 -175.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.596 HG12 HD11 ' A' ' 122' ' ' LEU . 29.7 mt -64.95 -46.22 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 109.325 -0.62 . . . . 1.1499999999999999 109.325 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.472 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 76.3 t-105 -52.95 -57.01 11.77 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 115.018 -0.992 . . . . 0.29999999999999999 111.066 177.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -77.52 -9.48 58.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.389 0.515 . . . . 2.54 112.389 -171.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.589 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 2.3 tp -88.44 -23.29 23.33 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.707 -0.397 . . . . 0.85999999999999999 109.977 176.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.563 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -103.66 -39.21 6.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.038 0.447 . . . . 0.45000000000000001 110.886 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.628 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 29.6 t70 -83.43 79.31 9.46 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.234 -0.654 . . . . 0.62 109.234 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 m -61.25 -33.14 55.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.202 -0.908 . . . . 1.76 111.26 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 5.1 p-10 -78.41 -24.78 46.07 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.354 -1.294 . . . . 1.7 111.446 -175.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.628 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 36.7 mtmm 47.63 50.68 14.87 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.114 0.884 . . . . 1.74 112.637 176.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -110.68 -10.85 14.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.583 -0.735 . . . . 1.51 110.281 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.09 22.91 9.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.163 -1.018 . . . . 0.28999999999999998 113.015 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.951 HD13 ' HG3' ' A' ' 66' ' ' LYS . 4.1 pp -152.94 168.32 26.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.069 0.434 . . . . 0.54000000000000004 111.212 174.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.639 ' O ' HG12 ' A' ' 67' ' ' ILE . 50.8 mt -145.08 118.87 9.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.82 -1.178 . . . . 0.68000000000000005 107.82 -166.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.441 ' H ' ' HB2' ' A' ' 105' ' ' GLU . 1.1 p30 -81.98 -173.25 4.38 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.518 -0.473 . . . . 1.5 110.758 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 54' ' ' ASP . 34.1 t70 -55.8 -36.96 67.99 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.423 0.689 . . . . 1.73 112.245 -173.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 4.2 tp10 -90.61 -22.0 21.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.428 0.632 . . . . 2.1400000000000001 110.483 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.568 ' OE1' ' HA ' ' A' ' 101' ' ' LEU . 3.1 mt-10 -73.64 -30.51 62.98 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.0 -0.545 . . . . 1.1100000000000001 110.047 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.62 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.8 OUTLIER -77.4 -34.09 54.88 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.953 -1.129 . . . . 1.0700000000000001 107.953 170.371 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.627 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -53.28 -48.88 67.95 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.378 0.608 . . . . 0.19 110.091 174.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 37.1 tp -75.85 -39.07 57.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.725 -0.67 . . . . 1.23 111.363 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.25 -56.46 12.81 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.05 0.452 . . . . 0.22 111.166 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.573 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 4.4 t30 -73.63 -24.32 60.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.829 -0.623 . . . . 1.1799999999999999 110.211 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.466 ' O ' HG23 ' A' ' 115' ' ' VAL . 82.6 t60 -70.28 -42.89 71.48 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.277 -0.569 . . . . 0.48999999999999999 109.825 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.563 HD12 ' HB2' ' A' ' 93' ' ' ALA . 80.4 mt -66.98 -31.44 72.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.738 -0.664 . . . . 0.55000000000000004 109.785 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.723 ' O ' ' HG2' ' A' ' 116' ' ' LYS . 60.0 mt -60.72 -45.49 97.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.512 -0.767 . . . . 0.81000000000000005 110.684 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.62 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 12.4 ttpt -65.26 -39.56 92.79 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.341 -0.544 . . . . 2.2200000000000002 110.433 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 111' ' ' HIS . 54.7 t -56.79 -46.4 83.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.666 -0.243 . . . . 0.48999999999999999 111.365 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.824 ' HE2' HD11 ' A' ' 81' ' ' LEU . 14.6 pttp -67.01 -28.19 68.04 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.107 0.479 . . . . 1.9099999999999999 109.92 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.8 tp -80.89 -17.39 50.78 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.868 -0.605 . . . . 1.28 110.971 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.62 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 45.0 mt-10 -75.46 0.55 16.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.034 0.445 . . . . 1.99 110.712 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.81 3.95 30.01 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.429 -0.891 . . . . 1.01 112.902 171.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.519 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.2 p80 -140.53 134.9 31.29 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.393 -0.523 . . . . 0.87 110.121 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.44 163.78 27.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.534 -0.757 . . . . 2.75 111.007 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.596 HD11 HG12 ' A' ' 89' ' ' ILE . 23.3 mt -69.89 134.34 87.91 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.35 -0.386 . . . . 2.7000000000000002 110.014 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 84.4 Cg_endo -93.18 14.83 1.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.894 2.396 . . . . 1.1000000000000001 113.114 -174.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.56 19.55 10.48 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.202 0.525 . . . . 1.3400000000000001 111.099 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -104.35 111.77 24.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.663 -0.699 . . . . 2.3599999999999999 109.582 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.9 tp -112.24 100.11 48.5 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.069 -0.514 . . . . 1.8300000000000001 109.983 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.446 ' C ' ' H ' ' A' ' 129' ' ' HIS . 4.7 Cg_endo -89.02 159.7 5.86 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.075 2.516 . . . . 1.0 111.238 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.17 28.41 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.842 2.362 . . . . 1.3400000000000001 113.104 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.446 ' H ' ' C ' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -100.35 -25.17 14.32 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.863 -0.791 . . . . 1.48 108.863 174.229 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.49 7.07 6.32 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.976 -0.557 . . . . 1.29 111.424 -167.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.99 121.04 84.07 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 108.255 -1.017 . . . . 1.72 108.255 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 CA--C 1.545 1.054 0 C-N-CA 122.743 2.295 . . . . 1.04 113.073 -176.157 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.82 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 21.1 t . . . . . 0 C--O 1.217 -0.651 0 N-CA-C 112.565 0.58 . . . . 1.21 112.565 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' A' ' 49' ' ' ASP . 1.0 OUTLIER -74.99 -15.86 15.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 120.826 -1.171 . . . . 0.66000000000000003 111.592 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.43 -14.12 61.65 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 119.517 -1.325 . . . . 0.71999999999999997 111.714 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.82 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -110.08 -27.87 8.96 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.986 0.422 . . . . 2.9700000000000002 110.874 176.551 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.792 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.0 OUTLIER -86.37 -18.66 31.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.515 -0.766 . . . . 1.8300000000000001 111.1 -177.556 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.484 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 58.8 tttm -52.32 -51.05 75.96 Favored Pre-proline 0 C--O 1.217 -0.619 0 CA-C-O 118.662 -0.685 . . . . 1.1299999999999999 112.643 -174.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 85.9 Cg_exo -41.95 -40.41 6.03 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 122.775 2.317 . . . . 0.56000000000000005 113.676 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.563 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 93.9 m -74.04 -44.15 55.31 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.61 0.719 . . . . 0.59999999999999998 110.744 -176.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.792 ' CE2' ' HB3' ' A' ' 49' ' ' ASP . 6.1 m-85 -74.64 -24.28 58.8 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.988 -0.551 . . . . 0.93999999999999995 110.109 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 24.7 t70 -81.1 -37.24 29.27 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.829 -1.078 . . . . 1.1599999999999999 110.257 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 52' ' ' THR . 13.5 pt-20 -67.13 -41.59 85.88 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.256 -0.429 . . . . 1.6299999999999999 109.963 175.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.462 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 56.1 mt -69.52 -30.38 45.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.583 -0.525 . . . . 0.60999999999999999 109.583 175.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 62' ' ' PRO . 55.3 t80 -57.68 -55.21 37.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.721 -0.672 . . . . 0.88 111.244 177.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.512 ' CD1' ' HG2' ' A' ' 62' ' ' PRO . 68.6 m-85 -70.51 -21.84 62.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.236 0.541 . . . . 1.03 110.611 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.462 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 23.0 m -72.97 -24.53 60.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.257 -0.883 . . . . 0.44 110.985 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.0 mt -94.54 7.98 43.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.79000000000000004 110.828 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.0 t 64.93 90.05 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 123.751 0.657 . . . . 0.64000000000000001 112.223 175.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 57' ' ' PHE . 5.7 Cg_exo -75.49 143.12 27.22 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.852 2.368 . . . . 0.46000000000000002 112.819 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.04 117.94 54.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.457 -0.942 . . . . 1.3300000000000001 108.457 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 68.89 21.15 7.69 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.636 0.585 . . . . 1.6699999999999999 111.567 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.435 ' C ' ' HD2' ' A' ' 66' ' ' LYS . . . 93.34 22.56 26.67 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.148 -0.478 . . . . 0.5 112.936 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.946 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -160.85 156.07 24.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.247 -0.279 . . . . 1.8200000000000001 110.247 178.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.501 HD13 ' CD2' ' A' ' 106' ' ' PHE . 2.2 pt -86.22 137.56 20.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.776 -0.453 . . . . 0.40999999999999998 109.776 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 p -59.35 128.43 37.04 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.204 -1.036 . . . . 0.69999999999999996 108.204 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.567 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -52.28 -32.87 37.74 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 114.942 0.737 . . . . 0.38 114.942 -164.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.56 -28.01 29.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.291 0.545 . . . . 0.44 112.434 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -78.73 -41.7 30.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.423 0.63 . . . . 2.1099999999999999 109.628 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.544 ' CB ' HD12 ' A' ' 101' ' ' LEU . . . -69.95 -31.14 68.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.583 0.706 . . . . 0.41999999999999998 109.287 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 30.6 mmmt -65.86 -37.46 86.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.951 -1.022 . . . . 1.6899999999999999 109.004 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.4 -46.01 83.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.476 -0.783 . . . . 1.3500000000000001 109.785 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.901 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 11.4 mm-40 -56.63 -53.02 62.55 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.864 -1.062 . . . . 1.48 111.36 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 16.7 ptp -72.55 -23.67 61.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.179 -0.464 . . . . 0.65000000000000002 111.685 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 73' ' ' LYS . 20.2 t -67.57 -55.7 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.858 0.361 . . . . 0.58999999999999997 110.798 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.901 ' HE2' ' HA ' ' A' ' 75' ' ' GLU . 57.2 pttt -67.7 -14.44 62.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.16 0.505 . . . . 1.2 110.977 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.1 t -66.32 -7.47 19.06 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.759 -0.655 . . . . 1.3700000000000001 110.995 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt 72.15 71.7 0.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.399 0.68 . . . . 2.6499999999999999 111.315 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.035 HD11 ' HE2' ' A' ' 116' ' ' LYS . 36.4 mt -131.82 162.21 57.82 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.519 -0.764 . . . . 1.1599999999999999 110.65 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.519 ' HG2' HG23 ' A' ' 85' ' ' VAL . 67.8 Cg_endo -76.76 169.01 22.55 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.568 2.178 . . . . 0.94999999999999996 110.864 166.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -66.0 -32.08 73.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.66 0.267 . . . . 1.53 111.344 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.5 m -63.6 -50.85 67.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.067 0.46 . . . . 1.24 110.856 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.519 HG23 ' HG2' ' A' ' 82' ' ' PRO . 84.7 t -63.04 -40.1 87.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 115.945 -0.57 . . . . 0.71999999999999997 110.502 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.792 HD12 ' HB2' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -59.76 -48.99 79.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.879 0.371 . . . . 1.45 111.321 177.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.33 -37.51 93.21 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.535 -0.757 . . . . 0.39000000000000001 112.209 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.675 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 17.2 ptmt -83.84 -29.43 27.29 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.241 -0.583 . . . . 1.6599999999999999 110.446 -175.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.5 mm -60.06 -48.04 89.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.363 -0.606 . . . . 1.1499999999999999 109.363 169.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.564 ' CE3' ' HD3' ' A' ' 73' ' ' LYS . 76.9 t-105 -57.43 -54.35 47.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.449 -0.796 . . . . 0.29999999999999999 111.187 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.675 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 18.1 ptpt -77.78 -8.11 57.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.925 -0.58 . . . . 2.54 111.915 -171.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 18.2 tp -93.24 -30.89 14.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.996 -0.372 . . . . 0.85999999999999999 109.996 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.498 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -81.84 -42.58 19.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.217 -0.447 . . . . 0.45000000000000001 110.957 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.488 ' HB2' HD21 ' A' ' 101' ' ' LEU . 50.6 t0 -87.28 97.84 11.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.175 0.512 . . . . 0.62 110.323 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 m -73.2 -25.78 21.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.624 -0.716 . . . . 1.76 111.681 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.64 -25.78 26.41 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.377 -0.601 . . . . 1.7 109.377 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.2 mttp 57.27 69.16 0.77 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.131 -0.941 . . . . 1.74 110.504 -174.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.497 ' HB2' ' HG ' ' A' ' 100' ' ' LEU . 2.7 m-20 -96.05 -46.18 6.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.802 -1.09 . . . . 1.51 110.6 -174.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.45 14.32 20.33 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 109.435 -1.466 . . . . 0.28999999999999998 109.435 -162.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.946 HD13 ' HG3' ' A' ' 66' ' ' LYS . 3.6 pp -152.8 171.02 18.89 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.048 -1.076 . . . . 0.54000000000000004 108.292 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 105' ' ' GLU . 48.0 mt -143.35 117.52 9.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.618 -0.512 . . . . 0.68000000000000005 109.618 -174.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 4.0 p30 -74.3 -174.2 1.91 Allowed 'General case' 0 C--N 1.317 -0.845 0 O-C-N 122.199 -0.313 . . . . 1.5 110.656 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.2 -36.23 65.71 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.088 0.947 . . . . 1.73 109.995 -176.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.522 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 29.4 tt0 -88.19 -25.08 23.1 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.772 -1.103 . . . . 2.1400000000000001 109.871 -173.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.552 ' HB3' HD22 ' A' ' 101' ' ' LEU . 2.0 mt-10 -81.5 -32.36 32.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.041 -0.527 . . . . 1.1100000000000001 111.496 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.636 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -63.82 -43.0 97.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.176 -1.416 . . . . 1.0700000000000001 107.176 169.426 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.663 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -48.98 -50.24 36.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.602 -0.726 . . . . 0.19 110.842 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.636 HD12 ' HG3' ' A' ' 132' ' ' PRO . 1.4 tt -66.35 -47.94 71.82 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.748 -0.206 . . . . 1.23 110.78 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.33 -54.66 33.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.948 0.404 . . . . 0.22 111.894 -176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.538 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 9.0 t-20 -70.9 -30.66 67.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.238 0.542 . . . . 1.1799999999999999 109.583 -175.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.464 ' O ' HG23 ' A' ' 115' ' ' VAL . 61.7 t60 -67.94 -37.14 81.25 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.653 -0.703 . . . . 0.48999999999999999 109.897 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.46 ' HA ' ' HB ' ' A' ' 115' ' ' VAL . 21.6 mt -67.9 -33.48 74.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.056 0.455 . . . . 0.55000000000000004 110.421 175.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.779 ' HA ' ' HE3' ' A' ' 116' ' ' LYS . 75.9 mt -62.13 -45.82 97.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.689 -0.687 . . . . 0.81000000000000005 110.894 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.487 ' HD3' ' OH ' ' A' ' 53' ' ' TYR . 21.5 ptmt -73.8 -26.86 60.83 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.265 -0.574 . . . . 2.2200000000000002 110.927 176.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 111' ' ' HIS . 3.4 t -62.76 -47.45 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.744 0.307 . . . . 0.48999999999999999 110.933 176.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 1.035 ' HE2' HD11 ' A' ' 81' ' ' LEU . 20.6 pttp -72.22 -22.47 61.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.09 0.471 . . . . 1.9099999999999999 110.112 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 23.0 tp -70.64 -22.36 62.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.953 -0.567 . . . . 1.28 109.782 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 45.6 mt-10 -68.34 -12.01 60.43 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 116.028 -0.533 . . . . 1.99 110.429 173.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.96 -13.76 58.89 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.307 -0.717 . . . . 1.01 111.307 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -94.49 125.45 39.14 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.473 -0.566 . . . . 0.87 109.473 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.71 141.13 35.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.424 -0.807 . . . . 2.75 112.252 -174.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.903 HD13 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -63.75 130.16 94.23 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.882 -1.053 . . . . 2.7000000000000002 110.941 176.276 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.759 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 13.5 Cg_endo -87.83 1.18 6.9 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.066 2.51 . . . . 1.1000000000000001 114.176 -170.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 65.94 18.73 11.15 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.722 0.773 . . . . 1.3400000000000001 109.777 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.759 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 37.0 t70 -105.31 140.68 38.08 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.731 -1.122 . . . . 2.3599999999999999 108.593 175.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.52 102.48 32.81 Favored Pre-proline 0 C--N 1.309 -1.155 0 CA-C-N 115.782 -0.645 . . . . 1.8300000000000001 110.085 -176.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.28 156.64 11.0 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.269 2.646 . . . . 1.0 112.415 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.456 ' O ' HG12 ' A' ' 131' ' ' VAL . 18.8 Cg_exo -64.0 -19.01 65.9 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.941 2.427 . . . . 1.3400000000000001 112.241 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -90.2 15.73 9.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.126 -0.488 . . . . 1.48 109.722 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.06 17.52 0.96 Allowed 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.225 -0.898 . . . . 1.29 109.483 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 128' ' ' PRO . 9.6 p -98.12 119.26 62.38 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 115.983 -0.553 . . . . 1.72 109.702 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.636 ' HG3' HD12 ' A' ' 108' ' ' LEU . 15.0 Cg_exo . . . . . 0 CA--C 1.538 0.693 0 C-N-CA 122.235 1.957 . . . . 1.04 111.427 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.0 t . . . . . 0 CA--C 1.543 0.695 0 N-CA-C 113.572 0.953 . . . . 1.21 113.572 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.94 -26.49 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.226 -0.922 . . . . 0.66000000000000003 112.022 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.96 -11.19 30.12 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.449 -0.881 . . . . 0.71999999999999997 112.398 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.411 ' NZ ' ' HB3' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -102.01 -27.63 12.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 112.154 0.427 . . . . 2.9700000000000002 112.154 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -114.67 6.67 15.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.187 0.517 . . . . 1.8300000000000001 110.572 -175.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.666 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 74.2 tttt -55.86 -43.47 99.22 Favored Pre-proline 0 C--O 1.22 -0.473 0 CA-C-O 118.774 -0.631 . . . . 1.1299999999999999 111.757 177.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -44.69 -30.46 4.18 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 122.734 2.289 . . . . 0.56000000000000005 113.304 178.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.694 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 28.6 m -73.43 -43.87 59.46 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.067 0.937 . . . . 0.59999999999999998 109.937 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.554 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 3.6 m-85 -82.05 -24.93 35.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.597 -0.729 . . . . 0.93999999999999995 110.117 -175.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 1.7 t70 -77.82 -35.81 50.9 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.949 -1.023 . . . . 1.1599999999999999 109.55 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.694 ' HG3' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -68.03 -36.73 80.42 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.054 -0.521 . . . . 1.6299999999999999 109.778 176.176 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.437 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 55.7 mt -70.42 -33.84 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.462 -0.57 . . . . 0.60999999999999999 109.462 173.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 90.3 t80 -56.1 -57.52 11.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.349 -0.842 . . . . 0.88 111.348 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.616 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 57.4 m-85 -68.77 -22.8 64.27 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.991 0.424 . . . . 1.03 111.045 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.9 m -70.06 -27.92 65.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.927 -0.579 . . . . 0.44 110.698 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 63.6 mt -87.24 -3.97 59.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.644 -0.253 . . . . 0.79000000000000004 111.063 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.2 t 69.05 86.9 0.12 Allowed Pre-proline 0 N--CA 1.468 0.443 0 O-C-N 123.847 0.717 . . . . 0.64000000000000001 111.533 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.616 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 59.6 Cg_endo -77.0 151.97 31.27 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.882 2.388 . . . . 0.46000000000000002 113.443 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.5 m -120.1 121.6 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.577 -0.738 . . . . 1.3300000000000001 110.756 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 63.26 24.25 14.2 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.915 -0.584 . . . . 1.6699999999999999 112.014 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.43 36.78 9.35 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.687 -0.768 . . . . 0.5 112.754 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.655 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -171.56 162.99 6.63 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.327 -0.62 . . . . 1.8200000000000001 109.327 169.419 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.48 HD13 ' CD2' ' A' ' 106' ' ' PHE . 2.0 pt -92.97 134.85 29.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 109.741 -0.466 . . . . 0.40999999999999998 109.741 170.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 p -59.33 134.32 56.89 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.652 -1.24 . . . . 0.69999999999999996 107.652 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.611 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -52.18 -28.26 25.87 Favored Glycine 0 C--O 1.22 -0.732 0 N-CA-C 115.422 0.929 . . . . 0.38 115.422 -167.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.91 -27.03 50.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.774 0.787 . . . . 0.44 112.047 175.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.414 ' ND2' ' N ' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -79.31 -36.5 39.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.785 0.802 . . . . 2.1099999999999999 109.472 -178.13 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.65 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -75.8 -31.34 59.39 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.235 -0.893 . . . . 0.41999999999999998 110.09 177.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 14.2 mmmm -65.18 -34.51 78.56 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.433 -0.951 . . . . 1.6899999999999999 108.433 173.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 74' ' ' LYS . 1.7 tppp? -58.96 -49.02 79.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.122 -0.944 . . . . 1.3500000000000001 109.719 174.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 57.4 mm-40 -56.69 -53.02 62.51 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.254 -0.884 . . . . 1.48 112.226 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.65 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 15.0 ptp -70.8 -24.7 62.62 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.698 -0.401 . . . . 0.65000000000000002 110.857 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.06 -46.02 82.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 122.109 -0.369 . . . . 0.58999999999999997 110.991 172.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 18.1 ptpt -73.79 -18.28 60.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.72 -0.218 . . . . 1.2 111.432 -175.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.2 p -67.33 3.22 1.32 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.546 0.573 . . . . 1.3700000000000001 112.546 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 74.44 29.34 1.21 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.987 0.515 . . . . 2.6499999999999999 111.003 172.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.543 HD13 ' HD3' ' A' ' 116' ' ' LYS . 61.6 mt -109.44 162.05 21.67 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.125 -0.488 . . . . 1.1599999999999999 111.33 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.567 ' O ' HD22 ' A' ' 86' ' ' LEU . 92.3 Cg_endo -81.96 150.43 16.06 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.745 2.297 . . . . 0.94999999999999996 111.464 174.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -51.29 -29.9 16.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.536 -0.756 . . . . 1.53 112.657 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -62.95 -49.64 73.95 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.429 0.633 . . . . 1.24 110.71 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 89' ' ' ILE . 67.6 t -63.52 -41.83 94.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-N 115.273 -0.876 . . . . 0.71999999999999997 110.315 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.567 HD22 ' O ' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -64.18 -39.05 93.17 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.721 0.296 . . . . 1.45 110.765 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -57.92 -45.96 93.04 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.913 -0.66 . . . . 0.39000000000000001 111.907 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.705 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 44.7 pttt -81.1 -27.76 35.47 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.739 -0.785 . . . . 1.6599999999999999 111.715 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 85' ' ' VAL . 60.0 mt -60.6 -46.3 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 109.662 -0.496 . . . . 1.1499999999999999 109.662 171.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.481 ' HZ3' ' HB3' ' A' ' 72' ' ' ALA . 67.6 t-105 -56.99 -56.92 15.5 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.702 -0.681 . . . . 0.29999999999999999 111.088 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.705 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 9.0 ptpp? -70.38 -9.51 56.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 2.54 111.665 -174.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 124' ' ' ALA . 14.0 tp -93.32 -33.05 14.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.85999999999999999 110.347 175.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.404 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -87.31 -42.84 12.6 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.121 0.415 . . . . 0.45000000000000001 112.121 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.523 ' HB2' HD21 ' A' ' 101' ' ' LEU . 53.8 t0 -84.98 98.65 10.5 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.628 -0.508 . . . . 0.62 109.628 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.02 -29.82 34.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.532 -0.758 . . . . 1.76 111.244 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -27.39 37.57 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.177 -0.675 . . . . 1.7 109.177 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 58.8 45.52 15.39 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 122.318 1.056 . . . . 1.74 108.439 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -105.0 6.7 33.65 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.649 -1.614 . . . . 1.51 111.801 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.51 18.62 70.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.467 -0.873 . . . . 0.28999999999999998 112.527 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.655 HD13 ' HG3' ' A' ' 66' ' ' LYS . 4.3 pp -153.3 175.21 13.35 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.693 -0.484 . . . . 0.54000000000000004 109.693 175.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.585 HD12 ' CB ' ' A' ' 72' ' ' ALA . 46.3 mt -149.79 113.45 5.03 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.931 -1.136 . . . . 0.68000000000000005 107.931 -173.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.1 p-10 -75.75 -172.54 1.93 Allowed 'General case' 0 C--N 1.313 -0.991 0 O-C-N 122.352 -0.217 . . . . 1.5 110.678 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.52 -36.42 66.69 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.852 0.358 . . . . 1.73 111.057 -175.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 0.2 OUTLIER -90.51 -26.81 19.58 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.013 0.375 . . . . 2.1400000000000001 112.013 -179.243 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.475 ' HB3' HD22 ' A' ' 101' ' ' LEU . 2.3 mt-10 -70.8 -34.55 71.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.026 0.441 . . . . 1.1100000000000001 109.91 175.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.666 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -66.7 -42.56 86.24 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 107.649 -1.241 . . . . 1.0700000000000001 107.649 170.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.554 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -53.0 -41.02 64.23 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.846 -0.616 . . . . 0.19 110.558 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.467 HD12 ' HD3' ' A' ' 132' ' ' PRO . 1.0 OUTLIER -73.74 -50.84 18.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.004 -0.544 . . . . 1.23 110.883 178.053 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.9 -52.07 45.61 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.26 0.552 . . . . 0.22 111.198 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.501 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 7.2 t-20 -71.18 -27.16 63.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.646 -0.706 . . . . 1.1799999999999999 109.515 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 60.8 t60 -68.69 -40.83 79.88 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 120.19 -0.604 . . . . 0.48999999999999999 109.59 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.525 ' HA ' ' HB ' ' A' ' 115' ' ' VAL . 42.8 mt -68.57 -35.37 77.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.307 -0.406 . . . . 0.55000000000000004 110.735 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 110' ' ' ASN . 97.4 mt -59.26 -52.43 60.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.334 -0.394 . . . . 0.81000000000000005 110.186 174.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 19.1 ptmt -72.28 -21.61 61.33 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.126 -0.63 . . . . 2.2200000000000002 110.858 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.525 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 2.5 t -59.15 -47.47 90.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.998 -0.371 . . . . 0.48999999999999999 109.998 171.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.794 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 4.8 ptmm? -85.44 2.63 43.71 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 120.182 -0.607 . . . . 1.9099999999999999 110.527 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 51.8 tp -88.4 -19.52 26.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.573 -0.74 . . . . 1.28 109.311 168.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 55.2 mt-10 -67.08 -17.18 64.77 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.889 -0.596 . . . . 1.99 110.234 176.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.39 -21.34 13.05 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.026 -0.607 . . . . 1.01 111.94 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.794 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -106.83 135.94 47.51 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.89 -1.152 . . . . 0.87 107.89 174.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.52 ' HA ' ' CB ' ' A' ' 116' ' ' LYS . 13.4 pt-20 -93.26 163.29 13.67 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.737 -0.785 . . . . 2.75 110.937 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.882 HD13 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -62.86 127.57 90.76 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-O 121.367 0.603 . . . . 2.7000000000000002 110.763 177.293 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.508 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 72.8 Cg_endo -95.86 13.8 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.478 2.786 . . . . 1.1000000000000001 113.014 -174.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.503 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . 65.87 36.31 6.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.311 -0.858 . . . . 1.3400000000000001 111.181 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.508 ' OD1' ' HG2' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -114.99 142.69 46.29 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.55 0.69 . . . . 2.3599999999999999 109.914 169.256 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.3 tp -126.25 96.54 36.39 Favored Pre-proline 0 C--N 1.306 -1.32 0 CA-C-N 114.964 -1.017 . . . . 1.8300000000000001 110.032 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -73.2 150.81 48.23 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.755 2.303 . . . . 1.0 111.833 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.22 -16.25 45.23 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.785 2.323 . . . . 1.3400000000000001 112.248 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.403 ' O ' HD12 ' A' ' 130' ' ' LEU . 21.6 p-80 -98.38 21.83 10.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.143 -0.481 . . . . 1.48 110.867 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 129' ' ' HIS . 1.0 OUTLIER -138.27 12.91 2.82 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.576 -0.284 . . . . 1.29 110.729 174.143 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 m -91.18 125.55 58.06 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 109.401 -0.592 . . . . 1.72 109.401 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.467 ' HD3' HD12 ' A' ' 108' ' ' LEU . 51.3 Cg_exo . . . . . 0 CA--C 1.535 0.538 0 C-N-CA 122.6 2.2 . . . . 1.04 111.829 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 121.126 0.488 . . . . 1.21 111.266 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 t -88.14 -17.69 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 O-C-N 121.667 -0.646 . . . . 0.66000000000000003 111.194 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.78 -16.37 59.09 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.441 -0.885 . . . . 0.71999999999999997 111.906 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -99.82 -28.21 13.24 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.991 0.367 . . . . 2.9700000000000002 111.991 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.4 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 60.2 m-20 -108.01 0.4 21.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.956 0.408 . . . . 1.8300000000000001 111.094 -173.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.544 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 54.2 tttp -51.37 -48.63 85.59 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.048 -0.523 . . . . 1.1299999999999999 112.063 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 26.2 Cg_endo -62.02 -28.99 81.04 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.762 1.641 . . . . 0.56000000000000005 111.902 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.602 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 92.4 m -74.72 -37.69 62.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.719 0.771 . . . . 0.59999999999999998 110.274 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.464 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 24.0 m-85 -74.51 -24.41 58.98 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.829 -0.623 . . . . 0.93999999999999995 110.269 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.59 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 13.1 t70 -81.36 -32.39 32.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.577 -0.738 . . . . 1.1599999999999999 110.887 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 52' ' ' THR . 17.2 pt-20 -70.0 -44.38 69.5 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.926 -0.484 . . . . 1.6299999999999999 110.022 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.52 -30.12 48.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.819 0.818 . . . . 0.60999999999999999 109.066 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.948 ' HE1' HG23 ' A' ' 67' ' ' ILE . 0.7 OUTLIER -64.88 -57.21 9.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.304 -1.316 . . . . 0.88 111.019 176.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.645 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 27.6 m-85 -62.88 -22.82 66.99 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.998 0.427 . . . . 1.03 110.965 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.7 m -69.09 -22.07 64.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.647 -0.706 . . . . 0.44 110.834 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.9 mt -97.47 -7.24 32.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.53 -0.305 . . . . 0.79000000000000004 110.649 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.43 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 10.3 t 70.12 95.11 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.694 0.798 . . . . 0.64000000000000001 111.797 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.645 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 11.0 Cg_endo -62.09 160.87 28.39 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.422 2.748 . . . . 0.46000000000000002 113.855 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.2 t -129.12 102.99 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.315 -0.857 . . . . 1.3300000000000001 110.006 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.1 m120 66.17 28.19 10.18 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.008 0.523 . . . . 1.6699999999999999 111.859 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.89 21.89 27.09 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.895 -0.669 . . . . 0.5 113.301 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.642 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -169.98 152.0 4.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.147 -1.057 . . . . 1.8200000000000001 108.147 174.156 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.948 HG23 ' HE1' ' A' ' 57' ' ' PHE . 1.1 pt -90.8 139.28 17.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 119.531 -0.868 . . . . 0.40999999999999998 110.183 174.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.6 p -60.37 139.58 57.59 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.338 -0.986 . . . . 0.69999999999999996 108.338 169.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.561 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -53.5 -35.72 52.03 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 115.098 0.799 . . . . 0.38 115.098 -164.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.01 -22.44 15.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.54 0.67 . . . . 0.44 112.794 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -80.25 -40.68 26.51 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.675 0.75 . . . . 2.1099999999999999 109.689 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.634 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -73.79 -31.25 63.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.436 -0.802 . . . . 0.41999999999999998 109.663 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.2 mmmm -64.29 -35.03 79.5 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.643 -0.873 . . . . 1.6899999999999999 108.643 173.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 1.1 tppp? -59.16 -44.66 92.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.337 -0.847 . . . . 1.3500000000000001 110.006 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 60.2 mm-40 -60.16 -53.17 60.85 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.275 -0.875 . . . . 1.48 111.823 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.634 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 12.5 ptp -71.13 -18.23 62.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.432 -0.349 . . . . 0.65000000000000002 110.858 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.48 HG23 HD11 ' A' ' 86' ' ' LEU . 2.4 t -74.23 -47.91 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.309 -0.405 . . . . 0.58999999999999997 110.795 171.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 18.1 ptpt -70.39 -13.33 62.1 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.976 0.417 . . . . 1.2 110.354 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.5 t -65.86 -7.34 15.79 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.896 -0.593 . . . . 1.3700000000000001 110.517 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 68.04 67.56 0.34 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.927 0.891 . . . . 2.6499999999999999 110.889 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.023 HD21 ' HE3' ' A' ' 116' ' ' LYS . 22.6 mt -132.65 159.73 71.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.897 -0.592 . . . . 1.1599999999999999 111.029 -175.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.53 ' HG2' HG23 ' A' ' 85' ' ' VAL . 62.9 Cg_endo -76.96 163.62 30.78 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.536 2.157 . . . . 0.94999999999999996 110.922 169.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 7.3 m-20 -61.57 -24.09 66.42 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.248 0.462 . . . . 1.53 112.248 -174.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.8 m -62.78 -48.94 76.97 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 120.998 0.428 . . . . 1.24 110.74 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.53 HG23 ' HG2' ' A' ' 82' ' ' PRO . 21.8 t -67.23 -43.53 88.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.328 -0.619 . . . . 0.71999999999999997 109.328 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 82' ' ' PRO . 3.3 mm? -46.55 -57.49 4.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.531 -0.759 . . . . 1.45 111.009 172.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.4 -40.74 99.07 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.031 -0.986 . . . . 0.39000000000000001 113.702 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.848 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 55.7 pttt -85.28 -25.09 27.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.618 -0.833 . . . . 1.6599999999999999 112.209 -175.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.618 HG12 ' CD1' ' A' ' 122' ' ' LEU . 18.6 mt -65.2 -43.05 95.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.424 -0.954 . . . . 1.1499999999999999 108.424 170.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.417 ' CH2' ' HG ' ' A' ' 101' ' ' LEU . 73.9 t-105 -60.57 -53.29 59.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.943 -1.026 . . . . 0.29999999999999999 111.301 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.848 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -72.82 -12.34 60.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.579 -0.282 . . . . 2.54 111.616 -174.383 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.2 tp -91.25 -25.12 19.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.689 -0.486 . . . . 0.85999999999999999 109.689 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.634 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -93.1 -43.08 9.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.031 0.443 . . . . 0.45000000000000001 112.0 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.504 ' HB2' HD21 ' A' ' 101' ' ' LEU . 46.9 t0 -88.46 94.29 9.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.193 0.52 . . . . 0.62 110.171 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.5 t -64.35 -23.27 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.289 -0.869 . . . . 1.76 111.18 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.0 -26.77 15.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.57 -0.741 . . . . 1.7 110.726 -174.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt 60.23 58.71 2.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.348 1.071 . . . . 1.74 109.096 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -106.11 -18.81 13.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.454 -1.703 . . . . 1.51 111.278 -170.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.64 13.89 49.08 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.479 -0.867 . . . . 0.28999999999999998 112.553 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.6 pp -148.05 179.0 8.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.767 -0.457 . . . . 0.54000000000000004 109.767 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.609 HD12 ' CB ' ' A' ' 72' ' ' ALA . 25.2 mt -151.27 114.64 4.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.83 -1.174 . . . . 0.68000000000000005 107.83 -175.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.585 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.5 p30 -78.98 -174.36 4.0 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.49 -0.484 . . . . 1.5 109.996 178.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.625 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 3.9 p30 -57.84 -33.73 68.96 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.16 0.429 . . . . 1.73 112.16 -174.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.942 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 16.5 tt0 -85.74 -27.0 25.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.53 0.681 . . . . 2.1400000000000001 110.391 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.562 ' HB3' HD22 ' A' ' 101' ' ' LEU . 3.0 mt-10 -75.25 -33.69 61.33 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.603 -0.726 . . . . 1.1100000000000001 110.499 176.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.551 ' CE2' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -66.89 -40.87 87.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.753 -1.203 . . . . 1.0700000000000001 107.753 172.098 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.464 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -52.61 -48.94 65.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.289 -0.868 . . . . 0.19 110.799 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.634 HD13 ' HA ' ' A' ' 93' ' ' ALA . 1.3 tt -65.55 -53.27 44.45 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.352 -0.385 . . . . 1.23 110.121 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.6 -53.36 24.41 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.619 0.6 . . . . 0.22 112.619 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 10.2 t-20 -70.57 -32.1 69.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.169 0.509 . . . . 1.1799999999999999 110.167 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.541 ' O ' HG23 ' A' ' 115' ' ' VAL . 78.0 t60 -66.4 -35.26 79.86 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.975 -0.557 . . . . 0.48999999999999999 109.706 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 112' ' ' LEU . 25.2 mt -69.12 -36.6 77.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.843 -0.617 . . . . 0.55000000000000004 110.463 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.602 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 47.5 mm -59.49 -41.66 85.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.884 0.373 . . . . 0.81000000000000005 110.195 172.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.687 ' HE2' ' O ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -57.11 -49.39 76.06 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.72 -0.673 . . . . 2.2200000000000002 109.624 173.07 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 111' ' ' HIS . 78.6 t -60.32 -42.07 89.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.766 -0.652 . . . . 0.48999999999999999 111.577 -176.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 1.023 ' HE3' HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -75.27 -21.56 58.43 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.863 -0.335 . . . . 1.9099999999999999 111.278 178.511 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.1 tp -79.75 -19.4 48.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.746 0.307 . . . . 1.28 110.535 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.606 ' HG2' ' NZ ' ' A' ' 114' ' ' LYS . 37.2 mt-10 -62.92 -16.73 60.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.148 0.499 . . . . 1.99 110.427 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 112.07 4.91 25.57 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.667 -0.777 . . . . 1.01 111.627 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.495 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 2.7 p80 -126.85 140.41 52.37 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.305 0.574 . . . . 0.87 110.36 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -71.77 152.16 42.94 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.123 -0.944 . . . . 2.75 111.363 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.618 ' CD1' HG12 ' A' ' 89' ' ' ILE . 39.9 mt -67.12 141.15 96.17 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 115.839 -0.619 . . . . 2.7000000000000002 110.398 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -87.64 4.04 6.08 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.055 2.503 . . . . 1.1000000000000001 113.515 -173.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 58.81 19.95 7.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.37 0.605 . . . . 1.3400000000000001 111.1 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -112.91 136.2 52.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.741 -0.837 . . . . 2.3599999999999999 108.741 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.554 HD22 HG23 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -116.16 102.62 53.69 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 109.303 -0.629 . . . . 1.8300000000000001 109.303 -177.127 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 2.0 Cg_endo -79.96 157.27 23.83 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.061 2.507 . . . . 1.0 112.155 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -55.0 -40.33 86.47 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.397 2.065 . . . . 1.3400000000000001 111.843 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.662 ' O ' HD12 ' A' ' 130' ' ' LEU . 50.1 p-80 -81.89 30.88 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.658 -0.701 . . . . 1.48 111.709 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.662 HD12 ' O ' ' A' ' 129' ' ' HIS . 0.7 OUTLIER -146.86 9.89 1.02 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.063 0.394 . . . . 1.29 112.063 171.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.554 HG23 HD22 ' A' ' 126' ' ' LEU . 7.3 t -97.33 115.16 65.68 Favored Pre-proline 0 C--N 1.322 -0.598 0 C-N-CA 120.177 -0.609 . . . . 1.72 110.806 176.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.942 ' HB3' ' HG2' ' A' ' 104' ' ' GLU . 84.0 Cg_exo . . . . . 0 N--CA 1.46 -0.474 0 C-N-CA 123.751 2.967 . . . . 1.04 111.49 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 t . . . . . 0 CA--C 1.546 0.81 0 CA-C-O 121.043 0.449 . . . . 1.21 111.823 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.485 HG22 ' HE2' ' A' ' 53' ' ' TYR . 1.2 t -94.76 -21.99 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 121.46 -0.775 . . . . 0.66000000000000003 111.672 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.78 -14.25 57.91 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.074 -1.06 . . . . 0.71999999999999997 111.842 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -104.53 -28.35 11.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 111.923 0.342 . . . . 2.9700000000000002 111.923 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -107.36 1.94 24.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.515 0.674 . . . . 1.8300000000000001 110.154 -171.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 55.7 tttm -55.69 -46.99 99.65 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.05 -0.977 . . . . 1.1299999999999999 112.086 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 11.1 Cg_endo -55.84 -26.87 59.68 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.23 1.953 . . . . 0.56000000000000005 112.636 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.555 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . 9.5 m -70.35 -45.16 66.68 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.852 0.834 . . . . 0.59999999999999998 108.99 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.569 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 16.7 m-85 -75.74 -24.21 56.1 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.116 -0.947 . . . . 0.93999999999999995 109.581 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.602 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 15.1 t70 -78.09 -37.98 45.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.534 -0.757 . . . . 1.1599999999999999 111.145 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.555 ' OE2' ' HA ' ' A' ' 52' ' ' THR . 15.5 pt-20 -68.06 -37.1 80.92 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.515 -0.474 . . . . 1.6299999999999999 110.559 176.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.7 mt -70.14 -28.24 35.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.251 0.548 . . . . 0.60999999999999999 109.612 173.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.602 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 66.4 t80 -61.51 -54.17 46.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.347 -0.842 . . . . 0.88 111.194 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.593 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 42.0 m-85 -68.75 -22.5 64.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.132 0.492 . . . . 1.03 110.786 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.9 m -72.77 -25.69 61.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.696 -0.683 . . . . 0.44 110.863 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.422 HD11 ' HG2' ' A' ' 75' ' ' GLU . 25.9 mt -87.6 -0.01 56.26 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.638 -0.256 . . . . 0.79000000000000004 111.439 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 t 67.55 87.51 0.12 Allowed Pre-proline 0 N--CA 1.467 0.377 0 CA-C-O 121.297 0.57 . . . . 0.64000000000000001 110.916 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.593 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 71.6 Cg_endo -81.03 159.28 20.75 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.634 2.222 . . . . 0.46000000000000002 112.65 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 97.4 t -128.92 121.21 53.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.081 -0.509 . . . . 1.3300000000000001 109.794 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 66.38 23.04 10.69 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.117 -0.492 . . . . 1.6699999999999999 112.168 174.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.21 23.02 23.4 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.871 -0.68 . . . . 0.5 112.114 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.897 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -167.48 159.77 12.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.588 -0.523 . . . . 1.8200000000000001 109.588 175.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.438 ' H ' HG12 ' A' ' 67' ' ' ILE . 1.5 pt -89.76 132.43 34.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 120.129 -0.628 . . . . 0.40999999999999998 110.345 173.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -59.2 130.55 47.5 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.693 -1.225 . . . . 0.69999999999999996 107.693 170.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.586 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -53.71 -26.26 31.75 Favored Glycine 0 C--O 1.219 -0.819 0 N-CA-C 114.69 0.636 . . . . 0.38 114.69 -166.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.15 -39.53 43.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 117.475 0.637 . . . . 0.44 111.437 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.44 -31.83 48.27 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.16 -0.473 . . . . 2.1099999999999999 110.087 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.685 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -74.05 -36.19 64.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.678 -0.692 . . . . 0.41999999999999998 109.718 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 14.7 mmmm -66.28 -37.97 86.7 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.707 -0.849 . . . . 1.6899999999999999 108.707 173.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -56.59 -44.89 81.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.526 -0.761 . . . . 1.3500000000000001 110.255 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.8 tp10 -61.81 -53.07 60.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.544 -1.207 . . . . 1.48 111.162 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.685 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 12.5 ptp -73.05 -16.69 61.48 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 122.068 -0.395 . . . . 0.65000000000000002 111.353 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.478 HG23 HD11 ' A' ' 86' ' ' LEU . 2.3 t -74.17 -49.64 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.577 0.227 . . . . 0.58999999999999997 110.832 173.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 14.6 ptpt -68.28 -12.18 60.62 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.085 0.469 . . . . 1.2 109.851 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 76' ' ' MET . 62.4 m -67.69 3.93 1.26 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.29 -0.868 . . . . 1.3700000000000001 111.835 170.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 74.36 37.95 0.55 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.26 0.624 . . . . 2.6499999999999999 111.686 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.585 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . 22.8 mt -113.49 157.47 41.26 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 120.809 -0.357 . . . . 1.1599999999999999 111.539 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.447 ' O ' HD23 ' A' ' 86' ' ' LEU . 84.3 Cg_endo -83.91 164.26 13.69 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.898 2.399 . . . . 0.94999999999999996 111.307 169.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.549 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 84.6 m-20 -54.75 -29.34 53.62 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.282 0.475 . . . . 1.53 112.282 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -59.94 -54.02 50.96 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.302 0.572 . . . . 1.24 110.776 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 24.0 t -66.31 -41.68 89.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.641 -0.708 . . . . 0.71999999999999997 109.927 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.585 ' CD2' ' HB2' ' A' ' 81' ' ' LEU . 3.9 mm? -49.52 -55.13 14.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.9 -0.591 . . . . 1.45 110.856 173.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.91 -44.5 97.33 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.392 -0.822 . . . . 0.39000000000000001 113.324 -175.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.618 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 55.5 pttt -80.19 -27.45 38.87 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.654 -0.818 . . . . 1.6599999999999999 111.676 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.404 HD13 HD13 ' A' ' 113' ' ' ILE . 17.4 mt -69.63 -41.55 80.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 120.536 -0.465 . . . . 1.1499999999999999 109.841 173.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.433 ' CH2' ' HG ' ' A' ' 101' ' ' LEU . 75.9 t-105 -55.87 -58.85 6.13 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.754 -0.657 . . . . 0.29999999999999999 110.346 175.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.618 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -69.44 -17.26 63.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.812 -0.631 . . . . 2.54 111.765 -172.82 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 14.3 tp -82.35 -37.4 25.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.129 -0.323 . . . . 0.85999999999999999 110.129 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.755 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -91.08 -33.75 15.36 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 120.556 -0.458 . . . . 0.45000000000000001 111.528 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 27.6 t0 -83.84 80.97 8.97 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.615 0.721 . . . . 0.62 109.922 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.448 HG22 HD11 ' A' ' 126' ' ' LEU . 16.0 t -67.34 -25.44 33.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 114.917 -1.038 . . . . 1.76 110.817 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.412 ' C ' ' HG3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -90.43 -23.84 20.91 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.619 -0.718 . . . . 1.7 112.234 -178.214 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.549 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 21.8 mtpt 67.02 45.22 1.8 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.769 0.795 . . . . 1.74 110.364 167.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 p30 -105.31 -1.06 25.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.759 -1.11 . . . . 1.51 112.371 -171.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.87 19.38 77.71 Favored Glycine 0 C--N 1.322 -0.224 0 C-N-CA 119.506 -1.33 . . . . 0.28999999999999998 112.326 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.897 HD13 ' HG3' ' A' ' 66' ' ' LYS . 4.4 pp -151.33 171.41 17.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.796 -0.816 . . . . 0.54000000000000004 108.796 174.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.581 HD12 ' HB1' ' A' ' 72' ' ' ALA . 44.2 mt -148.59 116.17 6.26 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.82 -1.178 . . . . 0.68000000000000005 107.82 -172.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -77.13 -175.94 3.83 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.086 -0.646 . . . . 1.5 109.366 178.791 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -60.26 -31.18 69.97 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.358 0.526 . . . . 1.73 111.164 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.644 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 34.0 tt0 -73.91 -39.94 63.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.426 0.631 . . . . 2.1400000000000001 110.107 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . 3.8 mt-10 -66.99 -39.16 87.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.672 -0.695 . . . . 1.1100000000000001 111.919 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.626 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -64.63 -39.2 93.28 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.158 -1.052 . . . . 1.0700000000000001 108.158 175.32 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.569 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -50.95 -49.14 60.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.19 110.581 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.755 HD13 ' HA ' ' A' ' 93' ' ' ALA . 1.1 tt -70.56 -50.42 37.65 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.443 -0.503 . . . . 1.23 110.509 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.47 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -45.73 -55.63 6.25 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.33 0.492 . . . . 0.22 112.33 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.553 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 2.6 t-20 -72.84 -23.31 60.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.677 -0.49 . . . . 1.1799999999999999 109.677 -177.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.496 ' CD2' HD11 ' A' ' 130' ' ' LEU . 70.8 t60 -68.01 -43.93 77.71 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.236 -0.653 . . . . 0.48999999999999999 109.236 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.639 HD22 ' CD1' ' A' ' 122' ' ' LEU . 46.7 mt -64.64 -32.81 74.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.107 -0.497 . . . . 0.55000000000000004 110.191 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 109' ' ' ALA . 41.4 mm -61.11 -50.92 78.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.886 -0.597 . . . . 0.81000000000000005 111.001 176.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.485 ' HD3' ' OH ' ' A' ' 53' ' ' TYR . 18.7 ptmt -72.33 -24.47 61.31 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.086 -0.646 . . . . 2.2200000000000002 110.823 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 111' ' ' HIS . 11.5 t -60.46 -47.22 93.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.318 -0.401 . . . . 0.48999999999999999 110.39 172.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 0.9 OUTLIER -85.38 0.5 51.97 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 120.36 -0.536 . . . . 1.9099999999999999 110.635 178.548 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.1 tp -81.83 -26.6 34.15 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.604 -0.517 . . . . 1.28 109.604 171.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.33 -22.17 65.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.801 -0.636 . . . . 1.99 111.169 177.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.09 10.79 13.24 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.351 -0.928 . . . . 1.01 112.698 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.61 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -127.21 133.49 50.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.553 -0.536 . . . . 0.87 109.553 174.402 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -78.34 163.36 25.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.783 0.325 . . . . 2.75 110.935 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.639 ' CD1' HD22 ' A' ' 112' ' ' LEU . 3.5 mm? -70.44 144.86 92.27 Favored Pre-proline 0 CA--C 1.513 -0.474 0 CA-C-N 116.077 -0.51 . . . . 2.7000000000000002 111.818 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.616 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 68.9 Cg_endo -77.62 -6.37 16.12 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 124.453 3.435 . . . . 1.1000000000000001 113.404 -173.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.22 19.53 11.72 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.632 0.73 . . . . 1.3400000000000001 109.655 -170.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.616 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 38.8 t70 -120.45 145.82 46.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.943 -1.026 . . . . 2.3599999999999999 108.985 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.448 HD11 HG22 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -115.15 104.41 53.79 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 116.353 -0.385 . . . . 1.8300000000000001 110.018 -176.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 5.7 Cg_endo -87.9 147.01 6.85 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.334 2.689 . . . . 1.0 111.982 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -55.08 -30.35 69.95 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.762 2.308 . . . . 1.3400000000000001 113.321 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -80.94 22.72 0.6 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.995 -0.282 . . . . 1.48 111.109 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.496 HD11 ' CD2' ' A' ' 111' ' ' HIS . 0.6 OUTLIER -150.29 8.52 0.62 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.619 -0.433 . . . . 1.29 111.477 177.599 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.1 132.09 31.57 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.942 -0.762 . . . . 1.72 108.942 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.704 ' HD3' HD12 ' A' ' 108' ' ' LEU . 37.4 Cg_exo . . . . . 0 C--O 1.237 0.448 0 C-N-CA 122.29 1.994 . . . . 1.04 112.539 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 t . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 112.153 0.427 . . . . 1.21 112.153 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 2.2 t -80.54 -17.74 12.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 120.951 -1.093 . . . . 0.66000000000000003 111.321 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.71 -17.15 62.27 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.694 -1.241 . . . . 0.71999999999999997 111.741 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 17.8 ptmt -106.97 -29.4 9.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.002 0.371 . . . . 2.9700000000000002 112.002 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 84.5 m-20 -89.33 -11.55 43.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 1.8300000000000001 110.676 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 49.9 tttm -49.87 -51.48 60.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.209 -0.905 . . . . 1.1299999999999999 112.409 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 8.0 Cg_endo -50.6 -35.64 47.39 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 122.726 2.284 . . . . 0.56000000000000005 113.837 -178.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.672 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 87.5 m -72.5 -40.64 66.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.999 0.904 . . . . 0.59999999999999998 110.328 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.65 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 10.3 m-85 -76.86 -23.85 52.63 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.766 0.793 . . . . 0.93999999999999995 109.279 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 7.2 t70 -80.66 -33.32 35.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.635 -1.166 . . . . 1.1599999999999999 110.776 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.672 ' HG2' ' O ' ' A' ' 52' ' ' THR . 14.0 pt-20 -69.47 -35.9 76.04 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.606 -0.516 . . . . 1.6299999999999999 109.606 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 52' ' ' THR . 46.5 mt -71.84 -29.8 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.224 -0.658 . . . . 0.60999999999999999 109.224 174.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 72.7 t80 -61.81 -57.42 11.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.146 -0.933 . . . . 0.88 111.534 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 42.8 m-85 -64.1 -22.32 66.89 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.037 0.446 . . . . 1.03 110.908 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.5 m -73.07 -32.05 64.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.923 -0.58 . . . . 0.44 111.516 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.1 mt -84.89 1.3 47.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.624 0.25 . . . . 0.79000000000000004 111.261 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t 70.9 85.76 0.12 Allowed Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.604 -0.726 . . . . 0.64000000000000001 111.125 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 74.3 Cg_endo -81.63 123.86 4.42 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.702 2.268 . . . . 0.46000000000000002 112.647 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.5 t -87.33 109.72 19.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.245 -0.434 . . . . 1.3300000000000001 110.027 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 66.06 23.75 11.05 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.322 0.389 . . . . 1.6699999999999999 111.378 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.67 27.79 12.29 Favored Glycine 0 C--O 1.228 -0.254 0 C-N-CA 121.054 -0.593 . . . . 0.5 113.565 170.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -164.39 147.39 9.09 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.306 -0.627 . . . . 1.8200000000000001 109.306 172.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.939 ' HB ' HD21 ' A' ' 71' ' ' ASN . 3.0 pt -86.89 137.11 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 120.695 -0.402 . . . . 0.40999999999999998 110.437 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.5 p -60.32 124.3 19.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.755 -1.202 . . . . 0.69999999999999996 107.755 170.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.586 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -46.94 -31.76 5.77 Favored Glycine 0 C--O 1.222 -0.608 0 C-N-CA 121.302 -0.475 . . . . 0.38 114.26 -168.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -43.73 -52.0 6.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.31 0.485 . . . . 0.44 112.31 173.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.939 HD21 ' HB ' ' A' ' 67' ' ' ILE . 11.7 p30 -71.03 -30.85 67.17 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.056 0.389 . . . . 2.1099999999999999 110.586 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.582 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -72.12 -31.76 66.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.585 0.707 . . . . 0.41999999999999998 109.612 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 31.6 mmmt -68.32 -35.85 78.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.072 -0.967 . . . . 1.6899999999999999 109.474 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.805 ' HG2' ' HA ' ' A' ' 71' ' ' ASN . 9.0 mmmm -59.45 -48.58 81.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 1.3500000000000001 109.503 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 23.6 mm-40 -54.73 -52.49 62.33 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.793 -1.094 . . . . 1.48 112.182 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.582 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 14.7 ptp -69.54 -29.38 66.95 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.126 -0.63 . . . . 0.65000000000000002 110.916 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.42 -45.83 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.489 0.185 . . . . 0.58999999999999997 110.854 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 17.4 ptpt -72.78 -14.32 61.5 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.038 0.446 . . . . 1.2 110.458 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 50.1 m -66.15 -13.03 59.51 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.454 -0.794 . . . . 1.3700000000000001 110.186 168.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 97.3 mttt 71.91 39.63 0.81 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.599 0.76 . . . . 2.6499999999999999 112.014 165.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.87 HD11 ' HE2' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -102.18 159.45 29.34 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.841 -0.618 . . . . 1.1599999999999999 110.115 -179.142 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.537 ' HG2' HG23 ' A' ' 85' ' ' VAL . 31.6 Cg_endo -66.88 153.3 78.39 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.893 1.729 . . . . 0.94999999999999996 110.742 172.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.782 ' HA ' HD12 ' A' ' 86' ' ' LEU . 6.4 m-20 -49.86 -31.74 12.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.005 -0.543 . . . . 1.53 112.042 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.5 m -60.33 -55.59 31.84 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.209 0.528 . . . . 1.24 110.628 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.588 ' O ' HG13 ' A' ' 89' ' ' ILE . 91.1 t -60.63 -44.46 96.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 CA-C-N 115.745 -0.661 . . . . 0.71999999999999997 110.071 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.782 HD12 ' HA ' ' A' ' 83' ' ' ASN . 24.9 mt -60.08 -49.96 75.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.383 -0.372 . . . . 1.45 111.984 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -55.77 -42.41 85.43 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.146 -0.782 . . . . 0.39000000000000001 111.146 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 61.6 pttt -86.51 -13.49 45.83 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.491 -0.883 . . . . 1.6599999999999999 111.778 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 85' ' ' VAL . 23.0 mt -71.59 -43.51 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 N-CA-C 108.511 -0.922 . . . . 1.1499999999999999 108.511 170.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.451 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 71.4 t-105 -60.36 -56.77 17.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.82 -0.627 . . . . 0.29999999999999999 111.021 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 62.7 mttm -72.22 -21.45 61.4 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.65 -0.705 . . . . 2.54 111.965 -169.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 5.5 tp -86.32 -19.65 29.51 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.801 -0.444 . . . . 0.85999999999999999 109.801 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.892 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -93.05 -44.29 8.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.126 0.488 . . . . 0.45000000000000001 110.921 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.521 ' HB2' HD21 ' A' ' 101' ' ' LEU . 46.9 t0 -87.99 74.46 8.93 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.031 -1.1 . . . . 0.62 108.031 173.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.1 t -69.87 -6.96 7.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.19 -0.914 . . . . 1.76 109.81 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -94.18 -26.33 16.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.967 -1.015 . . . . 1.7 109.725 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 59.66 73.34 0.49 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.329 -0.85 . . . . 1.74 111.833 169.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.504 ' OD1' ' HG ' ' A' ' 100' ' ' LEU . 1.4 p30 -128.28 -23.47 3.25 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.913 -1.039 . . . . 1.51 112.078 -171.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.78 7.47 38.88 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.165 -1.016 . . . . 0.28999999999999998 112.529 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.504 ' HG ' ' OD1' ' A' ' 98' ' ' ASP . 3.6 pp -142.21 -175.21 4.35 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.805 -0.813 . . . . 0.54000000000000004 108.805 174.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.642 ' O ' HG12 ' A' ' 67' ' ' ILE . 50.8 mt -151.45 112.6 4.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.367 -1.345 . . . . 0.68000000000000005 107.367 -177.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.7 p30 -76.73 -175.75 3.55 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.674 -0.81 . . . . 1.5 109.809 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.08 -32.96 66.8 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.105 0.478 . . . . 1.73 111.879 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 35.5 tt0 -85.81 -29.01 24.12 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.314 0.578 . . . . 2.1400000000000001 110.246 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.49 ' HB3' HD22 ' A' ' 101' ' ' LEU . 4.0 mt-10 -75.15 -33.39 61.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.764 -0.653 . . . . 1.1100000000000001 110.977 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.672 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.6 OUTLIER -66.99 -40.23 87.32 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.638 -1.245 . . . . 1.0700000000000001 107.638 171.107 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.65 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -51.15 -46.19 61.94 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.078 -0.51 . . . . 0.19 110.607 175.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.892 HD22 ' HA ' ' A' ' 93' ' ' ALA . 1.4 tt -67.6 -48.89 65.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.309 -0.405 . . . . 1.23 110.353 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.403 ' HB2' HD13 ' A' ' 101' ' ' LEU . . . -49.88 -57.29 7.75 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.921 -0.582 . . . . 0.22 112.296 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.451 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 3.3 t30 -70.61 -28.64 65.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.02 0.438 . . . . 1.1799999999999999 110.066 -174.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.553 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 66.7 t60 -69.88 -36.37 75.4 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.48999999999999999 110.032 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.536 HD22 HD22 ' A' ' 122' ' ' LEU . 41.8 mt -69.2 -35.97 76.8 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.949 -0.389 . . . . 0.55000000000000004 109.949 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.687 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 76.3 mt -58.37 -45.21 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.414 -0.357 . . . . 0.81000000000000005 111.379 172.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 111' ' ' HIS . 5.5 ptmm? -67.7 -33.05 74.13 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 119.658 -0.817 . . . . 2.2200000000000002 110.605 177.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 111' ' ' HIS . 37.4 t -62.75 -44.25 99.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.899 0.38 . . . . 0.48999999999999999 110.719 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.87 ' HE2' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -76.6 -6.88 53.85 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.099 0.476 . . . . 1.9099999999999999 110.391 176.173 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.1 tp -91.09 -15.89 28.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.339 0.59 . . . . 1.28 109.831 172.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 50.0 mt-10 -81.42 2.07 30.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.635 -0.711 . . . . 1.99 110.761 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.79 5.75 33.25 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.281 -0.962 . . . . 1.01 113.076 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.627 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -141.13 137.29 32.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.304 0.573 . . . . 0.87 111.161 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.54 163.93 25.88 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.216 -0.902 . . . . 2.75 111.421 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.536 HD22 HD22 ' A' ' 112' ' ' LEU . 39.4 mt -73.36 144.9 84.71 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.908 -0.587 . . . . 2.7000000000000002 110.823 -178.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.587 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 46.9 Cg_endo -82.56 -1.07 10.45 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.216 2.611 . . . . 1.1000000000000001 113.497 -172.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.54 19.4 11.21 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.744 0.783 . . . . 1.3400000000000001 109.954 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.587 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 32.2 t70 -117.31 150.53 38.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.687 -1.142 . . . . 2.3599999999999999 109.207 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 2.3 tm? -124.37 103.14 32.61 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 109.216 -0.661 . . . . 1.8300000000000001 109.216 -177.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 4.8 Cg_exo -77.55 147.92 25.65 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.97 2.447 . . . . 1.0 112.66 -176.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.483 ' HA ' HG13 ' A' ' 131' ' ' VAL . 50.9 Cg_exo -53.45 -35.52 76.2 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.258 2.639 . . . . 1.3400000000000001 112.848 177.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.535 ' O ' HD12 ' A' ' 130' ' ' LEU . 49.9 p-80 -82.27 18.48 1.41 Allowed 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 120.62 -0.432 . . . . 1.48 110.996 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.535 HD12 ' O ' ' A' ' 129' ' ' HIS . 2.9 mp -138.7 16.41 2.7 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.475 0.485 . . . . 1.29 110.888 172.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.483 HG13 ' HA ' ' A' ' 128' ' ' PRO . 32.4 m -77.66 116.52 58.87 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 120.133 -0.627 . . . . 1.72 110.211 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 C--O 1.239 0.557 0 C-N-CA 122.099 1.866 . . . . 1.04 111.611 178.466 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.453 ' HB ' ' CE1' ' A' ' 111' ' ' HIS . 12.4 t . . . . . 0 N--CA 1.448 -0.527 0 CA-C-O 121.011 0.434 . . . . 1.21 111.408 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 4.1 t -83.6 -27.66 7.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 121.771 -0.581 . . . . 0.66000000000000003 111.717 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.43 -19.47 53.39 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 119.564 -1.303 . . . . 0.71999999999999997 112.053 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 3.7 ptpp? -101.63 -28.6 12.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.336 0.495 . . . . 2.9700000000000002 112.336 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -106.55 5.81 29.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.716 0.77 . . . . 1.8300000000000001 110.36 -172.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.575 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 62.0 tttm -59.34 -46.69 99.02 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.17 -0.923 . . . . 1.1299999999999999 112.222 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 18.2 Cg_endo -60.02 -23.48 73.23 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.905 1.737 . . . . 0.56000000000000005 112.397 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.758 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 81.8 m -78.23 -36.48 47.02 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.433 0.635 . . . . 0.59999999999999998 110.023 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.46 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 16.1 m-85 -80.55 -25.34 38.67 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.344 -0.942 . . . . 0.93999999999999995 109.917 177.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 4.4 t70 -76.45 -34.94 58.71 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.096 -0.956 . . . . 1.1599999999999999 110.154 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.758 ' HG2' ' O ' ' A' ' 52' ' ' THR . 12.7 pt-20 -65.3 -42.28 93.21 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.53 -0.544 . . . . 1.6299999999999999 109.53 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 52' ' ' THR . 60.0 mt -67.38 -32.72 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 109.621 -0.511 . . . . 0.60999999999999999 109.621 175.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.55 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 66.8 t80 -57.06 -55.27 36.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.192 -0.913 . . . . 0.88 111.755 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.482 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 67.7 m-85 -69.23 -23.1 63.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.989 0.423 . . . . 1.03 110.61 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.0 m -70.41 -21.69 62.81 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.614 -0.721 . . . . 0.44 110.771 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.416 HD11 ' CG ' ' A' ' 75' ' ' GLU . 35.0 mt -88.7 -1.05 57.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.664 -0.244 . . . . 0.79000000000000004 111.301 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.2 t 65.55 81.12 0.22 Allowed Pre-proline 0 N--CA 1.465 0.315 0 O-C-N 123.594 0.559 . . . . 0.64000000000000001 111.218 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 62.9 Cg_endo -80.22 166.56 20.43 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.346 2.031 . . . . 0.46000000000000002 111.517 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' A' ' 64' ' ' ASN . 2.2 m -135.57 118.66 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 121.211 -0.196 . . . . 1.3300000000000001 110.62 -177.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.458 ' HB3' ' NZ ' ' A' ' 66' ' ' LYS . 28.7 t-20 67.95 21.66 8.84 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 122.242 1.02 . . . . 1.6699999999999999 109.901 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.34 26.19 16.57 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.592 -0.813 . . . . 0.5 114.418 172.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -166.21 157.28 13.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.488 0.644 . . . . 1.8200000000000001 110.075 174.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.415 HD13 ' CD2' ' A' ' 106' ' ' PHE . 1.8 pt -91.58 128.92 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 120.622 -0.431 . . . . 0.40999999999999998 110.564 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -71.79 82.6 0.89 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.899 -0.592 . . . . 0.69999999999999996 111.485 179.621 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.589 ' H ' ' HA ' ' A' ' 100' ' ' LEU . . . 44.28 -76.58 0.0 OUTLIER Glycine 0 C--O 1.226 -0.347 0 CA-C-N 113.844 -1.525 . . . . 0.38 116.201 167.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' THR . . . -46.6 -29.01 1.63 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.043 0.757 . . . . 0.44 113.043 -176.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -71.72 -42.65 67.07 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.148 0.499 . . . . 2.1099999999999999 110.101 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.486 ' CB ' HD12 ' A' ' 101' ' ' LEU . . . -72.0 -33.89 68.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.48 0.657 . . . . 0.41999999999999998 109.993 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.661 ' O ' HG23 ' A' ' 77' ' ' VAL . 29.6 mmmt -64.32 -38.95 92.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.363 -0.835 . . . . 1.6899999999999999 109.576 174.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.404 ' HB2' ' HE3' ' A' ' 74' ' ' LYS . 1.0 OUTLIER -54.84 -47.18 74.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.506 -0.77 . . . . 1.3500000000000001 109.992 175.62 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.68 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 8.7 mm-40 -60.7 -48.67 80.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.371 -1.286 . . . . 1.48 111.919 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.475 ' SD ' ' HD2' ' A' ' 73' ' ' LYS . 17.6 ptp -70.34 -15.53 62.88 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.739 -0.384 . . . . 0.65000000000000002 111.125 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 73' ' ' LYS . 54.0 t -75.41 -50.25 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.749 0.309 . . . . 0.58999999999999997 110.56 171.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.68 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 8.7 ptmt -68.72 -11.83 60.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.089 0.471 . . . . 1.2 110.453 -177.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.3 t -69.24 -8.1 42.83 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.845 -0.616 . . . . 1.3700000000000001 110.409 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 47.5 mttp 65.98 68.58 0.46 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.552 -0.749 . . . . 2.6499999999999999 110.431 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.691 ' HB2' HD12 ' A' ' 86' ' ' LEU . 27.7 mt -130.09 158.93 72.57 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.426 -0.806 . . . . 1.1599999999999999 110.632 -175.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.546 ' HG2' HG23 ' A' ' 85' ' ' VAL . 61.5 Cg_endo -75.5 164.35 32.6 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.322 2.015 . . . . 0.94999999999999996 110.796 168.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.95 -25.91 68.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.897 0.38 . . . . 1.53 111.326 -177.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -53.99 48.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.232 0.539 . . . . 1.24 110.527 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.546 HG23 ' HG2' ' A' ' 82' ' ' PRO . 85.1 t -63.75 -46.21 95.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.506 -0.77 . . . . 0.71999999999999997 110.382 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.691 HD12 ' HB2' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -53.87 -53.0 58.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.016 0.436 . . . . 1.45 111.766 177.057 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.84 -35.03 89.44 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.7 -0.682 . . . . 0.39000000000000001 112.539 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.861 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 53.6 pttt -89.32 -21.0 23.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.703 -0.799 . . . . 1.6599999999999999 111.009 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.2 mt -69.4 -43.52 80.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.299 -0.63 . . . . 1.1499999999999999 109.299 170.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.47 ' CE3' ' HD3' ' A' ' 73' ' ' LYS . 76.6 t-105 -58.6 -54.98 40.93 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.214 -0.448 . . . . 0.29999999999999999 110.882 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.861 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -71.46 -15.6 62.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.879 -0.6 . . . . 2.54 112.031 -173.125 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.409 HD23 HD23 ' A' ' 122' ' ' LEU . 13.4 tp -94.24 -24.93 17.27 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.929 -0.308 . . . . 0.85999999999999999 110.26 176.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.884 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -80.34 -42.66 22.53 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.096 0.474 . . . . 0.45000000000000001 110.614 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.519 ' HB2' HD21 ' A' ' 101' ' ' LEU . 48.3 t0 -100.99 114.54 28.56 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.458 -0.571 . . . . 0.62 109.458 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.2 t -74.68 -23.04 17.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.189 -0.914 . . . . 1.76 111.554 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.85 -25.4 13.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.985 0.421 . . . . 1.7 110.192 -175.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.507 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 57.8 mttt 60.92 71.71 0.55 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.129 -0.941 . . . . 1.74 110.87 169.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.431 ' OD1' ' HG ' ' A' ' 100' ' ' LEU . 1.9 p30 -101.66 -22.27 14.48 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.384 -1.28 . . . . 1.51 111.749 -171.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.41 9.81 28.53 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.71 -0.757 . . . . 0.28999999999999998 112.392 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.589 ' HA ' ' H ' ' A' ' 69' ' ' GLY . 3.7 pp -148.26 178.61 8.42 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.252 0.621 . . . . 0.54000000000000004 109.521 176.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.519 HD21 ' HB2' ' A' ' 94' ' ' ASP . 87.2 mt -146.96 122.55 10.46 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.25 -0.648 . . . . 0.68000000000000005 109.25 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -74.16 -173.96 1.8 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.866 -0.521 . . . . 1.5 110.317 176.378 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -59.83 -34.05 72.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.98 0.419 . . . . 1.73 111.404 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 26.3 tt0 -86.3 -33.87 20.51 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.918 0.39 . . . . 2.1400000000000001 110.755 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . 2.4 mt-10 -62.2 -39.2 91.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.298 -0.41 . . . . 1.1100000000000001 110.496 174.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.582 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -62.88 -43.61 98.33 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.193 -1.04 . . . . 1.0700000000000001 108.193 173.197 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 104' ' ' GLU . . . -50.75 -47.44 59.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.683 -0.69 . . . . 0.19 110.986 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.884 HD22 ' HA ' ' A' ' 93' ' ' ALA . 2.5 tt -66.82 -50.77 61.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.021 -0.363 . . . . 1.23 110.021 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.81 -57.21 7.82 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.796 0.665 . . . . 0.22 112.796 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.425 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 0.2 OUTLIER -66.72 -29.04 68.92 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.286 0.565 . . . . 1.1799999999999999 109.485 -176.599 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.556 ' O ' HG23 ' A' ' 115' ' ' VAL . 64.5 t60 -68.1 -42.9 79.62 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.992 -0.549 . . . . 0.48999999999999999 109.886 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.7 ' HB3' HD21 ' A' ' 122' ' ' LEU . 34.5 mt -64.03 -34.68 78.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.064 -0.516 . . . . 0.55000000000000004 110.589 176.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 110' ' ' ASN . 95.2 mt -61.41 -48.6 88.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.921 -0.581 . . . . 0.81000000000000005 110.495 174.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.539 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 17.6 ptpt -72.48 -21.29 61.23 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 119.651 -0.819 . . . . 2.2200000000000002 111.007 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 111' ' ' HIS . 15.4 t -60.57 -47.97 90.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.595 0.236 . . . . 0.48999999999999999 110.452 171.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 5.7 ptmm? -84.98 -1.21 56.51 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.259 -0.576 . . . . 1.9099999999999999 110.379 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.523 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 38.2 tp -85.89 -19.79 30.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.473 -0.785 . . . . 1.28 108.963 172.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.539 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 43.0 mt-10 -67.87 -16.52 64.13 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 115.558 -0.746 . . . . 1.99 109.529 173.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.57 -20.21 13.77 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.65 -0.704 . . . . 1.01 112.175 174.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.673 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -99.13 138.91 35.55 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.822 -0.436 . . . . 0.87 109.822 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -73.37 164.0 27.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.242 0.544 . . . . 2.75 111.335 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 112' ' ' LEU . 4.5 mp -73.23 141.7 81.16 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.448 -0.796 . . . . 2.7000000000000002 110.391 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -88.66 -0.01 6.5 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.344 2.696 . . . . 1.1000000000000001 113.52 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 60.89 27.84 17.65 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.463 0.649 . . . . 1.3400000000000001 110.857 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -130.15 126.48 37.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.5 -0.773 . . . . 2.3599999999999999 109.148 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 126' ' ' LEU . 1.1 tm? -103.35 103.2 33.81 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.227 -0.657 . . . . 1.8300000000000001 109.227 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 7.8 Cg_endo -87.36 164.42 8.2 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.449 2.766 . . . . 1.0 112.669 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.445 ' O ' HG12 ' A' ' 131' ' ' VAL . 12.2 Cg_endo -56.03 -26.44 59.27 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.444 2.763 . . . . 1.3400000000000001 113.446 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.569 ' O ' HD12 ' A' ' 130' ' ' LEU . 7.3 p-80 -86.55 23.41 1.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.517 -0.473 . . . . 1.48 111.271 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 129' ' ' HIS . 0.3 OUTLIER -149.61 14.68 0.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.955 0.159 . . . . 1.29 111.107 175.386 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 128' ' ' PRO . 7.4 p -82.72 111.31 28.28 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.25 0.548 . . . . 1.72 111.025 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo . . . . . 0 C--O 1.234 0.309 0 C-N-CA 122.724 2.283 . . . . 1.04 113.373 -177.728 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 N-CA-C 112.593 -0.203 . . . . 42.189999999999998 112.593 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -88.67 8.01 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.288 2.659 . . . . 41.840000000000003 112.86 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -107.56 124.34 49.79 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.662 -0.866 . . . . 43.409999999999997 108.662 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.06 0.62 82.96 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.728 -0.748 . . . . 41.270000000000003 111.363 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.6 t -164.6 131.56 3.08 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.733 -0.84 . . . . 40.149999999999999 108.733 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.538 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.1 pm0 -76.16 116.82 17.22 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.619 0.723 . . . . 38.670000000000002 111.033 -177.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.1 t -84.83 99.0 10.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.338 -0.846 . . . . 37.240000000000002 109.254 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.783 HD23 ' H ' ' A' ' 8' ' ' LEU . 2.4 pt? -88.84 140.43 29.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.709 -0.678 . . . . 36.32 110.396 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.3 mmm -72.45 144.36 86.46 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.427 -0.582 . . . . 35.030000000000001 109.427 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -48.47 -46.84 22.19 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.295 2.663 . . . . 34.310000000000002 112.098 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.1 t -109.79 112.06 23.88 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.09 -0.707 . . . . 33.799999999999997 109.09 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -80.66 97.27 7.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.948 0.404 . . . . 34.579999999999998 110.683 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 m -111.67 141.1 28.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.127 -0.488 . . . . 33.82 110.619 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -106.64 115.21 47.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.951 -0.568 . . . . 35.100000000000001 110.784 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.69 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 98.4 mttt -102.24 86.48 2.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.969 -0.559 . . . . 35.140000000000001 110.071 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.2 112.79 4.19 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.512 -0.767 . . . . 36.609999999999999 112.652 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.85 0.88 89.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.206 -0.521 . . . . 36.640000000000001 112.403 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.69 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . . . -105.34 98.95 8.58 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.862 0.363 . . . . 35.420000000000002 111.012 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -78.46 103.78 8.63 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.334 -0.617 . . . . 35.770000000000003 109.334 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -89.26 125.52 35.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.427 -0.806 . . . . 33.670000000000002 111.612 -169.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.34 67.06 0.51 Allowed Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.858 -0.687 . . . . 33.350000000000001 111.786 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.4 m -69.95 112.1 6.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.089 0.471 . . . . 32.890000000000001 110.78 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 62.7 mtm -75.95 102.28 5.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.018 -0.537 . . . . 33.5 109.649 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -81.51 158.18 24.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.084 -0.507 . . . . 33.880000000000003 111.14 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.66 -33.69 4.36 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.673 -1.071 . . . . 33.450000000000003 114.623 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -85.64 132.94 4.3 Favored 'Trans proline' 0 C--N 1.351 0.707 0 CA-C-N 120.955 2.377 . . . . 32.82 111.686 172.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -127.62 130.35 48.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.86 0.362 . . . . 34.289999999999999 111.029 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.11 158.28 20.01 Favored Glycine 0 N--CA 1.454 -0.133 0 CA-C-N 116.108 -0.496 . . . . 31.66 112.036 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -165.41 123.1 1.55 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.867 0.333 . . . . 31.329999999999998 110.147 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.93 116.77 0.76 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.83 -0.7 . . . . 28.859999999999999 112.305 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -95.75 170.23 9.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.459 0.171 . . . . 27.66 110.57 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.37 91.88 0.95 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.7 -0.762 . . . . 24.739999999999998 111.955 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -77.52 132.67 38.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.698 0.285 . . . . 22.32 110.735 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.18 98.04 1.59 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.782 -0.723 . . . . 19.489999999999998 111.791 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.1 118.57 19.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.824 0.345 . . . . 17.420000000000002 111.197 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.16 101.85 1.85 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.772 -0.728 . . . . 14.76 111.504 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.97 -177.01 5.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.513 0.197 . . . . 13.02 110.761 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.41 71.54 2.91 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.351 -0.928 . . . . 10.279999999999999 111.98 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.8 pt -67.2 154.44 8.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.275 -1.009 . . . . 9.1199999999999992 108.275 170.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.88 72.96 2.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.485 0.659 . . . . 6.5199999999999996 110.715 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -128.18 95.81 4.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.044 -0.98 . . . . 6.3099999999999996 110.396 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.7 p -113.32 93.28 2.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.856 0.836 . . . . 3.3300000000000001 110.289 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -142.36 100.84 3.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.392 -0.822 . . . . 3.9399999999999999 111.032 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.715 ' CE2' ' HG ' ' A' ' 130' ' ' LEU . 7.1 t90 -73.9 140.68 45.82 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.053 -0.721 . . . . 1.3300000000000001 109.053 174.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.466 ' N ' ' CD1' ' A' ' 44' ' ' TRP . 18.2 t -52.74 -12.84 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 114.142 -1.39 . . . . 1.21 113.157 -175.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.0 -24.17 11.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 121.329 -0.857 . . . . 0.66000000000000003 112.143 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.98 -13.39 26.45 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.174 -1.012 . . . . 0.71999999999999997 112.452 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.479 ' HE2' ' HB3' ' A' ' 48' ' ' LYS . 7.8 ptpt -112.03 -0.96 15.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 112.745 0.646 . . . . 2.9700000000000002 112.745 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -133.77 2.16 3.4 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.367 0.603 . . . . 1.8300000000000001 110.666 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 63.5 tttm -54.83 -46.14 99.55 Favored Pre-proline 0 C--O 1.222 -0.386 0 CA-C-N 115.691 -0.686 . . . . 1.1299999999999999 111.166 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 55.2 Cg_exo -42.47 -33.24 2.59 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 123.074 2.516 . . . . 0.56000000000000005 113.993 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.681 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 25.6 m -73.8 -48.38 31.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.097 0.951 . . . . 0.59999999999999998 110.022 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.538 ' CD1' ' HB3' ' A' ' 110' ' ' ASN . 7.4 m-85 -76.17 -25.11 54.9 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.47 -0.786 . . . . 0.93999999999999995 110.149 -175.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.591 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 18.3 t70 -82.55 -33.41 28.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.632 -1.167 . . . . 1.1599999999999999 109.637 -176.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.681 ' HG3' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -69.28 -39.41 78.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.331 -0.618 . . . . 1.6299999999999999 109.331 175.742 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.617 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 60.3 mt -69.03 -32.0 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.254 -0.647 . . . . 0.60999999999999999 109.254 175.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.591 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 70.4 t80 -55.64 -52.87 62.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.168 -0.924 . . . . 0.88 110.952 175.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.735 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 82.6 m-85 -75.12 -22.45 58.19 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.941 0.401 . . . . 1.03 110.916 177.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.617 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 10.4 m -70.19 -32.64 70.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.44 111.043 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.8 mt -83.6 -8.53 59.29 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.219 -0.289 . . . . 0.79000000000000004 110.219 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.6 t 72.89 96.65 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.463 -0.79 . . . . 0.64000000000000001 111.287 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.735 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 61.5 Cg_endo -83.52 172.27 10.43 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.588 2.192 . . . . 0.46000000000000002 112.28 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.0 t -136.06 114.37 15.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.234 -0.654 . . . . 1.3300000000000001 109.234 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 70.31 23.76 4.95 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.133 0.492 . . . . 1.6699999999999999 111.58 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.47 25.21 19.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.954 -0.641 . . . . 0.5 112.661 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.607 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -168.5 154.27 6.79 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.6 -0.889 . . . . 1.8200000000000001 108.6 175.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.86 ' HB ' HD21 ' A' ' 71' ' ' ASN . 3.1 pt -86.58 137.19 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 120.316 -0.554 . . . . 0.40999999999999998 110.21 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.8 p -60.3 130.7 47.94 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 107.352 -1.351 . . . . 0.69999999999999996 107.352 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.669 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -50.98 -25.75 10.31 Favored Glycine 0 C--O 1.22 -0.742 0 C-N-CA 120.682 -0.771 . . . . 0.38 113.784 -172.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -46.92 -55.77 7.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.139 0.47 . . . . 0.44 111.467 173.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.86 HD21 ' HB ' ' A' ' 67' ' ' ILE . 9.5 p30 -72.96 -27.07 61.61 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.87 0.367 . . . . 2.1099999999999999 110.545 -175.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.728 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -68.92 -37.29 78.84 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.392 -0.596 . . . . 0.41999999999999998 109.392 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.669 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.9 mmmm -67.72 -38.77 84.04 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.174 -0.921 . . . . 1.6899999999999999 109.843 177.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.809 ' HG2' ' HA ' ' A' ' 71' ' ' ASN . 10.4 mmmm -56.23 -50.6 70.83 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.654 0.74 . . . . 1.3500000000000001 109.655 175.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -55.9 -52.81 62.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.972 -1.467 . . . . 1.48 111.445 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.728 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 12.8 ptp -73.45 -21.88 60.34 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.107 -0.371 . . . . 0.65000000000000002 111.752 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.41 -45.71 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.787 0.327 . . . . 0.58999999999999997 110.462 174.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 15.2 ptpt -70.83 -14.82 62.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.257 0.551 . . . . 1.2 110.1 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 76' ' ' MET . 67.6 m -63.94 -1.59 1.52 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.563 -0.744 . . . . 1.3700000000000001 111.583 171.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 71.24 72.07 0.18 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.621 0.769 . . . . 2.6499999999999999 111.434 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.843 HD11 ' HE2' ' A' ' 116' ' ' LYS . 29.1 mt -142.77 161.36 49.51 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.934 -0.576 . . . . 1.1599999999999999 111.782 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -82.56 168.54 14.39 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.093 2.529 . . . . 0.94999999999999996 110.198 166.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -63.75 -18.15 63.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.83 0.347 . . . . 1.53 111.5 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -64.63 -67.83 0.4 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.961 -0.563 . . . . 1.24 110.863 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 89' ' ' ILE . 39.8 t -60.64 -44.58 97.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 115.811 -0.631 . . . . 0.71999999999999997 110.297 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.563 HD11 ' HG3' ' A' ' 76' ' ' MET . 22.7 tp -55.52 -51.35 67.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.325 -0.852 . . . . 1.45 111.443 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.36 -43.19 97.54 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.789 -0.641 . . . . 0.39000000000000001 111.967 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.831 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 56.4 pttt -80.39 -16.45 54.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.562 -0.855 . . . . 1.6599999999999999 111.754 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.656 HD11 ' HD3' ' A' ' 116' ' ' LYS . 13.5 mt -71.8 -46.32 61.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.857 -0.794 . . . . 1.1499999999999999 108.857 171.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -56.06 -53.24 59.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.755 -0.657 . . . . 0.29999999999999999 111.212 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.831 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -73.03 -14.31 61.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.117 -0.492 . . . . 2.54 112.128 -174.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.614 HD23 HD13 ' A' ' 112' ' ' LEU . 13.6 tp -93.41 -23.89 18.25 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.662 -0.415 . . . . 0.85999999999999999 110.488 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.724 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -89.04 -42.9 11.48 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.797 0.332 . . . . 0.45000000000000001 111.376 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.62 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 55.3 t0 -92.57 105.54 17.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.759 -0.46 . . . . 0.62 109.759 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.544 HG21 ' HG3' ' A' ' 135' ' ' LYS . 23.5 t -73.09 -27.4 24.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.595 -0.729 . . . . 1.76 111.262 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.613 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.0 OUTLIER -88.16 -26.48 22.41 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.109 -0.496 . . . . 1.7 109.677 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.9 mttt 60.22 58.83 2.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.955 -1.02 . . . . 1.74 109.364 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.632 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 6.4 m-20 -83.57 -35.2 24.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.024 -1.444 . . . . 1.51 111.629 -170.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.72 16.41 33.87 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 109.889 -1.284 . . . . 0.28999999999999998 109.889 -164.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.542 HD13 ' HG3' ' A' ' 66' ' ' LYS . 4.2 pp -153.32 177.01 11.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.379 -0.971 . . . . 0.54000000000000004 108.379 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.634 ' O ' HG12 ' A' ' 67' ' ' ILE . 46.4 mt -151.74 120.37 6.5 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.231 -1.396 . . . . 0.68000000000000005 107.231 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.7 p30 -80.96 -175.75 5.55 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.499 -0.881 . . . . 1.5 110.176 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -57.95 -32.52 67.9 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 111.738 0.273 . . . . 1.73 111.738 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.734 ' HG2' ' HD2' ' A' ' 133' ' ' PRO . 4.0 tp10 -87.33 -27.92 22.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.319 0.581 . . . . 2.1400000000000001 110.029 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.474 ' HB3' HD22 ' A' ' 101' ' ' LEU . 1.1 mt-10 -74.75 -27.91 60.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.05 -0.523 . . . . 1.1100000000000001 110.656 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.673 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -73.61 -36.06 65.44 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.439 -1.319 . . . . 1.0700000000000001 107.439 169.219 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.538 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -56.37 -45.77 80.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.02 -0.537 . . . . 0.19 110.286 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.724 HD22 ' HA ' ' A' ' 93' ' ' ALA . 3.5 tt -71.27 -48.6 49.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.931 -0.577 . . . . 1.23 110.278 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.533 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -46.53 -56.25 6.3 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.531 0.519 . . . . 0.22 111.138 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.538 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 11.1 t-20 -73.32 -23.98 60.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.601 -0.727 . . . . 1.1799999999999999 110.379 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.591 ' O ' HG23 ' A' ' 115' ' ' VAL . 65.7 t60 -69.76 -41.94 74.52 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.357 -0.609 . . . . 0.48999999999999999 109.357 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.635 HD22 HD22 ' A' ' 122' ' ' LEU . 30.2 mt -73.71 -27.32 61.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.187 -0.461 . . . . 0.55000000000000004 110.436 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 109' ' ' ALA . 68.7 mt -60.97 -45.46 98.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.464 -0.335 . . . . 0.81000000000000005 111.021 172.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.463 ' HE3' ' HE1' ' A' ' 53' ' ' TYR . 17.4 ptpt -75.35 -21.18 58.54 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.687 -0.805 . . . . 2.2200000000000002 111.488 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 111' ' ' HIS . 40.1 t -68.43 -43.27 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.471 0.177 . . . . 0.48999999999999999 110.706 173.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.843 ' HE2' HD11 ' A' ' 81' ' ' LEU . 16.0 pttp -69.12 -28.26 66.3 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.291 -0.633 . . . . 1.9099999999999999 109.291 174.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.1 tt -69.61 -24.28 63.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.53 -0.759 . . . . 1.28 110.248 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 6.5 mm-40 -59.02 -13.23 6.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.573 -0.739 . . . . 1.99 111.299 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.81 8.81 29.53 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.924 -0.655 . . . . 1.01 111.926 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.754 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.5 p80 -137.89 135.16 35.86 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.017 -0.364 . . . . 0.87 110.017 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -71.85 164.5 25.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.203 -0.453 . . . . 2.75 111.316 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.635 HD22 HD22 ' A' ' 112' ' ' LEU . 41.8 mt -74.59 137.17 74.16 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.92 -0.582 . . . . 2.7000000000000002 110.268 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 87.3 Cg_endo -90.16 13.83 2.21 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.181 2.588 . . . . 1.1000000000000001 113.396 -172.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.56 22.76 13.5 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.253 -0.43 . . . . 1.3400000000000001 111.162 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -112.55 140.69 47.1 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.366 -0.605 . . . . 2.3599999999999999 109.366 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -121.52 106.23 37.9 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 108.944 -0.762 . . . . 1.8300000000000001 108.944 178.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 2.2 Cg_endo -82.48 148.08 14.3 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.019 2.479 . . . . 1.0 112.351 -176.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.52 -13.59 37.32 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.777 2.318 . . . . 1.3400000000000001 112.579 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -98.01 24.22 7.26 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.209 -0.293 . . . . 1.48 110.209 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.715 ' HG ' ' CE2' ' A' ' 44' ' ' TRP . 0.3 OUTLIER -149.45 12.78 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.92 0.391 . . . . 1.29 110.481 177.188 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.6 m -91.86 128.42 45.98 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.598 -0.519 . . . . 1.72 109.598 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.724 ' HD3' HD12 ' A' ' 108' ' ' LEU . 51.0 Cg_exo -54.57 148.05 45.71 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.553 2.168 . . . . 1.04 110.991 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.734 ' HD2' ' HG2' ' A' ' 104' ' ' GLU . 72.2 Cg_exo -39.52 -47.34 3.42 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.95 3.1 . . . . 1.4399999999999999 114.372 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.422 ' HB3' ' HD2' ' A' ' 135' ' ' LYS . 29.2 t -58.71 -24.06 60.78 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.59 0.589 . . . . 2.2999999999999998 112.59 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.544 ' HG3' HG21 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -120.96 34.29 5.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.995 0.426 . . . . 3.4199999999999999 111.637 -173.512 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -69.57 78.12 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.73 0.776 . . . . 4.7199999999999998 110.949 175.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -162.67 134.29 5.18 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.865 -0.522 . . . . 5.0099999999999998 111.826 -172.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -106.05 106.24 16.65 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.514 -0.551 . . . . 6.3899999999999997 109.514 174.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.66 -0.686 . . . . 6.9100000000000001 110.007 -178.793 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.632 'CA ' ' OD2' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 CA-C-O 119.926 -0.375 . . . . 42.189999999999998 112.989 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.18 -50.35 7.51 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.033 2.489 . . . . 41.840000000000003 113.289 -176.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.9 pp -65.31 143.84 57.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.006 0.431 . . . . 43.409999999999997 110.6 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.03 -28.19 10.81 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.248 -1.141 . . . . 41.270000000000003 110.248 -172.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 m -90.2 115.69 27.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.192 -0.504 . . . . 40.149999999999999 109.777 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -90.68 129.86 36.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.856 0.36 . . . . 38.670000000000002 111.71 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.4 t -88.1 110.73 20.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.18 -0.674 . . . . 37.240000000000002 109.18 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.1 tp -99.34 107.42 19.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 36.32 111.01 -176.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.421 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 25.6 mmt -95.42 116.1 66.01 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 35.030000000000001 110.031 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 29.9 Cg_exo -62.22 -32.39 82.46 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.883 2.389 . . . . 34.310000000000002 112.856 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.7 t -118.0 96.01 5.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.117 0.484 . . . . 33.799999999999997 110.726 -177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -140.16 93.02 2.59 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.066 -0.716 . . . . 34.579999999999998 109.066 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.7 t -89.96 105.15 15.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.219 -0.446 . . . . 33.82 110.408 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.3 t -113.26 109.16 27.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.149 -0.478 . . . . 35.100000000000001 111.568 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.722 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 47.3 mtmt -126.92 112.78 15.7 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.962 -0.755 . . . . 35.140000000000001 108.962 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.93 105.15 3.26 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.812 -0.708 . . . . 36.609999999999999 112.488 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.88 5.82 86.88 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.075 -0.584 . . . . 36.640000000000001 112.585 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.722 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . . . -87.71 104.56 16.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.778 0.323 . . . . 35.420000000000002 111.272 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -80.76 141.93 34.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.003 -0.544 . . . . 35.770000000000003 110.429 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -121.85 149.15 43.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.327 -0.397 . . . . 33.670000000000002 110.175 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.74 116.04 5.3 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.629 -0.796 . . . . 33.350000000000001 112.586 -175.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.9 p -88.97 111.54 22.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.044 0.45 . . . . 32.890000000000001 110.993 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 55.1 mtt -65.91 131.22 45.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 33.5 111.789 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -118.49 140.08 50.44 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.456 -0.572 . . . . 33.880000000000003 109.456 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.72 -32.31 5.04 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.924 -0.931 . . . . 33.450000000000003 114.168 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.81 124.79 10.97 Favored 'Trans proline' 0 C--N 1.355 0.908 0 CA-C-N 120.592 2.196 . . . . 32.82 111.289 168.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -100.01 111.47 23.77 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.969 -0.382 . . . . 34.289999999999999 109.969 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.11 153.71 40.02 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.392 -0.909 . . . . 31.66 111.99 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -82.85 125.43 31.32 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.687 -0.486 . . . . 31.329999999999998 109.687 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -150.3 121.37 1.24 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.15 -1.024 . . . . 28.859999999999999 112.876 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -131.64 168.35 17.88 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.109 -0.7 . . . . 27.66 109.109 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.29 93.56 0.14 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.068 -0.587 . . . . 24.739999999999998 111.809 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.47 163.94 13.2 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.088 0.471 . . . . 22.32 111.425 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.46 104.44 1.32 Allowed Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.428 -1.069 . . . . 19.489999999999998 110.428 172.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -39.26 117.54 0.71 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.122 0.569 . . . . 17.420000000000002 112.524 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.49 139.89 14.74 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.548 -0.751 . . . . 14.76 111.556 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.468 ' HG2' ' H ' ' A' ' 38' ' ' GLY . 11.8 tt0 -95.16 -174.05 3.11 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.332 -0.247 . . . . 13.02 110.332 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.468 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -75.94 72.09 1.86 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.66 -0.781 . . . . 10.279999999999999 113.093 -171.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.447 ' H ' HG12 ' A' ' 39' ' ' ILE . 2.3 pt -58.13 144.97 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 109.264 -0.643 . . . . 9.1199999999999992 109.264 169.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.41 79.27 2.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.115 0.484 . . . . 6.5199999999999996 111.501 -172.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -121.58 107.89 12.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.599 -0.728 . . . . 6.3099999999999996 109.725 172.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 p -77.53 134.21 28.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.018 -0.537 . . . . 3.3300000000000001 109.9 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -146.53 124.34 11.93 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.737 -0.665 . . . . 3.9399999999999999 109.545 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.69 ' NE1' ' HG ' ' A' ' 130' ' ' LEU . 13.6 t90 -89.28 137.35 32.4 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.603 0.716 . . . . 1.3300000000000001 109.417 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 t -62.89 -10.75 6.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.747 -1.115 . . . . 1.21 112.135 -173.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.689 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 84.0 t -88.53 -13.55 9.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 O-C-N 121.553 -0.717 . . . . 0.66000000000000003 111.386 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.46 -12.63 70.02 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 119.457 -1.354 . . . . 0.71999999999999997 111.839 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -111.7 -28.26 8.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.563 0.579 . . . . 2.9700000000000002 112.563 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -108.56 8.41 27.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.473 0.654 . . . . 1.8300000000000001 109.946 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.769 ' HE3' ' HG3' ' A' ' 104' ' ' GLU . 42.5 tttt -57.1 -46.43 99.86 Favored Pre-proline 0 C--O 1.22 -0.466 0 CA-C-N 115.417 -0.811 . . . . 1.1299999999999999 112.167 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 7.3 Cg_endo -49.95 -28.39 18.54 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 122.561 2.174 . . . . 0.56000000000000005 112.802 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.629 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 9.2 m -72.34 -42.32 65.49 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 122.301 1.048 . . . . 0.59999999999999998 109.91 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.546 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 8.2 m-85 -79.55 -24.61 42.02 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.109 -0.951 . . . . 0.93999999999999995 109.742 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.588 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 14.3 t70 -81.6 -34.45 30.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.474 -0.785 . . . . 1.1599999999999999 110.63 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.629 ' HG2' ' O ' ' A' ' 52' ' ' THR . 13.2 pt-20 -66.14 -40.45 90.6 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.528 -0.469 . . . . 1.6299999999999999 109.819 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.6 mt -69.54 -29.45 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.114 -0.634 . . . . 0.60999999999999999 109.612 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 71.8 t80 -58.59 -58.29 9.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.409 -0.814 . . . . 0.88 111.462 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.449 ' HE1' ' OD1' ' A' ' 54' ' ' ASP . 38.8 m-85 -66.96 -23.02 65.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.959 0.409 . . . . 1.03 110.813 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.0 m -70.75 -26.37 63.33 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.019 -0.537 . . . . 0.44 110.973 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.526 HD11 ' CG ' ' A' ' 75' ' ' GLU . 53.6 mt -87.74 4.22 45.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.015 0.376 . . . . 0.79000000000000004 112.015 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t 65.48 81.63 0.21 Allowed Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.027 -0.533 . . . . 0.64000000000000001 110.906 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 72.6 Cg_endo -81.48 153.06 17.95 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.733 2.289 . . . . 0.46000000000000002 113.176 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.7 126.86 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.894 -0.594 . . . . 1.3300000000000001 110.248 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 60.72 23.31 13.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.702 -0.681 . . . . 1.6699999999999999 111.627 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.34 26.67 25.03 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.769 -0.729 . . . . 0.5 112.898 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.722 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -160.32 148.56 16.66 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 120.934 0.397 . . . . 1.8200000000000001 110.039 173.522 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.729 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 4.1 pt -85.89 131.45 34.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.951 -0.568 . . . . 0.40999999999999998 109.965 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.7 p -59.7 112.22 1.73 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.751 -0.833 . . . . 0.69999999999999996 108.751 174.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.566 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -42.2 -27.21 0.41 Allowed Glycine 0 C--O 1.218 -0.896 0 N-CA-C 116.684 1.434 . . . . 0.38 116.684 -160.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.68 -30.87 9.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 118.236 1.018 . . . . 0.44 112.359 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.729 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 13.3 p30 -81.07 -38.32 27.53 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.863 0.364 . . . . 2.1099999999999999 111.559 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.666 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -69.39 -34.58 74.73 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.497 0.665 . . . . 0.41999999999999998 109.223 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.566 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.2 mmmm -64.06 -39.25 93.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.756 -1.111 . . . . 1.6899999999999999 108.864 174.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -55.79 -48.49 75.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.355 -0.839 . . . . 1.3500000000000001 109.714 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.651 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 7.2 mm-40 -60.68 -52.19 66.18 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.062 -0.972 . . . . 1.48 112.051 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.666 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 13.4 ptp -69.35 -24.13 63.86 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.878 -0.329 . . . . 0.65000000000000002 111.487 -178.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 73' ' ' LYS . 45.8 t -73.13 -49.08 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.652 0.263 . . . . 0.58999999999999997 110.644 174.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.651 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 8.0 ptmt -68.06 -11.96 59.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.185 0.517 . . . . 1.2 110.249 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.3 t -68.29 -9.44 47.6 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.942 -0.572 . . . . 1.3700000000000001 110.039 174.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.486 ' NZ ' ' HB2' ' A' ' 80' ' ' LYS . 8.4 mtmp? 73.49 73.19 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.5 0.72 . . . . 2.6499999999999999 110.989 176.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.034 HD11 ' HE2' ' A' ' 116' ' ' LYS . 25.1 mt -136.35 163.56 49.11 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.566 -0.743 . . . . 1.1599999999999999 110.997 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.425 ' HG2' HG23 ' A' ' 85' ' ' VAL . 71.7 Cg_endo -79.78 168.71 19.02 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.618 2.212 . . . . 0.94999999999999996 111.408 167.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 93.8 m-20 -64.72 -26.83 68.54 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.833 0.308 . . . . 1.53 111.833 -177.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.4 p -62.95 -50.82 69.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.259 -0.428 . . . . 1.24 110.896 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 89' ' ' ILE . 46.7 t -66.83 -43.78 89.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.928 -0.578 . . . . 0.71999999999999997 109.925 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.564 ' CD2' ' HB2' ' A' ' 81' ' ' LEU . 2.8 mm? -48.27 -53.41 17.27 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.282 0.563 . . . . 1.45 110.744 172.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.43 -45.96 94.68 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.943 -1.026 . . . . 0.39000000000000001 112.984 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.87 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 56.3 pttt -83.27 -21.54 33.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 119.677 -0.809 . . . . 1.6599999999999999 112.304 -175.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.599 HD11 ' HD3' ' A' ' 116' ' ' LYS . 29.8 mt -67.26 -44.91 87.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.853 -0.795 . . . . 1.1499999999999999 108.853 171.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -62.98 -54.69 34.38 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 115.658 -0.701 . . . . 0.29999999999999999 111.405 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.87 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 64.6 pttt -71.82 -10.17 59.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.571 -0.286 . . . . 2.54 111.721 -173.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.645 HD13 ' HA ' ' A' ' 124' ' ' ALA . 8.6 tp -92.34 -34.07 14.34 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.736 -0.468 . . . . 0.85999999999999999 109.736 173.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.729 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -82.92 -44.44 15.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.896 0.379 . . . . 0.45000000000000001 112.004 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.625 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 42.1 t0 -92.01 76.28 5.47 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.81 -0.811 . . . . 0.62 108.81 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.452 HG11 ' HE2' ' A' ' 135' ' ' LYS . 16.3 t -64.9 -25.22 37.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.258 -0.883 . . . . 1.76 109.982 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -79.48 -25.85 41.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.603 -1.18 . . . . 1.7 110.278 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 55.71 73.82 0.41 Allowed 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.468 -0.787 . . . . 1.74 111.525 174.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -123.45 -24.22 4.64 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.409 -1.269 . . . . 1.51 112.419 -169.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.91 16.46 28.26 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.053 -1.07 . . . . 0.28999999999999998 111.82 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.722 HD13 ' HG3' ' A' ' 66' ' ' LYS . 3.3 pp -151.61 -174.57 4.88 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.649 -0.871 . . . . 0.54000000000000004 108.649 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.608 HD12 ' HB1' ' A' ' 72' ' ' ALA . 45.0 mt -150.12 120.56 7.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.218 -0.66 . . . . 0.68000000000000005 109.218 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.8 p-10 -74.98 -175.65 2.65 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.635 -0.506 . . . . 1.5 109.635 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.456 ' OD1' ' HE2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -60.24 -33.85 72.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.663 0.268 . . . . 1.73 111.191 -177.181 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.769 ' HG3' ' HE3' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -83.24 -37.43 23.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.79 -0.186 . . . . 2.1400000000000001 111.037 176.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.545 ' HB3' HD22 ' A' ' 101' ' ' LEU . 3.7 mt-10 -62.43 -38.35 89.41 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.208 -0.197 . . . . 1.1100000000000001 110.99 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.584 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.6 OUTLIER -68.96 -40.1 79.09 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.526 -0.916 . . . . 1.0700000000000001 108.526 172.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.546 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -48.93 -50.67 34.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.597 -0.729 . . . . 0.19 111.426 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.729 ' CD1' ' HA ' ' A' ' 93' ' ' ALA . 0.5 OUTLIER -83.41 -33.36 25.75 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 118.993 -1.083 . . . . 1.23 112.031 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.32 -54.18 9.43 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.318 0.58 . . . . 0.22 111.173 170.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.482 ' HA ' HD12 ' A' ' 113' ' ' ILE . 2.9 t-20 -75.97 -33.87 59.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.571 . . . . 1.1799999999999999 110.702 -176.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 108' ' ' LEU . 85.5 t60 -66.37 -34.88 78.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.519 . . . . 0.48999999999999999 109.945 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.802 ' HB3' HD21 ' A' ' 122' ' ' LEU . 73.0 mt -71.81 -31.65 66.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.717 -0.674 . . . . 0.55000000000000004 110.021 176.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.597 ' HA ' ' HE3' ' A' ' 116' ' ' LYS . 60.8 mt -61.11 -42.67 94.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.73 -0.668 . . . . 0.81000000000000005 110.747 171.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.601 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -68.44 -35.34 77.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.297 -0.41 . . . . 2.2200000000000002 110.335 175.715 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.6 t -59.57 -49.05 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.256 -0.429 . . . . 0.48999999999999999 111.522 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 1.034 ' HE2' HD11 ' A' ' 81' ' ' LEU . 20.0 pttp -68.0 -28.84 67.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.026 0.441 . . . . 1.9099999999999999 110.303 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.5 tp -70.49 -20.57 62.84 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.847 -0.615 . . . . 1.28 110.839 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.601 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 42.2 mt-10 -71.42 -9.84 58.82 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.888 -0.597 . . . . 1.99 111.037 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.43 1.21 24.8 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.2 -1.0 . . . . 1.01 112.948 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.716 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -129.45 134.01 47.6 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.874 -0.417 . . . . 0.87 109.874 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -72.12 164.62 25.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.252 0.549 . . . . 2.75 111.242 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.802 HD21 ' HB3' ' A' ' 112' ' ' LEU . 5.2 mp -68.87 141.5 92.43 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.792 -0.64 . . . . 2.7000000000000002 110.46 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.578 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 67.9 Cg_endo -91.5 -7.06 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.483 2.788 . . . . 1.1000000000000001 112.624 -174.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.645 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . 61.53 37.55 16.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.699 -0.682 . . . . 1.3400000000000001 111.319 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.578 ' OD1' ' HG2' ' A' ' 123' ' ' PRO . 1.2 p-10 -111.61 135.5 52.11 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.956 -0.565 . . . . 2.3599999999999999 109.746 170.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.7 tp -115.49 91.42 28.99 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.191 -0.913 . . . . 1.8300000000000001 109.918 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 94.5 Cg_endo -98.03 171.22 0.67 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.609 2.872 . . . . 1.0 113.189 -175.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.55 ' HA ' HG23 ' A' ' 131' ' ' VAL . 9.3 Cg_endo -54.92 -29.49 64.2 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.941 2.427 . . . . 1.3400000000000001 112.993 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.543 ' O ' HD12 ' A' ' 130' ' ' LEU . 16.5 p-80 -84.84 22.16 1.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.997 0.369 . . . . 1.48 111.997 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.69 ' HG ' ' NE1' ' A' ' 44' ' ' TRP . 1.0 OUTLIER -149.76 18.4 0.9 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.582 0.353 . . . . 1.29 111.091 169.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.55 HG23 ' HA ' ' A' ' 128' ' ' PRO . 96.7 t -70.19 112.59 13.16 Favored Pre-proline 0 C--N 1.328 -0.356 0 C-N-CA 120.549 -0.46 . . . . 1.72 110.968 -176.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.668 ' HB2' ' HG3' ' A' ' 135' ' ' LYS . 18.1 Cg_exo -66.25 123.07 10.7 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.629 2.22 . . . . 1.04 111.841 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.68 ' HD2' ' HG2' ' A' ' 104' ' ' GLU . 16.0 Cg_exo -68.32 2.62 2.64 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.191 2.594 . . . . 1.4399999999999999 112.411 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 59.1 p -97.63 -30.45 12.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.622 0.248 . . . . 2.2999999999999998 111.356 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.668 ' HG3' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -91.11 2.29 56.44 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.673 -0.411 . . . . 3.4199999999999999 111.81 -176.176 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.33 82.38 0.76 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.276 -0.638 . . . . 4.7199999999999998 109.276 172.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -147.05 132.25 18.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.662 -0.699 . . . . 5.0099999999999998 110.187 -176.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -133.86 100.93 4.9 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.421 -0.585 . . . . 6.3899999999999997 109.421 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 . . . . . 0 C--O 1.247 0.959 0 CA-C-O 117.986 -1.007 . . . . 6.9100000000000001 110.167 -176.29 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.625 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 N-CA-C 111.898 -0.481 . . . . 42.189999999999998 111.898 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.06 -18.23 24.16 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.881 2.387 . . . . 41.840000000000003 113.187 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 34.9 tp -108.48 135.16 50.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.586 -0.524 . . . . 43.409999999999997 109.586 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.64 30.59 8.92 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.645 -0.982 . . . . 41.270000000000003 110.645 -173.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 p -81.91 130.84 35.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.064 -0.568 . . . . 40.149999999999999 111.295 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -94.67 131.9 39.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.604 -0.726 . . . . 38.670000000000002 110.518 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.7 t -81.79 98.9 8.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.079 -0.51 . . . . 37.240000000000002 110.265 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.7 mt -83.61 95.94 8.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.816 -0.629 . . . . 36.32 110.197 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.423 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 92.3 mmm -82.79 133.67 48.54 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.956 -0.566 . . . . 35.030000000000001 111.01 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 30.8 Cg_exo -62.73 -27.85 75.96 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.751 2.301 . . . . 34.310000000000002 111.727 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 p -83.94 90.18 7.36 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.46 -0.791 . . . . 33.799999999999997 110.769 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -124.69 84.05 2.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.614 -0.721 . . . . 34.579999999999998 109.95 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.7 p -85.79 130.84 35.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.969 -0.559 . . . . 33.82 110.798 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.1 m -122.27 134.58 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.764 -0.653 . . . . 35.100000000000001 110.357 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.597 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 98.7 mttt -115.49 85.52 2.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.186 0.517 . . . . 35.140000000000001 110.685 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.22 105.58 2.18 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.659 -0.782 . . . . 36.609999999999999 111.961 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.42 25.45 70.42 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.803 -0.713 . . . . 36.640000000000001 112.097 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . . . -126.97 107.43 10.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.807 0.337 . . . . 35.420000000000002 110.484 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -119.11 105.53 11.49 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.299 -0.409 . . . . 35.770000000000003 110.8 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.53 90.96 2.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.234 0.54 . . . . 33.670000000000002 109.888 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.25 69.94 2.52 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.761 -0.654 . . . . 33.350000000000001 112.031 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 p -78.45 99.25 6.35 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.016 0.436 . . . . 32.890000000000001 110.058 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.6 tpt -142.68 137.1 29.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.98 -0.555 . . . . 33.5 110.321 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -109.36 162.26 14.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.843 -0.617 . . . . 33.880000000000003 109.471 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.3 -33.15 4.62 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 119.156 -0.802 . . . . 33.450000000000003 113.716 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -82.43 19.1 1.33 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 CA-C-N 120.444 2.122 . . . . 32.82 111.447 168.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -90.92 113.18 25.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.688 -0.687 . . . . 34.289999999999999 110.078 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.31 -178.78 47.64 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 111.223 -0.751 . . . . 31.66 111.223 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -99.94 123.35 44.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.544 -0.539 . . . . 31.329999999999998 109.544 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.41 -172.38 44.49 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.182 -0.767 . . . . 28.859999999999999 111.182 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -71.84 127.49 32.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.041 0.42 . . . . 27.66 110.403 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.44 157.21 50.66 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.066 -0.588 . . . . 24.739999999999998 112.088 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -70.53 134.16 47.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.788 0.328 . . . . 22.32 111.218 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.03 141.54 29.34 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.254 -0.738 . . . . 19.489999999999998 111.254 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.54 127.28 13.08 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.11 0.481 . . . . 17.420000000000002 112.269 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -115.29 139.96 15.91 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 111.173 -0.771 . . . . 14.76 111.173 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -86.04 154.04 21.7 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.592 0.234 . . . . 13.02 110.579 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.6 71.64 2.08 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.684 -0.769 . . . . 10.279999999999999 111.446 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 pt -62.09 153.37 6.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.044 -0.724 . . . . 9.1199999999999992 109.044 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -75.77 77.67 2.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.019 0.914 . . . . 6.5199999999999996 111.466 -172.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.72 105.79 1.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.977 -1.01 . . . . 6.3099999999999996 110.027 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 p -118.15 111.87 35.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.502 0.668 . . . . 3.3300000000000001 111.629 -176.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -147.71 108.05 4.1 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.602 -0.726 . . . . 3.9399999999999999 110.357 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.729 ' CH2' ' HG ' ' A' ' 108' ' ' LEU . 11.8 t90 -116.78 139.99 49.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.648 0.737 . . . . 1.3300000000000001 109.799 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.661 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 23.8 t -53.94 -25.92 13.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.201 -1.363 . . . . 1.21 112.561 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.726 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 0.5 OUTLIER -63.07 -13.4 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 O-C-N 121.995 -0.441 . . . . 0.66000000000000003 112.089 -174.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.48 -4.58 31.98 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.255 -0.974 . . . . 0.71999999999999997 111.935 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 11.7 ptmm? -105.33 -28.32 10.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 111.838 0.31 . . . . 2.9700000000000002 111.838 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.714 ' OD1' ' HA ' ' A' ' 46' ' ' VAL . 12.7 p-10 -114.58 1.34 14.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.051 0.453 . . . . 1.8300000000000001 111.235 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.619 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 49.6 tttm -56.48 -46.25 99.84 Favored Pre-proline 0 C--O 1.223 -0.334 0 CA-C-N 115.438 -0.801 . . . . 1.1299999999999999 112.293 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 4.3 Cg_endo -46.48 -35.09 15.81 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.869 2.38 . . . . 0.56000000000000005 113.315 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.707 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 56.5 m -76.57 -36.44 57.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.376 0.607 . . . . 0.59999999999999998 110.995 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' A' ' 110' ' ' ASN . 8.4 m-85 -81.96 -23.87 35.84 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.198 0.523 . . . . 0.93999999999999995 110.224 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.605 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 1.1 t70 -75.44 -39.47 58.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.032 -0.985 . . . . 1.1599999999999999 109.783 175.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.707 ' HG3' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -68.38 -38.65 81.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.504 -0.316 . . . . 1.6299999999999999 110.729 178.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.533 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 48.2 mt -70.95 -29.3 36.61 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 109.366 -0.605 . . . . 0.60999999999999999 109.366 174.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.605 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 66.1 t80 -57.43 -54.51 46.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.71 -0.677 . . . . 0.88 111.213 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.586 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 75.3 m-85 -71.53 -22.89 61.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.166 0.507 . . . . 1.03 110.498 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.533 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 18.3 m -72.09 -30.48 65.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.768 -0.651 . . . . 0.44 110.874 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 34.4 mt -84.87 0.94 49.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.79000000000000004 110.979 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t 66.46 88.59 0.11 Allowed Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.511 -0.768 . . . . 0.64000000000000001 111.464 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.586 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 64.8 Cg_endo -85.09 159.88 11.53 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.47 2.113 . . . . 0.46000000000000002 113.257 177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.8 p -141.46 134.25 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.93 -0.577 . . . . 1.3300000000000001 109.958 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 63.81 20.53 12.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.479 -0.782 . . . . 1.6699999999999999 109.73 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.58 -0.06 67.51 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.145 -0.934 . . . . 0.5 113.618 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -134.59 163.78 28.96 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 117.946 0.873 . . . . 1.8200000000000001 110.472 177.7 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pt -90.49 135.01 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 C-N-CA 120.642 -0.423 . . . . 0.40999999999999998 109.982 170.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.32 126.73 28.84 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.147 -1.057 . . . . 0.69999999999999996 108.147 171.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.54 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -49.45 -31.91 14.56 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.571 -0.74 . . . . 0.38 114.816 -166.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.67 -33.1 21.26 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 117.366 0.583 . . . . 0.44 112.389 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.61 -38.49 39.76 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.366 0.603 . . . . 2.1099999999999999 109.932 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.581 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -72.29 -33.21 67.24 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.789 -0.641 . . . . 0.41999999999999998 109.327 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.4 mmmm -65.34 -37.87 88.39 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 114.959 -1.018 . . . . 1.6899999999999999 108.78 174.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -56.54 -44.65 81.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.942 -1.026 . . . . 1.3500000000000001 110.416 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.667 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 3.3 mm-40 -64.01 -52.87 57.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.142 -0.936 . . . . 1.48 111.74 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.581 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 16.0 ptp -66.37 -21.07 66.23 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.582 -0.447 . . . . 0.65000000000000002 110.807 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 73' ' ' LYS . 5.1 t -68.64 -46.53 79.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.58999999999999997 111.013 172.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.667 ' HE2' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -70.36 -16.36 62.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.12 0.486 . . . . 1.2 110.04 -176.532 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.9 t -65.01 -6.81 9.48 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.411 -0.813 . . . . 1.3700000000000001 111.716 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 77.9 mttt 67.44 68.22 0.38 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.383 0.611 . . . . 2.6499999999999999 110.596 175.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.51 HD13 HG12 ' A' ' 85' ' ' VAL . 20.7 mt -128.95 156.87 77.3 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.577 -0.738 . . . . 1.1599999999999999 110.691 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.556 ' HG2' HG23 ' A' ' 85' ' ' VAL . 53.0 Cg_endo -73.21 162.93 39.36 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.194 1.929 . . . . 0.94999999999999996 110.541 168.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -63.0 -27.47 69.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.334 -0.394 . . . . 1.53 111.539 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.1 p -67.38 -45.76 75.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.2 0.524 . . . . 1.24 110.723 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.556 HG23 ' HG2' ' A' ' 82' ' ' PRO . 90.5 t -67.37 -42.92 87.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 115.904 -0.589 . . . . 0.71999999999999997 110.053 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.476 ' CD2' ' HB2' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -48.66 -55.29 11.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.4 0.619 . . . . 1.45 110.587 171.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -56.79 -53.29 45.19 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.873 -1.058 . . . . 0.39000000000000001 113.247 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 14.4 pttp -81.12 -17.33 50.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.516 -0.873 . . . . 1.6599999999999999 112.651 -173.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.745 HG12 HD11 ' A' ' 122' ' ' LEU . 7.8 mt -69.73 -48.42 64.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 108.71 -0.848 . . . . 1.1499999999999999 108.71 169.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.433 ' CE3' ' HD3' ' A' ' 73' ' ' LYS . 67.2 t-105 -53.44 -55.43 25.22 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.497 -0.774 . . . . 0.29999999999999999 111.237 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.46 -30.28 71.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.38 -0.827 . . . . 2.54 112.538 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 112' ' ' LEU . 4.6 tp -84.09 -13.0 54.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.643 -0.503 . . . . 0.85999999999999999 109.643 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.495 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -101.63 -42.92 6.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.315 -0.402 . . . . 0.45000000000000001 111.38 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.636 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 51.5 t0 -80.43 97.76 7.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.312 -0.625 . . . . 0.62 109.312 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.553 ' HB ' ' HE2' ' A' ' 135' ' ' LYS . 44.4 t -71.95 -28.71 30.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.896 -0.593 . . . . 1.76 110.325 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.602 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 0.2 OUTLIER -79.2 -26.63 42.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.963 -0.562 . . . . 1.7 109.595 176.276 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 56.39 44.66 24.12 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.954 0.883 . . . . 1.74 109.05 -173.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -108.74 -0.16 20.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.181 -1.372 . . . . 1.51 112.167 -166.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.15 10.26 59.83 Favored Glycine 0 CA--C 1.511 -0.156 0 C-N-CA 120.287 -0.959 . . . . 0.28999999999999998 112.507 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.464 HD13 ' CB ' ' A' ' 66' ' ' LYS . 4.2 pp -152.89 156.13 38.37 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.227 0.537 . . . . 0.54000000000000004 110.246 175.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 105' ' ' GLU . 63.4 mt -121.82 119.0 30.39 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.115 -0.948 . . . . 0.68000000000000005 109.48 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.1 p30 -71.09 -178.36 1.96 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.508 -0.553 . . . . 1.5 109.508 174.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -34.44 68.02 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.487 0.66 . . . . 1.73 111.08 -178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.591 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 23.5 tt0 -83.95 -31.81 25.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.548 0.69 . . . . 2.1400000000000001 109.424 -176.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HB3' HD22 ' A' ' 101' ' ' LEU . 3.6 mt-10 -72.91 -30.28 63.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.583 -0.735 . . . . 1.1100000000000001 111.358 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.624 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -68.78 -44.19 74.15 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.062 -1.088 . . . . 1.0700000000000001 108.062 171.396 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 104' ' ' GLU . . . -47.48 -46.6 27.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 0.19 110.62 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.729 ' HG ' ' CH2' ' A' ' 44' ' ' TRP . 1.0 OUTLIER -69.81 -46.66 65.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.23 110.427 178.634 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.44 ' HB2' HD13 ' A' ' 101' ' ' LEU . . . -50.02 -53.76 24.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.089 0.471 . . . . 0.22 111.527 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.431 ' HA ' HD12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -72.39 -25.45 61.5 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.349 -0.611 . . . . 1.1799999999999999 109.349 -177.101 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.48 ' O ' HG23 ' A' ' 115' ' ' VAL . 51.4 t60 -70.24 -39.8 74.85 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.592 -0.521 . . . . 0.48999999999999999 109.592 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.525 HD22 HD22 ' A' ' 122' ' ' LEU . 46.6 mt -68.78 -36.53 78.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.838 0.352 . . . . 0.55000000000000004 110.594 177.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 110' ' ' ASN . 95.6 mt -57.42 -48.94 81.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.931 -0.577 . . . . 0.81000000000000005 110.528 175.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 19.8 ptmt -70.29 -28.46 65.21 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.123 -0.631 . . . . 2.2200000000000002 110.502 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 111' ' ' HIS . 6.4 t -62.13 -45.19 99.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.688 -0.233 . . . . 0.48999999999999999 110.989 176.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 3.7 ptmm? -84.07 -2.42 56.67 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 119.733 -0.787 . . . . 1.9099999999999999 110.846 178.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.9 tp -83.64 -23.12 31.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.459 -0.571 . . . . 1.28 109.459 170.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 48.5 mt-10 -66.44 -14.13 61.75 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.006 -0.543 . . . . 1.99 111.355 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.05 8.13 20.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.628 -0.796 . . . . 1.01 112.589 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -132.61 140.2 48.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.92 0.391 . . . . 0.87 109.964 177.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -77.06 164.96 25.23 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.865 -0.607 . . . . 2.75 110.962 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.745 HD11 HG12 ' A' ' 89' ' ' ILE . 27.1 mt -70.82 141.89 87.65 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.168 -0.469 . . . . 2.7000000000000002 110.291 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -92.25 12.86 2.0 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.035 2.49 . . . . 1.1000000000000001 113.105 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 59.96 21.93 10.99 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.756 -0.656 . . . . 1.3400000000000001 111.198 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -111.93 139.94 47.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.084 -0.709 . . . . 2.3599999999999999 109.084 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.83 93.34 47.58 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.542 -0.911 . . . . 1.8300000000000001 108.542 176.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 9.8 Cg_exo -73.21 153.49 51.32 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.828 2.352 . . . . 1.0 112.491 -174.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -67.47 -7.21 18.5 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.117 2.545 . . . . 1.3400000000000001 112.374 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -105.82 13.76 29.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.838 -0.619 . . . . 1.48 109.602 175.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.578 ' HG ' ' NE1' ' A' ' 44' ' ' TRP . 1.5 mp -134.6 -4.54 2.57 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.338 -0.846 . . . . 1.29 110.658 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.606 HG11 ' HD2' ' A' ' 136' ' ' ARG . 29.3 t -66.03 120.6 70.74 Favored Pre-proline 0 N--CA 1.44 -0.936 0 N-CA-C 109.285 -0.635 . . . . 1.72 109.285 174.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.897 ' HB2' ' HG2' ' A' ' 135' ' ' LYS . 51.9 Cg_exo -53.07 122.67 11.55 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.899 1.733 . . . . 1.04 109.412 174.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 132' ' ' PRO . 1.2 Cg_endo -49.03 -33.02 25.29 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.332 2.688 . . . . 1.4399999999999999 113.712 -172.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.3 m -80.28 -2.59 45.78 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.634 0.235 . . . . 2.2999999999999998 111.634 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.897 ' HG2' ' HB2' ' A' ' 132' ' ' PRO . 14.2 mmmt -102.58 5.26 39.18 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.055 -0.35 . . . . 3.4199999999999999 110.055 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.639 ' HA ' ' NH1' ' A' ' 136' ' ' ARG . 9.3 mmm180 -75.69 101.64 5.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.934 0.397 . . . . 4.7199999999999998 111.307 174.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.92 121.79 9.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.901 -0.591 . . . . 5.0099999999999998 110.596 172.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -98.12 110.09 22.73 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.142 -0.481 . . . . 6.3899999999999997 110.34 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.534 -0.746 . . . . 6.9100000000000001 109.711 175.207 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.636 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 111.971 -0.452 . . . . 42.189999999999998 111.971 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.29 -23.69 58.96 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.782 2.321 . . . . 41.840000000000003 112.382 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -81.66 133.97 35.42 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.398 -0.593 . . . . 43.409999999999997 109.398 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.42 29.48 58.07 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.47 -0.872 . . . . 41.270000000000003 111.651 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 p -76.94 161.81 28.08 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 120.661 0.267 . . . . 40.149999999999999 110.616 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -55.07 118.12 4.05 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.016 -0.538 . . . . 38.670000000000002 111.056 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.9 m -111.84 119.66 39.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.823 -0.626 . . . . 37.240000000000002 110.452 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.3 tp -100.98 144.43 29.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.921 -0.581 . . . . 36.32 109.97 177.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.7 mtm -71.05 153.33 94.64 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.356 -0.384 . . . . 35.030000000000001 110.762 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -58.58 162.27 12.96 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.991 2.46 . . . . 34.310000000000002 112.982 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.9 t -99.91 103.43 15.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.722 -0.672 . . . . 33.799999999999997 109.833 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -74.49 170.5 15.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.941 0.401 . . . . 34.579999999999998 111.305 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.36 116.03 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 33.82 110.473 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.09 141.65 41.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.35 -0.386 . . . . 35.100000000000001 110.758 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -149.91 97.12 2.54 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.637 -0.505 . . . . 35.140000000000001 109.637 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.13 147.36 16.82 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.99 -0.624 . . . . 36.609999999999999 112.576 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 6.7 70.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.938 -0.648 . . . . 36.640000000000001 112.769 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.1 90.57 6.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.006 0.431 . . . . 35.420000000000002 111.207 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -119.98 122.97 42.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.96 -0.564 . . . . 35.770000000000003 110.626 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -115.3 143.75 44.79 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.708 -0.478 . . . . 33.670000000000002 109.708 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.99 67.13 0.89 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.595 -0.812 . . . . 33.350000000000001 111.621 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m -117.22 104.1 10.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.11 -0.33 . . . . 32.890000000000001 110.11 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -133.12 108.65 8.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.42 0.628 . . . . 33.5 111.038 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -122.99 113.7 19.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.533 -0.758 . . . . 33.880000000000003 109.939 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.4 ' N ' ' CD ' ' A' ' 26' ' ' PRO . . . 119.03 -32.32 5.16 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.952 -0.915 . . . . 33.450000000000003 114.451 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 25' ' ' GLY . 9.5 Cg_exo -74.7 107.02 2.37 Favored 'Trans proline' 0 C--N 1.36 1.171 0 CA-C-N 120.837 2.319 . . . . 32.82 112.067 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -87.29 49.03 1.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.198 0.523 . . . . 34.289999999999999 110.477 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.54 117.48 0.46 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.525 -0.762 . . . . 31.66 111.768 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -104.12 122.84 46.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.054 -0.35 . . . . 31.329999999999998 110.054 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.25 96.39 0.1 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.609 -0.805 . . . . 28.859999999999999 111.463 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -130.84 142.5 50.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.909 0.385 . . . . 27.66 111.066 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.55 99.28 1.33 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.128 -0.789 . . . . 24.739999999999998 111.128 173.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -72.87 118.13 15.44 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.896 -0.409 . . . . 22.32 109.896 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.08 138.67 14.64 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.879 -0.677 . . . . 19.489999999999998 112.561 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.31 139.79 48.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.84 0.352 . . . . 17.420000000000002 110.245 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.95 133.77 11.81 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 121.007 -0.616 . . . . 14.76 111.63 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.457 ' HG2' ' H ' ' A' ' 38' ' ' GLY . 38.4 tt0 -88.14 172.64 9.35 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.457 -0.572 . . . . 13.02 109.457 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.457 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -78.76 87.67 1.15 Allowed Glycine 0 CA--C 1.501 -0.819 0 C-N-CA 120.706 -0.759 . . . . 10.279999999999999 112.046 -175.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.68 149.74 11.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.781 -0.822 . . . . 9.1199999999999992 108.781 169.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -76.66 72.98 3.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.434 0.635 . . . . 6.5199999999999996 110.946 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -134.69 96.0 3.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.111 -0.95 . . . . 6.3099999999999996 109.498 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.3 t -121.49 119.99 60.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.265 -0.425 . . . . 3.3300000000000001 110.815 -176.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -121.07 94.92 4.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.193 -0.458 . . . . 3.9399999999999999 111.004 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.74 ' CD1' HD22 ' A' ' 130' ' ' LEU . 6.5 t90 -126.33 137.18 53.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.212 0.53 . . . . 1.3300000000000001 109.799 170.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.561 ' H ' ' HD1' ' A' ' 44' ' ' TRP . 8.0 t -78.51 -4.52 6.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.365 -0.834 . . . . 1.21 111.07 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.605 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 99.1 t -89.26 -20.11 7.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 O-C-N 121.652 -0.655 . . . . 0.66000000000000003 111.865 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.68 -11.59 57.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.612 -1.28 . . . . 0.71999999999999997 112.234 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -109.5 -27.77 9.26 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.311 0.486 . . . . 2.9700000000000002 112.311 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -108.68 7.04 26.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.896 0.855 . . . . 1.8300000000000001 110.336 -173.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.688 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 83.0 tttt -61.5 -40.21 69.1 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 114.661 -1.154 . . . . 1.1299999999999999 112.82 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.2 Cg_endo -46.2 -30.97 8.36 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 122.678 2.252 . . . . 0.56000000000000005 112.841 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.569 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 99.0 m -75.3 -40.79 58.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.793 0.806 . . . . 0.59999999999999998 110.566 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.627 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 9.1 m-85 -79.55 -28.49 41.23 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.078 -0.51 . . . . 0.93999999999999995 110.579 -174.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.591 ' OD2' ' HA ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -86.12 -27.64 24.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.799 -0.637 . . . . 1.1599999999999999 110.181 -179.064 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 52' ' ' THR . 11.5 pt-20 -66.24 -43.1 87.56 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.346 -0.613 . . . . 1.6299999999999999 109.346 173.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 52' ' ' THR . 53.6 mt -67.9 -32.89 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 120.28 -0.568 . . . . 0.60999999999999999 109.517 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 79.2 t80 -55.1 -52.99 61.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.477 -0.783 . . . . 0.88 111.276 175.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.548 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 74.7 m-85 -73.92 -23.3 59.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.738 0.304 . . . . 1.03 111.314 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 25.2 m -66.76 -35.24 79.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.057 -0.519 . . . . 0.44 110.769 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.533 HD11 ' CG ' ' A' ' 75' ' ' GLU . 54.9 mt -85.39 -4.48 59.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.122 -0.49 . . . . 0.79000000000000004 111.404 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.0 t 67.06 95.21 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 121.586 0.708 . . . . 0.64000000000000001 111.312 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.548 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 22.9 Cg_endo -80.96 138.84 11.73 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.808 2.339 . . . . 0.46000000000000002 112.377 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.401 HG21 HG23 ' A' ' 68' ' ' THR . 13.9 m -99.94 122.05 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.044 -0.525 . . . . 1.3300000000000001 110.873 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 62.92 24.14 14.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.65 -0.704 . . . . 1.6699999999999999 111.232 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.74 14.3 53.02 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.963 -0.636 . . . . 0.5 113.728 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.951 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -155.03 151.78 28.83 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.759 -0.46 . . . . 1.8200000000000001 109.759 174.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.878 ' HB ' HD21 ' A' ' 71' ' ' ASN . 4.2 pt -80.5 135.93 24.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 C-N-CA 120.623 -0.431 . . . . 0.40999999999999998 110.529 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.401 HG23 HG21 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -60.03 128.76 38.41 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.883 -1.155 . . . . 0.69999999999999996 107.883 167.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.611 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -49.92 -29.43 13.92 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 121.172 -0.537 . . . . 0.38 113.917 -169.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.58 47.4 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.721 0.638 . . . . 0.44 112.721 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.878 HD21 ' HB ' ' A' ' 67' ' ' ILE . 15.2 p30 -82.1 -33.03 29.93 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.074 0.464 . . . . 2.1099999999999999 110.538 -176.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.656 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -69.93 -35.89 74.9 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.378 0.609 . . . . 0.41999999999999998 109.388 177.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 31.4 mmmt -66.12 -37.84 86.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.163 -0.926 . . . . 1.6899999999999999 108.984 175.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.463 ' O ' ' HD2' ' A' ' 78' ' ' LYS . 2.2 tppp? -54.84 -48.2 73.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.683 -0.689 . . . . 1.3500000000000001 109.956 176.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.691 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 3.0 mm-40 -63.43 -51.94 63.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.041 -0.982 . . . . 1.48 111.957 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.656 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 14.9 ptp -67.95 -23.02 65.02 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.481 -0.488 . . . . 0.65000000000000002 111.409 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.471 HG23 HD11 ' A' ' 86' ' ' LEU . 24.9 t -71.85 -49.51 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.481 0.181 . . . . 0.58999999999999997 111.186 173.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.691 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 2.5 ptmt -69.93 -9.1 53.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.264 0.554 . . . . 1.2 110.306 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.0 t -73.34 0.57 11.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.444 -0.798 . . . . 1.3700000000000001 110.893 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.5 mttp 73.09 68.09 0.11 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.91 -0.586 . . . . 2.6499999999999999 110.872 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.824 HD11 ' HE2' ' A' ' 116' ' ' LYS . 18.4 mt -138.64 159.68 66.46 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.627 -0.715 . . . . 1.1599999999999999 111.358 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.535 ' HG2' HG23 ' A' ' 85' ' ' VAL . 74.2 Cg_endo -77.95 168.56 21.91 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.836 2.357 . . . . 0.94999999999999996 111.385 167.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 92.5 m-20 -63.45 -27.72 69.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.153 -0.476 . . . . 1.53 112.044 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -52.6 63.31 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.057 0.456 . . . . 1.24 111.167 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.535 HG23 ' HG2' ' A' ' 82' ' ' PRO . 22.6 t -62.54 -41.98 94.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.822 -0.626 . . . . 0.71999999999999997 109.723 177.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.471 HD11 HG23 ' A' ' 77' ' ' VAL . 2.7 mm? -49.51 -50.05 43.31 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.837 -0.619 . . . . 1.45 111.382 173.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.08 -44.84 86.81 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.946 -0.645 . . . . 0.39000000000000001 113.186 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.589 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 56.3 pttt -76.57 -31.29 57.44 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.964 -0.694 . . . . 1.6599999999999999 111.36 -175.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.596 HG12 HD11 ' A' ' 122' ' ' LEU . 29.7 mt -64.95 -46.22 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 109.325 -0.62 . . . . 1.1499999999999999 109.325 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.472 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 76.3 t-105 -52.95 -57.01 11.77 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 115.018 -0.992 . . . . 0.29999999999999999 111.066 177.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -77.52 -9.48 58.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.389 0.515 . . . . 2.54 112.389 -171.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.589 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 2.3 tp -88.44 -23.29 23.33 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.707 -0.397 . . . . 0.85999999999999999 109.977 176.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.563 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -103.66 -39.21 6.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.038 0.447 . . . . 0.45000000000000001 110.886 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.651 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 29.6 t70 -83.43 79.31 9.46 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.234 -0.654 . . . . 0.62 109.234 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.765 HG21 ' HG3' ' A' ' 135' ' ' LYS . 7.1 m -61.25 -33.14 55.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.202 -0.908 . . . . 1.76 111.26 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 5.1 p-10 -78.41 -24.78 46.07 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.354 -1.294 . . . . 1.7 111.446 -175.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.628 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 36.7 mtmm 47.63 50.68 14.87 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.114 0.884 . . . . 1.74 112.637 176.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -110.68 -10.85 14.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.583 -0.735 . . . . 1.51 110.281 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.09 22.91 9.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.163 -1.018 . . . . 0.28999999999999998 113.015 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.951 HD13 ' HG3' ' A' ' 66' ' ' LYS . 4.1 pp -152.94 168.32 26.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.069 0.434 . . . . 0.54000000000000004 111.212 174.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.639 ' O ' HG12 ' A' ' 67' ' ' ILE . 50.8 mt -145.08 118.87 9.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.82 -1.178 . . . . 0.68000000000000005 107.82 -166.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.441 ' H ' ' HB2' ' A' ' 105' ' ' GLU . 1.1 p30 -81.98 -173.25 4.38 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.518 -0.473 . . . . 1.5 110.758 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 54' ' ' ASP . 34.1 t70 -55.8 -36.96 67.99 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.423 0.689 . . . . 1.73 112.245 -173.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.844 ' HG2' ' HD3' ' A' ' 133' ' ' PRO . 4.2 tp10 -90.61 -22.0 21.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.428 0.632 . . . . 2.1400000000000001 110.483 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.568 ' OE1' ' HA ' ' A' ' 101' ' ' LEU . 3.1 mt-10 -73.64 -30.51 62.98 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.0 -0.545 . . . . 1.1100000000000001 110.047 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.62 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.8 OUTLIER -77.4 -34.09 54.88 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.953 -1.129 . . . . 1.0700000000000001 107.953 170.371 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.627 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -53.28 -48.88 67.95 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.378 0.608 . . . . 0.19 110.091 174.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.648 HD13 ' HZ2' ' A' ' 44' ' ' TRP . 37.1 tp -75.85 -39.07 57.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.725 -0.67 . . . . 1.23 111.363 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.25 -56.46 12.81 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.05 0.452 . . . . 0.22 111.166 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.573 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 4.4 t30 -73.63 -24.32 60.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.829 -0.623 . . . . 1.1799999999999999 110.211 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.466 ' O ' HG23 ' A' ' 115' ' ' VAL . 82.6 t60 -70.28 -42.89 71.48 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.277 -0.569 . . . . 0.48999999999999999 109.825 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.563 HD12 ' HB2' ' A' ' 93' ' ' ALA . 80.4 mt -66.98 -31.44 72.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.738 -0.664 . . . . 0.55000000000000004 109.785 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.723 ' O ' ' HG2' ' A' ' 116' ' ' LYS . 60.0 mt -60.72 -45.49 97.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.512 -0.767 . . . . 0.81000000000000005 110.684 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.62 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 12.4 ttpt -65.26 -39.56 92.79 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.341 -0.544 . . . . 2.2200000000000002 110.433 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 111' ' ' HIS . 54.7 t -56.79 -46.4 83.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.666 -0.243 . . . . 0.48999999999999999 111.365 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.824 ' HE2' HD11 ' A' ' 81' ' ' LEU . 14.6 pttp -67.01 -28.19 68.04 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.107 0.479 . . . . 1.9099999999999999 109.92 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.8 tp -80.89 -17.39 50.78 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.868 -0.605 . . . . 1.28 110.971 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.62 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 45.0 mt-10 -75.46 0.55 16.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.034 0.445 . . . . 1.99 110.712 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.81 3.95 30.01 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.429 -0.891 . . . . 1.01 112.902 171.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.519 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.2 p80 -140.53 134.9 31.29 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.393 -0.523 . . . . 0.87 110.121 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.44 163.78 27.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.534 -0.757 . . . . 2.75 111.007 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.596 HD11 HG12 ' A' ' 89' ' ' ILE . 23.3 mt -69.89 134.34 87.91 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.35 -0.386 . . . . 2.7000000000000002 110.014 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 84.4 Cg_endo -93.18 14.83 1.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.894 2.396 . . . . 1.1000000000000001 113.114 -174.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.56 19.55 10.48 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.202 0.525 . . . . 1.3400000000000001 111.099 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -104.35 111.77 24.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.663 -0.699 . . . . 2.3599999999999999 109.582 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.9 tp -112.24 100.11 48.5 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.069 -0.514 . . . . 1.8300000000000001 109.983 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.446 ' C ' ' H ' ' A' ' 129' ' ' HIS . 4.7 Cg_endo -89.02 159.7 5.86 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.075 2.516 . . . . 1.0 111.238 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.17 28.41 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.842 2.362 . . . . 1.3400000000000001 113.104 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.446 ' H ' ' C ' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -100.35 -25.17 14.32 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.863 -0.791 . . . . 1.48 108.863 174.229 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.74 HD22 ' CD1' ' A' ' 44' ' ' TRP . 0.7 OUTLIER -127.49 7.07 6.32 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.976 -0.557 . . . . 1.29 111.424 -167.342 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.99 121.04 84.07 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 108.255 -1.017 . . . . 1.72 108.255 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 1.152 ' HB2' ' HE3' ' A' ' 135' ' ' LYS . 53.5 Cg_exo -47.8 152.58 2.9 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.743 2.295 . . . . 1.04 113.073 -176.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.844 ' HD3' ' HG2' ' A' ' 104' ' ' GLU . 94.1 Cg_exo -43.39 -56.51 2.28 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 124.145 3.23 . . . . 1.4399999999999999 114.365 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.4 m -67.5 -4.68 12.15 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.345 0.498 . . . . 2.2999999999999998 112.345 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 1.152 ' HE3' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -120.71 10.59 11.03 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.671 0.619 . . . . 3.4199999999999999 112.671 -171.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.619 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 0.1 OUTLIER -85.43 74.8 10.29 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.54 -0.464 . . . . 4.7199999999999998 110.071 178.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -165.67 141.63 5.17 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.248 0.547 . . . . 5.0099999999999998 111.798 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -116.98 113.34 22.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.048 -0.978 . . . . 6.3899999999999997 108.457 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.026 0 O-C-N 123.683 0.614 . . . . 6.9100000000000001 109.86 -168.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.651 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.774 -0.531 . . . . 42.189999999999998 111.774 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.418 ' HD3' ' HA2' ' A' ' 1' ' ' GLY . 7.7 Cg_exo -72.99 -41.83 1.22 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.771 2.314 . . . . 41.840000000000003 112.007 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.9 tp -72.05 133.22 45.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.933 -0.576 . . . . 43.409999999999997 110.54 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.01 -2.2 65.88 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.935 -0.65 . . . . 41.270000000000003 112.318 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.8 t -96.71 131.31 43.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.82 0.343 . . . . 40.149999999999999 110.487 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -78.01 122.25 25.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.021 -0.536 . . . . 38.670000000000002 109.643 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.3 m -78.08 109.03 11.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.289 -0.414 . . . . 37.240000000000002 110.714 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.71 131.27 45.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.698 -0.683 . . . . 36.32 110.821 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 65.7 mtt -108.57 123.93 35.86 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.102 -0.499 . . . . 35.030000000000001 110.082 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -58.39 -33.84 98.18 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.212 2.608 . . . . 34.310000000000002 112.352 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 p -107.62 89.04 2.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.329 0.585 . . . . 33.799999999999997 110.388 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -101.68 59.81 0.87 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.718 -0.674 . . . . 34.579999999999998 110.392 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.5 t -119.4 105.0 16.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.76 -0.655 . . . . 33.82 110.156 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 m -88.79 102.63 13.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.558 0.694 . . . . 35.100000000000001 110.917 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.925 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 68.2 mttm -85.99 82.93 7.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.727 -0.67 . . . . 35.140000000000001 110.322 177.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.31 109.42 2.8 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.939 -0.648 . . . . 36.609999999999999 112.137 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.16 4.59 90.17 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.971 -0.633 . . . . 36.640000000000001 112.503 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.925 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . . . -94.44 97.89 10.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.994 0.426 . . . . 35.420000000000002 110.619 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -87.71 117.36 26.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.933 -0.576 . . . . 35.770000000000003 110.501 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.57 139.05 39.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.106 0.479 . . . . 33.670000000000002 110.174 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -112.42 83.93 0.34 Allowed Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.686 -0.688 . . . . 33.350000000000001 111.519 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.4 m -147.33 143.37 28.0 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.364 -0.236 . . . . 32.890000000000001 110.364 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.4 tpt -60.45 138.24 58.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.241 0.544 . . . . 33.5 111.648 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -90.89 149.81 21.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.736 -0.665 . . . . 33.880000000000003 110.146 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.65 -32.01 5.17 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.674 -1.07 . . . . 33.450000000000003 114.682 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -73.28 1.27 6.89 Favored 'Trans proline' 0 C--N 1.359 1.122 0 CA-C-N 120.992 2.396 . . . . 32.82 112.295 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -82.6 123.66 29.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.25 -0.432 . . . . 34.289999999999999 110.028 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.24 171.18 53.22 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.734 -0.746 . . . . 31.66 112.811 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . 36.8 m80 -132.8 164.92 25.76 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.354 -0.61 . . . . 31.329999999999998 109.354 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.21 96.15 1.46 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.422 -0.894 . . . . 28.859999999999999 111.958 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 29' ' ' HIS . 33.9 m-85 -110.52 170.0 8.38 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.895 -0.409 . . . . 27.66 109.895 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.63 158.3 49.59 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.917 -0.873 . . . . 24.739999999999998 110.917 169.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -47.16 132.69 12.32 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.529 0.566 . . . . 22.32 112.529 -176.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.67 108.22 2.73 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.476 -1.05 . . . . 19.489999999999998 110.476 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.75 140.98 58.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.776 0.322 . . . . 17.420000000000002 110.368 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.69 109.81 3.17 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.744 -0.741 . . . . 14.76 112.278 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 2.1 pm0 -78.91 -175.89 4.73 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.342 -0.244 . . . . 13.02 110.342 176.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.56 71.9 2.76 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.388 -0.91 . . . . 10.279999999999999 112.765 -172.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 pp -66.61 154.92 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 109.118 -0.697 . . . . 9.1199999999999992 109.118 168.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.82 75.65 2.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.449 0.642 . . . . 6.5199999999999996 110.905 -175.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -94.1 87.54 5.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.357 -0.838 . . . . 6.3099999999999996 109.318 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.93 135.66 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.915 -0.584 . . . . 3.3300000000000001 110.952 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -82.41 110.41 17.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.594 0.712 . . . . 3.9399999999999999 110.731 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.593 ' CD2' ' HA ' ' A' ' 130' ' ' LEU . 6.5 t90 -120.13 141.3 49.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.137 -0.938 . . . . 1.3300000000000001 109.173 175.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.82 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 21.1 t -49.96 -18.73 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 CA-C-N 114.985 -1.007 . . . . 1.21 112.565 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.476 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 1.0 OUTLIER -74.99 -15.86 15.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 120.826 -1.171 . . . . 0.66000000000000003 111.592 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.43 -14.12 61.65 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 119.517 -1.325 . . . . 0.71999999999999997 111.714 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.82 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -110.08 -27.87 8.96 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.986 0.422 . . . . 2.9700000000000002 110.874 176.551 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.792 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.0 OUTLIER -86.37 -18.66 31.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.515 -0.766 . . . . 1.8300000000000001 111.1 -177.556 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.484 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 58.8 tttm -52.32 -51.05 75.96 Favored Pre-proline 0 C--O 1.217 -0.619 0 CA-C-O 118.662 -0.685 . . . . 1.1299999999999999 112.643 -174.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 85.9 Cg_exo -41.95 -40.41 6.03 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 122.775 2.317 . . . . 0.56000000000000005 113.676 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.563 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 93.9 m -74.04 -44.15 55.31 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.61 0.719 . . . . 0.59999999999999998 110.744 -176.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.792 ' CE2' ' HB3' ' A' ' 49' ' ' ASP . 6.1 m-85 -74.64 -24.28 58.8 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.988 -0.551 . . . . 0.93999999999999995 110.109 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 24.7 t70 -81.1 -37.24 29.27 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.829 -1.078 . . . . 1.1599999999999999 110.257 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 52' ' ' THR . 13.5 pt-20 -67.13 -41.59 85.88 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.256 -0.429 . . . . 1.6299999999999999 109.963 175.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.462 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 56.1 mt -69.52 -30.38 45.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.583 -0.525 . . . . 0.60999999999999999 109.583 175.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 62' ' ' PRO . 55.3 t80 -57.68 -55.21 37.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.721 -0.672 . . . . 0.88 111.244 177.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.512 ' CD1' ' HG2' ' A' ' 62' ' ' PRO . 68.6 m-85 -70.51 -21.84 62.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.236 0.541 . . . . 1.03 110.611 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.462 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 23.0 m -72.97 -24.53 60.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.257 -0.883 . . . . 0.44 110.985 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.0 mt -94.54 7.98 43.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.79000000000000004 110.828 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.0 t 64.93 90.05 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 123.751 0.657 . . . . 0.64000000000000001 112.223 175.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 57' ' ' PHE . 5.7 Cg_exo -75.49 143.12 27.22 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.852 2.368 . . . . 0.46000000000000002 112.819 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.04 117.94 54.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.457 -0.942 . . . . 1.3300000000000001 108.457 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 68.89 21.15 7.69 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.636 0.585 . . . . 1.6699999999999999 111.567 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.435 ' C ' ' HD2' ' A' ' 66' ' ' LYS . . . 93.34 22.56 26.67 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.148 -0.478 . . . . 0.5 112.936 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.946 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -160.85 156.07 24.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.247 -0.279 . . . . 1.8200000000000001 110.247 178.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.501 HD13 ' CD2' ' A' ' 106' ' ' PHE . 2.2 pt -86.22 137.56 20.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.776 -0.453 . . . . 0.40999999999999998 109.776 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 p -59.35 128.43 37.04 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.204 -1.036 . . . . 0.69999999999999996 108.204 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.567 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -52.28 -32.87 37.74 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 114.942 0.737 . . . . 0.38 114.942 -164.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.56 -28.01 29.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.291 0.545 . . . . 0.44 112.434 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -78.73 -41.7 30.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.423 0.63 . . . . 2.1099999999999999 109.628 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.544 ' CB ' HD12 ' A' ' 101' ' ' LEU . . . -69.95 -31.14 68.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.583 0.706 . . . . 0.41999999999999998 109.287 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 30.6 mmmt -65.86 -37.46 86.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.951 -1.022 . . . . 1.6899999999999999 109.004 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.4 -46.01 83.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.476 -0.783 . . . . 1.3500000000000001 109.785 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.901 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 11.4 mm-40 -56.63 -53.02 62.55 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.864 -1.062 . . . . 1.48 111.36 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 16.7 ptp -72.55 -23.67 61.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.179 -0.464 . . . . 0.65000000000000002 111.685 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 73' ' ' LYS . 20.2 t -67.57 -55.7 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.858 0.361 . . . . 0.58999999999999997 110.798 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.901 ' HE2' ' HA ' ' A' ' 75' ' ' GLU . 57.2 pttt -67.7 -14.44 62.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.16 0.505 . . . . 1.2 110.977 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.1 t -66.32 -7.47 19.06 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.759 -0.655 . . . . 1.3700000000000001 110.995 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt 72.15 71.7 0.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.399 0.68 . . . . 2.6499999999999999 111.315 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.035 HD11 ' HE2' ' A' ' 116' ' ' LYS . 36.4 mt -131.82 162.21 57.82 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.519 -0.764 . . . . 1.1599999999999999 110.65 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.519 ' HG2' HG23 ' A' ' 85' ' ' VAL . 67.8 Cg_endo -76.76 169.01 22.55 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.568 2.178 . . . . 0.94999999999999996 110.864 166.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -66.0 -32.08 73.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.66 0.267 . . . . 1.53 111.344 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.5 m -63.6 -50.85 67.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.067 0.46 . . . . 1.24 110.856 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.519 HG23 ' HG2' ' A' ' 82' ' ' PRO . 84.7 t -63.04 -40.1 87.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 115.945 -0.57 . . . . 0.71999999999999997 110.502 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.792 HD12 ' HB2' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -59.76 -48.99 79.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.879 0.371 . . . . 1.45 111.321 177.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.33 -37.51 93.21 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.535 -0.757 . . . . 0.39000000000000001 112.209 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.675 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 17.2 ptmt -83.84 -29.43 27.29 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.241 -0.583 . . . . 1.6599999999999999 110.446 -175.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.5 mm -60.06 -48.04 89.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.363 -0.606 . . . . 1.1499999999999999 109.363 169.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.564 ' CE3' ' HD3' ' A' ' 73' ' ' LYS . 76.9 t-105 -57.43 -54.35 47.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.449 -0.796 . . . . 0.29999999999999999 111.187 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.675 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 18.1 ptpt -77.78 -8.11 57.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.925 -0.58 . . . . 2.54 111.915 -171.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 18.2 tp -93.24 -30.89 14.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.996 -0.372 . . . . 0.85999999999999999 109.996 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.498 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -81.84 -42.58 19.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.217 -0.447 . . . . 0.45000000000000001 110.957 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.615 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 50.6 t0 -87.28 97.84 11.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.175 0.512 . . . . 0.62 110.323 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.725 ' CG2' ' HG3' ' A' ' 135' ' ' LYS . 29.7 m -73.2 -25.78 21.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.624 -0.716 . . . . 1.76 111.681 -178.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.625 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 0.1 OUTLIER -85.64 -25.78 26.41 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.377 -0.601 . . . . 1.7 109.377 179.054 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.2 mttp 57.27 69.16 0.77 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.131 -0.941 . . . . 1.74 110.504 -174.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.615 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 2.7 m-20 -96.05 -46.18 6.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.802 -1.09 . . . . 1.51 110.6 -174.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.45 14.32 20.33 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 109.435 -1.466 . . . . 0.28999999999999998 109.435 -162.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.946 HD13 ' HG3' ' A' ' 66' ' ' LYS . 3.6 pp -152.8 171.02 18.89 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.048 -1.076 . . . . 0.54000000000000004 108.292 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 105' ' ' GLU . 48.0 mt -143.35 117.52 9.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.618 -0.512 . . . . 0.68000000000000005 109.618 -174.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 4.0 p30 -74.3 -174.2 1.91 Allowed 'General case' 0 C--N 1.317 -0.845 0 O-C-N 122.199 -0.313 . . . . 1.5 110.656 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.2 -36.23 65.71 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.088 0.947 . . . . 1.73 109.995 -176.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.522 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 29.4 tt0 -88.19 -25.08 23.1 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.772 -1.103 . . . . 2.1400000000000001 109.871 -173.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.552 ' HB3' HD22 ' A' ' 101' ' ' LEU . 2.0 mt-10 -81.5 -32.36 32.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.041 -0.527 . . . . 1.1100000000000001 111.496 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.636 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -63.82 -43.0 97.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.176 -1.416 . . . . 1.0700000000000001 107.176 169.426 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.663 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -48.98 -50.24 36.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.602 -0.726 . . . . 0.19 110.842 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.636 HD12 ' HG3' ' A' ' 132' ' ' PRO . 1.4 tt -66.35 -47.94 71.82 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.748 -0.206 . . . . 1.23 110.78 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.33 -54.66 33.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.948 0.404 . . . . 0.22 111.894 -176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.538 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 9.0 t-20 -70.9 -30.66 67.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.238 0.542 . . . . 1.1799999999999999 109.583 -175.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.464 ' O ' HG23 ' A' ' 115' ' ' VAL . 61.7 t60 -67.94 -37.14 81.25 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.653 -0.703 . . . . 0.48999999999999999 109.897 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.46 ' HA ' ' HB ' ' A' ' 115' ' ' VAL . 21.6 mt -67.9 -33.48 74.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.056 0.455 . . . . 0.55000000000000004 110.421 175.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.779 ' HA ' ' HE3' ' A' ' 116' ' ' LYS . 75.9 mt -62.13 -45.82 97.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.689 -0.687 . . . . 0.81000000000000005 110.894 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.487 ' HD3' ' OH ' ' A' ' 53' ' ' TYR . 21.5 ptmt -73.8 -26.86 60.83 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.265 -0.574 . . . . 2.2200000000000002 110.927 176.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 111' ' ' HIS . 3.4 t -62.76 -47.45 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.744 0.307 . . . . 0.48999999999999999 110.933 176.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 1.035 ' HE2' HD11 ' A' ' 81' ' ' LEU . 20.6 pttp -72.22 -22.47 61.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.09 0.471 . . . . 1.9099999999999999 110.112 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 23.0 tp -70.64 -22.36 62.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.953 -0.567 . . . . 1.28 109.782 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 45.6 mt-10 -68.34 -12.01 60.43 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 116.028 -0.533 . . . . 1.99 110.429 173.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.96 -13.76 58.89 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.307 -0.717 . . . . 1.01 111.307 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -94.49 125.45 39.14 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.473 -0.566 . . . . 0.87 109.473 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.71 141.13 35.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.424 -0.807 . . . . 2.75 112.252 -174.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.903 HD13 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -63.75 130.16 94.23 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.882 -1.053 . . . . 2.7000000000000002 110.941 176.276 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.759 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 13.5 Cg_endo -87.83 1.18 6.9 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.066 2.51 . . . . 1.1000000000000001 114.176 -170.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 65.94 18.73 11.15 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.722 0.773 . . . . 1.3400000000000001 109.777 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.759 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 37.0 t70 -105.31 140.68 38.08 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.731 -1.122 . . . . 2.3599999999999999 108.593 175.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.52 102.48 32.81 Favored Pre-proline 0 C--N 1.309 -1.155 0 CA-C-N 115.782 -0.645 . . . . 1.8300000000000001 110.085 -176.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.28 156.64 11.0 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.269 2.646 . . . . 1.0 112.415 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.456 ' O ' HG12 ' A' ' 131' ' ' VAL . 18.8 Cg_exo -64.0 -19.01 65.9 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.941 2.427 . . . . 1.3400000000000001 112.241 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -90.2 15.73 9.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.126 -0.488 . . . . 1.48 109.722 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.593 ' HA ' ' CD2' ' A' ' 44' ' ' TRP . 0.2 OUTLIER -149.06 17.52 0.96 Allowed 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.225 -0.898 . . . . 1.29 109.483 175.079 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 128' ' ' PRO . 9.6 p -98.12 119.26 62.38 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 115.983 -0.553 . . . . 1.72 109.702 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.707 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 15.0 Cg_exo -62.43 115.71 3.05 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.235 1.957 . . . . 1.04 111.427 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.99 -16.6 28.98 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.862 2.374 . . . . 1.4399999999999999 115.031 -172.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 56.9 m -76.6 -9.52 58.72 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.457 -0.777 . . . . 2.2999999999999998 111.163 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.725 ' HG3' ' CG2' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -112.33 -7.7 13.97 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.769 -0.826 . . . . 3.4199999999999999 108.769 176.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 17.7 mmm180 -96.69 111.33 23.53 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.531 -1.213 . . . . 4.7199999999999998 110.417 174.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.66 144.41 26.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.939 -0.573 . . . . 5.0099999999999998 109.823 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -92.41 124.2 36.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.658 -0.701 . . . . 6.3899999999999997 110.864 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.238 -0.886 . . . . 6.9100000000000001 109.589 173.916 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.625 'CA ' ' OD2' ' A' ' 96' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 111.85 -0.5 . . . . 42.189999999999998 111.85 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.695 ' HB2' HD12 ' A' ' 3' ' ' LEU . 2.7 Cg_exo -78.53 -46.68 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.958 2.439 . . . . 41.840000000000003 111.81 175.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.695 HD12 ' HB2' ' A' ' 2' ' ' PRO . 6.3 mp -98.3 139.46 34.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.862 -0.608 . . . . 43.409999999999997 109.8 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.25 -27.57 6.8 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.761 -0.733 . . . . 41.270000000000003 112.937 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.9 m -90.17 117.73 29.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.75 0.31 . . . . 40.149999999999999 110.267 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -71.06 130.68 42.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.828 -0.624 . . . . 38.670000000000002 110.435 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.06 99.02 3.79 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.29 -0.633 . . . . 37.240000000000002 109.29 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.3 tp -82.24 125.27 30.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.318 -0.401 . . . . 36.32 110.884 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.448 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 22.2 ptt? -94.14 130.55 33.91 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.858 -0.61 . . . . 35.030000000000001 109.427 173.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 49.9 Cg_exo -56.14 -39.41 91.41 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.778 2.319 . . . . 34.310000000000002 112.73 -176.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 p -87.05 91.81 8.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.116 0.484 . . . . 33.799999999999997 110.186 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -133.18 101.75 5.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.983 -0.553 . . . . 34.579999999999998 110.548 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 m -132.13 121.18 45.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.831 -0.622 . . . . 33.82 109.748 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.5 t -82.04 96.0 3.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.375 0.607 . . . . 35.100000000000001 111.255 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -98.06 79.61 2.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.561 0.696 . . . . 35.140000000000001 109.9 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -105.94 108.06 2.9 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.839 -0.696 . . . . 36.609999999999999 112.341 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.18 24.0 74.72 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.222 -0.513 . . . . 36.640000000000001 113.094 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.12 104.45 9.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.989 0.423 . . . . 35.420000000000002 111.058 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -107.96 88.58 2.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.993 -0.549 . . . . 35.770000000000003 109.945 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -117.93 112.81 20.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.782 -0.645 . . . . 33.670000000000002 110.919 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.72 66.38 0.24 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.898 -0.881 . . . . 33.350000000000001 110.898 175.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 t -120.67 130.43 54.1 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.113 0.482 . . . . 32.890000000000001 110.452 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 62.9 mtt -107.07 95.71 5.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.951 -0.568 . . . . 33.5 110.213 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -114.54 140.41 48.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.698 -0.683 . . . . 33.880000000000003 109.81 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.91 -32.48 4.77 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.092 -0.838 . . . . 33.450000000000003 113.811 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -70.73 95.91 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 120.59 2.195 . . . . 32.82 110.427 165.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -80.24 115.45 19.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.965 -0.561 . . . . 34.289999999999999 111.571 -173.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.72 129.5 1.17 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.634 -0.712 . . . . 31.66 111.797 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -76.1 140.26 41.75 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.951 -0.389 . . . . 31.329999999999998 109.951 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.55 177.49 33.7 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.219 -0.991 . . . . 28.859999999999999 112.3 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -138.88 144.39 39.15 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.609 0.243 . . . . 27.66 110.469 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.83 92.07 0.38 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.651 -0.785 . . . . 24.739999999999998 112.16 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.27 122.33 23.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.708 0.29 . . . . 22.32 110.413 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.68 115.01 4.26 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.731 -0.747 . . . . 19.489999999999998 111.745 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.98 116.37 18.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.963 0.411 . . . . 17.420000000000002 110.245 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.07 103.19 1.14 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.617 -0.802 . . . . 14.76 112.692 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -100.41 -175.38 2.9 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.479 -0.563 . . . . 13.02 109.479 173.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.51 72.32 2.38 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 119.971 -1.109 . . . . 10.279999999999999 111.021 175.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.2 pt -60.32 150.55 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 109.068 -0.716 . . . . 9.1199999999999992 109.068 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' HB3' ' HE ' ' A' ' 136' ' ' ARG . 8.8 t70 -74.74 80.51 2.07 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.56 -0.533 . . . . 6.5199999999999996 109.56 -175.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -75.29 98.95 3.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.431 -0.804 . . . . 6.3099999999999996 110.512 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.64 142.65 39.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.551 -0.749 . . . . 3.3300000000000001 110.08 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -98.85 94.28 6.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.297 0.57 . . . . 3.9399999999999999 110.232 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.613 ' CH2' ' HG ' ' A' ' 108' ' ' LEU . 3.8 t90 -75.96 142.39 41.98 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.385 -0.825 . . . . 1.3300000000000001 109.554 173.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.506 ' N ' ' CD1' ' A' ' 44' ' ' TRP . 12.0 t -45.61 -14.21 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.936 1.294 . . . . 1.21 113.572 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.44 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 2.1 t -86.94 -26.49 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.226 -0.922 . . . . 0.66000000000000003 112.022 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.96 -11.19 30.12 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.449 -0.881 . . . . 0.71999999999999997 112.398 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.505 ' HB3' ' HZ3' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -102.01 -27.63 12.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 112.154 0.427 . . . . 2.9700000000000002 112.154 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -114.67 6.67 15.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.187 0.517 . . . . 1.8300000000000001 110.572 -175.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.666 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 74.2 tttt -55.86 -43.47 99.22 Favored Pre-proline 0 C--O 1.22 -0.473 0 CA-C-O 118.774 -0.631 . . . . 1.1299999999999999 111.757 177.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -44.69 -30.46 4.18 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 122.734 2.289 . . . . 0.56000000000000005 113.304 178.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.694 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 28.6 m -73.43 -43.87 59.46 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.067 0.937 . . . . 0.59999999999999998 109.937 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.554 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 3.6 m-85 -82.05 -24.93 35.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.597 -0.729 . . . . 0.93999999999999995 110.117 -175.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 1.7 t70 -77.82 -35.81 50.9 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.949 -1.023 . . . . 1.1599999999999999 109.55 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.694 ' HG3' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -68.03 -36.73 80.42 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.054 -0.521 . . . . 1.6299999999999999 109.778 176.176 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.437 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 55.7 mt -70.42 -33.84 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.462 -0.57 . . . . 0.60999999999999999 109.462 173.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 90.3 t80 -56.1 -57.52 11.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.349 -0.842 . . . . 0.88 111.348 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.616 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 57.4 m-85 -68.77 -22.8 64.27 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.991 0.424 . . . . 1.03 111.045 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.9 m -70.06 -27.92 65.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.927 -0.579 . . . . 0.44 110.698 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 63.6 mt -87.24 -3.97 59.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.644 -0.253 . . . . 0.79000000000000004 111.063 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.2 t 69.05 86.9 0.12 Allowed Pre-proline 0 N--CA 1.468 0.443 0 O-C-N 123.847 0.717 . . . . 0.64000000000000001 111.533 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.616 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 59.6 Cg_endo -77.0 151.97 31.27 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.882 2.388 . . . . 0.46000000000000002 113.443 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.5 m -120.1 121.6 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.577 -0.738 . . . . 1.3300000000000001 110.756 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 63.26 24.25 14.2 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.915 -0.584 . . . . 1.6699999999999999 112.014 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.43 36.78 9.35 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.687 -0.768 . . . . 0.5 112.754 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.655 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -171.56 162.99 6.63 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.327 -0.62 . . . . 1.8200000000000001 109.327 169.419 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.48 HD13 ' CD2' ' A' ' 106' ' ' PHE . 2.0 pt -92.97 134.85 29.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 109.741 -0.466 . . . . 0.40999999999999998 109.741 170.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 p -59.33 134.32 56.89 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.652 -1.24 . . . . 0.69999999999999996 107.652 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.611 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -52.18 -28.26 25.87 Favored Glycine 0 C--O 1.22 -0.732 0 N-CA-C 115.422 0.929 . . . . 0.38 115.422 -167.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.91 -27.03 50.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.774 0.787 . . . . 0.44 112.047 175.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.414 ' ND2' ' N ' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -79.31 -36.5 39.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.785 0.802 . . . . 2.1099999999999999 109.472 -178.13 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.65 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -75.8 -31.34 59.39 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.235 -0.893 . . . . 0.41999999999999998 110.09 177.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 14.2 mmmm -65.18 -34.51 78.56 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.433 -0.951 . . . . 1.6899999999999999 108.433 173.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 74' ' ' LYS . 1.7 tppp? -58.96 -49.02 79.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.122 -0.944 . . . . 1.3500000000000001 109.719 174.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 57.4 mm-40 -56.69 -53.02 62.51 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.254 -0.884 . . . . 1.48 112.226 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.65 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 15.0 ptp -70.8 -24.7 62.62 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.698 -0.401 . . . . 0.65000000000000002 110.857 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.06 -46.02 82.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 122.109 -0.369 . . . . 0.58999999999999997 110.991 172.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 18.1 ptpt -73.79 -18.28 60.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.72 -0.218 . . . . 1.2 111.432 -175.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.2 p -67.33 3.22 1.32 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.546 0.573 . . . . 1.3700000000000001 112.546 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 74.44 29.34 1.21 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.987 0.515 . . . . 2.6499999999999999 111.003 172.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.543 HD13 ' HD3' ' A' ' 116' ' ' LYS . 61.6 mt -109.44 162.05 21.67 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.125 -0.488 . . . . 1.1599999999999999 111.33 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.567 ' O ' HD22 ' A' ' 86' ' ' LEU . 92.3 Cg_endo -81.96 150.43 16.06 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.745 2.297 . . . . 0.94999999999999996 111.464 174.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -51.29 -29.9 16.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.536 -0.756 . . . . 1.53 112.657 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -62.95 -49.64 73.95 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.429 0.633 . . . . 1.24 110.71 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 89' ' ' ILE . 67.6 t -63.52 -41.83 94.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-N 115.273 -0.876 . . . . 0.71999999999999997 110.315 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.567 HD22 ' O ' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -64.18 -39.05 93.17 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.721 0.296 . . . . 1.45 110.765 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -57.92 -45.96 93.04 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.913 -0.66 . . . . 0.39000000000000001 111.907 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.705 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 44.7 pttt -81.1 -27.76 35.47 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.739 -0.785 . . . . 1.6599999999999999 111.715 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 85' ' ' VAL . 60.0 mt -60.6 -46.3 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 109.662 -0.496 . . . . 1.1499999999999999 109.662 171.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.481 ' HZ3' ' HB3' ' A' ' 72' ' ' ALA . 67.6 t-105 -56.99 -56.92 15.5 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.702 -0.681 . . . . 0.29999999999999999 111.088 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.705 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 9.0 ptpp? -70.38 -9.51 56.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 2.54 111.665 -174.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 124' ' ' ALA . 14.0 tp -93.32 -33.05 14.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.85999999999999999 110.347 175.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.404 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -87.31 -42.84 12.6 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.121 0.415 . . . . 0.45000000000000001 112.121 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.648 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 53.8 t0 -84.98 98.65 10.5 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.628 -0.508 . . . . 0.62 109.628 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.538 ' HB ' ' HE2' ' A' ' 135' ' ' LYS . 41.0 t -72.02 -29.82 34.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.532 -0.758 . . . . 1.76 111.244 -174.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.601 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.0 OUTLIER -80.55 -27.39 37.57 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.177 -0.675 . . . . 1.7 109.177 179.412 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 58.8 45.52 15.39 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 122.318 1.056 . . . . 1.74 108.439 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -105.0 6.7 33.65 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.649 -1.614 . . . . 1.51 111.801 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.51 18.62 70.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.467 -0.873 . . . . 0.28999999999999998 112.527 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.655 HD13 ' HG3' ' A' ' 66' ' ' LYS . 4.3 pp -153.3 175.21 13.35 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.693 -0.484 . . . . 0.54000000000000004 109.693 175.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.585 HD12 ' CB ' ' A' ' 72' ' ' ALA . 46.3 mt -149.79 113.45 5.03 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.931 -1.136 . . . . 0.68000000000000005 107.931 -173.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.1 p-10 -75.75 -172.54 1.93 Allowed 'General case' 0 C--N 1.313 -0.991 0 O-C-N 122.352 -0.217 . . . . 1.5 110.678 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.52 -36.42 66.69 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.852 0.358 . . . . 1.73 111.057 -175.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 0.2 OUTLIER -90.51 -26.81 19.58 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.013 0.375 . . . . 2.1400000000000001 112.013 -179.243 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.595 ' OE1' 'CA ' ' A' ' 141' ' ' ' CA' . 2.3 mt-10 -70.8 -34.55 71.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.026 0.441 . . . . 1.1100000000000001 109.91 175.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.666 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -66.7 -42.56 86.24 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 107.649 -1.241 . . . . 1.0700000000000001 107.649 170.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.554 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -53.0 -41.02 64.23 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.846 -0.616 . . . . 0.19 110.558 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.613 ' HG ' ' CH2' ' A' ' 44' ' ' TRP . 1.0 OUTLIER -73.74 -50.84 18.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.004 -0.544 . . . . 1.23 110.883 178.053 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.9 -52.07 45.61 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.26 0.552 . . . . 0.22 111.198 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.501 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 7.2 t-20 -71.18 -27.16 63.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.646 -0.706 . . . . 1.1799999999999999 109.515 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 60.8 t60 -68.69 -40.83 79.88 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 120.19 -0.604 . . . . 0.48999999999999999 109.59 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.525 ' HA ' ' HB ' ' A' ' 115' ' ' VAL . 42.8 mt -68.57 -35.37 77.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.307 -0.406 . . . . 0.55000000000000004 110.735 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 110' ' ' ASN . 97.4 mt -59.26 -52.43 60.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.334 -0.394 . . . . 0.81000000000000005 110.186 174.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 19.1 ptmt -72.28 -21.61 61.33 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.126 -0.63 . . . . 2.2200000000000002 110.858 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.525 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 2.5 t -59.15 -47.47 90.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.998 -0.371 . . . . 0.48999999999999999 109.998 171.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.794 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 4.8 ptmm? -85.44 2.63 43.71 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 120.182 -0.607 . . . . 1.9099999999999999 110.527 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 51.8 tp -88.4 -19.52 26.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.573 -0.74 . . . . 1.28 109.311 168.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 55.2 mt-10 -67.08 -17.18 64.77 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.889 -0.596 . . . . 1.99 110.234 176.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.39 -21.34 13.05 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.026 -0.607 . . . . 1.01 111.94 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.794 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -106.83 135.94 47.51 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.89 -1.152 . . . . 0.87 107.89 174.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.52 ' HA ' ' CB ' ' A' ' 116' ' ' LYS . 13.4 pt-20 -93.26 163.29 13.67 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.737 -0.785 . . . . 2.75 110.937 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.882 HD13 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -62.86 127.57 90.76 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-O 121.367 0.603 . . . . 2.7000000000000002 110.763 177.293 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.508 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 72.8 Cg_endo -95.86 13.8 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.478 2.786 . . . . 1.1000000000000001 113.014 -174.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.503 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . 65.87 36.31 6.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.311 -0.858 . . . . 1.3400000000000001 111.181 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.508 ' OD1' ' HG2' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -114.99 142.69 46.29 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.55 0.69 . . . . 2.3599999999999999 109.914 169.256 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.3 tp -126.25 96.54 36.39 Favored Pre-proline 0 C--N 1.306 -1.32 0 CA-C-N 114.964 -1.017 . . . . 1.8300000000000001 110.032 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -73.2 150.81 48.23 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.755 2.303 . . . . 1.0 111.833 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.22 -16.25 45.23 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.785 2.323 . . . . 1.3400000000000001 112.248 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.403 ' O ' HD12 ' A' ' 130' ' ' LEU . 21.6 p-80 -98.38 21.83 10.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.143 -0.481 . . . . 1.48 110.867 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.548 ' HG ' ' NE1' ' A' ' 44' ' ' TRP . 1.0 OUTLIER -138.27 12.91 2.82 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.576 -0.284 . . . . 1.29 110.729 174.143 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 m -91.18 125.55 58.06 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 109.401 -0.592 . . . . 1.72 109.401 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.764 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 51.3 Cg_exo -50.65 146.9 19.0 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.6 2.2 . . . . 1.04 111.829 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -43.24 -27.9 1.28 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.399 3.399 . . . . 1.4399999999999999 115.957 -175.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.5 m -88.72 -10.55 47.97 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.654 0.612 . . . . 2.2999999999999998 112.654 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.764 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -119.46 9.15 11.48 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.508 0.558 . . . . 3.4199999999999999 112.508 -177.411 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.483 ' HE ' ' HB3' ' A' ' 40' ' ' ASP . 0.6 OUTLIER -84.55 95.59 8.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.984 0.421 . . . . 4.7199999999999998 110.28 173.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -167.5 136.41 2.62 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.255 -0.276 . . . . 5.0099999999999998 110.255 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.588 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 61.2 m-70 -92.21 96.95 10.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.941 -0.572 . . . . 6.3899999999999997 110.001 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.588 ' HG2' ' O ' ' A' ' 138' ' ' HIS . 7.1 mm-40 . . . . . 0 C--O 1.254 1.312 0 O-C-N 125.198 1.561 . . . . 6.9100000000000001 108.237 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.648 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 111.957 -0.457 . . . . 42.189999999999998 111.957 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.18 133.11 39.21 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.805 2.336 . . . . 41.840000000000003 112.039 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.79 144.7 47.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.105 -0.498 . . . . 43.409999999999997 110.01 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.97 -8.83 18.71 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.722 -0.751 . . . . 41.270000000000003 111.507 -173.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.2 m -85.84 153.05 22.52 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.266 -0.642 . . . . 40.149999999999999 109.266 173.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -68.36 127.12 31.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.203 0.525 . . . . 38.670000000000002 111.934 -174.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.9 m -80.8 134.06 35.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.346 -0.843 . . . . 37.240000000000002 109.952 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.8 mt -102.46 161.55 13.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.066 0.46 . . . . 36.32 111.382 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.6 mtt -105.86 145.12 30.27 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.699 -0.682 . . . . 35.030000000000001 109.994 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.78 -37.53 66.76 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.328 2.019 . . . . 34.310000000000002 112.071 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.6 m -86.13 89.72 7.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.181 -0.463 . . . . 33.799999999999997 109.948 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -95.56 94.45 7.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.201 0.524 . . . . 34.579999999999998 109.589 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.12 129.91 66.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.693 -0.685 . . . . 33.82 111.151 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 p -119.57 124.62 73.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.828 -0.624 . . . . 35.100000000000001 110.366 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -113.25 105.78 13.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.102 -0.499 . . . . 35.140000000000001 110.311 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.63 124.2 17.74 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.991 -0.623 . . . . 36.609999999999999 112.048 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.41 23.03 41.55 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.417 -0.897 . . . . 36.640000000000001 112.371 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.08 133.78 55.75 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.295 -0.261 . . . . 35.420000000000002 110.295 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -80.34 118.67 22.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.278 0.561 . . . . 35.770000000000003 110.472 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -143.37 134.22 25.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.725 -0.67 . . . . 33.670000000000002 110.402 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.53 67.48 0.56 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.702 -0.761 . . . . 33.350000000000001 111.84 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.3 p -106.46 144.97 32.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.79 0.328 . . . . 32.890000000000001 111.199 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.5 ptp -147.52 138.95 23.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.737 -0.468 . . . . 33.5 109.737 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.494 ' C ' ' HD2' ' A' ' 26' ' ' PRO . 87.0 m-20 -101.31 146.88 26.98 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.456 -0.338 . . . . 33.880000000000003 111.139 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.613 ' N ' ' HD2' ' A' ' 26' ' ' PRO . . . 119.84 -33.33 4.64 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 118.497 -1.168 . . . . 33.450000000000003 115.13 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 25' ' ' GLY . 9.5 Cg_endo -55.99 -40.93 81.93 Favored 'Trans proline' 0 C--N 1.361 1.219 0 CA-C-N 121.068 2.434 . . . . 32.82 112.611 175.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -127.52 161.87 27.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.022 -0.535 . . . . 34.289999999999999 110.073 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.11 154.69 45.02 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.993 -0.622 . . . . 31.66 111.85 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -79.76 126.56 31.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.233 0.54 . . . . 31.329999999999998 111.4 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.01 -175.15 25.55 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.83 -0.7 . . . . 28.859999999999999 111.472 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -111.7 168.08 9.84 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.758 0.279 . . . . 27.66 110.446 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.74 95.09 0.69 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.963 -0.637 . . . . 24.739999999999998 111.681 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -130.47 153.99 48.23 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.622 0.248 . . . . 22.32 110.373 -177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.98 98.25 1.7 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.513 -0.851 . . . . 19.489999999999998 111.122 173.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.18 160.96 19.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.98 0.419 . . . . 17.420000000000002 111.254 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.99 100.77 1.19 Allowed Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 111.039 -0.825 . . . . 14.76 111.039 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -76.95 -173.7 2.81 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.33 -0.435 . . . . 13.02 110.805 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.23 73.48 2.17 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 110.752 -0.939 . . . . 10.279999999999999 110.752 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.402 ' H ' HG13 ' A' ' 39' ' ' ILE . 9.1 mt -63.34 156.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.079 -1.061 . . . . 9.1199999999999992 108.759 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.44 69.77 1.2 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.905 0.86 . . . . 6.5199999999999996 109.169 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -142.16 106.45 4.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.35 -1.296 . . . . 6.3099999999999996 108.638 172.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.5 91.62 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.253 0.549 . . . . 3.3300000000000001 110.309 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -119.38 88.71 2.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.661 -0.699 . . . . 3.9399999999999999 109.436 172.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.658 ' NE1' ' HG ' ' A' ' 130' ' ' LEU . 9.6 t90 -96.52 137.82 35.02 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.416 -0.811 . . . . 1.3300000000000001 109.729 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.491 ' H ' ' HD1' ' A' ' 44' ' ' TRP . 4.8 t -71.26 1.08 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 114.502 -1.226 . . . . 1.21 111.266 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.454 ' HB ' ' CD2' ' A' ' 44' ' ' TRP . 2.3 t -88.14 -17.69 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 O-C-N 121.667 -0.646 . . . . 0.66000000000000003 111.194 175.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.78 -16.37 59.09 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.441 -0.885 . . . . 0.71999999999999997 111.906 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -99.82 -28.21 13.24 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.991 0.367 . . . . 2.9700000000000002 111.991 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.4 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 60.2 m-20 -108.01 0.4 21.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.956 0.408 . . . . 1.8300000000000001 111.094 -173.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.544 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 54.2 tttp -51.37 -48.63 85.59 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.048 -0.523 . . . . 1.1299999999999999 112.063 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 26.2 Cg_endo -62.02 -28.99 81.04 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.762 1.641 . . . . 0.56000000000000005 111.902 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.602 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 92.4 m -74.72 -37.69 62.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.719 0.771 . . . . 0.59999999999999998 110.274 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.464 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 24.0 m-85 -74.51 -24.41 58.98 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.829 -0.623 . . . . 0.93999999999999995 110.269 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.59 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 13.1 t70 -81.36 -32.39 32.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.577 -0.738 . . . . 1.1599999999999999 110.887 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 52' ' ' THR . 17.2 pt-20 -70.0 -44.38 69.5 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.926 -0.484 . . . . 1.6299999999999999 110.022 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.52 -30.12 48.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.819 0.818 . . . . 0.60999999999999999 109.066 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.948 ' HE1' HG23 ' A' ' 67' ' ' ILE . 0.7 OUTLIER -64.88 -57.21 9.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.304 -1.316 . . . . 0.88 111.019 176.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.645 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 27.6 m-85 -62.88 -22.82 66.99 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.998 0.427 . . . . 1.03 110.965 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.7 m -69.09 -22.07 64.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.647 -0.706 . . . . 0.44 110.834 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.9 mt -97.47 -7.24 32.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.53 -0.305 . . . . 0.79000000000000004 110.649 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.43 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 10.3 t 70.12 95.11 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.694 0.798 . . . . 0.64000000000000001 111.797 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.645 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 11.0 Cg_endo -62.09 160.87 28.39 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.422 2.748 . . . . 0.46000000000000002 113.855 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.2 t -129.12 102.99 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.315 -0.857 . . . . 1.3300000000000001 110.006 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.1 m120 66.17 28.19 10.18 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.008 0.523 . . . . 1.6699999999999999 111.859 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.89 21.89 27.09 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.895 -0.669 . . . . 0.5 113.301 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.642 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -169.98 152.0 4.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.147 -1.057 . . . . 1.8200000000000001 108.147 174.156 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.948 HG23 ' HE1' ' A' ' 57' ' ' PHE . 1.1 pt -90.8 139.28 17.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 119.531 -0.868 . . . . 0.40999999999999998 110.183 174.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.6 p -60.37 139.58 57.59 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.338 -0.986 . . . . 0.69999999999999996 108.338 169.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.561 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -53.5 -35.72 52.03 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 115.098 0.799 . . . . 0.38 115.098 -164.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.01 -22.44 15.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.54 0.67 . . . . 0.44 112.794 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -80.25 -40.68 26.51 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.675 0.75 . . . . 2.1099999999999999 109.689 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.634 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -73.79 -31.25 63.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.436 -0.802 . . . . 0.41999999999999998 109.663 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.2 mmmm -64.29 -35.03 79.5 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.643 -0.873 . . . . 1.6899999999999999 108.643 173.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 1.1 tppp? -59.16 -44.66 92.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.337 -0.847 . . . . 1.3500000000000001 110.006 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 60.2 mm-40 -60.16 -53.17 60.85 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.275 -0.875 . . . . 1.48 111.823 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.634 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 12.5 ptp -71.13 -18.23 62.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.432 -0.349 . . . . 0.65000000000000002 110.858 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.48 HG23 HD11 ' A' ' 86' ' ' LEU . 2.4 t -74.23 -47.91 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.309 -0.405 . . . . 0.58999999999999997 110.795 171.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 18.1 ptpt -70.39 -13.33 62.1 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.976 0.417 . . . . 1.2 110.354 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.5 t -65.86 -7.34 15.79 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.896 -0.593 . . . . 1.3700000000000001 110.517 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 68.04 67.56 0.34 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.927 0.891 . . . . 2.6499999999999999 110.889 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.023 HD21 ' HE3' ' A' ' 116' ' ' LYS . 22.6 mt -132.65 159.73 71.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.897 -0.592 . . . . 1.1599999999999999 111.029 -175.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.53 ' HG2' HG23 ' A' ' 85' ' ' VAL . 62.9 Cg_endo -76.96 163.62 30.78 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.536 2.157 . . . . 0.94999999999999996 110.922 169.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 7.3 m-20 -61.57 -24.09 66.42 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.248 0.462 . . . . 1.53 112.248 -174.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.8 m -62.78 -48.94 76.97 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 120.998 0.428 . . . . 1.24 110.74 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.53 HG23 ' HG2' ' A' ' 82' ' ' PRO . 21.8 t -67.23 -43.53 88.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.328 -0.619 . . . . 0.71999999999999997 109.328 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 82' ' ' PRO . 3.3 mm? -46.55 -57.49 4.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.531 -0.759 . . . . 1.45 111.009 172.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.4 -40.74 99.07 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.031 -0.986 . . . . 0.39000000000000001 113.702 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.848 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 55.7 pttt -85.28 -25.09 27.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.618 -0.833 . . . . 1.6599999999999999 112.209 -175.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.618 HG12 ' CD1' ' A' ' 122' ' ' LEU . 18.6 mt -65.2 -43.05 95.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.424 -0.954 . . . . 1.1499999999999999 108.424 170.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.417 ' CH2' ' HG ' ' A' ' 101' ' ' LEU . 73.9 t-105 -60.57 -53.29 59.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.943 -1.026 . . . . 0.29999999999999999 111.301 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.848 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -72.82 -12.34 60.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.579 -0.282 . . . . 2.54 111.616 -174.383 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.2 tp -91.25 -25.12 19.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.689 -0.486 . . . . 0.85999999999999999 109.689 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.634 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -93.1 -43.08 9.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.031 0.443 . . . . 0.45000000000000001 112.0 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.504 ' HB2' HD21 ' A' ' 101' ' ' LEU . 46.9 t0 -88.46 94.29 9.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.193 0.52 . . . . 0.62 110.171 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.602 HG21 ' HG3' ' A' ' 135' ' ' LYS . 56.5 t -64.35 -23.27 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.289 -0.869 . . . . 1.76 111.18 -176.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.0 -26.77 15.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.57 -0.741 . . . . 1.7 110.726 -174.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt 60.23 58.71 2.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.348 1.071 . . . . 1.74 109.096 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -106.11 -18.81 13.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.454 -1.703 . . . . 1.51 111.278 -170.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.64 13.89 49.08 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.479 -0.867 . . . . 0.28999999999999998 112.553 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.6 pp -148.05 179.0 8.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.767 -0.457 . . . . 0.54000000000000004 109.767 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.609 HD12 ' CB ' ' A' ' 72' ' ' ALA . 25.2 mt -151.27 114.64 4.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.83 -1.174 . . . . 0.68000000000000005 107.83 -175.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.585 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.5 p30 -78.98 -174.36 4.0 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.49 -0.484 . . . . 1.5 109.996 178.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.625 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 3.9 p30 -57.84 -33.73 68.96 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.16 0.429 . . . . 1.73 112.16 -174.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.942 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 16.5 tt0 -85.74 -27.0 25.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.53 0.681 . . . . 2.1400000000000001 110.391 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.562 ' HB3' HD22 ' A' ' 101' ' ' LEU . 3.0 mt-10 -75.25 -33.69 61.33 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.603 -0.726 . . . . 1.1100000000000001 110.499 176.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.551 ' CE2' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -66.89 -40.87 87.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.753 -1.203 . . . . 1.0700000000000001 107.753 172.098 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.464 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -52.61 -48.94 65.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.289 -0.868 . . . . 0.19 110.799 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.634 HD13 ' HA ' ' A' ' 93' ' ' ALA . 1.3 tt -65.55 -53.27 44.45 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.352 -0.385 . . . . 1.23 110.121 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.6 -53.36 24.41 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.619 0.6 . . . . 0.22 112.619 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 10.2 t-20 -70.57 -32.1 69.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.169 0.509 . . . . 1.1799999999999999 110.167 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.541 ' O ' HG23 ' A' ' 115' ' ' VAL . 78.0 t60 -66.4 -35.26 79.86 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.975 -0.557 . . . . 0.48999999999999999 109.706 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 112' ' ' LEU . 25.2 mt -69.12 -36.6 77.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.843 -0.617 . . . . 0.55000000000000004 110.463 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.602 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 47.5 mm -59.49 -41.66 85.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.884 0.373 . . . . 0.81000000000000005 110.195 172.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.687 ' HE2' ' O ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -57.11 -49.39 76.06 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.72 -0.673 . . . . 2.2200000000000002 109.624 173.07 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 111' ' ' HIS . 78.6 t -60.32 -42.07 89.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.766 -0.652 . . . . 0.48999999999999999 111.577 -176.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 1.023 ' HE3' HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -75.27 -21.56 58.43 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.863 -0.335 . . . . 1.9099999999999999 111.278 178.511 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.1 tp -79.75 -19.4 48.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.746 0.307 . . . . 1.28 110.535 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.606 ' HG2' ' NZ ' ' A' ' 114' ' ' LYS . 37.2 mt-10 -62.92 -16.73 60.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.148 0.499 . . . . 1.99 110.427 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 112.07 4.91 25.57 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.667 -0.777 . . . . 1.01 111.627 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.495 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 2.7 p80 -126.85 140.41 52.37 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.305 0.574 . . . . 0.87 110.36 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -71.77 152.16 42.94 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.123 -0.944 . . . . 2.75 111.363 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.618 ' CD1' HG12 ' A' ' 89' ' ' ILE . 39.9 mt -67.12 141.15 96.17 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 115.839 -0.619 . . . . 2.7000000000000002 110.398 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -87.64 4.04 6.08 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.055 2.503 . . . . 1.1000000000000001 113.515 -173.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 58.81 19.95 7.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.37 0.605 . . . . 1.3400000000000001 111.1 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -112.91 136.2 52.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.741 -0.837 . . . . 2.3599999999999999 108.741 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.554 HD22 HG23 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -116.16 102.62 53.69 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 109.303 -0.629 . . . . 1.8300000000000001 109.303 -177.127 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 2.0 Cg_endo -79.96 157.27 23.83 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.061 2.507 . . . . 1.0 112.155 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -55.0 -40.33 86.47 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.397 2.065 . . . . 1.3400000000000001 111.843 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.662 ' O ' HD12 ' A' ' 130' ' ' LEU . 50.1 p-80 -81.89 30.88 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.658 -0.701 . . . . 1.48 111.709 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.662 HD12 ' O ' ' A' ' 129' ' ' HIS . 0.7 OUTLIER -146.86 9.89 1.02 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.063 0.394 . . . . 1.29 112.063 171.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.554 HG23 HD22 ' A' ' 126' ' ' LEU . 7.3 t -97.33 115.16 65.68 Favored Pre-proline 0 C--N 1.322 -0.598 0 C-N-CA 120.177 -0.609 . . . . 1.72 110.806 176.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.942 ' HB3' ' HG2' ' A' ' 104' ' ' GLU . 84.0 Cg_exo -49.4 128.45 20.45 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.751 2.967 . . . . 1.04 111.49 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.496 ' HA ' ' NH1' ' A' ' 136' ' ' ARG . 99.0 Cg_exo -45.48 -31.99 7.53 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.035 2.49 . . . . 1.4399999999999999 113.211 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.5 p -67.24 -19.16 65.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.173 0.805 . . . . 2.2999999999999998 113.173 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.602 ' HG3' HG21 ' A' ' 95' ' ' VAL . 13.9 mmmt -82.68 -2.76 55.0 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 120.222 -0.591 . . . . 3.4199999999999999 111.758 -171.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.496 ' NH1' ' HA ' ' A' ' 133' ' ' PRO . 3.6 ptp85 -110.48 68.62 0.67 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.24 -0.652 . . . . 4.7199999999999998 109.24 173.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.3 mtp85 -155.1 120.26 4.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.902 -0.59 . . . . 5.0099999999999998 111.411 -175.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -130.6 106.85 8.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.713 -0.676 . . . . 6.3899999999999997 109.872 172.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 C--O 1.252 1.217 0 CA-C-O 118.475 -0.774 . . . . 6.9100000000000001 110.068 178.065 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 5' ' ' SER . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 111.47 -0.652 . . . . 42.189999999999998 111.47 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.82 -28.29 51.18 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.588 2.192 . . . . 41.840000000000003 112.029 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -114.86 126.93 55.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.128 -0.693 . . . . 43.409999999999997 109.128 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.58 -32.37 7.29 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.851 -0.69 . . . . 41.270000000000003 112.129 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 2.8 m -105.44 104.44 14.16 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.982 -0.747 . . . . 40.149999999999999 108.982 175.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.491 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -84.75 145.65 27.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.171 0.51 . . . . 38.670000000000002 111.665 -173.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.2 t -103.37 123.6 47.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.805 -0.634 . . . . 37.240000000000002 109.369 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 8' ' ' LEU . 3.6 mm? -87.7 92.09 8.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.186 0.517 . . . . 36.32 110.991 -177.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 89.9 mmm -111.03 113.14 55.0 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.682 -0.69 . . . . 35.030000000000001 110.276 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.45 -11.27 31.55 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.889 2.393 . . . . 34.310000000000002 111.95 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 t -94.44 92.96 7.39 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.827 -0.624 . . . . 33.799999999999997 109.668 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -127.25 105.64 8.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.774 -0.648 . . . . 34.579999999999998 109.893 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.87 130.24 43.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.182 -0.463 . . . . 33.82 110.369 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.68 135.8 32.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.998 0.428 . . . . 35.100000000000001 110.006 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -122.08 132.99 54.77 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.138 -0.483 . . . . 35.140000000000001 110.341 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.54 129.45 28.0 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.396 -0.907 . . . . 36.609999999999999 111.28 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.67 -11.78 68.02 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.86 -0.686 . . . . 36.640000000000001 111.998 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.17 88.12 3.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.412 -0.588 . . . . 35.420000000000002 109.412 176.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -104.57 100.96 10.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.871 -0.604 . . . . 35.770000000000003 111.247 -174.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -116.72 144.94 43.84 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.799 -0.637 . . . . 33.670000000000002 109.727 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.77 121.85 6.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.824 -0.703 . . . . 33.350000000000001 112.585 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.9 p -92.07 156.04 17.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.674 0.273 . . . . 32.890000000000001 110.784 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 72.1 mtm -87.04 102.98 14.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.911 0.386 . . . . 33.5 110.33 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -107.31 137.01 46.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.95 -0.568 . . . . 33.880000000000003 110.899 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.5 -32.86 4.88 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.686 -1.063 . . . . 33.450000000000003 114.73 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -67.76 -53.02 0.47 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 CA-C-N 120.931 2.366 . . . . 32.82 111.851 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -86.77 104.29 16.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.196 -0.457 . . . . 34.289999999999999 109.939 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.54 120.78 18.35 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.957 -0.639 . . . . 31.66 112.428 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -139.8 128.49 23.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.804 0.335 . . . . 31.329999999999998 110.442 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.33 125.46 7.68 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.494 -0.86 . . . . 28.859999999999999 112.494 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -123.9 108.87 12.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.521 0.201 . . . . 27.66 110.646 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.45 116.66 5.87 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.758 -0.734 . . . . 24.739999999999998 111.652 174.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -93.36 119.2 32.21 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.033 0.444 . . . . 22.32 110.783 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.38 140.1 18.73 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.042 -0.599 . . . . 19.489999999999998 112.05 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.34 121.89 15.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.093 0.473 . . . . 17.420000000000002 111.073 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.55 114.15 3.77 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 111.266 -0.734 . . . . 14.76 111.266 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.84 153.84 34.43 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.371 -0.415 . . . . 13.02 110.777 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.88 72.24 2.47 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.61 -0.805 . . . . 10.279999999999999 111.549 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.22 154.73 3.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.391 -0.404 . . . . 9.1199999999999992 109.971 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -75.8 70.07 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.225 -0.59 . . . . 6.5199999999999996 110.622 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -147.82 82.18 1.51 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.133 -0.94 . . . . 6.3099999999999996 108.816 173.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.12 92.58 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.808 0.813 . . . . 3.3300000000000001 110.883 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -94.42 89.63 5.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.305 -0.861 . . . . 3.9399999999999999 109.155 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.806 ' CH2' ' HG ' ' A' ' 108' ' ' LEU . 12.5 t90 -98.5 137.0 37.82 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.989 0.9 . . . . 1.3300000000000001 109.554 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.489 ' H ' ' HD1' ' A' ' 44' ' ' TRP . 8.0 t -67.74 4.97 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 113.831 -1.531 . . . . 1.21 111.823 -176.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.66 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 1.2 t -94.76 -21.99 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 121.46 -0.775 . . . . 0.66000000000000003 111.672 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.78 -14.25 57.91 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.074 -1.06 . . . . 0.71999999999999997 111.842 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -104.53 -28.35 11.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 111.923 0.342 . . . . 2.9700000000000002 111.923 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -107.36 1.94 24.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.515 0.674 . . . . 1.8300000000000001 110.154 -171.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 55.7 tttm -55.69 -46.99 99.65 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.05 -0.977 . . . . 1.1299999999999999 112.086 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 11.1 Cg_endo -55.84 -26.87 59.68 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.23 1.953 . . . . 0.56000000000000005 112.636 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.555 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . 9.5 m -70.35 -45.16 66.68 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.852 0.834 . . . . 0.59999999999999998 108.99 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.569 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 16.7 m-85 -75.74 -24.21 56.1 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.116 -0.947 . . . . 0.93999999999999995 109.581 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.602 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 15.1 t70 -78.09 -37.98 45.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.534 -0.757 . . . . 1.1599999999999999 111.145 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.555 ' OE2' ' HA ' ' A' ' 52' ' ' THR . 15.5 pt-20 -68.06 -37.1 80.92 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.515 -0.474 . . . . 1.6299999999999999 110.559 176.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.7 mt -70.14 -28.24 35.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.251 0.548 . . . . 0.60999999999999999 109.612 173.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.602 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 66.4 t80 -61.51 -54.17 46.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.347 -0.842 . . . . 0.88 111.194 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.593 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 42.0 m-85 -68.75 -22.5 64.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.132 0.492 . . . . 1.03 110.786 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.9 m -72.77 -25.69 61.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.696 -0.683 . . . . 0.44 110.863 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.422 HD11 ' HG2' ' A' ' 75' ' ' GLU . 25.9 mt -87.6 -0.01 56.26 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.638 -0.256 . . . . 0.79000000000000004 111.439 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 t 67.55 87.51 0.12 Allowed Pre-proline 0 N--CA 1.467 0.377 0 CA-C-O 121.297 0.57 . . . . 0.64000000000000001 110.916 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.593 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 71.6 Cg_endo -81.03 159.28 20.75 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.634 2.222 . . . . 0.46000000000000002 112.65 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 97.4 t -128.92 121.21 53.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.081 -0.509 . . . . 1.3300000000000001 109.794 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 66.38 23.04 10.69 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.117 -0.492 . . . . 1.6699999999999999 112.168 174.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.21 23.02 23.4 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.871 -0.68 . . . . 0.5 112.114 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.897 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -167.48 159.77 12.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.588 -0.523 . . . . 1.8200000000000001 109.588 175.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.438 ' H ' HG12 ' A' ' 67' ' ' ILE . 1.5 pt -89.76 132.43 34.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 120.129 -0.628 . . . . 0.40999999999999998 110.345 173.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -59.2 130.55 47.5 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.693 -1.225 . . . . 0.69999999999999996 107.693 170.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.586 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -53.71 -26.26 31.75 Favored Glycine 0 C--O 1.219 -0.819 0 N-CA-C 114.69 0.636 . . . . 0.38 114.69 -166.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.15 -39.53 43.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 117.475 0.637 . . . . 0.44 111.437 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.44 -31.83 48.27 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.16 -0.473 . . . . 2.1099999999999999 110.087 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.685 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -74.05 -36.19 64.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.678 -0.692 . . . . 0.41999999999999998 109.718 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 14.7 mmmm -66.28 -37.97 86.7 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.707 -0.849 . . . . 1.6899999999999999 108.707 173.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -56.59 -44.89 81.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.526 -0.761 . . . . 1.3500000000000001 110.255 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.8 tp10 -61.81 -53.07 60.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.544 -1.207 . . . . 1.48 111.162 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.685 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 12.5 ptp -73.05 -16.69 61.48 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 122.068 -0.395 . . . . 0.65000000000000002 111.353 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.478 HG23 HD11 ' A' ' 86' ' ' LEU . 2.3 t -74.17 -49.64 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.577 0.227 . . . . 0.58999999999999997 110.832 173.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 14.6 ptpt -68.28 -12.18 60.62 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.085 0.469 . . . . 1.2 109.851 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 76' ' ' MET . 62.4 m -67.69 3.93 1.26 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.29 -0.868 . . . . 1.3700000000000001 111.835 170.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 74.36 37.95 0.55 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.26 0.624 . . . . 2.6499999999999999 111.686 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.585 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . 22.8 mt -113.49 157.47 41.26 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 120.809 -0.357 . . . . 1.1599999999999999 111.539 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.447 ' O ' HD23 ' A' ' 86' ' ' LEU . 84.3 Cg_endo -83.91 164.26 13.69 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.898 2.399 . . . . 0.94999999999999996 111.307 169.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.549 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 84.6 m-20 -54.75 -29.34 53.62 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.282 0.475 . . . . 1.53 112.282 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -59.94 -54.02 50.96 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.302 0.572 . . . . 1.24 110.776 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 24.0 t -66.31 -41.68 89.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.641 -0.708 . . . . 0.71999999999999997 109.927 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.585 ' CD2' ' HB2' ' A' ' 81' ' ' LEU . 3.9 mm? -49.52 -55.13 14.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.9 -0.591 . . . . 1.45 110.856 173.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.91 -44.5 97.33 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.392 -0.822 . . . . 0.39000000000000001 113.324 -175.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.618 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 55.5 pttt -80.19 -27.45 38.87 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.654 -0.818 . . . . 1.6599999999999999 111.676 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.404 HD13 HD13 ' A' ' 113' ' ' ILE . 17.4 mt -69.63 -41.55 80.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 120.536 -0.465 . . . . 1.1499999999999999 109.841 173.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.433 ' CH2' ' HG ' ' A' ' 101' ' ' LEU . 75.9 t-105 -55.87 -58.85 6.13 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.754 -0.657 . . . . 0.29999999999999999 110.346 175.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.618 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -69.44 -17.26 63.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.812 -0.631 . . . . 2.54 111.765 -172.82 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 14.3 tp -82.35 -37.4 25.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.129 -0.323 . . . . 0.85999999999999999 110.129 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.755 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -91.08 -33.75 15.36 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 120.556 -0.458 . . . . 0.45000000000000001 111.528 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.628 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 27.6 t0 -83.84 80.97 8.97 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.615 0.721 . . . . 0.62 109.922 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.448 HG22 HD11 ' A' ' 126' ' ' LEU . 16.0 t -67.34 -25.44 33.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 114.917 -1.038 . . . . 1.76 110.817 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.626 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.0 OUTLIER -90.43 -23.84 20.91 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.619 -0.718 . . . . 1.7 112.234 -178.214 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.549 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 21.8 mtpt 67.02 45.22 1.8 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.769 0.795 . . . . 1.74 110.364 167.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 p30 -105.31 -1.06 25.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.759 -1.11 . . . . 1.51 112.371 -171.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.87 19.38 77.71 Favored Glycine 0 C--N 1.322 -0.224 0 C-N-CA 119.506 -1.33 . . . . 0.28999999999999998 112.326 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.897 HD13 ' HG3' ' A' ' 66' ' ' LYS . 4.4 pp -151.33 171.41 17.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.796 -0.816 . . . . 0.54000000000000004 108.796 174.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.581 HD12 ' HB1' ' A' ' 72' ' ' ALA . 44.2 mt -148.59 116.17 6.26 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.82 -1.178 . . . . 0.68000000000000005 107.82 -172.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -77.13 -175.94 3.83 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.086 -0.646 . . . . 1.5 109.366 178.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -60.26 -31.18 69.97 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.358 0.526 . . . . 1.73 111.164 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.644 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 34.0 tt0 -73.91 -39.94 63.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.426 0.631 . . . . 2.1400000000000001 110.107 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.665 ' OE2' 'CA ' ' A' ' 141' ' ' ' CA' . 3.8 mt-10 -66.99 -39.16 87.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.672 -0.695 . . . . 1.1100000000000001 111.919 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.626 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -64.63 -39.2 93.28 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.158 -1.052 . . . . 1.0700000000000001 108.158 175.32 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.569 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -50.95 -49.14 60.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.19 110.581 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.806 ' HG ' ' CH2' ' A' ' 44' ' ' TRP . 1.1 tt -70.56 -50.42 37.65 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.443 -0.503 . . . . 1.23 110.509 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.47 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -45.73 -55.63 6.25 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.33 0.492 . . . . 0.22 112.33 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.553 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 2.6 t-20 -72.84 -23.31 60.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.677 -0.49 . . . . 1.1799999999999999 109.677 -177.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.496 ' CD2' HD11 ' A' ' 130' ' ' LEU . 70.8 t60 -68.01 -43.93 77.71 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.236 -0.653 . . . . 0.48999999999999999 109.236 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.639 HD22 ' CD1' ' A' ' 122' ' ' LEU . 46.7 mt -64.64 -32.81 74.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.107 -0.497 . . . . 0.55000000000000004 110.191 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 109' ' ' ALA . 41.4 mm -61.11 -50.92 78.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.886 -0.597 . . . . 0.81000000000000005 111.001 176.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.485 ' HD3' ' OH ' ' A' ' 53' ' ' TYR . 18.7 ptmt -72.33 -24.47 61.31 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.086 -0.646 . . . . 2.2200000000000002 110.823 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 111' ' ' HIS . 11.5 t -60.46 -47.22 93.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.318 -0.401 . . . . 0.48999999999999999 110.39 172.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 0.9 OUTLIER -85.38 0.5 51.97 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 120.36 -0.536 . . . . 1.9099999999999999 110.635 178.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.1 tp -81.83 -26.6 34.15 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.604 -0.517 . . . . 1.28 109.604 171.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.33 -22.17 65.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.801 -0.636 . . . . 1.99 111.169 177.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.09 10.79 13.24 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.351 -0.928 . . . . 1.01 112.698 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.61 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -127.21 133.49 50.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.553 -0.536 . . . . 0.87 109.553 174.402 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -78.34 163.36 25.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.783 0.325 . . . . 2.75 110.935 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.639 ' CD1' HD22 ' A' ' 112' ' ' LEU . 3.5 mm? -70.44 144.86 92.27 Favored Pre-proline 0 CA--C 1.513 -0.474 0 CA-C-N 116.077 -0.51 . . . . 2.7000000000000002 111.818 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.616 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 68.9 Cg_endo -77.62 -6.37 16.12 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 124.453 3.435 . . . . 1.1000000000000001 113.404 -173.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.22 19.53 11.72 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.632 0.73 . . . . 1.3400000000000001 109.655 -170.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.616 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 38.8 t70 -120.45 145.82 46.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.943 -1.026 . . . . 2.3599999999999999 108.985 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.448 HD11 HG22 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -115.15 104.41 53.79 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 116.353 -0.385 . . . . 1.8300000000000001 110.018 -176.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 5.7 Cg_endo -87.9 147.01 6.85 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.334 2.689 . . . . 1.0 111.982 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -55.08 -30.35 69.95 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.762 2.308 . . . . 1.3400000000000001 113.321 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -80.94 22.72 0.6 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.995 -0.282 . . . . 1.48 111.109 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.531 ' HA ' ' CD2' ' A' ' 44' ' ' TRP . 0.6 OUTLIER -150.29 8.52 0.62 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.619 -0.433 . . . . 1.29 111.477 177.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.1 132.09 31.57 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.942 -0.762 . . . . 1.72 108.942 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.862 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 37.4 Cg_exo -57.23 142.92 94.68 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.29 1.994 . . . . 1.04 112.539 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.484 ' HA ' ' HG2' ' A' ' 136' ' ' ARG . 89.7 Cg_exo -46.06 -23.77 1.99 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.581 3.521 . . . . 1.4399999999999999 115.914 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.6 p -82.33 -24.05 34.79 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.837 -0.539 . . . . 2.2999999999999998 112.32 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.862 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -119.15 17.9 13.13 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.553 0.575 . . . . 3.4199999999999999 112.553 -174.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.484 ' HG2' ' HA ' ' A' ' 133' ' ' PRO . 0.3 OUTLIER -73.76 71.3 1.45 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.19 0.519 . . . . 4.7199999999999998 110.016 172.253 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -157.83 113.85 2.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.922 -0.581 . . . . 5.0099999999999998 110.754 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -93.09 111.02 22.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.031 -0.532 . . . . 6.3899999999999997 109.569 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.319 -0.848 . . . . 6.9100000000000001 110.047 -176.342 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.665 'CA ' ' OE2' ' A' ' 105' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.4 ' HA3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 112.509 -0.237 . . . . 42.189999999999998 112.509 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.4 ' HD3' ' HA3' ' A' ' 1' ' ' GLY . 27.0 Cg_exo -63.16 -58.21 0.32 Allowed 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.067 2.512 . . . . 41.840000000000003 113.127 -177.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.773 HD23 ' H ' ' A' ' 3' ' ' LEU . 2.5 pt? -87.52 145.51 26.2 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.516 -0.311 . . . . 43.409999999999997 110.672 -176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 112.83 -15.18 23.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.974 -0.631 . . . . 41.270000000000003 112.438 177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.5 m -83.53 102.62 12.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.873 0.368 . . . . 40.149999999999999 110.663 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -64.84 135.75 56.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.915 -0.584 . . . . 38.670000000000002 110.022 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.4 t -89.92 114.22 25.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.094 0.473 . . . . 37.240000000000002 110.993 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -129.04 140.2 51.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.842 -0.617 . . . . 36.32 109.856 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.462 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 65.0 mtt -84.3 132.04 48.74 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 110.32 -0.252 . . . . 35.030000000000001 110.32 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 54.4 Cg_exo -52.01 -72.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.262 2.641 . . . . 34.310000000000002 113.548 -172.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 p -93.73 89.54 6.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.246 0.546 . . . . 33.799999999999997 110.459 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -104.32 93.99 5.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.537 -0.756 . . . . 34.579999999999998 109.834 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.29 136.49 57.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.819 -0.628 . . . . 33.82 109.609 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 p -119.16 112.46 37.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.395 0.617 . . . . 35.100000000000001 111.559 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -101.07 75.71 1.68 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.587 -0.733 . . . . 35.140000000000001 109.199 175.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.43 105.42 1.84 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.713 -0.756 . . . . 36.609999999999999 112.904 -173.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.95 26.66 70.36 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 121.545 -0.36 . . . . 36.640000000000001 112.822 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.27 123.89 39.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.645 0.26 . . . . 35.420000000000002 110.447 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -83.55 106.31 15.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.088 -0.505 . . . . 35.770000000000003 110.432 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -90.81 93.3 9.17 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.915 -0.772 . . . . 33.670000000000002 108.915 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.6 128.26 9.11 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.587 -0.816 . . . . 33.350000000000001 112.479 -174.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.0 m -147.86 104.79 3.61 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.947 0.403 . . . . 32.890000000000001 110.435 176.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 21.7 ptm -154.99 118.75 4.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.327 0.584 . . . . 33.5 110.461 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -110.21 132.46 54.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.809 -0.632 . . . . 33.880000000000003 110.066 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.706 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . 112.62 12.74 12.46 Favored Glycine 0 CA--C 1.543 1.783 0 CA-C-O 118.226 -1.319 . . . . 33.450000000000003 115.801 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.706 ' HD3' ' N ' ' A' ' 25' ' ' GLY . 7.8 Cg_exo -72.72 -57.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.366 1.464 0 CA-C-N 122.059 2.93 . . . . 32.82 111.504 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -127.39 141.74 51.61 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.537 -0.542 . . . . 34.289999999999999 109.537 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.19 169.05 14.05 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.872 -0.68 . . . . 31.66 111.447 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -80.99 163.88 22.95 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.643 -0.503 . . . . 31.329999999999998 109.643 177.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.79 97.71 0.09 OUTLIER Glycine 0 C--N 1.33 0.241 0 O-C-N 123.393 0.433 . . . . 28.859999999999999 113.66 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -102.77 170.87 7.74 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.041 -0.355 . . . . 27.66 110.041 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.14 136.91 49.5 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.116 -0.564 . . . . 24.739999999999998 112.95 -175.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -61.18 131.39 50.32 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.717 0.294 . . . . 22.32 110.766 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.99 135.7 12.81 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.682 -0.771 . . . . 19.489999999999998 113.307 -173.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.42 161.68 14.13 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.096 -0.335 . . . . 17.420000000000002 110.096 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.78 104.08 1.65 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.068 -0.587 . . . . 14.76 112.738 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER -94.07 -178.05 4.51 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.105 -0.702 . . . . 13.02 109.105 177.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.435 ' H ' ' CD ' ' A' ' 37' ' ' GLU . . . -77.93 71.16 2.43 Favored Glycine 0 CA--C 1.503 -0.711 0 C-N-CA 120.306 -0.949 . . . . 10.279999999999999 111.99 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.401 ' H ' HG12 ' A' ' 39' ' ' ILE . 5.9 pt -63.89 157.22 4.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.588 -0.806 . . . . 9.1199999999999992 109.013 171.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.17 80.72 1.29 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.983 0.897 . . . . 6.5199999999999996 109.824 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.62 104.28 0.26 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.293 -1.321 . . . . 6.3099999999999996 110.117 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 p -114.63 103.65 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.66 0.743 . . . . 3.3300000000000001 110.828 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -93.65 93.14 7.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.725 -0.67 . . . . 3.9399999999999999 109.761 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.728 ' CH2' ' HG ' ' A' ' 108' ' ' LEU . 10.5 t90 -125.05 140.11 53.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.63 -0.713 . . . . 1.3300000000000001 110.202 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.513 ' H ' ' HD1' ' A' ' 44' ' ' TRP . 14.1 t -61.14 -12.23 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 114.928 -1.033 . . . . 1.21 112.153 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 2.2 t -80.54 -17.74 12.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 120.951 -1.093 . . . . 0.66000000000000003 111.321 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.71 -17.15 62.27 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.694 -1.241 . . . . 0.71999999999999997 111.741 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 17.8 ptmt -106.97 -29.4 9.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.002 0.371 . . . . 2.9700000000000002 112.002 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 84.5 m-20 -89.33 -11.55 43.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 1.8300000000000001 110.676 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 49.9 tttm -49.87 -51.48 60.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.209 -0.905 . . . . 1.1299999999999999 112.409 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 8.0 Cg_endo -50.6 -35.64 47.39 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 122.726 2.284 . . . . 0.56000000000000005 113.837 -178.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.672 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 87.5 m -72.5 -40.64 66.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.999 0.904 . . . . 0.59999999999999998 110.328 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.65 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 10.3 m-85 -76.86 -23.85 52.63 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.766 0.793 . . . . 0.93999999999999995 109.279 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 7.2 t70 -80.66 -33.32 35.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.635 -1.166 . . . . 1.1599999999999999 110.776 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.672 ' HG2' ' O ' ' A' ' 52' ' ' THR . 14.0 pt-20 -69.47 -35.9 76.04 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.606 -0.516 . . . . 1.6299999999999999 109.606 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 52' ' ' THR . 46.5 mt -71.84 -29.8 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.224 -0.658 . . . . 0.60999999999999999 109.224 174.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 72.7 t80 -61.81 -57.42 11.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.146 -0.933 . . . . 0.88 111.534 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 42.8 m-85 -64.1 -22.32 66.89 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.037 0.446 . . . . 1.03 110.908 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.5 m -73.07 -32.05 64.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.923 -0.58 . . . . 0.44 111.516 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.1 mt -84.89 1.3 47.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.624 0.25 . . . . 0.79000000000000004 111.261 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t 70.9 85.76 0.12 Allowed Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.604 -0.726 . . . . 0.64000000000000001 111.125 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 74.3 Cg_endo -81.63 123.86 4.42 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.702 2.268 . . . . 0.46000000000000002 112.647 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.5 t -87.33 109.72 19.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.245 -0.434 . . . . 1.3300000000000001 110.027 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 66.06 23.75 11.05 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.322 0.389 . . . . 1.6699999999999999 111.378 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.67 27.79 12.29 Favored Glycine 0 C--O 1.228 -0.254 0 C-N-CA 121.054 -0.593 . . . . 0.5 113.565 170.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -164.39 147.39 9.09 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.306 -0.627 . . . . 1.8200000000000001 109.306 172.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.939 ' HB ' HD21 ' A' ' 71' ' ' ASN . 3.0 pt -86.89 137.11 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 120.695 -0.402 . . . . 0.40999999999999998 110.437 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.5 p -60.32 124.3 19.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.755 -1.202 . . . . 0.69999999999999996 107.755 170.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.586 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -46.94 -31.76 5.77 Favored Glycine 0 C--O 1.222 -0.608 0 C-N-CA 121.302 -0.475 . . . . 0.38 114.26 -168.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -43.73 -52.0 6.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.31 0.485 . . . . 0.44 112.31 173.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.939 HD21 ' HB ' ' A' ' 67' ' ' ILE . 11.7 p30 -71.03 -30.85 67.17 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.056 0.389 . . . . 2.1099999999999999 110.586 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.582 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -72.12 -31.76 66.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.585 0.707 . . . . 0.41999999999999998 109.612 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 31.6 mmmt -68.32 -35.85 78.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.072 -0.967 . . . . 1.6899999999999999 109.474 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.805 ' HG2' ' HA ' ' A' ' 71' ' ' ASN . 9.0 mmmm -59.45 -48.58 81.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 1.3500000000000001 109.503 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 23.6 mm-40 -54.73 -52.49 62.33 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.793 -1.094 . . . . 1.48 112.182 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.582 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 14.7 ptp -69.54 -29.38 66.95 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.126 -0.63 . . . . 0.65000000000000002 110.916 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.42 -45.83 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.489 0.185 . . . . 0.58999999999999997 110.854 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 17.4 ptpt -72.78 -14.32 61.5 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.038 0.446 . . . . 1.2 110.458 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 50.1 m -66.15 -13.03 59.51 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.454 -0.794 . . . . 1.3700000000000001 110.186 168.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 97.3 mttt 71.91 39.63 0.81 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.599 0.76 . . . . 2.6499999999999999 112.014 165.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.87 HD11 ' HE2' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -102.18 159.45 29.34 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.841 -0.618 . . . . 1.1599999999999999 110.115 -179.142 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.537 ' HG2' HG23 ' A' ' 85' ' ' VAL . 31.6 Cg_endo -66.88 153.3 78.39 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.893 1.729 . . . . 0.94999999999999996 110.742 172.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.782 ' HA ' HD12 ' A' ' 86' ' ' LEU . 6.4 m-20 -49.86 -31.74 12.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.005 -0.543 . . . . 1.53 112.042 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.5 m -60.33 -55.59 31.84 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.209 0.528 . . . . 1.24 110.628 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.588 ' O ' HG13 ' A' ' 89' ' ' ILE . 91.1 t -60.63 -44.46 96.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 CA-C-N 115.745 -0.661 . . . . 0.71999999999999997 110.071 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.782 HD12 ' HA ' ' A' ' 83' ' ' ASN . 24.9 mt -60.08 -49.96 75.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.383 -0.372 . . . . 1.45 111.984 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -55.77 -42.41 85.43 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.146 -0.782 . . . . 0.39000000000000001 111.146 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 61.6 pttt -86.51 -13.49 45.83 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.491 -0.883 . . . . 1.6599999999999999 111.778 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 85' ' ' VAL . 23.0 mt -71.59 -43.51 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 N-CA-C 108.511 -0.922 . . . . 1.1499999999999999 108.511 170.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.451 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 71.4 t-105 -60.36 -56.77 17.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.82 -0.627 . . . . 0.29999999999999999 111.021 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 62.7 mttm -72.22 -21.45 61.4 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.65 -0.705 . . . . 2.54 111.965 -169.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 5.5 tp -86.32 -19.65 29.51 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.801 -0.444 . . . . 0.85999999999999999 109.801 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.892 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -93.05 -44.29 8.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.126 0.488 . . . . 0.45000000000000001 110.921 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 46.9 t0 -87.99 74.46 8.93 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.031 -1.1 . . . . 0.62 108.031 173.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.442 HG12 ' NZ ' ' A' ' 135' ' ' LYS . 17.1 t -69.87 -6.96 7.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.19 -0.914 . . . . 1.76 109.81 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -94.18 -26.33 16.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.967 -1.015 . . . . 1.7 109.725 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 59.66 73.34 0.49 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.329 -0.85 . . . . 1.74 111.833 169.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.68 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 1.4 p30 -128.28 -23.47 3.25 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.913 -1.039 . . . . 1.51 112.078 -171.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.78 7.47 38.88 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.165 -1.016 . . . . 0.28999999999999998 112.529 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.504 ' HG ' ' OD1' ' A' ' 98' ' ' ASP . 3.6 pp -142.21 -175.21 4.35 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.805 -0.813 . . . . 0.54000000000000004 108.805 174.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.642 ' O ' HG12 ' A' ' 67' ' ' ILE . 50.8 mt -151.45 112.6 4.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.367 -1.345 . . . . 0.68000000000000005 107.367 -177.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.7 p30 -76.73 -175.75 3.55 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.674 -0.81 . . . . 1.5 109.809 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.08 -32.96 66.8 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.105 0.478 . . . . 1.73 111.879 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 35.5 tt0 -85.81 -29.01 24.12 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.314 0.578 . . . . 2.1400000000000001 110.246 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.49 ' HB3' HD22 ' A' ' 101' ' ' LEU . 4.0 mt-10 -75.15 -33.39 61.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.764 -0.653 . . . . 1.1100000000000001 110.977 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.672 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.6 OUTLIER -66.99 -40.23 87.32 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.638 -1.245 . . . . 1.0700000000000001 107.638 171.107 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.65 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -51.15 -46.19 61.94 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.078 -0.51 . . . . 0.19 110.607 175.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.892 HD22 ' HA ' ' A' ' 93' ' ' ALA . 1.4 tt -67.6 -48.89 65.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.309 -0.405 . . . . 1.23 110.353 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.403 ' HB2' HD13 ' A' ' 101' ' ' LEU . . . -49.88 -57.29 7.75 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.921 -0.582 . . . . 0.22 112.296 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.451 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 3.3 t30 -70.61 -28.64 65.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.02 0.438 . . . . 1.1799999999999999 110.066 -174.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.553 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 66.7 t60 -69.88 -36.37 75.4 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.48999999999999999 110.032 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.536 HD22 HD22 ' A' ' 122' ' ' LEU . 41.8 mt -69.2 -35.97 76.8 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.949 -0.389 . . . . 0.55000000000000004 109.949 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.687 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 76.3 mt -58.37 -45.21 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.414 -0.357 . . . . 0.81000000000000005 111.379 172.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 111' ' ' HIS . 5.5 ptmm? -67.7 -33.05 74.13 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 119.658 -0.817 . . . . 2.2200000000000002 110.605 177.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 111' ' ' HIS . 37.4 t -62.75 -44.25 99.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.899 0.38 . . . . 0.48999999999999999 110.719 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.87 ' HE2' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -76.6 -6.88 53.85 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.099 0.476 . . . . 1.9099999999999999 110.391 176.173 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.1 tp -91.09 -15.89 28.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.339 0.59 . . . . 1.28 109.831 172.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 50.0 mt-10 -81.42 2.07 30.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.635 -0.711 . . . . 1.99 110.761 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.79 5.75 33.25 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.281 -0.962 . . . . 1.01 113.076 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.627 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -141.13 137.29 32.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.304 0.573 . . . . 0.87 111.161 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.54 163.93 25.88 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.216 -0.902 . . . . 2.75 111.421 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.536 HD22 HD22 ' A' ' 112' ' ' LEU . 39.4 mt -73.36 144.9 84.71 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.908 -0.587 . . . . 2.7000000000000002 110.823 -178.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.587 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 46.9 Cg_endo -82.56 -1.07 10.45 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.216 2.611 . . . . 1.1000000000000001 113.497 -172.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.54 19.4 11.21 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.744 0.783 . . . . 1.3400000000000001 109.954 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.587 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 32.2 t70 -117.31 150.53 38.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.687 -1.142 . . . . 2.3599999999999999 109.207 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 2.3 tm? -124.37 103.14 32.61 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 109.216 -0.661 . . . . 1.8300000000000001 109.216 -177.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 4.8 Cg_exo -77.55 147.92 25.65 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.97 2.447 . . . . 1.0 112.66 -176.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.483 ' HA ' HG13 ' A' ' 131' ' ' VAL . 50.9 Cg_exo -53.45 -35.52 76.2 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.258 2.639 . . . . 1.3400000000000001 112.848 177.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.535 ' O ' HD12 ' A' ' 130' ' ' LEU . 49.9 p-80 -82.27 18.48 1.41 Allowed 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 120.62 -0.432 . . . . 1.48 110.996 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.609 ' HG ' ' CE2' ' A' ' 44' ' ' TRP . 2.9 mp -138.7 16.41 2.7 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.475 0.485 . . . . 1.29 110.888 172.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.483 HG13 ' HA ' ' A' ' 128' ' ' PRO . 32.4 m -77.66 116.52 58.87 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 120.133 -0.627 . . . . 1.72 110.211 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.625 ' HG2' ' HG3' ' A' ' 135' ' ' LYS . 37.2 Cg_endo -67.59 116.75 4.41 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.099 1.866 . . . . 1.04 111.611 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.4 -24.06 20.52 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 123.033 2.488 . . . . 1.4399999999999999 112.695 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.6 t -56.49 -33.5 66.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.409 -0.36 . . . . 2.2999999999999998 111.027 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.682 ' HD3' ' HD2' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -100.48 4.51 43.72 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.372 0.606 . . . . 3.4199999999999999 110.632 178.257 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.682 ' HD2' ' HD3' ' A' ' 135' ' ' LYS . 10.0 mmm180 -94.96 69.49 3.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.189 -0.459 . . . . 4.7199999999999998 110.523 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.446 ' NH1' ' HA ' ' A' ' 135' ' ' LYS . 0.5 OUTLIER -83.1 101.92 11.48 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.857 -0.61 . . . . 5.0099999999999998 110.527 177.221 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -98.95 95.57 7.25 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.703 -0.851 . . . . 6.3899999999999997 108.703 172.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.694 -0.669 . . . . 6.9100000000000001 110.039 178.162 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.68 'CA ' ' OD2' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.931 0 N-CA-C 111.734 -0.546 . . . . 42.189999999999998 111.734 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.62 112.78 3.15 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.646 2.231 . . . . 41.840000000000003 111.339 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.68 109.17 17.81 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.932 -0.396 . . . . 43.409999999999997 109.932 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.3 4.67 64.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.152 -0.547 . . . . 41.270000000000003 112.059 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.6 m -74.93 130.59 39.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.123 0.487 . . . . 40.149999999999999 110.963 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.06 116.72 9.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.337 -0.847 . . . . 38.670000000000002 110.953 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.0 m -75.92 107.09 7.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.918 -0.583 . . . . 37.240000000000002 109.909 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.8 tp -85.18 135.68 33.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.007 -0.542 . . . . 36.32 110.529 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.438 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 64.9 mtm -101.22 119.7 57.08 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.99 -0.55 . . . . 35.030000000000001 110.121 177.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 9' ' ' MET . 11.9 Cg_endo -56.19 111.12 0.68 Allowed 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.613 2.208 . . . . 34.310000000000002 111.513 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.8 m -84.38 88.76 7.28 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.228 0.537 . . . . 33.799999999999997 110.658 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -90.82 98.14 11.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.301 -0.629 . . . . 34.579999999999998 109.301 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.0 m -90.53 126.92 43.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.108 -0.496 . . . . 33.82 111.427 -176.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.3 t -81.32 95.28 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.47 -0.937 . . . . 35.100000000000001 108.47 173.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -108.53 143.09 38.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.021 -0.99 . . . . 35.140000000000001 110.66 -171.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.96 130.09 27.32 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.337 -1.105 . . . . 36.609999999999999 110.337 174.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.06 30.57 12.43 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.224 -0.989 . . . . 36.640000000000001 111.027 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.74 123.63 18.92 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.857 0.36 . . . . 35.420000000000002 110.659 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -88.33 129.35 35.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.969 -0.56 . . . . 35.770000000000003 110.263 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -72.96 116.37 13.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.121 -0.491 . . . . 33.670000000000002 111.137 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.96 67.68 0.27 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.756 -0.735 . . . . 33.350000000000001 111.365 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.1 t -84.58 152.99 23.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.84 0.353 . . . . 32.890000000000001 110.917 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.69 138.88 45.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 33.5 109.765 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -102.41 141.25 35.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.452 -0.34 . . . . 33.880000000000003 110.326 -174.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.712 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . 115.37 3.8 20.63 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-O 118.028 -1.429 . . . . 33.450000000000003 115.894 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.712 ' HD3' ' N ' ' A' ' 25' ' ' GLY . 2.7 Cg_endo -82.33 -19.14 6.77 Favored 'Trans proline' 0 C--N 1.372 1.795 0 CA-C-N 122.355 3.077 . . . . 32.82 112.403 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -127.25 153.69 45.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.658 -0.497 . . . . 34.289999999999999 109.658 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.57 115.89 7.41 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.808 -0.711 . . . . 31.66 111.886 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -130.9 152.92 49.7 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.848 -0.427 . . . . 31.329999999999998 109.848 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.43 -172.59 2.18 Favored Glycine 0 CA--C 1.521 0.429 0 O-C-N 123.841 0.713 . . . . 28.859999999999999 112.668 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -59.56 167.36 2.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.707 0.289 . . . . 27.66 111.198 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.42 107.61 1.06 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.073 -0.512 . . . . 24.739999999999998 112.353 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 33' ' ' GLU . 6.2 pt-20 -81.1 117.18 21.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.021 0.439 . . . . 22.32 110.582 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.21 126.26 7.75 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.633 -0.712 . . . . 19.489999999999998 112.3 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.69 162.27 14.01 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.01 -0.367 . . . . 17.420000000000002 110.01 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -110.93 116.37 4.26 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.935 -0.65 . . . . 14.76 111.726 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -81.42 179.7 7.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.495 0.188 . . . . 13.02 110.6 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.53 71.76 2.88 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.302 -0.952 . . . . 10.279999999999999 112.732 -172.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.4 HG13 ' H ' ' A' ' 39' ' ' ILE . 1.6 pp -71.18 155.92 7.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 108.414 -0.958 . . . . 9.1199999999999992 108.414 168.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -75.24 73.41 2.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.931 0.872 . . . . 6.5199999999999996 111.312 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -110.72 81.57 1.45 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.226 -1.398 . . . . 6.3099999999999996 107.226 170.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.97 110.35 28.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.176 0.513 . . . . 3.3300000000000001 111.975 -169.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -140.59 103.02 4.45 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.217 -1.031 . . . . 3.9399999999999999 108.217 167.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.655 ' CE2' ' HG ' ' A' ' 130' ' ' LEU . 9.1 t90 -86.71 133.48 33.67 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.724 0.773 . . . . 1.3300000000000001 109.837 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.465 ' H ' ' HD1' ' A' ' 44' ' ' TRP . 12.4 t -69.35 -6.17 5.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.596 -1.184 . . . . 1.21 111.408 -177.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 4.1 t -83.6 -27.66 7.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 121.771 -0.581 . . . . 0.66000000000000003 111.717 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.43 -19.47 53.39 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 119.564 -1.303 . . . . 0.71999999999999997 112.053 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 3.7 ptpp? -101.63 -28.6 12.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.336 0.495 . . . . 2.9700000000000002 112.336 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -106.55 5.81 29.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.716 0.77 . . . . 1.8300000000000001 110.36 -172.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.575 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 62.0 tttm -59.34 -46.69 99.02 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.17 -0.923 . . . . 1.1299999999999999 112.222 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 18.2 Cg_endo -60.02 -23.48 73.23 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.905 1.737 . . . . 0.56000000000000005 112.397 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.758 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 81.8 m -78.23 -36.48 47.02 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.433 0.635 . . . . 0.59999999999999998 110.023 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.46 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 16.1 m-85 -80.55 -25.34 38.67 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.344 -0.942 . . . . 0.93999999999999995 109.917 177.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 4.4 t70 -76.45 -34.94 58.71 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.096 -0.956 . . . . 1.1599999999999999 110.154 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.758 ' HG2' ' O ' ' A' ' 52' ' ' THR . 12.7 pt-20 -65.3 -42.28 93.21 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.53 -0.544 . . . . 1.6299999999999999 109.53 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 52' ' ' THR . 60.0 mt -67.38 -32.72 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 109.621 -0.511 . . . . 0.60999999999999999 109.621 175.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.55 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 66.8 t80 -57.06 -55.27 36.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.192 -0.913 . . . . 0.88 111.755 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.482 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 67.7 m-85 -69.23 -23.1 63.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.989 0.423 . . . . 1.03 110.61 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.0 m -70.41 -21.69 62.81 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.614 -0.721 . . . . 0.44 110.771 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.416 HD11 ' CG ' ' A' ' 75' ' ' GLU . 35.0 mt -88.7 -1.05 57.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.664 -0.244 . . . . 0.79000000000000004 111.301 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.2 t 65.55 81.12 0.22 Allowed Pre-proline 0 N--CA 1.465 0.315 0 O-C-N 123.594 0.559 . . . . 0.64000000000000001 111.218 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 62.9 Cg_endo -80.22 166.56 20.43 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.346 2.031 . . . . 0.46000000000000002 111.517 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' A' ' 64' ' ' ASN . 2.2 m -135.57 118.66 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 121.211 -0.196 . . . . 1.3300000000000001 110.62 -177.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.458 ' HB3' ' NZ ' ' A' ' 66' ' ' LYS . 28.7 t-20 67.95 21.66 8.84 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 122.242 1.02 . . . . 1.6699999999999999 109.901 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.34 26.19 16.57 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.592 -0.813 . . . . 0.5 114.418 172.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -166.21 157.28 13.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.488 0.644 . . . . 1.8200000000000001 110.075 174.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.415 HD13 ' CD2' ' A' ' 106' ' ' PHE . 1.8 pt -91.58 128.92 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 120.622 -0.431 . . . . 0.40999999999999998 110.564 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -71.79 82.6 0.89 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.899 -0.592 . . . . 0.69999999999999996 111.485 179.621 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.589 ' H ' ' HA ' ' A' ' 100' ' ' LEU . . . 44.28 -76.58 0.0 OUTLIER Glycine 0 C--O 1.226 -0.347 0 CA-C-N 113.844 -1.525 . . . . 0.38 116.201 167.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' THR . . . -46.6 -29.01 1.63 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.043 0.757 . . . . 0.44 113.043 -176.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -71.72 -42.65 67.07 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.148 0.499 . . . . 2.1099999999999999 110.101 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.486 ' CB ' HD12 ' A' ' 101' ' ' LEU . . . -72.0 -33.89 68.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.48 0.657 . . . . 0.41999999999999998 109.993 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.661 ' O ' HG23 ' A' ' 77' ' ' VAL . 29.6 mmmt -64.32 -38.95 92.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.363 -0.835 . . . . 1.6899999999999999 109.576 174.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.404 ' HB2' ' HE3' ' A' ' 74' ' ' LYS . 1.0 OUTLIER -54.84 -47.18 74.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.506 -0.77 . . . . 1.3500000000000001 109.992 175.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.68 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 8.7 mm-40 -60.7 -48.67 80.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.371 -1.286 . . . . 1.48 111.919 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.475 ' SD ' ' HD2' ' A' ' 73' ' ' LYS . 17.6 ptp -70.34 -15.53 62.88 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.739 -0.384 . . . . 0.65000000000000002 111.125 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 73' ' ' LYS . 54.0 t -75.41 -50.25 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.749 0.309 . . . . 0.58999999999999997 110.56 171.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.68 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 8.7 ptmt -68.72 -11.83 60.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.089 0.471 . . . . 1.2 110.453 -177.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.3 t -69.24 -8.1 42.83 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.845 -0.616 . . . . 1.3700000000000001 110.409 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 47.5 mttp 65.98 68.58 0.46 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.552 -0.749 . . . . 2.6499999999999999 110.431 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.691 ' HB2' HD12 ' A' ' 86' ' ' LEU . 27.7 mt -130.09 158.93 72.57 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.426 -0.806 . . . . 1.1599999999999999 110.632 -175.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.546 ' HG2' HG23 ' A' ' 85' ' ' VAL . 61.5 Cg_endo -75.5 164.35 32.6 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.322 2.015 . . . . 0.94999999999999996 110.796 168.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.95 -25.91 68.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.897 0.38 . . . . 1.53 111.326 -177.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -53.99 48.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.232 0.539 . . . . 1.24 110.527 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.546 HG23 ' HG2' ' A' ' 82' ' ' PRO . 85.1 t -63.75 -46.21 95.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.506 -0.77 . . . . 0.71999999999999997 110.382 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.691 HD12 ' HB2' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -53.87 -53.0 58.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.016 0.436 . . . . 1.45 111.766 177.057 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.84 -35.03 89.44 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.7 -0.682 . . . . 0.39000000000000001 112.539 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.861 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 53.6 pttt -89.32 -21.0 23.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.703 -0.799 . . . . 1.6599999999999999 111.009 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.2 mt -69.4 -43.52 80.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.299 -0.63 . . . . 1.1499999999999999 109.299 170.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.47 ' CE3' ' HD3' ' A' ' 73' ' ' LYS . 76.6 t-105 -58.6 -54.98 40.93 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.214 -0.448 . . . . 0.29999999999999999 110.882 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.861 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -71.46 -15.6 62.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.879 -0.6 . . . . 2.54 112.031 -173.125 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.409 HD23 HD23 ' A' ' 122' ' ' LEU . 13.4 tp -94.24 -24.93 17.27 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.929 -0.308 . . . . 0.85999999999999999 110.26 176.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.884 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -80.34 -42.66 22.53 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.096 0.474 . . . . 0.45000000000000001 110.614 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.519 ' HB2' HD21 ' A' ' 101' ' ' LEU . 48.3 t0 -100.99 114.54 28.56 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.458 -0.571 . . . . 0.62 109.458 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.2 t -74.68 -23.04 17.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.189 -0.914 . . . . 1.76 111.554 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.1 OUTLIER -103.85 -25.4 13.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.985 0.421 . . . . 1.7 110.192 -175.736 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.507 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 57.8 mttt 60.92 71.71 0.55 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.129 -0.941 . . . . 1.74 110.87 169.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.622 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 1.9 p30 -101.66 -22.27 14.48 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.384 -1.28 . . . . 1.51 111.749 -171.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.41 9.81 28.53 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.71 -0.757 . . . . 0.28999999999999998 112.392 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.589 ' HA ' ' H ' ' A' ' 69' ' ' GLY . 3.7 pp -148.26 178.61 8.42 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.252 0.621 . . . . 0.54000000000000004 109.521 176.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.519 HD21 ' HB2' ' A' ' 94' ' ' ASP . 87.2 mt -146.96 122.55 10.46 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.25 -0.648 . . . . 0.68000000000000005 109.25 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -74.16 -173.96 1.8 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.866 -0.521 . . . . 1.5 110.317 176.378 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -59.83 -34.05 72.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.98 0.419 . . . . 1.73 111.404 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 26.3 tt0 -86.3 -33.87 20.51 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.918 0.39 . . . . 2.1400000000000001 110.755 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.626 ' OE2' 'CA ' ' A' ' 141' ' ' ' CA' . 2.4 mt-10 -62.2 -39.2 91.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.298 -0.41 . . . . 1.1100000000000001 110.496 174.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.582 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -62.88 -43.61 98.33 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.193 -1.04 . . . . 1.0700000000000001 108.193 173.197 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 104' ' ' GLU . . . -50.75 -47.44 59.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.683 -0.69 . . . . 0.19 110.986 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.884 HD22 ' HA ' ' A' ' 93' ' ' ALA . 2.5 tt -66.82 -50.77 61.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.021 -0.363 . . . . 1.23 110.021 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.81 -57.21 7.82 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.796 0.665 . . . . 0.22 112.796 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.425 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 0.2 OUTLIER -66.72 -29.04 68.92 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.286 0.565 . . . . 1.1799999999999999 109.485 -176.599 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.556 ' O ' HG23 ' A' ' 115' ' ' VAL . 64.5 t60 -68.1 -42.9 79.62 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.992 -0.549 . . . . 0.48999999999999999 109.886 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.7 ' HB3' HD21 ' A' ' 122' ' ' LEU . 34.5 mt -64.03 -34.68 78.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.064 -0.516 . . . . 0.55000000000000004 110.589 176.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 110' ' ' ASN . 95.2 mt -61.41 -48.6 88.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.921 -0.581 . . . . 0.81000000000000005 110.495 174.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.539 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 17.6 ptpt -72.48 -21.29 61.23 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 119.651 -0.819 . . . . 2.2200000000000002 111.007 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 111' ' ' HIS . 15.4 t -60.57 -47.97 90.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.595 0.236 . . . . 0.48999999999999999 110.452 171.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 5.7 ptmm? -84.98 -1.21 56.51 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.259 -0.576 . . . . 1.9099999999999999 110.379 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.523 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 38.2 tp -85.89 -19.79 30.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.473 -0.785 . . . . 1.28 108.963 172.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.539 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 43.0 mt-10 -67.87 -16.52 64.13 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 115.558 -0.746 . . . . 1.99 109.529 173.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.57 -20.21 13.77 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.65 -0.704 . . . . 1.01 112.175 174.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.673 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -99.13 138.91 35.55 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.822 -0.436 . . . . 0.87 109.822 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -73.37 164.0 27.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.242 0.544 . . . . 2.75 111.335 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 112' ' ' LEU . 4.5 mp -73.23 141.7 81.16 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.448 -0.796 . . . . 2.7000000000000002 110.391 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -88.66 -0.01 6.5 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.344 2.696 . . . . 1.1000000000000001 113.52 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 60.89 27.84 17.65 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.463 0.649 . . . . 1.3400000000000001 110.857 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -130.15 126.48 37.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.5 -0.773 . . . . 2.3599999999999999 109.148 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 126' ' ' LEU . 1.1 tm? -103.35 103.2 33.81 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.227 -0.657 . . . . 1.8300000000000001 109.227 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 7.8 Cg_endo -87.36 164.42 8.2 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.449 2.766 . . . . 1.0 112.669 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.445 ' O ' HG12 ' A' ' 131' ' ' VAL . 12.2 Cg_endo -56.03 -26.44 59.27 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.444 2.763 . . . . 1.3400000000000001 113.446 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.569 ' O ' HD12 ' A' ' 130' ' ' LEU . 7.3 p-80 -86.55 23.41 1.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.517 -0.473 . . . . 1.48 111.271 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.655 ' HG ' ' CE2' ' A' ' 44' ' ' TRP . 0.3 OUTLIER -149.61 14.68 0.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.955 0.159 . . . . 1.29 111.107 175.386 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 128' ' ' PRO . 7.4 p -82.72 111.31 28.28 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.25 0.548 . . . . 1.72 111.025 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.61 ' HG2' ' HG3' ' A' ' 135' ' ' LYS . 22.6 Cg_endo -63.44 120.9 8.49 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.724 2.283 . . . . 1.04 113.373 -177.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.4 ' HD2' ' OE1' ' A' ' 104' ' ' GLU . 31.6 Cg_exo -61.57 0.24 1.17 Allowed 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.082 2.522 . . . . 1.4399999999999999 112.54 170.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 27.4 t -79.35 -33.91 42.61 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.679 -0.237 . . . . 2.2999999999999998 111.354 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.61 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -87.45 1.51 53.24 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.919 0.711 . . . . 3.4199999999999999 112.919 -171.453 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.427 ' HG3' ' H ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -79.45 69.22 5.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.428 0.632 . . . . 4.7199999999999998 111.292 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 137' ' ' ARG . 11.2 ptm85 -133.76 107.77 8.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.435 0.636 . . . . 5.0099999999999998 110.145 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -106.87 140.02 40.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.634 -0.712 . . . . 6.3899999999999997 110.923 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 . . . . . 0 C--O 1.244 0.774 0 CA-C-O 118.192 -0.909 . . . . 6.9100000000000001 109.109 174.096 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.626 'CA ' ' OE2' ' A' ' 105' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.2 t . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 113.157 0.799 . . . . 1.21 113.157 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.0 -24.17 11.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 121.329 -0.857 . . . . 0.66000000000000003 112.143 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.98 -13.39 26.45 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.174 -1.012 . . . . 0.71999999999999997 112.452 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.479 ' HE2' ' HB3' ' A' ' 48' ' ' LYS . 7.8 ptpt -112.03 -0.96 15.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 112.745 0.646 . . . . 2.9700000000000002 112.745 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -133.77 2.16 3.4 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.367 0.603 . . . . 1.8300000000000001 110.666 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 63.5 tttm -54.83 -46.14 99.55 Favored Pre-proline 0 C--O 1.222 -0.386 0 CA-C-N 115.691 -0.686 . . . . 1.1299999999999999 111.166 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 55.2 Cg_exo -42.47 -33.24 2.59 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 123.074 2.516 . . . . 0.56000000000000005 113.993 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.681 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 25.6 m -73.8 -48.38 31.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.097 0.951 . . . . 0.59999999999999998 110.022 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.538 ' CD1' ' HB3' ' A' ' 110' ' ' ASN . 7.4 m-85 -76.17 -25.11 54.9 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.47 -0.786 . . . . 0.93999999999999995 110.149 -175.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.591 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 18.3 t70 -82.55 -33.41 28.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.632 -1.167 . . . . 1.1599999999999999 109.637 -176.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.681 ' HG3' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -69.28 -39.41 78.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.331 -0.618 . . . . 1.6299999999999999 109.331 175.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.617 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 60.3 mt -69.03 -32.0 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.254 -0.647 . . . . 0.60999999999999999 109.254 175.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.591 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 70.4 t80 -55.64 -52.87 62.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.168 -0.924 . . . . 0.88 110.952 175.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.735 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 82.6 m-85 -75.12 -22.45 58.19 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.941 0.401 . . . . 1.03 110.916 177.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.617 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 10.4 m -70.19 -32.64 70.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.44 111.043 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.8 mt -83.6 -8.53 59.29 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.219 -0.289 . . . . 0.79000000000000004 110.219 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.6 t 72.89 96.65 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.463 -0.79 . . . . 0.64000000000000001 111.287 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.735 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 61.5 Cg_endo -83.52 172.27 10.43 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.588 2.192 . . . . 0.46000000000000002 112.28 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.0 t -136.06 114.37 15.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.234 -0.654 . . . . 1.3300000000000001 109.234 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.1 m120 70.31 23.76 4.95 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.133 0.492 . . . . 1.6699999999999999 111.58 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.47 25.21 19.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.954 -0.641 . . . . 0.5 112.661 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.607 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -168.5 154.27 6.79 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.6 -0.889 . . . . 1.8200000000000001 108.6 175.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.86 ' HB ' HD21 ' A' ' 71' ' ' ASN . 3.1 pt -86.58 137.19 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 120.316 -0.554 . . . . 0.40999999999999998 110.21 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.8 p -60.3 130.7 47.94 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 107.352 -1.351 . . . . 0.69999999999999996 107.352 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.669 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -50.98 -25.75 10.31 Favored Glycine 0 C--O 1.22 -0.742 0 C-N-CA 120.682 -0.771 . . . . 0.38 113.784 -172.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -46.92 -55.77 7.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.139 0.47 . . . . 0.44 111.467 173.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.86 HD21 ' HB ' ' A' ' 67' ' ' ILE . 9.5 p30 -72.96 -27.07 61.61 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.87 0.367 . . . . 2.1099999999999999 110.545 -175.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.728 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -68.92 -37.29 78.84 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.392 -0.596 . . . . 0.41999999999999998 109.392 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.669 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.9 mmmm -67.72 -38.77 84.04 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.174 -0.921 . . . . 1.6899999999999999 109.843 177.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.809 ' HG2' ' HA ' ' A' ' 71' ' ' ASN . 10.4 mmmm -56.23 -50.6 70.83 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.654 0.74 . . . . 1.3500000000000001 109.655 175.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -55.9 -52.81 62.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.972 -1.467 . . . . 1.48 111.445 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.728 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 12.8 ptp -73.45 -21.88 60.34 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.107 -0.371 . . . . 0.65000000000000002 111.752 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.41 -45.71 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.787 0.327 . . . . 0.58999999999999997 110.462 174.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 15.2 ptpt -70.83 -14.82 62.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.257 0.551 . . . . 1.2 110.1 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 76' ' ' MET . 67.6 m -63.94 -1.59 1.52 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.563 -0.744 . . . . 1.3700000000000001 111.583 171.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 71.24 72.07 0.18 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.621 0.769 . . . . 2.6499999999999999 111.434 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.843 HD11 ' HE2' ' A' ' 116' ' ' LYS . 29.1 mt -142.77 161.36 49.51 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.934 -0.576 . . . . 1.1599999999999999 111.782 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -82.56 168.54 14.39 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.093 2.529 . . . . 0.94999999999999996 110.198 166.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.75 -18.15 63.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.83 0.347 . . . . 1.53 111.5 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -64.63 -67.83 0.4 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.961 -0.563 . . . . 1.24 110.863 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 89' ' ' ILE . 39.8 t -60.64 -44.58 97.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 115.811 -0.631 . . . . 0.71999999999999997 110.297 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.563 HD11 ' HG3' ' A' ' 76' ' ' MET . 22.7 tp -55.52 -51.35 67.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.325 -0.852 . . . . 1.45 111.443 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.36 -43.19 97.54 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.789 -0.641 . . . . 0.39000000000000001 111.967 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.831 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 56.4 pttt -80.39 -16.45 54.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.562 -0.855 . . . . 1.6599999999999999 111.754 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.656 HD11 ' HD3' ' A' ' 116' ' ' LYS . 13.5 mt -71.8 -46.32 61.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.857 -0.794 . . . . 1.1499999999999999 108.857 171.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -56.06 -53.24 59.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.755 -0.657 . . . . 0.29999999999999999 111.212 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.831 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -73.03 -14.31 61.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.117 -0.492 . . . . 2.54 112.128 -174.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.614 HD23 HD13 ' A' ' 112' ' ' LEU . 13.6 tp -93.41 -23.89 18.25 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.662 -0.415 . . . . 0.85999999999999999 110.488 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.724 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -89.04 -42.9 11.48 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.797 0.332 . . . . 0.45000000000000001 111.376 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.567 ' HB2' HD21 ' A' ' 101' ' ' LEU . 55.3 t0 -92.57 105.54 17.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.759 -0.46 . . . . 0.62 109.759 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.5 t -73.09 -27.4 24.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.595 -0.729 . . . . 1.76 111.262 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.16 -26.48 22.41 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.109 -0.496 . . . . 1.7 109.677 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.9 mttt 60.22 58.83 2.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.955 -1.02 . . . . 1.74 109.364 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.503 ' HB2' ' HG ' ' A' ' 100' ' ' LEU . 6.4 m-20 -83.57 -35.2 24.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.024 -1.444 . . . . 1.51 111.629 -170.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.72 16.41 33.87 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 109.889 -1.284 . . . . 0.28999999999999998 109.889 -164.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.542 HD13 ' HG3' ' A' ' 66' ' ' LYS . 4.2 pp -153.32 177.01 11.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.379 -0.971 . . . . 0.54000000000000004 108.379 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.634 ' O ' HG12 ' A' ' 67' ' ' ILE . 46.4 mt -151.74 120.37 6.5 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.231 -1.396 . . . . 0.68000000000000005 107.231 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.7 p30 -80.96 -175.75 5.55 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.499 -0.881 . . . . 1.5 110.176 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -57.95 -32.52 67.9 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 111.738 0.273 . . . . 1.73 111.738 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 4.0 tp10 -87.33 -27.92 22.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.319 0.581 . . . . 2.1400000000000001 110.029 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.474 ' HB3' HD22 ' A' ' 101' ' ' LEU . 1.1 mt-10 -74.75 -27.91 60.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.05 -0.523 . . . . 1.1100000000000001 110.656 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.673 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -73.61 -36.06 65.44 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.439 -1.319 . . . . 1.0700000000000001 107.439 169.219 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.538 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -56.37 -45.77 80.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.02 -0.537 . . . . 0.19 110.286 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.724 HD22 ' HA ' ' A' ' 93' ' ' ALA . 3.5 tt -71.27 -48.6 49.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.931 -0.577 . . . . 1.23 110.278 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.533 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -46.53 -56.25 6.3 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.531 0.519 . . . . 0.22 111.138 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.538 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 11.1 t-20 -73.32 -23.98 60.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.601 -0.727 . . . . 1.1799999999999999 110.379 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.591 ' O ' HG23 ' A' ' 115' ' ' VAL . 65.7 t60 -69.76 -41.94 74.52 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.357 -0.609 . . . . 0.48999999999999999 109.357 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.635 HD22 HD22 ' A' ' 122' ' ' LEU . 30.2 mt -73.71 -27.32 61.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.187 -0.461 . . . . 0.55000000000000004 110.436 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 109' ' ' ALA . 68.7 mt -60.97 -45.46 98.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.464 -0.335 . . . . 0.81000000000000005 111.021 172.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.463 ' HE3' ' HE1' ' A' ' 53' ' ' TYR . 17.4 ptpt -75.35 -21.18 58.54 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.687 -0.805 . . . . 2.2200000000000002 111.488 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 111' ' ' HIS . 40.1 t -68.43 -43.27 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.471 0.177 . . . . 0.48999999999999999 110.706 173.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.843 ' HE2' HD11 ' A' ' 81' ' ' LEU . 16.0 pttp -69.12 -28.26 66.3 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.291 -0.633 . . . . 1.9099999999999999 109.291 174.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.1 tt -69.61 -24.28 63.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.53 -0.759 . . . . 1.28 110.248 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 6.5 mm-40 -59.02 -13.23 6.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.573 -0.739 . . . . 1.99 111.299 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.81 8.81 29.53 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.924 -0.655 . . . . 1.01 111.926 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.754 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.5 p80 -137.89 135.16 35.86 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.017 -0.364 . . . . 0.87 110.017 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -71.85 164.5 25.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.203 -0.453 . . . . 2.75 111.316 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.635 HD22 HD22 ' A' ' 112' ' ' LEU . 41.8 mt -74.59 137.17 74.16 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.92 -0.582 . . . . 2.7000000000000002 110.268 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 87.3 Cg_endo -90.16 13.83 2.21 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.181 2.588 . . . . 1.1000000000000001 113.396 -172.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.56 22.76 13.5 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.253 -0.43 . . . . 1.3400000000000001 111.162 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -112.55 140.69 47.1 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.366 -0.605 . . . . 2.3599999999999999 109.366 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -121.52 106.23 37.9 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 108.944 -0.762 . . . . 1.8300000000000001 108.944 178.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 2.2 Cg_endo -82.48 148.08 14.3 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.019 2.479 . . . . 1.0 112.351 -176.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.52 -13.59 37.32 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.777 2.318 . . . . 1.3400000000000001 112.579 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -98.01 24.22 7.26 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.209 -0.293 . . . . 1.48 110.209 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.45 12.78 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.92 0.391 . . . . 1.29 110.481 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.6 m -91.86 128.42 45.98 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.598 -0.519 . . . . 1.72 109.598 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.724 ' HD3' HD12 ' A' ' 108' ' ' LEU . 51.0 Cg_exo . . . . . 0 CA--C 1.535 0.554 0 C-N-CA 122.553 2.168 . . . . 1.04 110.991 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 CA--C 1.538 0.506 0 CA-C-O 121.069 0.461 . . . . 1.21 112.135 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.689 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 84.0 t -88.53 -13.55 9.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 O-C-N 121.553 -0.717 . . . . 0.66000000000000003 111.386 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.46 -12.63 70.02 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 119.457 -1.354 . . . . 0.71999999999999997 111.839 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -111.7 -28.26 8.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.563 0.579 . . . . 2.9700000000000002 112.563 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -108.56 8.41 27.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.473 0.654 . . . . 1.8300000000000001 109.946 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.769 ' HE3' ' HG3' ' A' ' 104' ' ' GLU . 42.5 tttt -57.1 -46.43 99.86 Favored Pre-proline 0 C--O 1.22 -0.466 0 CA-C-N 115.417 -0.811 . . . . 1.1299999999999999 112.167 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 7.3 Cg_endo -49.95 -28.39 18.54 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 122.561 2.174 . . . . 0.56000000000000005 112.802 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.629 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 9.2 m -72.34 -42.32 65.49 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 122.301 1.048 . . . . 0.59999999999999998 109.91 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.546 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 8.2 m-85 -79.55 -24.61 42.02 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.109 -0.951 . . . . 0.93999999999999995 109.742 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.588 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 14.3 t70 -81.6 -34.45 30.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.474 -0.785 . . . . 1.1599999999999999 110.63 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.629 ' HG2' ' O ' ' A' ' 52' ' ' THR . 13.2 pt-20 -66.14 -40.45 90.6 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.528 -0.469 . . . . 1.6299999999999999 109.819 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.6 mt -69.54 -29.45 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.114 -0.634 . . . . 0.60999999999999999 109.612 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 71.8 t80 -58.59 -58.29 9.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.409 -0.814 . . . . 0.88 111.462 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.449 ' HE1' ' OD1' ' A' ' 54' ' ' ASP . 38.8 m-85 -66.96 -23.02 65.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.959 0.409 . . . . 1.03 110.813 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.0 m -70.75 -26.37 63.33 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.019 -0.537 . . . . 0.44 110.973 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.526 HD11 ' CG ' ' A' ' 75' ' ' GLU . 53.6 mt -87.74 4.22 45.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.015 0.376 . . . . 0.79000000000000004 112.015 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t 65.48 81.63 0.21 Allowed Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.027 -0.533 . . . . 0.64000000000000001 110.906 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 72.6 Cg_endo -81.48 153.06 17.95 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.733 2.289 . . . . 0.46000000000000002 113.176 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.7 126.86 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.894 -0.594 . . . . 1.3300000000000001 110.248 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 60.72 23.31 13.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.702 -0.681 . . . . 1.6699999999999999 111.627 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.34 26.67 25.03 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.769 -0.729 . . . . 0.5 112.898 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.722 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -160.32 148.56 16.66 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 120.934 0.397 . . . . 1.8200000000000001 110.039 173.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.729 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 4.1 pt -85.89 131.45 34.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.951 -0.568 . . . . 0.40999999999999998 109.965 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.7 p -59.7 112.22 1.73 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.751 -0.833 . . . . 0.69999999999999996 108.751 174.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.566 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -42.2 -27.21 0.41 Allowed Glycine 0 C--O 1.218 -0.896 0 N-CA-C 116.684 1.434 . . . . 0.38 116.684 -160.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.68 -30.87 9.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 118.236 1.018 . . . . 0.44 112.359 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.729 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 13.3 p30 -81.07 -38.32 27.53 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.863 0.364 . . . . 2.1099999999999999 111.559 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.666 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -69.39 -34.58 74.73 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.497 0.665 . . . . 0.41999999999999998 109.223 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.566 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.2 mmmm -64.06 -39.25 93.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.756 -1.111 . . . . 1.6899999999999999 108.864 174.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -55.79 -48.49 75.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.355 -0.839 . . . . 1.3500000000000001 109.714 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.651 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 7.2 mm-40 -60.68 -52.19 66.18 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.062 -0.972 . . . . 1.48 112.051 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.666 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 13.4 ptp -69.35 -24.13 63.86 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.878 -0.329 . . . . 0.65000000000000002 111.487 -178.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 73' ' ' LYS . 45.8 t -73.13 -49.08 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.652 0.263 . . . . 0.58999999999999997 110.644 174.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.651 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 8.0 ptmt -68.06 -11.96 59.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.185 0.517 . . . . 1.2 110.249 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.3 t -68.29 -9.44 47.6 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.942 -0.572 . . . . 1.3700000000000001 110.039 174.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.486 ' NZ ' ' HB2' ' A' ' 80' ' ' LYS . 8.4 mtmp? 73.49 73.19 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.5 0.72 . . . . 2.6499999999999999 110.989 176.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.034 HD11 ' HE2' ' A' ' 116' ' ' LYS . 25.1 mt -136.35 163.56 49.11 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.566 -0.743 . . . . 1.1599999999999999 110.997 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.425 ' HG2' HG23 ' A' ' 85' ' ' VAL . 71.7 Cg_endo -79.78 168.71 19.02 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.618 2.212 . . . . 0.94999999999999996 111.408 167.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 13.4 m120 -64.72 -26.83 68.54 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.833 0.308 . . . . 1.53 111.833 -177.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.4 p -62.95 -50.82 69.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.259 -0.428 . . . . 1.24 110.896 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 89' ' ' ILE . 46.7 t -66.83 -43.78 89.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.928 -0.578 . . . . 0.71999999999999997 109.925 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.564 ' CD2' ' HB2' ' A' ' 81' ' ' LEU . 2.8 mm? -48.27 -53.41 17.27 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.282 0.563 . . . . 1.45 110.744 172.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.43 -45.96 94.68 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.943 -1.026 . . . . 0.39000000000000001 112.984 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.87 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 56.3 pttt -83.27 -21.54 33.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 119.677 -0.809 . . . . 1.6599999999999999 112.304 -175.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.599 HD11 ' HD3' ' A' ' 116' ' ' LYS . 29.8 mt -67.26 -44.91 87.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.853 -0.795 . . . . 1.1499999999999999 108.853 171.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -62.98 -54.69 34.38 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 115.658 -0.701 . . . . 0.29999999999999999 111.405 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.87 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 64.6 pttt -71.82 -10.17 59.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.571 -0.286 . . . . 2.54 111.721 -173.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.645 HD13 ' HA ' ' A' ' 124' ' ' ALA . 8.6 tp -92.34 -34.07 14.34 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.736 -0.468 . . . . 0.85999999999999999 109.736 173.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.729 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -82.92 -44.44 15.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.896 0.379 . . . . 0.45000000000000001 112.004 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.519 ' HB2' HD21 ' A' ' 101' ' ' LEU . 42.1 t0 -92.01 76.28 5.47 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.81 -0.811 . . . . 0.62 108.81 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.3 t -64.9 -25.22 37.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.258 -0.883 . . . . 1.76 109.982 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -79.48 -25.85 41.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.603 -1.18 . . . . 1.7 110.278 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 55.71 73.82 0.41 Allowed 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.468 -0.787 . . . . 1.74 111.525 174.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -123.45 -24.22 4.64 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.409 -1.269 . . . . 1.51 112.419 -169.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.91 16.46 28.26 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.053 -1.07 . . . . 0.28999999999999998 111.82 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.722 HD13 ' HG3' ' A' ' 66' ' ' LYS . 3.3 pp -151.61 -174.57 4.88 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.649 -0.871 . . . . 0.54000000000000004 108.649 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.608 HD12 ' HB1' ' A' ' 72' ' ' ALA . 45.0 mt -150.12 120.56 7.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.218 -0.66 . . . . 0.68000000000000005 109.218 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.8 p-10 -74.98 -175.65 2.65 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.635 -0.506 . . . . 1.5 109.635 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.456 ' OD1' ' HE2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -60.24 -33.85 72.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.663 0.268 . . . . 1.73 111.191 -177.181 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.769 ' HG3' ' HE3' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -83.24 -37.43 23.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.79 -0.186 . . . . 2.1400000000000001 111.037 176.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.545 ' HB3' HD22 ' A' ' 101' ' ' LEU . 3.7 mt-10 -62.43 -38.35 89.41 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.208 -0.197 . . . . 1.1100000000000001 110.99 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.584 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.6 OUTLIER -68.96 -40.1 79.09 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.526 -0.916 . . . . 1.0700000000000001 108.526 172.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.546 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -48.93 -50.67 34.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.597 -0.729 . . . . 0.19 111.426 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.729 ' CD1' ' HA ' ' A' ' 93' ' ' ALA . 0.5 OUTLIER -83.41 -33.36 25.75 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 118.993 -1.083 . . . . 1.23 112.031 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.32 -54.18 9.43 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.318 0.58 . . . . 0.22 111.173 170.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.482 ' HA ' HD12 ' A' ' 113' ' ' ILE . 2.9 t-20 -75.97 -33.87 59.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.571 . . . . 1.1799999999999999 110.702 -176.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 108' ' ' LEU . 85.5 t60 -66.37 -34.88 78.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.519 . . . . 0.48999999999999999 109.945 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.802 ' HB3' HD21 ' A' ' 122' ' ' LEU . 73.0 mt -71.81 -31.65 66.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.717 -0.674 . . . . 0.55000000000000004 110.021 176.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.597 ' HA ' ' HE3' ' A' ' 116' ' ' LYS . 60.8 mt -61.11 -42.67 94.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.73 -0.668 . . . . 0.81000000000000005 110.747 171.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.601 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -68.44 -35.34 77.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.297 -0.41 . . . . 2.2200000000000002 110.335 175.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.6 t -59.57 -49.05 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.256 -0.429 . . . . 0.48999999999999999 111.522 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 1.034 ' HE2' HD11 ' A' ' 81' ' ' LEU . 20.0 pttp -68.0 -28.84 67.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.026 0.441 . . . . 1.9099999999999999 110.303 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.5 tp -70.49 -20.57 62.84 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.847 -0.615 . . . . 1.28 110.839 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.601 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 42.2 mt-10 -71.42 -9.84 58.82 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.888 -0.597 . . . . 1.99 111.037 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.43 1.21 24.8 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.2 -1.0 . . . . 1.01 112.948 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.716 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -129.45 134.01 47.6 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.874 -0.417 . . . . 0.87 109.874 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -72.12 164.62 25.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.252 0.549 . . . . 2.75 111.242 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.802 HD21 ' HB3' ' A' ' 112' ' ' LEU . 5.2 mp -68.87 141.5 92.43 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.792 -0.64 . . . . 2.7000000000000002 110.46 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.578 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 67.9 Cg_endo -91.5 -7.06 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.483 2.788 . . . . 1.1000000000000001 112.624 -174.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.645 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . 61.53 37.55 16.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.699 -0.682 . . . . 1.3400000000000001 111.319 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.578 ' OD1' ' HG2' ' A' ' 123' ' ' PRO . 1.2 p-10 -111.61 135.5 52.11 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.956 -0.565 . . . . 2.3599999999999999 109.746 170.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.7 tp -115.49 91.42 28.99 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.191 -0.913 . . . . 1.8300000000000001 109.918 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 94.5 Cg_endo -98.03 171.22 0.67 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.609 2.872 . . . . 1.0 113.189 -175.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.55 ' HA ' HG23 ' A' ' 131' ' ' VAL . 9.3 Cg_endo -54.92 -29.49 64.2 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.941 2.427 . . . . 1.3400000000000001 112.993 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.543 ' O ' HD12 ' A' ' 130' ' ' LEU . 16.5 p-80 -84.84 22.16 1.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.997 0.369 . . . . 1.48 111.997 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 129' ' ' HIS . 1.0 OUTLIER -149.76 18.4 0.9 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.582 0.353 . . . . 1.29 111.091 169.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.55 HG23 ' HA ' ' A' ' 128' ' ' PRO . 96.7 t -70.19 112.59 13.16 Favored Pre-proline 0 C--N 1.328 -0.356 0 C-N-CA 120.549 -0.46 . . . . 1.72 110.968 -176.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo . . . . . 0 C--O 1.237 0.439 0 C-N-CA 122.629 2.22 . . . . 1.04 111.841 179.066 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.661 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 23.8 t . . . . . 0 C--O 1.223 -0.305 0 N-CA-C 112.561 0.578 . . . . 1.21 112.561 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.714 ' HA ' ' OD1' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -63.07 -13.4 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 O-C-N 121.995 -0.441 . . . . 0.66000000000000003 112.089 -174.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.48 -4.58 31.98 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.255 -0.974 . . . . 0.71999999999999997 111.935 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 11.7 ptmm? -105.33 -28.32 10.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 111.838 0.31 . . . . 2.9700000000000002 111.838 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.714 ' OD1' ' HA ' ' A' ' 46' ' ' VAL . 12.7 p-10 -114.58 1.34 14.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.051 0.453 . . . . 1.8300000000000001 111.235 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.619 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 49.6 tttm -56.48 -46.25 99.84 Favored Pre-proline 0 C--O 1.223 -0.334 0 CA-C-N 115.438 -0.801 . . . . 1.1299999999999999 112.293 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 4.3 Cg_endo -46.48 -35.09 15.81 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.869 2.38 . . . . 0.56000000000000005 113.315 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.707 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 56.5 m -76.57 -36.44 57.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.376 0.607 . . . . 0.59999999999999998 110.995 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' A' ' 110' ' ' ASN . 8.4 m-85 -81.96 -23.87 35.84 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.198 0.523 . . . . 0.93999999999999995 110.224 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.605 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 1.1 t70 -75.44 -39.47 58.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.032 -0.985 . . . . 1.1599999999999999 109.783 175.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.707 ' HG3' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -68.38 -38.65 81.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.504 -0.316 . . . . 1.6299999999999999 110.729 178.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.533 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 48.2 mt -70.95 -29.3 36.61 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 109.366 -0.605 . . . . 0.60999999999999999 109.366 174.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.605 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 66.1 t80 -57.43 -54.51 46.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.71 -0.677 . . . . 0.88 111.213 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.586 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 75.3 m-85 -71.53 -22.89 61.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.166 0.507 . . . . 1.03 110.498 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.533 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 18.3 m -72.09 -30.48 65.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.768 -0.651 . . . . 0.44 110.874 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 34.4 mt -84.87 0.94 49.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.79000000000000004 110.979 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t 66.46 88.59 0.11 Allowed Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.511 -0.768 . . . . 0.64000000000000001 111.464 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.586 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 64.8 Cg_endo -85.09 159.88 11.53 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.47 2.113 . . . . 0.46000000000000002 113.257 177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.8 p -141.46 134.25 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.93 -0.577 . . . . 1.3300000000000001 109.958 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 63.81 20.53 12.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.479 -0.782 . . . . 1.6699999999999999 109.73 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.58 -0.06 67.51 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.145 -0.934 . . . . 0.5 113.618 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -134.59 163.78 28.96 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 117.946 0.873 . . . . 1.8200000000000001 110.472 177.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pt -90.49 135.01 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 C-N-CA 120.642 -0.423 . . . . 0.40999999999999998 109.982 170.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.32 126.73 28.84 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.147 -1.057 . . . . 0.69999999999999996 108.147 171.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.54 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -49.45 -31.91 14.56 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.571 -0.74 . . . . 0.38 114.816 -166.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.67 -33.1 21.26 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 117.366 0.583 . . . . 0.44 112.389 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.61 -38.49 39.76 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.366 0.603 . . . . 2.1099999999999999 109.932 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.581 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -72.29 -33.21 67.24 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.789 -0.641 . . . . 0.41999999999999998 109.327 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.4 mmmm -65.34 -37.87 88.39 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 114.959 -1.018 . . . . 1.6899999999999999 108.78 174.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -56.54 -44.65 81.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.942 -1.026 . . . . 1.3500000000000001 110.416 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.667 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 3.3 mm-40 -64.01 -52.87 57.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.142 -0.936 . . . . 1.48 111.74 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.581 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 16.0 ptp -66.37 -21.07 66.23 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.582 -0.447 . . . . 0.65000000000000002 110.807 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 73' ' ' LYS . 5.1 t -68.64 -46.53 79.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.58999999999999997 111.013 172.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.667 ' HE2' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -70.36 -16.36 62.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.12 0.486 . . . . 1.2 110.04 -176.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.9 t -65.01 -6.81 9.48 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.411 -0.813 . . . . 1.3700000000000001 111.716 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 77.9 mttt 67.44 68.22 0.38 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.383 0.611 . . . . 2.6499999999999999 110.596 175.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.51 HD13 HG12 ' A' ' 85' ' ' VAL . 20.7 mt -128.95 156.87 77.3 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.577 -0.738 . . . . 1.1599999999999999 110.691 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.556 ' HG2' HG23 ' A' ' 85' ' ' VAL . 53.0 Cg_endo -73.21 162.93 39.36 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.194 1.929 . . . . 0.94999999999999996 110.541 168.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -63.0 -27.47 69.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.334 -0.394 . . . . 1.53 111.539 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.1 p -67.38 -45.76 75.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.2 0.524 . . . . 1.24 110.723 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.556 HG23 ' HG2' ' A' ' 82' ' ' PRO . 90.5 t -67.37 -42.92 87.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 115.904 -0.589 . . . . 0.71999999999999997 110.053 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.476 ' CD2' ' HB2' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -48.66 -55.29 11.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.4 0.619 . . . . 1.45 110.587 171.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -56.79 -53.29 45.19 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.873 -1.058 . . . . 0.39000000000000001 113.247 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 14.4 pttp -81.12 -17.33 50.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.516 -0.873 . . . . 1.6599999999999999 112.651 -173.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.745 HG12 HD11 ' A' ' 122' ' ' LEU . 7.8 mt -69.73 -48.42 64.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 108.71 -0.848 . . . . 1.1499999999999999 108.71 169.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.433 ' CE3' ' HD3' ' A' ' 73' ' ' LYS . 67.2 t-105 -53.44 -55.43 25.22 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.497 -0.774 . . . . 0.29999999999999999 111.237 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.46 -30.28 71.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.38 -0.827 . . . . 2.54 112.538 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 112' ' ' LEU . 4.6 tp -84.09 -13.0 54.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.643 -0.503 . . . . 0.85999999999999999 109.643 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.495 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -101.63 -42.92 6.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.315 -0.402 . . . . 0.45000000000000001 111.38 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.445 ' HB2' HD21 ' A' ' 101' ' ' LEU . 51.5 t0 -80.43 97.76 7.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.312 -0.625 . . . . 0.62 109.312 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -71.95 -28.71 30.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.896 -0.593 . . . . 1.76 110.325 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.2 -26.63 42.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.963 -0.562 . . . . 1.7 109.595 176.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 56.39 44.66 24.12 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.954 0.883 . . . . 1.74 109.05 -173.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -108.74 -0.16 20.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.181 -1.372 . . . . 1.51 112.167 -166.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.15 10.26 59.83 Favored Glycine 0 CA--C 1.511 -0.156 0 C-N-CA 120.287 -0.959 . . . . 0.28999999999999998 112.507 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.464 HD13 ' CB ' ' A' ' 66' ' ' LYS . 4.2 pp -152.89 156.13 38.37 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.227 0.537 . . . . 0.54000000000000004 110.246 175.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 105' ' ' GLU . 63.4 mt -121.82 119.0 30.39 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.115 -0.948 . . . . 0.68000000000000005 109.48 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.1 p30 -71.09 -178.36 1.96 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.508 -0.553 . . . . 1.5 109.508 174.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -34.44 68.02 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.487 0.66 . . . . 1.73 111.08 -178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.591 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 23.5 tt0 -83.95 -31.81 25.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.548 0.69 . . . . 2.1400000000000001 109.424 -176.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HB3' HD22 ' A' ' 101' ' ' LEU . 3.6 mt-10 -72.91 -30.28 63.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.583 -0.735 . . . . 1.1100000000000001 111.358 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.624 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -68.78 -44.19 74.15 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.062 -1.088 . . . . 1.0700000000000001 108.062 171.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 104' ' ' GLU . . . -47.48 -46.6 27.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 0.19 110.62 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.495 HD13 ' HA ' ' A' ' 93' ' ' ALA . 1.0 OUTLIER -69.81 -46.66 65.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.23 110.427 178.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.44 ' HB2' HD13 ' A' ' 101' ' ' LEU . . . -50.02 -53.76 24.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.089 0.471 . . . . 0.22 111.527 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.431 ' HA ' HD12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -72.39 -25.45 61.5 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.349 -0.611 . . . . 1.1799999999999999 109.349 -177.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.48 ' O ' HG23 ' A' ' 115' ' ' VAL . 51.4 t60 -70.24 -39.8 74.85 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.592 -0.521 . . . . 0.48999999999999999 109.592 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.525 HD22 HD22 ' A' ' 122' ' ' LEU . 46.6 mt -68.78 -36.53 78.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.838 0.352 . . . . 0.55000000000000004 110.594 177.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 110' ' ' ASN . 95.6 mt -57.42 -48.94 81.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.931 -0.577 . . . . 0.81000000000000005 110.528 175.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 19.8 ptmt -70.29 -28.46 65.21 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.123 -0.631 . . . . 2.2200000000000002 110.502 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 111' ' ' HIS . 6.4 t -62.13 -45.19 99.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.688 -0.233 . . . . 0.48999999999999999 110.989 176.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 3.7 ptmm? -84.07 -2.42 56.67 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 119.733 -0.787 . . . . 1.9099999999999999 110.846 178.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.9 tp -83.64 -23.12 31.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.459 -0.571 . . . . 1.28 109.459 170.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 48.5 mt-10 -66.44 -14.13 61.75 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.006 -0.543 . . . . 1.99 111.355 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.05 8.13 20.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.628 -0.796 . . . . 1.01 112.589 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -132.61 140.2 48.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.92 0.391 . . . . 0.87 109.964 177.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -77.06 164.96 25.23 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.865 -0.607 . . . . 2.75 110.962 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.745 HD11 HG12 ' A' ' 89' ' ' ILE . 27.1 mt -70.82 141.89 87.65 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.168 -0.469 . . . . 2.7000000000000002 110.291 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -92.25 12.86 2.0 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.035 2.49 . . . . 1.1000000000000001 113.105 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 59.96 21.93 10.99 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.756 -0.656 . . . . 1.3400000000000001 111.198 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -111.93 139.94 47.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.084 -0.709 . . . . 2.3599999999999999 109.084 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.83 93.34 47.58 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.542 -0.911 . . . . 1.8300000000000001 108.542 176.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 9.8 Cg_exo -73.21 153.49 51.32 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.828 2.352 . . . . 1.0 112.491 -174.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -67.47 -7.21 18.5 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.117 2.545 . . . . 1.3400000000000001 112.374 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -105.82 13.76 29.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.838 -0.619 . . . . 1.48 109.602 175.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 1.5 mp -134.6 -4.54 2.57 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.338 -0.846 . . . . 1.29 110.658 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 127' ' ' PRO . 29.3 t -66.03 120.6 70.74 Favored Pre-proline 0 N--CA 1.44 -0.936 0 N-CA-C 109.285 -0.635 . . . . 1.72 109.285 174.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.591 ' HB3' ' HG2' ' A' ' 104' ' ' GLU . 51.9 Cg_exo . . . . . 0 N--CA 1.453 -0.885 0 C-N-CA 121.899 1.733 . . . . 1.04 109.412 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 t . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 120.941 0.401 . . . . 1.21 111.07 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.605 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 99.1 t -89.26 -20.11 7.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 O-C-N 121.652 -0.655 . . . . 0.66000000000000003 111.865 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.68 -11.59 57.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.612 -1.28 . . . . 0.71999999999999997 112.234 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -109.5 -27.77 9.26 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.311 0.486 . . . . 2.9700000000000002 112.311 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -108.68 7.04 26.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.896 0.855 . . . . 1.8300000000000001 110.336 -173.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.688 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 83.0 tttt -61.5 -40.21 69.1 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 114.661 -1.154 . . . . 1.1299999999999999 112.82 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.2 Cg_endo -46.2 -30.97 8.36 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 122.678 2.252 . . . . 0.56000000000000005 112.841 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.569 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 99.0 m -75.3 -40.79 58.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.793 0.806 . . . . 0.59999999999999998 110.566 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.627 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 9.1 m-85 -79.55 -28.49 41.23 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.078 -0.51 . . . . 0.93999999999999995 110.579 -174.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.591 ' OD2' ' HA ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -86.12 -27.64 24.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.799 -0.637 . . . . 1.1599999999999999 110.181 -179.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 52' ' ' THR . 11.5 pt-20 -66.24 -43.1 87.56 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.346 -0.613 . . . . 1.6299999999999999 109.346 173.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 52' ' ' THR . 53.6 mt -67.9 -32.89 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 120.28 -0.568 . . . . 0.60999999999999999 109.517 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 79.2 t80 -55.1 -52.99 61.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.477 -0.783 . . . . 0.88 111.276 175.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.548 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 74.7 m-85 -73.92 -23.3 59.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.738 0.304 . . . . 1.03 111.314 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 25.2 m -66.76 -35.24 79.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.057 -0.519 . . . . 0.44 110.769 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.533 HD11 ' CG ' ' A' ' 75' ' ' GLU . 54.9 mt -85.39 -4.48 59.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.122 -0.49 . . . . 0.79000000000000004 111.404 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.0 t 67.06 95.21 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 121.586 0.708 . . . . 0.64000000000000001 111.312 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.548 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 22.9 Cg_endo -80.96 138.84 11.73 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.808 2.339 . . . . 0.46000000000000002 112.377 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.401 HG21 HG23 ' A' ' 68' ' ' THR . 13.9 m -99.94 122.05 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.044 -0.525 . . . . 1.3300000000000001 110.873 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 62.92 24.14 14.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.65 -0.704 . . . . 1.6699999999999999 111.232 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.74 14.3 53.02 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.963 -0.636 . . . . 0.5 113.728 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.951 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -155.03 151.78 28.83 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.759 -0.46 . . . . 1.8200000000000001 109.759 174.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.878 ' HB ' HD21 ' A' ' 71' ' ' ASN . 4.2 pt -80.5 135.93 24.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 C-N-CA 120.623 -0.431 . . . . 0.40999999999999998 110.529 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.401 HG23 HG21 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -60.03 128.76 38.41 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.883 -1.155 . . . . 0.69999999999999996 107.883 167.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.611 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -49.92 -29.43 13.92 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 121.172 -0.537 . . . . 0.38 113.917 -169.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.58 47.4 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.721 0.638 . . . . 0.44 112.721 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.878 HD21 ' HB ' ' A' ' 67' ' ' ILE . 15.2 p30 -82.1 -33.03 29.93 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.074 0.464 . . . . 2.1099999999999999 110.538 -176.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.656 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -69.93 -35.89 74.9 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.378 0.609 . . . . 0.41999999999999998 109.388 177.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 31.4 mmmt -66.12 -37.84 86.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.163 -0.926 . . . . 1.6899999999999999 108.984 175.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.463 ' O ' ' HD2' ' A' ' 78' ' ' LYS . 2.2 tppp? -54.84 -48.2 73.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.683 -0.689 . . . . 1.3500000000000001 109.956 176.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.691 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 3.0 mm-40 -63.43 -51.94 63.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.041 -0.982 . . . . 1.48 111.957 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.656 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 14.9 ptp -67.95 -23.02 65.02 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.481 -0.488 . . . . 0.65000000000000002 111.409 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.471 HG23 HD11 ' A' ' 86' ' ' LEU . 24.9 t -71.85 -49.51 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.481 0.181 . . . . 0.58999999999999997 111.186 173.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.691 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 2.5 ptmt -69.93 -9.1 53.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.264 0.554 . . . . 1.2 110.306 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.0 t -73.34 0.57 11.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.444 -0.798 . . . . 1.3700000000000001 110.893 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.5 mttp 73.09 68.09 0.11 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.91 -0.586 . . . . 2.6499999999999999 110.872 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.824 HD11 ' HE2' ' A' ' 116' ' ' LYS . 18.4 mt -138.64 159.68 66.46 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.627 -0.715 . . . . 1.1599999999999999 111.358 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.535 ' HG2' HG23 ' A' ' 85' ' ' VAL . 74.2 Cg_endo -77.95 168.56 21.91 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.836 2.357 . . . . 0.94999999999999996 111.385 167.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 15.0 m120 -63.45 -27.72 69.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.153 -0.476 . . . . 1.53 112.044 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -52.6 63.31 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.057 0.456 . . . . 1.24 111.167 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.535 HG23 ' HG2' ' A' ' 82' ' ' PRO . 22.6 t -62.54 -41.98 94.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.822 -0.626 . . . . 0.71999999999999997 109.723 177.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.471 HD11 HG23 ' A' ' 77' ' ' VAL . 2.7 mm? -49.51 -50.05 43.31 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.837 -0.619 . . . . 1.45 111.382 173.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.08 -44.84 86.81 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.946 -0.645 . . . . 0.39000000000000001 113.186 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.589 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 56.3 pttt -76.57 -31.29 57.44 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.964 -0.694 . . . . 1.6599999999999999 111.36 -175.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.596 HG12 HD11 ' A' ' 122' ' ' LEU . 29.7 mt -64.95 -46.22 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 109.325 -0.62 . . . . 1.1499999999999999 109.325 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.472 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 76.3 t-105 -52.95 -57.01 11.77 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 115.018 -0.992 . . . . 0.29999999999999999 111.066 177.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -77.52 -9.48 58.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.389 0.515 . . . . 2.54 112.389 -171.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.589 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 2.3 tp -88.44 -23.29 23.33 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.707 -0.397 . . . . 0.85999999999999999 109.977 176.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.563 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -103.66 -39.21 6.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.038 0.447 . . . . 0.45000000000000001 110.886 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.628 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 29.6 t70 -83.43 79.31 9.46 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.234 -0.654 . . . . 0.62 109.234 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 m -61.25 -33.14 55.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.202 -0.908 . . . . 1.76 111.26 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 5.1 p-10 -78.41 -24.78 46.07 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.354 -1.294 . . . . 1.7 111.446 -175.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.628 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 36.7 mtmm 47.63 50.68 14.87 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.114 0.884 . . . . 1.74 112.637 176.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -110.68 -10.85 14.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.583 -0.735 . . . . 1.51 110.281 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.09 22.91 9.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.163 -1.018 . . . . 0.28999999999999998 113.015 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.951 HD13 ' HG3' ' A' ' 66' ' ' LYS . 4.1 pp -152.94 168.32 26.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.069 0.434 . . . . 0.54000000000000004 111.212 174.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.639 ' O ' HG12 ' A' ' 67' ' ' ILE . 50.8 mt -145.08 118.87 9.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.82 -1.178 . . . . 0.68000000000000005 107.82 -166.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.441 ' H ' ' HB2' ' A' ' 105' ' ' GLU . 1.1 p30 -81.98 -173.25 4.38 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.518 -0.473 . . . . 1.5 110.758 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 54' ' ' ASP . 34.1 t70 -55.8 -36.96 67.99 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.423 0.689 . . . . 1.73 112.245 -173.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 4.2 tp10 -90.61 -22.0 21.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.428 0.632 . . . . 2.1400000000000001 110.483 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.568 ' OE1' ' HA ' ' A' ' 101' ' ' LEU . 3.1 mt-10 -73.64 -30.51 62.98 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.0 -0.545 . . . . 1.1100000000000001 110.047 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.62 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.8 OUTLIER -77.4 -34.09 54.88 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.953 -1.129 . . . . 1.0700000000000001 107.953 170.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.627 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -53.28 -48.88 67.95 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.378 0.608 . . . . 0.19 110.091 174.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 37.1 tp -75.85 -39.07 57.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.725 -0.67 . . . . 1.23 111.363 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.25 -56.46 12.81 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.05 0.452 . . . . 0.22 111.166 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.573 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 4.4 t30 -73.63 -24.32 60.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.829 -0.623 . . . . 1.1799999999999999 110.211 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.466 ' O ' HG23 ' A' ' 115' ' ' VAL . 82.6 t60 -70.28 -42.89 71.48 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.277 -0.569 . . . . 0.48999999999999999 109.825 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.563 HD12 ' HB2' ' A' ' 93' ' ' ALA . 80.4 mt -66.98 -31.44 72.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.738 -0.664 . . . . 0.55000000000000004 109.785 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.723 ' O ' ' HG2' ' A' ' 116' ' ' LYS . 60.0 mt -60.72 -45.49 97.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.512 -0.767 . . . . 0.81000000000000005 110.684 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.62 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 12.4 ttpt -65.26 -39.56 92.79 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.341 -0.544 . . . . 2.2200000000000002 110.433 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 111' ' ' HIS . 54.7 t -56.79 -46.4 83.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.666 -0.243 . . . . 0.48999999999999999 111.365 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.824 ' HE2' HD11 ' A' ' 81' ' ' LEU . 14.6 pttp -67.01 -28.19 68.04 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.107 0.479 . . . . 1.9099999999999999 109.92 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.8 tp -80.89 -17.39 50.78 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.868 -0.605 . . . . 1.28 110.971 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.62 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 45.0 mt-10 -75.46 0.55 16.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.034 0.445 . . . . 1.99 110.712 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.81 3.95 30.01 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.429 -0.891 . . . . 1.01 112.902 171.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.519 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.2 p80 -140.53 134.9 31.29 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.393 -0.523 . . . . 0.87 110.121 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.44 163.78 27.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.534 -0.757 . . . . 2.75 111.007 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.596 HD11 HG12 ' A' ' 89' ' ' ILE . 23.3 mt -69.89 134.34 87.91 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.35 -0.386 . . . . 2.7000000000000002 110.014 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 84.4 Cg_endo -93.18 14.83 1.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.894 2.396 . . . . 1.1000000000000001 113.114 -174.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.56 19.55 10.48 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.202 0.525 . . . . 1.3400000000000001 111.099 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -104.35 111.77 24.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.663 -0.699 . . . . 2.3599999999999999 109.582 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.9 tp -112.24 100.11 48.5 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.069 -0.514 . . . . 1.8300000000000001 109.983 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.446 ' C ' ' H ' ' A' ' 129' ' ' HIS . 4.7 Cg_endo -89.02 159.7 5.86 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.075 2.516 . . . . 1.0 111.238 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.17 28.41 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.842 2.362 . . . . 1.3400000000000001 113.104 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.446 ' H ' ' C ' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -100.35 -25.17 14.32 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.863 -0.791 . . . . 1.48 108.863 174.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.49 7.07 6.32 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.976 -0.557 . . . . 1.29 111.424 -167.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.99 121.04 84.07 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 108.255 -1.017 . . . . 1.72 108.255 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 CA--C 1.545 1.054 0 C-N-CA 122.743 2.295 . . . . 1.04 113.073 -176.157 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.82 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 21.1 t . . . . . 0 C--O 1.217 -0.651 0 N-CA-C 112.565 0.58 . . . . 1.21 112.565 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' A' ' 49' ' ' ASP . 1.0 OUTLIER -74.99 -15.86 15.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 120.826 -1.171 . . . . 0.66000000000000003 111.592 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.43 -14.12 61.65 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 119.517 -1.325 . . . . 0.71999999999999997 111.714 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.82 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -110.08 -27.87 8.96 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.986 0.422 . . . . 2.9700000000000002 110.874 176.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.792 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.0 OUTLIER -86.37 -18.66 31.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.515 -0.766 . . . . 1.8300000000000001 111.1 -177.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.484 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 58.8 tttm -52.32 -51.05 75.96 Favored Pre-proline 0 C--O 1.217 -0.619 0 CA-C-O 118.662 -0.685 . . . . 1.1299999999999999 112.643 -174.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 85.9 Cg_exo -41.95 -40.41 6.03 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 122.775 2.317 . . . . 0.56000000000000005 113.676 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.563 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 93.9 m -74.04 -44.15 55.31 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.61 0.719 . . . . 0.59999999999999998 110.744 -176.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.792 ' CE2' ' HB3' ' A' ' 49' ' ' ASP . 6.1 m-85 -74.64 -24.28 58.8 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.988 -0.551 . . . . 0.93999999999999995 110.109 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 24.7 t70 -81.1 -37.24 29.27 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.829 -1.078 . . . . 1.1599999999999999 110.257 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 52' ' ' THR . 13.5 pt-20 -67.13 -41.59 85.88 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.256 -0.429 . . . . 1.6299999999999999 109.963 175.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.462 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 56.1 mt -69.52 -30.38 45.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.583 -0.525 . . . . 0.60999999999999999 109.583 175.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 62' ' ' PRO . 55.3 t80 -57.68 -55.21 37.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.721 -0.672 . . . . 0.88 111.244 177.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.512 ' CD1' ' HG2' ' A' ' 62' ' ' PRO . 68.6 m-85 -70.51 -21.84 62.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.236 0.541 . . . . 1.03 110.611 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.462 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 23.0 m -72.97 -24.53 60.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.257 -0.883 . . . . 0.44 110.985 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.0 mt -94.54 7.98 43.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.79000000000000004 110.828 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.0 t 64.93 90.05 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 123.751 0.657 . . . . 0.64000000000000001 112.223 175.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 57' ' ' PHE . 5.7 Cg_exo -75.49 143.12 27.22 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.852 2.368 . . . . 0.46000000000000002 112.819 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.04 117.94 54.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.457 -0.942 . . . . 1.3300000000000001 108.457 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 68.89 21.15 7.69 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.636 0.585 . . . . 1.6699999999999999 111.567 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.435 ' C ' ' HD2' ' A' ' 66' ' ' LYS . . . 93.34 22.56 26.67 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.148 -0.478 . . . . 0.5 112.936 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.946 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -160.85 156.07 24.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.247 -0.279 . . . . 1.8200000000000001 110.247 178.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.501 HD13 ' CD2' ' A' ' 106' ' ' PHE . 2.2 pt -86.22 137.56 20.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.776 -0.453 . . . . 0.40999999999999998 109.776 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 p -59.35 128.43 37.04 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.204 -1.036 . . . . 0.69999999999999996 108.204 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.567 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -52.28 -32.87 37.74 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 114.942 0.737 . . . . 0.38 114.942 -164.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.56 -28.01 29.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.291 0.545 . . . . 0.44 112.434 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -78.73 -41.7 30.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.423 0.63 . . . . 2.1099999999999999 109.628 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.544 ' CB ' HD12 ' A' ' 101' ' ' LEU . . . -69.95 -31.14 68.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.583 0.706 . . . . 0.41999999999999998 109.287 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 30.6 mmmt -65.86 -37.46 86.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.951 -1.022 . . . . 1.6899999999999999 109.004 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.4 -46.01 83.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.476 -0.783 . . . . 1.3500000000000001 109.785 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.901 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 11.4 mm-40 -56.63 -53.02 62.55 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.864 -1.062 . . . . 1.48 111.36 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 16.7 ptp -72.55 -23.67 61.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.179 -0.464 . . . . 0.65000000000000002 111.685 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 73' ' ' LYS . 20.2 t -67.57 -55.7 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.858 0.361 . . . . 0.58999999999999997 110.798 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.901 ' HE2' ' HA ' ' A' ' 75' ' ' GLU . 57.2 pttt -67.7 -14.44 62.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.16 0.505 . . . . 1.2 110.977 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.1 t -66.32 -7.47 19.06 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.759 -0.655 . . . . 1.3700000000000001 110.995 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt 72.15 71.7 0.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.399 0.68 . . . . 2.6499999999999999 111.315 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.035 HD11 ' HE2' ' A' ' 116' ' ' LYS . 36.4 mt -131.82 162.21 57.82 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.519 -0.764 . . . . 1.1599999999999999 110.65 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.519 ' HG2' HG23 ' A' ' 85' ' ' VAL . 67.8 Cg_endo -76.76 169.01 22.55 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.568 2.178 . . . . 0.94999999999999996 110.864 166.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -66.0 -32.08 73.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.66 0.267 . . . . 1.53 111.344 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.5 m -63.6 -50.85 67.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.067 0.46 . . . . 1.24 110.856 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.519 HG23 ' HG2' ' A' ' 82' ' ' PRO . 84.7 t -63.04 -40.1 87.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 115.945 -0.57 . . . . 0.71999999999999997 110.502 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.792 HD12 ' HB2' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -59.76 -48.99 79.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.879 0.371 . . . . 1.45 111.321 177.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.33 -37.51 93.21 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.535 -0.757 . . . . 0.39000000000000001 112.209 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.675 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 17.2 ptmt -83.84 -29.43 27.29 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.241 -0.583 . . . . 1.6599999999999999 110.446 -175.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.5 mm -60.06 -48.04 89.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.363 -0.606 . . . . 1.1499999999999999 109.363 169.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.564 ' CE3' ' HD3' ' A' ' 73' ' ' LYS . 76.9 t-105 -57.43 -54.35 47.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.449 -0.796 . . . . 0.29999999999999999 111.187 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.675 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 18.1 ptpt -77.78 -8.11 57.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.925 -0.58 . . . . 2.54 111.915 -171.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 18.2 tp -93.24 -30.89 14.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.996 -0.372 . . . . 0.85999999999999999 109.996 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.498 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -81.84 -42.58 19.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.217 -0.447 . . . . 0.45000000000000001 110.957 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.488 ' HB2' HD21 ' A' ' 101' ' ' LEU . 50.6 t0 -87.28 97.84 11.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.175 0.512 . . . . 0.62 110.323 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 m -73.2 -25.78 21.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.624 -0.716 . . . . 1.76 111.681 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.64 -25.78 26.41 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.377 -0.601 . . . . 1.7 109.377 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.2 mttp 57.27 69.16 0.77 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.131 -0.941 . . . . 1.74 110.504 -174.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.497 ' HB2' ' HG ' ' A' ' 100' ' ' LEU . 2.7 m-20 -96.05 -46.18 6.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.802 -1.09 . . . . 1.51 110.6 -174.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.45 14.32 20.33 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 109.435 -1.466 . . . . 0.28999999999999998 109.435 -162.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.946 HD13 ' HG3' ' A' ' 66' ' ' LYS . 3.6 pp -152.8 171.02 18.89 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.048 -1.076 . . . . 0.54000000000000004 108.292 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 105' ' ' GLU . 48.0 mt -143.35 117.52 9.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.618 -0.512 . . . . 0.68000000000000005 109.618 -174.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 4.0 p30 -74.3 -174.2 1.91 Allowed 'General case' 0 C--N 1.317 -0.845 0 O-C-N 122.199 -0.313 . . . . 1.5 110.656 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.2 -36.23 65.71 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.088 0.947 . . . . 1.73 109.995 -176.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.522 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 29.4 tt0 -88.19 -25.08 23.1 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.772 -1.103 . . . . 2.1400000000000001 109.871 -173.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.552 ' HB3' HD22 ' A' ' 101' ' ' LEU . 2.0 mt-10 -81.5 -32.36 32.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.041 -0.527 . . . . 1.1100000000000001 111.496 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.636 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -63.82 -43.0 97.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.176 -1.416 . . . . 1.0700000000000001 107.176 169.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.663 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -48.98 -50.24 36.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.602 -0.726 . . . . 0.19 110.842 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.636 HD12 ' HG3' ' A' ' 132' ' ' PRO . 1.4 tt -66.35 -47.94 71.82 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.748 -0.206 . . . . 1.23 110.78 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.33 -54.66 33.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.948 0.404 . . . . 0.22 111.894 -176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.538 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 9.0 t-20 -70.9 -30.66 67.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.238 0.542 . . . . 1.1799999999999999 109.583 -175.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.464 ' O ' HG23 ' A' ' 115' ' ' VAL . 61.7 t60 -67.94 -37.14 81.25 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.653 -0.703 . . . . 0.48999999999999999 109.897 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.46 ' HA ' ' HB ' ' A' ' 115' ' ' VAL . 21.6 mt -67.9 -33.48 74.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.056 0.455 . . . . 0.55000000000000004 110.421 175.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.779 ' HA ' ' HE3' ' A' ' 116' ' ' LYS . 75.9 mt -62.13 -45.82 97.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.689 -0.687 . . . . 0.81000000000000005 110.894 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.487 ' HD3' ' OH ' ' A' ' 53' ' ' TYR . 21.5 ptmt -73.8 -26.86 60.83 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.265 -0.574 . . . . 2.2200000000000002 110.927 176.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 111' ' ' HIS . 3.4 t -62.76 -47.45 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.744 0.307 . . . . 0.48999999999999999 110.933 176.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 1.035 ' HE2' HD11 ' A' ' 81' ' ' LEU . 20.6 pttp -72.22 -22.47 61.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.09 0.471 . . . . 1.9099999999999999 110.112 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 23.0 tp -70.64 -22.36 62.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.953 -0.567 . . . . 1.28 109.782 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 45.6 mt-10 -68.34 -12.01 60.43 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 116.028 -0.533 . . . . 1.99 110.429 173.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.96 -13.76 58.89 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.307 -0.717 . . . . 1.01 111.307 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -94.49 125.45 39.14 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.473 -0.566 . . . . 0.87 109.473 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.71 141.13 35.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.424 -0.807 . . . . 2.75 112.252 -174.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.903 HD13 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -63.75 130.16 94.23 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.882 -1.053 . . . . 2.7000000000000002 110.941 176.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.759 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 13.5 Cg_endo -87.83 1.18 6.9 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.066 2.51 . . . . 1.1000000000000001 114.176 -170.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 65.94 18.73 11.15 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.722 0.773 . . . . 1.3400000000000001 109.777 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.759 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 37.0 t70 -105.31 140.68 38.08 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.731 -1.122 . . . . 2.3599999999999999 108.593 175.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.52 102.48 32.81 Favored Pre-proline 0 C--N 1.309 -1.155 0 CA-C-N 115.782 -0.645 . . . . 1.8300000000000001 110.085 -176.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.28 156.64 11.0 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.269 2.646 . . . . 1.0 112.415 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.456 ' O ' HG12 ' A' ' 131' ' ' VAL . 18.8 Cg_exo -64.0 -19.01 65.9 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.941 2.427 . . . . 1.3400000000000001 112.241 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -90.2 15.73 9.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.126 -0.488 . . . . 1.48 109.722 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.06 17.52 0.96 Allowed 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.225 -0.898 . . . . 1.29 109.483 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 128' ' ' PRO . 9.6 p -98.12 119.26 62.38 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 115.983 -0.553 . . . . 1.72 109.702 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.636 ' HG3' HD12 ' A' ' 108' ' ' LEU . 15.0 Cg_exo . . . . . 0 CA--C 1.538 0.693 0 C-N-CA 122.235 1.957 . . . . 1.04 111.427 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.0 t . . . . . 0 CA--C 1.543 0.695 0 N-CA-C 113.572 0.953 . . . . 1.21 113.572 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.94 -26.49 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.226 -0.922 . . . . 0.66000000000000003 112.022 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.96 -11.19 30.12 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.449 -0.881 . . . . 0.71999999999999997 112.398 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.411 ' NZ ' ' HB3' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -102.01 -27.63 12.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 112.154 0.427 . . . . 2.9700000000000002 112.154 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -114.67 6.67 15.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.187 0.517 . . . . 1.8300000000000001 110.572 -175.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.666 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 74.2 tttt -55.86 -43.47 99.22 Favored Pre-proline 0 C--O 1.22 -0.473 0 CA-C-O 118.774 -0.631 . . . . 1.1299999999999999 111.757 177.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -44.69 -30.46 4.18 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 122.734 2.289 . . . . 0.56000000000000005 113.304 178.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.694 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 28.6 m -73.43 -43.87 59.46 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.067 0.937 . . . . 0.59999999999999998 109.937 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.554 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 3.6 m-85 -82.05 -24.93 35.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.597 -0.729 . . . . 0.93999999999999995 110.117 -175.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 1.7 t70 -77.82 -35.81 50.9 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.949 -1.023 . . . . 1.1599999999999999 109.55 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.694 ' HG3' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -68.03 -36.73 80.42 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.054 -0.521 . . . . 1.6299999999999999 109.778 176.176 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.437 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 55.7 mt -70.42 -33.84 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.462 -0.57 . . . . 0.60999999999999999 109.462 173.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 90.3 t80 -56.1 -57.52 11.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.349 -0.842 . . . . 0.88 111.348 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.616 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 57.4 m-85 -68.77 -22.8 64.27 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.991 0.424 . . . . 1.03 111.045 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.9 m -70.06 -27.92 65.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.927 -0.579 . . . . 0.44 110.698 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 63.6 mt -87.24 -3.97 59.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.644 -0.253 . . . . 0.79000000000000004 111.063 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.2 t 69.05 86.9 0.12 Allowed Pre-proline 0 N--CA 1.468 0.443 0 O-C-N 123.847 0.717 . . . . 0.64000000000000001 111.533 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.616 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 59.6 Cg_endo -77.0 151.97 31.27 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.882 2.388 . . . . 0.46000000000000002 113.443 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.5 m -120.1 121.6 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.577 -0.738 . . . . 1.3300000000000001 110.756 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 63.26 24.25 14.2 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.915 -0.584 . . . . 1.6699999999999999 112.014 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.43 36.78 9.35 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.687 -0.768 . . . . 0.5 112.754 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.655 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -171.56 162.99 6.63 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.327 -0.62 . . . . 1.8200000000000001 109.327 169.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.48 HD13 ' CD2' ' A' ' 106' ' ' PHE . 2.0 pt -92.97 134.85 29.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 109.741 -0.466 . . . . 0.40999999999999998 109.741 170.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 p -59.33 134.32 56.89 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.652 -1.24 . . . . 0.69999999999999996 107.652 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.611 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -52.18 -28.26 25.87 Favored Glycine 0 C--O 1.22 -0.732 0 N-CA-C 115.422 0.929 . . . . 0.38 115.422 -167.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.91 -27.03 50.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.774 0.787 . . . . 0.44 112.047 175.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.414 ' ND2' ' N ' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -79.31 -36.5 39.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.785 0.802 . . . . 2.1099999999999999 109.472 -178.13 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.65 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -75.8 -31.34 59.39 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.235 -0.893 . . . . 0.41999999999999998 110.09 177.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 14.2 mmmm -65.18 -34.51 78.56 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.433 -0.951 . . . . 1.6899999999999999 108.433 173.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 74' ' ' LYS . 1.7 tppp? -58.96 -49.02 79.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.122 -0.944 . . . . 1.3500000000000001 109.719 174.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 57.4 mm-40 -56.69 -53.02 62.51 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.254 -0.884 . . . . 1.48 112.226 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.65 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 15.0 ptp -70.8 -24.7 62.62 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.698 -0.401 . . . . 0.65000000000000002 110.857 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.06 -46.02 82.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 122.109 -0.369 . . . . 0.58999999999999997 110.991 172.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 18.1 ptpt -73.79 -18.28 60.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.72 -0.218 . . . . 1.2 111.432 -175.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.2 p -67.33 3.22 1.32 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.546 0.573 . . . . 1.3700000000000001 112.546 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 74.44 29.34 1.21 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.987 0.515 . . . . 2.6499999999999999 111.003 172.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.543 HD13 ' HD3' ' A' ' 116' ' ' LYS . 61.6 mt -109.44 162.05 21.67 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.125 -0.488 . . . . 1.1599999999999999 111.33 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.567 ' O ' HD22 ' A' ' 86' ' ' LEU . 92.3 Cg_endo -81.96 150.43 16.06 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.745 2.297 . . . . 0.94999999999999996 111.464 174.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -51.29 -29.9 16.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.536 -0.756 . . . . 1.53 112.657 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -62.95 -49.64 73.95 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.429 0.633 . . . . 1.24 110.71 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 89' ' ' ILE . 67.6 t -63.52 -41.83 94.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-N 115.273 -0.876 . . . . 0.71999999999999997 110.315 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.567 HD22 ' O ' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -64.18 -39.05 93.17 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.721 0.296 . . . . 1.45 110.765 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -57.92 -45.96 93.04 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.913 -0.66 . . . . 0.39000000000000001 111.907 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.705 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 44.7 pttt -81.1 -27.76 35.47 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.739 -0.785 . . . . 1.6599999999999999 111.715 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 85' ' ' VAL . 60.0 mt -60.6 -46.3 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 109.662 -0.496 . . . . 1.1499999999999999 109.662 171.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.481 ' HZ3' ' HB3' ' A' ' 72' ' ' ALA . 67.6 t-105 -56.99 -56.92 15.5 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.702 -0.681 . . . . 0.29999999999999999 111.088 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.705 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 9.0 ptpp? -70.38 -9.51 56.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 2.54 111.665 -174.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 124' ' ' ALA . 14.0 tp -93.32 -33.05 14.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.85999999999999999 110.347 175.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.404 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -87.31 -42.84 12.6 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.121 0.415 . . . . 0.45000000000000001 112.121 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.523 ' HB2' HD21 ' A' ' 101' ' ' LEU . 53.8 t0 -84.98 98.65 10.5 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.628 -0.508 . . . . 0.62 109.628 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.02 -29.82 34.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.532 -0.758 . . . . 1.76 111.244 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -27.39 37.57 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.177 -0.675 . . . . 1.7 109.177 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 58.8 45.52 15.39 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 122.318 1.056 . . . . 1.74 108.439 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -105.0 6.7 33.65 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.649 -1.614 . . . . 1.51 111.801 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.51 18.62 70.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.467 -0.873 . . . . 0.28999999999999998 112.527 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.655 HD13 ' HG3' ' A' ' 66' ' ' LYS . 4.3 pp -153.3 175.21 13.35 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.693 -0.484 . . . . 0.54000000000000004 109.693 175.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.585 HD12 ' CB ' ' A' ' 72' ' ' ALA . 46.3 mt -149.79 113.45 5.03 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.931 -1.136 . . . . 0.68000000000000005 107.931 -173.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.1 p-10 -75.75 -172.54 1.93 Allowed 'General case' 0 C--N 1.313 -0.991 0 O-C-N 122.352 -0.217 . . . . 1.5 110.678 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.52 -36.42 66.69 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.852 0.358 . . . . 1.73 111.057 -175.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 0.2 OUTLIER -90.51 -26.81 19.58 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.013 0.375 . . . . 2.1400000000000001 112.013 -179.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.475 ' HB3' HD22 ' A' ' 101' ' ' LEU . 2.3 mt-10 -70.8 -34.55 71.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.026 0.441 . . . . 1.1100000000000001 109.91 175.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.666 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -66.7 -42.56 86.24 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 107.649 -1.241 . . . . 1.0700000000000001 107.649 170.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.554 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -53.0 -41.02 64.23 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.846 -0.616 . . . . 0.19 110.558 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.467 HD12 ' HD3' ' A' ' 132' ' ' PRO . 1.0 OUTLIER -73.74 -50.84 18.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.004 -0.544 . . . . 1.23 110.883 178.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.9 -52.07 45.61 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.26 0.552 . . . . 0.22 111.198 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.501 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 7.2 t-20 -71.18 -27.16 63.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.646 -0.706 . . . . 1.1799999999999999 109.515 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 60.8 t60 -68.69 -40.83 79.88 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 120.19 -0.604 . . . . 0.48999999999999999 109.59 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.525 ' HA ' ' HB ' ' A' ' 115' ' ' VAL . 42.8 mt -68.57 -35.37 77.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.307 -0.406 . . . . 0.55000000000000004 110.735 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 110' ' ' ASN . 97.4 mt -59.26 -52.43 60.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.334 -0.394 . . . . 0.81000000000000005 110.186 174.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 19.1 ptmt -72.28 -21.61 61.33 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.126 -0.63 . . . . 2.2200000000000002 110.858 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.525 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 2.5 t -59.15 -47.47 90.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.998 -0.371 . . . . 0.48999999999999999 109.998 171.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.794 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 4.8 ptmm? -85.44 2.63 43.71 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 120.182 -0.607 . . . . 1.9099999999999999 110.527 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 51.8 tp -88.4 -19.52 26.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.573 -0.74 . . . . 1.28 109.311 168.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 55.2 mt-10 -67.08 -17.18 64.77 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.889 -0.596 . . . . 1.99 110.234 176.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.39 -21.34 13.05 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.026 -0.607 . . . . 1.01 111.94 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.794 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -106.83 135.94 47.51 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.89 -1.152 . . . . 0.87 107.89 174.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.52 ' HA ' ' CB ' ' A' ' 116' ' ' LYS . 13.4 pt-20 -93.26 163.29 13.67 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.737 -0.785 . . . . 2.75 110.937 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.882 HD13 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -62.86 127.57 90.76 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-O 121.367 0.603 . . . . 2.7000000000000002 110.763 177.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.508 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 72.8 Cg_endo -95.86 13.8 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.478 2.786 . . . . 1.1000000000000001 113.014 -174.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.503 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . 65.87 36.31 6.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.311 -0.858 . . . . 1.3400000000000001 111.181 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.508 ' OD1' ' HG2' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -114.99 142.69 46.29 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.55 0.69 . . . . 2.3599999999999999 109.914 169.256 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.3 tp -126.25 96.54 36.39 Favored Pre-proline 0 C--N 1.306 -1.32 0 CA-C-N 114.964 -1.017 . . . . 1.8300000000000001 110.032 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -73.2 150.81 48.23 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.755 2.303 . . . . 1.0 111.833 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.22 -16.25 45.23 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.785 2.323 . . . . 1.3400000000000001 112.248 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.403 ' O ' HD12 ' A' ' 130' ' ' LEU . 21.6 p-80 -98.38 21.83 10.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.143 -0.481 . . . . 1.48 110.867 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 129' ' ' HIS . 1.0 OUTLIER -138.27 12.91 2.82 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.576 -0.284 . . . . 1.29 110.729 174.143 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 m -91.18 125.55 58.06 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 109.401 -0.592 . . . . 1.72 109.401 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.467 ' HD3' HD12 ' A' ' 108' ' ' LEU . 51.3 Cg_exo . . . . . 0 CA--C 1.535 0.538 0 C-N-CA 122.6 2.2 . . . . 1.04 111.829 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 121.126 0.488 . . . . 1.21 111.266 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 t -88.14 -17.69 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 O-C-N 121.667 -0.646 . . . . 0.66000000000000003 111.194 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.78 -16.37 59.09 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.441 -0.885 . . . . 0.71999999999999997 111.906 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -99.82 -28.21 13.24 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.991 0.367 . . . . 2.9700000000000002 111.991 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.4 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 60.2 m-20 -108.01 0.4 21.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.956 0.408 . . . . 1.8300000000000001 111.094 -173.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.544 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 54.2 tttp -51.37 -48.63 85.59 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.048 -0.523 . . . . 1.1299999999999999 112.063 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 26.2 Cg_endo -62.02 -28.99 81.04 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.762 1.641 . . . . 0.56000000000000005 111.902 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.602 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 92.4 m -74.72 -37.69 62.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.719 0.771 . . . . 0.59999999999999998 110.274 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.464 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 24.0 m-85 -74.51 -24.41 58.98 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.829 -0.623 . . . . 0.93999999999999995 110.269 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.59 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 13.1 t70 -81.36 -32.39 32.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.577 -0.738 . . . . 1.1599999999999999 110.887 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 52' ' ' THR . 17.2 pt-20 -70.0 -44.38 69.5 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.926 -0.484 . . . . 1.6299999999999999 110.022 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.52 -30.12 48.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.819 0.818 . . . . 0.60999999999999999 109.066 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.948 ' HE1' HG23 ' A' ' 67' ' ' ILE . 0.7 OUTLIER -64.88 -57.21 9.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.304 -1.316 . . . . 0.88 111.019 176.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.645 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 27.6 m-85 -62.88 -22.82 66.99 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.998 0.427 . . . . 1.03 110.965 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.7 m -69.09 -22.07 64.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.647 -0.706 . . . . 0.44 110.834 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.9 mt -97.47 -7.24 32.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.53 -0.305 . . . . 0.79000000000000004 110.649 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.43 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 10.3 t 70.12 95.11 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.694 0.798 . . . . 0.64000000000000001 111.797 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.645 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 11.0 Cg_endo -62.09 160.87 28.39 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.422 2.748 . . . . 0.46000000000000002 113.855 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.681 HG12 HD22 ' A' ' 64' ' ' ASN . 87.2 t -129.12 102.99 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.315 -0.857 . . . . 1.3300000000000001 110.006 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.681 HD22 HG12 ' A' ' 63' ' ' VAL . 53.7 m-80 66.17 28.19 10.18 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.008 0.523 . . . . 1.6699999999999999 111.859 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.89 21.89 27.09 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.895 -0.669 . . . . 0.5 113.301 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.642 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -169.98 152.0 4.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.147 -1.057 . . . . 1.8200000000000001 108.147 174.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.948 HG23 ' HE1' ' A' ' 57' ' ' PHE . 1.1 pt -90.8 139.28 17.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 119.531 -0.868 . . . . 0.40999999999999998 110.183 174.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.6 p -60.37 139.58 57.59 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.338 -0.986 . . . . 0.69999999999999996 108.338 169.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.561 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -53.5 -35.72 52.03 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 115.098 0.799 . . . . 0.38 115.098 -164.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.01 -22.44 15.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.54 0.67 . . . . 0.44 112.794 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -80.25 -40.68 26.51 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.675 0.75 . . . . 2.1099999999999999 109.689 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.634 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -73.79 -31.25 63.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.436 -0.802 . . . . 0.41999999999999998 109.663 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.2 mmmm -64.29 -35.03 79.5 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.643 -0.873 . . . . 1.6899999999999999 108.643 173.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 1.1 tppp? -59.16 -44.66 92.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.337 -0.847 . . . . 1.3500000000000001 110.006 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 60.2 mm-40 -60.16 -53.17 60.85 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.275 -0.875 . . . . 1.48 111.823 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.634 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 12.5 ptp -71.13 -18.23 62.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.432 -0.349 . . . . 0.65000000000000002 110.858 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.48 HG23 HD11 ' A' ' 86' ' ' LEU . 2.4 t -74.23 -47.91 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.309 -0.405 . . . . 0.58999999999999997 110.795 171.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 18.1 ptpt -70.39 -13.33 62.1 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.976 0.417 . . . . 1.2 110.354 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.5 t -65.86 -7.34 15.79 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.896 -0.593 . . . . 1.3700000000000001 110.517 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 68.04 67.56 0.34 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.927 0.891 . . . . 2.6499999999999999 110.889 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.023 HD21 ' HE3' ' A' ' 116' ' ' LYS . 22.6 mt -132.65 159.73 71.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.897 -0.592 . . . . 1.1599999999999999 111.029 -175.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.53 ' HG2' HG23 ' A' ' 85' ' ' VAL . 62.9 Cg_endo -76.96 163.62 30.78 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.536 2.157 . . . . 0.94999999999999996 110.922 169.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -61.57 -24.09 66.42 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.248 0.462 . . . . 1.53 112.248 -174.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.8 m -62.78 -48.94 76.97 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 120.998 0.428 . . . . 1.24 110.74 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.53 HG23 ' HG2' ' A' ' 82' ' ' PRO . 21.8 t -67.23 -43.53 88.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.328 -0.619 . . . . 0.71999999999999997 109.328 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 82' ' ' PRO . 3.3 mm? -46.55 -57.49 4.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.531 -0.759 . . . . 1.45 111.009 172.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.4 -40.74 99.07 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.031 -0.986 . . . . 0.39000000000000001 113.702 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.848 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 55.7 pttt -85.28 -25.09 27.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.618 -0.833 . . . . 1.6599999999999999 112.209 -175.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.618 HG12 ' CD1' ' A' ' 122' ' ' LEU . 18.6 mt -65.2 -43.05 95.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.424 -0.954 . . . . 1.1499999999999999 108.424 170.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.417 ' CH2' ' HG ' ' A' ' 101' ' ' LEU . 73.9 t-105 -60.57 -53.29 59.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.943 -1.026 . . . . 0.29999999999999999 111.301 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.848 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -72.82 -12.34 60.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.579 -0.282 . . . . 2.54 111.616 -174.383 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.2 tp -91.25 -25.12 19.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.689 -0.486 . . . . 0.85999999999999999 109.689 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.634 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -93.1 -43.08 9.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.031 0.443 . . . . 0.45000000000000001 112.0 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.504 ' HB2' HD21 ' A' ' 101' ' ' LEU . 46.9 t0 -88.46 94.29 9.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.193 0.52 . . . . 0.62 110.171 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.5 t -64.35 -23.27 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.289 -0.869 . . . . 1.76 111.18 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.0 -26.77 15.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.57 -0.741 . . . . 1.7 110.726 -174.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt 60.23 58.71 2.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.348 1.071 . . . . 1.74 109.096 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -106.11 -18.81 13.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.454 -1.703 . . . . 1.51 111.278 -170.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.64 13.89 49.08 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.479 -0.867 . . . . 0.28999999999999998 112.553 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.6 pp -148.05 179.0 8.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.767 -0.457 . . . . 0.54000000000000004 109.767 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.609 HD12 ' CB ' ' A' ' 72' ' ' ALA . 25.2 mt -151.27 114.64 4.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.83 -1.174 . . . . 0.68000000000000005 107.83 -175.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.585 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.5 p30 -78.98 -174.36 4.0 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.49 -0.484 . . . . 1.5 109.996 178.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.625 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 3.9 p30 -57.84 -33.73 68.96 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.16 0.429 . . . . 1.73 112.16 -174.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.942 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 16.5 tt0 -85.74 -27.0 25.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.53 0.681 . . . . 2.1400000000000001 110.391 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.562 ' HB3' HD22 ' A' ' 101' ' ' LEU . 3.0 mt-10 -75.25 -33.69 61.33 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.603 -0.726 . . . . 1.1100000000000001 110.499 176.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.551 ' CE2' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -66.89 -40.87 87.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.753 -1.203 . . . . 1.0700000000000001 107.753 172.098 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.464 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -52.61 -48.94 65.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.289 -0.868 . . . . 0.19 110.799 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.634 HD13 ' HA ' ' A' ' 93' ' ' ALA . 1.3 tt -65.55 -53.27 44.45 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.352 -0.385 . . . . 1.23 110.121 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.6 -53.36 24.41 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.619 0.6 . . . . 0.22 112.619 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 10.2 t-20 -70.57 -32.1 69.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.169 0.509 . . . . 1.1799999999999999 110.167 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.541 ' O ' HG23 ' A' ' 115' ' ' VAL . 78.0 t60 -66.4 -35.26 79.86 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.975 -0.557 . . . . 0.48999999999999999 109.706 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 112' ' ' LEU . 25.2 mt -69.12 -36.6 77.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.843 -0.617 . . . . 0.55000000000000004 110.463 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.602 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 47.5 mm -59.49 -41.66 85.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.884 0.373 . . . . 0.81000000000000005 110.195 172.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.687 ' HE2' ' O ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -57.11 -49.39 76.06 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.72 -0.673 . . . . 2.2200000000000002 109.624 173.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 111' ' ' HIS . 78.6 t -60.32 -42.07 89.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.766 -0.652 . . . . 0.48999999999999999 111.577 -176.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 1.023 ' HE3' HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -75.27 -21.56 58.43 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.863 -0.335 . . . . 1.9099999999999999 111.278 178.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.1 tp -79.75 -19.4 48.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.746 0.307 . . . . 1.28 110.535 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.606 ' HG2' ' NZ ' ' A' ' 114' ' ' LYS . 37.2 mt-10 -62.92 -16.73 60.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.148 0.499 . . . . 1.99 110.427 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 112.07 4.91 25.57 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.667 -0.777 . . . . 1.01 111.627 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.495 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 2.7 p80 -126.85 140.41 52.37 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.305 0.574 . . . . 0.87 110.36 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -71.77 152.16 42.94 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.123 -0.944 . . . . 2.75 111.363 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.618 ' CD1' HG12 ' A' ' 89' ' ' ILE . 39.9 mt -67.12 141.15 96.17 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 115.839 -0.619 . . . . 2.7000000000000002 110.398 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -87.64 4.04 6.08 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.055 2.503 . . . . 1.1000000000000001 113.515 -173.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 58.81 19.95 7.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.37 0.605 . . . . 1.3400000000000001 111.1 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -112.91 136.2 52.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.741 -0.837 . . . . 2.3599999999999999 108.741 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.554 HD22 HG23 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -116.16 102.62 53.69 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 109.303 -0.629 . . . . 1.8300000000000001 109.303 -177.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 2.0 Cg_endo -79.96 157.27 23.83 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.061 2.507 . . . . 1.0 112.155 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -55.0 -40.33 86.47 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.397 2.065 . . . . 1.3400000000000001 111.843 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.662 ' O ' HD12 ' A' ' 130' ' ' LEU . 50.1 p-80 -81.89 30.88 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.658 -0.701 . . . . 1.48 111.709 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.662 HD12 ' O ' ' A' ' 129' ' ' HIS . 0.7 OUTLIER -146.86 9.89 1.02 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.063 0.394 . . . . 1.29 112.063 171.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.554 HG23 HD22 ' A' ' 126' ' ' LEU . 7.3 t -97.33 115.16 65.68 Favored Pre-proline 0 C--N 1.322 -0.598 0 C-N-CA 120.177 -0.609 . . . . 1.72 110.806 176.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.942 ' HB3' ' HG2' ' A' ' 104' ' ' GLU . 84.0 Cg_exo . . . . . 0 N--CA 1.46 -0.474 0 C-N-CA 123.751 2.967 . . . . 1.04 111.49 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 t . . . . . 0 CA--C 1.546 0.81 0 CA-C-O 121.043 0.449 . . . . 1.21 111.823 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.485 HG22 ' HE2' ' A' ' 53' ' ' TYR . 1.2 t -94.76 -21.99 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 121.46 -0.775 . . . . 0.66000000000000003 111.672 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.78 -14.25 57.91 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.074 -1.06 . . . . 0.71999999999999997 111.842 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -104.53 -28.35 11.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 111.923 0.342 . . . . 2.9700000000000002 111.923 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -107.36 1.94 24.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.515 0.674 . . . . 1.8300000000000001 110.154 -171.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 55.7 tttm -55.69 -46.99 99.65 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.05 -0.977 . . . . 1.1299999999999999 112.086 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 11.1 Cg_endo -55.84 -26.87 59.68 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.23 1.953 . . . . 0.56000000000000005 112.636 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.555 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . 9.5 m -70.35 -45.16 66.68 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.852 0.834 . . . . 0.59999999999999998 108.99 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.569 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 16.7 m-85 -75.74 -24.21 56.1 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.116 -0.947 . . . . 0.93999999999999995 109.581 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.602 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 15.1 t70 -78.09 -37.98 45.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.534 -0.757 . . . . 1.1599999999999999 111.145 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.555 ' OE2' ' HA ' ' A' ' 52' ' ' THR . 15.5 pt-20 -68.06 -37.1 80.92 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.515 -0.474 . . . . 1.6299999999999999 110.559 176.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.7 mt -70.14 -28.24 35.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.251 0.548 . . . . 0.60999999999999999 109.612 173.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.602 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 66.4 t80 -61.51 -54.17 46.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.347 -0.842 . . . . 0.88 111.194 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.593 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 42.0 m-85 -68.75 -22.5 64.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.132 0.492 . . . . 1.03 110.786 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.9 m -72.77 -25.69 61.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.696 -0.683 . . . . 0.44 110.863 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.422 HD11 ' HG2' ' A' ' 75' ' ' GLU . 25.9 mt -87.6 -0.01 56.26 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.638 -0.256 . . . . 0.79000000000000004 111.439 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 t 67.55 87.51 0.12 Allowed Pre-proline 0 N--CA 1.467 0.377 0 CA-C-O 121.297 0.57 . . . . 0.64000000000000001 110.916 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.593 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 71.6 Cg_endo -81.03 159.28 20.75 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.634 2.222 . . . . 0.46000000000000002 112.65 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 97.4 t -128.92 121.21 53.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.081 -0.509 . . . . 1.3300000000000001 109.794 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 66.38 23.04 10.69 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.117 -0.492 . . . . 1.6699999999999999 112.168 174.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.21 23.02 23.4 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.871 -0.68 . . . . 0.5 112.114 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.897 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -167.48 159.77 12.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.588 -0.523 . . . . 1.8200000000000001 109.588 175.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.438 ' H ' HG12 ' A' ' 67' ' ' ILE . 1.5 pt -89.76 132.43 34.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 120.129 -0.628 . . . . 0.40999999999999998 110.345 173.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -59.2 130.55 47.5 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.693 -1.225 . . . . 0.69999999999999996 107.693 170.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.586 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -53.71 -26.26 31.75 Favored Glycine 0 C--O 1.219 -0.819 0 N-CA-C 114.69 0.636 . . . . 0.38 114.69 -166.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.15 -39.53 43.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 117.475 0.637 . . . . 0.44 111.437 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.44 -31.83 48.27 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.16 -0.473 . . . . 2.1099999999999999 110.087 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.685 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -74.05 -36.19 64.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.678 -0.692 . . . . 0.41999999999999998 109.718 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 14.7 mmmm -66.28 -37.97 86.7 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.707 -0.849 . . . . 1.6899999999999999 108.707 173.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -56.59 -44.89 81.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.526 -0.761 . . . . 1.3500000000000001 110.255 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.8 tp10 -61.81 -53.07 60.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.544 -1.207 . . . . 1.48 111.162 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.685 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 12.5 ptp -73.05 -16.69 61.48 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 122.068 -0.395 . . . . 0.65000000000000002 111.353 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.478 HG23 HD11 ' A' ' 86' ' ' LEU . 2.3 t -74.17 -49.64 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.577 0.227 . . . . 0.58999999999999997 110.832 173.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 14.6 ptpt -68.28 -12.18 60.62 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.085 0.469 . . . . 1.2 109.851 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 76' ' ' MET . 62.4 m -67.69 3.93 1.26 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.29 -0.868 . . . . 1.3700000000000001 111.835 170.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 74.36 37.95 0.55 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.26 0.624 . . . . 2.6499999999999999 111.686 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.585 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . 22.8 mt -113.49 157.47 41.26 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 120.809 -0.357 . . . . 1.1599999999999999 111.539 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.447 ' O ' HD23 ' A' ' 86' ' ' LEU . 84.3 Cg_endo -83.91 164.26 13.69 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.898 2.399 . . . . 0.94999999999999996 111.307 169.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.549 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 8.5 m120 -54.75 -29.34 53.62 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.282 0.475 . . . . 1.53 112.282 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -59.94 -54.02 50.96 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.302 0.572 . . . . 1.24 110.776 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 24.0 t -66.31 -41.68 89.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.641 -0.708 . . . . 0.71999999999999997 109.927 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.585 ' CD2' ' HB2' ' A' ' 81' ' ' LEU . 3.9 mm? -49.52 -55.13 14.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.9 -0.591 . . . . 1.45 110.856 173.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.91 -44.5 97.33 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.392 -0.822 . . . . 0.39000000000000001 113.324 -175.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.618 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 55.5 pttt -80.19 -27.45 38.87 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.654 -0.818 . . . . 1.6599999999999999 111.676 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.404 HD13 HD13 ' A' ' 113' ' ' ILE . 17.4 mt -69.63 -41.55 80.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 120.536 -0.465 . . . . 1.1499999999999999 109.841 173.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.433 ' CH2' ' HG ' ' A' ' 101' ' ' LEU . 75.9 t-105 -55.87 -58.85 6.13 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.754 -0.657 . . . . 0.29999999999999999 110.346 175.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.618 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -69.44 -17.26 63.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.812 -0.631 . . . . 2.54 111.765 -172.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 14.3 tp -82.35 -37.4 25.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.129 -0.323 . . . . 0.85999999999999999 110.129 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.755 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -91.08 -33.75 15.36 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 120.556 -0.458 . . . . 0.45000000000000001 111.528 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 27.6 t0 -83.84 80.97 8.97 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.615 0.721 . . . . 0.62 109.922 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.448 HG22 HD11 ' A' ' 126' ' ' LEU . 16.0 t -67.34 -25.44 33.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 114.917 -1.038 . . . . 1.76 110.817 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.412 ' C ' ' HG3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -90.43 -23.84 20.91 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.619 -0.718 . . . . 1.7 112.234 -178.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.549 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 21.8 mtpt 67.02 45.22 1.8 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.769 0.795 . . . . 1.74 110.364 167.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 p30 -105.31 -1.06 25.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.759 -1.11 . . . . 1.51 112.371 -171.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.87 19.38 77.71 Favored Glycine 0 C--N 1.322 -0.224 0 C-N-CA 119.506 -1.33 . . . . 0.28999999999999998 112.326 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.897 HD13 ' HG3' ' A' ' 66' ' ' LYS . 4.4 pp -151.33 171.41 17.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.796 -0.816 . . . . 0.54000000000000004 108.796 174.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.581 HD12 ' HB1' ' A' ' 72' ' ' ALA . 44.2 mt -148.59 116.17 6.26 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.82 -1.178 . . . . 0.68000000000000005 107.82 -172.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -77.13 -175.94 3.83 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.086 -0.646 . . . . 1.5 109.366 178.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -60.26 -31.18 69.97 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.358 0.526 . . . . 1.73 111.164 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.644 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 34.0 tt0 -73.91 -39.94 63.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.426 0.631 . . . . 2.1400000000000001 110.107 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . 3.8 mt-10 -66.99 -39.16 87.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.672 -0.695 . . . . 1.1100000000000001 111.919 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.626 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -64.63 -39.2 93.28 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.158 -1.052 . . . . 1.0700000000000001 108.158 175.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.569 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -50.95 -49.14 60.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.19 110.581 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.755 HD13 ' HA ' ' A' ' 93' ' ' ALA . 1.1 tt -70.56 -50.42 37.65 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.443 -0.503 . . . . 1.23 110.509 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.47 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -45.73 -55.63 6.25 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.33 0.492 . . . . 0.22 112.33 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.553 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 2.6 t-20 -72.84 -23.31 60.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.677 -0.49 . . . . 1.1799999999999999 109.677 -177.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.496 ' CD2' HD11 ' A' ' 130' ' ' LEU . 70.8 t60 -68.01 -43.93 77.71 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.236 -0.653 . . . . 0.48999999999999999 109.236 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.639 HD22 ' CD1' ' A' ' 122' ' ' LEU . 46.7 mt -64.64 -32.81 74.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.107 -0.497 . . . . 0.55000000000000004 110.191 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 109' ' ' ALA . 41.4 mm -61.11 -50.92 78.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.886 -0.597 . . . . 0.81000000000000005 111.001 176.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.485 ' HD3' ' OH ' ' A' ' 53' ' ' TYR . 18.7 ptmt -72.33 -24.47 61.31 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.086 -0.646 . . . . 2.2200000000000002 110.823 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 111' ' ' HIS . 11.5 t -60.46 -47.22 93.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.318 -0.401 . . . . 0.48999999999999999 110.39 172.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 0.9 OUTLIER -85.38 0.5 51.97 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 120.36 -0.536 . . . . 1.9099999999999999 110.635 178.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.1 tp -81.83 -26.6 34.15 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.604 -0.517 . . . . 1.28 109.604 171.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.33 -22.17 65.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.801 -0.636 . . . . 1.99 111.169 177.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.09 10.79 13.24 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.351 -0.928 . . . . 1.01 112.698 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.61 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -127.21 133.49 50.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.553 -0.536 . . . . 0.87 109.553 174.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -78.34 163.36 25.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.783 0.325 . . . . 2.75 110.935 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.639 ' CD1' HD22 ' A' ' 112' ' ' LEU . 3.5 mm? -70.44 144.86 92.27 Favored Pre-proline 0 CA--C 1.513 -0.474 0 CA-C-N 116.077 -0.51 . . . . 2.7000000000000002 111.818 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.616 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 68.9 Cg_endo -77.62 -6.37 16.12 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 124.453 3.435 . . . . 1.1000000000000001 113.404 -173.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.22 19.53 11.72 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.632 0.73 . . . . 1.3400000000000001 109.655 -170.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.616 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 38.8 t70 -120.45 145.82 46.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.943 -1.026 . . . . 2.3599999999999999 108.985 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.448 HD11 HG22 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -115.15 104.41 53.79 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 116.353 -0.385 . . . . 1.8300000000000001 110.018 -176.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 5.7 Cg_endo -87.9 147.01 6.85 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.334 2.689 . . . . 1.0 111.982 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -55.08 -30.35 69.95 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.762 2.308 . . . . 1.3400000000000001 113.321 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -80.94 22.72 0.6 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.995 -0.282 . . . . 1.48 111.109 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.496 HD11 ' CD2' ' A' ' 111' ' ' HIS . 0.6 OUTLIER -150.29 8.52 0.62 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.619 -0.433 . . . . 1.29 111.477 177.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.1 132.09 31.57 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.942 -0.762 . . . . 1.72 108.942 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.704 ' HD3' HD12 ' A' ' 108' ' ' LEU . 37.4 Cg_exo . . . . . 0 C--O 1.237 0.448 0 C-N-CA 122.29 1.994 . . . . 1.04 112.539 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 t . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 112.153 0.427 . . . . 1.21 112.153 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 2.2 t -80.54 -17.74 12.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 120.951 -1.093 . . . . 0.66000000000000003 111.321 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.71 -17.15 62.27 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.694 -1.241 . . . . 0.71999999999999997 111.741 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 17.8 ptmt -106.97 -29.4 9.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.002 0.371 . . . . 2.9700000000000002 112.002 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 84.5 m-20 -89.33 -11.55 43.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 1.8300000000000001 110.676 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 49.9 tttm -49.87 -51.48 60.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.209 -0.905 . . . . 1.1299999999999999 112.409 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 8.0 Cg_endo -50.6 -35.64 47.39 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 122.726 2.284 . . . . 0.56000000000000005 113.837 -178.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.672 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 87.5 m -72.5 -40.64 66.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.999 0.904 . . . . 0.59999999999999998 110.328 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.65 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 10.3 m-85 -76.86 -23.85 52.63 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.766 0.793 . . . . 0.93999999999999995 109.279 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 7.2 t70 -80.66 -33.32 35.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.635 -1.166 . . . . 1.1599999999999999 110.776 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.672 ' HG2' ' O ' ' A' ' 52' ' ' THR . 14.0 pt-20 -69.47 -35.9 76.04 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.606 -0.516 . . . . 1.6299999999999999 109.606 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 52' ' ' THR . 46.5 mt -71.84 -29.8 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.224 -0.658 . . . . 0.60999999999999999 109.224 174.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 72.7 t80 -61.81 -57.42 11.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.146 -0.933 . . . . 0.88 111.534 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 42.8 m-85 -64.1 -22.32 66.89 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.037 0.446 . . . . 1.03 110.908 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.5 m -73.07 -32.05 64.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.923 -0.58 . . . . 0.44 111.516 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.1 mt -84.89 1.3 47.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.624 0.25 . . . . 0.79000000000000004 111.261 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t 70.9 85.76 0.12 Allowed Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.604 -0.726 . . . . 0.64000000000000001 111.125 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 74.3 Cg_endo -81.63 123.86 4.42 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.702 2.268 . . . . 0.46000000000000002 112.647 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.5 t -87.33 109.72 19.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.245 -0.434 . . . . 1.3300000000000001 110.027 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.06 23.75 11.05 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.322 0.389 . . . . 1.6699999999999999 111.378 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.67 27.79 12.29 Favored Glycine 0 C--O 1.228 -0.254 0 C-N-CA 121.054 -0.593 . . . . 0.5 113.565 170.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -164.39 147.39 9.09 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.306 -0.627 . . . . 1.8200000000000001 109.306 172.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.939 ' HB ' HD21 ' A' ' 71' ' ' ASN . 3.0 pt -86.89 137.11 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 120.695 -0.402 . . . . 0.40999999999999998 110.437 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.5 p -60.32 124.3 19.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.755 -1.202 . . . . 0.69999999999999996 107.755 170.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.586 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -46.94 -31.76 5.77 Favored Glycine 0 C--O 1.222 -0.608 0 C-N-CA 121.302 -0.475 . . . . 0.38 114.26 -168.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -43.73 -52.0 6.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.31 0.485 . . . . 0.44 112.31 173.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.939 HD21 ' HB ' ' A' ' 67' ' ' ILE . 11.7 p30 -71.03 -30.85 67.17 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.056 0.389 . . . . 2.1099999999999999 110.586 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.582 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -72.12 -31.76 66.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.585 0.707 . . . . 0.41999999999999998 109.612 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 31.6 mmmt -68.32 -35.85 78.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.072 -0.967 . . . . 1.6899999999999999 109.474 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.805 ' HG2' ' HA ' ' A' ' 71' ' ' ASN . 9.0 mmmm -59.45 -48.58 81.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 1.3500000000000001 109.503 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 23.6 mm-40 -54.73 -52.49 62.33 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.793 -1.094 . . . . 1.48 112.182 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.582 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 14.7 ptp -69.54 -29.38 66.95 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.126 -0.63 . . . . 0.65000000000000002 110.916 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.42 -45.83 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.489 0.185 . . . . 0.58999999999999997 110.854 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 17.4 ptpt -72.78 -14.32 61.5 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.038 0.446 . . . . 1.2 110.458 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 50.1 m -66.15 -13.03 59.51 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.454 -0.794 . . . . 1.3700000000000001 110.186 168.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 97.3 mttt 71.91 39.63 0.81 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.599 0.76 . . . . 2.6499999999999999 112.014 165.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.87 HD11 ' HE2' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -102.18 159.45 29.34 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.841 -0.618 . . . . 1.1599999999999999 110.115 -179.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.537 ' HG2' HG23 ' A' ' 85' ' ' VAL . 31.6 Cg_endo -66.88 153.3 78.39 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.893 1.729 . . . . 0.94999999999999996 110.742 172.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.782 ' HA ' HD12 ' A' ' 86' ' ' LEU . 0.9 OUTLIER -49.86 -31.74 12.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.005 -0.543 . . . . 1.53 112.042 -179.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.5 m -60.33 -55.59 31.84 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.209 0.528 . . . . 1.24 110.628 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.588 ' O ' HG13 ' A' ' 89' ' ' ILE . 91.1 t -60.63 -44.46 96.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 CA-C-N 115.745 -0.661 . . . . 0.71999999999999997 110.071 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.782 HD12 ' HA ' ' A' ' 83' ' ' ASN . 24.9 mt -60.08 -49.96 75.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.383 -0.372 . . . . 1.45 111.984 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -55.77 -42.41 85.43 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.146 -0.782 . . . . 0.39000000000000001 111.146 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 61.6 pttt -86.51 -13.49 45.83 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.491 -0.883 . . . . 1.6599999999999999 111.778 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 85' ' ' VAL . 23.0 mt -71.59 -43.51 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 N-CA-C 108.511 -0.922 . . . . 1.1499999999999999 108.511 170.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.451 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 71.4 t-105 -60.36 -56.77 17.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.82 -0.627 . . . . 0.29999999999999999 111.021 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 62.7 mttm -72.22 -21.45 61.4 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.65 -0.705 . . . . 2.54 111.965 -169.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 5.5 tp -86.32 -19.65 29.51 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.801 -0.444 . . . . 0.85999999999999999 109.801 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.892 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -93.05 -44.29 8.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.126 0.488 . . . . 0.45000000000000001 110.921 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.521 ' HB2' HD21 ' A' ' 101' ' ' LEU . 46.9 t0 -87.99 74.46 8.93 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.031 -1.1 . . . . 0.62 108.031 173.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.1 t -69.87 -6.96 7.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.19 -0.914 . . . . 1.76 109.81 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -94.18 -26.33 16.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.967 -1.015 . . . . 1.7 109.725 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 59.66 73.34 0.49 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.329 -0.85 . . . . 1.74 111.833 169.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.504 ' OD1' ' HG ' ' A' ' 100' ' ' LEU . 1.4 p30 -128.28 -23.47 3.25 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.913 -1.039 . . . . 1.51 112.078 -171.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.78 7.47 38.88 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.165 -1.016 . . . . 0.28999999999999998 112.529 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.504 ' HG ' ' OD1' ' A' ' 98' ' ' ASP . 3.6 pp -142.21 -175.21 4.35 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.805 -0.813 . . . . 0.54000000000000004 108.805 174.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.642 ' O ' HG12 ' A' ' 67' ' ' ILE . 50.8 mt -151.45 112.6 4.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.367 -1.345 . . . . 0.68000000000000005 107.367 -177.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.7 p30 -76.73 -175.75 3.55 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.674 -0.81 . . . . 1.5 109.809 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.08 -32.96 66.8 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.105 0.478 . . . . 1.73 111.879 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 35.5 tt0 -85.81 -29.01 24.12 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.314 0.578 . . . . 2.1400000000000001 110.246 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.49 ' HB3' HD22 ' A' ' 101' ' ' LEU . 4.0 mt-10 -75.15 -33.39 61.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.764 -0.653 . . . . 1.1100000000000001 110.977 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.672 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.6 OUTLIER -66.99 -40.23 87.32 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.638 -1.245 . . . . 1.0700000000000001 107.638 171.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.65 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -51.15 -46.19 61.94 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.078 -0.51 . . . . 0.19 110.607 175.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.892 HD22 ' HA ' ' A' ' 93' ' ' ALA . 1.4 tt -67.6 -48.89 65.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.309 -0.405 . . . . 1.23 110.353 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.403 ' HB2' HD13 ' A' ' 101' ' ' LEU . . . -49.88 -57.29 7.75 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.921 -0.582 . . . . 0.22 112.296 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.451 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 11.4 t-20 -70.61 -28.64 65.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.02 0.438 . . . . 1.1799999999999999 110.066 -174.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.553 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 66.7 t60 -69.88 -36.37 75.4 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.48999999999999999 110.032 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.536 HD22 HD22 ' A' ' 122' ' ' LEU . 41.8 mt -69.2 -35.97 76.8 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.949 -0.389 . . . . 0.55000000000000004 109.949 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.687 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 76.3 mt -58.37 -45.21 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.414 -0.357 . . . . 0.81000000000000005 111.379 172.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 111' ' ' HIS . 5.5 ptmm? -67.7 -33.05 74.13 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 119.658 -0.817 . . . . 2.2200000000000002 110.605 177.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 111' ' ' HIS . 37.4 t -62.75 -44.25 99.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.899 0.38 . . . . 0.48999999999999999 110.719 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.87 ' HE2' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -76.6 -6.88 53.85 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.099 0.476 . . . . 1.9099999999999999 110.391 176.173 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.1 tp -91.09 -15.89 28.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.339 0.59 . . . . 1.28 109.831 172.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 50.0 mt-10 -81.42 2.07 30.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.635 -0.711 . . . . 1.99 110.761 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.79 5.75 33.25 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.281 -0.962 . . . . 1.01 113.076 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.627 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -141.13 137.29 32.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.304 0.573 . . . . 0.87 111.161 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.54 163.93 25.88 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.216 -0.902 . . . . 2.75 111.421 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.536 HD22 HD22 ' A' ' 112' ' ' LEU . 39.4 mt -73.36 144.9 84.71 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.908 -0.587 . . . . 2.7000000000000002 110.823 -178.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.587 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 46.9 Cg_endo -82.56 -1.07 10.45 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.216 2.611 . . . . 1.1000000000000001 113.497 -172.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.54 19.4 11.21 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.744 0.783 . . . . 1.3400000000000001 109.954 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.587 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 32.2 t70 -117.31 150.53 38.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.687 -1.142 . . . . 2.3599999999999999 109.207 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 2.3 tm? -124.37 103.14 32.61 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 109.216 -0.661 . . . . 1.8300000000000001 109.216 -177.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 4.8 Cg_exo -77.55 147.92 25.65 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.97 2.447 . . . . 1.0 112.66 -176.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.483 ' HA ' HG13 ' A' ' 131' ' ' VAL . 50.9 Cg_exo -53.45 -35.52 76.2 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.258 2.639 . . . . 1.3400000000000001 112.848 177.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.535 ' O ' HD12 ' A' ' 130' ' ' LEU . 49.9 p-80 -82.27 18.48 1.41 Allowed 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 120.62 -0.432 . . . . 1.48 110.996 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.535 HD12 ' O ' ' A' ' 129' ' ' HIS . 2.9 mp -138.7 16.41 2.7 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.475 0.485 . . . . 1.29 110.888 172.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.483 HG13 ' HA ' ' A' ' 128' ' ' PRO . 32.4 m -77.66 116.52 58.87 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 120.133 -0.627 . . . . 1.72 110.211 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 C--O 1.239 0.557 0 C-N-CA 122.099 1.866 . . . . 1.04 111.611 178.466 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.453 ' HB ' ' CE1' ' A' ' 111' ' ' HIS . 12.4 t . . . . . 0 N--CA 1.448 -0.527 0 CA-C-O 121.011 0.434 . . . . 1.21 111.408 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 4.1 t -83.6 -27.66 7.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 121.771 -0.581 . . . . 0.66000000000000003 111.717 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.43 -19.47 53.39 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 119.564 -1.303 . . . . 0.71999999999999997 112.053 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 3.7 ptpp? -101.63 -28.6 12.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.336 0.495 . . . . 2.9700000000000002 112.336 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -106.55 5.81 29.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.716 0.77 . . . . 1.8300000000000001 110.36 -172.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.575 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 62.0 tttm -59.34 -46.69 99.02 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.17 -0.923 . . . . 1.1299999999999999 112.222 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 18.2 Cg_endo -60.02 -23.48 73.23 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.905 1.737 . . . . 0.56000000000000005 112.397 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.758 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 81.8 m -78.23 -36.48 47.02 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.433 0.635 . . . . 0.59999999999999998 110.023 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.46 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 16.1 m-85 -80.55 -25.34 38.67 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.344 -0.942 . . . . 0.93999999999999995 109.917 177.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 4.4 t70 -76.45 -34.94 58.71 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.096 -0.956 . . . . 1.1599999999999999 110.154 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.758 ' HG2' ' O ' ' A' ' 52' ' ' THR . 12.7 pt-20 -65.3 -42.28 93.21 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.53 -0.544 . . . . 1.6299999999999999 109.53 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 52' ' ' THR . 60.0 mt -67.38 -32.72 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 109.621 -0.511 . . . . 0.60999999999999999 109.621 175.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.55 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 66.8 t80 -57.06 -55.27 36.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.192 -0.913 . . . . 0.88 111.755 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.482 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 67.7 m-85 -69.23 -23.1 63.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.989 0.423 . . . . 1.03 110.61 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.0 m -70.41 -21.69 62.81 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.614 -0.721 . . . . 0.44 110.771 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.416 HD11 ' CG ' ' A' ' 75' ' ' GLU . 35.0 mt -88.7 -1.05 57.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.664 -0.244 . . . . 0.79000000000000004 111.301 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.2 t 65.55 81.12 0.22 Allowed Pre-proline 0 N--CA 1.465 0.315 0 O-C-N 123.594 0.559 . . . . 0.64000000000000001 111.218 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 62.9 Cg_endo -80.22 166.56 20.43 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.346 2.031 . . . . 0.46000000000000002 111.517 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' A' ' 64' ' ' ASN . 2.2 m -135.57 118.66 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 121.211 -0.196 . . . . 1.3300000000000001 110.62 -177.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.588 ' HB3' ' HZ3' ' A' ' 66' ' ' LYS . 8.3 t30 67.95 21.66 8.84 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 122.242 1.02 . . . . 1.6699999999999999 109.901 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.34 26.19 16.57 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.592 -0.813 . . . . 0.5 114.418 172.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.588 ' HZ3' ' HB3' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -166.21 157.28 13.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.488 0.644 . . . . 1.8200000000000001 110.075 174.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.415 HD13 ' CD2' ' A' ' 106' ' ' PHE . 1.8 pt -91.58 128.92 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 120.622 -0.431 . . . . 0.40999999999999998 110.564 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -71.79 82.6 0.89 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.899 -0.592 . . . . 0.69999999999999996 111.485 179.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.589 ' H ' ' HA ' ' A' ' 100' ' ' LEU . . . 44.28 -76.58 0.0 OUTLIER Glycine 0 C--O 1.226 -0.347 0 CA-C-N 113.844 -1.525 . . . . 0.38 116.201 167.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' THR . . . -46.6 -29.01 1.63 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.043 0.757 . . . . 0.44 113.043 -176.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -71.72 -42.65 67.07 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.148 0.499 . . . . 2.1099999999999999 110.101 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.486 ' CB ' HD12 ' A' ' 101' ' ' LEU . . . -72.0 -33.89 68.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.48 0.657 . . . . 0.41999999999999998 109.993 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.661 ' O ' HG23 ' A' ' 77' ' ' VAL . 29.6 mmmt -64.32 -38.95 92.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.363 -0.835 . . . . 1.6899999999999999 109.576 174.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.404 ' HB2' ' HE3' ' A' ' 74' ' ' LYS . 1.0 OUTLIER -54.84 -47.18 74.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.506 -0.77 . . . . 1.3500000000000001 109.992 175.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.68 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 8.7 mm-40 -60.7 -48.67 80.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.371 -1.286 . . . . 1.48 111.919 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.475 ' SD ' ' HD2' ' A' ' 73' ' ' LYS . 17.6 ptp -70.34 -15.53 62.88 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.739 -0.384 . . . . 0.65000000000000002 111.125 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 73' ' ' LYS . 54.0 t -75.41 -50.25 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.749 0.309 . . . . 0.58999999999999997 110.56 171.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.68 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 8.7 ptmt -68.72 -11.83 60.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.089 0.471 . . . . 1.2 110.453 -177.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.3 t -69.24 -8.1 42.83 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.845 -0.616 . . . . 1.3700000000000001 110.409 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 47.5 mttp 65.98 68.58 0.46 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.552 -0.749 . . . . 2.6499999999999999 110.431 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.691 ' HB2' HD12 ' A' ' 86' ' ' LEU . 27.7 mt -130.09 158.93 72.57 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.426 -0.806 . . . . 1.1599999999999999 110.632 -175.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.546 ' HG2' HG23 ' A' ' 85' ' ' VAL . 61.5 Cg_endo -75.5 164.35 32.6 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.322 2.015 . . . . 0.94999999999999996 110.796 168.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -63.95 -25.91 68.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.897 0.38 . . . . 1.53 111.326 -177.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -53.99 48.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.232 0.539 . . . . 1.24 110.527 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.546 HG23 ' HG2' ' A' ' 82' ' ' PRO . 85.1 t -63.75 -46.21 95.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.506 -0.77 . . . . 0.71999999999999997 110.382 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.691 HD12 ' HB2' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -53.87 -53.0 58.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.016 0.436 . . . . 1.45 111.766 177.057 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.84 -35.03 89.44 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.7 -0.682 . . . . 0.39000000000000001 112.539 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.861 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 53.6 pttt -89.32 -21.0 23.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.703 -0.799 . . . . 1.6599999999999999 111.009 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.2 mt -69.4 -43.52 80.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.299 -0.63 . . . . 1.1499999999999999 109.299 170.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.47 ' CE3' ' HD3' ' A' ' 73' ' ' LYS . 76.6 t-105 -58.6 -54.98 40.93 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.214 -0.448 . . . . 0.29999999999999999 110.882 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.861 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -71.46 -15.6 62.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.879 -0.6 . . . . 2.54 112.031 -173.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.409 HD23 HD23 ' A' ' 122' ' ' LEU . 13.4 tp -94.24 -24.93 17.27 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.929 -0.308 . . . . 0.85999999999999999 110.26 176.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.884 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -80.34 -42.66 22.53 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.096 0.474 . . . . 0.45000000000000001 110.614 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.519 ' HB2' HD21 ' A' ' 101' ' ' LEU . 48.3 t0 -100.99 114.54 28.56 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.458 -0.571 . . . . 0.62 109.458 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.2 t -74.68 -23.04 17.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.189 -0.914 . . . . 1.76 111.554 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.85 -25.4 13.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.985 0.421 . . . . 1.7 110.192 -175.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.507 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 57.8 mttt 60.92 71.71 0.55 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.129 -0.941 . . . . 1.74 110.87 169.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.431 ' OD1' ' HG ' ' A' ' 100' ' ' LEU . 1.9 p30 -101.66 -22.27 14.48 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.384 -1.28 . . . . 1.51 111.749 -171.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.41 9.81 28.53 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.71 -0.757 . . . . 0.28999999999999998 112.392 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.589 ' HA ' ' H ' ' A' ' 69' ' ' GLY . 3.7 pp -148.26 178.61 8.42 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.252 0.621 . . . . 0.54000000000000004 109.521 176.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.519 HD21 ' HB2' ' A' ' 94' ' ' ASP . 87.2 mt -146.96 122.55 10.46 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.25 -0.648 . . . . 0.68000000000000005 109.25 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -74.16 -173.96 1.8 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.866 -0.521 . . . . 1.5 110.317 176.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -59.83 -34.05 72.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.98 0.419 . . . . 1.73 111.404 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 26.3 tt0 -86.3 -33.87 20.51 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.918 0.39 . . . . 2.1400000000000001 110.755 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . 2.4 mt-10 -62.2 -39.2 91.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.298 -0.41 . . . . 1.1100000000000001 110.496 174.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.582 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -62.88 -43.61 98.33 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.193 -1.04 . . . . 1.0700000000000001 108.193 173.197 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 104' ' ' GLU . . . -50.75 -47.44 59.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.683 -0.69 . . . . 0.19 110.986 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.884 HD22 ' HA ' ' A' ' 93' ' ' ALA . 2.5 tt -66.82 -50.77 61.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.021 -0.363 . . . . 1.23 110.021 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.81 -57.21 7.82 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.796 0.665 . . . . 0.22 112.796 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.425 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 0.2 OUTLIER -66.72 -29.04 68.92 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.286 0.565 . . . . 1.1799999999999999 109.485 -176.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.556 ' O ' HG23 ' A' ' 115' ' ' VAL . 64.5 t60 -68.1 -42.9 79.62 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.992 -0.549 . . . . 0.48999999999999999 109.886 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.7 ' HB3' HD21 ' A' ' 122' ' ' LEU . 34.5 mt -64.03 -34.68 78.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.064 -0.516 . . . . 0.55000000000000004 110.589 176.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 110' ' ' ASN . 95.2 mt -61.41 -48.6 88.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.921 -0.581 . . . . 0.81000000000000005 110.495 174.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.539 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 17.6 ptpt -72.48 -21.29 61.23 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 119.651 -0.819 . . . . 2.2200000000000002 111.007 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 111' ' ' HIS . 15.4 t -60.57 -47.97 90.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.595 0.236 . . . . 0.48999999999999999 110.452 171.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 5.7 ptmm? -84.98 -1.21 56.51 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.259 -0.576 . . . . 1.9099999999999999 110.379 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.523 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 38.2 tp -85.89 -19.79 30.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.473 -0.785 . . . . 1.28 108.963 172.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.539 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 43.0 mt-10 -67.87 -16.52 64.13 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 115.558 -0.746 . . . . 1.99 109.529 173.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.57 -20.21 13.77 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.65 -0.704 . . . . 1.01 112.175 174.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.673 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -99.13 138.91 35.55 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.822 -0.436 . . . . 0.87 109.822 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -73.37 164.0 27.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.242 0.544 . . . . 2.75 111.335 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 112' ' ' LEU . 4.5 mp -73.23 141.7 81.16 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.448 -0.796 . . . . 2.7000000000000002 110.391 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -88.66 -0.01 6.5 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.344 2.696 . . . . 1.1000000000000001 113.52 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 60.89 27.84 17.65 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.463 0.649 . . . . 1.3400000000000001 110.857 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -130.15 126.48 37.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.5 -0.773 . . . . 2.3599999999999999 109.148 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 126' ' ' LEU . 1.1 tm? -103.35 103.2 33.81 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.227 -0.657 . . . . 1.8300000000000001 109.227 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 7.8 Cg_endo -87.36 164.42 8.2 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.449 2.766 . . . . 1.0 112.669 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.445 ' O ' HG12 ' A' ' 131' ' ' VAL . 12.2 Cg_endo -56.03 -26.44 59.27 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.444 2.763 . . . . 1.3400000000000001 113.446 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.569 ' O ' HD12 ' A' ' 130' ' ' LEU . 7.3 p-80 -86.55 23.41 1.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.517 -0.473 . . . . 1.48 111.271 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 129' ' ' HIS . 0.3 OUTLIER -149.61 14.68 0.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.955 0.159 . . . . 1.29 111.107 175.386 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 128' ' ' PRO . 7.4 p -82.72 111.31 28.28 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.25 0.548 . . . . 1.72 111.025 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo . . . . . 0 C--O 1.234 0.309 0 C-N-CA 122.724 2.283 . . . . 1.04 113.373 -177.728 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 N-CA-C 112.593 -0.203 . . . . 42.189999999999998 112.593 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -88.67 8.01 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.288 2.659 . . . . 41.840000000000003 112.86 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -107.56 124.34 49.79 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.662 -0.866 . . . . 43.409999999999997 108.662 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.06 0.62 82.96 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.728 -0.748 . . . . 41.270000000000003 111.363 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.6 t -164.6 131.56 3.08 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.733 -0.84 . . . . 40.149999999999999 108.733 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.538 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.1 pm0 -76.16 116.82 17.22 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.619 0.723 . . . . 38.670000000000002 111.033 -177.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.1 t -84.83 99.0 10.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.338 -0.846 . . . . 37.240000000000002 109.254 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.783 HD23 ' H ' ' A' ' 8' ' ' LEU . 2.4 pt? -88.84 140.43 29.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.709 -0.678 . . . . 36.32 110.396 -178.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.3 mmm -72.45 144.36 86.46 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.427 -0.582 . . . . 35.030000000000001 109.427 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -48.47 -46.84 22.19 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.295 2.663 . . . . 34.310000000000002 112.098 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.1 t -109.79 112.06 23.88 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.09 -0.707 . . . . 33.799999999999997 109.09 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.66 97.27 7.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.948 0.404 . . . . 34.579999999999998 110.683 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.6 m -111.67 141.1 28.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.127 -0.488 . . . . 33.82 110.619 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -106.64 115.21 47.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.951 -0.568 . . . . 35.100000000000001 110.784 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.69 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 98.4 mttt -102.24 86.48 2.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.969 -0.559 . . . . 35.140000000000001 110.071 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.2 112.79 4.19 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.512 -0.767 . . . . 36.609999999999999 112.652 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.85 0.88 89.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.206 -0.521 . . . . 36.640000000000001 112.403 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.69 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . . . -105.34 98.95 8.58 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.862 0.363 . . . . 35.420000000000002 111.012 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -78.46 103.78 8.63 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.334 -0.617 . . . . 35.770000000000003 109.334 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -89.26 125.52 35.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.427 -0.806 . . . . 33.670000000000002 111.612 -169.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.34 67.06 0.51 Allowed Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.858 -0.687 . . . . 33.350000000000001 111.786 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.4 m -69.95 112.1 6.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.089 0.471 . . . . 32.890000000000001 110.78 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 62.7 mtm -75.95 102.28 5.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.018 -0.537 . . . . 33.5 109.649 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -81.51 158.18 24.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.084 -0.507 . . . . 33.880000000000003 111.14 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.66 -33.69 4.36 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.673 -1.071 . . . . 33.450000000000003 114.623 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -85.64 132.94 4.3 Favored 'Trans proline' 0 C--N 1.351 0.707 0 CA-C-N 120.955 2.377 . . . . 32.82 111.686 172.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -127.62 130.35 48.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.86 0.362 . . . . 34.289999999999999 111.029 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.11 158.28 20.01 Favored Glycine 0 N--CA 1.454 -0.133 0 CA-C-N 116.108 -0.496 . . . . 31.66 112.036 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -165.41 123.1 1.55 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.867 0.333 . . . . 31.329999999999998 110.147 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.93 116.77 0.76 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.83 -0.7 . . . . 28.859999999999999 112.305 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -95.75 170.23 9.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.459 0.171 . . . . 27.66 110.57 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.37 91.88 0.95 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.7 -0.762 . . . . 24.739999999999998 111.955 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -77.52 132.67 38.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.698 0.285 . . . . 22.32 110.735 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.18 98.04 1.59 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.782 -0.723 . . . . 19.489999999999998 111.791 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.1 118.57 19.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.824 0.345 . . . . 17.420000000000002 111.197 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.16 101.85 1.85 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.772 -0.728 . . . . 14.76 111.504 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.97 -177.01 5.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.513 0.197 . . . . 13.02 110.761 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.41 71.54 2.91 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.351 -0.928 . . . . 10.279999999999999 111.98 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.8 pt -67.2 154.44 8.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.275 -1.009 . . . . 9.1199999999999992 108.275 170.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.88 72.96 2.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.485 0.659 . . . . 6.5199999999999996 110.715 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -128.18 95.81 4.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.044 -0.98 . . . . 6.3099999999999996 110.396 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.7 p -113.32 93.28 2.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.856 0.836 . . . . 3.3300000000000001 110.289 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -142.36 100.84 3.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.392 -0.822 . . . . 3.9399999999999999 111.032 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.715 ' CE2' ' HG ' ' A' ' 130' ' ' LEU . 7.1 t90 -73.9 140.68 45.82 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.053 -0.721 . . . . 1.3300000000000001 109.053 174.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.466 ' N ' ' CD1' ' A' ' 44' ' ' TRP . 18.2 t -52.74 -12.84 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 114.142 -1.39 . . . . 1.21 113.157 -175.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -80.0 -24.17 11.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 121.329 -0.857 . . . . 0.66000000000000003 112.143 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.98 -13.39 26.45 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.174 -1.012 . . . . 0.71999999999999997 112.452 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.479 ' HE2' ' HB3' ' A' ' 48' ' ' LYS . 7.8 ptpt -112.03 -0.96 15.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 112.745 0.646 . . . . 2.9700000000000002 112.745 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -133.77 2.16 3.4 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.367 0.603 . . . . 1.8300000000000001 110.666 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 63.5 tttm -54.83 -46.14 99.55 Favored Pre-proline 0 C--O 1.222 -0.386 0 CA-C-N 115.691 -0.686 . . . . 1.1299999999999999 111.166 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 55.2 Cg_exo -42.47 -33.24 2.59 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 123.074 2.516 . . . . 0.56000000000000005 113.993 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.681 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 25.6 m -73.8 -48.38 31.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.097 0.951 . . . . 0.59999999999999998 110.022 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.538 ' CD1' ' HB3' ' A' ' 110' ' ' ASN . 7.4 m-85 -76.17 -25.11 54.9 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.47 -0.786 . . . . 0.93999999999999995 110.149 -175.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.591 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 18.3 t70 -82.55 -33.41 28.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.632 -1.167 . . . . 1.1599999999999999 109.637 -176.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.681 ' HG3' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -69.28 -39.41 78.39 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.331 -0.618 . . . . 1.6299999999999999 109.331 175.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.617 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 60.3 mt -69.03 -32.0 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.254 -0.647 . . . . 0.60999999999999999 109.254 175.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.591 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 70.4 t80 -55.64 -52.87 62.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.168 -0.924 . . . . 0.88 110.952 175.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.735 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 82.6 m-85 -75.12 -22.45 58.19 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.941 0.401 . . . . 1.03 110.916 177.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.617 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 10.4 m -70.19 -32.64 70.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.44 111.043 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 63.8 mt -83.6 -8.53 59.29 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.219 -0.289 . . . . 0.79000000000000004 110.219 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.6 t 72.89 96.65 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.463 -0.79 . . . . 0.64000000000000001 111.287 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.735 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 61.5 Cg_endo -83.52 172.27 10.43 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.588 2.192 . . . . 0.46000000000000002 112.28 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.0 t -136.06 114.37 15.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.234 -0.654 . . . . 1.3300000000000001 109.234 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.1 m120 70.31 23.76 4.95 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.133 0.492 . . . . 1.6699999999999999 111.58 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.47 25.21 19.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.954 -0.641 . . . . 0.5 112.661 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.607 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -168.5 154.27 6.79 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.6 -0.889 . . . . 1.8200000000000001 108.6 175.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.86 ' HB ' HD21 ' A' ' 71' ' ' ASN . 3.1 pt -86.58 137.19 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 120.316 -0.554 . . . . 0.40999999999999998 110.21 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.8 p -60.3 130.7 47.94 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 107.352 -1.351 . . . . 0.69999999999999996 107.352 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.669 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -50.98 -25.75 10.31 Favored Glycine 0 C--O 1.22 -0.742 0 C-N-CA 120.682 -0.771 . . . . 0.38 113.784 -172.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -46.92 -55.77 7.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.139 0.47 . . . . 0.44 111.467 173.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.86 HD21 ' HB ' ' A' ' 67' ' ' ILE . 9.5 p30 -72.96 -27.07 61.61 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.87 0.367 . . . . 2.1099999999999999 110.545 -175.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.728 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -68.92 -37.29 78.84 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.392 -0.596 . . . . 0.41999999999999998 109.392 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.669 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.9 mmmm -67.72 -38.77 84.04 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.174 -0.921 . . . . 1.6899999999999999 109.843 177.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.809 ' HG2' ' HA ' ' A' ' 71' ' ' ASN . 10.4 mmmm -56.23 -50.6 70.83 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.654 0.74 . . . . 1.3500000000000001 109.655 175.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -55.9 -52.81 62.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.972 -1.467 . . . . 1.48 111.445 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.728 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 12.8 ptp -73.45 -21.88 60.34 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.107 -0.371 . . . . 0.65000000000000002 111.752 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.41 -45.71 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.787 0.327 . . . . 0.58999999999999997 110.462 174.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 15.2 ptpt -70.83 -14.82 62.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.257 0.551 . . . . 1.2 110.1 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 76' ' ' MET . 67.6 m -63.94 -1.59 1.52 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.563 -0.744 . . . . 1.3700000000000001 111.583 171.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 71.24 72.07 0.18 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.621 0.769 . . . . 2.6499999999999999 111.434 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.843 HD11 ' HE2' ' A' ' 116' ' ' LYS . 29.1 mt -142.77 161.36 49.51 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.934 -0.576 . . . . 1.1599999999999999 111.782 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -82.56 168.54 14.39 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.093 2.529 . . . . 0.94999999999999996 110.198 166.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.75 -18.15 63.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.83 0.347 . . . . 1.53 111.5 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -64.63 -67.83 0.4 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.961 -0.563 . . . . 1.24 110.863 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 89' ' ' ILE . 39.8 t -60.64 -44.58 97.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 115.811 -0.631 . . . . 0.71999999999999997 110.297 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.563 HD11 ' HG3' ' A' ' 76' ' ' MET . 22.7 tp -55.52 -51.35 67.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.325 -0.852 . . . . 1.45 111.443 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.36 -43.19 97.54 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.789 -0.641 . . . . 0.39000000000000001 111.967 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.831 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 56.4 pttt -80.39 -16.45 54.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.562 -0.855 . . . . 1.6599999999999999 111.754 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.656 HD11 ' HD3' ' A' ' 116' ' ' LYS . 13.5 mt -71.8 -46.32 61.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 108.857 -0.794 . . . . 1.1499999999999999 108.857 171.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -56.06 -53.24 59.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.755 -0.657 . . . . 0.29999999999999999 111.212 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.831 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -73.03 -14.31 61.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.117 -0.492 . . . . 2.54 112.128 -174.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.614 HD23 HD13 ' A' ' 112' ' ' LEU . 13.6 tp -93.41 -23.89 18.25 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.662 -0.415 . . . . 0.85999999999999999 110.488 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.724 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -89.04 -42.9 11.48 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.797 0.332 . . . . 0.45000000000000001 111.376 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.62 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 55.3 t0 -92.57 105.54 17.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.759 -0.46 . . . . 0.62 109.759 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.544 HG21 ' HG3' ' A' ' 135' ' ' LYS . 23.5 t -73.09 -27.4 24.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.595 -0.729 . . . . 1.76 111.262 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.613 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.0 OUTLIER -88.16 -26.48 22.41 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.109 -0.496 . . . . 1.7 109.677 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.9 mttt 60.22 58.83 2.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.955 -1.02 . . . . 1.74 109.364 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.632 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 6.4 m-20 -83.57 -35.2 24.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.024 -1.444 . . . . 1.51 111.629 -170.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.72 16.41 33.87 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 109.889 -1.284 . . . . 0.28999999999999998 109.889 -164.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.542 HD13 ' HG3' ' A' ' 66' ' ' LYS . 4.2 pp -153.32 177.01 11.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.379 -0.971 . . . . 0.54000000000000004 108.379 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.634 ' O ' HG12 ' A' ' 67' ' ' ILE . 46.4 mt -151.74 120.37 6.5 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.231 -1.396 . . . . 0.68000000000000005 107.231 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.7 p30 -80.96 -175.75 5.55 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.499 -0.881 . . . . 1.5 110.176 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -57.95 -32.52 67.9 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 111.738 0.273 . . . . 1.73 111.738 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.734 ' HG2' ' HD2' ' A' ' 133' ' ' PRO . 4.0 tp10 -87.33 -27.92 22.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.319 0.581 . . . . 2.1400000000000001 110.029 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.474 ' HB3' HD22 ' A' ' 101' ' ' LEU . 1.1 mt-10 -74.75 -27.91 60.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.05 -0.523 . . . . 1.1100000000000001 110.656 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.673 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -73.61 -36.06 65.44 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.439 -1.319 . . . . 1.0700000000000001 107.439 169.219 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.538 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -56.37 -45.77 80.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.02 -0.537 . . . . 0.19 110.286 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.724 HD22 ' HA ' ' A' ' 93' ' ' ALA . 3.5 tt -71.27 -48.6 49.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.931 -0.577 . . . . 1.23 110.278 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.533 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -46.53 -56.25 6.3 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.531 0.519 . . . . 0.22 111.138 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.538 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 11.1 t-20 -73.32 -23.98 60.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.601 -0.727 . . . . 1.1799999999999999 110.379 -177.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.591 ' O ' HG23 ' A' ' 115' ' ' VAL . 65.7 t60 -69.76 -41.94 74.52 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.357 -0.609 . . . . 0.48999999999999999 109.357 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.635 HD22 HD22 ' A' ' 122' ' ' LEU . 30.2 mt -73.71 -27.32 61.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.187 -0.461 . . . . 0.55000000000000004 110.436 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 109' ' ' ALA . 68.7 mt -60.97 -45.46 98.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.464 -0.335 . . . . 0.81000000000000005 111.021 172.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.463 ' HE3' ' HE1' ' A' ' 53' ' ' TYR . 17.4 ptpt -75.35 -21.18 58.54 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.687 -0.805 . . . . 2.2200000000000002 111.488 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 111' ' ' HIS . 40.1 t -68.43 -43.27 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.471 0.177 . . . . 0.48999999999999999 110.706 173.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.843 ' HE2' HD11 ' A' ' 81' ' ' LEU . 16.0 pttp -69.12 -28.26 66.3 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.291 -0.633 . . . . 1.9099999999999999 109.291 174.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.1 tt -69.61 -24.28 63.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.53 -0.759 . . . . 1.28 110.248 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 6.5 mm-40 -59.02 -13.23 6.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.573 -0.739 . . . . 1.99 111.299 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.81 8.81 29.53 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.924 -0.655 . . . . 1.01 111.926 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.754 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.5 p80 -137.89 135.16 35.86 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.017 -0.364 . . . . 0.87 110.017 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -71.85 164.5 25.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.203 -0.453 . . . . 2.75 111.316 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.635 HD22 HD22 ' A' ' 112' ' ' LEU . 41.8 mt -74.59 137.17 74.16 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.92 -0.582 . . . . 2.7000000000000002 110.268 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 87.3 Cg_endo -90.16 13.83 2.21 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.181 2.588 . . . . 1.1000000000000001 113.396 -172.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.56 22.76 13.5 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.253 -0.43 . . . . 1.3400000000000001 111.162 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -112.55 140.69 47.1 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.366 -0.605 . . . . 2.3599999999999999 109.366 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -121.52 106.23 37.9 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 108.944 -0.762 . . . . 1.8300000000000001 108.944 178.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 2.2 Cg_endo -82.48 148.08 14.3 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.019 2.479 . . . . 1.0 112.351 -176.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.52 -13.59 37.32 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.777 2.318 . . . . 1.3400000000000001 112.579 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -98.01 24.22 7.26 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.209 -0.293 . . . . 1.48 110.209 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.715 ' HG ' ' CE2' ' A' ' 44' ' ' TRP . 0.3 OUTLIER -149.45 12.78 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.92 0.391 . . . . 1.29 110.481 177.188 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.6 m -91.86 128.42 45.98 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.598 -0.519 . . . . 1.72 109.598 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.724 ' HD3' HD12 ' A' ' 108' ' ' LEU . 51.0 Cg_exo -54.57 148.05 45.71 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.553 2.168 . . . . 1.04 110.991 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.734 ' HD2' ' HG2' ' A' ' 104' ' ' GLU . 72.2 Cg_exo -39.52 -47.34 3.42 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.95 3.1 . . . . 1.4399999999999999 114.372 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.422 ' HB3' ' HD2' ' A' ' 135' ' ' LYS . 29.2 t -58.71 -24.06 60.78 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.59 0.589 . . . . 2.2999999999999998 112.59 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.544 ' HG3' HG21 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -120.96 34.29 5.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.995 0.426 . . . . 3.4199999999999999 111.637 -173.512 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -69.57 78.12 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.73 0.776 . . . . 4.7199999999999998 110.949 175.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -162.67 134.29 5.18 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.865 -0.522 . . . . 5.0099999999999998 111.826 -172.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -106.05 106.24 16.65 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.514 -0.551 . . . . 6.3899999999999997 109.514 174.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.66 -0.686 . . . . 6.9100000000000001 110.007 -178.793 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.632 'CA ' ' OD2' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 CA-C-O 119.926 -0.375 . . . . 42.189999999999998 112.989 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.18 -50.35 7.51 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.033 2.489 . . . . 41.840000000000003 113.289 -176.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.9 pp -65.31 143.84 57.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.006 0.431 . . . . 43.409999999999997 110.6 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.03 -28.19 10.81 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.248 -1.141 . . . . 41.270000000000003 110.248 -172.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 m -90.2 115.69 27.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.192 -0.504 . . . . 40.149999999999999 109.777 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -90.68 129.86 36.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.856 0.36 . . . . 38.670000000000002 111.71 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.4 t -88.1 110.73 20.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.18 -0.674 . . . . 37.240000000000002 109.18 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.1 tp -99.34 107.42 19.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 36.32 111.01 -176.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.421 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 25.6 mmt -95.42 116.1 66.01 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 35.030000000000001 110.031 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 29.9 Cg_exo -62.22 -32.39 82.46 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.883 2.389 . . . . 34.310000000000002 112.856 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.7 t -118.0 96.01 5.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.117 0.484 . . . . 33.799999999999997 110.726 -177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -140.16 93.02 2.59 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.066 -0.716 . . . . 34.579999999999998 109.066 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.7 t -89.96 105.15 15.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.219 -0.446 . . . . 33.82 110.408 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.3 t -113.26 109.16 27.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.149 -0.478 . . . . 35.100000000000001 111.568 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.722 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 47.3 mtmt -126.92 112.78 15.7 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.962 -0.755 . . . . 35.140000000000001 108.962 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.93 105.15 3.26 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.812 -0.708 . . . . 36.609999999999999 112.488 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.88 5.82 86.88 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.075 -0.584 . . . . 36.640000000000001 112.585 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.722 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . . . -87.71 104.56 16.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.778 0.323 . . . . 35.420000000000002 111.272 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -80.76 141.93 34.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.003 -0.544 . . . . 35.770000000000003 110.429 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -121.85 149.15 43.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.327 -0.397 . . . . 33.670000000000002 110.175 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.74 116.04 5.3 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.629 -0.796 . . . . 33.350000000000001 112.586 -175.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.9 p -88.97 111.54 22.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.044 0.45 . . . . 32.890000000000001 110.993 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 55.1 mtt -65.91 131.22 45.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 33.5 111.789 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -118.49 140.08 50.44 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.456 -0.572 . . . . 33.880000000000003 109.456 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.72 -32.31 5.04 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.924 -0.931 . . . . 33.450000000000003 114.168 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.81 124.79 10.97 Favored 'Trans proline' 0 C--N 1.355 0.908 0 CA-C-N 120.592 2.196 . . . . 32.82 111.289 168.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -100.01 111.47 23.77 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.969 -0.382 . . . . 34.289999999999999 109.969 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.11 153.71 40.02 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.392 -0.909 . . . . 31.66 111.99 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -82.85 125.43 31.32 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.687 -0.486 . . . . 31.329999999999998 109.687 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -150.3 121.37 1.24 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.15 -1.024 . . . . 28.859999999999999 112.876 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -131.64 168.35 17.88 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.109 -0.7 . . . . 27.66 109.109 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.29 93.56 0.14 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.068 -0.587 . . . . 24.739999999999998 111.809 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.47 163.94 13.2 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.088 0.471 . . . . 22.32 111.425 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.46 104.44 1.32 Allowed Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.428 -1.069 . . . . 19.489999999999998 110.428 172.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -39.26 117.54 0.71 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.122 0.569 . . . . 17.420000000000002 112.524 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.49 139.89 14.74 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.548 -0.751 . . . . 14.76 111.556 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.468 ' HG2' ' H ' ' A' ' 38' ' ' GLY . 11.8 tt0 -95.16 -174.05 3.11 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.332 -0.247 . . . . 13.02 110.332 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.468 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -75.94 72.09 1.86 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.66 -0.781 . . . . 10.279999999999999 113.093 -171.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.447 ' H ' HG12 ' A' ' 39' ' ' ILE . 2.3 pt -58.13 144.97 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 109.264 -0.643 . . . . 9.1199999999999992 109.264 169.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.41 79.27 2.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.115 0.484 . . . . 6.5199999999999996 111.501 -172.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -121.58 107.89 12.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.599 -0.728 . . . . 6.3099999999999996 109.725 172.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 p -77.53 134.21 28.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.018 -0.537 . . . . 3.3300000000000001 109.9 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -146.53 124.34 11.93 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.737 -0.665 . . . . 3.9399999999999999 109.545 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.69 ' NE1' ' HG ' ' A' ' 130' ' ' LEU . 13.6 t90 -89.28 137.35 32.4 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.603 0.716 . . . . 1.3300000000000001 109.417 175.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 t -62.89 -10.75 6.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.747 -1.115 . . . . 1.21 112.135 -173.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.689 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 84.0 t -88.53 -13.55 9.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 O-C-N 121.553 -0.717 . . . . 0.66000000000000003 111.386 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.46 -12.63 70.02 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 119.457 -1.354 . . . . 0.71999999999999997 111.839 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -111.7 -28.26 8.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.563 0.579 . . . . 2.9700000000000002 112.563 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -108.56 8.41 27.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.473 0.654 . . . . 1.8300000000000001 109.946 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.769 ' HE3' ' HG3' ' A' ' 104' ' ' GLU . 42.5 tttt -57.1 -46.43 99.86 Favored Pre-proline 0 C--O 1.22 -0.466 0 CA-C-N 115.417 -0.811 . . . . 1.1299999999999999 112.167 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 7.3 Cg_endo -49.95 -28.39 18.54 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 122.561 2.174 . . . . 0.56000000000000005 112.802 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.629 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 9.2 m -72.34 -42.32 65.49 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 122.301 1.048 . . . . 0.59999999999999998 109.91 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.546 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 8.2 m-85 -79.55 -24.61 42.02 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.109 -0.951 . . . . 0.93999999999999995 109.742 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.588 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 14.3 t70 -81.6 -34.45 30.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.474 -0.785 . . . . 1.1599999999999999 110.63 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.629 ' HG2' ' O ' ' A' ' 52' ' ' THR . 13.2 pt-20 -66.14 -40.45 90.6 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.528 -0.469 . . . . 1.6299999999999999 109.819 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.6 mt -69.54 -29.45 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.114 -0.634 . . . . 0.60999999999999999 109.612 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.588 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 71.8 t80 -58.59 -58.29 9.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.409 -0.814 . . . . 0.88 111.462 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.449 ' HE1' ' OD1' ' A' ' 54' ' ' ASP . 38.8 m-85 -66.96 -23.02 65.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.959 0.409 . . . . 1.03 110.813 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.0 m -70.75 -26.37 63.33 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.019 -0.537 . . . . 0.44 110.973 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.526 HD11 ' CG ' ' A' ' 75' ' ' GLU . 53.6 mt -87.74 4.22 45.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.015 0.376 . . . . 0.79000000000000004 112.015 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t 65.48 81.63 0.21 Allowed Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.027 -0.533 . . . . 0.64000000000000001 110.906 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 72.6 Cg_endo -81.48 153.06 17.95 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.733 2.289 . . . . 0.46000000000000002 113.176 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.7 126.86 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.894 -0.594 . . . . 1.3300000000000001 110.248 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 60.72 23.31 13.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.702 -0.681 . . . . 1.6699999999999999 111.627 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.34 26.67 25.03 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.769 -0.729 . . . . 0.5 112.898 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.722 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -160.32 148.56 16.66 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 120.934 0.397 . . . . 1.8200000000000001 110.039 173.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.729 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 4.1 pt -85.89 131.45 34.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.951 -0.568 . . . . 0.40999999999999998 109.965 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.7 p -59.7 112.22 1.73 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.751 -0.833 . . . . 0.69999999999999996 108.751 174.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.566 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -42.2 -27.21 0.41 Allowed Glycine 0 C--O 1.218 -0.896 0 N-CA-C 116.684 1.434 . . . . 0.38 116.684 -160.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.68 -30.87 9.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 118.236 1.018 . . . . 0.44 112.359 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.729 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 13.3 p30 -81.07 -38.32 27.53 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.863 0.364 . . . . 2.1099999999999999 111.559 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.666 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -69.39 -34.58 74.73 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.497 0.665 . . . . 0.41999999999999998 109.223 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.566 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.2 mmmm -64.06 -39.25 93.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.756 -1.111 . . . . 1.6899999999999999 108.864 174.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -55.79 -48.49 75.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.355 -0.839 . . . . 1.3500000000000001 109.714 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.651 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 7.2 mm-40 -60.68 -52.19 66.18 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.062 -0.972 . . . . 1.48 112.051 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.666 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 13.4 ptp -69.35 -24.13 63.86 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.878 -0.329 . . . . 0.65000000000000002 111.487 -178.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 73' ' ' LYS . 45.8 t -73.13 -49.08 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.652 0.263 . . . . 0.58999999999999997 110.644 174.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.651 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 8.0 ptmt -68.06 -11.96 59.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.185 0.517 . . . . 1.2 110.249 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.3 t -68.29 -9.44 47.6 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.942 -0.572 . . . . 1.3700000000000001 110.039 174.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.486 ' NZ ' ' HB2' ' A' ' 80' ' ' LYS . 8.4 mtmp? 73.49 73.19 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.5 0.72 . . . . 2.6499999999999999 110.989 176.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.034 HD11 ' HE2' ' A' ' 116' ' ' LYS . 25.1 mt -136.35 163.56 49.11 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.566 -0.743 . . . . 1.1599999999999999 110.997 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.425 ' HG2' HG23 ' A' ' 85' ' ' VAL . 71.7 Cg_endo -79.78 168.71 19.02 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.618 2.212 . . . . 0.94999999999999996 111.408 167.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 13.4 m120 -64.72 -26.83 68.54 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.833 0.308 . . . . 1.53 111.833 -177.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.4 p -62.95 -50.82 69.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.259 -0.428 . . . . 1.24 110.896 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 89' ' ' ILE . 46.7 t -66.83 -43.78 89.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.928 -0.578 . . . . 0.71999999999999997 109.925 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.564 ' CD2' ' HB2' ' A' ' 81' ' ' LEU . 2.8 mm? -48.27 -53.41 17.27 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.282 0.563 . . . . 1.45 110.744 172.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.43 -45.96 94.68 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.943 -1.026 . . . . 0.39000000000000001 112.984 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.87 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 56.3 pttt -83.27 -21.54 33.27 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 119.677 -0.809 . . . . 1.6599999999999999 112.304 -175.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.599 HD11 ' HD3' ' A' ' 116' ' ' LYS . 29.8 mt -67.26 -44.91 87.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.853 -0.795 . . . . 1.1499999999999999 108.853 171.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -62.98 -54.69 34.38 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 115.658 -0.701 . . . . 0.29999999999999999 111.405 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.87 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 64.6 pttt -71.82 -10.17 59.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.571 -0.286 . . . . 2.54 111.721 -173.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.645 HD13 ' HA ' ' A' ' 124' ' ' ALA . 8.6 tp -92.34 -34.07 14.34 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.736 -0.468 . . . . 0.85999999999999999 109.736 173.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.729 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -82.92 -44.44 15.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.896 0.379 . . . . 0.45000000000000001 112.004 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.625 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 42.1 t0 -92.01 76.28 5.47 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.81 -0.811 . . . . 0.62 108.81 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.452 HG11 ' HE2' ' A' ' 135' ' ' LYS . 16.3 t -64.9 -25.22 37.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.258 -0.883 . . . . 1.76 109.982 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -79.48 -25.85 41.79 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.603 -1.18 . . . . 1.7 110.278 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 55.71 73.82 0.41 Allowed 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.468 -0.787 . . . . 1.74 111.525 174.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -123.45 -24.22 4.64 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.409 -1.269 . . . . 1.51 112.419 -169.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 99.91 16.46 28.26 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.053 -1.07 . . . . 0.28999999999999998 111.82 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.722 HD13 ' HG3' ' A' ' 66' ' ' LYS . 3.3 pp -151.61 -174.57 4.88 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.649 -0.871 . . . . 0.54000000000000004 108.649 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.608 HD12 ' HB1' ' A' ' 72' ' ' ALA . 45.0 mt -150.12 120.56 7.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.218 -0.66 . . . . 0.68000000000000005 109.218 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.8 p-10 -74.98 -175.65 2.65 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.635 -0.506 . . . . 1.5 109.635 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.456 ' OD1' ' HE2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -60.24 -33.85 72.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.663 0.268 . . . . 1.73 111.191 -177.181 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.769 ' HG3' ' HE3' ' A' ' 50' ' ' LYS . 0.4 OUTLIER -83.24 -37.43 23.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.79 -0.186 . . . . 2.1400000000000001 111.037 176.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.545 ' HB3' HD22 ' A' ' 101' ' ' LEU . 3.7 mt-10 -62.43 -38.35 89.41 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.208 -0.197 . . . . 1.1100000000000001 110.99 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.584 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.6 OUTLIER -68.96 -40.1 79.09 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.526 -0.916 . . . . 1.0700000000000001 108.526 172.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.546 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -48.93 -50.67 34.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.597 -0.729 . . . . 0.19 111.426 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.729 ' CD1' ' HA ' ' A' ' 93' ' ' ALA . 0.5 OUTLIER -83.41 -33.36 25.75 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 118.993 -1.083 . . . . 1.23 112.031 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -46.32 -54.18 9.43 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.318 0.58 . . . . 0.22 111.173 170.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.482 ' HA ' HD12 ' A' ' 113' ' ' ILE . 2.9 t-20 -75.97 -33.87 59.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.571 . . . . 1.1799999999999999 110.702 -176.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 108' ' ' LEU . 85.5 t60 -66.37 -34.88 78.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.519 . . . . 0.48999999999999999 109.945 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.802 ' HB3' HD21 ' A' ' 122' ' ' LEU . 73.0 mt -71.81 -31.65 66.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.717 -0.674 . . . . 0.55000000000000004 110.021 176.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.597 ' HA ' ' HE3' ' A' ' 116' ' ' LYS . 60.8 mt -61.11 -42.67 94.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.73 -0.668 . . . . 0.81000000000000005 110.747 171.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.601 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -68.44 -35.34 77.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.297 -0.41 . . . . 2.2200000000000002 110.335 175.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.6 t -59.57 -49.05 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.256 -0.429 . . . . 0.48999999999999999 111.522 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 1.034 ' HE2' HD11 ' A' ' 81' ' ' LEU . 20.0 pttp -68.0 -28.84 67.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.026 0.441 . . . . 1.9099999999999999 110.303 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.5 tp -70.49 -20.57 62.84 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.847 -0.615 . . . . 1.28 110.839 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.601 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 42.2 mt-10 -71.42 -9.84 58.82 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.888 -0.597 . . . . 1.99 111.037 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.43 1.21 24.8 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.2 -1.0 . . . . 1.01 112.948 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.716 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -129.45 134.01 47.6 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.874 -0.417 . . . . 0.87 109.874 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -72.12 164.62 25.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.252 0.549 . . . . 2.75 111.242 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.802 HD21 ' HB3' ' A' ' 112' ' ' LEU . 5.2 mp -68.87 141.5 92.43 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.792 -0.64 . . . . 2.7000000000000002 110.46 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.578 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 67.9 Cg_endo -91.5 -7.06 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.483 2.788 . . . . 1.1000000000000001 112.624 -174.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.645 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . 61.53 37.55 16.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.699 -0.682 . . . . 1.3400000000000001 111.319 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.578 ' OD1' ' HG2' ' A' ' 123' ' ' PRO . 1.2 p-10 -111.61 135.5 52.11 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.956 -0.565 . . . . 2.3599999999999999 109.746 170.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.7 tp -115.49 91.42 28.99 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.191 -0.913 . . . . 1.8300000000000001 109.918 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 94.5 Cg_endo -98.03 171.22 0.67 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.609 2.872 . . . . 1.0 113.189 -175.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.55 ' HA ' HG23 ' A' ' 131' ' ' VAL . 9.3 Cg_endo -54.92 -29.49 64.2 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.941 2.427 . . . . 1.3400000000000001 112.993 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.543 ' O ' HD12 ' A' ' 130' ' ' LEU . 16.5 p-80 -84.84 22.16 1.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.997 0.369 . . . . 1.48 111.997 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.69 ' HG ' ' NE1' ' A' ' 44' ' ' TRP . 1.0 OUTLIER -149.76 18.4 0.9 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.582 0.353 . . . . 1.29 111.091 169.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.55 HG23 ' HA ' ' A' ' 128' ' ' PRO . 96.7 t -70.19 112.59 13.16 Favored Pre-proline 0 C--N 1.328 -0.356 0 C-N-CA 120.549 -0.46 . . . . 1.72 110.968 -176.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.668 ' HB2' ' HG3' ' A' ' 135' ' ' LYS . 18.1 Cg_exo -66.25 123.07 10.7 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.629 2.22 . . . . 1.04 111.841 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.68 ' HD2' ' HG2' ' A' ' 104' ' ' GLU . 16.0 Cg_exo -68.32 2.62 2.64 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.191 2.594 . . . . 1.4399999999999999 112.411 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 59.1 p -97.63 -30.45 12.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.622 0.248 . . . . 2.2999999999999998 111.356 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.668 ' HG3' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -91.11 2.29 56.44 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.673 -0.411 . . . . 3.4199999999999999 111.81 -176.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.33 82.38 0.76 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.276 -0.638 . . . . 4.7199999999999998 109.276 172.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -147.05 132.25 18.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.662 -0.699 . . . . 5.0099999999999998 110.187 -176.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -133.86 100.93 4.9 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.421 -0.585 . . . . 6.3899999999999997 109.421 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 . . . . . 0 C--O 1.247 0.959 0 CA-C-O 117.986 -1.007 . . . . 6.9100000000000001 110.167 -176.29 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.625 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 N-CA-C 111.898 -0.481 . . . . 42.189999999999998 111.898 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.06 -18.23 24.16 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.881 2.387 . . . . 41.840000000000003 113.187 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 34.9 tp -108.48 135.16 50.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.586 -0.524 . . . . 43.409999999999997 109.586 177.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.64 30.59 8.92 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.645 -0.982 . . . . 41.270000000000003 110.645 -173.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 p -81.91 130.84 35.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.064 -0.568 . . . . 40.149999999999999 111.295 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -94.67 131.9 39.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.604 -0.726 . . . . 38.670000000000002 110.518 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.7 t -81.79 98.9 8.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.079 -0.51 . . . . 37.240000000000002 110.265 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.7 mt -83.61 95.94 8.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.816 -0.629 . . . . 36.32 110.197 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.423 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 92.3 mmm -82.79 133.67 48.54 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.956 -0.566 . . . . 35.030000000000001 111.01 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 30.8 Cg_exo -62.73 -27.85 75.96 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.751 2.301 . . . . 34.310000000000002 111.727 177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 p -83.94 90.18 7.36 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.46 -0.791 . . . . 33.799999999999997 110.769 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -124.69 84.05 2.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.614 -0.721 . . . . 34.579999999999998 109.95 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.7 p -85.79 130.84 35.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.969 -0.559 . . . . 33.82 110.798 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.1 m -122.27 134.58 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.764 -0.653 . . . . 35.100000000000001 110.357 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.597 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 98.7 mttt -115.49 85.52 2.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.186 0.517 . . . . 35.140000000000001 110.685 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.22 105.58 2.18 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.659 -0.782 . . . . 36.609999999999999 111.961 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.42 25.45 70.42 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.803 -0.713 . . . . 36.640000000000001 112.097 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . . . -126.97 107.43 10.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.807 0.337 . . . . 35.420000000000002 110.484 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -119.11 105.53 11.49 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.299 -0.409 . . . . 35.770000000000003 110.8 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.53 90.96 2.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.234 0.54 . . . . 33.670000000000002 109.888 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.25 69.94 2.52 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.761 -0.654 . . . . 33.350000000000001 112.031 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 p -78.45 99.25 6.35 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.016 0.436 . . . . 32.890000000000001 110.058 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.6 tpt -142.68 137.1 29.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.98 -0.555 . . . . 33.5 110.321 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -109.36 162.26 14.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.843 -0.617 . . . . 33.880000000000003 109.471 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.3 -33.15 4.62 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 119.156 -0.802 . . . . 33.450000000000003 113.716 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -82.43 19.1 1.33 Allowed 'Trans proline' 0 C--N 1.357 1.024 0 CA-C-N 120.444 2.122 . . . . 32.82 111.447 168.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -90.92 113.18 25.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.688 -0.687 . . . . 34.289999999999999 110.078 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.31 -178.78 47.64 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 111.223 -0.751 . . . . 31.66 111.223 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -99.94 123.35 44.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.544 -0.539 . . . . 31.329999999999998 109.544 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.41 -172.38 44.49 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.182 -0.767 . . . . 28.859999999999999 111.182 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -71.84 127.49 32.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.041 0.42 . . . . 27.66 110.403 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.44 157.21 50.66 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.066 -0.588 . . . . 24.739999999999998 112.088 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -70.53 134.16 47.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.788 0.328 . . . . 22.32 111.218 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.03 141.54 29.34 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.254 -0.738 . . . . 19.489999999999998 111.254 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.54 127.28 13.08 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.11 0.481 . . . . 17.420000000000002 112.269 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -115.29 139.96 15.91 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 111.173 -0.771 . . . . 14.76 111.173 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -86.04 154.04 21.7 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.592 0.234 . . . . 13.02 110.579 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.6 71.64 2.08 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.684 -0.769 . . . . 10.279999999999999 111.446 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 pt -62.09 153.37 6.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.044 -0.724 . . . . 9.1199999999999992 109.044 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -75.77 77.67 2.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.019 0.914 . . . . 6.5199999999999996 111.466 -172.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.72 105.79 1.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.977 -1.01 . . . . 6.3099999999999996 110.027 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 p -118.15 111.87 35.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.502 0.668 . . . . 3.3300000000000001 111.629 -176.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -147.71 108.05 4.1 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.602 -0.726 . . . . 3.9399999999999999 110.357 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.729 ' CH2' ' HG ' ' A' ' 108' ' ' LEU . 11.8 t90 -116.78 139.99 49.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.648 0.737 . . . . 1.3300000000000001 109.799 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.661 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 23.8 t -53.94 -25.92 13.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.201 -1.363 . . . . 1.21 112.561 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.726 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 0.5 OUTLIER -63.07 -13.4 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 O-C-N 121.995 -0.441 . . . . 0.66000000000000003 112.089 -174.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.48 -4.58 31.98 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.255 -0.974 . . . . 0.71999999999999997 111.935 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 11.7 ptmm? -105.33 -28.32 10.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 111.838 0.31 . . . . 2.9700000000000002 111.838 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.714 ' OD1' ' HA ' ' A' ' 46' ' ' VAL . 12.7 p-10 -114.58 1.34 14.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.051 0.453 . . . . 1.8300000000000001 111.235 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.619 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 49.6 tttm -56.48 -46.25 99.84 Favored Pre-proline 0 C--O 1.223 -0.334 0 CA-C-N 115.438 -0.801 . . . . 1.1299999999999999 112.293 177.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 4.3 Cg_endo -46.48 -35.09 15.81 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.869 2.38 . . . . 0.56000000000000005 113.315 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.707 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 56.5 m -76.57 -36.44 57.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.376 0.607 . . . . 0.59999999999999998 110.995 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' A' ' 110' ' ' ASN . 8.4 m-85 -81.96 -23.87 35.84 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.198 0.523 . . . . 0.93999999999999995 110.224 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.605 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 1.1 t70 -75.44 -39.47 58.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.032 -0.985 . . . . 1.1599999999999999 109.783 175.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.707 ' HG3' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -68.38 -38.65 81.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.504 -0.316 . . . . 1.6299999999999999 110.729 178.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.533 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 48.2 mt -70.95 -29.3 36.61 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 109.366 -0.605 . . . . 0.60999999999999999 109.366 174.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.605 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 66.1 t80 -57.43 -54.51 46.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.71 -0.677 . . . . 0.88 111.213 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.586 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 75.3 m-85 -71.53 -22.89 61.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.166 0.507 . . . . 1.03 110.498 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.533 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 18.3 m -72.09 -30.48 65.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.768 -0.651 . . . . 0.44 110.874 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 34.4 mt -84.87 0.94 49.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.79000000000000004 110.979 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t 66.46 88.59 0.11 Allowed Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.511 -0.768 . . . . 0.64000000000000001 111.464 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.586 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 64.8 Cg_endo -85.09 159.88 11.53 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.47 2.113 . . . . 0.46000000000000002 113.257 177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.8 p -141.46 134.25 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.93 -0.577 . . . . 1.3300000000000001 109.958 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 63.81 20.53 12.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.479 -0.782 . . . . 1.6699999999999999 109.73 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.58 -0.06 67.51 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.145 -0.934 . . . . 0.5 113.618 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -134.59 163.78 28.96 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 117.946 0.873 . . . . 1.8200000000000001 110.472 177.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pt -90.49 135.01 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 C-N-CA 120.642 -0.423 . . . . 0.40999999999999998 109.982 170.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.32 126.73 28.84 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.147 -1.057 . . . . 0.69999999999999996 108.147 171.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.54 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -49.45 -31.91 14.56 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 115.571 -0.74 . . . . 0.38 114.816 -166.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.67 -33.1 21.26 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 117.366 0.583 . . . . 0.44 112.389 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.61 -38.49 39.76 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.366 0.603 . . . . 2.1099999999999999 109.932 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.581 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -72.29 -33.21 67.24 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.789 -0.641 . . . . 0.41999999999999998 109.327 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.4 mmmm -65.34 -37.87 88.39 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 114.959 -1.018 . . . . 1.6899999999999999 108.78 174.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -56.54 -44.65 81.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.942 -1.026 . . . . 1.3500000000000001 110.416 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.667 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 3.3 mm-40 -64.01 -52.87 57.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.142 -0.936 . . . . 1.48 111.74 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.581 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 16.0 ptp -66.37 -21.07 66.23 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.582 -0.447 . . . . 0.65000000000000002 110.807 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 73' ' ' LYS . 5.1 t -68.64 -46.53 79.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.58999999999999997 111.013 172.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.667 ' HE2' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -70.36 -16.36 62.97 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.12 0.486 . . . . 1.2 110.04 -176.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.9 t -65.01 -6.81 9.48 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.411 -0.813 . . . . 1.3700000000000001 111.716 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 77.9 mttt 67.44 68.22 0.38 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.383 0.611 . . . . 2.6499999999999999 110.596 175.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.51 HD13 HG12 ' A' ' 85' ' ' VAL . 20.7 mt -128.95 156.87 77.3 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.577 -0.738 . . . . 1.1599999999999999 110.691 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.556 ' HG2' HG23 ' A' ' 85' ' ' VAL . 53.0 Cg_endo -73.21 162.93 39.36 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.194 1.929 . . . . 0.94999999999999996 110.541 168.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -63.0 -27.47 69.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.334 -0.394 . . . . 1.53 111.539 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.1 p -67.38 -45.76 75.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.2 0.524 . . . . 1.24 110.723 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.556 HG23 ' HG2' ' A' ' 82' ' ' PRO . 90.5 t -67.37 -42.92 87.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 115.904 -0.589 . . . . 0.71999999999999997 110.053 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.476 ' CD2' ' HB2' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -48.66 -55.29 11.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.4 0.619 . . . . 1.45 110.587 171.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -56.79 -53.29 45.19 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.873 -1.058 . . . . 0.39000000000000001 113.247 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 14.4 pttp -81.12 -17.33 50.27 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.516 -0.873 . . . . 1.6599999999999999 112.651 -173.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.745 HG12 HD11 ' A' ' 122' ' ' LEU . 7.8 mt -69.73 -48.42 64.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 108.71 -0.848 . . . . 1.1499999999999999 108.71 169.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.433 ' CE3' ' HD3' ' A' ' 73' ' ' LYS . 67.2 t-105 -53.44 -55.43 25.22 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.497 -0.774 . . . . 0.29999999999999999 111.237 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.46 -30.28 71.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.38 -0.827 . . . . 2.54 112.538 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 112' ' ' LEU . 4.6 tp -84.09 -13.0 54.15 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.643 -0.503 . . . . 0.85999999999999999 109.643 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.495 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -101.63 -42.92 6.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.315 -0.402 . . . . 0.45000000000000001 111.38 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.636 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 51.5 t0 -80.43 97.76 7.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.312 -0.625 . . . . 0.62 109.312 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.553 ' HB ' ' HE2' ' A' ' 135' ' ' LYS . 44.4 t -71.95 -28.71 30.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.896 -0.593 . . . . 1.76 110.325 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.602 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 0.2 OUTLIER -79.2 -26.63 42.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.963 -0.562 . . . . 1.7 109.595 176.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 56.39 44.66 24.12 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.954 0.883 . . . . 1.74 109.05 -173.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -108.74 -0.16 20.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.181 -1.372 . . . . 1.51 112.167 -166.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.15 10.26 59.83 Favored Glycine 0 CA--C 1.511 -0.156 0 C-N-CA 120.287 -0.959 . . . . 0.28999999999999998 112.507 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.464 HD13 ' CB ' ' A' ' 66' ' ' LYS . 4.2 pp -152.89 156.13 38.37 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.227 0.537 . . . . 0.54000000000000004 110.246 175.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 105' ' ' GLU . 63.4 mt -121.82 119.0 30.39 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.115 -0.948 . . . . 0.68000000000000005 109.48 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.1 p30 -71.09 -178.36 1.96 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.508 -0.553 . . . . 1.5 109.508 174.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -34.44 68.02 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.487 0.66 . . . . 1.73 111.08 -178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.591 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 23.5 tt0 -83.95 -31.81 25.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.548 0.69 . . . . 2.1400000000000001 109.424 -176.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HB3' HD22 ' A' ' 101' ' ' LEU . 3.6 mt-10 -72.91 -30.28 63.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.583 -0.735 . . . . 1.1100000000000001 111.358 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.624 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -68.78 -44.19 74.15 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.062 -1.088 . . . . 1.0700000000000001 108.062 171.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 104' ' ' GLU . . . -47.48 -46.6 27.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 0.19 110.62 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.729 ' HG ' ' CH2' ' A' ' 44' ' ' TRP . 1.0 OUTLIER -69.81 -46.66 65.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.23 110.427 178.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.44 ' HB2' HD13 ' A' ' 101' ' ' LEU . . . -50.02 -53.76 24.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.089 0.471 . . . . 0.22 111.527 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.431 ' HA ' HD12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -72.39 -25.45 61.5 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.349 -0.611 . . . . 1.1799999999999999 109.349 -177.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.48 ' O ' HG23 ' A' ' 115' ' ' VAL . 51.4 t60 -70.24 -39.8 74.85 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.592 -0.521 . . . . 0.48999999999999999 109.592 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.525 HD22 HD22 ' A' ' 122' ' ' LEU . 46.6 mt -68.78 -36.53 78.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.838 0.352 . . . . 0.55000000000000004 110.594 177.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 110' ' ' ASN . 95.6 mt -57.42 -48.94 81.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.931 -0.577 . . . . 0.81000000000000005 110.528 175.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 19.8 ptmt -70.29 -28.46 65.21 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.123 -0.631 . . . . 2.2200000000000002 110.502 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 111' ' ' HIS . 6.4 t -62.13 -45.19 99.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.688 -0.233 . . . . 0.48999999999999999 110.989 176.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 3.7 ptmm? -84.07 -2.42 56.67 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 119.733 -0.787 . . . . 1.9099999999999999 110.846 178.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.9 tp -83.64 -23.12 31.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.459 -0.571 . . . . 1.28 109.459 170.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 48.5 mt-10 -66.44 -14.13 61.75 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.006 -0.543 . . . . 1.99 111.355 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.05 8.13 20.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.628 -0.796 . . . . 1.01 112.589 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -132.61 140.2 48.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.92 0.391 . . . . 0.87 109.964 177.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -77.06 164.96 25.23 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.865 -0.607 . . . . 2.75 110.962 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.745 HD11 HG12 ' A' ' 89' ' ' ILE . 27.1 mt -70.82 141.89 87.65 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.168 -0.469 . . . . 2.7000000000000002 110.291 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -92.25 12.86 2.0 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.035 2.49 . . . . 1.1000000000000001 113.105 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 59.96 21.93 10.99 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.756 -0.656 . . . . 1.3400000000000001 111.198 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -111.93 139.94 47.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.084 -0.709 . . . . 2.3599999999999999 109.084 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.83 93.34 47.58 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.542 -0.911 . . . . 1.8300000000000001 108.542 176.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 9.8 Cg_exo -73.21 153.49 51.32 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.828 2.352 . . . . 1.0 112.491 -174.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -67.47 -7.21 18.5 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.117 2.545 . . . . 1.3400000000000001 112.374 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -105.82 13.76 29.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.838 -0.619 . . . . 1.48 109.602 175.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.578 ' HG ' ' NE1' ' A' ' 44' ' ' TRP . 1.5 mp -134.6 -4.54 2.57 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.338 -0.846 . . . . 1.29 110.658 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.606 HG11 ' HD2' ' A' ' 136' ' ' ARG . 29.3 t -66.03 120.6 70.74 Favored Pre-proline 0 N--CA 1.44 -0.936 0 N-CA-C 109.285 -0.635 . . . . 1.72 109.285 174.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.897 ' HB2' ' HG2' ' A' ' 135' ' ' LYS . 51.9 Cg_exo -53.07 122.67 11.55 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.899 1.733 . . . . 1.04 109.412 174.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 132' ' ' PRO . 1.2 Cg_endo -49.03 -33.02 25.29 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.332 2.688 . . . . 1.4399999999999999 113.712 -172.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.3 m -80.28 -2.59 45.78 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.634 0.235 . . . . 2.2999999999999998 111.634 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.897 ' HG2' ' HB2' ' A' ' 132' ' ' PRO . 14.2 mmmt -102.58 5.26 39.18 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.055 -0.35 . . . . 3.4199999999999999 110.055 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.639 ' HA ' ' NH1' ' A' ' 136' ' ' ARG . 9.3 mmm180 -75.69 101.64 5.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.934 0.397 . . . . 4.7199999999999998 111.307 174.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.92 121.79 9.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.901 -0.591 . . . . 5.0099999999999998 110.596 172.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -98.12 110.09 22.73 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.142 -0.481 . . . . 6.3899999999999997 110.34 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.534 -0.746 . . . . 6.9100000000000001 109.711 175.207 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.636 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 111.971 -0.452 . . . . 42.189999999999998 111.971 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.29 -23.69 58.96 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.782 2.321 . . . . 41.840000000000003 112.382 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -81.66 133.97 35.42 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.398 -0.593 . . . . 43.409999999999997 109.398 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.42 29.48 58.07 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.47 -0.872 . . . . 41.270000000000003 111.651 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 p -76.94 161.81 28.08 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 120.661 0.267 . . . . 40.149999999999999 110.616 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -55.07 118.12 4.05 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.016 -0.538 . . . . 38.670000000000002 111.056 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.9 m -111.84 119.66 39.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.823 -0.626 . . . . 37.240000000000002 110.452 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.3 tp -100.98 144.43 29.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.921 -0.581 . . . . 36.32 109.97 177.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.7 mtm -71.05 153.33 94.64 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.356 -0.384 . . . . 35.030000000000001 110.762 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -58.58 162.27 12.96 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.991 2.46 . . . . 34.310000000000002 112.982 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.9 t -99.91 103.43 15.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.722 -0.672 . . . . 33.799999999999997 109.833 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -74.49 170.5 15.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.941 0.401 . . . . 34.579999999999998 111.305 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.36 116.03 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 33.82 110.473 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.09 141.65 41.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.35 -0.386 . . . . 35.100000000000001 110.758 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -149.91 97.12 2.54 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.637 -0.505 . . . . 35.140000000000001 109.637 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.13 147.36 16.82 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.99 -0.624 . . . . 36.609999999999999 112.576 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 6.7 70.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.938 -0.648 . . . . 36.640000000000001 112.769 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.1 90.57 6.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.006 0.431 . . . . 35.420000000000002 111.207 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -119.98 122.97 42.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.96 -0.564 . . . . 35.770000000000003 110.626 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -115.3 143.75 44.79 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.708 -0.478 . . . . 33.670000000000002 109.708 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.99 67.13 0.89 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.595 -0.812 . . . . 33.350000000000001 111.621 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m -117.22 104.1 10.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.11 -0.33 . . . . 32.890000000000001 110.11 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -133.12 108.65 8.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.42 0.628 . . . . 33.5 111.038 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -122.99 113.7 19.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.533 -0.758 . . . . 33.880000000000003 109.939 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.4 ' N ' ' CD ' ' A' ' 26' ' ' PRO . . . 119.03 -32.32 5.16 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.952 -0.915 . . . . 33.450000000000003 114.451 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 25' ' ' GLY . 9.5 Cg_exo -74.7 107.02 2.37 Favored 'Trans proline' 0 C--N 1.36 1.171 0 CA-C-N 120.837 2.319 . . . . 32.82 112.067 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -87.29 49.03 1.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.198 0.523 . . . . 34.289999999999999 110.477 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.54 117.48 0.46 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.525 -0.762 . . . . 31.66 111.768 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -104.12 122.84 46.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.054 -0.35 . . . . 31.329999999999998 110.054 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.25 96.39 0.1 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.609 -0.805 . . . . 28.859999999999999 111.463 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -130.84 142.5 50.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.909 0.385 . . . . 27.66 111.066 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.55 99.28 1.33 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.128 -0.789 . . . . 24.739999999999998 111.128 173.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -72.87 118.13 15.44 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.896 -0.409 . . . . 22.32 109.896 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.08 138.67 14.64 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.879 -0.677 . . . . 19.489999999999998 112.561 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.31 139.79 48.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.84 0.352 . . . . 17.420000000000002 110.245 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.95 133.77 11.81 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 121.007 -0.616 . . . . 14.76 111.63 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.457 ' HG2' ' H ' ' A' ' 38' ' ' GLY . 38.4 tt0 -88.14 172.64 9.35 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.457 -0.572 . . . . 13.02 109.457 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.457 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -78.76 87.67 1.15 Allowed Glycine 0 CA--C 1.501 -0.819 0 C-N-CA 120.706 -0.759 . . . . 10.279999999999999 112.046 -175.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.68 149.74 11.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.781 -0.822 . . . . 9.1199999999999992 108.781 169.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -76.66 72.98 3.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.434 0.635 . . . . 6.5199999999999996 110.946 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -134.69 96.0 3.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.111 -0.95 . . . . 6.3099999999999996 109.498 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.3 t -121.49 119.99 60.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.265 -0.425 . . . . 3.3300000000000001 110.815 -176.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -121.07 94.92 4.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.193 -0.458 . . . . 3.9399999999999999 111.004 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.74 ' CD1' HD22 ' A' ' 130' ' ' LEU . 6.5 t90 -126.33 137.18 53.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.212 0.53 . . . . 1.3300000000000001 109.799 170.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.561 ' H ' ' HD1' ' A' ' 44' ' ' TRP . 8.0 t -78.51 -4.52 6.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.365 -0.834 . . . . 1.21 111.07 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.605 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 99.1 t -89.26 -20.11 7.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 O-C-N 121.652 -0.655 . . . . 0.66000000000000003 111.865 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.68 -11.59 57.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.612 -1.28 . . . . 0.71999999999999997 112.234 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -109.5 -27.77 9.26 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.311 0.486 . . . . 2.9700000000000002 112.311 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -108.68 7.04 26.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.896 0.855 . . . . 1.8300000000000001 110.336 -173.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.688 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 83.0 tttt -61.5 -40.21 69.1 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 114.661 -1.154 . . . . 1.1299999999999999 112.82 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.2 Cg_endo -46.2 -30.97 8.36 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 122.678 2.252 . . . . 0.56000000000000005 112.841 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.569 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 99.0 m -75.3 -40.79 58.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.793 0.806 . . . . 0.59999999999999998 110.566 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.627 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 9.1 m-85 -79.55 -28.49 41.23 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.078 -0.51 . . . . 0.93999999999999995 110.579 -174.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.591 ' OD2' ' HA ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -86.12 -27.64 24.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.799 -0.637 . . . . 1.1599999999999999 110.181 -179.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 52' ' ' THR . 11.5 pt-20 -66.24 -43.1 87.56 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.346 -0.613 . . . . 1.6299999999999999 109.346 173.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 52' ' ' THR . 53.6 mt -67.9 -32.89 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 120.28 -0.568 . . . . 0.60999999999999999 109.517 176.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 79.2 t80 -55.1 -52.99 61.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.477 -0.783 . . . . 0.88 111.276 175.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.548 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 74.7 m-85 -73.92 -23.3 59.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.738 0.304 . . . . 1.03 111.314 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 25.2 m -66.76 -35.24 79.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.057 -0.519 . . . . 0.44 110.769 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.533 HD11 ' CG ' ' A' ' 75' ' ' GLU . 54.9 mt -85.39 -4.48 59.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.122 -0.49 . . . . 0.79000000000000004 111.404 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.0 t 67.06 95.21 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 121.586 0.708 . . . . 0.64000000000000001 111.312 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.548 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 22.9 Cg_endo -80.96 138.84 11.73 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.808 2.339 . . . . 0.46000000000000002 112.377 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.401 HG21 HG23 ' A' ' 68' ' ' THR . 13.9 m -99.94 122.05 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.044 -0.525 . . . . 1.3300000000000001 110.873 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 62.92 24.14 14.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.65 -0.704 . . . . 1.6699999999999999 111.232 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.74 14.3 53.02 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.963 -0.636 . . . . 0.5 113.728 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.951 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -155.03 151.78 28.83 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.759 -0.46 . . . . 1.8200000000000001 109.759 174.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.878 ' HB ' HD21 ' A' ' 71' ' ' ASN . 4.2 pt -80.5 135.93 24.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 C-N-CA 120.623 -0.431 . . . . 0.40999999999999998 110.529 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.401 HG23 HG21 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -60.03 128.76 38.41 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.883 -1.155 . . . . 0.69999999999999996 107.883 167.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.611 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -49.92 -29.43 13.92 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 121.172 -0.537 . . . . 0.38 113.917 -169.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.58 47.4 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.721 0.638 . . . . 0.44 112.721 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.878 HD21 ' HB ' ' A' ' 67' ' ' ILE . 15.2 p30 -82.1 -33.03 29.93 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.074 0.464 . . . . 2.1099999999999999 110.538 -176.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.656 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -69.93 -35.89 74.9 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.378 0.609 . . . . 0.41999999999999998 109.388 177.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 31.4 mmmt -66.12 -37.84 86.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.163 -0.926 . . . . 1.6899999999999999 108.984 175.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.463 ' O ' ' HD2' ' A' ' 78' ' ' LYS . 2.2 tppp? -54.84 -48.2 73.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.683 -0.689 . . . . 1.3500000000000001 109.956 176.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.691 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 3.0 mm-40 -63.43 -51.94 63.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.041 -0.982 . . . . 1.48 111.957 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.656 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 14.9 ptp -67.95 -23.02 65.02 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.481 -0.488 . . . . 0.65000000000000002 111.409 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.471 HG23 HD11 ' A' ' 86' ' ' LEU . 24.9 t -71.85 -49.51 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.481 0.181 . . . . 0.58999999999999997 111.186 173.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.691 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 2.5 ptmt -69.93 -9.1 53.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.264 0.554 . . . . 1.2 110.306 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.0 t -73.34 0.57 11.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.444 -0.798 . . . . 1.3700000000000001 110.893 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.5 mttp 73.09 68.09 0.11 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.91 -0.586 . . . . 2.6499999999999999 110.872 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.824 HD11 ' HE2' ' A' ' 116' ' ' LYS . 18.4 mt -138.64 159.68 66.46 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.627 -0.715 . . . . 1.1599999999999999 111.358 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.535 ' HG2' HG23 ' A' ' 85' ' ' VAL . 74.2 Cg_endo -77.95 168.56 21.91 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.836 2.357 . . . . 0.94999999999999996 111.385 167.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 15.0 m120 -63.45 -27.72 69.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.153 -0.476 . . . . 1.53 112.044 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -52.6 63.31 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.057 0.456 . . . . 1.24 111.167 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.535 HG23 ' HG2' ' A' ' 82' ' ' PRO . 22.6 t -62.54 -41.98 94.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.822 -0.626 . . . . 0.71999999999999997 109.723 177.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.471 HD11 HG23 ' A' ' 77' ' ' VAL . 2.7 mm? -49.51 -50.05 43.31 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.837 -0.619 . . . . 1.45 111.382 173.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.08 -44.84 86.81 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.946 -0.645 . . . . 0.39000000000000001 113.186 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.589 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 56.3 pttt -76.57 -31.29 57.44 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.964 -0.694 . . . . 1.6599999999999999 111.36 -175.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.596 HG12 HD11 ' A' ' 122' ' ' LEU . 29.7 mt -64.95 -46.22 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 109.325 -0.62 . . . . 1.1499999999999999 109.325 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.472 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 76.3 t-105 -52.95 -57.01 11.77 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 115.018 -0.992 . . . . 0.29999999999999999 111.066 177.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -77.52 -9.48 58.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.389 0.515 . . . . 2.54 112.389 -171.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.589 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 2.3 tp -88.44 -23.29 23.33 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.707 -0.397 . . . . 0.85999999999999999 109.977 176.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.563 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -103.66 -39.21 6.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.038 0.447 . . . . 0.45000000000000001 110.886 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.651 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 29.6 t70 -83.43 79.31 9.46 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.234 -0.654 . . . . 0.62 109.234 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.765 HG21 ' HG3' ' A' ' 135' ' ' LYS . 7.1 m -61.25 -33.14 55.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.202 -0.908 . . . . 1.76 111.26 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 5.1 p-10 -78.41 -24.78 46.07 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.354 -1.294 . . . . 1.7 111.446 -175.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.628 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 36.7 mtmm 47.63 50.68 14.87 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.114 0.884 . . . . 1.74 112.637 176.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -110.68 -10.85 14.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.583 -0.735 . . . . 1.51 110.281 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.09 22.91 9.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.163 -1.018 . . . . 0.28999999999999998 113.015 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.951 HD13 ' HG3' ' A' ' 66' ' ' LYS . 4.1 pp -152.94 168.32 26.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.069 0.434 . . . . 0.54000000000000004 111.212 174.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.639 ' O ' HG12 ' A' ' 67' ' ' ILE . 50.8 mt -145.08 118.87 9.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.82 -1.178 . . . . 0.68000000000000005 107.82 -166.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.441 ' H ' ' HB2' ' A' ' 105' ' ' GLU . 1.1 p30 -81.98 -173.25 4.38 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.518 -0.473 . . . . 1.5 110.758 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 54' ' ' ASP . 34.1 t70 -55.8 -36.96 67.99 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.423 0.689 . . . . 1.73 112.245 -173.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.844 ' HG2' ' HD3' ' A' ' 133' ' ' PRO . 4.2 tp10 -90.61 -22.0 21.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.428 0.632 . . . . 2.1400000000000001 110.483 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.568 ' OE1' ' HA ' ' A' ' 101' ' ' LEU . 3.1 mt-10 -73.64 -30.51 62.98 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.0 -0.545 . . . . 1.1100000000000001 110.047 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.62 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.8 OUTLIER -77.4 -34.09 54.88 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.953 -1.129 . . . . 1.0700000000000001 107.953 170.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.627 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -53.28 -48.88 67.95 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.378 0.608 . . . . 0.19 110.091 174.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.648 HD13 ' HZ2' ' A' ' 44' ' ' TRP . 37.1 tp -75.85 -39.07 57.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.725 -0.67 . . . . 1.23 111.363 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.25 -56.46 12.81 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.05 0.452 . . . . 0.22 111.166 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.573 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 4.4 t30 -73.63 -24.32 60.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.829 -0.623 . . . . 1.1799999999999999 110.211 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.466 ' O ' HG23 ' A' ' 115' ' ' VAL . 82.6 t60 -70.28 -42.89 71.48 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.277 -0.569 . . . . 0.48999999999999999 109.825 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.563 HD12 ' HB2' ' A' ' 93' ' ' ALA . 80.4 mt -66.98 -31.44 72.01 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.738 -0.664 . . . . 0.55000000000000004 109.785 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.723 ' O ' ' HG2' ' A' ' 116' ' ' LYS . 60.0 mt -60.72 -45.49 97.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.512 -0.767 . . . . 0.81000000000000005 110.684 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.62 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 12.4 ttpt -65.26 -39.56 92.79 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.341 -0.544 . . . . 2.2200000000000002 110.433 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 111' ' ' HIS . 54.7 t -56.79 -46.4 83.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.666 -0.243 . . . . 0.48999999999999999 111.365 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.824 ' HE2' HD11 ' A' ' 81' ' ' LEU . 14.6 pttp -67.01 -28.19 68.04 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.107 0.479 . . . . 1.9099999999999999 109.92 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.8 tp -80.89 -17.39 50.78 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.868 -0.605 . . . . 1.28 110.971 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.62 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 45.0 mt-10 -75.46 0.55 16.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.034 0.445 . . . . 1.99 110.712 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.81 3.95 30.01 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.429 -0.891 . . . . 1.01 112.902 171.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.519 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.2 p80 -140.53 134.9 31.29 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.393 -0.523 . . . . 0.87 110.121 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.44 163.78 27.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.534 -0.757 . . . . 2.75 111.007 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.596 HD11 HG12 ' A' ' 89' ' ' ILE . 23.3 mt -69.89 134.34 87.91 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.35 -0.386 . . . . 2.7000000000000002 110.014 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 84.4 Cg_endo -93.18 14.83 1.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.894 2.396 . . . . 1.1000000000000001 113.114 -174.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.56 19.55 10.48 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.202 0.525 . . . . 1.3400000000000001 111.099 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -104.35 111.77 24.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.663 -0.699 . . . . 2.3599999999999999 109.582 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.9 tp -112.24 100.11 48.5 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.069 -0.514 . . . . 1.8300000000000001 109.983 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.446 ' C ' ' H ' ' A' ' 129' ' ' HIS . 4.7 Cg_endo -89.02 159.7 5.86 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.075 2.516 . . . . 1.0 111.238 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.17 28.41 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.842 2.362 . . . . 1.3400000000000001 113.104 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.446 ' H ' ' C ' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -100.35 -25.17 14.32 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.863 -0.791 . . . . 1.48 108.863 174.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.74 HD22 ' CD1' ' A' ' 44' ' ' TRP . 0.7 OUTLIER -127.49 7.07 6.32 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.976 -0.557 . . . . 1.29 111.424 -167.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.99 121.04 84.07 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 108.255 -1.017 . . . . 1.72 108.255 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 1.152 ' HB2' ' HE3' ' A' ' 135' ' ' LYS . 53.5 Cg_exo -47.8 152.58 2.9 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.743 2.295 . . . . 1.04 113.073 -176.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.844 ' HD3' ' HG2' ' A' ' 104' ' ' GLU . 94.1 Cg_exo -43.39 -56.51 2.28 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 124.145 3.23 . . . . 1.4399999999999999 114.365 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.4 m -67.5 -4.68 12.15 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.345 0.498 . . . . 2.2999999999999998 112.345 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 1.152 ' HE3' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -120.71 10.59 11.03 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.671 0.619 . . . . 3.4199999999999999 112.671 -171.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.619 ' HG3' ' O ' ' A' ' 133' ' ' PRO . 0.1 OUTLIER -85.43 74.8 10.29 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.54 -0.464 . . . . 4.7199999999999998 110.071 178.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -165.67 141.63 5.17 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.248 0.547 . . . . 5.0099999999999998 111.798 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -116.98 113.34 22.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.048 -0.978 . . . . 6.3899999999999997 108.457 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.026 0 O-C-N 123.683 0.614 . . . . 6.9100000000000001 109.86 -168.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.651 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.774 -0.531 . . . . 42.189999999999998 111.774 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.418 ' HD3' ' HA2' ' A' ' 1' ' ' GLY . 7.7 Cg_exo -72.99 -41.83 1.22 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.771 2.314 . . . . 41.840000000000003 112.007 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.9 tp -72.05 133.22 45.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.933 -0.576 . . . . 43.409999999999997 110.54 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.01 -2.2 65.88 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.935 -0.65 . . . . 41.270000000000003 112.318 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.8 t -96.71 131.31 43.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.82 0.343 . . . . 40.149999999999999 110.487 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -78.01 122.25 25.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.021 -0.536 . . . . 38.670000000000002 109.643 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.3 m -78.08 109.03 11.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.289 -0.414 . . . . 37.240000000000002 110.714 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.71 131.27 45.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.698 -0.683 . . . . 36.32 110.821 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 65.7 mtt -108.57 123.93 35.86 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.102 -0.499 . . . . 35.030000000000001 110.082 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -58.39 -33.84 98.18 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.212 2.608 . . . . 34.310000000000002 112.352 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 p -107.62 89.04 2.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.329 0.585 . . . . 33.799999999999997 110.388 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -101.68 59.81 0.87 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.718 -0.674 . . . . 34.579999999999998 110.392 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.5 t -119.4 105.0 16.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.76 -0.655 . . . . 33.82 110.156 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 m -88.79 102.63 13.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.558 0.694 . . . . 35.100000000000001 110.917 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.925 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 68.2 mttm -85.99 82.93 7.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.727 -0.67 . . . . 35.140000000000001 110.322 177.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.31 109.42 2.8 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.939 -0.648 . . . . 36.609999999999999 112.137 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.16 4.59 90.17 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.971 -0.633 . . . . 36.640000000000001 112.503 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.925 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . . . -94.44 97.89 10.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.994 0.426 . . . . 35.420000000000002 110.619 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -87.71 117.36 26.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.933 -0.576 . . . . 35.770000000000003 110.501 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -103.57 139.05 39.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.106 0.479 . . . . 33.670000000000002 110.174 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -112.42 83.93 0.34 Allowed Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.686 -0.688 . . . . 33.350000000000001 111.519 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.4 m -147.33 143.37 28.0 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.364 -0.236 . . . . 32.890000000000001 110.364 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.4 tpt -60.45 138.24 58.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.241 0.544 . . . . 33.5 111.648 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -90.89 149.81 21.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.736 -0.665 . . . . 33.880000000000003 110.146 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.65 -32.01 5.17 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.674 -1.07 . . . . 33.450000000000003 114.682 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -73.28 1.27 6.89 Favored 'Trans proline' 0 C--N 1.359 1.122 0 CA-C-N 120.992 2.396 . . . . 32.82 112.295 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -82.6 123.66 29.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.25 -0.432 . . . . 34.289999999999999 110.028 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.24 171.18 53.22 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.734 -0.746 . . . . 31.66 112.811 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . 36.8 m80 -132.8 164.92 25.76 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.354 -0.61 . . . . 31.329999999999998 109.354 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.21 96.15 1.46 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.422 -0.894 . . . . 28.859999999999999 111.958 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 29' ' ' HIS . 33.9 m-85 -110.52 170.0 8.38 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.895 -0.409 . . . . 27.66 109.895 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.63 158.3 49.59 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.917 -0.873 . . . . 24.739999999999998 110.917 169.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -47.16 132.69 12.32 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.529 0.566 . . . . 22.32 112.529 -176.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.67 108.22 2.73 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.476 -1.05 . . . . 19.489999999999998 110.476 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.75 140.98 58.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.776 0.322 . . . . 17.420000000000002 110.368 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.69 109.81 3.17 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.744 -0.741 . . . . 14.76 112.278 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 2.1 pm0 -78.91 -175.89 4.73 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.342 -0.244 . . . . 13.02 110.342 176.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.56 71.9 2.76 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.388 -0.91 . . . . 10.279999999999999 112.765 -172.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 pp -66.61 154.92 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 109.118 -0.697 . . . . 9.1199999999999992 109.118 168.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.82 75.65 2.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.449 0.642 . . . . 6.5199999999999996 110.905 -175.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -94.1 87.54 5.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.357 -0.838 . . . . 6.3099999999999996 109.318 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.93 135.66 25.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.915 -0.584 . . . . 3.3300000000000001 110.952 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -82.41 110.41 17.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.594 0.712 . . . . 3.9399999999999999 110.731 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.593 ' CD2' ' HA ' ' A' ' 130' ' ' LEU . 6.5 t90 -120.13 141.3 49.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.137 -0.938 . . . . 1.3300000000000001 109.173 175.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.82 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 21.1 t -49.96 -18.73 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 CA-C-N 114.985 -1.007 . . . . 1.21 112.565 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.476 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 1.0 OUTLIER -74.99 -15.86 15.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 120.826 -1.171 . . . . 0.66000000000000003 111.592 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.43 -14.12 61.65 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 119.517 -1.325 . . . . 0.71999999999999997 111.714 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.82 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -110.08 -27.87 8.96 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.986 0.422 . . . . 2.9700000000000002 110.874 176.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.792 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.0 OUTLIER -86.37 -18.66 31.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.515 -0.766 . . . . 1.8300000000000001 111.1 -177.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.484 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 58.8 tttm -52.32 -51.05 75.96 Favored Pre-proline 0 C--O 1.217 -0.619 0 CA-C-O 118.662 -0.685 . . . . 1.1299999999999999 112.643 -174.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 85.9 Cg_exo -41.95 -40.41 6.03 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 122.775 2.317 . . . . 0.56000000000000005 113.676 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.563 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 93.9 m -74.04 -44.15 55.31 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.61 0.719 . . . . 0.59999999999999998 110.744 -176.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.792 ' CE2' ' HB3' ' A' ' 49' ' ' ASP . 6.1 m-85 -74.64 -24.28 58.8 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.988 -0.551 . . . . 0.93999999999999995 110.109 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 24.7 t70 -81.1 -37.24 29.27 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.829 -1.078 . . . . 1.1599999999999999 110.257 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 52' ' ' THR . 13.5 pt-20 -67.13 -41.59 85.88 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.256 -0.429 . . . . 1.6299999999999999 109.963 175.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.462 ' HA ' ' HB ' ' A' ' 59' ' ' THR . 56.1 mt -69.52 -30.38 45.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.583 -0.525 . . . . 0.60999999999999999 109.583 175.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 62' ' ' PRO . 55.3 t80 -57.68 -55.21 37.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.721 -0.672 . . . . 0.88 111.244 177.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.512 ' CD1' ' HG2' ' A' ' 62' ' ' PRO . 68.6 m-85 -70.51 -21.84 62.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.236 0.541 . . . . 1.03 110.611 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.462 ' HB ' ' HA ' ' A' ' 56' ' ' ILE . 23.0 m -72.97 -24.53 60.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.257 -0.883 . . . . 0.44 110.985 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.0 mt -94.54 7.98 43.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.79000000000000004 110.828 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.0 t 64.93 90.05 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 123.751 0.657 . . . . 0.64000000000000001 112.223 175.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 57' ' ' PHE . 5.7 Cg_exo -75.49 143.12 27.22 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.852 2.368 . . . . 0.46000000000000002 112.819 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.04 117.94 54.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.457 -0.942 . . . . 1.3300000000000001 108.457 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 68.89 21.15 7.69 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.636 0.585 . . . . 1.6699999999999999 111.567 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.435 ' C ' ' HD2' ' A' ' 66' ' ' LYS . . . 93.34 22.56 26.67 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.148 -0.478 . . . . 0.5 112.936 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.946 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -160.85 156.07 24.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.247 -0.279 . . . . 1.8200000000000001 110.247 178.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.501 HD13 ' CD2' ' A' ' 106' ' ' PHE . 2.2 pt -86.22 137.56 20.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.776 -0.453 . . . . 0.40999999999999998 109.776 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 p -59.35 128.43 37.04 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.204 -1.036 . . . . 0.69999999999999996 108.204 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.567 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -52.28 -32.87 37.74 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 114.942 0.737 . . . . 0.38 114.942 -164.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.56 -28.01 29.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.291 0.545 . . . . 0.44 112.434 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -78.73 -41.7 30.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.423 0.63 . . . . 2.1099999999999999 109.628 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.544 ' CB ' HD12 ' A' ' 101' ' ' LEU . . . -69.95 -31.14 68.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.583 0.706 . . . . 0.41999999999999998 109.287 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 30.6 mmmt -65.86 -37.46 86.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.951 -1.022 . . . . 1.6899999999999999 109.004 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.4 -46.01 83.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.476 -0.783 . . . . 1.3500000000000001 109.785 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.901 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 11.4 mm-40 -56.63 -53.02 62.55 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.864 -1.062 . . . . 1.48 111.36 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 16.7 ptp -72.55 -23.67 61.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.179 -0.464 . . . . 0.65000000000000002 111.685 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 73' ' ' LYS . 20.2 t -67.57 -55.7 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.858 0.361 . . . . 0.58999999999999997 110.798 174.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.901 ' HE2' ' HA ' ' A' ' 75' ' ' GLU . 57.2 pttt -67.7 -14.44 62.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.16 0.505 . . . . 1.2 110.977 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.1 t -66.32 -7.47 19.06 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.759 -0.655 . . . . 1.3700000000000001 110.995 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt 72.15 71.7 0.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.399 0.68 . . . . 2.6499999999999999 111.315 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.035 HD11 ' HE2' ' A' ' 116' ' ' LYS . 36.4 mt -131.82 162.21 57.82 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.519 -0.764 . . . . 1.1599999999999999 110.65 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.519 ' HG2' HG23 ' A' ' 85' ' ' VAL . 67.8 Cg_endo -76.76 169.01 22.55 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.568 2.178 . . . . 0.94999999999999996 110.864 166.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -66.0 -32.08 73.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.66 0.267 . . . . 1.53 111.344 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.5 m -63.6 -50.85 67.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.067 0.46 . . . . 1.24 110.856 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.519 HG23 ' HG2' ' A' ' 82' ' ' PRO . 84.7 t -63.04 -40.1 87.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 115.945 -0.57 . . . . 0.71999999999999997 110.502 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.792 HD12 ' HB2' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -59.76 -48.99 79.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.879 0.371 . . . . 1.45 111.321 177.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.33 -37.51 93.21 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.535 -0.757 . . . . 0.39000000000000001 112.209 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.675 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 17.2 ptmt -83.84 -29.43 27.29 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.241 -0.583 . . . . 1.6599999999999999 110.446 -175.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.5 mm -60.06 -48.04 89.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.363 -0.606 . . . . 1.1499999999999999 109.363 169.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.564 ' CE3' ' HD3' ' A' ' 73' ' ' LYS . 76.9 t-105 -57.43 -54.35 47.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.449 -0.796 . . . . 0.29999999999999999 111.187 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.675 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 18.1 ptpt -77.78 -8.11 57.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.925 -0.58 . . . . 2.54 111.915 -171.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 18.2 tp -93.24 -30.89 14.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.996 -0.372 . . . . 0.85999999999999999 109.996 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.498 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -81.84 -42.58 19.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.217 -0.447 . . . . 0.45000000000000001 110.957 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.615 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 50.6 t0 -87.28 97.84 11.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.175 0.512 . . . . 0.62 110.323 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.725 ' CG2' ' HG3' ' A' ' 135' ' ' LYS . 29.7 m -73.2 -25.78 21.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.624 -0.716 . . . . 1.76 111.681 -178.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.625 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 0.1 OUTLIER -85.64 -25.78 26.41 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.377 -0.601 . . . . 1.7 109.377 179.054 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.2 mttp 57.27 69.16 0.77 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.131 -0.941 . . . . 1.74 110.504 -174.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.615 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 2.7 m-20 -96.05 -46.18 6.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.802 -1.09 . . . . 1.51 110.6 -174.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.45 14.32 20.33 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 109.435 -1.466 . . . . 0.28999999999999998 109.435 -162.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.946 HD13 ' HG3' ' A' ' 66' ' ' LYS . 3.6 pp -152.8 171.02 18.89 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.048 -1.076 . . . . 0.54000000000000004 108.292 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 105' ' ' GLU . 48.0 mt -143.35 117.52 9.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.618 -0.512 . . . . 0.68000000000000005 109.618 -174.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 4.0 p30 -74.3 -174.2 1.91 Allowed 'General case' 0 C--N 1.317 -0.845 0 O-C-N 122.199 -0.313 . . . . 1.5 110.656 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.2 -36.23 65.71 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.088 0.947 . . . . 1.73 109.995 -176.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.522 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 29.4 tt0 -88.19 -25.08 23.1 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.772 -1.103 . . . . 2.1400000000000001 109.871 -173.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.552 ' HB3' HD22 ' A' ' 101' ' ' LEU . 2.0 mt-10 -81.5 -32.36 32.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.041 -0.527 . . . . 1.1100000000000001 111.496 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.636 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -63.82 -43.0 97.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.176 -1.416 . . . . 1.0700000000000001 107.176 169.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.663 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -48.98 -50.24 36.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.602 -0.726 . . . . 0.19 110.842 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.636 HD12 ' HG3' ' A' ' 132' ' ' PRO . 1.4 tt -66.35 -47.94 71.82 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.748 -0.206 . . . . 1.23 110.78 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.33 -54.66 33.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.948 0.404 . . . . 0.22 111.894 -176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.538 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 9.0 t-20 -70.9 -30.66 67.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.238 0.542 . . . . 1.1799999999999999 109.583 -175.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.464 ' O ' HG23 ' A' ' 115' ' ' VAL . 61.7 t60 -67.94 -37.14 81.25 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.653 -0.703 . . . . 0.48999999999999999 109.897 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.46 ' HA ' ' HB ' ' A' ' 115' ' ' VAL . 21.6 mt -67.9 -33.48 74.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.056 0.455 . . . . 0.55000000000000004 110.421 175.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.779 ' HA ' ' HE3' ' A' ' 116' ' ' LYS . 75.9 mt -62.13 -45.82 97.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.689 -0.687 . . . . 0.81000000000000005 110.894 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.487 ' HD3' ' OH ' ' A' ' 53' ' ' TYR . 21.5 ptmt -73.8 -26.86 60.83 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.265 -0.574 . . . . 2.2200000000000002 110.927 176.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 111' ' ' HIS . 3.4 t -62.76 -47.45 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.744 0.307 . . . . 0.48999999999999999 110.933 176.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 1.035 ' HE2' HD11 ' A' ' 81' ' ' LEU . 20.6 pttp -72.22 -22.47 61.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.09 0.471 . . . . 1.9099999999999999 110.112 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 23.0 tp -70.64 -22.36 62.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.953 -0.567 . . . . 1.28 109.782 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 45.6 mt-10 -68.34 -12.01 60.43 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 116.028 -0.533 . . . . 1.99 110.429 173.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.96 -13.76 58.89 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.307 -0.717 . . . . 1.01 111.307 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -94.49 125.45 39.14 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.473 -0.566 . . . . 0.87 109.473 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.71 141.13 35.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.424 -0.807 . . . . 2.75 112.252 -174.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.903 HD13 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -63.75 130.16 94.23 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.882 -1.053 . . . . 2.7000000000000002 110.941 176.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.759 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 13.5 Cg_endo -87.83 1.18 6.9 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.066 2.51 . . . . 1.1000000000000001 114.176 -170.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 65.94 18.73 11.15 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.722 0.773 . . . . 1.3400000000000001 109.777 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.759 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 37.0 t70 -105.31 140.68 38.08 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.731 -1.122 . . . . 2.3599999999999999 108.593 175.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.52 102.48 32.81 Favored Pre-proline 0 C--N 1.309 -1.155 0 CA-C-N 115.782 -0.645 . . . . 1.8300000000000001 110.085 -176.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.28 156.64 11.0 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.269 2.646 . . . . 1.0 112.415 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.456 ' O ' HG12 ' A' ' 131' ' ' VAL . 18.8 Cg_exo -64.0 -19.01 65.9 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.941 2.427 . . . . 1.3400000000000001 112.241 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -90.2 15.73 9.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.126 -0.488 . . . . 1.48 109.722 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.593 ' HA ' ' CD2' ' A' ' 44' ' ' TRP . 0.2 OUTLIER -149.06 17.52 0.96 Allowed 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.225 -0.898 . . . . 1.29 109.483 175.079 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 128' ' ' PRO . 9.6 p -98.12 119.26 62.38 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 115.983 -0.553 . . . . 1.72 109.702 -177.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.707 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 15.0 Cg_exo -62.43 115.71 3.05 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.235 1.957 . . . . 1.04 111.427 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.99 -16.6 28.98 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.862 2.374 . . . . 1.4399999999999999 115.031 -172.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 56.9 m -76.6 -9.52 58.72 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.457 -0.777 . . . . 2.2999999999999998 111.163 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.725 ' HG3' ' CG2' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -112.33 -7.7 13.97 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.769 -0.826 . . . . 3.4199999999999999 108.769 176.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 17.7 mmm180 -96.69 111.33 23.53 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.531 -1.213 . . . . 4.7199999999999998 110.417 174.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.66 144.41 26.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.939 -0.573 . . . . 5.0099999999999998 109.823 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -92.41 124.2 36.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.658 -0.701 . . . . 6.3899999999999997 110.864 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.238 -0.886 . . . . 6.9100000000000001 109.589 173.916 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.625 'CA ' ' OD2' ' A' ' 96' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 111.85 -0.5 . . . . 42.189999999999998 111.85 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.695 ' HB2' HD12 ' A' ' 3' ' ' LEU . 2.7 Cg_exo -78.53 -46.68 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.958 2.439 . . . . 41.840000000000003 111.81 175.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.695 HD12 ' HB2' ' A' ' 2' ' ' PRO . 6.3 mp -98.3 139.46 34.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.862 -0.608 . . . . 43.409999999999997 109.8 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.25 -27.57 6.8 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.761 -0.733 . . . . 41.270000000000003 112.937 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.9 m -90.17 117.73 29.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.75 0.31 . . . . 40.149999999999999 110.267 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -71.06 130.68 42.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.828 -0.624 . . . . 38.670000000000002 110.435 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.06 99.02 3.79 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.29 -0.633 . . . . 37.240000000000002 109.29 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.3 tp -82.24 125.27 30.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.318 -0.401 . . . . 36.32 110.884 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.448 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 22.2 ptt? -94.14 130.55 33.91 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.858 -0.61 . . . . 35.030000000000001 109.427 173.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 49.9 Cg_exo -56.14 -39.41 91.41 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.778 2.319 . . . . 34.310000000000002 112.73 -176.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 p -87.05 91.81 8.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.116 0.484 . . . . 33.799999999999997 110.186 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -133.18 101.75 5.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.983 -0.553 . . . . 34.579999999999998 110.548 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 m -132.13 121.18 45.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.831 -0.622 . . . . 33.82 109.748 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.5 t -82.04 96.0 3.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.375 0.607 . . . . 35.100000000000001 111.255 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -98.06 79.61 2.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.561 0.696 . . . . 35.140000000000001 109.9 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -105.94 108.06 2.9 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.839 -0.696 . . . . 36.609999999999999 112.341 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.18 24.0 74.72 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.222 -0.513 . . . . 36.640000000000001 113.094 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.12 104.45 9.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.989 0.423 . . . . 35.420000000000002 111.058 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -107.96 88.58 2.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.993 -0.549 . . . . 35.770000000000003 109.945 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -117.93 112.81 20.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.782 -0.645 . . . . 33.670000000000002 110.919 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.72 66.38 0.24 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.898 -0.881 . . . . 33.350000000000001 110.898 175.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 t -120.67 130.43 54.1 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.113 0.482 . . . . 32.890000000000001 110.452 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 62.9 mtt -107.07 95.71 5.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.951 -0.568 . . . . 33.5 110.213 178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -114.54 140.41 48.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.698 -0.683 . . . . 33.880000000000003 109.81 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.91 -32.48 4.77 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.092 -0.838 . . . . 33.450000000000003 113.811 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -70.73 95.91 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 120.59 2.195 . . . . 32.82 110.427 165.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -80.24 115.45 19.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.965 -0.561 . . . . 34.289999999999999 111.571 -173.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.72 129.5 1.17 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.634 -0.712 . . . . 31.66 111.797 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -76.1 140.26 41.75 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.951 -0.389 . . . . 31.329999999999998 109.951 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.55 177.49 33.7 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.219 -0.991 . . . . 28.859999999999999 112.3 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -138.88 144.39 39.15 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.609 0.243 . . . . 27.66 110.469 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.83 92.07 0.38 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.651 -0.785 . . . . 24.739999999999998 112.16 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.27 122.33 23.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.708 0.29 . . . . 22.32 110.413 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.68 115.01 4.26 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.731 -0.747 . . . . 19.489999999999998 111.745 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.98 116.37 18.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.963 0.411 . . . . 17.420000000000002 110.245 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.07 103.19 1.14 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.617 -0.802 . . . . 14.76 112.692 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -100.41 -175.38 2.9 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.479 -0.563 . . . . 13.02 109.479 173.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.51 72.32 2.38 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 119.971 -1.109 . . . . 10.279999999999999 111.021 175.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.2 pt -60.32 150.55 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 109.068 -0.716 . . . . 9.1199999999999992 109.068 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' HB3' ' HE ' ' A' ' 136' ' ' ARG . 8.8 t70 -74.74 80.51 2.07 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.56 -0.533 . . . . 6.5199999999999996 109.56 -175.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -75.29 98.95 3.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.431 -0.804 . . . . 6.3099999999999996 110.512 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.64 142.65 39.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.551 -0.749 . . . . 3.3300000000000001 110.08 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -98.85 94.28 6.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.297 0.57 . . . . 3.9399999999999999 110.232 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.613 ' CH2' ' HG ' ' A' ' 108' ' ' LEU . 3.8 t90 -75.96 142.39 41.98 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.385 -0.825 . . . . 1.3300000000000001 109.554 173.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.506 ' N ' ' CD1' ' A' ' 44' ' ' TRP . 12.0 t -45.61 -14.21 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.936 1.294 . . . . 1.21 113.572 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.44 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 2.1 t -86.94 -26.49 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.226 -0.922 . . . . 0.66000000000000003 112.022 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.96 -11.19 30.12 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.449 -0.881 . . . . 0.71999999999999997 112.398 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.505 ' HB3' ' HZ3' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -102.01 -27.63 12.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 112.154 0.427 . . . . 2.9700000000000002 112.154 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -114.67 6.67 15.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.187 0.517 . . . . 1.8300000000000001 110.572 -175.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.666 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 74.2 tttt -55.86 -43.47 99.22 Favored Pre-proline 0 C--O 1.22 -0.473 0 CA-C-O 118.774 -0.631 . . . . 1.1299999999999999 111.757 177.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -44.69 -30.46 4.18 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 122.734 2.289 . . . . 0.56000000000000005 113.304 178.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.694 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 28.6 m -73.43 -43.87 59.46 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.067 0.937 . . . . 0.59999999999999998 109.937 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.554 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 3.6 m-85 -82.05 -24.93 35.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.597 -0.729 . . . . 0.93999999999999995 110.117 -175.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 1.7 t70 -77.82 -35.81 50.9 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.949 -1.023 . . . . 1.1599999999999999 109.55 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.694 ' HG3' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -68.03 -36.73 80.42 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.054 -0.521 . . . . 1.6299999999999999 109.778 176.176 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.437 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 55.7 mt -70.42 -33.84 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.462 -0.57 . . . . 0.60999999999999999 109.462 173.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 90.3 t80 -56.1 -57.52 11.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.349 -0.842 . . . . 0.88 111.348 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.616 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 57.4 m-85 -68.77 -22.8 64.27 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.991 0.424 . . . . 1.03 111.045 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.9 m -70.06 -27.92 65.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.927 -0.579 . . . . 0.44 110.698 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 63.6 mt -87.24 -3.97 59.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.644 -0.253 . . . . 0.79000000000000004 111.063 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.2 t 69.05 86.9 0.12 Allowed Pre-proline 0 N--CA 1.468 0.443 0 O-C-N 123.847 0.717 . . . . 0.64000000000000001 111.533 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.616 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 59.6 Cg_endo -77.0 151.97 31.27 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.882 2.388 . . . . 0.46000000000000002 113.443 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.5 m -120.1 121.6 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.577 -0.738 . . . . 1.3300000000000001 110.756 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 63.26 24.25 14.2 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.915 -0.584 . . . . 1.6699999999999999 112.014 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.43 36.78 9.35 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.687 -0.768 . . . . 0.5 112.754 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.655 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -171.56 162.99 6.63 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.327 -0.62 . . . . 1.8200000000000001 109.327 169.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.48 HD13 ' CD2' ' A' ' 106' ' ' PHE . 2.0 pt -92.97 134.85 29.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 109.741 -0.466 . . . . 0.40999999999999998 109.741 170.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 p -59.33 134.32 56.89 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.652 -1.24 . . . . 0.69999999999999996 107.652 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.611 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -52.18 -28.26 25.87 Favored Glycine 0 C--O 1.22 -0.732 0 N-CA-C 115.422 0.929 . . . . 0.38 115.422 -167.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.91 -27.03 50.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.774 0.787 . . . . 0.44 112.047 175.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.414 ' ND2' ' N ' ' A' ' 71' ' ' ASN . 0.3 OUTLIER -79.31 -36.5 39.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.785 0.802 . . . . 2.1099999999999999 109.472 -178.13 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.65 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -75.8 -31.34 59.39 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.235 -0.893 . . . . 0.41999999999999998 110.09 177.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 14.2 mmmm -65.18 -34.51 78.56 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.433 -0.951 . . . . 1.6899999999999999 108.433 173.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 74' ' ' LYS . 1.7 tppp? -58.96 -49.02 79.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.122 -0.944 . . . . 1.3500000000000001 109.719 174.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 57.4 mm-40 -56.69 -53.02 62.51 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.254 -0.884 . . . . 1.48 112.226 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.65 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 15.0 ptp -70.8 -24.7 62.62 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.698 -0.401 . . . . 0.65000000000000002 110.857 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.06 -46.02 82.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 122.109 -0.369 . . . . 0.58999999999999997 110.991 172.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 18.1 ptpt -73.79 -18.28 60.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.72 -0.218 . . . . 1.2 111.432 -175.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 91.2 p -67.33 3.22 1.32 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.546 0.573 . . . . 1.3700000000000001 112.546 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 74.44 29.34 1.21 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.987 0.515 . . . . 2.6499999999999999 111.003 172.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.543 HD13 ' HD3' ' A' ' 116' ' ' LYS . 61.6 mt -109.44 162.05 21.67 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.125 -0.488 . . . . 1.1599999999999999 111.33 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.567 ' O ' HD22 ' A' ' 86' ' ' LEU . 92.3 Cg_endo -81.96 150.43 16.06 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.745 2.297 . . . . 0.94999999999999996 111.464 174.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -51.29 -29.9 16.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.536 -0.756 . . . . 1.53 112.657 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -62.95 -49.64 73.95 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.429 0.633 . . . . 1.24 110.71 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.555 ' O ' HG13 ' A' ' 89' ' ' ILE . 67.6 t -63.52 -41.83 94.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-N 115.273 -0.876 . . . . 0.71999999999999997 110.315 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.567 HD22 ' O ' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -64.18 -39.05 93.17 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.721 0.296 . . . . 1.45 110.765 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -57.92 -45.96 93.04 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.913 -0.66 . . . . 0.39000000000000001 111.907 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.705 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 44.7 pttt -81.1 -27.76 35.47 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.739 -0.785 . . . . 1.6599999999999999 111.715 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 85' ' ' VAL . 60.0 mt -60.6 -46.3 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 109.662 -0.496 . . . . 1.1499999999999999 109.662 171.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.481 ' HZ3' ' HB3' ' A' ' 72' ' ' ALA . 67.6 t-105 -56.99 -56.92 15.5 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.702 -0.681 . . . . 0.29999999999999999 111.088 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.705 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 9.0 ptpp? -70.38 -9.51 56.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 2.54 111.665 -174.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 124' ' ' ALA . 14.0 tp -93.32 -33.05 14.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.85999999999999999 110.347 175.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.404 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -87.31 -42.84 12.6 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.121 0.415 . . . . 0.45000000000000001 112.121 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.648 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 53.8 t0 -84.98 98.65 10.5 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.628 -0.508 . . . . 0.62 109.628 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.538 ' HB ' ' HE2' ' A' ' 135' ' ' LYS . 41.0 t -72.02 -29.82 34.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.532 -0.758 . . . . 1.76 111.244 -174.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.601 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.0 OUTLIER -80.55 -27.39 37.57 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.177 -0.675 . . . . 1.7 109.177 179.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 58.8 45.52 15.39 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 122.318 1.056 . . . . 1.74 108.439 -174.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -105.0 6.7 33.65 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 113.649 -1.614 . . . . 1.51 111.801 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.51 18.62 70.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.467 -0.873 . . . . 0.28999999999999998 112.527 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.655 HD13 ' HG3' ' A' ' 66' ' ' LYS . 4.3 pp -153.3 175.21 13.35 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.693 -0.484 . . . . 0.54000000000000004 109.693 175.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.585 HD12 ' CB ' ' A' ' 72' ' ' ALA . 46.3 mt -149.79 113.45 5.03 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.931 -1.136 . . . . 0.68000000000000005 107.931 -173.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.1 p-10 -75.75 -172.54 1.93 Allowed 'General case' 0 C--N 1.313 -0.991 0 O-C-N 122.352 -0.217 . . . . 1.5 110.678 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.52 -36.42 66.69 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.852 0.358 . . . . 1.73 111.057 -175.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 0.2 OUTLIER -90.51 -26.81 19.58 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.013 0.375 . . . . 2.1400000000000001 112.013 -179.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.595 ' OE1' 'CA ' ' A' ' 141' ' ' ' CA' . 2.3 mt-10 -70.8 -34.55 71.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.026 0.441 . . . . 1.1100000000000001 109.91 175.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.666 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -66.7 -42.56 86.24 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 107.649 -1.241 . . . . 1.0700000000000001 107.649 170.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.554 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -53.0 -41.02 64.23 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.846 -0.616 . . . . 0.19 110.558 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.613 ' HG ' ' CH2' ' A' ' 44' ' ' TRP . 1.0 OUTLIER -73.74 -50.84 18.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.004 -0.544 . . . . 1.23 110.883 178.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.9 -52.07 45.61 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.26 0.552 . . . . 0.22 111.198 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.501 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 7.2 t-20 -71.18 -27.16 63.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.646 -0.706 . . . . 1.1799999999999999 109.515 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' A' ' 107' ' ' ALA . 60.8 t60 -68.69 -40.83 79.88 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 120.19 -0.604 . . . . 0.48999999999999999 109.59 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.525 ' HA ' ' HB ' ' A' ' 115' ' ' VAL . 42.8 mt -68.57 -35.37 77.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.307 -0.406 . . . . 0.55000000000000004 110.735 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 110' ' ' ASN . 97.4 mt -59.26 -52.43 60.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.334 -0.394 . . . . 0.81000000000000005 110.186 174.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 19.1 ptmt -72.28 -21.61 61.33 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.126 -0.63 . . . . 2.2200000000000002 110.858 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.525 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 2.5 t -59.15 -47.47 90.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.998 -0.371 . . . . 0.48999999999999999 109.998 171.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.794 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 4.8 ptmm? -85.44 2.63 43.71 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 120.182 -0.607 . . . . 1.9099999999999999 110.527 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 51.8 tp -88.4 -19.52 26.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.573 -0.74 . . . . 1.28 109.311 168.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 55.2 mt-10 -67.08 -17.18 64.77 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.889 -0.596 . . . . 1.99 110.234 176.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.39 -21.34 13.05 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.026 -0.607 . . . . 1.01 111.94 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.794 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -106.83 135.94 47.51 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.89 -1.152 . . . . 0.87 107.89 174.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.52 ' HA ' ' CB ' ' A' ' 116' ' ' LYS . 13.4 pt-20 -93.26 163.29 13.67 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.737 -0.785 . . . . 2.75 110.937 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.882 HD13 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -62.86 127.57 90.76 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-O 121.367 0.603 . . . . 2.7000000000000002 110.763 177.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.508 ' HG2' ' OD1' ' A' ' 125' ' ' ASP . 72.8 Cg_endo -95.86 13.8 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.478 2.786 . . . . 1.1000000000000001 113.014 -174.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.503 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . 65.87 36.31 6.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.311 -0.858 . . . . 1.3400000000000001 111.181 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.508 ' OD1' ' HG2' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -114.99 142.69 46.29 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.55 0.69 . . . . 2.3599999999999999 109.914 169.256 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.3 tp -126.25 96.54 36.39 Favored Pre-proline 0 C--N 1.306 -1.32 0 CA-C-N 114.964 -1.017 . . . . 1.8300000000000001 110.032 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -73.2 150.81 48.23 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.755 2.303 . . . . 1.0 111.833 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.22 -16.25 45.23 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.785 2.323 . . . . 1.3400000000000001 112.248 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.403 ' O ' HD12 ' A' ' 130' ' ' LEU . 21.6 p-80 -98.38 21.83 10.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.143 -0.481 . . . . 1.48 110.867 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.548 ' HG ' ' NE1' ' A' ' 44' ' ' TRP . 1.0 OUTLIER -138.27 12.91 2.82 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.576 -0.284 . . . . 1.29 110.729 174.143 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 m -91.18 125.55 58.06 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 109.401 -0.592 . . . . 1.72 109.401 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.764 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 51.3 Cg_exo -50.65 146.9 19.0 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.6 2.2 . . . . 1.04 111.829 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -43.24 -27.9 1.28 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.399 3.399 . . . . 1.4399999999999999 115.957 -175.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.5 m -88.72 -10.55 47.97 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.654 0.612 . . . . 2.2999999999999998 112.654 -175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.764 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -119.46 9.15 11.48 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.508 0.558 . . . . 3.4199999999999999 112.508 -177.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.483 ' HE ' ' HB3' ' A' ' 40' ' ' ASP . 0.6 OUTLIER -84.55 95.59 8.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.984 0.421 . . . . 4.7199999999999998 110.28 173.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -167.5 136.41 2.62 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.255 -0.276 . . . . 5.0099999999999998 110.255 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.588 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 61.2 m-70 -92.21 96.95 10.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.941 -0.572 . . . . 6.3899999999999997 110.001 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.588 ' HG2' ' O ' ' A' ' 138' ' ' HIS . 7.1 mm-40 . . . . . 0 C--O 1.254 1.312 0 O-C-N 125.198 1.561 . . . . 6.9100000000000001 108.237 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.648 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 111.957 -0.457 . . . . 42.189999999999998 111.957 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.18 133.11 39.21 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.805 2.336 . . . . 41.840000000000003 112.039 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.79 144.7 47.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.105 -0.498 . . . . 43.409999999999997 110.01 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.97 -8.83 18.71 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.722 -0.751 . . . . 41.270000000000003 111.507 -173.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.2 m -85.84 153.05 22.52 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.266 -0.642 . . . . 40.149999999999999 109.266 173.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -68.36 127.12 31.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.203 0.525 . . . . 38.670000000000002 111.934 -174.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.9 m -80.8 134.06 35.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.346 -0.843 . . . . 37.240000000000002 109.952 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.8 mt -102.46 161.55 13.63 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.066 0.46 . . . . 36.32 111.382 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.6 mtt -105.86 145.12 30.27 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.699 -0.682 . . . . 35.030000000000001 109.994 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.78 -37.53 66.76 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.328 2.019 . . . . 34.310000000000002 112.071 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.6 m -86.13 89.72 7.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.181 -0.463 . . . . 33.799999999999997 109.948 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -95.56 94.45 7.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.201 0.524 . . . . 34.579999999999998 109.589 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.12 129.91 66.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.693 -0.685 . . . . 33.82 111.151 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 p -119.57 124.62 73.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.828 -0.624 . . . . 35.100000000000001 110.366 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -113.25 105.78 13.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.102 -0.499 . . . . 35.140000000000001 110.311 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.63 124.2 17.74 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.991 -0.623 . . . . 36.609999999999999 112.048 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.41 23.03 41.55 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.417 -0.897 . . . . 36.640000000000001 112.371 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.08 133.78 55.75 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.295 -0.261 . . . . 35.420000000000002 110.295 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -80.34 118.67 22.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.278 0.561 . . . . 35.770000000000003 110.472 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -143.37 134.22 25.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.725 -0.67 . . . . 33.670000000000002 110.402 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.53 67.48 0.56 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.702 -0.761 . . . . 33.350000000000001 111.84 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.3 p -106.46 144.97 32.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.79 0.328 . . . . 32.890000000000001 111.199 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.5 ptp -147.52 138.95 23.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.737 -0.468 . . . . 33.5 109.737 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.494 ' C ' ' HD2' ' A' ' 26' ' ' PRO . 87.0 m-20 -101.31 146.88 26.98 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.456 -0.338 . . . . 33.880000000000003 111.139 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.613 ' N ' ' HD2' ' A' ' 26' ' ' PRO . . . 119.84 -33.33 4.64 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 118.497 -1.168 . . . . 33.450000000000003 115.13 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 25' ' ' GLY . 9.5 Cg_endo -55.99 -40.93 81.93 Favored 'Trans proline' 0 C--N 1.361 1.219 0 CA-C-N 121.068 2.434 . . . . 32.82 112.611 175.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -127.52 161.87 27.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.022 -0.535 . . . . 34.289999999999999 110.073 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.11 154.69 45.02 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.993 -0.622 . . . . 31.66 111.85 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -79.76 126.56 31.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.233 0.54 . . . . 31.329999999999998 111.4 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.01 -175.15 25.55 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.83 -0.7 . . . . 28.859999999999999 111.472 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -111.7 168.08 9.84 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.758 0.279 . . . . 27.66 110.446 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.74 95.09 0.69 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.963 -0.637 . . . . 24.739999999999998 111.681 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -130.47 153.99 48.23 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.622 0.248 . . . . 22.32 110.373 -177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.98 98.25 1.7 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.513 -0.851 . . . . 19.489999999999998 111.122 173.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.18 160.96 19.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.98 0.419 . . . . 17.420000000000002 111.254 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.99 100.77 1.19 Allowed Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 111.039 -0.825 . . . . 14.76 111.039 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -76.95 -173.7 2.81 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.33 -0.435 . . . . 13.02 110.805 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.23 73.48 2.17 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 110.752 -0.939 . . . . 10.279999999999999 110.752 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.402 ' H ' HG13 ' A' ' 39' ' ' ILE . 9.1 mt -63.34 156.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.079 -1.061 . . . . 9.1199999999999992 108.759 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.44 69.77 1.2 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.905 0.86 . . . . 6.5199999999999996 109.169 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -142.16 106.45 4.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.35 -1.296 . . . . 6.3099999999999996 108.638 172.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.5 91.62 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.253 0.549 . . . . 3.3300000000000001 110.309 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -119.38 88.71 2.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.661 -0.699 . . . . 3.9399999999999999 109.436 172.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.658 ' NE1' ' HG ' ' A' ' 130' ' ' LEU . 9.6 t90 -96.52 137.82 35.02 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.416 -0.811 . . . . 1.3300000000000001 109.729 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.491 ' H ' ' HD1' ' A' ' 44' ' ' TRP . 4.8 t -71.26 1.08 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 114.502 -1.226 . . . . 1.21 111.266 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.454 ' HB ' ' CD2' ' A' ' 44' ' ' TRP . 2.3 t -88.14 -17.69 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 O-C-N 121.667 -0.646 . . . . 0.66000000000000003 111.194 175.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.78 -16.37 59.09 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.441 -0.885 . . . . 0.71999999999999997 111.906 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -99.82 -28.21 13.24 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.991 0.367 . . . . 2.9700000000000002 111.991 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.4 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 60.2 m-20 -108.01 0.4 21.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.956 0.408 . . . . 1.8300000000000001 111.094 -173.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.544 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 54.2 tttp -51.37 -48.63 85.59 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.048 -0.523 . . . . 1.1299999999999999 112.063 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 26.2 Cg_endo -62.02 -28.99 81.04 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.762 1.641 . . . . 0.56000000000000005 111.902 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.602 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 92.4 m -74.72 -37.69 62.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.719 0.771 . . . . 0.59999999999999998 110.274 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.464 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 24.0 m-85 -74.51 -24.41 58.98 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.829 -0.623 . . . . 0.93999999999999995 110.269 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.59 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 13.1 t70 -81.36 -32.39 32.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.577 -0.738 . . . . 1.1599999999999999 110.887 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 52' ' ' THR . 17.2 pt-20 -70.0 -44.38 69.5 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.926 -0.484 . . . . 1.6299999999999999 110.022 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.52 -30.12 48.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.819 0.818 . . . . 0.60999999999999999 109.066 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.948 ' HE1' HG23 ' A' ' 67' ' ' ILE . 0.7 OUTLIER -64.88 -57.21 9.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.304 -1.316 . . . . 0.88 111.019 176.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.645 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 27.6 m-85 -62.88 -22.82 66.99 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.998 0.427 . . . . 1.03 110.965 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.7 m -69.09 -22.07 64.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.647 -0.706 . . . . 0.44 110.834 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.9 mt -97.47 -7.24 32.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.53 -0.305 . . . . 0.79000000000000004 110.649 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.43 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 10.3 t 70.12 95.11 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.694 0.798 . . . . 0.64000000000000001 111.797 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.645 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 11.0 Cg_endo -62.09 160.87 28.39 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.422 2.748 . . . . 0.46000000000000002 113.855 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.681 HG12 HD22 ' A' ' 64' ' ' ASN . 87.2 t -129.12 102.99 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.315 -0.857 . . . . 1.3300000000000001 110.006 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.681 HD22 HG12 ' A' ' 63' ' ' VAL . 53.7 m-80 66.17 28.19 10.18 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.008 0.523 . . . . 1.6699999999999999 111.859 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.89 21.89 27.09 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.895 -0.669 . . . . 0.5 113.301 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.642 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -169.98 152.0 4.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.147 -1.057 . . . . 1.8200000000000001 108.147 174.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.948 HG23 ' HE1' ' A' ' 57' ' ' PHE . 1.1 pt -90.8 139.28 17.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 119.531 -0.868 . . . . 0.40999999999999998 110.183 174.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.6 p -60.37 139.58 57.59 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.338 -0.986 . . . . 0.69999999999999996 108.338 169.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.561 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -53.5 -35.72 52.03 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 115.098 0.799 . . . . 0.38 115.098 -164.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.01 -22.44 15.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.54 0.67 . . . . 0.44 112.794 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -80.25 -40.68 26.51 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.675 0.75 . . . . 2.1099999999999999 109.689 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.634 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -73.79 -31.25 63.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.436 -0.802 . . . . 0.41999999999999998 109.663 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 13.2 mmmm -64.29 -35.03 79.5 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.643 -0.873 . . . . 1.6899999999999999 108.643 173.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 74' ' ' LYS . 1.1 tppp? -59.16 -44.66 92.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.337 -0.847 . . . . 1.3500000000000001 110.006 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 60.2 mm-40 -60.16 -53.17 60.85 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.275 -0.875 . . . . 1.48 111.823 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.634 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 12.5 ptp -71.13 -18.23 62.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.432 -0.349 . . . . 0.65000000000000002 110.858 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.48 HG23 HD11 ' A' ' 86' ' ' LEU . 2.4 t -74.23 -47.91 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.309 -0.405 . . . . 0.58999999999999997 110.795 171.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 18.1 ptpt -70.39 -13.33 62.1 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.976 0.417 . . . . 1.2 110.354 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.5 t -65.86 -7.34 15.79 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.896 -0.593 . . . . 1.3700000000000001 110.517 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 68.04 67.56 0.34 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.927 0.891 . . . . 2.6499999999999999 110.889 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.023 HD21 ' HE3' ' A' ' 116' ' ' LYS . 22.6 mt -132.65 159.73 71.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.897 -0.592 . . . . 1.1599999999999999 111.029 -175.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.53 ' HG2' HG23 ' A' ' 85' ' ' VAL . 62.9 Cg_endo -76.96 163.62 30.78 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.536 2.157 . . . . 0.94999999999999996 110.922 169.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -61.57 -24.09 66.42 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.248 0.462 . . . . 1.53 112.248 -174.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.8 m -62.78 -48.94 76.97 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 120.998 0.428 . . . . 1.24 110.74 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.53 HG23 ' HG2' ' A' ' 82' ' ' PRO . 21.8 t -67.23 -43.53 88.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.328 -0.619 . . . . 0.71999999999999997 109.328 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 82' ' ' PRO . 3.3 mm? -46.55 -57.49 4.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.531 -0.759 . . . . 1.45 111.009 172.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.4 -40.74 99.07 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.031 -0.986 . . . . 0.39000000000000001 113.702 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.848 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 55.7 pttt -85.28 -25.09 27.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.618 -0.833 . . . . 1.6599999999999999 112.209 -175.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.618 HG12 ' CD1' ' A' ' 122' ' ' LEU . 18.6 mt -65.2 -43.05 95.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.424 -0.954 . . . . 1.1499999999999999 108.424 170.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.417 ' CH2' ' HG ' ' A' ' 101' ' ' LEU . 73.9 t-105 -60.57 -53.29 59.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.943 -1.026 . . . . 0.29999999999999999 111.301 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.848 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -72.82 -12.34 60.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.579 -0.282 . . . . 2.54 111.616 -174.383 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.2 tp -91.25 -25.12 19.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.689 -0.486 . . . . 0.85999999999999999 109.689 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.634 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -93.1 -43.08 9.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.031 0.443 . . . . 0.45000000000000001 112.0 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.504 ' HB2' HD21 ' A' ' 101' ' ' LEU . 46.9 t0 -88.46 94.29 9.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.193 0.52 . . . . 0.62 110.171 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.602 HG21 ' HG3' ' A' ' 135' ' ' LYS . 56.5 t -64.35 -23.27 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.289 -0.869 . . . . 1.76 111.18 -176.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.0 -26.77 15.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.57 -0.741 . . . . 1.7 110.726 -174.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt 60.23 58.71 2.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.348 1.071 . . . . 1.74 109.096 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -106.11 -18.81 13.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.454 -1.703 . . . . 1.51 111.278 -170.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.64 13.89 49.08 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.479 -0.867 . . . . 0.28999999999999998 112.553 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.6 pp -148.05 179.0 8.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.767 -0.457 . . . . 0.54000000000000004 109.767 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.609 HD12 ' CB ' ' A' ' 72' ' ' ALA . 25.2 mt -151.27 114.64 4.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.83 -1.174 . . . . 0.68000000000000005 107.83 -175.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.585 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 1.5 p30 -78.98 -174.36 4.0 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.49 -0.484 . . . . 1.5 109.996 178.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.625 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 3.9 p30 -57.84 -33.73 68.96 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.16 0.429 . . . . 1.73 112.16 -174.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.942 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 16.5 tt0 -85.74 -27.0 25.53 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.53 0.681 . . . . 2.1400000000000001 110.391 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.562 ' HB3' HD22 ' A' ' 101' ' ' LEU . 3.0 mt-10 -75.25 -33.69 61.33 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.603 -0.726 . . . . 1.1100000000000001 110.499 176.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.551 ' CE2' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -66.89 -40.87 87.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.753 -1.203 . . . . 1.0700000000000001 107.753 172.098 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.464 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -52.61 -48.94 65.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.289 -0.868 . . . . 0.19 110.799 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.634 HD13 ' HA ' ' A' ' 93' ' ' ALA . 1.3 tt -65.55 -53.27 44.45 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.352 -0.385 . . . . 1.23 110.121 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.6 -53.36 24.41 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.619 0.6 . . . . 0.22 112.619 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 10.2 t-20 -70.57 -32.1 69.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.169 0.509 . . . . 1.1799999999999999 110.167 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.541 ' O ' HG23 ' A' ' 115' ' ' VAL . 78.0 t60 -66.4 -35.26 79.86 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.975 -0.557 . . . . 0.48999999999999999 109.706 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 112' ' ' LEU . 25.2 mt -69.12 -36.6 77.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.843 -0.617 . . . . 0.55000000000000004 110.463 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.602 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 47.5 mm -59.49 -41.66 85.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.884 0.373 . . . . 0.81000000000000005 110.195 172.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.687 ' HE2' ' O ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -57.11 -49.39 76.06 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.72 -0.673 . . . . 2.2200000000000002 109.624 173.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 111' ' ' HIS . 78.6 t -60.32 -42.07 89.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.766 -0.652 . . . . 0.48999999999999999 111.577 -176.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 1.023 ' HE3' HD21 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -75.27 -21.56 58.43 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.863 -0.335 . . . . 1.9099999999999999 111.278 178.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.1 tp -79.75 -19.4 48.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.746 0.307 . . . . 1.28 110.535 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.606 ' HG2' ' NZ ' ' A' ' 114' ' ' LYS . 37.2 mt-10 -62.92 -16.73 60.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.148 0.499 . . . . 1.99 110.427 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 112.07 4.91 25.57 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.667 -0.777 . . . . 1.01 111.627 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.495 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 2.7 p80 -126.85 140.41 52.37 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.305 0.574 . . . . 0.87 110.36 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -71.77 152.16 42.94 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.123 -0.944 . . . . 2.75 111.363 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.618 ' CD1' HG12 ' A' ' 89' ' ' ILE . 39.9 mt -67.12 141.15 96.17 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 115.839 -0.619 . . . . 2.7000000000000002 110.398 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -87.64 4.04 6.08 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.055 2.503 . . . . 1.1000000000000001 113.515 -173.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 58.81 19.95 7.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.37 0.605 . . . . 1.3400000000000001 111.1 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -112.91 136.2 52.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.741 -0.837 . . . . 2.3599999999999999 108.741 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.554 HD22 HG23 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -116.16 102.62 53.69 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 109.303 -0.629 . . . . 1.8300000000000001 109.303 -177.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 2.0 Cg_endo -79.96 157.27 23.83 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.061 2.507 . . . . 1.0 112.155 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -55.0 -40.33 86.47 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.397 2.065 . . . . 1.3400000000000001 111.843 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.662 ' O ' HD12 ' A' ' 130' ' ' LEU . 50.1 p-80 -81.89 30.88 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.658 -0.701 . . . . 1.48 111.709 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.662 HD12 ' O ' ' A' ' 129' ' ' HIS . 0.7 OUTLIER -146.86 9.89 1.02 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.063 0.394 . . . . 1.29 112.063 171.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.554 HG23 HD22 ' A' ' 126' ' ' LEU . 7.3 t -97.33 115.16 65.68 Favored Pre-proline 0 C--N 1.322 -0.598 0 C-N-CA 120.177 -0.609 . . . . 1.72 110.806 176.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.942 ' HB3' ' HG2' ' A' ' 104' ' ' GLU . 84.0 Cg_exo -49.4 128.45 20.45 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.751 2.967 . . . . 1.04 111.49 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.496 ' HA ' ' NH1' ' A' ' 136' ' ' ARG . 99.0 Cg_exo -45.48 -31.99 7.53 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.035 2.49 . . . . 1.4399999999999999 113.211 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.5 p -67.24 -19.16 65.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.173 0.805 . . . . 2.2999999999999998 113.173 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.602 ' HG3' HG21 ' A' ' 95' ' ' VAL . 13.9 mmmt -82.68 -2.76 55.0 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 120.222 -0.591 . . . . 3.4199999999999999 111.758 -171.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.496 ' NH1' ' HA ' ' A' ' 133' ' ' PRO . 3.6 ptp85 -110.48 68.62 0.67 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.24 -0.652 . . . . 4.7199999999999998 109.24 173.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.3 mtp85 -155.1 120.26 4.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.902 -0.59 . . . . 5.0099999999999998 111.411 -175.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -130.6 106.85 8.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.713 -0.676 . . . . 6.3899999999999997 109.872 172.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 C--O 1.252 1.217 0 CA-C-O 118.475 -0.774 . . . . 6.9100000000000001 110.068 178.065 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 5' ' ' SER . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 111.47 -0.652 . . . . 42.189999999999998 111.47 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.82 -28.29 51.18 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.588 2.192 . . . . 41.840000000000003 112.029 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -114.86 126.93 55.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.128 -0.693 . . . . 43.409999999999997 109.128 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.58 -32.37 7.29 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.851 -0.69 . . . . 41.270000000000003 112.129 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 2.8 m -105.44 104.44 14.16 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.982 -0.747 . . . . 40.149999999999999 108.982 175.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.491 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -84.75 145.65 27.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.171 0.51 . . . . 38.670000000000002 111.665 -173.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.2 t -103.37 123.6 47.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.805 -0.634 . . . . 37.240000000000002 109.369 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 8' ' ' LEU . 3.6 mm? -87.7 92.09 8.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.186 0.517 . . . . 36.32 110.991 -177.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 89.9 mmm -111.03 113.14 55.0 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.682 -0.69 . . . . 35.030000000000001 110.276 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.45 -11.27 31.55 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.889 2.393 . . . . 34.310000000000002 111.95 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 t -94.44 92.96 7.39 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.827 -0.624 . . . . 33.799999999999997 109.668 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -127.25 105.64 8.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.774 -0.648 . . . . 34.579999999999998 109.893 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.87 130.24 43.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.182 -0.463 . . . . 33.82 110.369 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.68 135.8 32.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.998 0.428 . . . . 35.100000000000001 110.006 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -122.08 132.99 54.77 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.138 -0.483 . . . . 35.140000000000001 110.341 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.54 129.45 28.0 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.396 -0.907 . . . . 36.609999999999999 111.28 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.67 -11.78 68.02 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.86 -0.686 . . . . 36.640000000000001 111.998 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.17 88.12 3.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.412 -0.588 . . . . 35.420000000000002 109.412 176.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -104.57 100.96 10.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.871 -0.604 . . . . 35.770000000000003 111.247 -174.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -116.72 144.94 43.84 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.799 -0.637 . . . . 33.670000000000002 109.727 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.77 121.85 6.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.824 -0.703 . . . . 33.350000000000001 112.585 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.9 p -92.07 156.04 17.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.674 0.273 . . . . 32.890000000000001 110.784 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 72.1 mtm -87.04 102.98 14.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.911 0.386 . . . . 33.5 110.33 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -107.31 137.01 46.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.95 -0.568 . . . . 33.880000000000003 110.899 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.5 -32.86 4.88 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.686 -1.063 . . . . 33.450000000000003 114.73 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -67.76 -53.02 0.47 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 CA-C-N 120.931 2.366 . . . . 32.82 111.851 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -86.77 104.29 16.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.196 -0.457 . . . . 34.289999999999999 109.939 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.54 120.78 18.35 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.957 -0.639 . . . . 31.66 112.428 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -139.8 128.49 23.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.804 0.335 . . . . 31.329999999999998 110.442 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.33 125.46 7.68 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.494 -0.86 . . . . 28.859999999999999 112.494 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -123.9 108.87 12.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.521 0.201 . . . . 27.66 110.646 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.45 116.66 5.87 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.758 -0.734 . . . . 24.739999999999998 111.652 174.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -93.36 119.2 32.21 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.033 0.444 . . . . 22.32 110.783 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.38 140.1 18.73 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.042 -0.599 . . . . 19.489999999999998 112.05 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.34 121.89 15.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.093 0.473 . . . . 17.420000000000002 111.073 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.55 114.15 3.77 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 111.266 -0.734 . . . . 14.76 111.266 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.84 153.84 34.43 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.371 -0.415 . . . . 13.02 110.777 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.88 72.24 2.47 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.61 -0.805 . . . . 10.279999999999999 111.549 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.22 154.73 3.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.391 -0.404 . . . . 9.1199999999999992 109.971 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -75.8 70.07 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.225 -0.59 . . . . 6.5199999999999996 110.622 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -147.82 82.18 1.51 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.133 -0.94 . . . . 6.3099999999999996 108.816 173.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.12 92.58 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.808 0.813 . . . . 3.3300000000000001 110.883 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -94.42 89.63 5.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.305 -0.861 . . . . 3.9399999999999999 109.155 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.806 ' CH2' ' HG ' ' A' ' 108' ' ' LEU . 12.5 t90 -98.5 137.0 37.82 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.989 0.9 . . . . 1.3300000000000001 109.554 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.489 ' H ' ' HD1' ' A' ' 44' ' ' TRP . 8.0 t -67.74 4.97 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 113.831 -1.531 . . . . 1.21 111.823 -176.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.66 ' HB ' ' CE2' ' A' ' 44' ' ' TRP . 1.2 t -94.76 -21.99 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 121.46 -0.775 . . . . 0.66000000000000003 111.672 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.78 -14.25 57.91 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.074 -1.06 . . . . 0.71999999999999997 111.842 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -104.53 -28.35 11.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 111.923 0.342 . . . . 2.9700000000000002 111.923 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -107.36 1.94 24.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.515 0.674 . . . . 1.8300000000000001 110.154 -171.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 55.7 tttm -55.69 -46.99 99.65 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.05 -0.977 . . . . 1.1299999999999999 112.086 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 11.1 Cg_endo -55.84 -26.87 59.68 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.23 1.953 . . . . 0.56000000000000005 112.636 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.555 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . 9.5 m -70.35 -45.16 66.68 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.852 0.834 . . . . 0.59999999999999998 108.99 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.569 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 16.7 m-85 -75.74 -24.21 56.1 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.116 -0.947 . . . . 0.93999999999999995 109.581 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.602 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 15.1 t70 -78.09 -37.98 45.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.534 -0.757 . . . . 1.1599999999999999 111.145 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.555 ' OE2' ' HA ' ' A' ' 52' ' ' THR . 15.5 pt-20 -68.06 -37.1 80.92 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.515 -0.474 . . . . 1.6299999999999999 110.559 176.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.7 mt -70.14 -28.24 35.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.251 0.548 . . . . 0.60999999999999999 109.612 173.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.602 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 66.4 t80 -61.51 -54.17 46.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.347 -0.842 . . . . 0.88 111.194 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.593 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 42.0 m-85 -68.75 -22.5 64.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.132 0.492 . . . . 1.03 110.786 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.9 m -72.77 -25.69 61.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.696 -0.683 . . . . 0.44 110.863 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.422 HD11 ' HG2' ' A' ' 75' ' ' GLU . 25.9 mt -87.6 -0.01 56.26 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.638 -0.256 . . . . 0.79000000000000004 111.439 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 t 67.55 87.51 0.12 Allowed Pre-proline 0 N--CA 1.467 0.377 0 CA-C-O 121.297 0.57 . . . . 0.64000000000000001 110.916 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.593 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 71.6 Cg_endo -81.03 159.28 20.75 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.634 2.222 . . . . 0.46000000000000002 112.65 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 97.4 t -128.92 121.21 53.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.081 -0.509 . . . . 1.3300000000000001 109.794 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 66.38 23.04 10.69 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.117 -0.492 . . . . 1.6699999999999999 112.168 174.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.21 23.02 23.4 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.871 -0.68 . . . . 0.5 112.114 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.897 ' HG3' HD13 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -167.48 159.77 12.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.588 -0.523 . . . . 1.8200000000000001 109.588 175.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.438 ' H ' HG12 ' A' ' 67' ' ' ILE . 1.5 pt -89.76 132.43 34.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 120.129 -0.628 . . . . 0.40999999999999998 110.345 173.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -59.2 130.55 47.5 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.693 -1.225 . . . . 0.69999999999999996 107.693 170.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.586 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -53.71 -26.26 31.75 Favored Glycine 0 C--O 1.219 -0.819 0 N-CA-C 114.69 0.636 . . . . 0.38 114.69 -166.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.15 -39.53 43.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 117.475 0.637 . . . . 0.44 111.437 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.44 -31.83 48.27 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.16 -0.473 . . . . 2.1099999999999999 110.087 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.685 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -74.05 -36.19 64.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.678 -0.692 . . . . 0.41999999999999998 109.718 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 14.7 mmmm -66.28 -37.97 86.7 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.707 -0.849 . . . . 1.6899999999999999 108.707 173.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -56.59 -44.89 81.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.526 -0.761 . . . . 1.3500000000000001 110.255 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.8 tp10 -61.81 -53.07 60.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.544 -1.207 . . . . 1.48 111.162 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.685 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 12.5 ptp -73.05 -16.69 61.48 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 122.068 -0.395 . . . . 0.65000000000000002 111.353 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.478 HG23 HD11 ' A' ' 86' ' ' LEU . 2.3 t -74.17 -49.64 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.577 0.227 . . . . 0.58999999999999997 110.832 173.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 14.6 ptpt -68.28 -12.18 60.62 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.085 0.469 . . . . 1.2 109.851 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 76' ' ' MET . 62.4 m -67.69 3.93 1.26 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.29 -0.868 . . . . 1.3700000000000001 111.835 170.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 74.36 37.95 0.55 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.26 0.624 . . . . 2.6499999999999999 111.686 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.585 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . 22.8 mt -113.49 157.47 41.26 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 120.809 -0.357 . . . . 1.1599999999999999 111.539 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.447 ' O ' HD23 ' A' ' 86' ' ' LEU . 84.3 Cg_endo -83.91 164.26 13.69 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.898 2.399 . . . . 0.94999999999999996 111.307 169.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.549 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 8.5 m120 -54.75 -29.34 53.62 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.282 0.475 . . . . 1.53 112.282 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -59.94 -54.02 50.96 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.302 0.572 . . . . 1.24 110.776 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 24.0 t -66.31 -41.68 89.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.641 -0.708 . . . . 0.71999999999999997 109.927 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.585 ' CD2' ' HB2' ' A' ' 81' ' ' LEU . 3.9 mm? -49.52 -55.13 14.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.9 -0.591 . . . . 1.45 110.856 173.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.91 -44.5 97.33 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.392 -0.822 . . . . 0.39000000000000001 113.324 -175.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.618 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 55.5 pttt -80.19 -27.45 38.87 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.654 -0.818 . . . . 1.6599999999999999 111.676 -174.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.404 HD13 HD13 ' A' ' 113' ' ' ILE . 17.4 mt -69.63 -41.55 80.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 120.536 -0.465 . . . . 1.1499999999999999 109.841 173.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.433 ' CH2' ' HG ' ' A' ' 101' ' ' LEU . 75.9 t-105 -55.87 -58.85 6.13 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.754 -0.657 . . . . 0.29999999999999999 110.346 175.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.618 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -69.44 -17.26 63.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.812 -0.631 . . . . 2.54 111.765 -172.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 14.3 tp -82.35 -37.4 25.74 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.129 -0.323 . . . . 0.85999999999999999 110.129 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.755 ' HA ' HD13 ' A' ' 108' ' ' LEU . . . -91.08 -33.75 15.36 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 120.556 -0.458 . . . . 0.45000000000000001 111.528 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.628 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 27.6 t0 -83.84 80.97 8.97 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.615 0.721 . . . . 0.62 109.922 177.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.448 HG22 HD11 ' A' ' 126' ' ' LEU . 16.0 t -67.34 -25.44 33.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 114.917 -1.038 . . . . 1.76 110.817 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.626 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.0 OUTLIER -90.43 -23.84 20.91 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.619 -0.718 . . . . 1.7 112.234 -178.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.549 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 21.8 mtpt 67.02 45.22 1.8 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.769 0.795 . . . . 1.74 110.364 167.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 p30 -105.31 -1.06 25.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.759 -1.11 . . . . 1.51 112.371 -171.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.87 19.38 77.71 Favored Glycine 0 C--N 1.322 -0.224 0 C-N-CA 119.506 -1.33 . . . . 0.28999999999999998 112.326 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.897 HD13 ' HG3' ' A' ' 66' ' ' LYS . 4.4 pp -151.33 171.41 17.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.796 -0.816 . . . . 0.54000000000000004 108.796 174.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.581 HD12 ' HB1' ' A' ' 72' ' ' ALA . 44.2 mt -148.59 116.17 6.26 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.82 -1.178 . . . . 0.68000000000000005 107.82 -172.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -77.13 -175.94 3.83 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.086 -0.646 . . . . 1.5 109.366 178.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -60.26 -31.18 69.97 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.358 0.526 . . . . 1.73 111.164 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.644 ' HG2' ' HB3' ' A' ' 132' ' ' PRO . 34.0 tt0 -73.91 -39.94 63.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.426 0.631 . . . . 2.1400000000000001 110.107 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.665 ' OE2' 'CA ' ' A' ' 141' ' ' ' CA' . 3.8 mt-10 -66.99 -39.16 87.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.672 -0.695 . . . . 1.1100000000000001 111.919 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.626 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -64.63 -39.2 93.28 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.158 -1.052 . . . . 1.0700000000000001 108.158 175.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.569 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -50.95 -49.14 60.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.19 110.581 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.806 ' HG ' ' CH2' ' A' ' 44' ' ' TRP . 1.1 tt -70.56 -50.42 37.65 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.443 -0.503 . . . . 1.23 110.509 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.47 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -45.73 -55.63 6.25 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.33 0.492 . . . . 0.22 112.33 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.553 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 2.6 t-20 -72.84 -23.31 60.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.677 -0.49 . . . . 1.1799999999999999 109.677 -177.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.496 ' CD2' HD11 ' A' ' 130' ' ' LEU . 70.8 t60 -68.01 -43.93 77.71 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.236 -0.653 . . . . 0.48999999999999999 109.236 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.639 HD22 ' CD1' ' A' ' 122' ' ' LEU . 46.7 mt -64.64 -32.81 74.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.107 -0.497 . . . . 0.55000000000000004 110.191 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 109' ' ' ALA . 41.4 mm -61.11 -50.92 78.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.886 -0.597 . . . . 0.81000000000000005 111.001 176.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.485 ' HD3' ' OH ' ' A' ' 53' ' ' TYR . 18.7 ptmt -72.33 -24.47 61.31 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.086 -0.646 . . . . 2.2200000000000002 110.823 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 111' ' ' HIS . 11.5 t -60.46 -47.22 93.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.318 -0.401 . . . . 0.48999999999999999 110.39 172.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 0.9 OUTLIER -85.38 0.5 51.97 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 120.36 -0.536 . . . . 1.9099999999999999 110.635 178.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 43.1 tp -81.83 -26.6 34.15 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.604 -0.517 . . . . 1.28 109.604 171.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.33 -22.17 65.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.801 -0.636 . . . . 1.99 111.169 177.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.09 10.79 13.24 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.351 -0.928 . . . . 1.01 112.698 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.61 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -127.21 133.49 50.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.553 -0.536 . . . . 0.87 109.553 174.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -78.34 163.36 25.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.783 0.325 . . . . 2.75 110.935 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.639 ' CD1' HD22 ' A' ' 112' ' ' LEU . 3.5 mm? -70.44 144.86 92.27 Favored Pre-proline 0 CA--C 1.513 -0.474 0 CA-C-N 116.077 -0.51 . . . . 2.7000000000000002 111.818 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.616 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 68.9 Cg_endo -77.62 -6.37 16.12 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 124.453 3.435 . . . . 1.1000000000000001 113.404 -173.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.22 19.53 11.72 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.632 0.73 . . . . 1.3400000000000001 109.655 -170.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.616 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 38.8 t70 -120.45 145.82 46.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.943 -1.026 . . . . 2.3599999999999999 108.985 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.448 HD11 HG22 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -115.15 104.41 53.79 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 116.353 -0.385 . . . . 1.8300000000000001 110.018 -176.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 5.7 Cg_endo -87.9 147.01 6.85 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.334 2.689 . . . . 1.0 111.982 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -55.08 -30.35 69.95 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.762 2.308 . . . . 1.3400000000000001 113.321 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -80.94 22.72 0.6 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.995 -0.282 . . . . 1.48 111.109 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.531 ' HA ' ' CD2' ' A' ' 44' ' ' TRP . 0.6 OUTLIER -150.29 8.52 0.62 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.619 -0.433 . . . . 1.29 111.477 177.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.1 132.09 31.57 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.942 -0.762 . . . . 1.72 108.942 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.862 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 37.4 Cg_exo -57.23 142.92 94.68 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.29 1.994 . . . . 1.04 112.539 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.484 ' HA ' ' HG2' ' A' ' 136' ' ' ARG . 89.7 Cg_exo -46.06 -23.77 1.99 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.581 3.521 . . . . 1.4399999999999999 115.914 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.6 p -82.33 -24.05 34.79 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.837 -0.539 . . . . 2.2999999999999998 112.32 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.862 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -119.15 17.9 13.13 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.553 0.575 . . . . 3.4199999999999999 112.553 -174.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.484 ' HG2' ' HA ' ' A' ' 133' ' ' PRO . 0.3 OUTLIER -73.76 71.3 1.45 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.19 0.519 . . . . 4.7199999999999998 110.016 172.253 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -157.83 113.85 2.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.922 -0.581 . . . . 5.0099999999999998 110.754 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -93.09 111.02 22.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.031 -0.532 . . . . 6.3899999999999997 109.569 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.319 -0.848 . . . . 6.9100000000000001 110.047 -176.342 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.665 'CA ' ' OE2' ' A' ' 105' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.4 ' HA3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 112.509 -0.237 . . . . 42.189999999999998 112.509 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.4 ' HD3' ' HA3' ' A' ' 1' ' ' GLY . 27.0 Cg_exo -63.16 -58.21 0.32 Allowed 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.067 2.512 . . . . 41.840000000000003 113.127 -177.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.773 HD23 ' H ' ' A' ' 3' ' ' LEU . 2.5 pt? -87.52 145.51 26.2 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.516 -0.311 . . . . 43.409999999999997 110.672 -176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 112.83 -15.18 23.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.974 -0.631 . . . . 41.270000000000003 112.438 177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.5 m -83.53 102.62 12.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.873 0.368 . . . . 40.149999999999999 110.663 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -64.84 135.75 56.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.915 -0.584 . . . . 38.670000000000002 110.022 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.4 t -89.92 114.22 25.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.094 0.473 . . . . 37.240000000000002 110.993 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -129.04 140.2 51.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.842 -0.617 . . . . 36.32 109.856 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.462 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 65.0 mtt -84.3 132.04 48.74 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 110.32 -0.252 . . . . 35.030000000000001 110.32 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 54.4 Cg_exo -52.01 -72.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.262 2.641 . . . . 34.310000000000002 113.548 -172.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.7 p -93.73 89.54 6.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.246 0.546 . . . . 33.799999999999997 110.459 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -104.32 93.99 5.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.537 -0.756 . . . . 34.579999999999998 109.834 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.29 136.49 57.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.819 -0.628 . . . . 33.82 109.609 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 p -119.16 112.46 37.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.395 0.617 . . . . 35.100000000000001 111.559 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -101.07 75.71 1.68 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.587 -0.733 . . . . 35.140000000000001 109.199 175.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.43 105.42 1.84 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.713 -0.756 . . . . 36.609999999999999 112.904 -173.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.95 26.66 70.36 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 121.545 -0.36 . . . . 36.640000000000001 112.822 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.27 123.89 39.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.645 0.26 . . . . 35.420000000000002 110.447 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -83.55 106.31 15.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.088 -0.505 . . . . 35.770000000000003 110.432 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -90.81 93.3 9.17 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.915 -0.772 . . . . 33.670000000000002 108.915 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.6 128.26 9.11 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.587 -0.816 . . . . 33.350000000000001 112.479 -174.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.0 m -147.86 104.79 3.61 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.947 0.403 . . . . 32.890000000000001 110.435 176.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 21.7 ptm -154.99 118.75 4.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.327 0.584 . . . . 33.5 110.461 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -110.21 132.46 54.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.809 -0.632 . . . . 33.880000000000003 110.066 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.706 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . 112.62 12.74 12.46 Favored Glycine 0 CA--C 1.543 1.783 0 CA-C-O 118.226 -1.319 . . . . 33.450000000000003 115.801 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.706 ' HD3' ' N ' ' A' ' 25' ' ' GLY . 7.8 Cg_exo -72.72 -57.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.366 1.464 0 CA-C-N 122.059 2.93 . . . . 32.82 111.504 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -127.39 141.74 51.61 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.537 -0.542 . . . . 34.289999999999999 109.537 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.19 169.05 14.05 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.872 -0.68 . . . . 31.66 111.447 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -80.99 163.88 22.95 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.643 -0.503 . . . . 31.329999999999998 109.643 177.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.79 97.71 0.09 OUTLIER Glycine 0 C--N 1.33 0.241 0 O-C-N 123.393 0.433 . . . . 28.859999999999999 113.66 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -102.77 170.87 7.74 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.041 -0.355 . . . . 27.66 110.041 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.14 136.91 49.5 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.116 -0.564 . . . . 24.739999999999998 112.95 -175.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -61.18 131.39 50.32 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.717 0.294 . . . . 22.32 110.766 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.99 135.7 12.81 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.682 -0.771 . . . . 19.489999999999998 113.307 -173.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.42 161.68 14.13 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.096 -0.335 . . . . 17.420000000000002 110.096 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.78 104.08 1.65 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.068 -0.587 . . . . 14.76 112.738 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER -94.07 -178.05 4.51 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.105 -0.702 . . . . 13.02 109.105 177.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.435 ' H ' ' CD ' ' A' ' 37' ' ' GLU . . . -77.93 71.16 2.43 Favored Glycine 0 CA--C 1.503 -0.711 0 C-N-CA 120.306 -0.949 . . . . 10.279999999999999 111.99 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.401 ' H ' HG12 ' A' ' 39' ' ' ILE . 5.9 pt -63.89 157.22 4.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.588 -0.806 . . . . 9.1199999999999992 109.013 171.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.17 80.72 1.29 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.983 0.897 . . . . 6.5199999999999996 109.824 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.62 104.28 0.26 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.293 -1.321 . . . . 6.3099999999999996 110.117 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 p -114.63 103.65 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.66 0.743 . . . . 3.3300000000000001 110.828 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -93.65 93.14 7.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.725 -0.67 . . . . 3.9399999999999999 109.761 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.728 ' CH2' ' HG ' ' A' ' 108' ' ' LEU . 10.5 t90 -125.05 140.11 53.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.63 -0.713 . . . . 1.3300000000000001 110.202 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.513 ' H ' ' HD1' ' A' ' 44' ' ' TRP . 14.1 t -61.14 -12.23 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 114.928 -1.033 . . . . 1.21 112.153 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 2.2 t -80.54 -17.74 12.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 120.951 -1.093 . . . . 0.66000000000000003 111.321 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.71 -17.15 62.27 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 119.694 -1.241 . . . . 0.71999999999999997 111.741 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 17.8 ptmt -106.97 -29.4 9.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.002 0.371 . . . . 2.9700000000000002 112.002 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 84.5 m-20 -89.33 -11.55 43.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 1.8300000000000001 110.676 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 49.9 tttm -49.87 -51.48 60.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.209 -0.905 . . . . 1.1299999999999999 112.409 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 8.0 Cg_endo -50.6 -35.64 47.39 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 122.726 2.284 . . . . 0.56000000000000005 113.837 -178.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.672 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 87.5 m -72.5 -40.64 66.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.999 0.904 . . . . 0.59999999999999998 110.328 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.65 ' CB ' ' HA ' ' A' ' 107' ' ' ALA . 10.3 m-85 -76.86 -23.85 52.63 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.766 0.793 . . . . 0.93999999999999995 109.279 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 7.2 t70 -80.66 -33.32 35.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.635 -1.166 . . . . 1.1599999999999999 110.776 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.672 ' HG2' ' O ' ' A' ' 52' ' ' THR . 14.0 pt-20 -69.47 -35.9 76.04 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.606 -0.516 . . . . 1.6299999999999999 109.606 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 52' ' ' THR . 46.5 mt -71.84 -29.8 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.224 -0.658 . . . . 0.60999999999999999 109.224 174.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 72.7 t80 -61.81 -57.42 11.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.146 -0.933 . . . . 0.88 111.534 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 42.8 m-85 -64.1 -22.32 66.89 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.037 0.446 . . . . 1.03 110.908 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.5 m -73.07 -32.05 64.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.923 -0.58 . . . . 0.44 111.516 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.1 mt -84.89 1.3 47.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.624 0.25 . . . . 0.79000000000000004 111.261 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t 70.9 85.76 0.12 Allowed Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.604 -0.726 . . . . 0.64000000000000001 111.125 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 74.3 Cg_endo -81.63 123.86 4.42 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.702 2.268 . . . . 0.46000000000000002 112.647 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.5 t -87.33 109.72 19.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.245 -0.434 . . . . 1.3300000000000001 110.027 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.06 23.75 11.05 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.322 0.389 . . . . 1.6699999999999999 111.378 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.67 27.79 12.29 Favored Glycine 0 C--O 1.228 -0.254 0 C-N-CA 121.054 -0.593 . . . . 0.5 113.565 170.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -164.39 147.39 9.09 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.306 -0.627 . . . . 1.8200000000000001 109.306 172.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.939 ' HB ' HD21 ' A' ' 71' ' ' ASN . 3.0 pt -86.89 137.11 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 120.695 -0.402 . . . . 0.40999999999999998 110.437 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.5 p -60.32 124.3 19.89 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.755 -1.202 . . . . 0.69999999999999996 107.755 170.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.586 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -46.94 -31.76 5.77 Favored Glycine 0 C--O 1.222 -0.608 0 C-N-CA 121.302 -0.475 . . . . 0.38 114.26 -168.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -43.73 -52.0 6.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.31 0.485 . . . . 0.44 112.31 173.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.939 HD21 ' HB ' ' A' ' 67' ' ' ILE . 11.7 p30 -71.03 -30.85 67.17 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.056 0.389 . . . . 2.1099999999999999 110.586 -173.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.582 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -72.12 -31.76 66.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.585 0.707 . . . . 0.41999999999999998 109.612 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 31.6 mmmt -68.32 -35.85 78.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.072 -0.967 . . . . 1.6899999999999999 109.474 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.805 ' HG2' ' HA ' ' A' ' 71' ' ' ASN . 9.0 mmmm -59.45 -48.58 81.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 1.3500000000000001 109.503 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 23.6 mm-40 -54.73 -52.49 62.33 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.793 -1.094 . . . . 1.48 112.182 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.582 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 14.7 ptp -69.54 -29.38 66.95 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.126 -0.63 . . . . 0.65000000000000002 110.916 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.42 -45.83 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.489 0.185 . . . . 0.58999999999999997 110.854 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 17.4 ptpt -72.78 -14.32 61.5 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.038 0.446 . . . . 1.2 110.458 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 81' ' ' LEU . 50.1 m -66.15 -13.03 59.51 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.454 -0.794 . . . . 1.3700000000000001 110.186 168.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 97.3 mttt 71.91 39.63 0.81 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.599 0.76 . . . . 2.6499999999999999 112.014 165.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.87 HD11 ' HE2' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -102.18 159.45 29.34 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.841 -0.618 . . . . 1.1599999999999999 110.115 -179.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.537 ' HG2' HG23 ' A' ' 85' ' ' VAL . 31.6 Cg_endo -66.88 153.3 78.39 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.893 1.729 . . . . 0.94999999999999996 110.742 172.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.782 ' HA ' HD12 ' A' ' 86' ' ' LEU . 0.9 OUTLIER -49.86 -31.74 12.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.005 -0.543 . . . . 1.53 112.042 -179.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.5 m -60.33 -55.59 31.84 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.209 0.528 . . . . 1.24 110.628 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.588 ' O ' HG13 ' A' ' 89' ' ' ILE . 91.1 t -60.63 -44.46 96.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 CA-C-N 115.745 -0.661 . . . . 0.71999999999999997 110.071 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.782 HD12 ' HA ' ' A' ' 83' ' ' ASN . 24.9 mt -60.08 -49.96 75.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.383 -0.372 . . . . 1.45 111.984 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -55.77 -42.41 85.43 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.146 -0.782 . . . . 0.39000000000000001 111.146 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 61.6 pttt -86.51 -13.49 45.83 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.491 -0.883 . . . . 1.6599999999999999 111.778 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 85' ' ' VAL . 23.0 mt -71.59 -43.51 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 N-CA-C 108.511 -0.922 . . . . 1.1499999999999999 108.511 170.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.451 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 71.4 t-105 -60.36 -56.77 17.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.82 -0.627 . . . . 0.29999999999999999 111.021 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 62.7 mttm -72.22 -21.45 61.4 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.65 -0.705 . . . . 2.54 111.965 -169.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 5.5 tp -86.32 -19.65 29.51 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.801 -0.444 . . . . 0.85999999999999999 109.801 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.892 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -93.05 -44.29 8.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.126 0.488 . . . . 0.45000000000000001 110.921 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 46.9 t0 -87.99 74.46 8.93 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.031 -1.1 . . . . 0.62 108.031 173.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.442 HG12 ' NZ ' ' A' ' 135' ' ' LYS . 17.1 t -69.87 -6.96 7.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.19 -0.914 . . . . 1.76 109.81 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -94.18 -26.33 16.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.967 -1.015 . . . . 1.7 109.725 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 59.66 73.34 0.49 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.329 -0.85 . . . . 1.74 111.833 169.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.68 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 1.4 p30 -128.28 -23.47 3.25 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.913 -1.039 . . . . 1.51 112.078 -171.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.78 7.47 38.88 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.165 -1.016 . . . . 0.28999999999999998 112.529 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.504 ' HG ' ' OD1' ' A' ' 98' ' ' ASP . 3.6 pp -142.21 -175.21 4.35 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.805 -0.813 . . . . 0.54000000000000004 108.805 174.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.642 ' O ' HG12 ' A' ' 67' ' ' ILE . 50.8 mt -151.45 112.6 4.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.367 -1.345 . . . . 0.68000000000000005 107.367 -177.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 2.7 p30 -76.73 -175.75 3.55 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.674 -0.81 . . . . 1.5 109.809 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -57.08 -32.96 66.8 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.105 0.478 . . . . 1.73 111.879 -173.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 35.5 tt0 -85.81 -29.01 24.12 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.314 0.578 . . . . 2.1400000000000001 110.246 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.49 ' HB3' HD22 ' A' ' 101' ' ' LEU . 4.0 mt-10 -75.15 -33.39 61.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.764 -0.653 . . . . 1.1100000000000001 110.977 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.672 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.6 OUTLIER -66.99 -40.23 87.32 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.638 -1.245 . . . . 1.0700000000000001 107.638 171.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.65 ' HA ' ' CB ' ' A' ' 53' ' ' TYR . . . -51.15 -46.19 61.94 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.078 -0.51 . . . . 0.19 110.607 175.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.892 HD22 ' HA ' ' A' ' 93' ' ' ALA . 1.4 tt -67.6 -48.89 65.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.309 -0.405 . . . . 1.23 110.353 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.403 ' HB2' HD13 ' A' ' 101' ' ' LEU . . . -49.88 -57.29 7.75 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.921 -0.582 . . . . 0.22 112.296 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.451 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 11.4 t-20 -70.61 -28.64 65.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.02 0.438 . . . . 1.1799999999999999 110.066 -174.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.553 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 66.7 t60 -69.88 -36.37 75.4 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.289 -0.414 . . . . 0.48999999999999999 110.032 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.536 HD22 HD22 ' A' ' 122' ' ' LEU . 41.8 mt -69.2 -35.97 76.8 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.949 -0.389 . . . . 0.55000000000000004 109.949 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.687 ' O ' ' HG3' ' A' ' 116' ' ' LYS . 76.3 mt -58.37 -45.21 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.414 -0.357 . . . . 0.81000000000000005 111.379 172.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 111' ' ' HIS . 5.5 ptmm? -67.7 -33.05 74.13 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 119.658 -0.817 . . . . 2.2200000000000002 110.605 177.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 111' ' ' HIS . 37.4 t -62.75 -44.25 99.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.899 0.38 . . . . 0.48999999999999999 110.719 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.87 ' HE2' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -76.6 -6.88 53.85 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.099 0.476 . . . . 1.9099999999999999 110.391 176.173 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.1 tp -91.09 -15.89 28.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.339 0.59 . . . . 1.28 109.831 172.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 50.0 mt-10 -81.42 2.07 30.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.635 -0.711 . . . . 1.99 110.761 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.79 5.75 33.25 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.281 -0.962 . . . . 1.01 113.076 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.627 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -141.13 137.29 32.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.304 0.573 . . . . 0.87 111.161 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.54 163.93 25.88 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.216 -0.902 . . . . 2.75 111.421 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.536 HD22 HD22 ' A' ' 112' ' ' LEU . 39.4 mt -73.36 144.9 84.71 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.908 -0.587 . . . . 2.7000000000000002 110.823 -178.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.587 ' HG2' ' H ' ' A' ' 125' ' ' ASP . 46.9 Cg_endo -82.56 -1.07 10.45 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.216 2.611 . . . . 1.1000000000000001 113.497 -172.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.54 19.4 11.21 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.744 0.783 . . . . 1.3400000000000001 109.954 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.587 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 32.2 t70 -117.31 150.53 38.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.687 -1.142 . . . . 2.3599999999999999 109.207 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 2.3 tm? -124.37 103.14 32.61 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 109.216 -0.661 . . . . 1.8300000000000001 109.216 -177.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 4.8 Cg_exo -77.55 147.92 25.65 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.97 2.447 . . . . 1.0 112.66 -176.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.483 ' HA ' HG13 ' A' ' 131' ' ' VAL . 50.9 Cg_exo -53.45 -35.52 76.2 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.258 2.639 . . . . 1.3400000000000001 112.848 177.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.535 ' O ' HD12 ' A' ' 130' ' ' LEU . 49.9 p-80 -82.27 18.48 1.41 Allowed 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 120.62 -0.432 . . . . 1.48 110.996 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.609 ' HG ' ' CE2' ' A' ' 44' ' ' TRP . 2.9 mp -138.7 16.41 2.7 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.475 0.485 . . . . 1.29 110.888 172.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.483 HG13 ' HA ' ' A' ' 128' ' ' PRO . 32.4 m -77.66 116.52 58.87 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 120.133 -0.627 . . . . 1.72 110.211 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.625 ' HG2' ' HG3' ' A' ' 135' ' ' LYS . 37.2 Cg_endo -67.59 116.75 4.41 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.099 1.866 . . . . 1.04 111.611 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.4 -24.06 20.52 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 123.033 2.488 . . . . 1.4399999999999999 112.695 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.6 t -56.49 -33.5 66.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.409 -0.36 . . . . 2.2999999999999998 111.027 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.682 ' HD3' ' HD2' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -100.48 4.51 43.72 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.372 0.606 . . . . 3.4199999999999999 110.632 178.257 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.682 ' HD2' ' HD3' ' A' ' 135' ' ' LYS . 10.0 mmm180 -94.96 69.49 3.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.189 -0.459 . . . . 4.7199999999999998 110.523 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.446 ' NH1' ' HA ' ' A' ' 135' ' ' LYS . 0.5 OUTLIER -83.1 101.92 11.48 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.857 -0.61 . . . . 5.0099999999999998 110.527 177.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -98.95 95.57 7.25 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.703 -0.851 . . . . 6.3899999999999997 108.703 172.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.694 -0.669 . . . . 6.9100000000000001 110.039 178.162 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.68 'CA ' ' OD2' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.931 0 N-CA-C 111.734 -0.546 . . . . 42.189999999999998 111.734 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.62 112.78 3.15 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.646 2.231 . . . . 41.840000000000003 111.339 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.68 109.17 17.81 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.932 -0.396 . . . . 43.409999999999997 109.932 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.3 4.67 64.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.152 -0.547 . . . . 41.270000000000003 112.059 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.6 m -74.93 130.59 39.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.123 0.487 . . . . 40.149999999999999 110.963 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.06 116.72 9.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.337 -0.847 . . . . 38.670000000000002 110.953 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.0 m -75.92 107.09 7.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.918 -0.583 . . . . 37.240000000000002 109.909 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.8 tp -85.18 135.68 33.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.007 -0.542 . . . . 36.32 110.529 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.438 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 64.9 mtm -101.22 119.7 57.08 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.99 -0.55 . . . . 35.030000000000001 110.121 177.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 9' ' ' MET . 11.9 Cg_endo -56.19 111.12 0.68 Allowed 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.613 2.208 . . . . 34.310000000000002 111.513 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.8 m -84.38 88.76 7.28 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.228 0.537 . . . . 33.799999999999997 110.658 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -90.82 98.14 11.6 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.301 -0.629 . . . . 34.579999999999998 109.301 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.0 m -90.53 126.92 43.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.108 -0.496 . . . . 33.82 111.427 -176.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.3 t -81.32 95.28 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.47 -0.937 . . . . 35.100000000000001 108.47 173.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -108.53 143.09 38.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.021 -0.99 . . . . 35.140000000000001 110.66 -171.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.96 130.09 27.32 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.337 -1.105 . . . . 36.609999999999999 110.337 174.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.06 30.57 12.43 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.224 -0.989 . . . . 36.640000000000001 111.027 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.74 123.63 18.92 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.857 0.36 . . . . 35.420000000000002 110.659 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -88.33 129.35 35.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.969 -0.56 . . . . 35.770000000000003 110.263 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -72.96 116.37 13.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.121 -0.491 . . . . 33.670000000000002 111.137 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.96 67.68 0.27 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.756 -0.735 . . . . 33.350000000000001 111.365 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.1 t -84.58 152.99 23.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.84 0.353 . . . . 32.890000000000001 110.917 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.69 138.88 45.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 33.5 109.765 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -102.41 141.25 35.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.452 -0.34 . . . . 33.880000000000003 110.326 -174.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.712 ' N ' ' HD3' ' A' ' 26' ' ' PRO . . . 115.37 3.8 20.63 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-O 118.028 -1.429 . . . . 33.450000000000003 115.894 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.712 ' HD3' ' N ' ' A' ' 25' ' ' GLY . 2.7 Cg_endo -82.33 -19.14 6.77 Favored 'Trans proline' 0 C--N 1.372 1.795 0 CA-C-N 122.355 3.077 . . . . 32.82 112.403 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -127.25 153.69 45.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.658 -0.497 . . . . 34.289999999999999 109.658 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.57 115.89 7.41 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.808 -0.711 . . . . 31.66 111.886 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -130.9 152.92 49.7 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.848 -0.427 . . . . 31.329999999999998 109.848 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.43 -172.59 2.18 Favored Glycine 0 CA--C 1.521 0.429 0 O-C-N 123.841 0.713 . . . . 28.859999999999999 112.668 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -59.56 167.36 2.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.707 0.289 . . . . 27.66 111.198 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.42 107.61 1.06 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.073 -0.512 . . . . 24.739999999999998 112.353 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 33' ' ' GLU . 6.2 pt-20 -81.1 117.18 21.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.021 0.439 . . . . 22.32 110.582 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.21 126.26 7.75 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.633 -0.712 . . . . 19.489999999999998 112.3 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.69 162.27 14.01 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.01 -0.367 . . . . 17.420000000000002 110.01 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -110.93 116.37 4.26 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.935 -0.65 . . . . 14.76 111.726 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -81.42 179.7 7.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.495 0.188 . . . . 13.02 110.6 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.53 71.76 2.88 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.302 -0.952 . . . . 10.279999999999999 112.732 -172.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.4 HG13 ' H ' ' A' ' 39' ' ' ILE . 1.6 pp -71.18 155.92 7.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 108.414 -0.958 . . . . 9.1199999999999992 108.414 168.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -75.24 73.41 2.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.931 0.872 . . . . 6.5199999999999996 111.312 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -110.72 81.57 1.45 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.226 -1.398 . . . . 6.3099999999999996 107.226 170.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.97 110.35 28.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.176 0.513 . . . . 3.3300000000000001 111.975 -169.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -140.59 103.02 4.45 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.217 -1.031 . . . . 3.9399999999999999 108.217 167.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.655 ' CE2' ' HG ' ' A' ' 130' ' ' LEU . 9.1 t90 -86.71 133.48 33.67 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.724 0.773 . . . . 1.3300000000000001 109.837 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.465 ' H ' ' HD1' ' A' ' 44' ' ' TRP . 12.4 t -69.35 -6.17 5.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.596 -1.184 . . . . 1.21 111.408 -177.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 4.1 t -83.6 -27.66 7.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 121.771 -0.581 . . . . 0.66000000000000003 111.717 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.43 -19.47 53.39 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 119.564 -1.303 . . . . 0.71999999999999997 112.053 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 3.7 ptpp? -101.63 -28.6 12.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 112.336 0.495 . . . . 2.9700000000000002 112.336 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -106.55 5.81 29.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.716 0.77 . . . . 1.8300000000000001 110.36 -172.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.575 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 62.0 tttm -59.34 -46.69 99.02 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.17 -0.923 . . . . 1.1299999999999999 112.222 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 18.2 Cg_endo -60.02 -23.48 73.23 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.905 1.737 . . . . 0.56000000000000005 112.397 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.758 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 81.8 m -78.23 -36.48 47.02 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.433 0.635 . . . . 0.59999999999999998 110.023 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.46 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 16.1 m-85 -80.55 -25.34 38.67 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.344 -0.942 . . . . 0.93999999999999995 109.917 177.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 57' ' ' PHE . 4.4 t70 -76.45 -34.94 58.71 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.096 -0.956 . . . . 1.1599999999999999 110.154 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.758 ' HG2' ' O ' ' A' ' 52' ' ' THR . 12.7 pt-20 -65.3 -42.28 93.21 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.53 -0.544 . . . . 1.6299999999999999 109.53 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 52' ' ' THR . 60.0 mt -67.38 -32.72 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 109.621 -0.511 . . . . 0.60999999999999999 109.621 175.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.55 ' HB3' ' O ' ' A' ' 54' ' ' ASP . 66.8 t80 -57.06 -55.27 36.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.192 -0.913 . . . . 0.88 111.755 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.482 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 67.7 m-85 -69.23 -23.1 63.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.989 0.423 . . . . 1.03 110.61 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.0 m -70.41 -21.69 62.81 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.614 -0.721 . . . . 0.44 110.771 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.416 HD11 ' CG ' ' A' ' 75' ' ' GLU . 35.0 mt -88.7 -1.05 57.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.664 -0.244 . . . . 0.79000000000000004 111.301 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.2 t 65.55 81.12 0.22 Allowed Pre-proline 0 N--CA 1.465 0.315 0 O-C-N 123.594 0.559 . . . . 0.64000000000000001 111.218 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 62.9 Cg_endo -80.22 166.56 20.43 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.346 2.031 . . . . 0.46000000000000002 111.517 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' A' ' 64' ' ' ASN . 2.2 m -135.57 118.66 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 121.211 -0.196 . . . . 1.3300000000000001 110.62 -177.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.588 ' HB3' ' HZ3' ' A' ' 66' ' ' LYS . 8.3 t30 67.95 21.66 8.84 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 122.242 1.02 . . . . 1.6699999999999999 109.901 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.34 26.19 16.57 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.592 -0.813 . . . . 0.5 114.418 172.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.588 ' HZ3' ' HB3' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -166.21 157.28 13.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.488 0.644 . . . . 1.8200000000000001 110.075 174.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.415 HD13 ' CD2' ' A' ' 106' ' ' PHE . 1.8 pt -91.58 128.92 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 120.622 -0.431 . . . . 0.40999999999999998 110.564 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -71.79 82.6 0.89 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.899 -0.592 . . . . 0.69999999999999996 111.485 179.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.589 ' H ' ' HA ' ' A' ' 100' ' ' LEU . . . 44.28 -76.58 0.0 OUTLIER Glycine 0 C--O 1.226 -0.347 0 CA-C-N 113.844 -1.525 . . . . 0.38 116.201 167.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' THR . . . -46.6 -29.01 1.63 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.043 0.757 . . . . 0.44 113.043 -176.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -71.72 -42.65 67.07 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.148 0.499 . . . . 2.1099999999999999 110.101 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.486 ' CB ' HD12 ' A' ' 101' ' ' LEU . . . -72.0 -33.89 68.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.48 0.657 . . . . 0.41999999999999998 109.993 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.661 ' O ' HG23 ' A' ' 77' ' ' VAL . 29.6 mmmt -64.32 -38.95 92.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.363 -0.835 . . . . 1.6899999999999999 109.576 174.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.404 ' HB2' ' HE3' ' A' ' 74' ' ' LYS . 1.0 OUTLIER -54.84 -47.18 74.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.506 -0.77 . . . . 1.3500000000000001 109.992 175.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.68 ' HA ' ' CD ' ' A' ' 78' ' ' LYS . 8.7 mm-40 -60.7 -48.67 80.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.371 -1.286 . . . . 1.48 111.919 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.475 ' SD ' ' HD2' ' A' ' 73' ' ' LYS . 17.6 ptp -70.34 -15.53 62.88 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.739 -0.384 . . . . 0.65000000000000002 111.125 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 73' ' ' LYS . 54.0 t -75.41 -50.25 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.749 0.309 . . . . 0.58999999999999997 110.56 171.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.68 ' CD ' ' HA ' ' A' ' 75' ' ' GLU . 8.7 ptmt -68.72 -11.83 60.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.089 0.471 . . . . 1.2 110.453 -177.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.3 t -69.24 -8.1 42.83 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.845 -0.616 . . . . 1.3700000000000001 110.409 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 47.5 mttp 65.98 68.58 0.46 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.552 -0.749 . . . . 2.6499999999999999 110.431 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.691 ' HB2' HD12 ' A' ' 86' ' ' LEU . 27.7 mt -130.09 158.93 72.57 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.426 -0.806 . . . . 1.1599999999999999 110.632 -175.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.546 ' HG2' HG23 ' A' ' 85' ' ' VAL . 61.5 Cg_endo -75.5 164.35 32.6 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.322 2.015 . . . . 0.94999999999999996 110.796 168.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -63.95 -25.91 68.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.897 0.38 . . . . 1.53 111.326 -177.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -53.99 48.54 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.232 0.539 . . . . 1.24 110.527 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.546 HG23 ' HG2' ' A' ' 82' ' ' PRO . 85.1 t -63.75 -46.21 95.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.506 -0.77 . . . . 0.71999999999999997 110.382 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.691 HD12 ' HB2' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -53.87 -53.0 58.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.016 0.436 . . . . 1.45 111.766 177.057 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.84 -35.03 89.44 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.7 -0.682 . . . . 0.39000000000000001 112.539 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.861 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 53.6 pttt -89.32 -21.0 23.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.703 -0.799 . . . . 1.6599999999999999 111.009 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.2 mt -69.4 -43.52 80.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.299 -0.63 . . . . 1.1499999999999999 109.299 170.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.47 ' CE3' ' HD3' ' A' ' 73' ' ' LYS . 76.6 t-105 -58.6 -54.98 40.93 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.214 -0.448 . . . . 0.29999999999999999 110.882 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.861 ' HG2' ' HA ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -71.46 -15.6 62.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.879 -0.6 . . . . 2.54 112.031 -173.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.409 HD23 HD23 ' A' ' 122' ' ' LEU . 13.4 tp -94.24 -24.93 17.27 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.929 -0.308 . . . . 0.85999999999999999 110.26 176.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.884 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -80.34 -42.66 22.53 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.096 0.474 . . . . 0.45000000000000001 110.614 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.519 ' HB2' HD21 ' A' ' 101' ' ' LEU . 48.3 t0 -100.99 114.54 28.56 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.458 -0.571 . . . . 0.62 109.458 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.2 t -74.68 -23.04 17.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.189 -0.914 . . . . 1.76 111.554 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.1 OUTLIER -103.85 -25.4 13.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.985 0.421 . . . . 1.7 110.192 -175.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.507 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 57.8 mttt 60.92 71.71 0.55 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.129 -0.941 . . . . 1.74 110.87 169.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.622 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 1.9 p30 -101.66 -22.27 14.48 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.384 -1.28 . . . . 1.51 111.749 -171.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.41 9.81 28.53 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.71 -0.757 . . . . 0.28999999999999998 112.392 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.589 ' HA ' ' H ' ' A' ' 69' ' ' GLY . 3.7 pp -148.26 178.61 8.42 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.252 0.621 . . . . 0.54000000000000004 109.521 176.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.519 HD21 ' HB2' ' A' ' 94' ' ' ASP . 87.2 mt -146.96 122.55 10.46 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.25 -0.648 . . . . 0.68000000000000005 109.25 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -74.16 -173.96 1.8 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.866 -0.521 . . . . 1.5 110.317 176.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -59.83 -34.05 72.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.98 0.419 . . . . 1.73 111.404 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 26.3 tt0 -86.3 -33.87 20.51 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.918 0.39 . . . . 2.1400000000000001 110.755 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.626 ' OE2' 'CA ' ' A' ' 141' ' ' ' CA' . 2.4 mt-10 -62.2 -39.2 91.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.298 -0.41 . . . . 1.1100000000000001 110.496 174.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.582 ' HD1' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -62.88 -43.61 98.33 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.193 -1.04 . . . . 1.0700000000000001 108.193 173.197 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 104' ' ' GLU . . . -50.75 -47.44 59.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.683 -0.69 . . . . 0.19 110.986 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.884 HD22 ' HA ' ' A' ' 93' ' ' ALA . 2.5 tt -66.82 -50.77 61.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.021 -0.363 . . . . 1.23 110.021 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.81 -57.21 7.82 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.796 0.665 . . . . 0.22 112.796 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.425 ' HB3' ' CD1' ' A' ' 53' ' ' TYR . 0.2 OUTLIER -66.72 -29.04 68.92 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.286 0.565 . . . . 1.1799999999999999 109.485 -176.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.556 ' O ' HG23 ' A' ' 115' ' ' VAL . 64.5 t60 -68.1 -42.9 79.62 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.992 -0.549 . . . . 0.48999999999999999 109.886 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.7 ' HB3' HD21 ' A' ' 122' ' ' LEU . 34.5 mt -64.03 -34.68 78.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.064 -0.516 . . . . 0.55000000000000004 110.589 176.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 110' ' ' ASN . 95.2 mt -61.41 -48.6 88.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.921 -0.581 . . . . 0.81000000000000005 110.495 174.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.539 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 17.6 ptpt -72.48 -21.29 61.23 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 119.651 -0.819 . . . . 2.2200000000000002 111.007 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 111' ' ' HIS . 15.4 t -60.57 -47.97 90.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.595 0.236 . . . . 0.48999999999999999 110.452 171.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 5.7 ptmm? -84.98 -1.21 56.51 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.259 -0.576 . . . . 1.9099999999999999 110.379 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.523 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 38.2 tp -85.89 -19.79 30.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.473 -0.785 . . . . 1.28 108.963 172.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.539 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 43.0 mt-10 -67.87 -16.52 64.13 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 115.558 -0.746 . . . . 1.99 109.529 173.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.57 -20.21 13.77 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.65 -0.704 . . . . 1.01 112.175 174.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.673 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 1.9 p80 -99.13 138.91 35.55 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.822 -0.436 . . . . 0.87 109.822 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -73.37 164.0 27.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.242 0.544 . . . . 2.75 111.335 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 112' ' ' LEU . 4.5 mp -73.23 141.7 81.16 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.448 -0.796 . . . . 2.7000000000000002 110.391 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -88.66 -0.01 6.5 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.344 2.696 . . . . 1.1000000000000001 113.52 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 60.89 27.84 17.65 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.463 0.649 . . . . 1.3400000000000001 110.857 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -130.15 126.48 37.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.5 -0.773 . . . . 2.3599999999999999 109.148 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 126' ' ' LEU . 1.1 tm? -103.35 103.2 33.81 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.227 -0.657 . . . . 1.8300000000000001 109.227 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 7.8 Cg_endo -87.36 164.42 8.2 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.449 2.766 . . . . 1.0 112.669 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.445 ' O ' HG12 ' A' ' 131' ' ' VAL . 12.2 Cg_endo -56.03 -26.44 59.27 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.444 2.763 . . . . 1.3400000000000001 113.446 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.569 ' O ' HD12 ' A' ' 130' ' ' LEU . 7.3 p-80 -86.55 23.41 1.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.517 -0.473 . . . . 1.48 111.271 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.655 ' HG ' ' CE2' ' A' ' 44' ' ' TRP . 0.3 OUTLIER -149.61 14.68 0.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.955 0.159 . . . . 1.29 111.107 175.386 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 128' ' ' PRO . 7.4 p -82.72 111.31 28.28 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.25 0.548 . . . . 1.72 111.025 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.61 ' HG2' ' HG3' ' A' ' 135' ' ' LYS . 22.6 Cg_endo -63.44 120.9 8.49 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.724 2.283 . . . . 1.04 113.373 -177.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.4 ' HD2' ' OE1' ' A' ' 104' ' ' GLU . 31.6 Cg_exo -61.57 0.24 1.17 Allowed 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.082 2.522 . . . . 1.4399999999999999 112.54 170.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 27.4 t -79.35 -33.91 42.61 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.679 -0.237 . . . . 2.2999999999999998 111.354 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.61 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -87.45 1.51 53.24 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.919 0.711 . . . . 3.4199999999999999 112.919 -171.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.427 ' HG3' ' H ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -79.45 69.22 5.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.428 0.632 . . . . 4.7199999999999998 111.292 179.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 137' ' ' ARG . 11.2 ptm85 -133.76 107.77 8.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.435 0.636 . . . . 5.0099999999999998 110.145 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -106.87 140.02 40.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.634 -0.712 . . . . 6.3899999999999997 110.923 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 . . . . . 0 C--O 1.244 0.774 0 CA-C-O 118.192 -0.909 . . . . 6.9100000000000001 109.109 174.096 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.626 'CA ' ' OE2' ' A' ' 105' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_